data_1o8r_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1o8r _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.1 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.193 0.521 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.538 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 10.9 t -126.83 163.32 23.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.236 -0.915 . . . . 0.0 110.66 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.578 ' CG2' ' CD2' ' A' ' 12' ' ' LEU . 45.6 t -82.78 122.44 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.499 -0.75 . . . . 0.0 109.524 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 50.3 tt0 -112.32 121.35 44.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.93 . . . . 0.0 110.822 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.524 ' OD2' ' CD2' ' A' ' 73' ' ' LEU . 93.3 m-20 -98.79 11.51 38.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.426 -0.796 . . . . 0.0 109.657 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.406 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 179.92 -138.36 3.37 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -88.83 14.35 10.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 110.176 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.4 m-85 -123.79 131.01 53.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.229 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.538 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 29.6 m -81.63 123.24 28.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.897 . . . . 0.0 110.085 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 22.9 m-85 -119.37 128.66 54.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.369 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.441 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 49.2 m -75.51 172.7 12.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.578 ' CD2' ' CG2' ' A' ' 3' ' ' VAL . 88.5 mt -106.47 -3.19 21.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 110.837 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.01 -73.91 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 110.321 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 m -47.83 -43.8 28.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 110.51 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.48 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 18.4 t -61.21 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.03 -1.043 . . . . 0.0 109.809 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HD2' ' HB2' ' A' ' 33' ' ' ARG . 19.3 tttt -55.23 -53.97 49.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 53.3 mttp -80.2 8.85 6.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.557 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 16.6 tp -60.9 -44.98 96.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 110.686 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.468 ' NZ ' ' HA ' ' A' ' 39' ' ' PRO . 57.5 mttt -66.82 -34.01 76.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.351 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -128.99 79.98 1.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.979 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 52' ' ' ASN . 9.0 tt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.11 -0.994 . . . . 0.0 110.392 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 13.5 ptt180 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.294 0.569 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.402 ' OD1' ' C ' ' A' ' 34' ' ' ASN . 30.3 p-10 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.481 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 3.1 Cg_exo . . . . . 0 N--CA 1.482 0.819 0 N-CA-C 110.677 -0.547 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.58 37.12 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.467 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 2.8 tt0 -138.77 64.41 35.63 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.178 -1.189 . . . . 0.0 110.23 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.499 ' CB ' ' HG3' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -61.71 102.27 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.847 1.446 . . . . 0.0 110.721 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.461 HG23 ' OG ' ' A' ' 49' ' ' SER . 14.6 p -134.52 127.87 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 110.083 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 43' ' ' VAL . 32.5 t . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.475 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.567 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.8 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.148 0.499 . . . . 0.0 109.755 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.461 ' OG ' HG23 ' A' ' 43' ' ' VAL . 22.7 t -59.9 -50.78 72.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.568 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 7.1 m120 -79.69 117.89 69.6 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 110.397 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.13 -10.93 13.99 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.762 1.401 . . . . 0.0 110.445 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.512 ' HB2' HD23 ' A' ' 21' ' ' LEU . 91.3 m-20 -138.32 42.3 2.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.85 . . . . 0.0 109.513 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.693 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -80.1 -177.24 0.87 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.552 -0.718 . . . . 0.0 109.568 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.693 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.5 Cg_exo -58.03 72.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.674 1.355 . . . . 0.0 109.667 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.627 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 23.1 pt-20 -40.1 -36.9 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.498 -0.751 . . . . 0.0 110.3 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' N ' ' CG ' ' A' ' 55' ' ' GLU . 96.3 mt-10 -54.12 -17.51 2.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 109.307 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' A' ' 54' ' ' PRO . 8.9 mp -97.9 8.55 44.55 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.736 0.779 . . . . 0.0 109.7 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.728 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -39.81 -52.04 5.2 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.716 -0.615 . . . . 0.0 110.72 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.728 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.97 -42.63 65.14 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.466 1.245 . . . . 0.0 110.051 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.6 mt -57.75 -41.35 81.76 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.031 -1.043 . . . . 0.0 109.879 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 15.7 m -69.19 -28.1 66.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.091 -1.005 . . . . 0.0 110.221 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 14.2 ttpt -88.28 6.51 36.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 2.4 pt-20 -111.39 144.14 29.91 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.986 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.64 -23.61 72.1 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.834 1.439 . . . . 0.0 111.103 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.504 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 80.1 m-20 -83.31 -4.88 58.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 0.0 110.717 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -51.48 -39.56 57.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.011 -1.056 . . . . 0.0 110.066 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.499 ' HG3' ' CB ' ' A' ' 42' ' ' PRO . 30.6 tt0 -54.12 -44.05 70.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 109.918 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -79.93 -35.31 37.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.532 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 93.9 mt -67.78 -52.83 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.947 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.499 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.3 tm? -43.33 -58.42 2.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.43 -0.794 . . . . 0.0 110.019 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 25.9 mt-30 -51.75 -54.94 22.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.033 -1.042 . . . . 0.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.6 ttm-85 -49.61 -56.24 10.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.445 -0.784 . . . . 0.0 109.788 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.524 ' CD2' ' OD2' ' A' ' 5' ' ' ASP . 57.2 mt -48.32 -46.83 36.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.89 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 74.9 mm-40 -55.53 -45.32 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 110.147 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.0 -54.55 40.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 110.38 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.458 HG21 HD12 ' A' ' 12' ' ' LEU . 10.9 mt -60.21 -31.63 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 109.69 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 33' ' ' ARG . . . -64.1 -32.06 73.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.856 . . . . 0.0 109.292 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 79.7 tt0 -92.99 14.71 16.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.581 -0.7 . . . . 0.0 109.68 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 9.7 t70 -178.86 124.61 0.25 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.406 -0.808 . . . . 0.0 109.928 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.515 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -61.68 -62.52 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.657 1.346 . . . . 0.0 110.773 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.43 -139.28 18.74 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.56 ' O ' HG12 ' A' ' 85' ' ' ILE . 60.2 p -79.92 -22.07 43.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.172 . . . . 0.0 110.065 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 7.6 t -54.71 -53.72 51.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 110.001 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 85.2 tt0 -57.96 -31.28 66.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 110.929 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 82' ' ' THR . 5.2 pt -99.6 13.96 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.981 -1.075 . . . . 0.0 110.334 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 33.8 m 50.44 20.53 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 110.221 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.522 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -60.7 -12.2 9.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.913 . . . . 0.0 110.021 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.437 ' CG ' ' O ' ' A' ' 87' ' ' ALA . 50.0 m-85 -154.82 -176.63 6.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.205 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.3 1.93 12.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.883 . . . . 0.0 110.326 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.81 -36.08 71.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.588 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -112.57 129.08 56.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.201 -0.937 . . . . 0.0 110.609 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.448 HG22 ' CD ' ' A' ' 4' ' ' GLN . 25.3 p -107.19 157.21 18.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.168 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.09 0.08 56.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.334 -1.098 . . . . 0.0 110.275 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.443 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 3.0 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.314 0.578 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 57.5 m -121.97 146.53 47.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 110.536 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.513 HG22 ' CG ' ' A' ' 12' ' ' LEU . 56.0 t -86.11 119.67 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 109.527 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 49.7 tt0 -109.88 116.86 32.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 110.848 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.452 ' OD2' HG22 ' A' ' 69' ' ' ILE . 57.0 t0 -93.08 10.98 29.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.396 -0.815 . . . . 0.0 109.666 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 4' ' ' GLN . . . 179.77 -134.72 2.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -86.66 5.92 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -1.151 . . . . 0.0 110.162 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 71.0 m-85 -124.1 137.76 54.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.103 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 p -81.17 124.06 28.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.439 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 18.1 m-30 -113.91 125.62 54.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.344 -0.847 . . . . 0.0 110.399 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.2 p -73.91 168.02 20.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.236 -0.915 . . . . 0.0 110.076 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 5.0 mp -94.12 -20.85 19.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.235 -0.916 . . . . 0.0 110.539 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.506 ' HG3' ' NE ' ' A' ' 33' ' ' ARG . 88.6 tt0 -57.62 -67.38 0.34 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.306 -0.872 . . . . 0.0 110.781 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.563 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 9.3 m -41.77 -47.44 4.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.09 -1.006 . . . . 0.0 110.317 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.488 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 96.9 t -64.4 -50.25 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.081 -1.012 . . . . 0.0 109.704 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -55.17 -49.49 71.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 108.969 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.517 ' HE2' ' NH1' ' A' ' 33' ' ' ARG . 31.0 mttt -80.47 4.4 18.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.8 . . . . 0.0 109.987 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.555 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 11.0 tp -64.97 -37.11 86.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -0.942 . . . . 0.0 110.446 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -57.92 -37.43 74.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 29.2 p-10 -132.14 126.47 33.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.121 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 52' ' ' ASN . 11.0 mt . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.16 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.517 ' NH1' ' HE2' ' A' ' 17' ' ' LYS . 34.6 mtt-85 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.254 0.55 . . . . 0.0 110.378 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 55.4 t-20 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.256 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.459 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.1 Cg_exo . . . . . 0 N--CA 1.481 0.767 0 N-CA-C 110.579 -0.585 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.43 21.28 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.486 ' O ' HD13 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -134.55 88.66 28.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.087 -1.243 . . . . 0.0 109.972 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.32 140.39 91.64 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.953 1.502 . . . . 0.0 110.704 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.529 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 16.6 m -131.33 169.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 110.299 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 43' ' ' VAL . 6.3 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.461 -0.775 . . . . 0.0 110.634 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.465 0.65 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.507 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -98.6 -72.54 0.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.163 -0.96 . . . . 0.0 110.092 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.445 ' OD1' HD13 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -76.67 113.67 31.7 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.461 -0.775 . . . . 0.0 110.011 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.46 -11.09 18.29 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.668 1.352 . . . . 0.0 110.676 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.464 ' HB3' HD23 ' A' ' 21' ' ' LEU . 42.2 t30 -130.6 34.44 4.14 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.286 -0.884 . . . . 0.0 110.376 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.712 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.2 -175.45 0.6 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.172 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.712 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.5 Cg_exo -58.28 74.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.499 1.262 . . . . 0.0 109.843 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 53' ' ' PHE . 87.0 tt0 -42.05 -36.87 1.24 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.451 -0.781 . . . . 0.0 110.222 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.582 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.7 mt-10 -52.79 -18.42 1.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.041 -1.037 . . . . 0.0 108.934 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.638 ' CD1' ' HB2' ' A' ' 54' ' ' PRO . 9.3 mp -94.12 14.95 18.38 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.901 0.858 . . . . 0.0 109.028 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.725 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -40.19 -52.24 5.7 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.034 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.725 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.9 Cg_exo -52.97 -43.28 58.1 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.509 1.268 . . . . 0.0 110.094 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.598 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 86.4 mt -60.24 -37.88 81.72 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.03 -1.043 . . . . 0.0 109.95 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.47 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 2.9 t -69.03 -30.62 69.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.02 -1.05 . . . . 0.0 110.216 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 34.4 tttm -89.95 -1.35 57.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.154 -0.967 . . . . 0.0 109.551 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.512 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 2.9 mt-10 -90.63 138.28 26.72 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.523 -0.736 . . . . 0.0 110.038 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.71 -20.75 66.94 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.632 1.332 . . . . 0.0 110.039 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.97 -2.39 57.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.377 -0.827 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.598 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -46.01 -35.55 4.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.098 -1.001 . . . . 0.0 109.8 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.56 -45.54 88.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -80.25 -41.22 25.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 60' ' ' LEU . 83.5 mt -57.53 -45.59 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.167 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -45.77 -58.48 3.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.852 . . . . 0.0 110.248 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.579 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 84.7 mt-30 -48.7 -56.2 9.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 0.0 110.023 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -48.88 -52.8 22.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.896 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.48 HD12 HD22 ' A' ' 57' ' ' LEU . 33.8 mt -51.42 -49.96 60.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.992 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.513 ' HG3' HD23 ' A' ' 70' ' ' LEU . 86.8 mt-10 -51.89 -54.25 31.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.219 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -55.57 -55.94 26.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.922 . . . . 0.0 110.537 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 79' ' ' ASP . 38.0 mm -58.35 -41.41 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.117 -0.989 . . . . 0.0 109.922 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.456 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -52.6 -37.14 57.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.286 -0.884 . . . . 0.0 109.657 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.2 tt0 -63.3 -44.03 96.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.79 . . . . 0.0 110.13 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 76' ' ' ILE . 6.5 t70 -136.73 143.4 42.64 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.054 -1.029 . . . . 0.0 110.231 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.537 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -59.41 -48.15 14.46 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.74 1.39 . . . . 0.0 110.588 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.41 -137.66 19.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.593 ' O ' HG12 ' A' ' 85' ' ' ILE . 44.2 p -76.08 -24.47 55.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -1.177 . . . . 0.0 109.312 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 22.8 t -47.55 -54.74 10.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.446 -0.784 . . . . 0.0 110.266 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.537 ' HB2' ' CB ' ' A' ' 80' ' ' PRO . 85.0 tt0 -60.39 -36.63 78.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.402 -0.811 . . . . 0.0 111.625 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 82' ' ' THR . 9.5 pt -86.88 10.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.741 -1.225 . . . . 0.0 110.58 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 87.5 m 52.78 19.81 1.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.828 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.553 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -78.33 -4.67 49.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.068 -1.02 . . . . 0.0 109.774 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -146.43 165.81 28.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.45 -0.781 . . . . 0.0 110.143 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.98 3.91 7.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 110.398 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.83 72.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.96 . . . . 0.0 110.555 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -108.07 122.3 46.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.173 -0.954 . . . . 0.0 110.662 -179.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.418 HG22 ' CD ' ' A' ' 4' ' ' GLN . 14.8 p -105.67 150.09 25.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.363 -0.836 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 94' ' ' CYS . . . 100.16 -6.89 58.31 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 93' ' ' GLY . 22.0 m . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.352 -1.087 . . . . 0.0 110.32 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.246 0.546 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 25.8 m -122.18 145.06 48.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.903 . . . . 0.0 110.399 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.539 HG22 ' CG ' ' A' ' 12' ' ' LEU . 64.9 t -88.43 119.94 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.042 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.481 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 12.0 pt20 -115.31 140.41 49.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 110.762 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.484 ' OD2' HD12 ' A' ' 60' ' ' LEU . 51.0 p30 -110.31 13.93 22.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.549 -0.719 . . . . 0.0 109.862 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.07 -135.58 2.61 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -81.99 3.72 25.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -1.126 . . . . 0.0 110.128 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 81.0 m-85 -122.87 151.58 41.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.475 ' OG ' ' CG2' ' A' ' 2' ' ' THR . 3.7 t -104.19 135.06 46.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.697 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 24.6 m-85 -121.62 133.67 54.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.534 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.0 m -73.49 167.2 21.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -0.864 . . . . 0.0 110.36 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 5.3 mp -95.13 -15.95 22.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 110.508 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.2 mt-10 -65.74 -69.2 0.31 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.078 -1.013 . . . . 0.0 110.282 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' GLU . 5.6 m -40.76 -53.07 2.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 110.606 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.628 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.2 m -57.31 -45.07 85.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.045 -1.034 . . . . 0.0 109.442 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.417 ' N ' HG22 ' A' ' 15' ' ' VAL . 55.2 tttm -54.09 -57.56 10.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.0 109.006 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -80.3 12.6 2.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.376 -0.827 . . . . 0.0 109.979 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.628 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 4.9 tt -65.62 -36.86 84.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 110.52 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -56.39 -48.76 76.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -0.881 . . . . 0.0 110.695 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -134.0 155.65 49.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.118 -0.989 . . . . 0.0 110.388 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.5 ' CD2' ' HB2' ' A' ' 52' ' ' ASN . 7.8 mt . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 109.978 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 38.2 t-20 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 120.869 -1.144 . . . . 0.0 111.522 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.816 0 N-CA-C 110.61 -0.573 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.87 13.28 29.92 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.427 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 0.7 OUTLIER -133.55 66.74 74.56 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.307 -1.113 . . . . 0.0 110.163 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.459 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 3.0 Cg_exo -61.88 135.09 53.63 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.937 1.493 . . . . 0.0 110.708 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.538 ' CG2' ' OG ' ' A' ' 49' ' ' SER . 3.1 p 178.46 91.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.1 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.603 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 6.4 p . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 110.195 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 97.1 m . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.367 0.603 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.539 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 48.9 m -61.34 -59.23 5.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 110.916 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -80.12 113.16 36.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.425 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -61.42 -7.59 8.95 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.677 1.356 . . . . 0.0 110.391 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.5 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 90.8 m-20 -135.07 40.53 2.89 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.263 -0.898 . . . . 0.0 110.218 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.646 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -80.03 177.19 3.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.93 . . . . 0.0 108.929 179.245 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.646 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.7 Cg_exo -58.06 74.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.544 1.286 . . . . 0.0 109.215 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.629 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.5 tt0 -39.34 -29.58 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.773 -0.579 . . . . 0.0 110.293 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.579 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.4 mt-10 -51.71 -20.96 2.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.979 -1.076 . . . . 0.0 108.482 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.697 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 75.2 mt -87.17 10.02 18.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.597 -0.689 . . . . 0.0 109.58 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.738 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.89 -51.07 5.66 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 110.415 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.738 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.57 -42.98 63.25 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.561 1.295 . . . . 0.0 110.205 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.587 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 6.6 mp -58.18 -42.79 86.84 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.007 -1.058 . . . . 0.0 110.068 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.466 ' HA ' HG23 ' A' ' 44' ' ' VAL . 3.7 t -62.71 -27.49 69.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 110.158 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -90.36 -4.44 57.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 110.874 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.505 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 10.4 pt-20 -113.54 142.63 27.95 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 0.0 110.228 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.45 -14.33 41.68 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.87 1.458 . . . . 0.0 110.982 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.508 ' O ' HG13 ' A' ' 69' ' ' ILE . 68.6 m-20 -79.68 -17.4 53.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.181 -0.949 . . . . 0.0 110.603 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -52.01 -37.01 51.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.999 -1.063 . . . . 0.0 110.079 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -55.65 -44.08 76.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -80.34 -36.61 33.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.706 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.516 ' CG2' HD22 ' A' ' 73' ' ' LEU . 84.1 mt -66.78 -50.68 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 0.0 109.904 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.579 HD23 ' HG3' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -42.11 -62.99 0.81 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 0.0 110.343 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.55 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 54.0 mt-30 -48.09 -52.47 20.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.073 -1.017 . . . . 0.0 110.231 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -55.27 -54.52 42.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.516 HD22 ' CG2' ' A' ' 69' ' ' ILE . 3.6 mm? -47.69 -52.51 18.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 109.93 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.579 ' HG3' HD23 ' A' ' 70' ' ' LEU . 68.0 mt-10 -52.78 -50.17 64.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 109.902 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.515 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.0 tt0 -53.76 -54.83 32.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.967 . . . . 0.0 109.971 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 79' ' ' ASP . 39.0 mm -56.07 -35.33 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.127 -0.983 . . . . 0.0 109.233 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -57.81 -32.82 67.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.433 -0.792 . . . . 0.0 109.293 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.602 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 94.3 mt-10 -60.19 -42.84 95.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.424 -0.798 . . . . 0.0 109.86 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.467 ' OD1' ' HD2' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -147.14 153.62 45.26 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 110.172 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.526 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 3.2 Cg_exo -60.13 -51.96 4.86 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.952 1.501 . . . . 0.0 110.618 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.15 -139.51 20.52 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.559 ' O ' HG12 ' A' ' 85' ' ' ILE . 45.6 p -79.83 -19.76 47.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -1.144 . . . . 0.0 109.778 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 48.8 t -54.39 -53.81 49.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 110.155 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.526 ' HB2' ' CB ' ' A' ' 80' ' ' PRO . 83.7 tt0 -58.68 -30.34 67.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 111.22 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 82' ' ' THR . 12.0 pt -95.94 12.73 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.913 -1.117 . . . . 0.0 110.56 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 3.4 t 51.47 19.87 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.285 -0.884 . . . . 0.0 110.961 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.526 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -77.72 -9.0 58.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 109.751 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -138.45 164.65 28.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.472 -0.767 . . . . 0.0 109.877 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.92 2.09 11.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 110.176 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.84 -37.23 85.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.574 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -98.2 120.31 38.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.1 -1.0 . . . . 0.0 110.59 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.462 HG22 ' OE1' ' A' ' 4' ' ' GLN . 41.5 p -104.03 154.58 19.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.365 -0.834 . . . . 0.0 110.142 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.76 -11.37 68.19 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 110.274 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.201 0.524 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 43.2 m -126.12 152.02 46.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.445 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.568 HG22 ' CD2' ' A' ' 12' ' ' LEU . 92.4 t -88.69 113.98 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.393 -0.817 . . . . 0.0 109.836 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.445 ' HB3' HG22 ' A' ' 92' ' ' THR . 47.8 tt0 -108.95 118.07 35.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.133 -0.979 . . . . 0.0 110.525 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 55.0 p30 -99.09 6.45 46.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.704 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -174.15 -143.26 4.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -79.91 3.62 19.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -1.149 . . . . 0.0 110.49 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.435 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 79.4 m-85 -120.23 140.8 50.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.101 -0.999 . . . . 0.0 110.46 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.482 ' OG ' ' CG2' ' A' ' 2' ' ' THR . 21.8 t -86.59 127.13 34.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.976 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.639 ' CD2' HD22 ' A' ' 57' ' ' LEU . 22.0 m-30 -116.93 130.07 56.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.139 -0.976 . . . . 0.0 110.656 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.2 p -80.03 174.6 11.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.324 -0.86 . . . . 0.0 110.286 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.598 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 2.5 mm? -99.89 -7.88 24.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 110.817 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -68.56 -71.3 0.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.178 -0.951 . . . . 0.0 111.056 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.51 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 4.1 m -51.91 -50.6 60.75 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.096 -1.003 . . . . 0.0 111.229 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.556 ' CG2' ' HA ' ' A' ' 12' ' ' LEU . 17.3 m -55.99 -48.65 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.884 -1.135 . . . . 0.0 110.212 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.479 ' NZ ' ' HE2' ' A' ' 17' ' ' LYS . 19.3 ttpp -55.69 -52.75 62.79 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.846 -1.159 . . . . 0.0 108.669 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HE2' ' NZ ' ' A' ' 16' ' ' LYS . 71.1 mmtt -80.47 12.73 2.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.791 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.579 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 54.9 tp -61.39 -51.0 70.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 110.144 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -62.85 -33.96 76.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.914 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -130.9 100.42 5.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.847 . . . . 0.0 109.623 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.468 HD23 ' CB ' ' A' ' 52' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.836 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.422 ' HB3' ' HE2' ' A' ' 16' ' ' LYS . 63.1 mtt180 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.376 0.607 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 30.3 t30 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 110.094 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.834 0 N-CA-C 110.542 -0.599 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.05 9.16 34.93 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 82.42 54.48 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.283 -1.128 . . . . 0.0 110.053 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.466 ' HG3' ' HG3' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -61.58 137.7 70.82 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.934 1.492 . . . . 0.0 110.488 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.49 ' C ' ' CG1' ' A' ' 44' ' ' VAL . 16.2 m -117.44 49.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.179 -0.951 . . . . 0.0 110.278 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.557 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 2.4 m . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 110.159 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.585 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 98.3 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.538 0.685 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.574 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 15.5 t -51.82 -51.22 58.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.256 -0.903 . . . . 0.0 110.783 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 4.5 m120 -80.06 111.93 25.99 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.407 -0.808 . . . . 0.0 110.679 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.7 -13.41 36.63 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.636 1.335 . . . . 0.0 110.507 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.468 ' CB ' HD23 ' A' ' 21' ' ' LEU . 97.2 m-20 -123.88 29.67 6.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.525 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.722 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -80.3 177.5 2.92 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 109.161 179.251 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.722 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.4 Cg_exo -58.3 74.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.662 1.349 . . . . 0.0 108.929 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.637 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.1 tt0 -39.22 -27.77 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.634 -0.666 . . . . 0.0 110.182 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' PRO . 75.1 mm-40 -53.61 -17.2 1.98 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.03 -1.044 . . . . 0.0 108.592 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.639 HD22 ' CD2' ' A' ' 10' ' ' PHE . 92.7 mt -92.44 9.07 35.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.689 -0.632 . . . . 0.0 109.615 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.721 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -39.88 -50.67 5.69 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 110.278 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.721 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -55.76 -44.93 42.99 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.482 1.254 . . . . 0.0 110.124 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -54.11 -44.29 71.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 110.093 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.502 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . 82.5 m -64.4 -27.56 69.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.965 . . . . 0.0 110.139 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -91.87 4.88 51.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.893 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.498 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 3.7 mt-10 -112.9 137.02 21.69 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.355 -0.841 . . . . 0.0 110.179 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.99 -21.64 72.75 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.673 1.354 . . . . 0.0 109.884 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -79.93 -10.91 59.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.43 -0.794 . . . . 0.0 110.867 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.68 -36.03 10.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.956 -1.09 . . . . 0.0 109.877 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.466 ' HG3' ' HG3' ' A' ' 42' ' ' PRO . 50.2 tt0 -59.97 -42.61 94.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.343 -0.848 . . . . 0.0 110.029 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.16 -39.04 30.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 109.906 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.469 ' CG2' HD12 ' A' ' 60' ' ' LEU . 89.4 mt -63.51 -44.43 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.829 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.548 HD21 ' HG2' ' A' ' 74' ' ' GLU . 2.0 tm? -52.36 -54.31 33.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 0.0 110.209 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -47.94 -52.9 17.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.291 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' LEU . 97.4 mtt180 -58.43 -62.14 2.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.455 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 45.5 mt -44.93 -52.92 8.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.19 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.548 ' HG2' HD21 ' A' ' 70' ' ' LEU . 78.4 mm-40 -54.98 -47.59 74.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 110.78 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -56.72 -52.78 63.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.923 . . . . 0.0 110.771 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.508 ' CG2' HG23 ' A' ' 3' ' ' VAL . 24.2 mm -63.61 -36.14 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 0.0 109.924 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -58.92 -33.71 70.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.43 -0.794 . . . . 0.0 109.881 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.463 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 83.5 tt0 -61.13 -37.9 84.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.685 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -150.35 160.62 32.71 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.032 -1.043 . . . . 0.0 110.675 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -61.54 -62.11 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.051 1.553 . . . . 0.0 110.569 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.34 -141.83 28.37 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.554 ' O ' HG12 ' A' ' 85' ' ' ILE . 70.6 p -79.55 -22.16 44.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -1.154 . . . . 0.0 109.581 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.522 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 32.5 t -52.89 -51.63 60.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 109.991 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.5 tt0 -58.62 -33.77 70.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 0.0 111.179 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 82' ' ' THR . 5.2 pt -97.3 13.49 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.893 -1.129 . . . . 0.0 110.463 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.71 14.14 1.67 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.266 -0.896 . . . . 0.0 110.487 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.532 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -65.08 -15.11 62.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 109.963 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -139.69 168.41 19.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 0.0 110.267 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.98 3.07 8.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 110.301 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -63.08 -36.92 85.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.428 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -102.97 121.01 41.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 110.496 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 4' ' ' GLN . 18.9 p -111.54 166.32 11.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 110.227 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.97 -26.19 15.97 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.18 -1.188 . . . . 0.0 110.292 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.462 HG11 ' SG ' ' A' ' 91' ' ' CYS . 47.2 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.317 0.579 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 11' ' ' SER . 28.8 m -119.23 147.31 44.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.182 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.528 ' CG2' HD23 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -89.62 118.97 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 109.952 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.51 ' CB ' HG22 ' A' ' 92' ' ' THR . 65.6 tt0 -111.66 129.3 56.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 110.543 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.49 ' OD2' HG22 ' A' ' 69' ' ' ILE . 90.6 m-20 -93.26 -81.24 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.759 . . . . 0.0 110.016 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.12 -126.32 3.81 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -84.69 8.27 17.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -1.184 . . . . 0.0 110.335 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.3 m-85 -120.2 137.79 54.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.36 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.433 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 25.2 t -88.55 130.26 35.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 110.179 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.646 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 18.6 m-85 -119.2 126.84 52.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.816 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.449 ' HA ' HG22 ' A' ' 2' ' ' THR . 38.8 t -75.65 169.14 18.69 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -0.996 . . . . 0.0 110.072 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.559 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 64.2 mt -102.36 -2.15 29.48 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.126 -0.984 . . . . 0.0 110.905 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -74.21 -73.6 0.22 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.084 -1.01 . . . . 0.0 110.6 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.495 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.6 m -43.0 -42.27 3.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.862 . . . . 0.0 110.826 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 6.2 m -65.29 -45.31 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.858 -1.151 . . . . 0.0 109.663 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.419 ' H ' HG21 ' A' ' 15' ' ' VAL . 46.7 tttm -53.34 -46.98 69.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.821 -1.174 . . . . 0.0 108.93 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 45.8 tptt -80.23 -1.51 40.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.516 -0.74 . . . . 0.0 109.993 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.564 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 53.9 tp -66.55 -40.84 89.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.137 -0.977 . . . . 0.0 110.194 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -56.62 -45.63 81.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.283 -0.885 . . . . 0.0 110.072 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -116.99 70.2 0.77 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.538 ' CD1' ' OD1' ' A' ' 52' ' ' ASN . 19.2 tp . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 110.506 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.509 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 48.0 mtt180 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.33 0.586 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 33' ' ' ARG . 33.0 m120 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.166 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 3.3 Cg_exo . . . . . 0 N--CA 1.483 0.87 0 N-CA-C 110.793 -0.503 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.86 -78.75 1.43 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.99 153.56 35.86 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.287 -1.125 . . . . 0.0 110.257 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.45 ' HB2' ' HG3' ' A' ' 67' ' ' GLN . 3.0 Cg_endo -61.69 139.65 81.96 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.963 1.507 . . . . 0.0 110.614 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.448 ' O ' ' CG1' ' A' ' 43' ' ' VAL . 13.4 p -177.44 71.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.947 . . . . 0.0 110.261 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.511 ' CG2' ' HA ' ' A' ' 61' ' ' CYS . 2.8 p . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.864 . . . . 0.0 110.139 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.7 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.368 0.604 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.534 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.1 t -61.0 -44.82 96.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 4.2 m120 -80.35 112.11 28.12 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.343 -0.848 . . . . 0.0 110.304 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -59.54 -10.26 10.92 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.766 1.403 . . . . 0.0 110.7 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.538 ' OD1' ' CD1' ' A' ' 21' ' ' LEU . 45.7 p-10 -136.97 41.81 2.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 110.366 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.683 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.24 177.15 3.13 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 109.116 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.683 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -58.3 75.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.591 1.311 . . . . 0.0 109.143 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.647 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.3 tt0 -39.06 -29.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.782 -0.574 . . . . 0.0 110.149 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.3 mt-10 -52.04 -18.88 1.58 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.025 -1.047 . . . . 0.0 108.634 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.646 ' CD2' ' CG ' ' A' ' 10' ' ' PHE . 88.6 mt -90.8 9.67 29.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.487 -0.758 . . . . 0.0 109.649 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.721 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.3 tmtt? -39.71 -51.51 5.21 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.359 -0.838 . . . . 0.0 110.63 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.721 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.28 -43.58 57.32 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.459 1.242 . . . . 0.0 109.997 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.55 ' CD1' ' CD1' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -55.6 -40.7 72.4 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.11 -0.994 . . . . 0.0 110.039 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.511 ' HA ' ' CG2' ' A' ' 44' ' ' VAL . 82.4 m -58.03 -23.37 54.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.215 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.502 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 35.5 mtmt -113.46 37.05 3.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 109.579 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.502 ' OE1' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -133.12 141.83 42.25 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.849 . . . . 0.0 110.36 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.93 -26.28 74.26 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.746 1.393 . . . . 0.0 110.075 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.465 ' O ' HG13 ' A' ' 69' ' ' ILE . 72.1 m-20 -80.19 -18.65 49.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.906 . . . . 0.0 110.439 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -45.39 -47.33 13.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.328 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HG3' ' HB2' ' A' ' 42' ' ' PRO . 61.0 tt0 -54.25 -43.62 71.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.492 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.15 -33.03 38.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.879 . . . . 0.0 110.473 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.55 ' CD1' ' CD1' ' A' ' 60' ' ' LEU . 94.5 mt -63.41 -44.88 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 0.0 110.357 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 70' ' ' LEU . 1.6 tm? -43.43 -66.93 0.32 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.439 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.467 ' HA ' ' HB3' ' A' ' 39' ' ' PRO . 97.7 mt-30 -47.31 -54.87 9.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.114 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -50.46 -58.88 4.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 110.094 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.488 ' HG ' HG21 ' A' ' 69' ' ' ILE . 40.2 mt -45.16 -51.68 10.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.183 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 73.3 mm-40 -51.63 -58.01 7.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 110.301 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 85.0 tt0 -52.04 -56.6 13.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.933 . . . . 0.0 110.592 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.496 HG23 HD23 ' A' ' 12' ' ' LEU . 22.4 mm -55.75 -38.42 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.152 -0.968 . . . . 0.0 109.888 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 74' ' ' GLU . . . -57.47 -32.54 67.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.595 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 81.8 tt0 -59.72 -43.25 94.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.423 -0.798 . . . . 0.0 110.136 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -147.22 157.31 45.98 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.214 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.511 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -61.55 -48.1 10.06 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.856 1.451 . . . . 0.0 110.6 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.23 -139.98 25.75 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.624 ' O ' HG12 ' A' ' 85' ' ' ILE . 32.1 p -84.06 -16.52 43.51 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -1.156 . . . . 0.0 109.954 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 41.1 t -57.46 -48.72 78.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.986 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.3 tt0 -61.97 -28.03 69.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 111.241 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 82' ' ' THR . 7.5 pt -97.54 7.26 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.863 -1.148 . . . . 0.0 110.304 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.0 m 61.33 15.86 6.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.0 110.614 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.514 ' HB2' ' CG1' ' A' ' 85' ' ' ILE . . . -67.2 -16.61 64.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -0.999 . . . . 0.0 109.853 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 87' ' ' ALA . 27.4 m-85 -138.81 166.65 23.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.922 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.7 2.29 10.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.314 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.29 -32.79 73.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.563 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -102.84 116.95 33.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.64 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.51 HG22 ' CB ' ' A' ' 4' ' ' GLN . 17.7 p -105.39 157.81 17.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 110.133 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.33 -26.0 24.75 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.326 -1.103 . . . . 0.0 110.289 179.938 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 94' ' ' CYS . 10.6 t . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.21 0.528 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 35.5 m -120.33 149.25 42.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 110.335 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.523 HG22 ' CD2' ' A' ' 12' ' ' LEU . 91.2 t -84.36 117.6 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.336 -0.853 . . . . 0.0 109.774 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.501 ' CB ' ' HA ' ' A' ' 9' ' ' SER . 19.4 pt20 -111.81 146.09 38.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.178 -0.951 . . . . 0.0 110.869 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -106.13 13.26 29.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 109.792 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.89 -126.96 1.38 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -84.87 5.88 27.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -1.213 . . . . 0.0 110.111 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 87.2 m-85 -124.86 138.58 54.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.24 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.501 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 78.4 p -96.86 137.94 35.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.217 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.599 ' CD1' HD22 ' A' ' 57' ' ' LEU . 24.6 m-85 -125.14 138.04 54.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.277 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.4 t -69.96 165.66 21.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.317 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.599 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 4.5 mp -97.67 -13.29 21.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.874 . . . . 0.0 110.328 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.434 ' OE2' ' HD3' ' A' ' 33' ' ' ARG . 70.9 mm-40 -68.66 -73.36 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.29 -0.881 . . . . 0.0 110.614 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 13' ' ' GLU . 4.0 m -42.49 -48.67 5.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.461 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.547 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 36.2 t -58.31 -45.24 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.946 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -56.95 -56.64 19.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.949 . . . . 0.0 109.086 179.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -80.61 11.81 3.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -0.811 . . . . 0.0 109.945 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 2.0 tt -62.06 -41.74 98.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -73.84 -64.52 0.99 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 110.108 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -58.06 -37.8 75.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.53 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 16.0 tp . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.302 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.508 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 76.3 mtt85 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.248 0.547 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.508 ' ND2' ' OD1' ' A' ' 79' ' ' ASP . 70.5 m-20 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 0.0 110.315 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.512 ' CA ' ' OE1' ' A' ' 74' ' ' GLU . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.86 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.82 -75.16 1.29 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -167.5 144.85 3.78 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.323 -1.104 . . . . 0.0 110.24 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.65 138.34 69.18 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.903 1.475 . . . . 0.0 110.517 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.586 ' HB ' ' CB ' ' A' ' 49' ' ' SER . 19.7 m -143.0 127.39 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 110.251 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 66' ' ' ALA . 69.4 t . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.994 . . . . 0.0 110.97 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 59.1 m . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.614 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 87.7 p -65.55 -42.23 92.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.021 . . . . 0.0 110.616 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 8.7 m120 -80.09 110.46 16.34 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.349 -0.845 . . . . 0.0 110.258 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -60.31 -17.86 49.29 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.734 1.386 . . . . 0.0 110.821 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.53 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 18.2 m120 -126.61 36.26 4.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 110.722 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.621 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -80.28 172.97 8.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.078 -1.014 . . . . 0.0 108.954 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.621 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.5 Cg_exo -58.03 75.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.507 1.267 . . . . 0.0 108.959 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.62 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.7 tt0 -39.4 -28.43 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.635 -0.666 . . . . 0.0 110.184 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt-10 -52.45 -17.04 1.04 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.053 -1.029 . . . . 0.0 108.65 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.599 HD22 ' CD1' ' A' ' 10' ' ' PHE . 62.2 mt -90.46 9.53 28.84 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.475 0.655 . . . . 0.0 109.583 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.734 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 12.9 mttt -39.87 -50.98 5.66 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 110.427 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.734 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.49 -42.62 66.39 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.596 1.314 . . . . 0.0 109.985 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.593 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 7.6 mp -57.92 -39.48 78.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.973 -1.079 . . . . 0.0 109.902 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.5 m -66.17 -28.86 69.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.128 -0.982 . . . . 0.0 110.474 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -89.6 5.96 43.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 111.145 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 10.0 pt-20 -121.97 148.75 52.25 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.947 -1.095 . . . . 0.0 110.305 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.8 Cg_endo -63.59 -20.34 69.18 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.988 1.52 . . . . 0.0 111.565 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.494 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 79.4 m-20 -80.03 -10.35 59.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.98 -1.075 . . . . 0.0 110.605 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.593 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.43 -45.43 25.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -0.93 . . . . 0.0 110.674 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -59.0 -42.55 90.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.903 . . . . 0.0 110.561 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -76.85 -31.91 57.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.093 -1.004 . . . . 0.0 110.152 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.545 ' CG2' HD22 ' A' ' 60' ' ' LEU . 99.8 mt -74.45 -46.03 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.923 . . . . 0.0 110.144 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.503 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 1.7 tm? -48.89 -59.3 3.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.882 . . . . 0.0 110.563 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -49.59 -52.93 26.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.059 -1.026 . . . . 0.0 110.096 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -51.41 -54.42 26.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 109.916 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.491 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 65.1 mt -51.26 -48.81 62.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.512 ' OE1' ' CA ' ' A' ' 39' ' ' PRO . 91.2 mt-10 -52.92 -48.4 67.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.062 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.29 -50.23 73.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.972 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.582 ' O ' ' O ' ' A' ' 79' ' ' ASP . 26.5 mm -62.97 -37.41 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.704 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.462 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . . . -56.38 -33.84 66.12 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.475 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.486 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 86.8 tt0 -62.61 -41.34 98.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.456 -0.777 . . . . 0.0 110.524 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -148.23 168.65 10.69 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.214 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.495 ' HD2' ' OD1' ' A' ' 79' ' ' ASP . 3.2 Cg_exo -58.59 -55.81 1.87 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.658 1.347 . . . . 0.0 110.495 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.587 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . 72.04 47.65 30.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.598 ' O ' HG12 ' A' ' 85' ' ' ILE . 1.2 p 72.45 -40.98 0.49 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.451 -1.029 . . . . 0.0 110.842 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 37.4 t -40.75 -47.46 2.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.941 -1.099 . . . . 0.0 109.907 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 86.4 tt0 -63.16 -42.75 99.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 111.006 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 82' ' ' THR . 2.5 pt -84.76 18.7 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.0 -1.063 . . . . 0.0 110.573 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 52.77 16.96 0.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 110.616 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.524 ' HB2' ' CG1' ' A' ' 85' ' ' ILE . . . -67.79 -22.4 65.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 109.758 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.581 ' CD1' ' CB ' ' A' ' 82' ' ' THR . 19.6 m-85 -131.91 170.26 15.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.762 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.42 0.1 34.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.104 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -59.12 -25.9 64.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 110.496 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -111.18 128.17 55.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.787 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.496 HG23 ' NE2' ' A' ' 4' ' ' GLN . 22.6 p -114.37 163.95 14.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 110.064 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.495 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 88.76 -24.13 13.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.534 ' O ' ' CG2' ' A' ' 1' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.331 -1.099 . . . . 0.0 110.497 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.441 ' HA ' ' SG ' ' A' ' 91' ' ' CYS . 92.2 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.222 0.534 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.451 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 60.1 m -126.15 149.21 49.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 110.568 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 10' ' ' PHE . 92.4 t -82.42 110.83 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.514 -0.741 . . . . 0.0 109.519 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.515 ' CB ' HG22 ' A' ' 92' ' ' THR . 35.3 tt0 -112.78 133.43 54.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 110.685 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -96.03 -71.68 0.66 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 109.421 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.0 -129.76 6.81 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -79.76 4.27 16.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -1.177 . . . . 0.0 110.655 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.485 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 99.2 m-85 -119.05 134.44 55.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.058 -1.026 . . . . 0.0 110.656 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.472 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 27.1 t -87.16 135.61 33.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.861 . . . . 0.0 109.97 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.527 ' CE1' HD21 ' A' ' 57' ' ' LEU . 69.6 m-85 -115.56 125.86 53.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 111.005 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.0 t -76.43 173.14 11.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.85 . . . . 0.0 109.796 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.606 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 4.5 mp -103.27 4.81 36.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.046 -1.034 . . . . 0.0 110.756 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.498 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 86.0 tt0 -71.89 -73.03 0.2 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.068 -1.02 . . . . 0.0 110.693 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.501 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 6.1 m -49.06 -45.72 43.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.081 -1.012 . . . . 0.0 110.684 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.568 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 24.2 t -58.38 -50.95 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.967 -1.083 . . . . 0.0 109.746 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 51.1 tttm -54.49 -54.45 40.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.779 -1.201 . . . . 0.0 108.656 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -80.47 14.46 2.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -0.756 . . . . 0.0 109.615 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 35.4 tp -61.44 -40.37 94.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -0.894 . . . . 0.0 110.198 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.468 ' HE3' ' HG3' ' A' ' 41' ' ' GLU . 28.4 mtpt -61.02 -44.68 97.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.004 . . . . 0.0 109.842 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -111.33 115.08 28.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.643 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.548 ' CG ' ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.006 . . . . 0.0 110.715 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 12' ' ' LEU . 82.3 mtt85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.232 0.539 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 33.2 p-10 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 110.245 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.482 0.812 0 N-CA-C 110.489 -0.62 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.46 18.88 0.7 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.468 ' HG3' ' HE3' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -125.52 74.96 69.49 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.283 -1.128 . . . . 0.0 110.2 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.65 146.81 96.51 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.885 1.466 . . . . 0.0 110.462 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.481 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 11.0 m -123.12 172.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 110.383 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 43' ' ' VAL . 2.9 t . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.452 -0.78 . . . . 0.0 111.015 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.2 m . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.396 0.617 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.588 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.3 t -68.78 -64.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 110.668 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.495 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 1.3 m120 -79.51 111.8 23.76 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.382 -0.824 . . . . 0.0 110.464 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -63.95 -9.02 17.51 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.694 1.365 . . . . 0.0 110.358 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.548 ' HB3' ' CG ' ' A' ' 21' ' ' LEU . 50.3 t-20 -131.1 30.98 4.49 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.289 -0.882 . . . . 0.0 110.178 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.726 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -77.15 -175.6 0.53 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 108.836 179.275 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.726 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.7 Cg_exo -59.02 73.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.536 1.282 . . . . 0.0 109.067 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.3 tt0 -39.43 -32.04 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.688 -0.633 . . . . 0.0 110.562 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.438 ' O ' ' HE1' ' A' ' 10' ' ' PHE . 46.5 tp10 -52.28 -25.3 9.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.957 -1.089 . . . . 0.0 108.625 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.62 ' CD1' ' HG2' ' A' ' 54' ' ' PRO . 89.2 mt -83.82 12.76 5.57 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.383 0.611 . . . . 0.0 109.814 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.709 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.58 -51.63 4.96 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.93 . . . . 0.0 110.532 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.94 -45.09 41.23 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.551 1.29 . . . . 0.0 110.184 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.605 ' CD1' ' CD1' ' A' ' 69' ' ' ILE . 2.8 mm? -53.81 -44.0 69.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.023 -1.048 . . . . 0.0 110.148 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.445 ' HA ' HG23 ' A' ' 44' ' ' VAL . 2.3 t -68.76 -29.1 67.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 0.0 110.312 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -79.95 3.29 20.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.622 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.533 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 9.7 pt-20 -126.39 141.65 40.59 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 110.155 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.16 -11.18 17.71 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.903 1.475 . . . . 0.0 110.667 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -79.88 -15.63 56.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.123 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -48.54 -36.41 15.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.34 -41.12 98.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 110.093 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -80.45 -40.91 25.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 109.84 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.605 ' CD1' ' CD1' ' A' ' 60' ' ' LEU . 84.6 mt -64.39 -41.29 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.037 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.535 HD23 ' HG2' ' A' ' 74' ' ' GLU . 1.2 tm? -53.02 -55.19 25.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 110.396 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.523 ' N ' HD11 ' A' ' 70' ' ' LEU . 94.7 mt-30 -50.46 -55.37 16.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 0.0 110.186 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -52.57 -57.0 11.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.055 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 35.4 mt -46.82 -49.66 19.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 110.083 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.535 ' HG2' HD23 ' A' ' 70' ' ' LEU . 77.8 mm-40 -54.48 -49.27 70.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.331 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 85.4 tt0 -56.3 -55.91 27.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.721 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 79' ' ' ASP . 28.9 mm -56.75 -36.53 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.062 -1.024 . . . . 0.0 109.462 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HA ' ' CD2' ' A' ' 12' ' ' LEU . . . -59.33 -30.03 68.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.502 -0.749 . . . . 0.0 109.275 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' ASN . 85.9 tt0 -62.36 -41.6 98.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 110.321 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.1 p30 -147.0 158.37 45.1 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.196 -0.94 . . . . 0.0 110.482 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.532 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.53 -57.5 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.969 1.51 . . . . 0.0 110.636 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.36 -140.74 24.92 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.591 ' O ' HG12 ' A' ' 85' ' ' ILE . 60.4 p -78.14 -22.34 48.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -1.158 . . . . 0.0 109.635 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 52.9 t -52.27 -53.05 48.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 110.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.0 tt0 -57.66 -34.28 69.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 111.261 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 82' ' ' THR . 6.3 pt -95.11 12.65 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.931 -1.106 . . . . 0.0 110.446 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.8 m 56.47 15.64 2.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 0.0 110.497 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.536 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -66.56 -10.14 42.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 110.026 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -146.19 167.97 22.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 110.387 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.23 4.83 6.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 0.0 110.493 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.68 88.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 110.519 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -99.03 121.95 41.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.526 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.515 HG22 ' CB ' ' A' ' 4' ' ' GLN . 24.8 p -110.58 152.94 25.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.161 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.73 -20.01 51.12 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.272 -1.134 . . . . 0.0 110.231 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.52 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 14.6 p . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.24 0.543 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 58.4 m -123.33 152.81 41.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.426 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.532 HG22 ' CD1' ' A' ' 12' ' ' LEU . 52.0 t -82.36 112.19 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.641 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 41.4 tt0 -111.49 123.49 50.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.098 -1.001 . . . . 0.0 110.71 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.529 ' OD2' ' CG2' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -79.73 -77.12 0.19 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 0.0 109.386 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.71 -124.54 5.36 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -81.84 3.64 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -1.152 . . . . 0.0 110.379 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.2 m-85 -114.57 132.9 56.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.145 -0.972 . . . . 0.0 110.436 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 51.6 p -85.57 130.11 34.66 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.641 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 18.4 m-85 -118.71 130.18 55.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 110.703 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.7 p -75.69 170.22 16.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.163 -0.961 . . . . 0.0 110.268 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 4.5 mp -95.91 -6.45 39.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 110.519 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.7 mt-10 -70.95 -71.62 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.222 -0.924 . . . . 0.0 110.667 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.468 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 4.3 m -43.17 -52.1 5.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.309 -0.869 . . . . 0.0 110.567 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 15.8 m -56.41 -49.33 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.942 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 14.4 tttp -55.27 -51.66 65.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.981 -1.074 . . . . 0.0 108.8 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -80.41 11.26 3.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.455 -0.778 . . . . 0.0 109.736 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 27.2 tp -64.58 -33.68 76.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.89 . . . . 0.0 109.948 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -62.19 -42.4 99.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 109.667 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -104.88 124.62 49.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.412 -0.805 . . . . 0.0 109.61 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.552 ' CD2' ' HD2' ' A' ' 51' ' ' PRO . 15.1 tp . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 110.576 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.504 ' HB3' ' HD2' ' A' ' 16' ' ' LYS . 95.4 mtt-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.196 0.522 . . . . 0.0 110.126 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.558 ' CA ' ' O ' ' A' ' 78' ' ' GLU . 32.6 p-10 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.426 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.531 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.481 0.77 0 N-CA-C 110.64 -0.562 . . . . 0.0 110.64 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.68 7.53 31.62 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.456 ' O ' HG22 ' A' ' 43' ' ' VAL . 43.6 mt-10 -82.67 145.18 50.18 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.336 -1.097 . . . . 0.0 110.101 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.8 122.91 11.67 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.79 1.416 . . . . 0.0 110.343 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.535 HG11 ' N ' ' A' ' 44' ' ' VAL . 94.7 t -141.87 158.22 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.955 . . . . 0.0 110.506 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.535 ' N ' HG11 ' A' ' 43' ' ' VAL . 25.8 t . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.456 -0.777 . . . . 0.0 111.169 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.0 m . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.413 0.625 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.575 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 47.0 t -77.47 -70.82 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.029 -1.044 . . . . 0.0 110.155 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.441 ' OD1' HD11 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -76.7 111.96 19.21 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.494 -0.753 . . . . 0.0 110.263 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -63.57 -10.04 20.44 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.627 1.33 . . . . 0.0 110.324 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.523 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 94.0 m-20 -127.03 31.62 5.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.716 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.08 -179.35 1.39 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 108.948 179.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.716 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.8 Cg_exo -59.36 75.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.562 1.296 . . . . 0.0 109.044 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.616 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.7 tt0 -39.27 -27.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.723 -0.611 . . . . 0.0 110.174 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' PRO . 74.3 mm-40 -53.68 -17.85 2.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.107 -0.996 . . . . 0.0 108.554 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.641 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 86.3 mt -91.54 9.63 31.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.658 -0.651 . . . . 0.0 109.608 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.729 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -39.54 -51.49 4.93 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.85 . . . . 0.0 110.756 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.05 -42.86 63.44 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.495 1.26 . . . . 0.0 109.784 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.592 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 4.1 tt -57.48 -38.85 75.22 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.116 -0.99 . . . . 0.0 109.77 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.491 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . 49.3 t -63.61 -29.27 70.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 110.474 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.521 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 53.4 mttp -104.05 30.41 5.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.596 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.521 ' OE1' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -129.5 136.74 29.58 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.407 -0.808 . . . . 0.0 110.437 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.2 -27.03 64.52 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.662 1.349 . . . . 0.0 109.883 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -81.32 -11.06 59.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 110.846 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.592 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.98 -38.29 16.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.029 -1.045 . . . . 0.0 110.126 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.76 -40.72 80.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -80.27 -39.43 28.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.763 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.571 ' CG2' ' CD1' ' A' ' 60' ' ' LEU . 81.1 mt -64.62 -51.39 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.335 -0.853 . . . . 0.0 109.956 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.523 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 2.4 tm? -46.8 -58.45 3.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.389 -0.82 . . . . 0.0 110.113 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HG3' ' HB2' ' A' ' 39' ' ' PRO . 55.7 tt0 -44.85 -51.56 9.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -58.72 -56.5 21.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.431 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 47.6 mt -47.12 -53.1 13.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 0.0 110.216 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.531 ' OE1' ' HA ' ' A' ' 39' ' ' PRO . 52.4 mt-10 -57.22 -46.06 83.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 110.406 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -57.99 -53.71 55.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.953 -1.092 . . . . 0.0 110.127 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 79' ' ' ASP . 54.2 mt -60.94 -33.94 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.15 -0.969 . . . . 0.0 109.403 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.73 -33.69 68.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.379 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.558 ' O ' ' CA ' ' A' ' 34' ' ' ASN . 84.4 tt0 -61.71 -40.81 96.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.479 -0.763 . . . . 0.0 110.22 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -147.11 155.4 47.01 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.078 -1.014 . . . . 0.0 110.26 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.449 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -59.1 -62.27 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.786 1.414 . . . . 0.0 110.669 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.78 -139.07 21.73 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 85' ' ' ILE . 45.4 p -81.03 -21.28 40.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -1.148 . . . . 0.0 109.973 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 9.1 t -53.8 -54.09 43.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.965 . . . . 0.0 109.99 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 34.6 tt0 -58.13 -31.05 66.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.331 -0.856 . . . . 0.0 111.113 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 82' ' ' THR . 6.6 pt -97.26 12.08 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.991 -1.068 . . . . 0.0 110.322 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 34.2 m 54.07 18.73 1.81 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.887 . . . . 0.0 110.578 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.555 ' O ' ' CD1' ' A' ' 88' ' ' TYR . . . -67.13 -12.28 59.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 0.0 110.067 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.555 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 26.9 m-85 -146.75 175.55 10.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.82 3.36 10.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 110.302 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.36 -32.46 73.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -114.5 123.37 49.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 0.0 110.564 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.466 HG23 ' OE1' ' A' ' 4' ' ' GLN . 27.0 p -117.13 161.01 20.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.378 -0.826 . . . . 0.0 110.211 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.47 -33.11 5.68 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.299 -1.118 . . . . 0.0 110.303 -179.889 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 1' ' ' VAL . 3.2 m . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.096 0.474 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.536 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 9.6 t -129.09 163.18 26.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.76 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 50.8 t -84.41 116.43 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.544 ' CB ' HG22 ' A' ' 92' ' ' THR . 46.4 tt0 -108.61 111.69 23.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.032 -1.042 . . . . 0.0 110.951 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -94.26 4.45 53.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.25 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.509 ' O ' ' CG ' ' A' ' 4' ' ' GLN . . . -169.64 -148.1 5.73 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.32 8.96 6.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -1.167 . . . . 0.0 110.516 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.46 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 95.3 m-85 -119.84 147.82 44.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.031 -1.043 . . . . 0.0 110.51 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.536 ' OG ' ' CG2' ' A' ' 2' ' ' THR . 2.0 t -89.03 120.97 30.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 109.829 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.641 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 92.9 m-85 -108.43 117.77 35.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.177 -0.952 . . . . 0.0 110.867 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.4 p -71.64 169.6 15.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 109.528 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 5.1 mp -104.49 -0.93 27.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.978 -1.076 . . . . 0.0 110.763 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -67.13 -69.97 0.28 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.124 -0.985 . . . . 0.0 110.715 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.493 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.1 m -42.42 -50.99 5.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.344 -0.848 . . . . 0.0 111.165 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.603 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.6 m -57.79 -48.05 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.102 -0.999 . . . . 0.0 109.669 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.536 ' HE3' ' CA ' ' A' ' 77' ' ' ALA . 15.7 mttt -54.86 -54.58 40.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.1 -1.0 . . . . 0.0 108.811 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 48.1 tttt -80.43 11.02 3.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -0.766 . . . . 0.0 109.552 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 16.8 tp -59.62 -33.41 71.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -0.97 . . . . 0.0 110.069 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -67.23 -39.23 86.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.589 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 24.7 t70 -118.14 88.15 2.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.633 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.545 ' CD2' ' HB2' ' A' ' 52' ' ' ASN . 6.3 tp . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.39 -0.819 . . . . 0.0 111.045 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.539 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 32.6 ptt180 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.272 0.558 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 33' ' ' ARG . 92.0 m-20 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 110.085 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.513 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.804 0 N-CA-C 110.546 -0.598 . . . . 0.0 110.546 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 104.58 20.77 9.78 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.467 ' O ' HD13 ' A' ' 70' ' ' LEU . 27.2 mt-10 -122.32 74.02 40.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.233 -1.157 . . . . 0.0 110.144 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_endo -61.09 143.61 99.02 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.936 1.493 . . . . 0.0 110.583 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.474 ' HB ' ' OG ' ' A' ' 49' ' ' SER . 6.0 m -140.25 54.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.552 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 54.8 t . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.258 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.564 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 87.2 m . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.311 0.577 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.507 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 60.7 p -60.87 -39.3 88.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.994 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 10.5 m-20 -80.54 113.77 42.26 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.48 -7.63 9.15 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.681 1.359 . . . . 0.0 110.87 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.545 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 93.1 m-20 -137.29 31.46 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 110.665 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.751 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.2 p90 -73.34 -175.7 0.41 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.13 -0.981 . . . . 0.0 108.762 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.751 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -60.57 73.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.494 1.26 . . . . 0.0 108.863 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.588 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.1 tt0 -39.22 -31.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.724 -0.61 . . . . 0.0 110.34 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 54' ' ' PRO . 97.4 mt-10 -53.71 -26.72 24.27 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.969 -1.082 . . . . 0.0 108.721 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.641 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 90.7 mt -84.38 7.38 19.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.731 -0.605 . . . . 0.0 109.534 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.713 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 7.3 mmtt -39.59 -51.62 4.98 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 110.303 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.713 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.53 -44.91 43.82 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.588 1.31 . . . . 0.0 109.824 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.57 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -52.06 -43.81 63.99 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.054 -1.029 . . . . 0.0 109.844 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.6 m -66.96 -27.52 67.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.371 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -82.63 4.97 22.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.902 . . . . 0.0 110.736 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 60' ' ' LEU . 8.5 pt-20 -127.98 144.7 52.44 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.025 -1.047 . . . . 0.0 110.229 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.16 -12.66 27.75 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.881 1.464 . . . . 0.0 110.736 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.474 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 83.7 m-20 -80.12 -18.41 49.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.892 . . . . 0.0 110.201 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.19 -39.36 13.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 110.22 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.06 -44.2 87.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 110.296 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -80.2 -39.12 29.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.208 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.516 HG22 ' CD1' ' A' ' 60' ' ' LEU . 77.8 mt -64.42 -47.45 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 1.8 tm? -49.06 -57.27 6.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.46 ' HG3' ' N ' ' A' ' 40' ' ' GLY . 51.5 tt0 -49.55 -53.02 25.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.114 -0.991 . . . . 0.0 110.013 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -55.01 -50.4 69.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 96.0 mt -51.07 -50.08 59.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.761 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 70.6 mm-40 -53.99 -52.56 60.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 110.292 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.513 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.2 tt0 -52.69 -55.06 25.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 110.499 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 79' ' ' ASP . 28.2 mm -56.85 -34.36 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 0.0 109.41 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.536 ' CA ' ' HE3' ' A' ' 16' ' ' LYS . . . -59.21 -32.79 70.26 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.466 ' OE2' ' HD3' ' A' ' 39' ' ' PRO . 95.4 mt-10 -59.4 -41.2 88.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 110.139 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -149.26 155.3 39.68 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.59 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -60.15 -57.28 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.88 1.463 . . . . 0.0 110.575 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.12 -138.95 19.98 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.589 ' O ' HG12 ' A' ' 85' ' ' ILE . 43.6 p -81.09 -21.04 40.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -1.176 . . . . 0.0 109.742 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 20.7 t -55.2 -53.01 61.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.86 . . . . 0.0 110.184 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.59 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 35.5 tt0 -62.49 -27.09 68.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.933 . . . . 0.0 111.407 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 82' ' ' THR . 5.9 pt -98.01 14.07 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.757 -1.214 . . . . 0.0 110.433 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 50.9 19.74 0.68 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 0.0 110.714 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.538 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -68.82 -11.85 60.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.067 -1.02 . . . . 0.0 110.025 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -148.62 175.4 11.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 110.085 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.41 1.73 15.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.048 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.94 75.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.314 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -105.83 128.15 53.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 110.536 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.544 HG22 ' CB ' ' A' ' 4' ' ' GLN . 33.2 p -110.79 155.79 22.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 110.109 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 93.54 -19.32 53.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.259 -1.142 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.441 ' HA ' ' SG ' ' A' ' 91' ' ' CYS . 25.6 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.266 0.555 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 68.0 m -123.78 148.39 46.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 110.446 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.543 ' CG2' ' HG ' ' A' ' 12' ' ' LEU . 47.8 t -79.82 110.38 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.307 -0.87 . . . . 0.0 109.742 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.502 ' CB ' HG22 ' A' ' 92' ' ' THR . 43.7 tt0 -110.41 121.09 44.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -0.95 . . . . 0.0 110.716 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.505 ' OD2' ' CD1' ' A' ' 73' ' ' LEU . 85.0 m-20 -95.94 6.12 49.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 109.576 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 4' ' ' GLN . . . -175.45 -139.85 3.21 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -79.8 3.21 20.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -1.19 . . . . 0.0 110.419 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 83.3 m-85 -121.32 131.15 54.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 110.359 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.8 m -79.96 132.3 36.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.336 -0.852 . . . . 0.0 110.201 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.67 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 22.1 m-85 -116.56 128.91 55.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 110.6 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 m -69.25 162.27 27.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.922 . . . . 0.0 110.349 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.543 ' HG ' ' CG2' ' A' ' 3' ' ' VAL . 5.2 mp -87.39 -25.87 23.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.867 . . . . 0.0 110.23 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.525 ' HG3' ' NE ' ' A' ' 33' ' ' ARG . 87.8 tt0 -61.77 -65.6 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.294 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.555 ' O ' ' CB ' ' A' ' 18' ' ' LEU . 4.4 m -43.83 -54.55 5.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.137 -0.977 . . . . 0.0 110.422 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.53 HG21 ' O ' ' A' ' 12' ' ' LEU . 30.3 m -61.46 -48.32 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 110.348 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.537 ' CE ' ' O ' ' A' ' 77' ' ' ALA . 8.7 ttmm -59.33 -55.5 33.97 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.074 -1.016 . . . . 0.0 109.371 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' OD1' ' A' ' 20' ' ' ASP . 28.9 mmtp -80.46 6.78 11.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.367 -0.833 . . . . 0.0 110.124 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.555 ' CB ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -73.21 -30.89 63.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.95 -1.094 . . . . 0.0 109.869 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -56.41 -39.09 72.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 109.748 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.529 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 26.3 p-10 -111.53 98.08 7.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.849 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' A' ' 52' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 110.498 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.525 ' NE ' ' HG3' ' A' ' 13' ' ' GLU . 71.3 mtt-85 . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.055 . . . . 0.0 111.205 -179.364 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.543 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 3.1 Cg_exo . . . . . 0 N--CA 1.482 0.85 0 N-CA-C 110.684 -0.545 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.522 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 95.31 14.68 47.14 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.491 ' O ' HG22 ' A' ' 43' ' ' VAL . 19.3 mm-40 -114.71 106.64 51.82 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.188 -1.183 . . . . 0.0 110.157 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.9 144.65 99.61 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.822 1.433 . . . . 0.0 110.478 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.567 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 38.6 t -147.67 54.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 110.234 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.567 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 24.9 t . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.301 -0.874 . . . . 0.0 110.767 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.571 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 94.2 m . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.256 0.55 . . . . 0.0 109.8 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.558 ' HB3' ' CG1' ' A' ' 43' ' ' VAL . 4.6 t -54.68 -58.1 8.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 111.113 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 8.8 m-20 -80.09 113.18 36.36 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.33 -0.856 . . . . 0.0 110.853 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -66.03 -13.32 39.32 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.68 1.358 . . . . 0.0 110.298 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.548 ' HB2' HD13 ' A' ' 21' ' ' LEU . 25.8 m120 -116.08 21.27 13.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 0.0 110.471 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.643 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -79.89 175.05 5.17 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 108.983 179.23 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.5 Cg_exo -57.59 75.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.63 1.331 . . . . 0.0 108.904 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.614 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.7 tt0 -39.44 -28.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.675 -0.641 . . . . 0.0 110.27 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.502 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.7 mt-10 -52.82 -19.37 2.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.023 -1.048 . . . . 0.0 108.55 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.67 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 68.0 mt -86.11 4.05 39.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.634 -0.666 . . . . 0.0 109.398 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.741 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -39.92 -51.18 5.68 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.502 -0.748 . . . . 0.0 110.375 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.741 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.32 -40.57 82.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.615 1.324 . . . . 0.0 110.382 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.566 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 6.5 mp -62.24 -36.66 82.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.92 -1.113 . . . . 0.0 109.885 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.466 ' HA ' HG23 ' A' ' 44' ' ' VAL . 81.4 m -64.79 -28.02 69.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 110.257 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -79.85 -10.23 59.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.609 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' A' ' 65' ' ' ASN . 8.4 pt-20 -114.67 144.1 31.24 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.014 . . . . 0.0 110.16 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.38 -11.74 27.19 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.875 1.461 . . . . 0.0 110.919 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.477 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 75.6 m-20 -81.39 -14.99 56.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 110.419 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -48.03 -39.99 21.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.171 -0.956 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -61.05 -39.69 90.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 110.101 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -80.03 -36.57 35.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.972 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.552 ' CG2' ' CD2' ' A' ' 60' ' ' LEU . 86.6 mt -68.43 -43.06 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.873 . . . . 0.0 109.922 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.534 HD23 ' HG3' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -51.83 -54.72 25.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -0.82 . . . . 0.0 110.435 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.543 ' HG3' ' CB ' ' A' ' 39' ' ' PRO . 64.1 tt0 -49.64 -54.9 15.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.102 -0.999 . . . . 0.0 110.664 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -50.36 -54.15 23.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.39 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.505 ' CD1' ' OD2' ' A' ' 5' ' ' ASP . 54.7 mt -50.26 -47.88 55.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.9 . . . . 0.0 110.406 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.534 ' HG3' HD23 ' A' ' 70' ' ' LEU . 80.3 mt-10 -55.6 -45.88 77.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 110.453 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.64 -54.4 47.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.049 -1.032 . . . . 0.0 110.674 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.9 mt -61.16 -37.63 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.059 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.537 ' O ' ' CE ' ' A' ' 16' ' ' LYS . . . -61.36 -32.85 72.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.457 -0.777 . . . . 0.0 110.054 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -58.44 -35.88 72.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.653 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.457 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -156.54 151.01 20.13 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.683 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.517 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 3.2 Cg_exo -61.67 82.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.012 1.532 . . . . 0.0 110.702 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.53 -134.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.573 ' O ' HG12 ' A' ' 85' ' ' ILE . 72.1 p -79.29 -14.37 59.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.12 -1.223 . . . . 0.0 109.545 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 19.6 t -54.16 -52.11 62.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 110.324 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.517 ' OE1' ' HB2' ' A' ' 80' ' ' PRO . 84.2 tt0 -56.6 -33.01 65.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.208 -0.933 . . . . 0.0 111.272 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 82' ' ' THR . 5.6 pt -98.05 11.76 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.897 -1.127 . . . . 0.0 110.441 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.8 m 54.3 17.12 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.883 . . . . 0.0 110.553 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.541 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -65.62 -11.1 41.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 109.9 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.454 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.5 OUTLIER -144.33 172.12 13.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.265 -0.897 . . . . 0.0 110.096 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.54 4.2 6.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 110.38 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.31 -35.26 80.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.0 110.634 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -106.57 121.16 43.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 0.0 110.632 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.502 HG22 ' CB ' ' A' ' 4' ' ' GLN . 14.6 p -104.92 156.08 18.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 110.126 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.38 -4.39 64.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.204 -1.174 . . . . 0.0 110.273 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.254 0.55 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 55.7 m -89.55 151.36 21.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 0.0 110.34 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 10' ' ' PHE . 0.9 OUTLIER -91.61 120.36 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.463 -0.773 . . . . 0.0 109.873 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 49.0 tt0 -110.27 130.05 55.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.644 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.471 ' OD2' HD23 ' A' ' 73' ' ' LEU . 90.4 m-20 -111.69 9.06 20.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 109.802 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.91 -135.98 2.6 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -81.87 -1.48 47.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -1.195 . . . . 0.0 110.199 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.473 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 55.4 m-85 -119.48 143.77 47.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.214 -0.929 . . . . 0.0 110.325 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.444 ' HB2' HG23 ' A' ' 2' ' ' THR . 60.7 p -90.38 128.76 36.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 110.172 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.607 ' CD1' HD13 ' A' ' 57' ' ' LEU . 21.7 m-30 -110.01 118.81 37.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.247 -0.908 . . . . 0.0 110.335 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.2 t -70.19 166.95 18.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.0 110.016 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.593 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 5.0 mp -95.22 1.25 54.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.196 -0.94 . . . . 0.0 110.628 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -74.54 -69.88 0.43 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.213 -0.929 . . . . 0.0 110.461 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 18' ' ' LEU . 3.8 m -52.03 -38.75 58.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.836 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.581 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 9.3 t -67.42 -55.41 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.909 -1.119 . . . . 0.0 109.84 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HD3' ' HG2' ' A' ' 33' ' ' ARG . 39.9 tttp -53.62 -55.78 22.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.941 -1.1 . . . . 0.0 108.904 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 20' ' ' ASP . 52.1 tttt -80.33 8.81 6.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.446 -0.784 . . . . 0.0 109.829 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 5.5 tt -55.7 -43.01 76.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 110.173 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -58.84 -49.14 78.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.934 . . . . 0.0 110.022 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 60.7 t0 -98.81 107.27 19.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 109.867 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.597 HD13 ' HB2' ' A' ' 52' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 110.438 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.402 ' HG2' ' HD3' ' A' ' 16' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.238 0.542 . . . . 0.0 109.97 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 78' ' ' GLU . 25.0 m120 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.468 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.507 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.1 Cg_exo . . . . . 0 N--CA 1.481 0.789 0 N-CA-C 110.617 -0.57 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.457 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 146.78 -8.92 1.34 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -119.46 76.47 18.3 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.001 -1.294 . . . . 0.0 110.474 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.543 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . 2.9 Cg_endo -62.56 128.48 23.61 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.818 1.431 . . . . 0.0 110.473 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.613 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 23.2 m -135.69 142.96 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.613 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.398 -0.814 . . . . 0.0 110.305 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.368 0.604 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.493 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 9.2 t -56.62 -60.19 3.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.0 110.455 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 21' ' ' LEU . 8.4 m120 -80.26 114.26 45.56 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 0.0 110.273 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -61.7 -5.04 5.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.8 1.421 . . . . 0.0 111.028 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.597 ' HB2' HD13 ' A' ' 21' ' ' LEU . 94.5 m-20 -140.32 33.73 1.88 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.143 -0.973 . . . . 0.0 110.347 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.721 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -75.28 -174.59 0.39 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 109.061 179.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.721 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.5 Cg_exo -57.86 72.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.406 1.214 . . . . 0.0 109.921 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.5 tt0 -41.16 -36.03 0.68 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.711 . . . . 0.0 110.314 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.78 -19.31 2.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 108.829 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.637 ' CD1' ' N ' ' A' ' 57' ' ' LEU . 8.2 mp -94.64 16.29 15.96 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.89 0.853 . . . . 0.0 109.113 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.722 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.76 -52.54 4.95 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.941 -0.474 . . . . 0.0 110.972 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.722 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.14 -44.87 45.33 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.506 1.266 . . . . 0.0 110.07 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.579 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 79.9 mt -59.04 -35.95 74.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.057 -1.027 . . . . 0.0 109.936 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.502 ' O ' HG12 ' A' ' 44' ' ' VAL . 50.6 t -64.65 -25.02 67.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.025 . . . . 0.0 110.384 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -113.45 29.67 7.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.127 -0.983 . . . . 0.0 109.415 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.485 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -118.55 139.91 27.61 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.606 -0.684 . . . . 0.0 110.484 -179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.51 -27.4 76.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.65 1.342 . . . . 0.0 109.964 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.37 -16.7 53.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.153 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -43.56 -39.61 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -54.54 -43.64 72.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.863 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.461 ' HG2' ' NE ' ' A' ' 72' ' ' ARG . 86.5 tt0 -80.05 -38.75 31.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.949 . . . . 0.0 109.88 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.519 HD12 ' CD2' ' A' ' 60' ' ' LEU . 78.6 mt -63.38 -55.19 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.638 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 1.1 tm? -42.34 -64.55 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.436 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.638 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 56.5 mt-30 -47.65 -53.39 15.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.077 -1.014 . . . . 0.0 110.465 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.461 ' NE ' ' HG2' ' A' ' 68' ' ' GLU . 62.2 mtt180 -54.87 -53.58 53.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 110.138 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.471 HD23 ' OD2' ' A' ' 5' ' ' ASP . 86.3 mt -49.86 -53.01 28.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 110.015 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.548 ' HG3' HD23 ' A' ' 70' ' ' LEU . 80.5 mt-10 -53.15 -45.11 68.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 110.237 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.1 tt0 -57.74 -54.02 51.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.353 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 79' ' ' ASP . 29.8 mm -59.43 -36.95 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.153 -0.967 . . . . 0.0 109.738 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.452 ' HB1' HG13 ' A' ' 15' ' ' VAL . . . -58.16 -33.9 69.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 109.575 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.477 ' O ' ' O ' ' A' ' 34' ' ' ASN . 85.8 tt0 -60.31 -40.16 89.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.497 -0.752 . . . . 0.0 110.347 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 76' ' ' ILE . 9.5 m-20 -145.54 153.13 50.97 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.135 -0.978 . . . . 0.0 110.31 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.535 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -59.76 -58.55 0.56 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.884 1.465 . . . . 0.0 110.57 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.14 -137.88 19.12 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.602 ' O ' HG12 ' A' ' 85' ' ' ILE . 53.1 p -82.38 -21.44 35.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -1.171 . . . . 0.0 110.107 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 38.9 t -54.58 -53.39 55.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 110.007 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 82.9 tt0 -60.33 -29.19 68.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 0.0 111.322 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.602 HG12 ' O ' ' A' ' 82' ' ' THR . 6.0 pt -97.22 13.54 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.863 -1.148 . . . . 0.0 110.276 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 62.9 m 55.43 15.15 1.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 0.0 110.574 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.531 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -63.72 -12.59 35.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.117 -0.989 . . . . 0.0 109.891 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.405 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 21.7 m-85 -149.48 173.8 13.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 110.324 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.46 3.85 10.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.393 -0.817 . . . . 0.0 110.453 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.66 -33.8 74.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.586 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -106.58 125.31 50.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.678 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -109.93 152.73 25.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.382 -0.824 . . . . 0.0 110.111 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.98 52.36 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.265 -1.139 . . . . 0.0 110.134 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.491 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 3.8 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.154 0.502 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.4 t -123.51 161.24 25.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.923 . . . . 0.0 110.64 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.512 ' CG2' HD22 ' A' ' 12' ' ' LEU . 71.0 t -91.9 119.72 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.568 -0.708 . . . . 0.0 109.544 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.533 ' HG3' ' OG1' ' A' ' 92' ' ' THR . 36.5 mt-30 -110.49 135.01 51.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.96 . . . . 0.0 110.787 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.429 ' OD2' ' CG2' ' A' ' 69' ' ' ILE . 80.8 m-20 -104.76 11.07 34.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.202 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.28 -131.88 1.97 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -89.6 10.16 24.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.191 -1.182 . . . . 0.0 110.57 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 92.6 m-85 -114.79 154.75 27.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 110.385 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.451 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 60.4 p -105.1 121.55 44.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.603 ' CD1' HD22 ' A' ' 57' ' ' LEU . 19.9 m-85 -118.99 128.06 54.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.942 . . . . 0.0 110.578 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 m -70.8 165.58 22.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.395 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.61 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 5.0 mp -96.37 -8.8 31.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.282 -0.886 . . . . 0.0 110.339 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' SER . 84.4 tt0 -70.97 -70.71 0.29 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.298 -0.876 . . . . 0.0 110.926 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.6 m -43.97 -48.85 8.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.161 -0.962 . . . . 0.0 110.677 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.625 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 14.3 m -59.46 -47.36 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.115 -0.991 . . . . 0.0 110.319 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.525 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 20.7 tttm -56.75 -55.27 36.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.831 -1.168 . . . . 0.0 109.075 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 20' ' ' ASP . 7.4 tptm -80.43 10.9 4.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.41 -0.806 . . . . 0.0 109.288 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.625 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 47.1 tp -56.31 -45.27 80.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 110.666 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -56.87 -46.28 81.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 110.191 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.517 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 22.3 t70 -105.78 122.26 45.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.915 . . . . 0.0 110.198 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.225 -0.922 . . . . 0.0 110.075 179.896 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.134 0.492 . . . . 0.0 110.028 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 81.5 m-20 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 110.519 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.479 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.842 0 N-CA-C 110.582 -0.584 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.51 -1.36 42.78 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.427 ' O ' HD13 ' A' ' 70' ' ' LEU . 1.2 mt-10 -132.46 75.5 73.75 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.211 -1.17 . . . . 0.0 110.147 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.63 143.09 96.44 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.951 1.501 . . . . 0.0 110.329 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.474 HG13 HD22 ' A' ' 18' ' ' LEU . 14.5 m -109.24 48.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 110.282 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.495 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 84.2 t . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.51 -0.744 . . . . 0.0 110.705 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 99.3 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.349 0.595 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.575 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 14.0 t -65.85 -73.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 110.89 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 8.6 m-20 -77.84 112.29 23.82 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.389 -0.819 . . . . 0.0 110.574 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.38 -9.17 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 O-C-N 123.673 1.354 . . . . 0.0 109.826 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -119.24 27.13 9.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.449 -0.782 . . . . 0.0 110.274 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.677 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.03 174.73 5.65 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.005 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -56.82 76.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.739 1.389 . . . . 0.0 108.952 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.633 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 2.7 pt-20 -39.38 -26.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.811 -0.556 . . . . 0.0 110.251 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 54' ' ' PRO . 49.2 tp10 -53.05 -19.02 2.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.011 -1.056 . . . . 0.0 108.38 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.603 HD22 ' CD1' ' A' ' 10' ' ' PHE . 58.2 mt -90.8 7.63 38.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.621 . . . . 0.0 109.579 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.713 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.69 -51.67 5.12 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 110.687 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.713 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -55.0 -43.16 62.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.502 1.264 . . . . 0.0 110.159 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.599 HD13 ' CE2' ' A' ' 10' ' ' PHE . 11.5 mt -58.76 -36.69 74.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.089 -1.007 . . . . 0.0 109.947 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.9 t -66.14 -26.57 67.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 110.293 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -92.19 3.73 54.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 111.049 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.535 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 6.1 pt-20 -119.17 145.89 39.34 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.853 -1.155 . . . . 0.0 110.269 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.53 -17.83 60.27 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.923 1.486 . . . . 0.0 111.252 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.479 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 21.8 m120 -79.7 -13.63 59.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.56 -42.37 23.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -59.75 -40.0 86.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 110.418 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -80.13 -36.64 34.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.068 -1.02 . . . . 0.0 109.985 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.535 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 88.7 mt -66.2 -44.53 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 109.986 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.543 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 1.3 tm? -51.02 -56.62 11.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.846 . . . . 0.0 110.214 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.481 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 23.7 mt-30 -47.78 -54.64 11.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 110.247 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -51.49 -54.74 23.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.387 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 52.3 mt -50.66 -49.53 56.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.272 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 79.1 mt-10 -55.29 -49.32 72.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.755 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -57.56 -54.75 43.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.033 -1.042 . . . . 0.0 110.725 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 79' ' ' ASP . 23.0 mm -60.56 -37.11 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.09 -1.006 . . . . 0.0 109.823 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.81 -32.27 67.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 0.0 109.663 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.0 tt0 -63.74 -40.32 96.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.46 -0.775 . . . . 0.0 110.31 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.463 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -151.32 156.41 34.97 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 0.0 110.076 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.505 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -59.08 -65.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.93 1.49 . . . . 0.0 110.643 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.14 -142.12 22.03 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.582 ' O ' HG12 ' A' ' 85' ' ' ILE . 65.0 p -77.42 -19.71 55.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -1.126 . . . . 0.0 109.836 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.69 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 48.8 t -58.79 -51.12 71.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.848 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.3 tt0 -52.96 -30.25 33.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.698 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 82' ' ' THR . 8.2 pt -103.69 11.6 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.093 -1.004 . . . . 0.0 110.123 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 57.9 m 57.92 17.58 4.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.321 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.539 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -70.51 -14.55 62.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.943 . . . . 0.0 110.093 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 37.8 t80 -132.34 165.27 24.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.305 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.22 -0.23 11.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 110.274 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -65.56 -41.73 92.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.158 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.69 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -93.26 111.86 23.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 110.251 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.533 ' OG1' ' HG3' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -110.88 4.21 19.55 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.499 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . -75.12 -52.05 7.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.499 ' C ' ' O ' ' A' ' 93' ' ' GLY . 1.4 m . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.423 -1.045 . . . . 0.0 110.494 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.452 HG22 ' SG ' ' A' ' 91' ' ' CYS . 4.5 m . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.223 0.535 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.4 m -117.83 146.21 44.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 110.387 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 90' ' ' ALA . 1.2 t -84.16 122.35 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.763 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HG2' ' HA ' ' A' ' 9' ' ' SER . 66.9 mt-30 -112.75 124.72 53.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.958 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.505 ' OD2' HD23 ' A' ' 60' ' ' LEU . 44.4 p30 -103.37 12.0 35.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.55 -139.01 3.5 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -89.08 19.59 4.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -1.177 . . . . 0.0 110.194 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.648 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.5 m-85 -126.67 158.37 36.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.305 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 74.2 m -102.64 115.82 31.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.148 -0.97 . . . . 0.0 110.423 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.648 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 17.2 m-30 -116.75 128.01 54.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.365 -0.835 . . . . 0.0 110.596 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.4 t -75.85 170.6 15.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.917 . . . . 0.0 110.116 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.627 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 6.9 mp -93.12 -16.97 24.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.155 -0.965 . . . . 0.0 110.645 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.4 mt-10 -64.47 -71.92 0.16 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.151 -0.968 . . . . 0.0 110.402 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.2 m -42.77 -51.72 5.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 0.0 110.376 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.56 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 49.5 t -56.12 -48.26 79.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.58 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HE3' ' HG3' ' A' ' 17' ' ' LYS . 6.3 ttpp -54.98 -54.67 39.97 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.168 -0.957 . . . . 0.0 108.686 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.455 ' HG3' ' HE3' ' A' ' 16' ' ' LYS . 45.0 mttt -80.62 14.12 2.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.449 -0.782 . . . . 0.0 109.911 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.8 tt -65.92 -35.05 79.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 110.073 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 41' ' ' GLU . 26.9 mttm -97.61 143.96 27.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 82.7 m-20 53.62 48.66 21.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.984 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.513 ' CD2' ' HB2' ' A' ' 52' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.857 . . . . 0.0 110.251 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 22.6 ptt-85 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.101 0.477 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 33' ' ' ARG . 80.2 m-20 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.0 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.576 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo . . . . . 0 N--CA 1.481 0.788 0 N-CA-C 110.541 -0.6 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.46 5.86 10.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.435 ' HB3' ' NZ ' ' A' ' 19' ' ' LYS . 1.7 mt-10 -133.52 74.0 71.91 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.298 -1.119 . . . . 0.0 110.157 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.547 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -60.67 146.06 97.83 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.836 1.44 . . . . 0.0 110.406 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.626 ' CG1' ' CB ' ' A' ' 49' ' ' SER . 45.4 t -131.38 122.34 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 110.538 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.614 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 21.7 t . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.228 -0.92 . . . . 0.0 110.49 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.565 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 74.9 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.254 0.549 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.626 ' CB ' ' CG1' ' A' ' 43' ' ' VAL . 30.5 t -64.16 -64.86 0.78 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.128 -0.982 . . . . 0.0 110.47 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 10.0 m-20 -80.27 114.15 44.77 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.811 . . . . 0.0 110.081 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -64.85 -2.33 5.31 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.693 1.365 . . . . 0.0 110.772 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.513 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 95.6 m-20 -124.18 22.98 8.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.64 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.79 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 3.6 p90 -80.06 -176.33 0.72 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 108.945 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.79 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 5.0 Cg_exo -56.39 74.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.562 1.296 . . . . 0.0 109.657 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.6 tt0 -41.4 -36.69 0.89 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.509 -0.744 . . . . 0.0 110.132 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.03 -17.77 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.92 . . . . 0.0 108.981 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.652 ' CD1' ' N ' ' A' ' 57' ' ' LEU . 8.4 mp -94.51 8.72 41.2 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.017 0.913 . . . . 0.0 109.327 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.752 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -41.79 -51.05 9.87 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.77 -0.581 . . . . 0.0 110.151 179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.752 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -53.8 -41.51 73.92 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.521 1.274 . . . . 0.0 110.1 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.593 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 9.5 mp -56.97 -42.47 80.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.948 -1.095 . . . . 0.0 109.402 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.48 ' O ' HG11 ' A' ' 44' ' ' VAL . 72.9 m -61.16 -24.52 66.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -99.31 1.6 44.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.323 -0.861 . . . . 0.0 110.769 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.492 ' OE2' ' HB2' ' A' ' 65' ' ' ASN . 10.1 pt-20 -117.79 147.28 40.74 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.084 -1.01 . . . . 0.0 110.288 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.01 -17.21 58.93 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.469 1.446 . . . . 0.0 111.258 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.492 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 53.2 m-20 -79.16 -20.83 47.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.09 -1.007 . . . . 0.0 110.87 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.593 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -46.57 -37.62 8.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.928 -1.108 . . . . 0.0 109.675 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.547 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.7 mt-30 -61.12 -41.37 96.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 110.187 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.8 mt-10 -80.14 -34.16 37.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.556 ' CG2' HD22 ' A' ' 60' ' ' LEU . 85.1 mt -73.02 -49.97 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 109.812 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.545 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 1.7 tm? -48.45 -56.59 7.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 109.922 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 93.8 mt-30 -47.3 -51.55 18.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 110.028 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 93.0 mtt-85 -58.18 -60.99 2.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' A' ' 5' ' ' ASP . 8.0 mt -46.17 -54.41 8.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.015 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.502 ' HG2' HD21 ' A' ' 70' ' ' LEU . 76.2 mm-40 -50.92 -42.72 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 109.821 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.576 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 81.1 tt0 -66.8 -51.52 54.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.513 ' O ' ' O ' ' A' ' 79' ' ' ASP . 67.1 mt -65.19 -38.86 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -0.942 . . . . 0.0 109.609 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 34' ' ' ASN . . . -57.6 -35.73 70.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -0.871 . . . . 0.0 109.547 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 83.2 tt0 -63.02 -38.22 90.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.533 -0.729 . . . . 0.0 110.448 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -149.69 157.2 38.67 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.107 -0.996 . . . . 0.0 110.437 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.514 ' HD3' ' ND2' ' A' ' 34' ' ' ASN . 3.1 Cg_exo -59.44 -71.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.981 1.516 . . . . 0.0 110.83 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.4 -140.39 21.96 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.55 ' O ' HG12 ' A' ' 85' ' ' ILE . 52.7 p -78.64 -23.09 46.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -1.178 . . . . 0.0 110.153 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.557 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 25.2 t -54.39 -51.81 63.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.917 . . . . 0.0 109.893 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -55.44 -33.53 63.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 111.115 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 82' ' ' THR . 4.3 pt -100.43 10.85 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.972 -1.08 . . . . 0.0 110.522 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.31 9.15 1.83 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.312 -0.867 . . . . 0.0 110.614 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.502 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -60.54 -14.56 20.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.056 -1.028 . . . . 0.0 109.543 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -135.68 164.52 27.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.464 -0.772 . . . . 0.0 110.123 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.62 3.41 5.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 110.23 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.66 -43.1 94.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.33 -0.856 . . . . 0.0 110.492 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.557 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -96.93 116.0 28.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.945 . . . . 0.0 110.645 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.515 HG22 ' HG3' ' A' ' 4' ' ' GLN . 44.8 p -107.89 171.23 7.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.48 -30.31 10.49 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.436 ' HB3' HG13 ' A' ' 1' ' ' VAL . 26.1 p . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.207 -1.172 . . . . 0.0 110.172 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.487 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 67.4 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.244 0.545 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.5 m -120.73 151.84 39.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.933 . . . . 0.0 110.258 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.559 HG22 ' CG ' ' A' ' 12' ' ' LEU . 61.9 t -81.01 113.41 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.911 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.543 ' HB3' ' CG2' ' A' ' 92' ' ' THR . 42.9 tt0 -111.61 132.23 54.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -93.84 -78.0 0.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.34 -0.85 . . . . 0.0 109.627 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.59 -128.43 5.8 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -80.47 10.26 4.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -1.12 . . . . 0.0 110.622 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.478 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 97.6 m-85 -124.47 137.79 54.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.993 . . . . 0.0 110.576 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.472 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 80.0 p -89.58 133.33 34.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 110.201 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.548 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 92.1 m-85 -115.62 123.07 47.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 110.578 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.5 m -72.77 171.64 12.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.217 -0.927 . . . . 0.0 110.243 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.624 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 4.3 mp -103.57 2.25 33.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.15 -0.969 . . . . 0.0 111.015 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 14' ' ' SER . 97.3 mt-10 -71.75 -77.27 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.927 -1.108 . . . . 0.0 110.846 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.8 m -41.04 -47.57 3.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.255 -0.903 . . . . 0.0 110.88 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.579 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 14.8 m -63.58 -50.43 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.014 . . . . 0.0 109.886 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.433 ' HE2' ' C ' ' A' ' 34' ' ' ASN . 39.5 tttm -53.34 -53.28 53.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.075 -1.015 . . . . 0.0 109.075 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.451 ' O ' ' O ' ' A' ' 20' ' ' ASP . 68.6 mttm -80.17 4.89 15.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.371 -0.83 . . . . 0.0 109.871 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 8.8 tp -55.8 -36.31 67.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 110.226 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -53.2 -41.92 65.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.565 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 17' ' ' LYS . 8.6 p-10 -111.67 133.77 53.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.798 . . . . 0.0 109.725 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.617 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.125 -0.984 . . . . 0.0 110.426 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.422 ' C ' ' HE3' ' A' ' 16' ' ' LYS . 80.5 mtm-85 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.339 0.59 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.488 ' OD1' ' HD3' ' A' ' 80' ' ' PRO . 73.8 m-20 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.379 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.572 ' HG3' ' CG ' ' A' ' 75' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.837 0 N-CA-C 110.65 -0.558 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.77 -76.64 1.31 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -165.15 129.56 1.81 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.404 -1.057 . . . . 0.0 110.069 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.482 ' HB2' ' HG3' ' A' ' 67' ' ' GLN . 3.0 Cg_endo -60.86 126.31 19.35 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.702 1.369 . . . . 0.0 110.502 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.519 HG12 ' CB ' ' A' ' 49' ' ' SER . 11.3 p -140.58 138.58 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.322 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 66' ' ' ALA . 73.8 t . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.297 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.533 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 62.7 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.199 0.523 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.519 ' CB ' HG12 ' A' ' 43' ' ' VAL . 22.1 t -59.5 -48.27 82.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.178 -0.951 . . . . 0.0 110.487 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.533 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 1.2 m120 -80.13 114.79 49.64 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.352 -0.842 . . . . 0.0 110.324 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -60.33 -10.36 13.05 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.703 1.37 . . . . 0.0 110.649 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.617 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 28.2 m120 -138.92 36.39 2.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.962 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.762 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 2.2 p90 -73.08 -175.84 0.41 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 108.957 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.762 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.7 Cg_exo -58.41 74.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.494 1.26 . . . . 0.0 109.524 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.8 tt0 -42.7 -36.37 1.41 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.414 -0.804 . . . . 0.0 110.441 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -52.55 -19.17 2.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.077 -1.014 . . . . 0.0 108.929 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 54' ' ' PRO . 8.1 mp -93.93 13.82 21.56 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.923 0.868 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.731 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.9 mttp -40.04 -52.01 5.57 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.729 -0.607 . . . . 0.0 110.201 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.731 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.08 -46.05 36.04 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.584 1.307 . . . . 0.0 109.661 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -48.78 -47.19 42.1 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.061 -1.024 . . . . 0.0 109.346 179.296 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.6 m -68.24 -27.23 66.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.418 -0.801 . . . . 0.0 110.286 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -86.43 4.96 37.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.998 . . . . 0.0 110.507 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.541 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 5.6 pt-20 -122.12 146.29 46.21 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.148 -0.97 . . . . 0.0 110.161 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.77 -17.98 58.04 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.862 1.454 . . . . 0.0 110.978 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.477 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 22.3 m120 -79.78 -12.09 59.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.578 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -49.94 -39.66 41.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.151 -0.968 . . . . 0.0 109.99 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.482 ' HG3' ' HB2' ' A' ' 42' ' ' PRO . 30.5 tt0 -56.8 -44.61 82.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.367 -0.833 . . . . 0.0 110.487 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.6 mt-10 -80.28 -35.06 36.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.982 . . . . 0.0 110.358 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.541 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 86.7 mt -69.05 -48.65 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.149 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.489 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 1.7 tm? -44.87 -63.53 0.9 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -48.4 -53.13 18.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 110.176 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 82.9 mtp180 -51.59 -58.33 6.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 109.91 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 47.0 mt -46.33 -48.77 18.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.787 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 86.7 mt-10 -54.63 -40.67 69.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.297 -0.877 . . . . 0.0 110.176 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.572 ' CG ' ' HG3' ' A' ' 39' ' ' PRO . 96.5 mt-10 -61.82 -54.78 37.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.031 -1.043 . . . . 0.0 110.269 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.49 HG23 HD22 ' A' ' 12' ' ' LEU . 42.4 mt -63.16 -42.49 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.881 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . . . -52.0 -37.19 52.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.56 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 84.1 tt0 -65.93 -42.57 89.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.495 -0.753 . . . . 0.0 110.349 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -143.56 153.57 58.73 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.067 -1.02 . . . . 0.0 110.449 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.528 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -61.99 -68.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.069 1.563 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.03 -140.13 18.27 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.533 ' HB ' ' CB ' ' A' ' 87' ' ' ALA . 47.6 p -81.29 -21.98 38.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -1.118 . . . . 0.0 110.033 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 10.7 t -56.47 -50.22 72.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.166 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 78.5 tt0 -63.24 -27.26 69.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.954 . . . . 0.0 111.175 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.526 ' CG1' ' HB2' ' A' ' 87' ' ' ALA . 5.7 pt -102.08 12.76 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.829 -1.169 . . . . 0.0 110.449 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.9 t 57.87 13.59 2.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 110.459 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.533 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -64.66 -21.49 66.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 110.035 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.421 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 2.6 t80 -134.85 169.48 17.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.84 . . . . 0.0 110.04 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.31 1.26 11.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.188 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -58.58 -39.82 81.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.588 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.6 OUTLIER -104.38 122.12 44.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.005 . . . . 0.0 110.786 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.543 ' CG2' ' HB3' ' A' ' 4' ' ' GLN . 25.9 p -101.31 170.15 8.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 110.237 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.18 4.16 78.18 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.257 -1.143 . . . . 0.0 110.143 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.231 0.539 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 88.5 m -126.14 152.98 45.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.31 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.567 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -91.03 117.84 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 109.758 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 9' ' ' SER . 31.2 mt-30 -110.3 139.82 45.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.228 -0.92 . . . . 0.0 110.63 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -108.59 9.62 27.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.697 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.75 -136.21 2.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -79.87 4.85 15.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -1.193 . . . . 0.0 109.566 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.652 ' CE1' ' O ' ' A' ' 9' ' ' SER . 35.7 t80 -119.26 161.32 20.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.473 -0.767 . . . . 0.0 109.78 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.652 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 82.5 p -115.5 133.13 56.33 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.955 -1.09 . . . . 0.0 110.929 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.504 ' O ' HG13 ' A' ' 3' ' ' VAL . 72.0 m-85 -112.47 121.96 46.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 110.779 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.2 p -69.83 168.08 15.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.061 -1.024 . . . . 0.0 109.918 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 43.3 mt -103.13 1.56 33.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.025 -1.047 . . . . 0.0 110.886 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -73.96 -75.63 0.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 0.0 110.515 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.1 m -42.53 -50.18 5.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 110.671 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.64 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 5.4 m -57.31 -44.32 83.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.806 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.443 ' H ' HG21 ' A' ' 15' ' ' VAL . 50.5 tttt -56.56 -56.05 26.17 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.847 -1.158 . . . . 0.0 108.68 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -80.5 13.74 2.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.535 -0.728 . . . . 0.0 109.842 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.64 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.5 tt -63.38 -41.38 98.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.87 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -56.6 -42.96 79.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.504 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -93.01 116.23 28.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.546 ' CD2' ' HB3' ' A' ' 50' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.122 -0.986 . . . . 0.0 110.753 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' NH2' ' CD ' ' A' ' 84' ' ' GLU . 24.3 ptt85 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.225 0.536 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 37.9 p-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 0.0 110.431 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.49 ' CG ' ' CG ' ' A' ' 75' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.835 0 N-CA-C 110.562 -0.591 . . . . 0.0 110.562 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.424 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 125.02 28.6 1.11 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -125.16 71.74 63.92 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.294 -1.121 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.424 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.07 90.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.864 1.455 . . . . 0.0 110.471 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.466 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 11.5 p -135.75 129.23 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 110.042 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.558 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 14.6 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.294 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.398 0.618 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.554 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 91.5 p -55.48 -79.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.83 . . . . 0.0 110.421 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.546 ' HB3' ' CD2' ' A' ' 21' ' ' LEU . 5.3 m120 -80.08 112.56 31.2 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.374 -0.829 . . . . 0.0 110.3 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.39 -5.38 8.2 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.664 1.349 . . . . 0.0 110.875 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.54 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 47.7 m-80 -132.4 29.64 4.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 110.549 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.797 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.5 p90 -78.61 -175.1 0.51 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 108.83 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.797 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 5.0 Cg_exo -55.64 75.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.383 1.202 . . . . 0.0 109.925 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 53' ' ' PHE . 22.6 pt-20 -44.46 -34.96 2.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.572 -0.705 . . . . 0.0 110.448 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -53.87 -19.34 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.051 -1.031 . . . . 0.0 108.832 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.691 HD11 ' HB2' ' A' ' 54' ' ' PRO . 6.8 mp -96.77 14.22 25.87 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.83 0.824 . . . . 0.0 109.221 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.735 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.76 -51.48 5.31 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.767 -0.583 . . . . 0.0 110.575 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.735 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -53.66 -44.32 50.1 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.37 1.195 . . . . 0.0 110.039 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.612 ' CD1' ' CD1' ' A' ' 69' ' ' ILE . 3.1 mm? -57.59 -38.89 75.63 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 109.608 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.533 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 43.6 t -67.17 -29.4 69.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.15 -0.969 . . . . 0.0 110.181 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.38 6.96 47.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.935 . . . . 0.0 110.08 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.508 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 2.8 mt-10 -99.58 144.34 28.12 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.369 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.03 -26.83 73.79 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.78 1.41 . . . . 0.0 110.178 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.428 ' HB2' HD13 ' A' ' 69' ' ' ILE . 76.1 m-20 -86.94 -3.19 59.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.542 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -42.52 -40.55 2.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.111 -0.993 . . . . 0.0 109.989 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -61.75 -39.72 92.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.476 -0.765 . . . . 0.0 110.454 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -80.3 -31.88 38.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.141 -0.975 . . . . 0.0 109.859 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.612 ' CD1' ' CD1' ' A' ' 60' ' ' LEU . 62.1 mt -74.55 -44.91 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 110.055 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.536 HD11 ' N ' ' A' ' 71' ' ' GLN . 1.7 tm? -50.03 -59.27 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 110.387 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.536 ' N ' HD11 ' A' ' 70' ' ' LEU . 62.6 tt0 -47.91 -52.64 18.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.333 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -55.25 -56.72 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 35.1 mt -49.43 -51.33 36.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 110.205 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 76.7 mm-40 -53.69 -49.82 67.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.967 . . . . 0.0 110.454 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.49 ' CG ' ' CG ' ' A' ' 39' ' ' PRO . 98.8 mt-10 -54.88 -52.14 63.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -0.962 . . . . 0.0 110.523 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.459 HG23 HG23 ' A' ' 3' ' ' VAL . 23.7 mm -62.86 -35.58 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 109.894 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.82 71.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.814 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.1 tt0 -62.05 -38.54 89.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 110.172 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.6 OUTLIER 175.04 94.42 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 110.077 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.558 ' CB ' ' HB3' ' A' ' 83' ' ' CYS . 3.1 Cg_exo -59.74 77.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.931 1.49 . . . . 0.0 110.714 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -42.64 -75.12 0.15 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.598 ' O ' HG12 ' A' ' 85' ' ' ILE . 65.8 p -71.44 -57.29 4.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.396 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.63 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 32.6 t -39.01 -50.79 1.8 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 110.046 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 81.7 tt0 -58.61 -42.97 89.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.041 -1.037 . . . . 0.0 110.731 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 82' ' ' THR . 8.6 pt -89.61 18.04 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.018 . . . . 0.0 110.219 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 7.2 m 57.83 15.0 2.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.317 -0.865 . . . . 0.0 110.547 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 82' ' ' THR . . . -65.53 -19.26 65.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.194 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -135.68 165.43 25.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.72 5.69 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.829 . . . . 0.0 110.563 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -69.58 -31.56 69.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 110.414 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.63 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.7 OUTLIER -108.56 123.81 49.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.818 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.526 ' OG1' ' NE2' ' A' ' 4' ' ' GLN . 44.0 p -110.8 164.05 13.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 110.131 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.6 -3.93 68.81 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.174 -1.192 . . . . 0.0 110.199 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.228 0.537 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 29.8 m -121.42 149.49 42.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 0.0 110.536 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.531 HG22 ' CG ' ' A' ' 12' ' ' LEU . 91.9 t -86.76 118.44 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.707 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.499 ' NE2' HG23 ' A' ' 92' ' ' THR . 21.5 pt20 -111.48 147.91 34.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 111.029 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.515 ' OD2' ' CD2' ' A' ' 73' ' ' LEU . 91.4 m-20 -111.76 12.1 21.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.429 -0.794 . . . . 0.0 109.771 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 174.07 -129.61 1.66 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.02 5.49 22.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -1.166 . . . . 0.0 110.162 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 86.8 m-85 -125.98 147.22 49.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.412 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 94.8 p -101.14 136.61 40.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 0.0 110.144 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.636 ' CD1' HD13 ' A' ' 57' ' ' LEU . 21.5 m-85 -121.35 132.52 54.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.452 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.1 t -71.32 166.69 21.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.295 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.608 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 5.2 mp -97.39 -9.64 27.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.302 -0.874 . . . . 0.0 110.404 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -67.75 -71.51 0.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.842 . . . . 0.0 110.729 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 m -46.34 -46.67 18.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.0 110.467 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.536 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 48.5 t -62.94 -51.62 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.048 -1.032 . . . . 0.0 109.941 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.503 ' NZ ' ' N ' ' A' ' 34' ' ' ASN . 43.0 tttt -54.18 -51.8 63.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.05 -1.031 . . . . 0.0 109.018 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 22.3 tttp -80.21 6.86 10.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 0.0 109.793 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.545 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 17.2 tp -61.54 -37.59 84.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -63.44 -37.05 85.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.08 -1.013 . . . . 0.0 110.047 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -113.33 101.78 9.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.08 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 52' ' ' ASN . 33.9 tp . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.91 . . . . 0.0 110.226 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 70.1 mtt85 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.181 0.515 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 35.3 p-10 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 110.599 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.477 ' HG3' ' HB2' ' A' ' 75' ' ' GLU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.838 0 N-CA-C 110.772 -0.511 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.512 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 126.3 32.44 0.73 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.47 75.5 44.03 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.289 -1.124 . . . . 0.0 110.283 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.469 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 2.9 Cg_endo -62.01 132.25 38.55 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.84 1.442 . . . . 0.0 110.811 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.508 ' CG2' ' OG ' ' A' ' 49' ' ' SER . 6.2 p 179.15 83.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.403 -0.81 . . . . 0.0 110.006 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.525 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 38.8 t . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.479 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.27 0.557 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.555 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 36.3 m -60.12 -53.19 60.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.67 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 3.2 m120 -80.32 111.5 22.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.433 -0.792 . . . . 0.0 110.506 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -58.95 -12.79 16.26 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.646 1.34 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.459 ' HB3' HD13 ' A' ' 21' ' ' LEU . 31.0 t30 -137.39 42.1 2.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.253 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.733 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.3 p90 -80.18 -177.58 0.95 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.391 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.733 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.5 Cg_exo -57.85 74.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.684 1.36 . . . . 0.0 109.693 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.0 tt0 -42.52 -35.55 1.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.481 -0.762 . . . . 0.0 110.348 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -53.7 -18.16 2.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 108.822 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.636 HD13 ' CD1' ' A' ' 10' ' ' PHE . 8.2 mp -96.39 13.3 28.23 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.754 0.788 . . . . 0.0 109.1 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.714 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -41.15 -52.3 7.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.908 -0.495 . . . . 0.0 111.168 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.714 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -53.8 -43.99 53.08 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.6 1.316 . . . . 0.0 110.17 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 17.9 mt -60.36 -34.36 73.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.139 -0.976 . . . . 0.0 109.902 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.457 ' HA ' HG12 ' A' ' 44' ' ' VAL . 36.8 t -66.27 -25.95 67.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.182 -0.949 . . . . 0.0 110.286 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -107.09 25.35 11.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.943 . . . . 0.0 109.323 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.476 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -110.48 143.19 27.62 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.624 -0.672 . . . . 0.0 110.462 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.53 -30.83 80.07 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.896 1.472 . . . . 0.0 109.816 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' ALA . 81.8 m-20 -86.23 -5.95 59.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 0.0 110.507 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -44.53 -41.56 6.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.106 -0.996 . . . . 0.0 110.068 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -55.13 -42.41 72.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.766 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.11 -37.38 33.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 109.863 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.452 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 87.7 mt -63.34 -49.18 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.098 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 1.3 tm? -48.7 -60.88 2.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 110.558 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.583 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 63.9 tt0 -47.07 -53.99 11.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 0.0 110.533 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -54.76 -53.22 57.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 110.112 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.515 ' CD2' ' OD2' ' A' ' 5' ' ' ASP . 73.5 mt -49.84 -52.0 35.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 86.7 mt-10 -52.53 -46.02 66.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.341 -0.849 . . . . 0.0 110.328 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 82.3 tt0 -62.76 -54.24 42.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.672 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 79' ' ' ASP . 32.8 mm -64.56 -43.4 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 110.185 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -55.75 -37.64 68.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 110.024 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 57.6 mm-40 -65.02 -36.16 83.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.365 -0.834 . . . . 0.0 111.087 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -135.55 149.16 68.52 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.868 -1.145 . . . . 0.0 110.725 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.469 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -60.58 -68.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.831 1.437 . . . . 0.0 110.596 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.53 -139.42 20.18 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.544 ' O ' HG12 ' A' ' 85' ' ' ILE . 64.6 p -80.19 -23.03 41.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.126 -1.22 . . . . 0.0 110.007 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 14.2 t -53.38 -53.51 50.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.903 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.8 tt0 -58.14 -32.29 68.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.375 -0.828 . . . . 0.0 111.05 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 82' ' ' THR . 5.2 pt -99.08 12.7 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.96 -1.088 . . . . 0.0 110.401 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 54.97 15.49 1.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.875 . . . . 0.0 110.51 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.52 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -62.02 -14.94 40.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.04 -1.037 . . . . 0.0 109.952 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 19.7 m-85 -144.75 174.35 11.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.03 3.18 10.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.847 . . . . 0.0 110.411 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -59.91 -36.78 77.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.609 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -104.22 123.83 48.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 0.0 110.633 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.499 HG23 ' NE2' ' A' ' 4' ' ' GLN . 23.4 p -105.6 160.53 15.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.381 -0.824 . . . . 0.0 110.146 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.65 3.19 56.28 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.349 -1.089 . . . . 0.0 110.218 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.575 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 9.7 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.333 0.587 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 90.8 m -129.44 154.45 46.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.961 . . . . 0.0 110.726 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.513 HG22 HD11 ' A' ' 12' ' ' LEU . 39.0 t -83.91 117.25 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.351 -0.843 . . . . 0.0 109.82 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.545 ' CB ' ' CG2' ' A' ' 92' ' ' THR . 48.7 tt0 -111.73 128.35 56.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 110.504 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.471 ' OD2' ' CD2' ' A' ' 73' ' ' LEU . 76.1 m-20 -114.24 10.38 17.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.471 -0.768 . . . . 0.0 109.692 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.74 -143.55 4.67 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -82.42 7.74 13.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -1.166 . . . . 0.0 110.221 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.416 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 74.4 m-85 -123.98 145.66 49.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 110.372 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -90.74 123.57 34.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.332 -0.855 . . . . 0.0 110.222 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CD1' ' CD2' ' A' ' 57' ' ' LEU . 20.9 m-85 -110.91 123.08 49.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.863 . . . . 0.0 110.329 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.407 ' HA ' HG21 ' A' ' 2' ' ' THR . 63.4 m -62.37 156.15 23.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.534 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.578 ' O ' ' CG2' ' A' ' 15' ' ' VAL . 45.9 tp -98.68 -20.91 16.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.238 -0.914 . . . . 0.0 110.546 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -62.42 -65.46 0.68 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.139 -0.976 . . . . 0.0 110.51 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.4 m -46.58 -48.54 19.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.968 . . . . 0.0 110.949 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.617 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 31.2 m -60.86 -44.97 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.104 -0.997 . . . . 0.0 110.086 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 1.5 tmmt? -58.54 -56.03 27.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 109.072 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 13.9 ttpt -80.31 8.46 7.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.294 -0.879 . . . . 0.0 109.14 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.617 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 7.7 tp -52.2 -38.67 58.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.582 -0.699 . . . . 0.0 110.027 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -57.25 -45.4 84.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.094 -1.004 . . . . 0.0 109.574 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -97.47 115.05 27.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.764 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.508 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 29.6 tp . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.666 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.318 0.58 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 16.7 p30 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 110.119 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.535 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.866 0 N-CA-C 110.568 -0.589 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.31 6.08 29.69 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.09 71.01 55.83 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.162 -1.199 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.74 147.71 94.69 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.865 1.455 . . . . 0.0 110.269 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.513 HG23 ' CB ' ' A' ' 49' ' ' SER . 12.2 p -158.47 72.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.42 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.49 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 30.6 t . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.1 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.566 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.316 0.579 . . . . 0.0 110.194 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.593 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 85.0 p -61.54 -54.88 37.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -0.92 . . . . 0.0 110.44 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 5.3 m-20 -80.2 110.87 18.08 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.392 -0.818 . . . . 0.0 110.399 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.81 -13.96 33.69 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.623 1.328 . . . . 0.0 110.715 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.508 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 86.3 m-20 -128.21 33.66 4.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 110.55 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.657 ' CE1' ' HA ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -80.25 175.94 4.29 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.129 -0.982 . . . . 0.0 108.792 179.082 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.649 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.1 Cg_exo -56.57 75.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.604 1.318 . . . . 0.0 109.388 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.657 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.5 tt0 -39.35 -27.14 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.712 -0.618 . . . . 0.0 110.387 -178.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.3 mt-10 -53.68 -17.34 2.17 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.964 -1.085 . . . . 0.0 108.657 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.627 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 34.8 mt -95.09 9.17 40.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.566 -0.709 . . . . 0.0 109.676 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.716 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.6 -51.74 4.95 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.28 -0.887 . . . . 0.0 110.678 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.716 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.84 -41.88 74.07 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.496 1.261 . . . . 0.0 110.017 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 55.9 mt -60.39 -36.6 78.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.113 -0.992 . . . . 0.0 110.163 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.533 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 73.6 m -67.53 -28.32 67.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.957 . . . . 0.0 110.272 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -101.22 24.33 9.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.211 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.487 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -113.45 143.55 29.57 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.588 -0.695 . . . . 0.0 110.588 -179.252 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.26 -31.98 73.6 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.813 1.428 . . . . 0.0 109.818 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -86.98 1.67 52.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.361 -0.837 . . . . 0.0 110.701 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.17 -42.63 20.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.068 -1.02 . . . . 0.0 110.058 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.437 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 92.1 mt-30 -56.15 -41.39 75.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.848 . . . . 0.0 110.098 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -79.92 -35.52 37.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 110.135 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.513 ' CD1' HD21 ' A' ' 60' ' ' LEU . 91.6 mt -67.6 -47.95 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.0 109.79 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.647 HD23 ' HG3' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -53.95 -53.28 54.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 0.0 110.378 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.558 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 97.9 mt-30 -49.7 -51.26 39.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.252 -0.905 . . . . 0.0 110.722 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -55.42 -59.64 4.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.317 -0.864 . . . . 0.0 110.711 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.471 ' CD2' ' OD2' ' A' ' 5' ' ' ASP . 60.9 mt -44.38 -49.09 9.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.301 -0.875 . . . . 0.0 110.42 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.647 ' HG3' HD23 ' A' ' 70' ' ' LEU . 70.7 mt-10 -61.82 -26.72 68.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 0.0 110.752 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.535 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.3 tt0 -71.63 -50.41 30.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.929 -1.107 . . . . 0.0 109.785 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.1 mm -67.82 -36.48 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.346 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.543 ' HA ' ' CG ' ' A' ' 12' ' ' LEU . . . -63.28 -29.16 70.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.617 -0.677 . . . . 0.0 109.667 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 84.8 tt0 -62.99 -34.7 78.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.423 -0.798 . . . . 0.0 110.384 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.417 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -161.33 147.01 10.84 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.144 -0.973 . . . . 0.0 110.765 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.48 ' CB ' ' OE1' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.47 84.04 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.052 1.554 . . . . 0.0 110.598 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.68 -130.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.207 -1.957 . . . . 0.0 108.207 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.528 ' HB ' ' CB ' ' A' ' 87' ' ' ALA . 82.8 p -82.76 -16.96 45.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.246 . . . . 0.0 109.321 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.438 ' SG ' ' N ' ' A' ' 91' ' ' CYS . 5.5 t -51.11 -50.38 58.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.733 -0.604 . . . . 0.0 110.37 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' OE1' ' CB ' ' A' ' 80' ' ' PRO . 76.2 tt0 -61.05 -34.87 75.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.268 -0.895 . . . . 0.0 111.364 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.545 ' CG1' ' HB2' ' A' ' 87' ' ' ALA . 4.3 pt -97.24 17.36 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.588 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 m 51.14 17.37 0.46 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.945 . . . . 0.0 110.81 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.545 ' HB2' ' CG1' ' A' ' 85' ' ' ILE . . . -67.55 -13.81 62.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.056 -1.028 . . . . 0.0 109.663 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -141.22 170.27 16.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.79 . . . . 0.0 109.996 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.73 4.43 7.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.12 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -59.27 -40.35 85.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.639 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.531 ' SG ' ' CG2' ' A' ' 1' ' ' VAL . 1.0 OUTLIER -103.04 128.24 49.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.214 -0.929 . . . . 0.0 110.689 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.545 ' CG2' ' CB ' ' A' ' 4' ' ' GLN . 16.9 p -108.0 165.45 11.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.25 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.29 -7.07 61.82 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.319 -1.107 . . . . 0.0 110.21 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.449 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 6.4 m . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.107 0.48 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 14.6 t -129.75 164.09 24.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.565 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 43.2 t -80.06 110.98 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.352 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.54 ' CB ' HG22 ' A' ' 92' ' ' THR . 46.2 tt0 -109.53 121.15 44.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.111 -0.993 . . . . 0.0 110.578 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -99.12 5.65 46.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.821 . . . . 0.0 109.673 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.93 -141.18 3.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -79.92 0.17 32.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -1.193 . . . . 0.0 110.36 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.483 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 92.4 m-85 -112.64 138.07 49.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.179 -0.95 . . . . 0.0 110.462 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.536 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 73.4 m -89.11 128.79 35.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.359 -0.838 . . . . 0.0 110.144 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.58 ' CE1' HD21 ' A' ' 57' ' ' LEU . 91.6 m-85 -111.79 119.14 37.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.897 . . . . 0.0 110.483 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.7 p -70.88 168.38 16.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.93 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.514 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 65.0 mt -99.51 2.94 45.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.978 . . . . 0.0 110.425 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 14' ' ' SER . 81.7 tt0 -76.28 -71.02 0.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 110.503 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.472 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.6 m -42.42 -49.45 5.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.007 -1.058 . . . . 0.0 110.271 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.607 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 7.8 m -58.9 -48.89 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.181 -0.949 . . . . 0.0 109.851 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -54.68 -55.91 24.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.894 -1.129 . . . . 0.0 108.972 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -80.33 12.34 3.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.415 -0.803 . . . . 0.0 109.621 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.607 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 39.1 tp -57.96 -37.15 73.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.354 -0.842 . . . . 0.0 110.376 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -55.29 -43.21 74.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.127 -0.983 . . . . 0.0 110.006 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -99.96 109.94 22.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 110.042 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.542 HD22 ' ND2' ' A' ' 50' ' ' ASN . 93.8 mt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.895 . . . . 0.0 110.277 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.118 0.485 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 86.9 m-20 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 110.76 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.513 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.891 0 N-CA-C 110.495 -0.617 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 71' ' ' GLN . . . 102.02 -0.35 51.43 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.91 139.54 95.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.214 -1.168 . . . . 0.0 110.214 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.68 110.0 0.87 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.756 1.398 . . . . 0.0 110.329 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.488 HG11 HG22 ' A' ' 44' ' ' VAL . 63.3 t -135.97 143.04 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.142 -0.974 . . . . 0.0 110.515 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.585 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 46.4 t . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.775 . . . . 0.0 110.861 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.506 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.223 0.535 . . . . 0.0 110.038 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.612 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 6.6 p -96.16 -53.46 3.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 110.566 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.542 ' ND2' HD22 ' A' ' 21' ' ' LEU . 9.6 m-20 -80.06 111.35 21.22 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.401 -0.812 . . . . 0.0 110.439 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.612 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.91 -13.62 40.72 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.704 1.37 . . . . 0.0 110.371 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.484 ' HB2' HD21 ' A' ' 21' ' ' LEU . 95.2 m-20 -114.27 20.16 15.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.415 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.639 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.15 173.45 7.7 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 108.961 179.193 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.639 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.1 Cg_exo -57.37 75.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.632 1.333 . . . . 0.0 108.925 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.631 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 23.9 pt-20 -39.11 -26.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.745 -0.597 . . . . 0.0 110.596 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt-10 -51.68 -22.23 3.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.944 -1.097 . . . . 0.0 108.452 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.621 ' CD1' ' HG2' ' A' ' 54' ' ' PRO . 66.7 mt -83.14 8.86 11.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.662 -0.649 . . . . 0.0 109.472 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.725 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.75 -51.49 5.29 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.457 -0.777 . . . . 0.0 110.601 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.725 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.97 -41.43 78.81 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.52 1.274 . . . . 0.0 110.571 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.569 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 5.9 mp -62.48 -35.45 79.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.88 -1.138 . . . . 0.0 110.384 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.517 ' HA ' HG12 ' A' ' 44' ' ' VAL . 84.3 m -67.22 -28.19 67.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.064 -1.023 . . . . 0.0 110.536 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.447 ' NZ ' ' HE2' ' A' ' 58' ' ' LYS . 91.2 mttt -81.64 -3.08 52.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.825 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 11.4 pt-20 -125.38 147.02 56.31 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.94 -1.1 . . . . 0.0 110.376 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.27 -6.94 10.9 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.903 1.475 . . . . 0.0 111.024 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -79.92 -22.69 42.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.087 -1.008 . . . . 0.0 110.161 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.69 -39.37 17.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.419 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.57 -41.51 97.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 110.278 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.39 -38.17 30.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.558 ' CG2' ' CD2' ' A' ' 60' ' ' LEU . 95.7 mt -65.17 -39.39 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 110.489 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.505 ' O ' HD23 ' A' ' 70' ' ' LEU . 2.3 tm? -56.42 -51.34 68.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.937 . . . . 0.0 110.499 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.476 ' HG2' ' HA3' ' A' ' 40' ' ' GLY . 89.6 mt-30 -49.64 -54.78 16.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.103 -0.998 . . . . 0.0 110.117 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -52.36 -54.33 33.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.39 -0.818 . . . . 0.0 110.119 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 41.5 mt -48.43 -50.47 31.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.879 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 69.6 mm-40 -53.9 -51.78 62.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.892 . . . . 0.0 110.279 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -54.78 -56.85 14.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.039 -1.038 . . . . 0.0 110.536 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 79' ' ' ASP . 20.1 mt -58.9 -35.16 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.121 -0.987 . . . . 0.0 109.465 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 34' ' ' ASN . . . -57.89 -34.72 70.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.545 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -60.39 -40.65 91.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -148.01 153.69 42.19 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.163 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -58.56 -59.22 0.52 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.895 1.471 . . . . 0.0 110.574 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.33 -138.69 20.15 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.58 ' O ' HG12 ' A' ' 85' ' ' ILE . 65.5 p -82.31 -21.13 36.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -1.11 . . . . 0.0 110.058 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 42.3 t -55.64 -53.35 57.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.208 -0.933 . . . . 0.0 110.109 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.7 tt0 -60.7 -27.81 68.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 111.22 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 82' ' ' THR . 6.2 pt -99.05 13.51 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 110.273 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 55.37 16.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.504 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.531 ' HB2' ' CG1' ' A' ' 85' ' ' ILE . . . -67.29 -15.35 63.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.967 . . . . 0.0 109.931 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.46 169.49 17.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.13 3.09 11.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 110.185 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.53 -34.8 77.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.458 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -103.51 123.25 46.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.737 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.54 HG22 ' CB ' ' A' ' 4' ' ' GLN . 21.8 p -111.63 154.98 24.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 109.754 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 44.14 4.82 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.342 -1.093 . . . . 0.0 110.282 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 91' ' ' CYS . 3.4 t . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.164 0.507 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 30.8 m -126.25 142.66 51.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.55 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.56 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 90.4 t -82.24 119.66 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.496 -0.752 . . . . 0.0 109.448 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.483 ' HB2' HG22 ' A' ' 92' ' ' THR . 44.8 tt0 -113.5 133.11 55.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.879 -1.138 . . . . 0.0 110.787 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -92.06 -78.89 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.567 -0.708 . . . . 0.0 109.65 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.0 -122.16 4.67 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -85.19 10.01 13.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.157 . . . . 0.0 110.341 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.466 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 98.1 m-85 -122.45 137.9 54.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.448 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.436 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 60.7 p -89.64 128.35 36.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 110.076 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.705 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 23.2 m-30 -117.07 126.98 53.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 0.0 110.746 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.1 t -61.48 157.92 16.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.079 . . . . 0.0 109.727 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HB3' ' CG2' ' A' ' 3' ' ' VAL . 1.5 pt? -100.5 -25.31 14.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -1.0 . . . . 0.0 111.071 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.21 -65.86 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.078 -1.014 . . . . 0.0 110.74 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.6 m -52.59 -38.86 60.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.363 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.567 ' CG1' ' HG ' ' A' ' 73' ' ' LEU . 6.8 t -58.15 -46.4 88.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.135 -0.978 . . . . 0.0 109.621 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HD3' ' CD ' ' A' ' 33' ' ' ARG . 18.9 tttt -57.73 -53.84 53.67 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.056 -1.028 . . . . 0.0 108.74 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 20' ' ' ASP . 51.4 mttm -80.34 12.05 3.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.535 -0.728 . . . . 0.0 109.751 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 8.7 tt -59.55 -39.08 82.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.136 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -50.61 -42.54 56.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 17' ' ' LYS . 39.0 p30 -150.31 146.4 26.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.809 . . . . 0.0 109.605 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.52 ' CD2' ' CG ' ' A' ' 52' ' ' ASN . 14.7 tp . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.986 . . . . 0.0 110.759 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.488 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 8.8 mmt85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.228 0.537 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 18.0 p-10 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 110.305 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.482 0.797 0 N-CA-C 110.71 -0.534 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.55 12.23 2.54 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.537 ' O ' HD13 ' A' ' 70' ' ' LEU . 3.8 pt-20 -119.48 77.87 19.8 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.094 -1.239 . . . . 0.0 110.138 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.32 143.52 99.7 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.978 1.515 . . . . 0.0 110.672 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.534 ' CG2' HG22 ' A' ' 44' ' ' VAL . 20.2 m -121.77 -166.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 110.273 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.534 HG22 ' CG2' ' A' ' 43' ' ' VAL . 11.3 t . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.468 -0.77 . . . . 0.0 110.552 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 71.8 m . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.478 0.656 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.503 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 87.8 p -59.89 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.459 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' LEU . 1.8 m120 -66.09 112.94 10.28 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.868 . . . . 0.0 110.691 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.7 -7.1 15.47 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.713 1.375 . . . . 0.0 109.721 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.52 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 26.5 p30 -124.95 26.06 7.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.511 -0.743 . . . . 0.0 110.368 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.714 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -79.15 179.89 1.63 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.213 -0.929 . . . . 0.0 108.575 179.102 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.714 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.7 Cg_exo -57.73 75.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 N-CA-C 108.89 -1.235 . . . . 0.0 108.89 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.638 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.2 tt0 -39.2 -27.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.706 -0.621 . . . . 0.0 110.085 -178.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.516 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 96.3 mt-10 -52.6 -17.91 1.5 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.068 -1.02 . . . . 0.0 108.74 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.705 ' CD2' ' CG ' ' A' ' 10' ' ' PHE . 33.5 mt -89.47 8.46 30.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.553 -0.717 . . . . 0.0 109.683 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.749 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.65 -50.42 5.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 110.463 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.749 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.58 -41.04 81.03 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.457 1.24 . . . . 0.0 110.027 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.533 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 34.7 mt -59.81 -41.41 91.21 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.095 -1.003 . . . . 0.0 110.153 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 t -69.13 -31.08 69.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.084 -1.01 . . . . 0.0 110.294 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -80.03 4.62 16.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.565 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.525 ' OE1' ' CD1' ' A' ' 69' ' ' ILE . 8.1 pt-20 -124.0 138.18 30.19 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.074 -1.016 . . . . 0.0 110.128 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.98 -16.51 45.85 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.767 1.403 . . . . 0.0 110.647 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 20.5 m120 -80.05 -8.24 59.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 110.023 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -51.02 -34.45 29.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.818 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -62.79 -38.62 91.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.683 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.29 -43.69 20.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.525 ' CD1' ' OE1' ' A' ' 63' ' ' GLU . 66.8 mt -62.69 -39.94 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.866 . . . . 0.0 109.557 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.623 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 1.5 tm? -46.93 -65.94 0.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.606 -0.684 . . . . 0.0 110.627 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.623 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 92.7 mt-30 -46.56 -53.48 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 110.385 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 18.2 tpp180 -55.49 -54.46 43.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.12 -0.988 . . . . 0.0 109.946 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.567 ' HG ' ' CG1' ' A' ' 15' ' ' VAL . 10.0 tp -50.08 -53.64 25.76 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.295 -0.878 . . . . 0.0 109.96 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 88.0 mt-10 -50.71 -45.24 58.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 96.7 mt-10 -54.1 -53.33 54.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.09 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.555 HG23 ' CG2' ' A' ' 3' ' ' VAL . 6.0 mt -61.12 -38.15 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.924 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . . . -59.79 -37.17 78.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 110.049 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.435 ' HG2' ' HG3' ' A' ' 16' ' ' LYS . 47.3 mt-10 -103.66 12.9 34.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.662 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 1.6 t70 -160.26 106.86 1.38 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.487 -0.758 . . . . 0.0 109.696 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.527 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 3.4 Cg_exo -57.17 -65.63 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.803 1.423 . . . . 0.0 110.592 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.56 -136.74 17.09 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.595 ' O ' HG12 ' A' ' 85' ' ' ILE . 80.8 p -78.62 -22.93 46.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.311 -1.111 . . . . 0.0 110.01 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 5.0 t -45.72 -58.04 3.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 0.0 110.522 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.527 ' HG3' ' HB3' ' A' ' 80' ' ' PRO . 56.2 mt-10 -56.96 -37.58 71.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.301 -0.875 . . . . 0.0 111.526 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 82' ' ' THR . 8.0 pt -89.28 12.97 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.853 -1.154 . . . . 0.0 110.503 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 59.9 m 51.45 19.75 0.88 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 110.782 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.561 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -74.3 -2.89 27.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.046 -1.034 . . . . 0.0 109.919 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 3.4 m-85 -151.9 171.47 17.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.306 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.59 4.9 6.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.292 -0.88 . . . . 0.0 110.441 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.32 -31.1 72.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.911 . . . . 0.0 110.67 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.469 ' HB3' HG12 ' A' ' 1' ' ' VAL . 0.7 OUTLIER -114.81 125.84 54.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.05 -1.031 . . . . 0.0 110.637 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 4' ' ' GLN . 33.2 p -114.36 152.2 31.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.389 -0.819 . . . . 0.0 110.396 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.76 -21.61 45.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.295 -1.121 . . . . 0.0 110.273 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.485 ' CG2' ' SG ' ' A' ' 91' ' ' CYS . 3.1 p . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.213 0.53 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.443 HG21 ' HA ' ' A' ' 11' ' ' SER . 57.0 m -118.07 154.5 31.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.302 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.515 HG22 ' HB2' ' A' ' 12' ' ' LEU . 96.3 t -82.25 123.23 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 109.801 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.526 ' CB ' HG22 ' A' ' 92' ' ' THR . 62.6 tt0 -113.09 122.31 47.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.946 . . . . 0.0 110.7 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.431 ' OD2' ' CD2' ' A' ' 73' ' ' LEU . 88.4 m-20 -99.9 13.49 33.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.429 -0.794 . . . . 0.0 109.864 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.521 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . 174.24 -132.96 2.38 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -90.63 15.46 10.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -1.153 . . . . 0.0 109.955 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.604 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . 87.0 m-85 -129.5 128.66 43.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.471 -0.768 . . . . 0.0 110.092 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.3 p -79.95 123.42 27.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 109.998 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' A' ' 8' ' ' PHE . 85.7 m-85 -116.71 125.35 51.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 110.61 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.443 ' HA ' HG21 ' A' ' 2' ' ' THR . 80.8 p -66.16 165.08 14.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 109.787 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.515 ' HB2' HG22 ' A' ' 3' ' ' VAL . 15.1 tp -110.93 -8.91 14.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 110.853 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.464 ' HG3' ' HD3' ' A' ' 33' ' ' ARG . 86.2 tt0 -60.17 -69.73 0.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.056 -1.027 . . . . 0.0 110.606 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.9 m -44.67 -39.55 5.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 0.0 110.547 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 25.2 t -64.99 -49.22 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.035 -1.04 . . . . 0.0 109.535 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.548 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 78.5 mttt -55.22 -50.74 68.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.08 -1.012 . . . . 0.0 108.808 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -80.14 4.54 17.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.529 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.649 HD11 ' HD3' ' A' ' 54' ' ' PRO . 18.7 tp -56.97 -25.79 58.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.0 110.193 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -61.33 -35.81 78.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.841 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -86.5 109.96 19.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.882 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.651 ' CD2' ' ND2' ' A' ' 50' ' ' ASN . 1.2 mm? . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.473 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.548 ' HB3' ' HD2' ' A' ' 16' ' ' LYS . 74.1 mtt85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.2 0.524 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 4.0 p30 . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.233 -0.917 . . . . 0.0 110.159 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.5 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 3.0 Cg_exo . . . . . 0 N--CA 1.482 0.834 0 N-CA-C 110.603 -0.576 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.45 4.58 2.01 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER 60.72 72.18 0.75 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.084 -1.245 . . . . 0.0 109.988 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.591 ' CD ' HD13 ' A' ' 70' ' ' LEU . 3.0 Cg_endo -61.58 -165.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.952 1.501 . . . . 0.0 110.988 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.561 HG11 ' CB ' ' A' ' 49' ' ' SER . 0.2 OUTLIER -96.05 129.28 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.748 . . . . 0.0 110.175 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.599 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 3.1 p . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.333 -0.854 . . . . 0.0 110.198 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.468 ' HA ' HG21 ' A' ' 44' ' ' VAL . 1.5 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.321 0.581 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.731 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 87.3 p -64.02 -41.12 97.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 110.926 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.651 ' ND2' ' CD2' ' A' ' 21' ' ' LEU . 5.8 m-20 -80.68 106.9 6.06 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.897 . . . . 0.0 110.619 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.731 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -61.11 -16.26 44.79 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.682 1.359 . . . . 0.0 110.33 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -128.03 36.54 4.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.232 -0.917 . . . . 0.0 111.145 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.64 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.1 172.23 10.37 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.776 -1.203 . . . . 0.0 108.484 178.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.649 ' HD3' HD11 ' A' ' 18' ' ' LEU . 4.1 Cg_exo -54.45 76.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.505 1.266 . . . . 0.0 109.39 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.6 tt0 -39.65 -27.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.744 -0.598 . . . . 0.0 110.084 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.7 mt-10 -52.7 -17.89 1.54 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.068 -1.02 . . . . 0.0 108.449 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.593 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 89.2 mt -90.24 11.2 21.88 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.609 0.719 . . . . 0.0 109.136 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.722 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -39.95 -51.99 5.43 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.416 -0.803 . . . . 0.0 110.262 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.722 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -54.0 -46.07 36.36 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.461 1.242 . . . . 0.0 109.373 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.588 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 11.7 tp -49.58 -49.46 46.48 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.264 -0.898 . . . . 0.0 109.749 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.498 ' SG ' HG21 ' A' ' 44' ' ' VAL . 1.2 t -61.33 -27.94 68.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 110.609 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 22.7 ttpt -81.01 -2.05 46.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 110.56 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 59' ' ' PRO . 11.2 pt-20 -126.43 144.85 50.85 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.064 -1.023 . . . . 0.0 110.074 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.27 -8.65 12.91 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.785 1.413 . . . . 0.0 110.801 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -79.58 -18.0 52.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 110.668 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' A' ' 60' ' ' LEU . . . -45.08 -40.03 6.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.079 -1.013 . . . . 0.0 109.941 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.44 ' O ' ' CD ' ' A' ' 41' ' ' GLU . 93.7 mt-30 -66.01 -39.12 90.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -0.869 . . . . 0.0 109.979 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -80.5 -44.95 18.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.173 -0.954 . . . . 0.0 109.672 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.583 ' CG2' HD12 ' A' ' 60' ' ' LEU . 57.9 mt -63.73 -42.19 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.814 . . . . 0.0 109.899 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.591 HD13 ' CD ' ' A' ' 42' ' ' PRO . 2.2 tm? -52.34 -52.69 51.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.459 -0.776 . . . . 0.0 109.902 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.5 ' HG3' ' HB2' ' A' ' 39' ' ' PRO . 46.0 tt0 -42.74 -53.53 4.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.095 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -59.11 -53.1 62.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 110.65 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.431 ' CD2' ' OD2' ' A' ' 5' ' ' ASP . 63.6 mt -50.58 -55.7 15.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.085 -1.009 . . . . 0.0 110.145 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.549 ' HG3' HD12 ' A' ' 70' ' ' LEU . 26.9 mt-10 -54.61 -50.74 67.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 110.442 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.26 -54.06 45.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.433 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.487 ' C ' HD22 ' A' ' 12' ' ' LEU . 70.2 mt -61.65 -34.34 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.998 . . . . 0.0 109.735 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.471 ' O ' ' HE2' ' A' ' 16' ' ' LYS . . . -57.07 -34.73 68.57 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.323 -0.861 . . . . 0.0 109.599 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.31 -40.94 92.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 110.115 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -153.71 160.4 30.98 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.901 . . . . 0.0 110.259 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.537 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -60.39 -59.72 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.916 1.482 . . . . 0.0 110.544 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.11 -140.04 25.06 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.55 ' O ' HG12 ' A' ' 85' ' ' ILE . 73.1 p -82.14 -21.94 36.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.272 -1.134 . . . . 0.0 110.163 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 4.6 t -55.8 -49.21 73.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.716 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 82.7 tt0 -59.54 -32.13 70.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.822 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 82' ' ' THR . 5.5 pt -99.3 10.51 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.99 -1.069 . . . . 0.0 110.328 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.7 m 56.96 16.5 2.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.88 . . . . 0.0 110.641 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.543 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -60.53 -18.8 54.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.965 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -140.37 177.82 7.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 110.182 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.81 1.53 12.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.871 . . . . 0.0 110.335 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.45 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . . . -58.56 -40.86 84.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.658 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.553 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER -112.79 122.67 48.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.928 . . . . 0.0 110.81 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.526 HG22 ' CB ' ' A' ' 4' ' ' GLN . 25.6 p -105.18 176.25 5.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 110.262 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.42 -6.81 65.85 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.391 -1.064 . . . . 0.0 110.209 -179.921 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.53 ' CG2' ' SG ' ' A' ' 91' ' ' CYS . 10.6 p . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.211 0.529 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.51 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 30.7 m -90.09 148.03 23.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 110.802 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.599 ' CG2' ' CD2' ' A' ' 12' ' ' LEU . 22.9 t -97.06 118.53 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.581 -0.699 . . . . 0.0 109.435 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.524 ' CB ' ' HA ' ' A' ' 9' ' ' SER . 20.9 pt20 -120.56 177.47 5.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.081 -1.012 . . . . 0.0 110.936 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -151.45 -62.19 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.741 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.82 -115.81 0.74 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -108.21 13.2 26.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.227 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.521 ' CD1' ' OE2' ' A' ' 56' ' ' GLU . 97.9 m-85 -131.77 159.36 38.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.524 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 37.6 m -101.07 136.31 41.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.937 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.689 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 6.6 m-30 -112.69 123.23 49.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.654 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 m -66.33 160.11 25.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.599 ' CD2' ' CG2' ' A' ' 3' ' ' VAL . 99.5 mt -86.97 -27.33 23.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 110.735 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -61.56 -66.3 0.56 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 0.0 110.671 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.479 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.6 m -44.27 -48.71 9.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.977 -1.077 . . . . 0.0 110.151 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 58.5 t -59.05 -46.72 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.218 -0.926 . . . . 0.0 110.109 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 25.1 tttm -58.9 -52.43 65.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.806 -1.184 . . . . 0.0 108.562 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -80.65 11.98 3.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.35 -0.844 . . . . 0.0 109.368 178.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.548 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 59.1 tp -57.17 -37.08 71.59 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.416 -0.803 . . . . 0.0 110.097 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -60.75 -38.88 86.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 109.38 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -141.55 124.73 16.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.594 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' CD1' ' CB ' ' A' ' 52' ' ' ASN . 4.5 mm? . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.616 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.456 ' NH2' ' CG ' ' A' ' 33' ' ' ARG . 13.4 mmt-85 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.3 0.572 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.486 ' O ' ' CE ' ' A' ' 16' ' ' LYS . 44.9 p-10 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.968 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.834 0 N-CA-C 110.494 -0.618 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.529 ' N ' ' HG2' ' A' ' 71' ' ' GLN . . . 117.2 40.16 0.76 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.48 ' O ' HD13 ' A' ' 70' ' ' LEU . 6.8 mt-10 -130.14 73.14 81.61 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.308 -1.113 . . . . 0.0 110.374 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -60.68 141.77 95.96 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.908 1.478 . . . . 0.0 110.146 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.517 ' CG2' HD22 ' A' ' 18' ' ' LEU . 24.0 m -140.51 54.83 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.667 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 61' ' ' CYS . 17.1 m . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.583 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 1.2 m . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.347 0.594 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.618 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -87.78 -58.34 2.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.415 -0.803 . . . . 0.0 110.228 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.492 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 6.4 m120 -78.93 110.27 13.9 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.419 -0.801 . . . . 0.0 110.326 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.618 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -61.99 -11.39 21.28 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.721 1.379 . . . . 0.0 110.336 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.562 ' CB ' ' CD1' ' A' ' 21' ' ' LEU . 99.6 m-20 -130.52 34.23 4.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.842 . . . . 0.0 110.734 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.68 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.17 174.23 6.46 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.038 -1.039 . . . . 0.0 108.719 178.953 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.68 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.0 Cg_exo -56.36 76.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.624 1.329 . . . . 0.0 108.889 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.647 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.7 tt0 -39.07 -26.31 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.884 -0.51 . . . . 0.0 110.377 -178.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.521 ' OE2' ' CD1' ' A' ' 8' ' ' PHE . 39.3 tp10 -53.13 -20.76 4.09 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.931 -1.105 . . . . 0.0 108.174 178.145 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.689 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 82.2 mt -84.35 8.45 16.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.623 -0.673 . . . . 0.0 109.657 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.702 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.57 -51.49 4.98 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.73 -179.568 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.702 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -56.71 -44.31 46.47 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.632 1.333 . . . . 0.0 110.744 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.589 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 1.5 mt -60.63 -40.04 90.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.814 -1.179 . . . . 0.0 110.503 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.478 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 46.2 t -65.56 -28.14 68.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.034 -1.041 . . . . 0.0 110.697 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 46.2 tttm -90.75 6.69 43.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.639 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.488 ' OE2' ' HB2' ' A' ' 65' ' ' ASN . 12.7 pt-20 -130.84 144.61 54.21 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.959 -1.088 . . . . 0.0 110.4 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.22 -8.31 12.06 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.91 1.479 . . . . 0.0 110.797 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.488 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 83.9 m-20 -79.23 -23.79 43.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 110.194 -179.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -51.33 -36.3 42.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.083 -1.01 . . . . 0.0 109.685 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.458 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.8 mt-30 -61.65 -43.55 98.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.0 109.758 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -80.27 -41.17 25.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 109.609 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.489 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 86.0 mt -64.24 -46.26 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 109.87 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.504 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 2.2 tm? -49.38 -53.86 20.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.946 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.529 ' HG2' ' N ' ' A' ' 40' ' ' GLY . 87.9 mt-30 -45.41 -53.9 8.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -57.79 -54.62 44.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 48.4 mt -44.98 -56.1 4.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.338 -0.851 . . . . 0.0 109.705 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 64.6 mt-10 -51.12 -53.6 32.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 110.154 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 78' ' ' GLU . 82.8 tt0 -55.23 -54.49 42.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 110.693 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.515 ' CG2' HG23 ' A' ' 3' ' ' VAL . 24.7 mm -58.75 -37.52 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 109.81 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -57.21 -33.06 67.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.591 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' ASN . 99.2 mt-10 -60.12 -41.92 93.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 110.52 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -147.83 159.54 40.37 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.93 . . . . 0.0 110.275 -179.797 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.527 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -59.77 -57.21 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.883 1.465 . . . . 0.0 110.65 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.02 -140.89 26.38 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.617 ' O ' HG12 ' A' ' 85' ' ' ILE . 79.6 p -78.08 -21.51 50.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -1.116 . . . . 0.0 109.932 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.454 ' C ' ' SG ' ' A' ' 91' ' ' CYS . 42.0 t -54.52 -54.15 44.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 109.976 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.0 tt0 -55.77 -32.17 63.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 111.028 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 82' ' ' THR . 7.8 pt -96.92 10.89 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.922 -1.111 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 57.21 18.83 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.521 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -70.89 -7.59 46.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.997 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -147.06 167.64 23.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.37 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.01 4.94 5.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.386 -0.821 . . . . 0.0 110.5 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -65.36 -35.42 80.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.161 -0.962 . . . . 0.0 110.482 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.53 ' SG ' ' CG2' ' A' ' 1' ' ' VAL . 0.1 OUTLIER -96.53 120.48 36.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.705 -179.712 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.462 ' CG2' ' NE2' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -104.77 -5.39 21.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 110.577 -179.438 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . -83.76 -36.05 14.68 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.21 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.402 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 18.5 m . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.243 0.544 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.454 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 37.0 m -88.17 151.16 22.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.387 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.531 HG22 ' CG ' ' A' ' 12' ' ' LEU . 85.2 t -94.23 121.94 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.717 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.526 ' HG2' ' HA ' ' A' ' 9' ' ' SER . 10.4 mt-30 -109.64 139.06 45.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 110.815 -179.391 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -111.59 11.53 21.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 109.784 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.23 -131.38 1.87 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -88.5 8.44 28.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.141 -1.211 . . . . 0.0 110.191 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 92.0 m-85 -121.7 158.83 27.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.193 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.526 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 22.4 t -105.43 123.41 47.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.363 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 17.6 m-30 -119.19 130.46 55.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.843 . . . . 0.0 110.51 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.4 m -78.62 172.73 13.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.021 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.531 ' CG ' HG22 ' A' ' 3' ' ' VAL . 53.0 mt -97.35 -5.29 36.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.0 110.636 -179.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.3 mt-10 -74.29 -73.17 0.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.361 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' ' 13' ' ' GLU . 5.2 m -39.91 -51.43 2.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.677 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.672 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 27.4 m -63.93 -45.67 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.069 -1.019 . . . . 0.0 109.697 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 16.6 tttt -55.12 -56.89 14.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.88 -1.138 . . . . 0.0 109.063 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -80.22 8.31 7.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.818 . . . . 0.0 109.467 178.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.672 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 15.4 tp -54.57 -34.84 62.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.403 -0.811 . . . . 0.0 110.331 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -60.48 -41.55 94.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.993 . . . . 0.0 109.895 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.39 98.02 10.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.988 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 11.0 tp . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.341 -179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.501 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 24.3 ptt-85 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 41.9 p-10 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.07 -1.019 . . . . 0.0 110.856 -179.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.549 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.3 Cg_exo . . . . . 0 N--CA 1.481 0.759 0 N-CA-C 110.774 -0.51 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.34 19.32 1.73 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -104.3 117.47 59.22 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 110.06 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.23 101.02 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.658 1.346 . . . . 0.0 110.53 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.589 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 90.7 t -132.12 172.33 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.726 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 0.0 111.441 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.322 0.582 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.586 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 13.2 t -107.69 -70.7 0.79 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.944 . . . . 0.0 110.144 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.477 ' HB3' ' CD1' ' A' ' 21' ' ' LEU . 5.6 m-20 -79.2 111.51 20.89 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.591 -0.693 . . . . 0.0 110.092 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -64.45 -9.14 19.14 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.612 1.322 . . . . 0.0 110.114 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.507 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 96.8 m-20 -125.68 31.89 5.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.797 . . . . 0.0 110.218 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.736 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -79.85 178.02 2.59 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 108.803 179.09 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.736 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -57.86 75.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.493 1.26 . . . . 0.0 108.936 179.352 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.627 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.8 tt0 -39.28 -27.54 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.86 -0.525 . . . . 0.0 110.139 -178.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.0 mt-10 -52.21 -18.37 1.49 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.048 -1.032 . . . . 0.0 108.401 178.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.597 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 81.7 mt -88.8 9.95 22.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.637 -0.665 . . . . 0.0 109.571 179.092 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.733 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -39.63 -51.28 5.14 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 110.344 -179.854 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.733 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -54.87 -43.52 58.55 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.5 1.263 . . . . 0.0 109.666 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.584 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -53.42 -42.07 66.68 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.109 -0.994 . . . . 0.0 109.674 179.403 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.5 ' SG ' HG21 ' A' ' 44' ' ' VAL . 22.0 m -64.85 -28.05 69.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.131 -0.981 . . . . 0.0 110.335 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -90.66 2.55 55.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 111.434 -178.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.557 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 25.7 pt-20 -120.83 142.9 35.41 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.625 -1.297 . . . . 0.0 110.317 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -64.0 -18.29 63.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.91 1.479 . . . . 0.0 111.239 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -79.69 -12.3 59.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.985 -1.072 . . . . 0.0 110.344 -179.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.586 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . . . -47.42 -41.16 19.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 110.461 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -56.68 -42.23 78.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 -179.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.4 mt-10 -79.92 -34.35 39.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.173 -0.955 . . . . 0.0 110.322 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.557 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 90.3 mt -68.96 -46.96 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.138 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.554 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -47.69 -62.5 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.525 -179.787 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.522 ' N ' HD12 ' A' ' 70' ' ' LEU . 51.4 tt0 -49.62 -54.08 20.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.13 -0.981 . . . . 0.0 110.736 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 75.5 mtt-85 -52.7 -53.59 45.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.229 -0.919 . . . . 0.0 110.518 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.595 ' CD2' HG13 ' A' ' 15' ' ' VAL . 7.2 tp -51.09 -48.83 61.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.072 -1.017 . . . . 0.0 110.015 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 43.1 mt-10 -55.63 -41.13 73.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.376 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.549 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -66.24 -55.94 13.69 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.057 -1.027 . . . . 0.0 110.464 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.471 HG23 HG23 ' A' ' 3' ' ' VAL . 22.2 mm -58.77 -40.77 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.336 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -62.76 -28.48 70.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.534 -0.729 . . . . 0.0 109.08 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 80.6 tt0 -65.36 -36.42 83.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.619 -0.676 . . . . 0.0 110.443 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.2 m-20 -149.14 158.04 39.1 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.824 -1.173 . . . . 0.0 110.524 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.517 ' CB ' ' OE1' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -61.72 -71.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.057 1.556 . . . . 0.0 110.653 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.89 -140.05 23.58 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.56 ' O ' HG12 ' A' ' 85' ' ' ILE . 70.5 p -79.08 -24.32 43.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -1.168 . . . . 0.0 109.732 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 11.3 t -53.18 -53.55 48.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.517 ' OE1' ' CB ' ' A' ' 80' ' ' PRO . 83.2 tt0 -58.47 -32.19 68.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 111.057 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 82' ' ' THR . 5.1 pt -98.46 11.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.957 -1.09 . . . . 0.0 110.291 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 34.4 m 59.39 12.12 2.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.177 -0.952 . . . . 0.0 110.514 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.526 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -64.89 -16.18 62.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 109.997 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -137.17 166.57 23.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 110.188 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.85 2.88 7.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 110.289 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.35 -38.8 90.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 0.0 110.433 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.7 OUTLIER -104.11 118.25 36.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 110.636 -179.663 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.511 HG23 ' NE2' ' A' ' 4' ' ' GLN . 72.8 p -103.13 166.55 10.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.376 -0.827 . . . . 0.0 110.069 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.16 -5.08 78.27 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.303 -1.116 . . . . 0.0 110.213 179.988 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.422 HG11 ' SG ' ' A' ' 91' ' ' CYS . 54.6 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.284 0.564 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.559 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 7.2 t -129.21 168.49 16.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.375 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -93.01 114.83 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.647 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.522 ' OE1' ' CG2' ' A' ' 92' ' ' THR . 61.2 tt0 -110.7 121.02 44.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.952 -179.216 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.49 ' OD2' HD22 ' A' ' 60' ' ' LEU . 58.4 p30 -99.92 3.64 44.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.362 -0.836 . . . . 0.0 109.325 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . -172.53 -142.56 3.82 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -82.1 1.42 36.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.2 -1.176 . . . . 0.0 110.498 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.467 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 98.6 m-85 -109.19 134.43 51.75 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.621 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.559 ' OG ' ' CG2' ' A' ' 2' ' ' THR . 1.0 OUTLIER -85.47 126.55 33.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.355 -0.841 . . . . 0.0 109.981 179.779 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CD1' HD13 ' A' ' 57' ' ' LEU . 21.7 m-30 -117.7 127.21 53.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.023 -1.048 . . . . 0.0 110.777 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 15' ' ' VAL . 59.9 p -76.7 172.89 12.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.314 -0.866 . . . . 0.0 110.339 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.611 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 5.0 mp -100.64 -6.34 25.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.309 -0.869 . . . . 0.0 110.61 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 92.2 mt-10 -71.72 -73.89 0.17 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 0.0 110.82 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.3 m -43.5 -49.19 7.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.182 -0.949 . . . . 0.0 110.581 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.599 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 6.0 m -59.02 -46.41 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.541 ' CD ' ' HB3' ' A' ' 33' ' ' ARG . 23.0 tttt -58.15 -55.02 40.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.876 -1.14 . . . . 0.0 108.844 179.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.504 ' O ' ' O ' ' A' ' 20' ' ' ASP . 95.6 mttt -80.49 11.48 3.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 178.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.599 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.7 tt -58.73 -29.72 66.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 110.183 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -65.48 -34.91 79.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.182 -0.949 . . . . 0.0 110.144 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' A' ' 17' ' ' LYS . 60.6 t0 -133.82 141.71 47.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 110.147 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.539 HD13 ' CB ' ' A' ' 52' ' ' ASN . 1.9 mm? . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.041 -1.037 . . . . 0.0 110.569 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.541 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 32.4 mtt-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.276 0.56 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 50.3 t30 . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 110.197 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.86 0 N-CA-C 110.552 -0.595 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.444 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 162.54 37.45 0.02 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 43' ' ' VAL . 1.2 mm-40 -123.86 72.21 52.7 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.236 -1.155 . . . . 0.0 110.211 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.52 75.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.888 1.467 . . . . 0.0 110.379 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.627 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 88.8 t -120.67 127.39 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.962 . . . . 0.0 110.29 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.627 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.409 -0.807 . . . . 0.0 110.158 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.307 0.575 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.546 ' OG ' ' CG1' ' A' ' 43' ' ' VAL . 44.1 m -51.74 -62.8 1.4 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.263 -0.898 . . . . 0.0 111.083 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 3.9 m-20 -80.32 114.18 45.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.564 -179.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.8 0.84 1.73 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.806 1.424 . . . . 0.0 110.596 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.539 ' CB ' HD13 ' A' ' 21' ' ' LEU . 27.0 m120 -133.67 31.78 3.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.095 -1.003 . . . . 0.0 110.692 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.843 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 10.5 p90 -76.8 -177.23 0.73 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.039 -1.038 . . . . 0.0 108.772 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.843 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 5.0 Cg_exo -54.93 75.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.518 1.273 . . . . 0.0 110.108 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.628 ' N ' ' O ' ' A' ' 53' ' ' PHE . 84.7 tt0 -44.95 -33.87 2.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.571 -0.705 . . . . 0.0 110.032 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.516 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.3 mt-10 -54.39 -18.79 4.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.015 -1.053 . . . . 0.0 108.52 178.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.627 HD13 ' CD1' ' A' ' 10' ' ' PHE . 7.8 mp -97.5 9.2 43.04 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.931 0.872 . . . . 0.0 109.009 178.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.774 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -43.74 -49.35 19.97 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.685 -0.634 . . . . 0.0 109.934 179.556 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.774 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.86 -42.74 64.01 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.436 1.229 . . . . 0.0 109.73 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.58 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 10.7 mp -55.74 -40.74 72.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.051 -1.031 . . . . 0.0 109.129 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.5 ' HA ' HG23 ' A' ' 44' ' ' VAL . 41.4 t -64.3 -26.0 68.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 110.166 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.514 ' CE ' ' HD2' ' A' ' 58' ' ' LYS . 29.6 mttt -88.09 -4.96 58.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.88 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.518 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 9.1 pt-20 -113.1 147.69 37.84 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.012 -1.055 . . . . 0.0 110.337 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.9 -17.81 61.33 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.953 1.501 . . . . 0.0 111.034 -179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.469 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 74.5 m-20 -79.71 -13.73 59.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.085 -1.009 . . . . 0.0 110.59 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -46.93 -40.24 13.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 110.097 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -57.36 -40.79 78.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 110.061 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 98.0 mt-10 -80.3 -34.9 36.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.915 179.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.54 ' CG2' HD22 ' A' ' 60' ' ' LEU . 78.0 mt -72.64 -54.39 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 109.864 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -44.64 -60.15 2.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.87 . . . . 0.0 110.155 179.864 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.555 ' N ' HD12 ' A' ' 70' ' ' LEU . 94.2 mt-30 -51.65 -52.88 44.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.088 -1.007 . . . . 0.0 110.049 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 54.6 mtp180 -55.29 -56.45 19.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.823 . . . . 0.0 109.955 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' A' ' 3' ' ' VAL . 54.0 mt -47.45 -51.04 21.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.143 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 75.6 mm-40 -56.76 -38.39 72.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.859 . . . . 0.0 110.467 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -70.67 -54.04 13.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.164 -0.96 . . . . 0.0 110.297 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 79' ' ' ASP . 57.8 mt -65.35 -31.03 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.576 ' CB ' HG22 ' A' ' 15' ' ' VAL . . . -67.12 -34.85 78.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.403 -0.811 . . . . 0.0 109.503 179.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.49 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 97.1 mt-10 -94.18 16.07 15.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.474 -0.766 . . . . 0.0 109.78 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 76' ' ' ILE . 9.8 t0 -169.51 127.74 0.85 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.48 -0.763 . . . . 0.0 110.152 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.409 ' CB ' ' OE1' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -61.66 -74.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.74 1.39 . . . . 0.0 110.749 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.68 -141.65 24.78 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.578 ' O ' HG12 ' A' ' 85' ' ' ILE . 58.5 p -79.32 -22.87 43.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -1.197 . . . . 0.0 109.954 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 9.3 t -53.73 -52.17 60.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' OE1' ' CB ' ' A' ' 80' ' ' PRO . 83.6 tt0 -58.78 -32.32 69.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.88 . . . . 0.0 111.102 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 82' ' ' THR . 7.3 pt -96.59 11.73 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.933 -1.104 . . . . 0.0 110.458 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 58.56 13.6 2.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.58 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.531 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -67.7 -14.62 63.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.181 -0.949 . . . . 0.0 109.912 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.475 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 5.9 m-85 -137.83 165.99 25.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 0.0 110.331 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.14 3.57 5.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.338 -0.851 . . . . 0.0 110.283 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -63.05 -39.87 96.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.925 . . . . 0.0 110.392 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER -103.61 118.73 37.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.548 -179.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.522 ' CG2' ' OE1' ' A' ' 4' ' ' GLN . 6.5 m -112.08 6.25 19.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.375 -0.828 . . . . 0.0 110.3 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.03 -56.56 5.23 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.274 -1.133 . . . . 0.0 110.311 179.955 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.451 HG11 ' SG ' ' A' ' 91' ' ' CYS . 3.2 t . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.165 0.507 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.541 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 12.8 t -126.56 155.79 41.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 12' ' ' LEU . 53.0 t -95.9 122.77 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.552 -0.717 . . . . 0.0 109.163 179.005 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 8' ' ' PHE . 3.2 pt20 -129.22 -178.71 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.058 . . . . 0.0 111.548 -178.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 4' ' ' GLN . 93.1 m-20 -137.74 -60.3 0.65 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.526 0.679 . . . . 0.0 109.464 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.29 -143.76 15.19 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.581 ' OD1' ' CE2' ' A' ' 8' ' ' PHE . 16.2 p30 -81.08 8.58 8.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.028 -1.278 . . . . 0.0 110.334 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.581 ' CE2' ' OD1' ' A' ' 7' ' ' ASN . 83.6 m-85 -112.91 139.07 48.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -0.973 . . . . 0.0 110.383 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.541 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 50.9 m -101.9 139.06 38.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.334 -0.854 . . . . 0.0 110.627 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.595 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 20.4 m-85 -124.28 134.4 53.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 110.402 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.0 p -75.11 170.89 15.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.239 -0.913 . . . . 0.0 110.177 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.547 ' CD2' HG22 ' A' ' 3' ' ' VAL . 9.3 mt -104.58 -2.28 25.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.217 -0.927 . . . . 0.0 110.524 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.578 ' HG2' ' CD ' ' A' ' 33' ' ' ARG . 36.7 mt-10 -64.23 -71.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 0.0 110.548 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.622 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.5 OUTLIER -57.14 -38.79 74.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.39 -0.819 . . . . 0.0 111.344 -179.12 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.708 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 13.0 t -61.55 -49.92 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.844 -1.16 . . . . 0.0 109.46 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.508 ' CE ' ' O ' ' A' ' 77' ' ' ALA . 17.0 mttt -56.87 -55.05 39.37 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.816 -1.178 . . . . 0.0 108.864 178.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.71 10.96 4.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.018 178.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.708 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 13.1 tp -75.09 -10.37 59.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.088 -1.007 . . . . 0.0 109.893 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -63.58 -32.48 73.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 0.0 109.391 179.093 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -126.49 122.77 36.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.48 -0.762 . . . . 0.0 109.633 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.551 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 1.1 tm? . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.202 -0.936 . . . . 0.0 110.639 -179.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.578 ' CD ' ' HG2' ' A' ' 13' ' ' GLU . 69.6 mtm180 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.312 0.577 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.431 ' OD1' ' HD3' ' A' ' 80' ' ' PRO . 3.3 m-20 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.887 . . . . 0.0 110.055 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.487 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 3.0 Cg_exo . . . . . 0 N--CA 1.482 0.803 0 N-CA-C 110.757 -0.516 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.1 10.7 55.88 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -94.56 151.18 39.05 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.184 -1.186 . . . . 0.0 110.232 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.79 111.51 1.07 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.876 1.461 . . . . 0.0 110.211 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.483 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 78.4 t -133.79 152.82 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 110.736 -179.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.541 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 74.3 t . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.529 -0.732 . . . . 0.0 111.275 179.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.486 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 55.6 m . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.157 0.503 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.502 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 38.6 m -60.72 -63.8 1.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.938 . . . . 0.0 110.751 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.535 ' ND2' HD13 ' A' ' 18' ' ' LEU . 4.0 m-20 -72.29 113.42 20.55 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 110.512 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -62.45 -13.02 30.55 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.636 1.335 . . . . 0.0 110.639 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.551 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 87.3 m-20 -128.19 34.02 4.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 110.109 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.702 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.04 -178.63 1.17 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.794 . . . . 0.0 109.249 179.549 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.702 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.8 Cg_exo -61.47 75.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 N-CA-C 108.655 -1.325 . . . . 0.0 108.655 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.639 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.2 tt0 -39.07 -27.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.764 -0.585 . . . . 0.0 110.118 -178.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 54' ' ' PRO . 71.9 mm-40 -53.35 -17.92 2.19 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.977 -1.077 . . . . 0.0 108.614 178.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.62 ' CD1' ' HG2' ' A' ' 54' ' ' PRO . 87.3 mt -92.06 6.53 46.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.692 . . . . 0.0 109.696 179.147 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.731 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.68 -51.4 5.2 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 110.452 -179.722 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.731 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -54.04 -42.42 67.07 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.34 1.179 . . . . 0.0 109.67 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.526 ' HG ' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -54.99 -42.83 72.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.088 -1.007 . . . . 0.0 109.816 179.46 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.463 ' HA ' HG23 ' A' ' 44' ' ' VAL . 73.1 m -68.84 -29.75 68.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.222 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 62' ' ' LYS . 51.6 tptt -79.93 -4.33 51.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.434 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.533 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 6.7 pt-20 -114.04 142.45 27.93 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 110.108 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.58 -17.22 52.9 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.873 1.459 . . . . 0.0 111.099 -179.555 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.497 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 70.1 m-20 -79.9 -7.9 59.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.005 . . . . 0.0 110.33 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -50.42 -37.62 38.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 110.06 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.01 -39.0 93.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.211 -0.931 . . . . 0.0 110.142 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -80.17 -39.01 30.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.533 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 76.7 mt -68.06 -42.81 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.35 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.587 HD23 ' CG ' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -50.73 -59.21 4.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -0.768 . . . . 0.0 110.169 179.861 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.501 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 52.7 tt0 -50.5 -55.77 14.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 110.355 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 73' ' ' LEU . 50.5 mtt180 -55.06 -62.97 1.31 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 0.0 110.431 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.463 ' HG ' HG12 ' A' ' 15' ' ' VAL . 13.1 tp -41.73 -50.29 4.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.957 . . . . 0.0 109.992 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.587 ' CG ' HD23 ' A' ' 70' ' ' LEU . 63.0 mm-40 -55.3 -46.45 76.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 110.318 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -54.89 -53.12 59.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.088 -1.008 . . . . 0.0 110.37 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' ' 79' ' ' ASP . 26.0 mm -59.11 -35.0 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.104 -0.997 . . . . 0.0 109.404 179.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.508 ' O ' ' CE ' ' A' ' 16' ' ' LYS . . . -59.59 -30.49 68.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.559 -0.713 . . . . 0.0 109.527 179.169 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.0 -40.6 96.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 110.41 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 2.5 p30 -148.97 159.52 37.24 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.099 -1.001 . . . . 0.0 110.482 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -62.63 -60.83 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.988 1.52 . . . . 0.0 110.494 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.02 -141.33 24.1 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.532 ' O ' HG12 ' A' ' 85' ' ' ILE . 61.5 p -83.11 -18.3 40.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -1.141 . . . . 0.0 109.775 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 11.0 t -58.53 -53.35 59.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 0.0 110.047 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 48.1 tp10 -59.61 -23.98 63.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 111.081 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 82' ' ' THR . 7.3 pt -105.42 17.26 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.0 -1.062 . . . . 0.0 110.366 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.0 m 49.95 19.36 0.45 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.893 . . . . 0.0 110.65 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.515 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -65.04 -13.47 58.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.035 -1.04 . . . . 0.0 110.005 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -148.24 179.96 7.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.321 -0.862 . . . . 0.0 110.044 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.24 1.68 20.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 110.003 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.97 81.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.332 -0.855 . . . . 0.0 110.415 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.5 OUTLIER -108.05 129.43 55.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.533 -179.653 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.496 ' CG2' ' CD ' ' A' ' 4' ' ' GLN . 19.5 p -109.81 159.81 16.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.378 -0.826 . . . . 0.0 110.146 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.67 -12.77 61.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.278 -1.131 . . . . 0.0 110.228 179.994 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.483 ' CG1' ' SG ' ' A' ' 91' ' ' CYS . 79.0 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.172 0.511 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.472 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 60.8 m -132.45 150.04 52.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.843 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.555 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -92.98 119.39 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 109.419 179.379 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.581 ' CB ' ' HA ' ' A' ' 9' ' ' SER . 1.4 pt20 -116.27 148.29 40.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.079 -1.013 . . . . 0.0 110.933 -179.164 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -96.14 -74.85 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.76 . . . . 0.0 109.478 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.53 -121.12 4.67 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -85.62 14.48 5.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -1.14 . . . . 0.0 110.15 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.692 ' CE1' ' CE1' ' A' ' 10' ' ' PHE . 25.8 t80 -125.89 148.66 49.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.39 -0.819 . . . . 0.0 110.015 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.581 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 12.5 t -107.26 137.74 44.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.17 -0.956 . . . . 0.0 110.724 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.692 ' CE1' ' CE1' ' A' ' 8' ' ' PHE . 84.9 m-85 -119.56 132.1 55.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.19 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -67.14 164.2 18.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.088 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.555 ' CD2' ' HB ' ' A' ' 3' ' ' VAL . 54.1 mt -101.44 -5.19 25.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.982 . . . . 0.0 110.432 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.556 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 83.1 tt0 -69.04 -73.02 0.16 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.426 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.4 m -42.36 -55.3 3.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.032 -1.043 . . . . 0.0 110.545 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.636 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 15.8 m -51.81 -43.95 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.091 -1.006 . . . . 0.0 110.083 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.485 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 37.3 tttm -56.26 -58.75 6.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.832 -1.168 . . . . 0.0 108.644 178.701 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 75.1 mmtt -80.62 17.78 1.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.353 -0.842 . . . . 0.0 109.57 178.528 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 2.1 tt -65.77 -41.16 92.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.198 -0.939 . . . . 0.0 110.012 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -53.16 -41.99 65.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 110.287 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -140.26 80.33 1.75 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.19 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 52' ' ' ASN . 6.6 tt . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.556 ' HD2' ' HA ' ' A' ' 13' ' ' GLU . 82.9 mtm-85 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.285 0.564 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 63.7 m-20 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 110.57 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.553 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 2.9 Cg_endo . . . . . 0 N--CA 1.481 0.789 0 N-CA-C 110.53 -0.604 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.0 17.84 42.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.533 ' CG ' ' OE1' ' A' ' 74' ' ' GLU . 7.9 pt-20 -135.59 79.3 47.77 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.214 -1.168 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HB3' ' HG3' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -61.17 131.59 37.42 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.862 1.454 . . . . 0.0 110.387 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.06 53.18 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 110.435 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.568 ' CG2' ' HA ' ' A' ' 61' ' ' CYS . 7.4 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 110.696 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.548 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 73.5 m . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.272 0.558 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.555 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.6 m -54.07 -50.76 66.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 110.144 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 18' ' ' LEU . 2.7 m120 -71.45 112.22 13.05 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.785 . . . . 0.0 110.615 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -63.08 -10.52 21.02 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.694 1.365 . . . . 0.0 110.118 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.488 ' O ' HD23 ' A' ' 21' ' ' LEU . 14.3 m120 -130.21 33.92 4.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.379 -0.826 . . . . 0.0 110.461 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.68 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -79.09 179.64 1.72 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 108.719 179.082 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.68 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.6 Cg_exo -58.35 74.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.512 1.269 . . . . 0.0 109.184 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 53' ' ' PHE . 82.9 tt0 -39.5 -26.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.668 -0.645 . . . . 0.0 110.349 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.8 mt-10 -56.83 -15.7 5.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.023 -1.048 . . . . 0.0 108.619 178.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.619 HD21 ' CE1' ' A' ' 10' ' ' PHE . 78.4 mt -92.09 14.17 16.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.646 -0.659 . . . . 0.0 109.609 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.729 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.84 -49.49 5.68 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 110.085 179.818 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.3 Cg_exo -56.51 -47.67 22.78 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.444 1.233 . . . . 0.0 109.573 179.147 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.61 ' CD1' ' CG2' ' A' ' 69' ' ' ILE . 12.0 tp -46.55 -52.65 12.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.727 179.428 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.568 ' HA ' ' CG2' ' A' ' 44' ' ' VAL . 85.0 m -67.01 -30.47 70.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 110.55 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 51.2 tttm -79.94 3.44 19.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 110.616 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.518 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 8.2 pt-20 -127.9 144.05 49.97 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.984 -1.072 . . . . 0.0 110.124 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.39 -17.22 56.45 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.805 1.424 . . . . 0.0 110.853 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.505 ' O ' HG13 ' A' ' 69' ' ' ILE . 22.6 m120 -79.88 -9.49 59.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 110.417 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.593 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.92 -42.37 27.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.013 . . . . 0.0 109.806 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.461 ' HG3' ' HB3' ' A' ' 42' ' ' PRO . 64.0 tt0 -59.62 -43.37 93.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.537 -0.727 . . . . 0.0 110.37 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.26 -39.74 32.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 109.974 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.61 ' CG2' ' CD1' ' A' ' 60' ' ' LEU . 68.7 mt -67.48 -47.84 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.629 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.52 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 1.4 tm? -50.54 -55.6 15.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 110.014 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.553 ' HG3' ' CB ' ' A' ' 39' ' ' PRO . 52.2 tt0 -47.27 -52.18 16.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 110.186 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -54.73 -51.48 65.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 0.0 110.086 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 53.0 mt -53.52 -52.16 60.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 0.0 110.054 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.533 ' OE1' ' CG ' ' A' ' 41' ' ' GLU . 73.2 mt-10 -55.29 -37.9 67.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.873 . . . . 0.0 110.511 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.519 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 82.1 tt0 -65.31 -53.58 41.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.985 . . . . 0.0 110.926 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.475 HG22 ' CG2' ' A' ' 3' ' ' VAL . 20.6 mm -61.35 -39.13 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.594 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.06 -26.92 68.55 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.491 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.9 tt0 -66.3 -35.12 79.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.507 -0.746 . . . . 0.0 111.063 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER -162.11 96.14 1.23 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.809 -1.182 . . . . 0.0 111.041 -179.381 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.613 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 2.7 Cg_endo -67.82 44.71 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.757 1.398 . . . . 0.0 110.483 179.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . -51.52 -74.38 0.3 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.543 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.649 ' O ' HG12 ' A' ' 85' ' ' ILE . 74.3 p -69.37 -58.81 3.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -1.123 . . . . 0.0 110.296 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.633 ' CA ' ' HB2' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -39.16 -46.9 1.52 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 110.495 -179.586 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 80' ' ' PRO . 81.8 tt0 -63.75 -25.1 68.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.043 . . . . 0.0 110.527 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.649 HG12 ' O ' ' A' ' 82' ' ' THR . 26.5 pt -107.23 18.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.268 -179.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.19 15.66 4.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.519 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.531 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -59.75 -23.89 63.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 109.935 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -141.75 169.23 17.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.59 5.16 11.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 110.322 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.11 -43.26 95.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.934 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.633 ' HB2' ' CA ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -94.67 133.61 38.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.193 -0.942 . . . . 0.0 110.389 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.511 HG22 ' CG ' ' A' ' 4' ' ' GLN . 42.3 p -116.16 154.39 30.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.318 -0.864 . . . . 0.0 110.144 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 101.99 -9.02 56.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.44 -1.035 . . . . 0.0 110.386 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.551 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 7.8 p . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.313 0.577 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 53.5 m -127.08 155.59 43.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.95 . . . . 0.0 110.676 -179.544 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.532 ' CG2' HD22 ' A' ' 12' ' ' LEU . 4.0 t -91.13 117.17 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.497 179.389 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.511 ' CB ' ' HA ' ' A' ' 9' ' ' SER . 4.1 pt20 -126.87 175.18 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.073 -1.017 . . . . 0.0 111.201 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.513 ' OD2' ' CG2' ' A' ' 69' ' ' ILE . 96.8 m-20 -136.94 -58.38 0.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.573 0.702 . . . . 0.0 109.5 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.37 -140.18 11.28 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.587 ' OD1' ' CD2' ' A' ' 8' ' ' PHE . 13.9 p30 -79.65 2.04 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.164 -1.198 . . . . 0.0 110.266 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.587 ' CD2' ' OD1' ' A' ' 7' ' ' ASN . 77.9 m-85 -110.71 152.77 26.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 49.0 m -112.0 136.99 50.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 0.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.651 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 11.2 m-85 -117.16 127.79 54.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.264 -0.897 . . . . 0.0 110.285 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.5 m -72.22 164.67 25.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.352 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.532 HD22 ' CG2' ' A' ' 3' ' ' VAL . 83.9 mt -85.24 -24.29 27.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.942 . . . . 0.0 110.431 -179.753 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 14' ' ' SER . 86.0 tt0 -64.18 -69.16 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.308 -0.87 . . . . 0.0 110.372 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.1 m -43.82 -51.41 7.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.125 -0.984 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.608 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 54.4 t -59.16 -49.03 84.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.228 -0.92 . . . . 0.0 109.327 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 tptm -53.21 -56.45 16.35 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 20' ' ' ASP . 57.6 mttt -80.85 13.75 2.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.573 -0.704 . . . . 0.0 110.076 178.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.1 tt -65.65 -47.36 75.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.987 . . . . 0.0 110.297 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.34 -47.17 86.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -0.962 . . . . 0.0 109.834 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 17' ' ' LYS . 83.9 m-20 -103.2 122.5 44.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 109.787 179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.526 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 18.9 tp . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.744 -179.604 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.473 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 29.5 ptt-85 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.31 0.576 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.581 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 28.3 m-20 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 110.655 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.1 Cg_exo . . . . . 0 N--CA 1.482 0.822 0 N-CA-C 110.633 -0.564 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.455 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 145.34 -7.46 1.57 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 43' ' ' VAL . 11.1 mm-40 -119.84 74.81 19.62 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.239 . . . . 0.0 110.396 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_endo -61.74 115.6 2.9 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.78 1.41 . . . . 0.0 110.487 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.625 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 89.6 t -136.42 141.7 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.223 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.625 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.472 -0.767 . . . . 0.0 110.611 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.37 0.605 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.594 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 58.1 p -52.96 -42.98 66.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.308 -0.87 . . . . 0.0 111.0 -179.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -80.3 110.68 17.53 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.186 -0.946 . . . . 0.0 110.46 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -58.3 -10.62 8.85 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.753 1.397 . . . . 0.0 110.787 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.526 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 97.9 m-20 -139.56 42.95 2.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.121 -0.987 . . . . 0.0 110.712 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.742 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -78.61 177.2 2.98 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.092 -1.005 . . . . 0.0 108.433 178.778 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.742 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.8 Cg_exo -57.51 76.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 N-CA-C 108.628 -1.336 . . . . 0.0 108.628 179.124 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.63 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.9 tt0 -38.88 -28.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.803 -0.561 . . . . 0.0 110.075 -178.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.7 mt-10 -51.66 -18.18 1.11 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.996 -1.065 . . . . 0.0 108.587 178.257 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.651 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 78.7 mt -86.77 2.95 47.03 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.43 0.633 . . . . 0.0 109.861 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.731 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 20.6 tptt -39.99 -49.61 5.97 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 110.366 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.731 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.85 -41.1 80.78 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.357 1.188 . . . . 0.0 110.434 179.678 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.558 ' CD2' ' CG2' ' A' ' 69' ' ' ILE . 6.2 mp -61.08 -37.6 83.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.876 -1.14 . . . . 0.0 110.179 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.447 ' HA ' HG23 ' A' ' 44' ' ' VAL . 57.3 m -62.73 -25.23 68.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.574 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -98.89 10.94 40.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.115 -0.991 . . . . 0.0 111.399 -179.15 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.528 ' CG ' ' HA ' ' A' ' 60' ' ' LEU . 12.6 pt-20 -133.65 147.1 63.15 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.746 -1.221 . . . . 0.0 110.536 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.25 -11.16 23.98 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.911 1.48 . . . . 0.0 110.939 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.407 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 79.4 m-20 -78.93 -23.72 44.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.1 -1.0 . . . . 0.0 110.428 -179.046 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB3' ' CG2' ' A' ' 44' ' ' VAL . . . -49.14 -39.3 28.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.973 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -57.16 -44.94 83.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.27 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 73.5 mm-40 -79.13 -31.9 44.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.558 ' CG2' ' CD2' ' A' ' 60' ' ' LEU . 95.5 mt -76.34 -53.45 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.096 -1.003 . . . . 0.0 109.928 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.62 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -44.69 -65.42 0.53 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.432 -0.793 . . . . 0.0 110.484 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.62 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 50.9 tt0 -49.06 -54.79 14.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.124 -0.985 . . . . 0.0 110.697 -179.702 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 44.5 mtp85 -54.97 -55.32 32.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 28.7 mt -47.43 -50.77 21.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.158 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 75.4 mt-10 -56.22 -48.19 76.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 34.8 tt0 -53.79 -52.92 58.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.042 -1.036 . . . . 0.0 109.894 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 79' ' ' ASP . 62.2 mt -59.92 -34.3 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -0.932 . . . . 0.0 109.156 179.224 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 74' ' ' GLU . . . -56.15 -32.83 64.65 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.034 179.031 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 83.2 tt0 -64.2 -43.49 94.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.522 -0.736 . . . . 0.0 109.67 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.48 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 2.0 t70 -143.17 147.58 41.29 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.956 179.784 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.567 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -56.64 -56.11 2.24 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.841 1.442 . . . . 0.0 110.583 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.19 -137.13 21.57 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.554 ' HA ' ' CD1' ' A' ' 85' ' ' ILE . 71.9 p -82.16 -23.09 35.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -1.087 . . . . 0.0 110.625 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 91' ' ' CYS . 7.7 t -56.29 -54.38 46.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.065 -1.022 . . . . 0.0 110.033 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 76.9 tt0 -58.05 -27.34 63.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 111.178 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.554 ' CD1' ' HA ' ' A' ' 82' ' ' THR . 8.9 pt -101.14 14.84 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.89 -1.131 . . . . 0.0 110.27 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 73.3 m 54.76 16.32 1.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.897 . . . . 0.0 110.539 179.594 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.522 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -65.51 -12.31 51.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.82 174.5 11.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.85 3.89 9.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.304 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -61.52 -42.82 99.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.908 . . . . 0.0 110.417 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.535 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 1.2 m -106.2 124.55 49.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.79 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.471 HG22 ' HG2' ' A' ' 4' ' ' GLN . 36.8 p -109.61 163.23 13.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.158 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.02 3.32 51.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.395 -1.061 . . . . 0.0 110.283 179.975 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.517 ' CG1' ' SG ' ' A' ' 91' ' ' CYS . 52.9 t . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.287 0.565 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.526 ' OG1' ' HA ' ' A' ' 11' ' ' SER . 11.7 t -118.48 164.04 15.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 0.0 110.357 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.526 ' CG1' HG22 ' A' ' 76' ' ' ILE . 65.3 t -81.07 124.46 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 109.569 179.492 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.556 ' CB ' ' CG2' ' A' ' 92' ' ' THR . 48.9 tt0 -113.65 121.53 44.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.055 -1.028 . . . . 0.0 110.9 -179.333 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.517 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 52.6 p30 -97.74 13.44 30.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.441 -0.787 . . . . 0.0 109.647 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 173.51 -132.13 2.24 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -93.67 16.57 13.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.164 -1.198 . . . . 0.0 109.773 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.65 ' CB ' ' CZ ' ' A' ' 10' ' ' PHE . 44.8 m-85 -121.06 128.09 52.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.456 -0.777 . . . . 0.0 110.429 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.49 ' HB2' ' CG2' ' A' ' 2' ' ' THR . 14.7 p -82.18 118.29 22.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 8' ' ' PHE . 21.4 m-85 -117.93 123.32 45.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.807 -179.207 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.526 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 45.6 t -67.87 168.78 10.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.28 -0.888 . . . . 0.0 110.083 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 4.6 mp -95.81 0.84 52.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 110.629 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -73.28 -73.93 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.088 -1.008 . . . . 0.0 110.488 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.52 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.4 m -42.68 -41.09 3.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.114 -0.991 . . . . 0.0 110.556 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.476 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 33.1 t -69.26 -50.89 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 109.805 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.497 ' HD3' ' HB2' ' A' ' 33' ' ' ARG . 9.6 ttpp -48.06 -46.52 33.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.221 -0.924 . . . . 0.0 109.102 179.243 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 18' ' ' LEU . 49.9 mttm -74.03 -54.96 6.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 0.0 109.003 178.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -27.88 -41.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.804 -0.56 . . . . 0.0 110.551 -179.999 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 17' ' ' LYS . 22.4 mttm -51.76 -45.62 63.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 109.947 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 21' ' ' LEU . 52.0 p30 -112.86 -3.15 14.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 110.063 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.404 -0.81 . . . . 0.0 110.451 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.497 ' HB2' ' HD3' ' A' ' 16' ' ' LYS . 6.3 ptp180 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.314 0.578 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 41.5 p-10 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.202 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.542 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.801 0 N-CA-C 110.653 -0.557 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.94 4.87 1.08 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.821 -1.181 . . . . 0.0 110.169 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.523 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -134.61 60.47 42.57 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.881 -1.364 . . . . 0.0 110.612 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -62.16 139.41 78.03 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.824 1.433 . . . . 0.0 110.515 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.518 ' HB ' ' CB ' ' A' ' 49' ' ' SER . 14.8 m -141.93 119.68 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.334 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.556 ' CG2' ' HB3' ' A' ' 66' ' ' ALA . 69.2 t . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 0.0 110.473 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.526 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.383 0.611 . . . . 0.0 110.147 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.531 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.3 t -69.54 -56.0 8.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 110.442 -179.817 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.535 ' ND2' HD21 ' A' ' 21' ' ' LEU . 7.2 m120 -78.28 113.06 30.54 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.481 -0.762 . . . . 0.0 110.452 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -62.45 -12.69 28.91 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.747 1.393 . . . . 0.0 110.459 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.475 ' HB2' HD12 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -127.8 36.41 4.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 110.045 179.886 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.707 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 3.0 p90 -80.14 178.86 2.11 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.203 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.707 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.2 Cg_exo -56.53 75.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.676 1.356 . . . . 0.0 109.872 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.9 tt0 -43.56 -34.19 1.34 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.833 . . . . 0.0 110.298 -179.503 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -54.31 -18.65 4.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.934 -1.104 . . . . 0.0 108.626 178.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 54' ' ' PRO . 8.5 mp -95.3 18.69 11.97 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.092 0.949 . . . . 0.0 108.99 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.719 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -43.19 -51.02 14.41 Favored Pre-proline 0 N--CA 1.489 1.483 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.52 179.818 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.719 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.24 -49.12 17.4 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.502 1.264 . . . . 0.0 109.658 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -48.1 -49.1 33.01 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.09 -1.006 . . . . 0.0 109.753 179.446 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.513 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 87.0 m -63.49 -23.95 67.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 19.9 tttt -90.68 5.62 47.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 0.0 110.743 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 59' ' ' PRO . 8.6 pt-20 -125.96 144.76 49.7 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.891 -1.13 . . . . 0.0 110.317 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.54 -13.59 30.44 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.94 1.495 . . . . 0.0 110.803 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.489 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 84.7 m-20 -79.78 -22.65 42.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.292 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.591 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -46.23 -40.05 10.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.11 -0.994 . . . . 0.0 109.797 179.775 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -62.48 -36.95 84.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 0.0 109.23 179.3 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.49 -38.9 29.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.524 -0.735 . . . . 0.0 109.407 178.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.561 ' CG2' ' CD1' ' A' ' 60' ' ' LEU . 80.0 mt -70.92 -46.18 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 109.898 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.595 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 2.1 tm? -40.66 -68.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.506 -0.746 . . . . 0.0 110.554 -179.768 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.595 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 25.3 mt-30 -42.77 -52.4 5.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.143 -0.973 . . . . 0.0 110.459 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -53.71 -59.05 5.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.004 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.517 ' CD2' ' HB3' ' A' ' 5' ' ' ASP . 36.7 mt -47.57 -54.14 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 110.051 179.705 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.52 ' HG3' HD23 ' A' ' 70' ' ' LEU . 70.3 mt-10 -52.19 -45.78 65.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 110.06 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.542 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 83.7 tt0 -57.62 -51.36 69.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.809 179.752 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.526 HG22 ' CG1' ' A' ' 3' ' ' VAL . 23.6 mm -60.64 -38.75 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 109.519 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 78' ' ' GLU . . . -54.52 -38.39 66.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.429 -0.794 . . . . 0.0 109.65 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.735 ' O ' ' CB ' ' A' ' 79' ' ' ASP . 83.8 tt0 -44.14 -33.56 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.89 . . . . 0.0 109.611 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.735 ' CB ' ' O ' ' A' ' 78' ' ' GLU . 19.5 t70 95.04 73.13 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 76' ' ' ILE . 3.0 Cg_exo -60.86 -34.97 90.55 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.022 1.538 . . . . 0.0 110.185 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.16 -28.89 9.58 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.195 -2.362 . . . . 0.0 107.195 -178.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.562 ' O ' HG12 ' A' ' 85' ' ' ILE . 75.6 p -74.3 -40.75 62.06 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.11 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.677 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 53.5 t -58.81 -40.96 85.65 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.834 178.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.37 -33.37 75.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.066 -1.021 . . . . 0.0 110.349 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.562 HG12 ' O ' ' A' ' 82' ' ' THR . 17.8 pt -94.44 11.32 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.934 . . . . 0.0 110.237 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER 67.83 12.42 8.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.355 -0.841 . . . . 0.0 110.527 179.721 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.484 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -58.64 -35.76 73.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.22 -0.925 . . . . 0.0 109.897 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -123.15 166.8 14.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.937 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.91 -7.28 47.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.152 -0.967 . . . . 0.0 109.974 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -51.82 -37.1 50.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.83 . . . . 0.0 110.861 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.677 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -104.13 118.8 37.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.906 . . . . 0.0 111.139 -179.149 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.556 ' CG2' ' CB ' ' A' ' 4' ' ' GLN . 18.4 p -98.16 177.86 5.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 110.197 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.75 -5.9 84.16 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.442 ' OXT' ' SG ' ' A' ' 86' ' ' CYS . 23.9 p . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.166 . . . . 0.0 110.118 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.229 0.538 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.435 HG21 ' HA ' ' A' ' 11' ' ' SER . 37.0 m -89.26 150.89 22.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 110.293 -179.851 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.57 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 88.0 t -80.08 104.8 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 110.123 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.513 ' HB3' ' CG2' ' A' ' 92' ' ' THR . 48.1 tt0 -108.64 123.69 49.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 110.36 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -100.75 5.07 43.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.098 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.44 -138.62 2.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -79.74 -0.12 32.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -1.123 . . . . 0.0 110.251 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.433 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 84.4 m-85 -116.8 130.7 56.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.197 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m -86.01 136.18 33.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 110.126 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.581 ' CD1' HD22 ' A' ' 57' ' ' LEU . 57.0 m-85 -115.09 125.73 53.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 110.191 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.435 ' HA ' HG21 ' A' ' 2' ' ' THR . 33.8 t -73.07 169.9 16.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.92 . . . . 0.0 110.179 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.2 mm? -100.63 -3.99 29.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.115 -0.99 . . . . 0.0 110.413 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 14' ' ' SER . 97.5 mt-10 -70.23 -72.9 0.18 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -0.999 . . . . 0.0 110.432 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.492 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.5 m -41.12 -50.69 3.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 110.662 -179.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 30.8 m -63.1 -47.96 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.096 -1.003 . . . . 0.0 109.743 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.574 ' CD ' ' HA ' ' A' ' 33' ' ' ARG . 6.8 ttpp -56.53 -55.42 34.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.084 -1.01 . . . . 0.0 109.159 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -80.11 7.6 8.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.49 179.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.574 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 13.0 tp -54.1 -35.65 62.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.577 -0.702 . . . . 0.0 110.131 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -55.48 -41.84 73.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.116 -0.99 . . . . 0.0 109.507 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.7 105.92 16.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.778 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.502 ' CD2' ' HD2' ' A' ' 51' ' ' PRO . 11.8 tp . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.595 -179.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.574 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 76.1 mtm180 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.22 0.533 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 10.6 p30 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.265 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.459 ' HG3' ' HB2' ' A' ' 75' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.481 0.791 0 N-CA-C 110.479 -0.623 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.38 8.52 43.61 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.488 ' O ' HD13 ' A' ' 70' ' ' LEU . 3.4 tp10 -123.49 76.04 54.11 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.279 -1.13 . . . . 0.0 110.115 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.47 141.81 96.4 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.001 1.527 . . . . 0.0 110.689 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 49' ' ' SER . 15.5 m -121.21 58.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.378 -0.826 . . . . 0.0 110.186 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.421 HG21 ' C ' ' A' ' 43' ' ' VAL . 4.5 t . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.327 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.8 m . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.523 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 6.0 t -62.63 -73.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.053 -1.029 . . . . 0.0 111.099 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 28.3 m-20 -79.98 113.68 40.16 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.837 -179.184 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -64.59 -7.2 13.84 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.793 1.417 . . . . 0.0 110.329 179.521 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.48 ' HB2' HD13 ' A' ' 21' ' ' LEU . 15.3 m120 -129.16 32.5 4.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.0 109.864 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.726 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -79.86 -176.55 0.74 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 108.956 179.412 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.726 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.7 Cg_exo -59.28 74.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.442 1.233 . . . . 0.0 109.051 179.201 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.589 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.8 tt0 -39.28 -32.33 0.11 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.687 -0.633 . . . . 0.0 110.551 -178.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 54' ' ' PRO . 77.7 tt0 -52.31 -24.95 8.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.905 -1.122 . . . . 0.0 108.604 178.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.606 ' CD1' ' HG2' ' A' ' 54' ' ' PRO . 91.7 mt -85.28 1.23 49.19 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.437 0.636 . . . . 0.0 109.543 179.151 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.754 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.8 tmmt? -40.93 -49.65 7.7 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.459 -0.775 . . . . 0.0 110.493 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.754 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -53.98 -39.77 83.73 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.398 1.21 . . . . 0.0 110.557 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.561 HD12 ' CG2' ' A' ' 69' ' ' ILE . 9.6 mt -67.64 -30.65 70.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.927 -1.108 . . . . 0.0 110.029 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 46.0 t -69.34 -26.18 64.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 110.066 179.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -96.11 20.38 10.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 108.981 179.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.493 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -114.84 142.0 27.69 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.71 -0.619 . . . . 0.0 110.538 -179.11 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.93 -26.49 74.3 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.789 1.415 . . . . 0.0 109.425 178.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -86.06 -5.08 59.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.815 . . . . 0.0 110.538 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -45.26 -37.97 5.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.046 . . . . 0.0 110.101 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 94.0 mt-30 -59.55 -41.05 89.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 110.25 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.33 -39.31 28.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.096 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.561 ' CG2' HD12 ' A' ' 60' ' ' LEU . 84.8 mt -63.29 -47.89 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.135 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.525 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 1.4 tm? -53.05 -53.37 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 110.211 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 73.7 mt-30 -48.33 -55.23 11.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.396 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -50.17 -52.16 37.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.363 -0.835 . . . . 0.0 110.188 -179.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 56.5 mt -53.13 -49.2 67.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.26 -0.9 . . . . 0.0 110.094 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 74.4 mt-10 -54.8 -43.38 72.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 110.727 -179.776 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.8 tt0 -62.9 -55.63 24.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.033 -1.042 . . . . 0.0 110.904 -179.308 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.1 mt -62.12 -38.11 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HB1' HG22 ' A' ' 15' ' ' VAL . . . -60.11 -32.35 70.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.448 -0.783 . . . . 0.0 109.8 179.596 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.3 tt0 -62.08 -37.06 83.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 110.556 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 78' ' ' GLU . 3.0 m-20 -165.15 151.44 8.97 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.016 . . . . 0.0 110.706 -179.796 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.567 ' HB3' ' CG ' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.38 74.95 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.968 1.509 . . . . 0.0 110.719 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 80' ' ' PRO . . . -61.28 -134.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.269 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.516 ' O ' HG12 ' A' ' 85' ' ' ILE . 59.4 p -75.39 -20.88 58.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.997 -1.296 . . . . 0.0 109.281 179.24 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.613 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 9.9 t -60.29 -46.23 90.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.533 -0.729 . . . . 0.0 109.404 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.567 ' CG ' ' HB3' ' A' ' 80' ' ' PRO . 49.8 tp10 -58.57 -30.23 67.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.271 -0.893 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 82' ' ' THR . 7.4 pt -103.2 12.85 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.96 -1.087 . . . . 0.0 110.39 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 4.4 t 60.52 14.24 4.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.281 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.514 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -64.47 -21.64 66.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.083 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.46 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 1.7 m-85 -131.59 166.51 21.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.58 2.99 3.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 110.368 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -65.9 -38.56 89.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -0.936 . . . . 0.0 110.409 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.613 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -108.56 115.15 29.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 110.715 -179.568 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.513 ' CG2' ' HB3' ' A' ' 4' ' ' GLN . 41.4 p -100.27 176.9 5.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 110.254 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.03 78.47 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.297 -1.119 . . . . 0.0 110.257 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.205 0.526 . . . . 0.0 110.142 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.488 ' HB ' ' HB ' ' A' ' 92' ' ' THR . 63.0 m -130.55 149.4 52.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.655 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -92.35 119.92 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.623 -0.673 . . . . 0.0 109.64 179.569 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 51.5 tt0 -111.74 121.31 44.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 110.824 -179.286 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.527 ' OD2' ' CD2' ' A' ' 73' ' ' LEU . 83.0 m-20 -97.31 9.14 43.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 109.818 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.55 -138.13 3.2 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -82.4 4.5 23.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.167 -1.196 . . . . 0.0 110.185 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 78.3 m-85 -121.89 132.63 54.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 110.389 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB3' HG22 ' A' ' 92' ' ' THR . 26.8 p -80.73 127.63 32.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 110.034 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 20.2 m-30 -114.6 126.7 55.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.87 . . . . 0.0 110.445 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.8 m -71.55 166.78 21.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.515 ' CD2' ' HB ' ' A' ' 3' ' ' VAL . 51.5 mt -96.91 -8.81 29.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.558 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.531 ' HG2' ' CD ' ' A' ' 33' ' ' ARG . 95.3 mt-10 -63.8 -68.07 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.065 -1.022 . . . . 0.0 110.394 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.465 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.1 m -45.2 -50.69 11.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.271 -0.893 . . . . 0.0 111.191 -179.438 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.529 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 25.1 m -57.58 -48.43 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 0.0 110.269 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.479 ' HD3' ' HB3' ' A' ' 33' ' ' ARG . 28.8 ttpp -50.5 -51.25 49.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.865 -1.147 . . . . 0.0 108.643 179.165 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.631 ' O ' ' C ' ' A' ' 18' ' ' LEU . 63.6 mttp -67.97 -57.36 6.31 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.066 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.631 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.4 OUTLIER 1.66 -71.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 120.832 0.349 . . . . 0.0 111.373 179.32 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.614 ' N ' ' O ' ' A' ' 17' ' ' LYS . 86.0 tttt -49.47 -59.28 3.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.916 -1.115 . . . . 0.0 109.248 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 17' ' ' LYS . 24.7 t70 -109.11 97.24 6.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.426 -0.796 . . . . 0.0 109.461 178.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.523 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 31.6 tp . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.893 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.531 ' CD ' ' HG2' ' A' ' 13' ' ' GLU . 85.2 mtt-85 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.305 0.574 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 78' ' ' GLU . 88.4 m-20 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 0.0 110.31 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.501 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.806 0 N-CA-C 110.47 -0.627 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.52 3.78 49.92 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.96 83.55 37.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.279 -1.13 . . . . 0.0 110.147 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.437 ' HA ' HD21 ' A' ' 70' ' ' LEU . 2.9 Cg_endo -61.6 140.38 86.4 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.9 1.474 . . . . 0.0 110.591 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.555 ' CG2' ' CB ' ' A' ' 49' ' ' SER . 11.3 p -148.12 64.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.441 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 94.5 t . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.293 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.308 0.575 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.555 ' CB ' ' CG2' ' A' ' 43' ' ' VAL . 34.1 t -69.73 -76.2 0.1 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.181 -0.95 . . . . 0.0 110.258 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.528 ' OD1' ' O ' ' A' ' 18' ' ' LEU . 5.8 m120 -80.48 115.86 57.92 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 110.725 -179.837 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -64.63 1.84 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.657 1.346 . . . . 0.0 110.681 179.281 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.512 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 89.0 m-20 -133.84 31.77 3.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 110.064 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.85 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 11.0 p90 -76.21 -176.73 0.63 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 109.132 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.85 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.5 Cg_exo -56.4 73.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.382 1.201 . . . . 0.0 110.037 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.61 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.0 tt0 -42.81 -34.62 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.564 -0.71 . . . . 0.0 110.309 -179.511 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.521 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 96.0 mt-10 -54.87 -17.43 3.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.991 . . . . 0.0 108.809 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.597 HD13 ' CD1' ' A' ' 10' ' ' PHE . 8.7 mp -97.87 11.63 36.73 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.816 0.817 . . . . 0.0 109.184 179.202 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.715 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.87 -52.08 5.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.778 -0.576 . . . . 0.0 110.758 -179.818 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.715 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -53.08 -42.91 61.31 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.428 1.225 . . . . 0.0 110.25 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.569 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 11.0 mp -60.78 -35.58 76.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.064 -1.023 . . . . 0.0 109.769 179.447 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 51.8 t -66.73 -28.99 68.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.16 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -104.4 24.18 12.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 109.191 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.519 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -116.42 140.78 27.0 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.627 -0.671 . . . . 0.0 110.548 -179.232 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.91 -30.39 67.5 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.734 1.386 . . . . 0.0 109.698 179.047 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -80.03 -7.49 58.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.418 -0.801 . . . . 0.0 110.61 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -46.03 -39.65 9.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.043 179.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.35 -41.1 92.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 110.342 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -80.17 -37.62 32.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.918 179.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.503 ' CG2' HD22 ' A' ' 60' ' ' LEU . 90.0 mt -66.08 -41.91 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 110.188 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.466 HD12 ' OE2' ' A' ' 74' ' ' GLU . 1.6 tp -56.44 -57.91 10.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 110.723 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -47.46 -17.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.084 -1.01 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 69' ' ' ILE . 27.5 ttm-85 -86.85 -58.1 2.72 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.617 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.547 ' CD1' HD22 ' A' ' 57' ' ' LEU . 69.6 mt -51.36 -50.79 58.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.392 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.501 ' OE1' ' HA ' ' A' ' 39' ' ' PRO . 88.7 mt-10 -55.41 -54.87 38.38 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.478 -0.764 . . . . 0.0 109.465 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 83.8 tt0 -61.15 -53.95 50.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 110.16 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.53 ' O ' ' O ' ' A' ' 79' ' ' ASP . 23.3 mm -62.18 -33.83 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 109.749 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 73' ' ' LEU . . . -59.06 -34.38 71.89 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.407 179.454 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 84.8 tt0 -58.7 -39.58 81.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 110.285 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.53 ' O ' ' O ' ' A' ' 76' ' ' ILE . 14.5 p-10 -145.03 153.73 53.74 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.11 -0.993 . . . . 0.0 110.358 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.539 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -58.83 -54.27 2.97 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.888 1.468 . . . . 0.0 110.537 179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.98 -139.67 24.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.597 ' O ' HG12 ' A' ' 85' ' ' ILE . 44.6 p -80.08 -20.76 44.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -1.107 . . . . 0.0 110.164 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.614 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 5.5 t -55.44 -54.24 46.21 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.179 -0.951 . . . . 0.0 109.956 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.5 tt0 -56.08 -30.38 61.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 111.04 -179.493 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 82' ' ' THR . 9.0 pt -98.8 15.41 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.892 -1.13 . . . . 0.0 110.344 -179.507 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.6 m 50.89 23.51 1.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 110.376 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.602 ' O ' ' CD1' ' A' ' 88' ' ' TYR . . . -71.62 -11.23 60.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 34.1 m-85 -150.56 171.56 16.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 110.126 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.82 1.96 18.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.948 . . . . 0.0 110.202 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.1 -11.61 41.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.359 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.614 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.7 OUTLIER -108.41 -172.53 2.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.97 . . . . 0.0 110.382 -179.878 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.488 ' HB ' ' HB ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -150.55 -15.81 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.273 -0.892 . . . . 0.0 110.997 -179.903 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.1 -23.33 72.96 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.488 1.463 0 O-C-N 121.159 -1.201 . . . . 0.0 110.35 -179.9 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.453 HG12 ' SG ' ' A' ' 91' ' ' CYS . 33.8 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.29 0.567 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 61.2 m -119.39 149.43 41.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.238 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 90' ' ' ALA . 1.2 t -83.69 113.16 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.877 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.547 ' HB3' ' CG2' ' A' ' 92' ' ' THR . 64.3 tt0 -110.54 119.19 38.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.418 -0.801 . . . . 0.0 110.694 -179.456 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -101.28 7.06 43.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 109.713 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.476 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . -169.67 -143.1 3.77 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -81.02 4.93 18.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.309 -1.112 . . . . 0.0 110.424 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.547 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 66.3 m-85 -125.63 136.86 53.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.311 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.413 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 67.2 m -79.65 131.15 35.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.93 . . . . 0.0 110.037 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.639 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 18.4 m-85 -113.44 121.92 45.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 110.618 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.1 p -75.35 171.29 14.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.241 -0.912 . . . . 0.0 109.871 179.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.593 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 2.7 mm? -103.2 -12.07 17.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 0.0 110.772 -179.6 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.524 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 90.8 mt-10 -63.25 -74.1 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.092 -1.005 . . . . 0.0 110.535 -179.855 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 6.3 m -40.6 -44.37 2.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 110.478 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.64 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.1 t -62.22 -46.51 96.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.158 -0.964 . . . . 0.0 109.457 179.551 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.545 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -54.93 -50.28 69.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.021 -1.049 . . . . 0.0 108.551 178.479 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -80.36 6.6 11.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.511 -0.743 . . . . 0.0 109.657 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.64 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 44.3 tp -63.74 -23.36 67.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.38 -0.825 . . . . 0.0 110.426 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -67.52 -32.59 73.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.024 -1.048 . . . . 0.0 110.303 -179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -116.96 122.5 44.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.141 -0.975 . . . . 0.0 110.174 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.531 HD12 ' HB3' ' A' ' 50' ' ' ASN . 8.9 tp . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.4 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.524 ' HD2' ' HG2' ' A' ' 13' ' ' GLU . 67.4 mtt85 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.157 0.503 . . . . 0.0 109.958 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.591 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 14.7 p30 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.747 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.74 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . 3.0 Cg_endo . . . . . 0 N--CA 1.483 0.883 0 N-CA-C 110.592 -0.58 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.06 42.51 0.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 0.8 OUTLIER -122.95 169.72 9.43 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.322 -1.105 . . . . 0.0 110.32 -179.913 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.491 ' O ' ' C ' ' A' ' 43' ' ' VAL . 2.9 Cg_endo -62.26 155.28 57.75 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 124.022 1.538 . . . . 0.0 111.178 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.653 HG11 ' O ' ' A' ' 43' ' ' VAL . 7.1 p 33.73 83.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.598 -0.689 . . . . 0.0 111.047 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.568 HG12 ' CB ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 120.8 -1.187 . . . . 0.0 108.47 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.543 ' CB ' ' HB ' ' A' ' 44' ' ' VAL . 35.3 t . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 43' ' ' VAL . 90.3 p -61.03 -25.96 67.28 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.277 -0.889 . . . . 0.0 108.744 178.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HB3' HD12 ' A' ' 21' ' ' LEU . 1.2 m-20 -50.32 130.79 25.05 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.705 . . . . 0.0 110.143 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.45 1.55 2.5 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.795 1.419 . . . . 0.0 111.106 179.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.516 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 10.8 m120 -113.39 7.12 17.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.067 -1.021 . . . . 0.0 110.842 -179.633 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.74 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -80.1 -177.13 0.84 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.073 -1.017 . . . . 0.0 109.493 179.449 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.74 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.6 Cg_exo -61.0 73.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.7 1.368 . . . . 0.0 109.038 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.594 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.3 tt0 -38.87 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.761 -0.587 . . . . 0.0 110.19 -178.523 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.488 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 50.1 mt-10 -55.11 -22.81 17.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.093 -1.004 . . . . 0.0 109.107 178.797 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.639 ' CD2' ' CG ' ' A' ' 10' ' ' PHE . 31.6 mt -92.38 11.59 25.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.455 -0.778 . . . . 0.0 109.742 179.35 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.721 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.85 -51.39 5.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.43 -0.794 . . . . 0.0 110.677 179.967 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.721 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.33 -44.73 46.04 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.531 1.279 . . . . 0.0 110.511 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.59 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 10.9 mp -57.88 -41.44 82.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.933 -1.104 . . . . 0.0 110.212 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.6 m -66.65 -25.96 66.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.919 -1.113 . . . . 0.0 110.063 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -97.95 1.06 47.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.892 . . . . 0.0 110.427 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.528 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 5.6 pt-20 -108.08 139.9 21.14 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.107 -0.995 . . . . 0.0 110.081 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.89 -21.73 72.87 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.805 1.424 . . . . 0.0 110.988 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.471 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 75.9 m-20 -79.44 -11.31 59.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 110.579 -179.138 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.59 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -48.6 -32.02 7.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 109.86 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.79 -38.13 86.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.418 -0.801 . . . . 0.0 109.739 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.3 -41.89 24.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.271 -0.893 . . . . 0.0 109.398 179.101 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.528 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 65.1 mt -67.33 -49.15 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.372 -0.83 . . . . 0.0 109.67 179.534 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.608 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -41.8 -67.08 0.28 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.781 . . . . 0.0 110.005 179.898 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.74 ' HA ' ' HB3' ' A' ' 39' ' ' PRO . 90.8 mt-30 -44.99 -51.96 9.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.094 -1.004 . . . . 0.0 110.268 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -63.47 -50.71 68.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.452 -0.78 . . . . 0.0 110.153 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.529 ' CD2' HD12 ' A' ' 57' ' ' LEU . 13.5 tp -46.19 -60.13 2.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.708 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.566 ' HG3' HD23 ' A' ' 70' ' ' LEU . 54.7 mt-10 -50.72 -49.4 57.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.977 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.82 -54.83 24.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 110.246 -179.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.416 HG23 HG23 ' A' ' 3' ' ' VAL . 25.2 mm -57.42 -39.24 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 0.0 109.545 179.759 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -55.82 -34.36 65.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.469 -0.769 . . . . 0.0 109.529 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.591 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.5 tt0 -62.49 -42.98 99.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.51 -0.744 . . . . 0.0 110.017 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.416 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 14.9 p-10 -151.97 158.56 33.82 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.975 -1.078 . . . . 0.0 110.311 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.565 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -59.83 -54.24 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.017 1.535 . . . . 0.0 110.407 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.09 -140.23 29.54 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 85' ' ' ILE . 43.5 p -82.17 -20.43 37.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -1.102 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.593 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 21.8 t -57.99 -46.13 85.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 0.0 109.787 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 80.4 tt0 -62.24 -29.28 70.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.17 -0.956 . . . . 0.0 111.34 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 82' ' ' THR . 3.9 pt -97.38 6.38 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.893 -1.129 . . . . 0.0 110.398 -179.496 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER 67.32 6.2 4.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 179.615 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.452 ' HB1' ' HB ' ' A' ' 82' ' ' THR . . . -66.15 -17.86 64.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 109.93 179.732 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.497 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.3 OUTLIER -128.06 157.63 40.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 110.186 -179.889 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.49 -0.59 10.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.089 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.72 -32.9 74.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.385 -0.822 . . . . 0.0 110.557 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.593 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -108.42 111.9 24.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 110.796 -179.504 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.547 ' CG2' ' HB3' ' A' ' 4' ' ' GLN . 21.0 p -101.85 174.53 5.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.395 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.3 -14.74 64.58 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.423 -1.046 . . . . 0.0 110.227 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.1 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.193 0.521 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.538 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 10.9 t -126.83 163.32 23.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.236 -0.915 . . . . 0.0 110.66 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.578 ' CG2' ' CD2' ' A' ' 12' ' ' LEU . 45.6 t -82.78 122.44 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.499 -0.75 . . . . 0.0 109.524 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 50.3 tt0 -112.32 121.35 44.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.93 . . . . 0.0 110.822 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.524 ' OD2' ' CD2' ' A' ' 73' ' ' LEU . 93.3 m-20 -98.79 11.51 38.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.426 -0.796 . . . . 0.0 109.657 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.406 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 179.92 -138.36 3.37 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -88.83 14.35 10.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 110.176 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.4 m-85 -123.79 131.01 53.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.229 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.538 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 29.6 m -81.63 123.24 28.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.897 . . . . 0.0 110.085 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 22.9 m-85 -119.37 128.66 54.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.369 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.441 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 49.2 m -75.51 172.7 12.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.578 ' CD2' ' CG2' ' A' ' 3' ' ' VAL . 88.5 mt -106.47 -3.19 21.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 110.837 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.01 -73.91 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 110.321 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 m -47.83 -43.8 28.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 110.51 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.48 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 18.4 t -61.21 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.03 -1.043 . . . . 0.0 109.809 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.464 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 19.3 tttt -55.23 -53.97 49.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 53.3 mttp -80.2 8.85 6.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.557 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 16.6 tp -60.9 -44.98 96.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 110.686 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' A' ' 38' ' ' ILE . 57.5 mttt -66.82 -34.01 76.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.351 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -128.99 79.98 1.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.979 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 52' ' ' ASN . 9.0 tt -113.59 125.58 54.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.11 -0.994 . . . . 0.0 110.392 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.409 ' HG3' ' C ' ' A' ' 21' ' ' LEU . 95.3 mt-30 -148.22 54.39 1.03 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.828 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 12.5 pt-20 -174.46 163.67 2.64 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.326 -0.859 . . . . 0.0 110.095 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 3.0 Cg_exo -61.4 166.25 11.64 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.88 1.463 . . . . 0.0 110.649 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -44.97 136.96 4.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.288 -0.883 . . . . 0.0 110.235 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -119.0 116.14 34.34 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.208 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.46 -158.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.657 1.346 . . . . 0.0 110.582 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -56.2 142.26 37.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 110.181 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' A' ' 31' ' ' LYS . 41.1 t -118.14 137.35 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.914 . . . . 0.0 110.246 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.1 -27.44 45.83 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.441 ' HB2' HG13 ' A' ' 29' ' ' VAL . 96.3 mttt -72.92 156.53 38.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.326 -1.102 . . . . 0.0 110.265 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.4 tp -90.43 135.2 33.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 0.0 110.312 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 13.5 ptt180 -70.38 62.74 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.173 -0.954 . . . . 0.0 110.174 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.563 ' OD1' ' CD2' ' A' ' 35' ' ' PHE . 30.3 p-10 -133.37 11.13 4.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.563 ' CD2' ' OD1' ' A' ' 34' ' ' ASN . 94.0 m-85 -101.32 8.08 42.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.464 ' HB1' ' HG3' ' A' ' 16' ' ' LYS . . . -61.01 146.22 88.08 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.253 -0.904 . . . . 0.0 110.303 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HG2' ' HD2' ' A' ' 19' ' ' LYS . 2.8 Cg_endo -63.56 -150.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.835 1.439 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.484 ' O ' ' NZ ' ' A' ' 19' ' ' LYS . 1.3 mp -108.1 136.56 19.78 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.946 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.481 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 3.1 Cg_exo -61.1 145.79 98.45 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.677 1.356 . . . . 0.0 110.677 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.58 37.12 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.467 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 2.8 tt0 -138.77 64.41 35.63 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.178 -1.189 . . . . 0.0 110.23 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.499 ' CB ' ' HG3' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -61.71 102.27 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.847 1.446 . . . . 0.0 110.721 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.461 HG23 ' OG ' ' A' ' 49' ' ' SER . 14.6 p -134.52 127.87 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 110.083 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 43' ' ' VAL . 32.5 t -155.0 85.16 3.59 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.475 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 49' ' ' SER . 3.0 Cg_endo -61.66 -149.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.875 1.46 . . . . 0.0 110.117 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 46' ' ' ILE . 78.4 mt -52.98 -51.99 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 108.977 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.495 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 44.9 mt -111.11 -74.64 0.64 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.495 -0.753 . . . . 0.0 109.105 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.567 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.8 m -147.72 148.74 31.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.755 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.521 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 22.7 t -59.9 -50.78 72.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.568 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 7.1 m120 -79.69 117.89 69.6 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 110.397 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.13 -10.93 13.99 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.762 1.401 . . . . 0.0 110.445 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.512 ' HB2' HD23 ' A' ' 21' ' ' LEU . 91.3 m-20 -138.32 42.3 2.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.85 . . . . 0.0 109.513 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.693 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -80.1 -177.24 0.87 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.552 -0.718 . . . . 0.0 109.568 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.693 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.5 Cg_exo -58.03 72.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.674 1.355 . . . . 0.0 109.667 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.627 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 23.1 pt-20 -40.1 -36.9 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.498 -0.751 . . . . 0.0 110.3 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' N ' ' CG ' ' A' ' 55' ' ' GLU . 96.3 mt-10 -54.12 -17.51 2.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 109.307 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.633 ' CD1' ' HB2' ' A' ' 54' ' ' PRO . 8.9 mp -97.9 8.55 44.55 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.736 0.779 . . . . 0.0 109.7 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.728 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -39.81 -52.04 5.2 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.716 -0.615 . . . . 0.0 110.72 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.728 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.97 -42.63 65.14 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.466 1.245 . . . . 0.0 110.051 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.6 mt -57.75 -41.35 81.76 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.031 -1.043 . . . . 0.0 109.879 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 15.7 m -69.19 -28.1 66.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.091 -1.005 . . . . 0.0 110.221 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 14.2 ttpt -88.28 6.51 36.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 2.4 pt-20 -111.39 144.14 29.91 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.986 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.64 -23.61 72.1 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.834 1.439 . . . . 0.0 111.103 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.504 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 80.1 m-20 -83.31 -4.88 58.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 0.0 110.717 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -51.48 -39.56 57.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.011 -1.056 . . . . 0.0 110.066 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.499 ' HG3' ' CB ' ' A' ' 42' ' ' PRO . 30.6 tt0 -54.12 -44.05 70.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 109.918 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -79.93 -35.31 37.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.532 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 93.9 mt -67.78 -52.83 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.947 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.499 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.3 tm? -43.33 -58.42 2.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.43 -0.794 . . . . 0.0 110.019 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 74' ' ' GLU . 25.9 mt-30 -51.75 -54.94 22.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.033 -1.042 . . . . 0.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.6 ttm-85 -49.61 -56.24 10.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.445 -0.784 . . . . 0.0 109.788 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.524 ' CD2' ' OD2' ' A' ' 5' ' ' ASP . 57.2 mt -48.32 -46.83 36.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.89 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 74.9 mm-40 -55.53 -45.32 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 110.147 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.0 -54.55 40.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 110.38 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.458 HG21 HD12 ' A' ' 12' ' ' LEU . 10.9 mt -60.21 -31.63 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 109.69 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 33' ' ' ARG . . . -64.1 -32.06 73.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.856 . . . . 0.0 109.292 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 79.7 tt0 -92.99 14.71 16.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.581 -0.7 . . . . 0.0 109.68 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 9.7 t70 -178.86 124.61 0.25 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.406 -0.808 . . . . 0.0 109.928 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.515 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -61.68 -62.52 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.657 1.346 . . . . 0.0 110.773 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.43 -139.28 18.74 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.56 ' O ' HG12 ' A' ' 85' ' ' ILE . 60.2 p -79.92 -22.07 43.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.172 . . . . 0.0 110.065 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 7.6 t -54.71 -53.72 51.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 110.001 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 85.2 tt0 -57.96 -31.28 66.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 110.929 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 82' ' ' THR . 5.2 pt -99.6 13.96 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.981 -1.075 . . . . 0.0 110.334 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 33.8 m 50.44 20.53 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 110.221 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.522 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -60.7 -12.2 9.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.913 . . . . 0.0 110.021 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.437 ' CG ' ' O ' ' A' ' 87' ' ' ALA . 50.0 m-85 -154.82 -176.63 6.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.205 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.3 1.93 12.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.883 . . . . 0.0 110.326 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.81 -36.08 71.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.588 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.522 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -112.57 129.08 56.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.201 -0.937 . . . . 0.0 110.609 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.448 HG22 ' CD ' ' A' ' 4' ' ' GLN . 25.3 p -107.19 157.21 18.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.168 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.09 0.08 56.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.334 -1.098 . . . . 0.0 110.275 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.443 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 3.0 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.314 0.578 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 57.5 m -121.97 146.53 47.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 110.536 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.513 HG22 ' CG ' ' A' ' 12' ' ' LEU . 56.0 t -86.11 119.67 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 109.527 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 49.7 tt0 -109.88 116.86 32.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 110.848 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.452 ' OD2' HG22 ' A' ' 69' ' ' ILE . 57.0 t0 -93.08 10.98 29.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.396 -0.815 . . . . 0.0 109.666 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 4' ' ' GLN . . . 179.77 -134.72 2.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -86.66 5.92 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -1.151 . . . . 0.0 110.162 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.65 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 71.0 m-85 -124.1 137.76 54.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.103 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 p -81.17 124.06 28.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.439 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.65 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 18.1 m-30 -113.91 125.62 54.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.344 -0.847 . . . . 0.0 110.399 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.2 p -73.91 168.02 20.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.236 -0.915 . . . . 0.0 110.076 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 5.0 mp -94.12 -20.85 19.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.235 -0.916 . . . . 0.0 110.539 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.528 ' OE1' ' CG ' ' A' ' 26' ' ' GLU . 88.6 tt0 -57.62 -67.38 0.34 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.306 -0.872 . . . . 0.0 110.781 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.563 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 9.3 m -41.77 -47.44 4.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.09 -1.006 . . . . 0.0 110.317 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.488 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 96.9 t -64.4 -50.25 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.081 -1.012 . . . . 0.0 109.704 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.503 ' HE2' ' N ' ' A' ' 36' ' ' ALA . 10.1 tptp -55.17 -49.49 71.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 108.969 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.517 ' HE2' ' NH1' ' A' ' 33' ' ' ARG . 31.0 mttt -80.47 4.4 18.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.8 . . . . 0.0 109.987 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.555 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 11.0 tp -64.97 -37.11 86.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -0.942 . . . . 0.0 110.446 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -57.92 -37.43 74.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 29.2 p-10 -132.14 126.47 33.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.121 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 52' ' ' ASN . 11.0 mt -87.77 124.69 33.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.16 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.413 ' HG3' ' C ' ' A' ' 21' ' ' LEU . 89.5 mt-30 -145.7 55.32 1.19 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 0.0 110.368 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.504 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 0.3 OUTLIER 54.6 62.92 7.75 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.219 -0.926 . . . . 0.0 110.452 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HD2' ' ND2' ' A' ' 52' ' ' ASN . 2.9 Cg_endo -62.78 61.4 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.89 1.469 . . . . 0.0 110.483 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 23' ' ' GLU . 94.4 mt-30 -63.76 -19.54 65.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.188 -0.945 . . . . 0.0 110.277 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.624 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 0.5 OUTLIER 66.98 54.37 0.77 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.353 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.624 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -61.48 152.28 74.22 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.778 1.41 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -63.15 101.74 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.177 -0.952 . . . . 0.0 110.058 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.47 HG23 ' HB2' ' A' ' 31' ' ' LYS . 13.4 p -123.27 141.44 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 110.296 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.16 2.9 69.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.47 ' HB2' HG23 ' A' ' 29' ' ' VAL . 27.2 mttt -80.92 147.53 30.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -1.177 . . . . 0.0 110.169 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.7 tp -99.18 123.32 43.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.133 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.517 ' NH1' ' HE2' ' A' ' 17' ' ' LYS . 34.6 mtt-85 -69.89 136.61 50.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.927 . . . . 0.0 110.378 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 55.4 t-20 -172.09 31.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.256 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.585 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 65.4 t80 -109.82 7.45 24.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.863 . . . . 0.0 110.148 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.503 ' N ' ' HE2' ' A' ' 16' ' ' LYS . . . -58.35 123.03 64.0 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.174 -0.954 . . . . 0.0 110.303 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.77 -143.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.769 1.405 . . . . 0.0 110.549 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.501 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -108.82 165.54 12.47 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.915 . . . . 0.0 110.019 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 38' ' ' ILE . 3.1 Cg_exo -59.8 158.46 28.72 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.808 1.425 . . . . 0.0 110.579 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.43 21.28 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.486 ' O ' HD13 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -134.55 88.66 28.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.087 -1.243 . . . . 0.0 109.972 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.32 140.39 91.64 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.953 1.502 . . . . 0.0 110.704 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.529 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 16.6 m -131.33 169.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 110.299 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.577 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 6.3 t 66.89 56.06 0.85 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.461 -0.775 . . . . 0.0 110.634 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.8 Cg_endo -61.03 -45.46 19.6 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.796 1.419 . . . . 0.0 109.846 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.503 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 67.5 mt -147.09 -39.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.459 -0.776 . . . . 0.0 109.44 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' O ' ' O ' ' A' ' 48' ' ' CYS . 69.8 mt -143.75 78.54 1.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.492 -0.755 . . . . 0.0 109.64 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.527 ' O ' ' O ' ' A' ' 47' ' ' LEU . 99.1 m 56.23 144.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.411 -0.806 . . . . 0.0 110.479 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.507 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -98.6 -72.54 0.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.163 -0.96 . . . . 0.0 110.092 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.445 ' OD1' HD13 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -76.67 113.67 31.7 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.461 -0.775 . . . . 0.0 110.011 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.46 -11.09 18.29 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.668 1.352 . . . . 0.0 110.676 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.549 ' ND2' ' HD2' ' A' ' 24' ' ' PRO . 42.2 t30 -130.6 34.44 4.14 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.286 -0.884 . . . . 0.0 110.376 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.712 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.2 -175.45 0.6 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.172 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.712 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.5 Cg_exo -58.28 74.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.499 1.262 . . . . 0.0 109.843 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 53' ' ' PHE . 87.0 tt0 -42.05 -36.87 1.24 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.451 -0.781 . . . . 0.0 110.222 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.582 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.7 mt-10 -52.79 -18.42 1.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.041 -1.037 . . . . 0.0 108.934 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.638 ' CD1' ' HB2' ' A' ' 54' ' ' PRO . 9.3 mp -94.12 14.95 18.38 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.901 0.858 . . . . 0.0 109.028 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.725 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -40.19 -52.24 5.7 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.034 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.725 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.9 Cg_exo -52.97 -43.28 58.1 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.509 1.268 . . . . 0.0 110.094 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.598 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 86.4 mt -60.24 -37.88 81.72 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.03 -1.043 . . . . 0.0 109.95 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.47 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 2.9 t -69.03 -30.62 69.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.02 -1.05 . . . . 0.0 110.216 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 34.4 tttm -89.95 -1.35 57.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.154 -0.967 . . . . 0.0 109.551 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.512 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 2.9 mt-10 -90.63 138.28 26.72 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.523 -0.736 . . . . 0.0 110.038 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.71 -20.75 66.94 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.632 1.332 . . . . 0.0 110.039 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.97 -2.39 57.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.377 -0.827 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.598 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -46.01 -35.55 4.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.098 -1.001 . . . . 0.0 109.8 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.56 -45.54 88.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -80.25 -41.22 25.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.519 ' CG2' HD21 ' A' ' 60' ' ' LEU . 83.5 mt -57.53 -45.59 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.167 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -45.77 -58.48 3.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.852 . . . . 0.0 110.248 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.579 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 84.7 mt-30 -48.7 -56.2 9.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 0.0 110.023 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -48.88 -52.8 22.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.896 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.48 HD12 HD22 ' A' ' 57' ' ' LEU . 33.8 mt -51.42 -49.96 60.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.992 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.513 ' HG3' HD23 ' A' ' 70' ' ' LEU . 86.8 mt-10 -51.89 -54.25 31.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.219 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -55.57 -55.94 26.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.922 . . . . 0.0 110.537 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 79' ' ' ASP . 38.0 mm -58.35 -41.41 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.117 -0.989 . . . . 0.0 109.922 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.456 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -52.6 -37.14 57.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.286 -0.884 . . . . 0.0 109.657 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.2 tt0 -63.3 -44.03 96.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.79 . . . . 0.0 110.13 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 76' ' ' ILE . 6.5 t70 -136.73 143.4 42.64 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.054 -1.029 . . . . 0.0 110.231 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.537 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -59.41 -48.15 14.46 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.74 1.39 . . . . 0.0 110.588 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.41 -137.66 19.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.593 ' O ' HG12 ' A' ' 85' ' ' ILE . 44.2 p -76.08 -24.47 55.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -1.177 . . . . 0.0 109.312 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.508 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 22.8 t -47.55 -54.74 10.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.446 -0.784 . . . . 0.0 110.266 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.537 ' HB2' ' CB ' ' A' ' 80' ' ' PRO . 85.0 tt0 -60.39 -36.63 78.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.402 -0.811 . . . . 0.0 111.625 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 82' ' ' THR . 9.5 pt -86.88 10.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.741 -1.225 . . . . 0.0 110.58 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 87.5 m 52.78 19.81 1.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.828 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.553 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -78.33 -4.67 49.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.068 -1.02 . . . . 0.0 109.774 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -146.43 165.81 28.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.45 -0.781 . . . . 0.0 110.143 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.98 3.91 7.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 110.398 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.83 72.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.96 . . . . 0.0 110.555 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -108.07 122.3 46.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.173 -0.954 . . . . 0.0 110.662 -179.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.418 HG22 ' CD ' ' A' ' 4' ' ' GLN . 14.8 p -105.67 150.09 25.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.363 -0.836 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 94' ' ' CYS . . . 100.16 -6.89 58.31 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 93' ' ' GLY . 22.0 m . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.352 -1.087 . . . . 0.0 110.32 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.246 0.546 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 25.8 m -122.18 145.06 48.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.903 . . . . 0.0 110.399 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.539 HG22 ' CG ' ' A' ' 12' ' ' LEU . 64.9 t -88.43 119.94 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.042 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.481 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 12.0 pt20 -115.31 140.41 49.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 110.762 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.484 ' OD2' HD12 ' A' ' 60' ' ' LEU . 51.0 p30 -110.31 13.93 22.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.549 -0.719 . . . . 0.0 109.862 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.07 -135.58 2.61 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -81.99 3.72 25.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -1.126 . . . . 0.0 110.128 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 81.0 m-85 -122.87 151.58 41.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.475 ' OG ' ' CG2' ' A' ' 2' ' ' THR . 3.7 t -104.19 135.06 46.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.697 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 24.6 m-85 -121.62 133.67 54.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.534 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.0 m -73.49 167.2 21.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -0.864 . . . . 0.0 110.36 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 5.3 mp -95.13 -15.95 22.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 110.508 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.2 mt-10 -65.74 -69.2 0.31 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.078 -1.013 . . . . 0.0 110.282 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' GLU . 5.6 m -40.76 -53.07 2.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 110.606 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.628 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.2 m -57.31 -45.07 85.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.045 -1.034 . . . . 0.0 109.442 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.532 ' O ' ' HG3' ' A' ' 37' ' ' PRO . 55.2 tttm -54.09 -57.56 10.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.0 109.006 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -80.3 12.6 2.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.376 -0.827 . . . . 0.0 109.979 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.628 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 4.9 tt -65.62 -36.86 84.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 110.52 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HD2' ' CB ' ' A' ' 37' ' ' PRO . 21.3 tttt -56.39 -48.76 76.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -0.881 . . . . 0.0 110.695 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -134.0 155.65 49.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.118 -0.989 . . . . 0.0 110.388 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.5 ' CD2' ' HB2' ' A' ' 52' ' ' ASN . 7.8 mt -114.16 121.91 45.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 109.978 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -136.91 159.35 42.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 110.249 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.597 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 1.5 mt-10 53.27 179.55 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.99 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.597 ' HD2' ' CB ' ' A' ' 23' ' ' GLU . 3.3 Cg_exo -58.27 176.93 0.32 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.721 1.38 . . . . 0.0 110.557 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 24' ' ' PRO . 95.1 mt-30 -41.5 -83.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.512 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -129.16 79.26 74.7 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.095 -1.003 . . . . 0.0 110.357 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.522 ' CG ' ' OE1' ' A' ' 23' ' ' GLU . 3.0 Cg_endo -63.68 133.83 41.25 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.812 1.427 . . . . 0.0 110.553 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 27' ' ' PRO . 28.4 tpt180 41.79 87.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.275 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 28' ' ' ARG . 5.6 p -43.55 124.07 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.271 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.83 106.66 2.78 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -61.01 -29.01 69.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -1.138 . . . . 0.0 110.477 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.2 mt -112.21 135.54 52.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.14 -0.975 . . . . 0.0 110.748 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -122.57 135.76 54.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.428 -0.795 . . . . 0.0 109.353 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 38.2 t-20 -158.16 -65.99 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.869 -1.144 . . . . 0.0 111.522 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.404 ' C ' ' HE2' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -58.58 70.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.401 -0.812 . . . . 0.0 111.28 -178.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.584 ' N ' ' O ' ' A' ' 34' ' ' ASN . . . -80.35 163.0 59.21 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.162 -0.961 . . . . 0.0 109.81 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.567 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 2.9 Cg_endo -65.1 -3.54 7.41 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.736 1.387 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 3.6 mt 71.44 123.24 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.25 -0.906 . . . . 0.0 110.172 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 2.9 Cg_endo -61.89 -178.24 0.3 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.75 1.395 . . . . 0.0 110.61 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.87 13.28 29.92 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.427 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 0.7 OUTLIER -133.55 66.74 74.56 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.307 -1.113 . . . . 0.0 110.163 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.459 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 3.0 Cg_exo -61.88 135.09 53.63 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.937 1.493 . . . . 0.0 110.708 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.538 ' CG2' ' OG ' ' A' ' 49' ' ' SER . 3.1 p 178.46 91.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.1 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.603 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 6.4 p -133.63 64.16 66.89 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 110.195 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 3.1 Cg_exo -59.47 159.58 23.08 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.765 1.403 . . . . 0.0 110.477 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 46' ' ' ILE . 81.2 mt -47.74 -35.18 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 0.0 110.134 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.586 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 2.9 mm? -86.2 0.55 53.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.083 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 97.1 m 59.38 131.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.36 -0.837 . . . . 0.0 110.207 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.539 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 48.9 m -61.34 -59.23 5.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 110.916 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -80.12 113.16 36.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.425 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -61.42 -7.59 8.95 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.677 1.356 . . . . 0.0 110.391 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.5 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 90.8 m-20 -135.07 40.53 2.89 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.263 -0.898 . . . . 0.0 110.218 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.646 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -80.03 177.19 3.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.93 . . . . 0.0 108.929 179.245 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.646 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.7 Cg_exo -58.06 74.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.544 1.286 . . . . 0.0 109.215 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.629 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.5 tt0 -39.34 -29.58 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.773 -0.579 . . . . 0.0 110.293 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.4 mt-10 -51.71 -20.96 2.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.979 -1.076 . . . . 0.0 108.482 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.697 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 75.2 mt -87.17 10.02 18.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.597 -0.689 . . . . 0.0 109.58 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.738 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.89 -51.07 5.66 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 110.415 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.738 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.57 -42.98 63.25 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.561 1.295 . . . . 0.0 110.205 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.587 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 6.6 mp -58.18 -42.79 86.84 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.007 -1.058 . . . . 0.0 110.068 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.466 ' HA ' HG23 ' A' ' 44' ' ' VAL . 3.7 t -62.71 -27.49 69.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 110.158 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -90.36 -4.44 57.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 110.874 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.505 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 10.4 pt-20 -113.54 142.63 27.95 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 0.0 110.228 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.45 -14.33 41.68 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.87 1.458 . . . . 0.0 110.982 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.508 ' O ' HG13 ' A' ' 69' ' ' ILE . 68.6 m-20 -79.68 -17.4 53.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.181 -0.949 . . . . 0.0 110.603 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.587 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -52.01 -37.01 51.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.999 -1.063 . . . . 0.0 110.079 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -55.65 -44.08 76.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -80.34 -36.61 33.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.706 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.516 ' CG2' HD22 ' A' ' 73' ' ' LEU . 84.1 mt -66.78 -50.68 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 0.0 109.904 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.579 HD23 ' HG3' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -42.11 -62.99 0.81 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 0.0 110.343 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.55 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 54.0 mt-30 -48.09 -52.47 20.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.073 -1.017 . . . . 0.0 110.231 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -55.27 -54.52 42.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.516 HD22 ' CG2' ' A' ' 69' ' ' ILE . 3.6 mm? -47.69 -52.51 18.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 109.93 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.579 ' HG3' HD23 ' A' ' 70' ' ' LEU . 68.0 mt-10 -52.78 -50.17 64.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 109.902 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.515 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.0 tt0 -53.76 -54.83 32.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.967 . . . . 0.0 109.971 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 79' ' ' ASP . 39.0 mm -56.07 -35.33 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.127 -0.983 . . . . 0.0 109.233 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -57.81 -32.82 67.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.433 -0.792 . . . . 0.0 109.293 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.602 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 94.3 mt-10 -60.19 -42.84 95.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.424 -0.798 . . . . 0.0 109.86 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.467 ' OD1' ' HD2' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -147.14 153.62 45.26 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 110.172 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.526 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 3.2 Cg_exo -60.13 -51.96 4.86 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.952 1.501 . . . . 0.0 110.618 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.15 -139.51 20.52 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.559 ' O ' HG12 ' A' ' 85' ' ' ILE . 45.6 p -79.83 -19.76 47.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -1.144 . . . . 0.0 109.778 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 48.8 t -54.39 -53.81 49.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 110.155 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.526 ' HB2' ' CB ' ' A' ' 80' ' ' PRO . 83.7 tt0 -58.68 -30.34 67.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 111.22 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 82' ' ' THR . 12.0 pt -95.94 12.73 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.913 -1.117 . . . . 0.0 110.56 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 3.4 t 51.47 19.87 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.285 -0.884 . . . . 0.0 110.961 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.526 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -77.72 -9.0 58.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 109.751 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -138.45 164.65 28.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.472 -0.767 . . . . 0.0 109.877 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.92 2.09 11.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 110.176 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.84 -37.23 85.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.574 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -98.2 120.31 38.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.1 -1.0 . . . . 0.0 110.59 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.462 HG22 ' OE1' ' A' ' 4' ' ' GLN . 41.5 p -104.03 154.58 19.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.365 -0.834 . . . . 0.0 110.142 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.76 -11.37 68.19 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 110.274 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.201 0.524 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 43.2 m -126.12 152.02 46.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.445 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.568 HG22 ' CD2' ' A' ' 12' ' ' LEU . 92.4 t -88.69 113.98 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.393 -0.817 . . . . 0.0 109.836 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.445 ' HB3' HG22 ' A' ' 92' ' ' THR . 47.8 tt0 -108.95 118.07 35.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.133 -0.979 . . . . 0.0 110.525 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 55.0 p30 -99.09 6.45 46.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.704 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -174.15 -143.26 4.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -79.91 3.62 19.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -1.149 . . . . 0.0 110.49 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.435 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 79.4 m-85 -120.23 140.8 50.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.101 -0.999 . . . . 0.0 110.46 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.482 ' OG ' ' CG2' ' A' ' 2' ' ' THR . 21.8 t -86.59 127.13 34.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.976 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.639 ' CD2' HD22 ' A' ' 57' ' ' LEU . 22.0 m-30 -116.93 130.07 56.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.139 -0.976 . . . . 0.0 110.656 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.2 p -80.03 174.6 11.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.324 -0.86 . . . . 0.0 110.286 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.598 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 2.5 mm? -99.89 -7.88 24.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 110.817 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -68.56 -71.3 0.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.178 -0.951 . . . . 0.0 111.056 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.51 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 4.1 m -51.91 -50.6 60.75 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.096 -1.003 . . . . 0.0 111.229 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.556 ' CG2' ' HA ' ' A' ' 12' ' ' LEU . 17.3 m -55.99 -48.65 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.884 -1.135 . . . . 0.0 110.212 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.479 ' NZ ' ' HE2' ' A' ' 17' ' ' LYS . 19.3 ttpp -55.69 -52.75 62.79 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.846 -1.159 . . . . 0.0 108.669 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HE2' ' NZ ' ' A' ' 16' ' ' LYS . 71.1 mmtt -80.47 12.73 2.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.791 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.579 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 54.9 tp -61.39 -51.0 70.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 110.144 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 37' ' ' PRO . 62.8 mttp -62.85 -33.96 76.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.914 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -130.9 100.42 5.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.847 . . . . 0.0 109.623 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.468 HD23 ' CB ' ' A' ' 52' ' ' ASN . 0.7 OUTLIER -95.33 126.84 40.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.836 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.518 ' O ' ' HG3' ' A' ' 27' ' ' PRO . 92.8 mt-30 -133.22 150.62 51.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.385 -0.822 . . . . 0.0 109.376 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' CB ' ' HB3' ' A' ' 27' ' ' PRO . 2.7 mt-10 42.83 92.3 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.069 -1.02 . . . . 0.0 109.732 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 3.1 Cg_exo -58.69 172.77 1.38 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.885 1.466 . . . . 0.0 110.919 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 80.0 mt-30 58.8 52.95 6.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 110.218 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 25' ' ' GLN . 96.4 mt-10 50.55 101.38 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.866 . . . . 0.0 110.404 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.518 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 2.8 Cg_endo -62.44 -20.18 69.69 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.779 1.41 . . . . 0.0 110.418 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 66.6 mtt85 55.27 54.17 9.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 110.067 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.47 143.71 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 0.0 110.113 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.87 117.47 3.48 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' O ' HD22 ' A' ' 32' ' ' LEU . 44.4 tttp -59.96 -42.24 93.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -1.149 . . . . 0.0 110.385 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 31' ' ' LYS . 55.1 mt -119.37 143.3 47.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.391 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.422 ' HB3' ' HE2' ' A' ' 16' ' ' LYS . 63.1 mtt180 -89.94 53.63 2.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.966 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 30.3 t30 -108.34 117.79 35.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 110.094 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.557 ' O ' ' HD3' ' A' ' 37' ' ' PRO . 71.4 t80 -162.65 97.11 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.999 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 35' ' ' PHE . . . -39.89 98.42 0.17 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.399 -0.813 . . . . 0.0 110.249 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 35' ' ' PHE . 2.8 Cg_endo -65.91 -11.33 30.43 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.882 1.464 . . . . 0.0 110.567 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 5.0 mt 56.87 88.81 0.12 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.062 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -60.81 164.96 12.7 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.97 1.511 . . . . 0.0 110.542 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.05 9.16 34.93 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 82.42 54.48 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.283 -1.128 . . . . 0.0 110.053 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.466 ' HG3' ' HG3' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -61.58 137.7 70.82 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.934 1.492 . . . . 0.0 110.488 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.49 ' C ' ' CG1' ' A' ' 44' ' ' VAL . 16.2 m -117.44 49.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.179 -0.951 . . . . 0.0 110.278 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 2.4 m -151.66 52.09 0.89 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 110.159 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 44' ' ' VAL . 3.2 Cg_exo -57.57 -15.87 21.88 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.655 1.345 . . . . 0.0 110.791 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 45' ' ' PRO . 18.7 tt -179.98 -29.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.897 . . . . 0.0 110.074 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.54 ' O ' ' O ' ' A' ' 48' ' ' CYS . 24.3 tp -159.05 70.01 0.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.134 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.585 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 98.3 m 44.58 102.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.361 -0.837 . . . . 0.0 110.397 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.574 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 15.5 t -51.82 -51.22 58.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.256 -0.903 . . . . 0.0 110.783 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 4.5 m120 -80.06 111.93 25.99 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.407 -0.808 . . . . 0.0 110.679 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.7 -13.41 36.63 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.636 1.335 . . . . 0.0 110.507 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.468 ' CB ' HD23 ' A' ' 21' ' ' LEU . 97.2 m-20 -123.88 29.67 6.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.525 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.722 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -80.3 177.5 2.92 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 109.161 179.251 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.722 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.4 Cg_exo -58.3 74.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.662 1.349 . . . . 0.0 108.929 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.637 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.1 tt0 -39.22 -27.77 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.634 -0.666 . . . . 0.0 110.182 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' PRO . 75.1 mm-40 -53.61 -17.2 1.98 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.03 -1.044 . . . . 0.0 108.592 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.639 HD22 ' CD2' ' A' ' 10' ' ' PHE . 92.7 mt -92.44 9.07 35.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.689 -0.632 . . . . 0.0 109.615 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.721 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -39.88 -50.67 5.69 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 110.278 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.721 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -55.76 -44.93 42.99 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.482 1.254 . . . . 0.0 110.124 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -54.11 -44.29 71.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 110.093 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.502 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . 82.5 m -64.4 -27.56 69.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.965 . . . . 0.0 110.139 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -91.87 4.88 51.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.893 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.498 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 3.7 mt-10 -112.9 137.02 21.69 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.355 -0.841 . . . . 0.0 110.179 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.99 -21.64 72.75 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.673 1.354 . . . . 0.0 109.884 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -79.93 -10.91 59.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.43 -0.794 . . . . 0.0 110.867 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.68 -36.03 10.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.956 -1.09 . . . . 0.0 109.877 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.466 ' HG3' ' HG3' ' A' ' 42' ' ' PRO . 50.2 tt0 -59.97 -42.61 94.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.343 -0.848 . . . . 0.0 110.029 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.16 -39.04 30.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 109.906 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.469 ' CG2' HD12 ' A' ' 60' ' ' LEU . 89.4 mt -63.51 -44.43 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.829 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.548 HD21 ' HG2' ' A' ' 74' ' ' GLU . 2.0 tm? -52.36 -54.31 33.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 0.0 110.209 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -47.94 -52.9 17.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.291 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' LEU . 97.4 mtt180 -58.43 -62.14 2.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.455 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 45.5 mt -44.93 -52.92 8.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.19 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.548 ' HG2' HD21 ' A' ' 70' ' ' LEU . 78.4 mm-40 -54.98 -47.59 74.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 110.78 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -56.72 -52.78 63.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.923 . . . . 0.0 110.771 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.508 ' CG2' HG23 ' A' ' 3' ' ' VAL . 24.2 mm -63.61 -36.14 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 0.0 109.924 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -58.92 -33.71 70.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.43 -0.794 . . . . 0.0 109.881 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.463 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 83.5 tt0 -61.13 -37.9 84.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.685 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -150.35 160.62 32.71 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.032 -1.043 . . . . 0.0 110.675 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -61.54 -62.11 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.051 1.553 . . . . 0.0 110.569 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.34 -141.83 28.37 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.554 ' O ' HG12 ' A' ' 85' ' ' ILE . 70.6 p -79.55 -22.16 44.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -1.154 . . . . 0.0 109.581 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.522 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 32.5 t -52.89 -51.63 60.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 109.991 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.5 tt0 -58.62 -33.77 70.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 0.0 111.179 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 82' ' ' THR . 5.2 pt -97.3 13.49 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.893 -1.129 . . . . 0.0 110.463 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.71 14.14 1.67 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.266 -0.896 . . . . 0.0 110.487 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.532 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -65.08 -15.11 62.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 109.963 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -139.69 168.41 19.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 0.0 110.267 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.98 3.07 8.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 110.301 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -63.08 -36.92 85.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.428 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -102.97 121.01 41.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 110.496 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 4' ' ' GLN . 18.9 p -111.54 166.32 11.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 110.227 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.97 -26.19 15.97 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.18 -1.188 . . . . 0.0 110.292 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.462 HG11 ' SG ' ' A' ' 91' ' ' CYS . 47.2 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.317 0.579 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.449 HG22 ' HA ' ' A' ' 11' ' ' SER . 28.8 m -119.23 147.31 44.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.182 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.528 ' CG2' HD23 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -89.62 118.97 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 109.952 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.51 ' CB ' HG22 ' A' ' 92' ' ' THR . 65.6 tt0 -111.66 129.3 56.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 110.543 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.49 ' OD2' HG22 ' A' ' 69' ' ' ILE . 90.6 m-20 -93.26 -81.24 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.759 . . . . 0.0 110.016 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.12 -126.32 3.81 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -84.69 8.27 17.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -1.184 . . . . 0.0 110.335 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.3 m-85 -120.2 137.79 54.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.36 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.433 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 25.2 t -88.55 130.26 35.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 110.179 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.646 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 18.6 m-85 -119.2 126.84 52.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.816 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.449 ' HA ' HG22 ' A' ' 2' ' ' THR . 38.8 t -75.65 169.14 18.69 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -0.996 . . . . 0.0 110.072 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.559 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 64.2 mt -102.36 -2.15 29.48 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.126 -0.984 . . . . 0.0 110.905 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -74.21 -73.6 0.22 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.084 -1.01 . . . . 0.0 110.6 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.495 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.6 m -43.0 -42.27 3.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.862 . . . . 0.0 110.826 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 6.2 m -65.29 -45.31 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.858 -1.151 . . . . 0.0 109.663 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.444 ' CE ' ' HB2' ' A' ' 35' ' ' PHE . 46.7 tttm -53.34 -46.98 69.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.821 -1.174 . . . . 0.0 108.93 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 45.8 tptt -80.23 -1.51 40.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.516 -0.74 . . . . 0.0 109.993 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.564 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 53.9 tp -66.55 -40.84 89.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.137 -0.977 . . . . 0.0 110.194 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 38' ' ' ILE . 20.8 tttp -56.62 -45.63 81.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.283 -0.885 . . . . 0.0 110.072 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -116.99 70.2 0.77 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.538 ' CD1' ' OD1' ' A' ' 52' ' ' ASN . 19.2 tp -54.03 -48.2 70.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 110.506 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 21' ' ' LEU . 3.1 tt0 46.79 -173.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.134 -0.978 . . . . 0.0 109.88 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -50.28 147.04 7.93 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.985 . . . . 0.0 109.946 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.47 133.1 46.96 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.796 1.419 . . . . 0.0 110.491 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 6.8 tt0 -169.93 50.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.297 -0.877 . . . . 0.0 110.394 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.639 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 0.6 OUTLIER -131.32 49.97 5.39 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 110.688 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.639 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.7 Cg_endo -60.41 -30.79 91.64 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.579 1.305 . . . . 0.0 110.247 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.46 ' O ' ' OE2' ' A' ' 26' ' ' GLU . 88.3 mtm-85 -139.37 174.64 10.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.421 -0.799 . . . . 0.0 110.071 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.0 m -123.91 157.49 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.153 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.34 179.66 48.08 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -64.68 -39.78 94.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -1.147 . . . . 0.0 110.053 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.2 tp -161.5 135.72 6.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.299 -0.876 . . . . 0.0 110.089 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.509 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 48.0 mtt180 -127.67 133.45 49.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 110.199 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 33' ' ' ARG . 33.0 m120 -150.53 46.62 0.88 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.166 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.444 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 13.7 m-85 -108.54 8.31 27.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.217 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 78' ' ' GLU . . . -56.57 125.07 65.86 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 110.06 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' O ' HG13 ' A' ' 38' ' ' ILE . 2.9 Cg_endo -62.14 -80.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.714 1.376 . . . . 0.0 110.926 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.591 HG22 ' HD2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -165.1 150.43 8.37 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.927 . . . . 0.0 110.136 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.591 ' HD2' HG22 ' A' ' 38' ' ' ILE . 3.3 Cg_exo -57.62 139.58 90.69 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.907 1.477 . . . . 0.0 110.793 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.86 -78.75 1.43 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.99 153.56 35.86 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.287 -1.125 . . . . 0.0 110.257 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.45 ' HB2' ' HG3' ' A' ' 67' ' ' GLN . 3.0 Cg_endo -61.69 139.65 81.96 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.963 1.507 . . . . 0.0 110.614 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.448 ' O ' ' CG1' ' A' ' 43' ' ' VAL . 13.4 p -177.44 71.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.947 . . . . 0.0 110.261 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.511 ' CG2' ' HA ' ' A' ' 61' ' ' CYS . 2.8 p -129.54 66.07 76.15 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.864 . . . . 0.0 110.139 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.436 ' HD3' ' C ' ' A' ' 43' ' ' VAL . 3.1 Cg_exo -61.47 164.81 14.53 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.896 1.472 . . . . 0.0 110.483 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.48 HD11 HG22 ' A' ' 46' ' ' ILE . 88.1 mt -48.39 -42.45 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 110.121 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 48' ' ' CYS . 53.1 mt -82.79 -3.29 56.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 110.047 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.7 m 59.52 128.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.248 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.534 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.1 t -61.0 -44.82 96.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 4.2 m120 -80.35 112.11 28.12 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.343 -0.848 . . . . 0.0 110.304 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -59.54 -10.26 10.92 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.766 1.403 . . . . 0.0 110.7 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.538 ' OD1' ' CD1' ' A' ' 21' ' ' LEU . 45.7 p-10 -136.97 41.81 2.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 110.366 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.683 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.24 177.15 3.13 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 109.116 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.683 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -58.3 75.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.591 1.311 . . . . 0.0 109.143 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.647 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.3 tt0 -39.06 -29.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.782 -0.574 . . . . 0.0 110.149 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.3 mt-10 -52.04 -18.88 1.58 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.025 -1.047 . . . . 0.0 108.634 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.646 ' CD2' ' CG ' ' A' ' 10' ' ' PHE . 88.6 mt -90.8 9.67 29.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.487 -0.758 . . . . 0.0 109.649 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.721 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.3 tmtt? -39.71 -51.51 5.21 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.359 -0.838 . . . . 0.0 110.63 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.721 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.28 -43.58 57.32 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.459 1.242 . . . . 0.0 109.997 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.55 ' CD1' ' CD1' ' A' ' 69' ' ' ILE . 0.3 OUTLIER -55.6 -40.7 72.4 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.11 -0.994 . . . . 0.0 110.039 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.511 ' HA ' ' CG2' ' A' ' 44' ' ' VAL . 82.4 m -58.03 -23.37 54.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.215 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.502 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 35.5 mtmt -113.46 37.05 3.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 109.579 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.502 ' OE1' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -133.12 141.83 42.25 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.849 . . . . 0.0 110.36 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.93 -26.28 74.26 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.746 1.393 . . . . 0.0 110.075 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.465 ' O ' HG13 ' A' ' 69' ' ' ILE . 72.1 m-20 -80.19 -18.65 49.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.906 . . . . 0.0 110.439 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -45.39 -47.33 13.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.328 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.45 ' HG3' ' HB2' ' A' ' 42' ' ' PRO . 61.0 tt0 -54.25 -43.62 71.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.492 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.15 -33.03 38.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.879 . . . . 0.0 110.473 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.55 ' CD1' ' CD1' ' A' ' 60' ' ' LEU . 94.5 mt -63.41 -44.88 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 0.0 110.357 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 70' ' ' LEU . 1.6 tm? -43.43 -66.93 0.32 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.439 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.467 ' HA ' ' HB3' ' A' ' 39' ' ' PRO . 97.7 mt-30 -47.31 -54.87 9.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.114 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -50.46 -58.88 4.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 110.094 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.488 ' HG ' HG21 ' A' ' 69' ' ' ILE . 40.2 mt -45.16 -51.68 10.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.183 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 73.3 mm-40 -51.63 -58.01 7.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 110.301 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 85.0 tt0 -52.04 -56.6 13.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.933 . . . . 0.0 110.592 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.496 HG23 HD23 ' A' ' 12' ' ' LEU . 22.4 mm -55.75 -38.42 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.152 -0.968 . . . . 0.0 109.888 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 74' ' ' GLU . . . -57.47 -32.54 67.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.595 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 81.8 tt0 -59.72 -43.25 94.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.423 -0.798 . . . . 0.0 110.136 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -147.22 157.31 45.98 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.214 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.511 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -61.55 -48.1 10.06 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.856 1.451 . . . . 0.0 110.6 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.23 -139.98 25.75 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.624 ' O ' HG12 ' A' ' 85' ' ' ILE . 32.1 p -84.06 -16.52 43.51 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -1.156 . . . . 0.0 109.954 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 41.1 t -57.46 -48.72 78.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.986 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.3 tt0 -61.97 -28.03 69.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 111.241 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 82' ' ' THR . 7.5 pt -97.54 7.26 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.863 -1.148 . . . . 0.0 110.304 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.0 m 61.33 15.86 6.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.0 110.614 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.514 ' HB2' ' CG1' ' A' ' 85' ' ' ILE . . . -67.2 -16.61 64.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -0.999 . . . . 0.0 109.853 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 87' ' ' ALA . 27.4 m-85 -138.81 166.65 23.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.922 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.7 2.29 10.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.314 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.29 -32.79 73.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.563 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -102.84 116.95 33.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.64 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.51 HG22 ' CB ' ' A' ' 4' ' ' GLN . 17.7 p -105.39 157.81 17.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 110.133 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.33 -26.0 24.75 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.326 -1.103 . . . . 0.0 110.289 179.938 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 94' ' ' CYS . 10.6 t . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.21 0.528 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 35.5 m -120.33 149.25 42.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 110.335 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.523 HG22 ' CD2' ' A' ' 12' ' ' LEU . 91.2 t -84.36 117.6 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.336 -0.853 . . . . 0.0 109.774 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.501 ' CB ' ' HA ' ' A' ' 9' ' ' SER . 19.4 pt20 -111.81 146.09 38.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.178 -0.951 . . . . 0.0 110.869 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -106.13 13.26 29.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 109.792 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.89 -126.96 1.38 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -84.87 5.88 27.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -1.213 . . . . 0.0 110.111 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 87.2 m-85 -124.86 138.58 54.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.24 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.501 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 78.4 p -96.86 137.94 35.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.217 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.599 ' CD1' HD22 ' A' ' 57' ' ' LEU . 24.6 m-85 -125.14 138.04 54.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.277 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.4 t -69.96 165.66 21.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.317 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.599 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 4.5 mp -97.67 -13.29 21.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.874 . . . . 0.0 110.328 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' OE2' ' HD3' ' A' ' 33' ' ' ARG . 70.9 mm-40 -68.66 -73.36 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.29 -0.881 . . . . 0.0 110.614 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 13' ' ' GLU . 4.0 m -42.49 -48.67 5.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.461 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.547 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 36.2 t -58.31 -45.24 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.946 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -56.95 -56.64 19.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.949 . . . . 0.0 109.086 179.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -80.61 11.81 3.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -0.811 . . . . 0.0 109.945 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 2.0 tt -62.06 -41.74 98.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -73.84 -64.52 0.99 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 110.108 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 22' ' ' GLN . 90.0 m-20 -58.06 -37.8 75.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.53 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 16.0 tp 52.17 29.24 6.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.302 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 20' ' ' ASP . 95.1 mm-40 -95.24 147.58 23.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.092 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.494 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER 49.0 74.14 0.87 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.071 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.22 62.28 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 124.006 1.529 . . . . 0.0 110.731 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 23' ' ' GLU . 32.5 tt0 -144.6 168.61 19.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 110.014 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' N ' ' HG2' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -124.21 69.02 49.28 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.0 110.393 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.464 ' HD3' ' C ' ' A' ' 25' ' ' GLN . 2.9 Cg_endo -61.13 145.94 98.19 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.84 1.442 . . . . 0.0 110.348 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.493 ' NH2' ' HB2' ' A' ' 28' ' ' ARG . 43.2 mtm105 -114.19 97.35 6.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.144 -0.972 . . . . 0.0 110.18 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -125.19 118.13 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.112 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.18 9.32 60.29 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.0 mttp 50.27 42.75 26.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.336 -1.096 . . . . 0.0 110.262 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.4 tp -115.19 124.53 51.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 110.253 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.508 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 76.3 mtt85 -114.07 55.1 0.74 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.983 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.508 ' ND2' ' OD1' ' A' ' 79' ' ' ASP . 70.5 m-20 -130.1 148.17 51.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 0.0 110.315 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.507 ' N ' ' HE2' ' A' ' 16' ' ' LYS . 62.9 t80 -173.7 -71.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 109.902 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 78' ' ' GLU . . . -56.97 113.43 6.09 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.382 -0.824 . . . . 0.0 109.893 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.57 ' C ' HG13 ' A' ' 38' ' ' ILE . 3.0 Cg_endo -60.84 -27.89 85.53 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.711 1.374 . . . . 0.0 110.832 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.766 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -164.64 171.05 5.93 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.251 -0.906 . . . . 0.0 110.17 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.521 ' HD2' ' CG2' ' A' ' 38' ' ' ILE . 3.0 Cg_exo -62.16 148.89 92.38 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.892 1.469 . . . . 0.0 110.54 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.82 -75.16 1.29 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -167.5 144.85 3.78 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.323 -1.104 . . . . 0.0 110.24 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.65 138.34 69.18 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.903 1.475 . . . . 0.0 110.517 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.586 ' HB ' ' CB ' ' A' ' 49' ' ' SER . 19.7 m -143.0 127.39 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 110.251 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 66' ' ' ALA . 69.4 t -156.94 70.97 4.68 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.994 . . . . 0.0 110.97 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -61.19 -143.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.778 1.41 . . . . 0.0 109.53 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.526 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 16.0 mm -49.67 -32.94 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.81 -1.181 . . . . 0.0 108.485 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.526 ' CD1' ' C ' ' A' ' 46' ' ' ILE . 6.8 mp -142.38 -74.94 0.29 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 59.1 m -139.44 137.7 35.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.534 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.614 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 87.7 p -65.55 -42.23 92.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.021 . . . . 0.0 110.616 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 8.7 m120 -80.09 110.46 16.34 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.349 -0.845 . . . . 0.0 110.258 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -60.31 -17.86 49.29 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.734 1.386 . . . . 0.0 110.821 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.53 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 18.2 m120 -126.61 36.26 4.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 110.722 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.621 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -80.28 172.97 8.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.078 -1.014 . . . . 0.0 108.954 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.621 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.5 Cg_exo -58.03 75.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.507 1.267 . . . . 0.0 108.959 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.62 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.7 tt0 -39.4 -28.43 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.635 -0.666 . . . . 0.0 110.184 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt-10 -52.45 -17.04 1.04 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.053 -1.029 . . . . 0.0 108.65 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.599 HD22 ' CD1' ' A' ' 10' ' ' PHE . 62.2 mt -90.46 9.53 28.84 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.475 0.655 . . . . 0.0 109.583 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.734 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 12.9 mttt -39.87 -50.98 5.66 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 110.427 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.734 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.49 -42.62 66.39 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.596 1.314 . . . . 0.0 109.985 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.593 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 7.6 mp -57.92 -39.48 78.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.973 -1.079 . . . . 0.0 109.902 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 12.5 m -66.17 -28.86 69.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.128 -0.982 . . . . 0.0 110.474 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -89.6 5.96 43.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 111.145 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 10.0 pt-20 -121.97 148.75 52.25 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.947 -1.095 . . . . 0.0 110.305 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.8 Cg_endo -63.59 -20.34 69.18 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.988 1.52 . . . . 0.0 111.565 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.494 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 79.4 m-20 -80.03 -10.35 59.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.98 -1.075 . . . . 0.0 110.605 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.593 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.43 -45.43 25.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -0.93 . . . . 0.0 110.674 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -59.0 -42.55 90.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.903 . . . . 0.0 110.561 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -76.85 -31.91 57.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.093 -1.004 . . . . 0.0 110.152 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.545 ' CG2' HD22 ' A' ' 60' ' ' LEU . 99.8 mt -74.45 -46.03 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.923 . . . . 0.0 110.144 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.503 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 1.7 tm? -48.89 -59.3 3.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.882 . . . . 0.0 110.563 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -49.59 -52.93 26.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.059 -1.026 . . . . 0.0 110.096 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -51.41 -54.42 26.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 109.916 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.491 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 65.1 mt -51.26 -48.81 62.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.512 ' OE1' ' CA ' ' A' ' 39' ' ' PRO . 91.2 mt-10 -52.92 -48.4 67.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.062 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.29 -50.23 73.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.972 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.582 ' O ' ' O ' ' A' ' 79' ' ' ASP . 26.5 mm -62.97 -37.41 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.704 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.462 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . . . -56.38 -33.84 66.12 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.475 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.486 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 86.8 tt0 -62.61 -41.34 98.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.456 -0.777 . . . . 0.0 110.524 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -148.23 168.65 10.69 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.214 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.495 ' HD2' ' OD1' ' A' ' 79' ' ' ASP . 3.2 Cg_exo -58.59 -55.81 1.87 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.658 1.347 . . . . 0.0 110.495 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.587 ' O ' ' OG1' ' A' ' 82' ' ' THR . . . 72.04 47.65 30.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.598 ' O ' HG12 ' A' ' 85' ' ' ILE . 1.2 p 72.45 -40.98 0.49 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.451 -1.029 . . . . 0.0 110.842 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 37.4 t -40.75 -47.46 2.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.941 -1.099 . . . . 0.0 109.907 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 86.4 tt0 -63.16 -42.75 99.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 111.006 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 82' ' ' THR . 2.5 pt -84.76 18.7 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.0 -1.063 . . . . 0.0 110.573 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 52.77 16.96 0.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 110.616 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.524 ' HB2' ' CG1' ' A' ' 85' ' ' ILE . . . -67.79 -22.4 65.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 109.758 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.581 ' CD1' ' CB ' ' A' ' 82' ' ' THR . 19.6 m-85 -131.91 170.26 15.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.762 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.42 0.1 34.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.104 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -59.12 -25.9 64.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 110.496 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -111.18 128.17 55.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.787 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.496 HG23 ' NE2' ' A' ' 4' ' ' GLN . 22.6 p -114.37 163.95 14.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 110.064 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.495 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 88.76 -24.13 13.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.534 ' O ' ' CG2' ' A' ' 1' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.331 -1.099 . . . . 0.0 110.497 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.441 ' HA ' ' SG ' ' A' ' 91' ' ' CYS . 92.2 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.222 0.534 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.451 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 60.1 m -126.15 149.21 49.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 110.568 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 10' ' ' PHE . 92.4 t -82.42 110.83 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.514 -0.741 . . . . 0.0 109.519 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.515 ' CB ' HG22 ' A' ' 92' ' ' THR . 35.3 tt0 -112.78 133.43 54.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 110.685 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -96.03 -71.68 0.66 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 109.421 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.0 -129.76 6.81 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -79.76 4.27 16.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -1.177 . . . . 0.0 110.655 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.485 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 99.2 m-85 -119.05 134.44 55.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.058 -1.026 . . . . 0.0 110.656 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.472 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 27.1 t -87.16 135.61 33.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.861 . . . . 0.0 109.97 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.527 ' CE1' HD21 ' A' ' 57' ' ' LEU . 69.6 m-85 -115.56 125.86 53.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 111.005 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.0 t -76.43 173.14 11.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.85 . . . . 0.0 109.796 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.606 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 4.5 mp -103.27 4.81 36.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.046 -1.034 . . . . 0.0 110.756 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.498 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 86.0 tt0 -71.89 -73.03 0.2 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.068 -1.02 . . . . 0.0 110.693 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.501 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 6.1 m -49.06 -45.72 43.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.081 -1.012 . . . . 0.0 110.684 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.568 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 24.2 t -58.38 -50.95 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.967 -1.083 . . . . 0.0 109.746 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 51.1 tttm -54.49 -54.45 40.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.779 -1.201 . . . . 0.0 108.656 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -80.47 14.46 2.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -0.756 . . . . 0.0 109.615 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 35.4 tp -61.44 -40.37 94.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -0.894 . . . . 0.0 110.198 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.468 ' HE3' ' HG3' ' A' ' 41' ' ' GLU . 28.4 mtpt -61.02 -44.68 97.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.004 . . . . 0.0 109.842 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -111.33 115.08 28.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.643 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.548 ' CG ' ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -96.08 107.1 19.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.006 . . . . 0.0 110.715 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 62.5 tt0 179.06 55.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.458 -0.776 . . . . 0.0 109.955 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.52 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 3.4 pm0 -149.69 164.07 22.31 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.068 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 3.1 Cg_exo -61.28 152.32 73.16 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.83 1.437 . . . . 0.0 110.552 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' A' ' 24' ' ' PRO . 56.7 tp60 -58.91 -117.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.91 . . . . 0.0 110.132 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.473 ' CG ' ' OE1' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -129.88 64.6 72.68 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.007 -1.058 . . . . 0.0 110.307 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -61.64 -36.36 75.78 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.754 1.397 . . . . 0.0 110.543 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.482 ' NH2' ' HG3' ' A' ' 28' ' ' ARG . 14.5 mmt85 -140.85 151.52 44.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.343 -0.848 . . . . 0.0 110.212 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.454 HG23 ' OE2' ' A' ' 26' ' ' GLU . 46.4 t -124.09 142.66 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.127 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.34 22.42 0.79 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HB2' ' NH2' ' A' ' 33' ' ' ARG . 2.2 mtpm? -104.31 153.06 21.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.139 -1.212 . . . . 0.0 110.151 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.8 tp -81.34 137.71 35.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.046 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 12' ' ' LEU . 82.3 mtt85 -126.64 141.49 51.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 110.307 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 33.2 p-10 -132.94 175.85 9.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 110.245 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.549 ' CD2' ' N ' ' A' ' 36' ' ' ALA . 68.5 t80 -167.19 173.0 9.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.292 -0.88 . . . . 0.0 110.137 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.549 ' N ' ' CD2' ' A' ' 35' ' ' PHE . . . -60.56 149.05 79.71 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 0.0 110.198 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' O ' ' CD1' ' A' ' 38' ' ' ILE . 2.9 Cg_endo -61.82 -26.87 79.86 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.94 1.495 . . . . 0.0 110.537 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.446 ' CD1' ' O ' ' A' ' 37' ' ' PRO . 8.9 mm -128.17 121.52 21.68 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 110.056 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.4 138.77 78.6 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.738 1.389 . . . . 0.0 110.489 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.46 18.88 0.7 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.468 ' HG3' ' HE3' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -125.52 74.96 69.49 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.283 -1.128 . . . . 0.0 110.2 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.65 146.81 96.51 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.885 1.466 . . . . 0.0 110.462 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.481 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 11.0 m -123.12 172.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 110.383 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.656 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 2.9 t 67.38 49.3 0.49 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.452 -0.78 . . . . 0.0 111.015 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.656 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.8 Cg_endo -61.64 -51.34 4.17 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.562 1.296 . . . . 0.0 109.972 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 47' ' ' LEU . 77.9 mt -121.83 -33.36 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.421 -0.799 . . . . 0.0 109.722 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 48' ' ' CYS . 27.1 tp -177.93 98.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.419 -0.801 . . . . 0.0 109.812 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.481 ' O ' ' O ' ' A' ' 47' ' ' LEU . 96.2 m 47.6 99.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 0.0 110.25 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.588 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.3 t -68.78 -64.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 110.668 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.495 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 1.3 m120 -79.51 111.8 23.76 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.382 -0.824 . . . . 0.0 110.464 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -63.95 -9.02 17.51 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.694 1.365 . . . . 0.0 110.358 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.548 ' HB3' ' CG ' ' A' ' 21' ' ' LEU . 50.3 t-20 -131.1 30.98 4.49 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.289 -0.882 . . . . 0.0 110.178 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.726 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -77.15 -175.6 0.53 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 108.836 179.275 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.726 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.7 Cg_exo -59.02 73.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.536 1.282 . . . . 0.0 109.067 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.3 tt0 -39.43 -32.04 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.688 -0.633 . . . . 0.0 110.562 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.438 ' O ' ' HE1' ' A' ' 10' ' ' PHE . 46.5 tp10 -52.28 -25.3 9.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.957 -1.089 . . . . 0.0 108.625 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.62 ' CD1' ' HG2' ' A' ' 54' ' ' PRO . 89.2 mt -83.82 12.76 5.57 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.383 0.611 . . . . 0.0 109.814 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.709 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.58 -51.63 4.96 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.93 . . . . 0.0 110.532 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.94 -45.09 41.23 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.551 1.29 . . . . 0.0 110.184 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.605 ' CD1' ' CD1' ' A' ' 69' ' ' ILE . 2.8 mm? -53.81 -44.0 69.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.023 -1.048 . . . . 0.0 110.148 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.445 ' HA ' HG23 ' A' ' 44' ' ' VAL . 2.3 t -68.76 -29.1 67.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 0.0 110.312 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -79.95 3.29 20.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.622 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.533 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 9.7 pt-20 -126.39 141.65 40.59 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 110.155 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.16 -11.18 17.71 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.903 1.475 . . . . 0.0 110.667 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -79.88 -15.63 56.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.123 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -48.54 -36.41 15.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.34 -41.12 98.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 110.093 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -80.45 -40.91 25.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 109.84 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.605 ' CD1' ' CD1' ' A' ' 60' ' ' LEU . 84.6 mt -64.39 -41.29 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.037 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.535 HD23 ' HG2' ' A' ' 74' ' ' GLU . 1.2 tm? -53.02 -55.19 25.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 110.396 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.523 ' N ' HD11 ' A' ' 70' ' ' LEU . 94.7 mt-30 -50.46 -55.37 16.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 0.0 110.186 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -52.57 -57.0 11.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.055 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 35.4 mt -46.82 -49.66 19.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 110.083 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.535 ' HG2' HD23 ' A' ' 70' ' ' LEU . 77.8 mm-40 -54.48 -49.27 70.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.331 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.464 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 85.4 tt0 -56.3 -55.91 27.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.721 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 79' ' ' ASP . 28.9 mm -56.75 -36.53 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.062 -1.024 . . . . 0.0 109.462 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HA ' ' CD2' ' A' ' 12' ' ' LEU . . . -59.33 -30.03 68.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.502 -0.749 . . . . 0.0 109.275 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.524 ' HA ' ' N ' ' A' ' 35' ' ' PHE . 85.9 tt0 -62.36 -41.6 98.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 110.321 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.1 p30 -147.0 158.37 45.1 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.196 -0.94 . . . . 0.0 110.482 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.532 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.53 -57.5 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.969 1.51 . . . . 0.0 110.636 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.36 -140.74 24.92 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.591 ' O ' HG12 ' A' ' 85' ' ' ILE . 60.4 p -78.14 -22.34 48.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -1.158 . . . . 0.0 109.635 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 52.9 t -52.27 -53.05 48.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 110.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.0 tt0 -57.66 -34.28 69.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 111.261 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.591 HG12 ' O ' ' A' ' 82' ' ' THR . 6.3 pt -95.11 12.65 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.931 -1.106 . . . . 0.0 110.446 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.8 m 56.47 15.64 2.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 0.0 110.497 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.536 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -66.56 -10.14 42.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 110.026 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -146.19 167.97 22.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 110.387 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.23 4.83 6.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 0.0 110.493 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.68 88.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 110.519 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -99.03 121.95 41.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.526 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.515 HG22 ' CB ' ' A' ' 4' ' ' GLN . 24.8 p -110.58 152.94 25.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.161 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.73 -20.01 51.12 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.272 -1.134 . . . . 0.0 110.231 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.52 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 14.6 p . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.24 0.543 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 58.4 m -123.33 152.81 41.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.426 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.532 HG22 ' CD1' ' A' ' 12' ' ' LEU . 52.0 t -82.36 112.19 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.641 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 41.4 tt0 -111.49 123.49 50.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.098 -1.001 . . . . 0.0 110.71 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.529 ' OD2' ' CG2' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -79.73 -77.12 0.19 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 0.0 109.386 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.71 -124.54 5.36 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -81.84 3.64 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -1.152 . . . . 0.0 110.379 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.2 m-85 -114.57 132.9 56.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.145 -0.972 . . . . 0.0 110.436 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 51.6 p -85.57 130.11 34.66 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.641 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 18.4 m-85 -118.71 130.18 55.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 110.703 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.7 p -75.69 170.22 16.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.163 -0.961 . . . . 0.0 110.268 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 4.5 mp -95.91 -6.45 39.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 110.519 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.7 mt-10 -70.95 -71.62 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.222 -0.924 . . . . 0.0 110.667 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.468 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 4.3 m -43.17 -52.1 5.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.309 -0.869 . . . . 0.0 110.567 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 15.8 m -56.41 -49.33 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.942 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 14.4 tttp -55.27 -51.66 65.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.981 -1.074 . . . . 0.0 108.8 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -80.41 11.26 3.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.455 -0.778 . . . . 0.0 109.736 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 27.2 tp -64.58 -33.68 76.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.89 . . . . 0.0 109.948 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -62.19 -42.4 99.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 109.667 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -104.88 124.62 49.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.412 -0.805 . . . . 0.0 109.61 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.552 ' CD2' ' HD2' ' A' ' 51' ' ' PRO . 15.1 tp -93.57 130.02 39.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 110.576 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 23' ' ' GLU . 25.4 mt-30 -132.7 171.48 13.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.982 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -42.51 156.64 0.24 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.171 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.54 60.64 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 124.0 1.526 . . . . 0.0 110.666 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' GLU . 92.3 mt-30 -121.51 134.91 55.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 110.035 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 22.0 mm-40 -134.77 66.07 67.99 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.119 -0.988 . . . . 0.0 110.483 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -62.18 151.95 79.01 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.836 1.44 . . . . 0.0 110.321 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.4 mtt-85 -109.27 141.01 42.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.225 -0.922 . . . . 0.0 110.257 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.7 t -123.56 136.36 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.317 -0.865 . . . . 0.0 110.146 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.87 -32.83 55.83 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -71.05 143.5 50.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -1.132 . . . . 0.0 110.194 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.7 tp -86.35 128.17 34.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.187 -0.946 . . . . 0.0 110.335 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.504 ' HB3' ' HD2' ' A' ' 16' ' ' LYS . 95.4 mtt-85 -73.28 137.67 45.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.126 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.558 ' CA ' ' O ' ' A' ' 78' ' ' GLU . 32.6 p-10 -156.32 19.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.426 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.467 ' HB2' ' NZ ' ' A' ' 16' ' ' LYS . 98.6 m-85 -99.65 18.5 17.9 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.133 -0.979 . . . . 0.0 110.205 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.495 ' CB ' ' HA ' ' A' ' 78' ' ' GLU . . . -55.55 136.23 70.61 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.287 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.75 -149.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.834 1.439 . . . . 0.0 110.717 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.484 HG21 ' HD2' ' A' ' 39' ' ' PRO . 1.9 mp -104.17 139.62 20.28 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 110.204 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.531 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 2.9 Cg_endo -62.63 178.07 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.818 1.431 . . . . 0.0 110.64 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.68 7.53 31.62 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.456 ' O ' HG22 ' A' ' 43' ' ' VAL . 43.6 mt-10 -82.67 145.18 50.18 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.336 -1.097 . . . . 0.0 110.101 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.8 122.91 11.67 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.79 1.416 . . . . 0.0 110.343 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.535 HG11 ' N ' ' A' ' 44' ' ' VAL . 94.7 t -141.87 158.22 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.955 . . . . 0.0 110.506 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.675 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 25.8 t 62.19 51.46 1.82 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.456 -0.777 . . . . 0.0 111.169 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.675 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.7 Cg_endo -63.52 -145.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.632 1.333 . . . . 0.0 109.851 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.9 mm -65.87 -31.25 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.558 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.587 ' O ' ' O ' ' A' ' 48' ' ' CYS . 1.0 OUTLIER -150.76 71.89 1.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.577 -0.702 . . . . 0.0 109.526 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.587 ' O ' ' O ' ' A' ' 47' ' ' LEU . 82.0 m 54.35 129.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.444 -0.785 . . . . 0.0 110.504 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.611 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 47.0 t -77.47 -70.82 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.029 -1.044 . . . . 0.0 110.155 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.441 ' OD1' HD11 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -76.7 111.96 19.21 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.494 -0.753 . . . . 0.0 110.263 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -63.57 -10.04 20.44 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.627 1.33 . . . . 0.0 110.324 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.523 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 94.0 m-20 -127.03 31.62 5.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.716 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.08 -179.35 1.39 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 108.948 179.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.716 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.8 Cg_exo -59.36 75.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.562 1.296 . . . . 0.0 109.044 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.616 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.7 tt0 -39.27 -27.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.723 -0.611 . . . . 0.0 110.174 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' PRO . 74.3 mm-40 -53.68 -17.85 2.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.107 -0.996 . . . . 0.0 108.554 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.641 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 86.3 mt -91.54 9.63 31.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.658 -0.651 . . . . 0.0 109.608 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.729 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -39.54 -51.49 4.93 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.85 . . . . 0.0 110.756 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.05 -42.86 63.44 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.495 1.26 . . . . 0.0 109.784 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.592 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 4.1 tt -57.48 -38.85 75.22 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.116 -0.99 . . . . 0.0 109.77 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.491 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . 49.3 t -63.61 -29.27 70.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 110.474 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.521 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 53.4 mttp -104.05 30.41 5.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.596 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.521 ' OE1' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -129.5 136.74 29.58 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.407 -0.808 . . . . 0.0 110.437 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.2 -27.03 64.52 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.662 1.349 . . . . 0.0 109.883 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -81.32 -11.06 59.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 110.846 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.592 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.98 -38.29 16.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.029 -1.045 . . . . 0.0 110.126 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.76 -40.72 80.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -80.27 -39.43 28.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.763 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.571 ' CG2' ' CD1' ' A' ' 60' ' ' LEU . 81.1 mt -64.62 -51.39 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.335 -0.853 . . . . 0.0 109.956 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.523 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 2.4 tm? -46.8 -58.45 3.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.389 -0.82 . . . . 0.0 110.113 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HG3' ' HB2' ' A' ' 39' ' ' PRO . 55.7 tt0 -44.85 -51.56 9.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -58.72 -56.5 21.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.431 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 47.6 mt -47.12 -53.1 13.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 0.0 110.216 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.531 ' OE1' ' HA ' ' A' ' 39' ' ' PRO . 52.4 mt-10 -57.22 -46.06 83.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 110.406 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -57.99 -53.71 55.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.953 -1.092 . . . . 0.0 110.127 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 79' ' ' ASP . 54.2 mt -60.94 -33.94 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.15 -0.969 . . . . 0.0 109.403 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.73 -33.69 68.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.379 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.558 ' O ' ' CA ' ' A' ' 34' ' ' ASN . 84.4 tt0 -61.71 -40.81 96.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.479 -0.763 . . . . 0.0 110.22 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -147.11 155.4 47.01 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.078 -1.014 . . . . 0.0 110.26 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.449 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -59.1 -62.27 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.786 1.414 . . . . 0.0 110.669 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.78 -139.07 21.73 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 85' ' ' ILE . 45.4 p -81.03 -21.28 40.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -1.148 . . . . 0.0 109.973 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 9.1 t -53.8 -54.09 43.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.965 . . . . 0.0 109.99 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 34.6 tt0 -58.13 -31.05 66.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.331 -0.856 . . . . 0.0 111.113 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 82' ' ' THR . 6.6 pt -97.26 12.08 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.991 -1.068 . . . . 0.0 110.322 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 34.2 m 54.07 18.73 1.81 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.887 . . . . 0.0 110.578 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.555 ' O ' ' CD1' ' A' ' 88' ' ' TYR . . . -67.13 -12.28 59.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 0.0 110.067 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.555 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 26.9 m-85 -146.75 175.55 10.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.82 3.36 10.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 110.302 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.36 -32.46 73.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -114.5 123.37 49.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 0.0 110.564 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.466 HG23 ' OE1' ' A' ' 4' ' ' GLN . 27.0 p -117.13 161.01 20.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.378 -0.826 . . . . 0.0 110.211 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.47 -33.11 5.68 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.299 -1.118 . . . . 0.0 110.303 -179.889 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 1' ' ' VAL . 3.2 m . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.096 0.474 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.536 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 9.6 t -129.09 163.18 26.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.76 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 50.8 t -84.41 116.43 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.544 ' CB ' HG22 ' A' ' 92' ' ' THR . 46.4 tt0 -108.61 111.69 23.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.032 -1.042 . . . . 0.0 110.951 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -94.26 4.45 53.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.25 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.509 ' O ' ' CG ' ' A' ' 4' ' ' GLN . . . -169.64 -148.1 5.73 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.32 8.96 6.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -1.167 . . . . 0.0 110.516 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.46 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 95.3 m-85 -119.84 147.82 44.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.031 -1.043 . . . . 0.0 110.51 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.536 ' OG ' ' CG2' ' A' ' 2' ' ' THR . 2.0 t -89.03 120.97 30.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 109.829 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.641 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 92.9 m-85 -108.43 117.77 35.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.177 -0.952 . . . . 0.0 110.867 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.4 p -71.64 169.6 15.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 109.528 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 5.1 mp -104.49 -0.93 27.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.978 -1.076 . . . . 0.0 110.763 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -67.13 -69.97 0.28 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.124 -0.985 . . . . 0.0 110.715 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.493 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.1 m -42.42 -50.99 5.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.344 -0.848 . . . . 0.0 111.165 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.603 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.6 m -57.79 -48.05 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.102 -0.999 . . . . 0.0 109.669 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.536 ' HE3' ' CA ' ' A' ' 77' ' ' ALA . 15.7 mttt -54.86 -54.58 40.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.1 -1.0 . . . . 0.0 108.811 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 48.1 tttt -80.43 11.02 3.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -0.766 . . . . 0.0 109.552 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.603 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 16.8 tp -59.62 -33.41 71.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -0.97 . . . . 0.0 110.069 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HD2' ' CB ' ' A' ' 37' ' ' PRO . 78.6 tttt -67.23 -39.23 86.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.589 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 24.7 t70 -118.14 88.15 2.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.633 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.545 ' CD2' ' HB2' ' A' ' 52' ' ' ASN . 6.3 tp -61.5 -33.31 73.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.39 -0.819 . . . . 0.0 111.045 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 25.7 mt-30 -79.09 162.73 25.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.108 -0.995 . . . . 0.0 110.427 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 22' ' ' GLN . 3.5 mt-10 56.72 86.11 0.17 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.382 -0.824 . . . . 0.0 110.517 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.519 ' HA ' ' CE ' ' A' ' 17' ' ' LYS . 2.9 Cg_endo -63.3 102.68 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.979 1.515 . . . . 0.0 110.459 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -64.3 -36.09 82.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.21 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.2 72.71 81.97 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.361 -0.837 . . . . 0.0 110.213 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 24' ' ' PRO . 3.0 Cg_exo -61.78 -21.71 72.78 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.945 1.497 . . . . 0.0 110.7 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -120.21 -177.28 3.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.299 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.25 150.77 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 0.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.88 -9.65 37.28 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -87.12 172.47 9.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -1.156 . . . . 0.0 110.288 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.5 ' CD1' ' C ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -63.27 118.81 8.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.172 -0.955 . . . . 0.0 110.191 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.539 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 32.6 ptt180 -136.67 66.76 1.47 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 110.277 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 33' ' ' ARG . 92.0 m-20 -137.2 72.27 1.42 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 110.085 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 84.1 t80 -178.13 82.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 110.375 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.458 ' O ' ' N ' ' A' ' 38' ' ' ILE . . . -77.09 153.06 82.45 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.936 . . . . 0.0 110.032 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 38' ' ' ILE . 2.8 Cg_endo -64.05 52.79 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.804 1.423 . . . . 0.0 111.033 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.523 ' O ' ' O ' ' A' ' 37' ' ' PRO . 10.0 mt 53.81 113.94 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.197 -0.94 . . . . 0.0 110.532 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.513 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo -61.12 162.56 19.23 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.635 1.334 . . . . 0.0 110.546 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 104.58 20.77 9.78 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.467 ' O ' HD13 ' A' ' 70' ' ' LEU . 27.2 mt-10 -122.32 74.02 40.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.233 -1.157 . . . . 0.0 110.144 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_endo -61.09 143.61 99.02 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.936 1.493 . . . . 0.0 110.583 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.474 ' HB ' ' OG ' ' A' ' 49' ' ' SER . 6.0 m -140.25 54.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.588 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 54.8 t -136.06 54.31 9.59 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.258 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -60.54 -34.93 92.11 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.679 1.357 . . . . 0.0 110.359 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.47 HD11 HG22 ' A' ' 46' ' ' ILE . 78.6 mt -145.16 -36.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 110.215 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' O ' ' O ' ' A' ' 48' ' ' CYS . 21.3 tp -177.38 101.58 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.109 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.564 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 87.2 m 33.67 95.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.465 -0.772 . . . . 0.0 110.637 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.507 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 60.7 p -60.87 -39.3 88.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.994 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 10.5 m-20 -80.54 113.77 42.26 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.48 -7.63 9.15 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.681 1.359 . . . . 0.0 110.87 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.545 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 93.1 m-20 -137.29 31.46 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 110.665 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.751 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.2 p90 -73.34 -175.7 0.41 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.13 -0.981 . . . . 0.0 108.762 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.751 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -60.57 73.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.494 1.26 . . . . 0.0 108.863 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.588 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.1 tt0 -39.22 -31.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.724 -0.61 . . . . 0.0 110.34 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 54' ' ' PRO . 97.4 mt-10 -53.71 -26.72 24.27 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.969 -1.082 . . . . 0.0 108.721 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.641 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 90.7 mt -84.38 7.38 19.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.731 -0.605 . . . . 0.0 109.534 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.713 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 7.3 mmtt -39.59 -51.62 4.98 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 110.303 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.713 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.53 -44.91 43.82 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.588 1.31 . . . . 0.0 109.824 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.57 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -52.06 -43.81 63.99 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.054 -1.029 . . . . 0.0 109.844 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.6 m -66.96 -27.52 67.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.371 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -82.63 4.97 22.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.902 . . . . 0.0 110.736 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 60' ' ' LEU . 8.5 pt-20 -127.98 144.7 52.44 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.025 -1.047 . . . . 0.0 110.229 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.16 -12.66 27.75 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.881 1.464 . . . . 0.0 110.736 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.474 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 83.7 m-20 -80.12 -18.41 49.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.892 . . . . 0.0 110.201 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.19 -39.36 13.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 110.22 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.06 -44.2 87.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 110.296 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -80.2 -39.12 29.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.208 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.516 HG22 ' CD1' ' A' ' 60' ' ' LEU . 77.8 mt -64.42 -47.45 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 74' ' ' GLU . 1.8 tm? -49.06 -57.27 6.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.46 ' HG3' ' N ' ' A' ' 40' ' ' GLY . 51.5 tt0 -49.55 -53.02 25.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.114 -0.991 . . . . 0.0 110.013 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -55.01 -50.4 69.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 96.0 mt -51.07 -50.08 59.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.761 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 70.6 mm-40 -53.99 -52.56 60.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 110.292 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.513 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.2 tt0 -52.69 -55.06 25.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 110.499 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 79' ' ' ASP . 28.2 mm -56.85 -34.36 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 0.0 109.41 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.536 ' CA ' ' HE3' ' A' ' 16' ' ' LYS . . . -59.21 -32.79 70.26 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.466 ' OE2' ' HD3' ' A' ' 39' ' ' PRO . 95.4 mt-10 -59.4 -41.2 88.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 110.139 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -149.26 155.3 39.68 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.59 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -60.15 -57.28 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.88 1.463 . . . . 0.0 110.575 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.12 -138.95 19.98 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.589 ' O ' HG12 ' A' ' 85' ' ' ILE . 43.6 p -81.09 -21.04 40.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -1.176 . . . . 0.0 109.742 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 20.7 t -55.2 -53.01 61.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.86 . . . . 0.0 110.184 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.59 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 35.5 tt0 -62.49 -27.09 68.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.933 . . . . 0.0 111.407 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 82' ' ' THR . 5.9 pt -98.01 14.07 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.757 -1.214 . . . . 0.0 110.433 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 50.9 19.74 0.68 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 0.0 110.714 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.538 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -68.82 -11.85 60.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.067 -1.02 . . . . 0.0 110.025 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -148.62 175.4 11.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 110.085 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.41 1.73 15.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.048 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.94 75.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.314 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -105.83 128.15 53.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 110.536 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.544 HG22 ' CB ' ' A' ' 4' ' ' GLN . 33.2 p -110.79 155.79 22.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 110.109 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 93.54 -19.32 53.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.259 -1.142 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.441 ' HA ' ' SG ' ' A' ' 91' ' ' CYS . 25.6 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.266 0.555 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 68.0 m -123.78 148.39 46.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 110.446 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.543 ' CG2' ' HG ' ' A' ' 12' ' ' LEU . 47.8 t -79.82 110.38 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.307 -0.87 . . . . 0.0 109.742 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.502 ' CB ' HG22 ' A' ' 92' ' ' THR . 43.7 tt0 -110.41 121.09 44.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -0.95 . . . . 0.0 110.716 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.505 ' OD2' ' CD1' ' A' ' 73' ' ' LEU . 85.0 m-20 -95.94 6.12 49.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 109.576 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 4' ' ' GLN . . . -175.45 -139.85 3.21 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -79.8 3.21 20.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -1.19 . . . . 0.0 110.419 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 83.3 m-85 -121.32 131.15 54.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 110.359 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.8 m -79.96 132.3 36.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.336 -0.852 . . . . 0.0 110.201 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.67 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 22.1 m-85 -116.56 128.91 55.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 110.6 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 m -69.25 162.27 27.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.922 . . . . 0.0 110.349 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.543 ' HG ' ' CG2' ' A' ' 3' ' ' VAL . 5.2 mp -87.39 -25.87 23.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.867 . . . . 0.0 110.23 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.525 ' HG3' ' NE ' ' A' ' 33' ' ' ARG . 87.8 tt0 -61.77 -65.6 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.294 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.555 ' O ' ' CB ' ' A' ' 18' ' ' LEU . 4.4 m -43.83 -54.55 5.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.137 -0.977 . . . . 0.0 110.422 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.53 HG21 ' O ' ' A' ' 12' ' ' LEU . 30.3 m -61.46 -48.32 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 110.348 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HD3' ' HB3' ' A' ' 35' ' ' PHE . 8.7 ttmm -59.33 -55.5 33.97 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.074 -1.016 . . . . 0.0 109.371 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' OD1' ' A' ' 20' ' ' ASP . 28.9 mmtp -80.46 6.78 11.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.367 -0.833 . . . . 0.0 110.124 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.555 ' CB ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -73.21 -30.89 63.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.95 -1.094 . . . . 0.0 109.869 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HD3' ' HB ' ' A' ' 38' ' ' ILE . 18.7 tptm -56.41 -39.09 72.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 109.748 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.529 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 26.3 p-10 -111.53 98.08 7.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.849 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -80.74 113.18 18.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 110.498 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.538 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 91.8 mt-30 -142.25 134.3 27.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.852 . . . . 0.0 109.933 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 22' ' ' GLN . 8.7 mt-10 59.41 136.0 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.403 -0.811 . . . . 0.0 110.174 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 3.0 Cg_exo -61.59 155.25 54.42 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.735 1.387 . . . . 0.0 110.542 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 91.8 mt-30 56.6 -159.68 0.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -107.21 110.52 63.33 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 110.2 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.443 ' HG3' ' HB2' ' A' ' 23' ' ' GLU . 3.0 Cg_exo -61.37 -24.54 78.74 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.709 1.373 . . . . 0.0 110.53 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -125.47 146.26 49.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 110.105 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.4 t -117.19 134.5 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.273 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.407 ' N ' ' NH2' ' A' ' 33' ' ' ARG . . . 174.87 105.47 0.19 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -60.54 -28.86 68.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -1.136 . . . . 0.0 110.126 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 mt -93.36 127.43 38.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 110.421 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.525 ' NE ' ' HG3' ' A' ' 13' ' ' GLU . 71.3 mtt-85 -144.92 153.47 41.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.863 . . . . 0.0 109.701 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -136.61 20.35 3.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.055 . . . . 0.0 111.205 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.538 ' HB3' ' HD3' ' A' ' 16' ' ' LYS . 63.6 t80 -87.27 124.18 33.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.989 -1.07 . . . . 0.0 109.603 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.513 ' CA ' ' HG3' ' A' ' 78' ' ' GLU . . . -79.99 113.88 41.87 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 110.594 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 35' ' ' PHE . 2.9 Cg_endo -65.55 -148.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.797 1.419 . . . . 0.0 110.409 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.476 ' HB ' ' HD3' ' A' ' 19' ' ' LYS . 2.6 mp -132.84 79.7 62.94 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.902 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.543 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 3.1 Cg_exo -60.67 150.21 83.41 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.841 1.443 . . . . 0.0 110.684 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.522 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 95.31 14.68 47.14 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.491 ' O ' HG22 ' A' ' 43' ' ' VAL . 19.3 mm-40 -114.71 106.64 51.82 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.188 -1.183 . . . . 0.0 110.157 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.9 144.65 99.61 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.822 1.433 . . . . 0.0 110.478 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.567 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 38.6 t -147.67 54.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 110.234 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.567 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 24.9 t -161.13 74.33 2.59 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.301 -0.874 . . . . 0.0 110.767 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.433 ' C ' ' CG2' ' A' ' 46' ' ' ILE . 3.0 Cg_endo -61.43 -39.75 53.72 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.755 1.397 . . . . 0.0 109.582 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.509 ' CG1' ' N ' ' A' ' 47' ' ' LEU . 12.2 pt -148.65 -39.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.509 ' N ' ' CG1' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -130.94 -115.82 0.23 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.571 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 94.2 m -115.23 116.66 28.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.756 -1.215 . . . . 0.0 109.8 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.558 ' HB3' ' CG1' ' A' ' 43' ' ' VAL . 4.6 t -54.68 -58.1 8.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 111.113 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 8.8 m-20 -80.09 113.18 36.36 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.33 -0.856 . . . . 0.0 110.853 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -66.03 -13.32 39.32 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.68 1.358 . . . . 0.0 110.298 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.548 ' HB2' HD13 ' A' ' 21' ' ' LEU . 25.8 m120 -116.08 21.27 13.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 0.0 110.471 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.643 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -79.89 175.05 5.17 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 108.983 179.23 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.5 Cg_exo -57.59 75.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.63 1.331 . . . . 0.0 108.904 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.614 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.7 tt0 -39.44 -28.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.675 -0.641 . . . . 0.0 110.27 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.502 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.7 mt-10 -52.82 -19.37 2.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.023 -1.048 . . . . 0.0 108.55 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.67 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 68.0 mt -86.11 4.05 39.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.634 -0.666 . . . . 0.0 109.398 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.741 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -39.92 -51.18 5.68 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.502 -0.748 . . . . 0.0 110.375 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.741 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.32 -40.57 82.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.615 1.324 . . . . 0.0 110.382 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.566 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 6.5 mp -62.24 -36.66 82.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.92 -1.113 . . . . 0.0 109.885 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 81.4 m -64.79 -28.02 69.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 110.257 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -79.85 -10.23 59.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.609 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' A' ' 65' ' ' ASN . 8.4 pt-20 -114.67 144.1 31.24 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.014 . . . . 0.0 110.16 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.38 -11.74 27.19 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.875 1.461 . . . . 0.0 110.919 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.477 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 75.6 m-20 -81.39 -14.99 56.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 110.419 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -48.03 -39.99 21.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.171 -0.956 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -61.05 -39.69 90.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 110.101 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -80.03 -36.57 35.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.972 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.552 ' CG2' ' CD2' ' A' ' 60' ' ' LEU . 86.6 mt -68.43 -43.06 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.873 . . . . 0.0 109.922 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.534 HD23 ' HG3' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -51.83 -54.72 25.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -0.82 . . . . 0.0 110.435 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.543 ' HG3' ' CB ' ' A' ' 39' ' ' PRO . 64.1 tt0 -49.64 -54.9 15.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.102 -0.999 . . . . 0.0 110.664 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -50.36 -54.15 23.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.39 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.505 ' CD1' ' OD2' ' A' ' 5' ' ' ASP . 54.7 mt -50.26 -47.88 55.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.9 . . . . 0.0 110.406 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.534 ' HG3' HD23 ' A' ' 70' ' ' LEU . 80.3 mt-10 -55.6 -45.88 77.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 110.453 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.64 -54.4 47.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.049 -1.032 . . . . 0.0 110.674 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.9 mt -61.16 -37.63 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.059 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.537 ' O ' ' CE ' ' A' ' 16' ' ' LYS . . . -61.36 -32.85 72.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.457 -0.777 . . . . 0.0 110.054 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.513 ' HG3' ' CA ' ' A' ' 36' ' ' ALA . 80.3 tt0 -58.44 -35.88 72.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.653 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.457 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -156.54 151.01 20.13 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.683 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.517 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 3.2 Cg_exo -61.67 82.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.012 1.532 . . . . 0.0 110.702 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.53 -134.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.573 ' O ' HG12 ' A' ' 85' ' ' ILE . 72.1 p -79.29 -14.37 59.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.12 -1.223 . . . . 0.0 109.545 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 19.6 t -54.16 -52.11 62.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 110.324 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.517 ' OE1' ' HB2' ' A' ' 80' ' ' PRO . 84.2 tt0 -56.6 -33.01 65.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.208 -0.933 . . . . 0.0 111.272 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 82' ' ' THR . 5.6 pt -98.05 11.76 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.897 -1.127 . . . . 0.0 110.441 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.8 m 54.3 17.12 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.883 . . . . 0.0 110.553 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.541 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -65.62 -11.1 41.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 109.9 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.454 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.5 OUTLIER -144.33 172.12 13.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.265 -0.897 . . . . 0.0 110.096 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.54 4.2 6.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 110.38 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.31 -35.26 80.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.0 110.634 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -106.57 121.16 43.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 0.0 110.632 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.502 HG22 ' CB ' ' A' ' 4' ' ' GLN . 14.6 p -104.92 156.08 18.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 110.126 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.38 -4.39 64.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.204 -1.174 . . . . 0.0 110.273 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.254 0.55 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 55.7 m -89.55 151.36 21.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 0.0 110.34 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 10' ' ' PHE . 0.9 OUTLIER -91.61 120.36 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.463 -0.773 . . . . 0.0 109.873 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 49.0 tt0 -110.27 130.05 55.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.644 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.471 ' OD2' HD23 ' A' ' 73' ' ' LEU . 90.4 m-20 -111.69 9.06 20.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 109.802 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.91 -135.98 2.6 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -81.87 -1.48 47.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -1.195 . . . . 0.0 110.199 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.473 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 55.4 m-85 -119.48 143.77 47.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.214 -0.929 . . . . 0.0 110.325 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.444 ' HB2' HG23 ' A' ' 2' ' ' THR . 60.7 p -90.38 128.76 36.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 110.172 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.607 ' CD1' HD13 ' A' ' 57' ' ' LEU . 21.7 m-30 -110.01 118.81 37.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.247 -0.908 . . . . 0.0 110.335 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.2 t -70.19 166.95 18.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.0 110.016 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.593 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 5.0 mp -95.22 1.25 54.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.196 -0.94 . . . . 0.0 110.628 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.528 ' OE2' ' N ' ' A' ' 30' ' ' GLY . 93.6 mt-10 -74.54 -69.88 0.43 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.213 -0.929 . . . . 0.0 110.461 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 18' ' ' LEU . 3.8 m -52.03 -38.75 58.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.836 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.581 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 9.3 t -67.42 -55.41 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.909 -1.119 . . . . 0.0 109.84 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HD3' ' HG2' ' A' ' 33' ' ' ARG . 39.9 tttp -53.62 -55.78 22.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.941 -1.1 . . . . 0.0 108.904 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 20' ' ' ASP . 52.1 tttt -80.33 8.81 6.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.446 -0.784 . . . . 0.0 109.829 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 5.5 tt -55.7 -43.01 76.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 110.173 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -58.84 -49.14 78.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.934 . . . . 0.0 110.022 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 60.7 t0 -98.81 107.27 19.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 109.867 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.597 HD13 ' HB2' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -112.95 125.48 54.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 110.438 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.533 ' N ' HD12 ' A' ' 21' ' ' LEU . 94.1 mt-30 -121.14 152.89 38.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 110.26 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.643 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 2.5 mm-40 -45.31 -51.92 23.75 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.69 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 3.0 Cg_exo -61.33 147.98 94.13 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.636 1.335 . . . . 0.0 110.761 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.484 ' HG2' ' N ' ' A' ' 26' ' ' GLU . 51.1 tt0 -98.78 167.15 10.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -0.915 . . . . 0.0 110.24 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.484 ' N ' ' HG2' ' A' ' 25' ' ' GLN . 0.4 OUTLIER -113.62 85.5 9.28 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 25' ' ' GLN . 3.0 Cg_exo -60.88 -15.41 38.19 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.01 1.532 . . . . 0.0 110.623 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 81.2 mtt180 -55.92 152.47 10.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 110.1 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.443 HG12 ' HE2' ' A' ' 31' ' ' LYS . 46.4 t -83.49 148.19 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.278 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' N ' ' OE2' ' A' ' 13' ' ' GLU . . . -70.91 60.21 0.98 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.443 ' HE2' HG12 ' A' ' 29' ' ' VAL . 25.4 mttt -91.11 -65.02 1.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -1.125 . . . . 0.0 110.216 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 34' ' ' ASN . 53.2 mt -89.9 -0.83 57.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 110.169 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.45 ' CD ' ' HA3' ' A' ' 30' ' ' GLY . 0.7 OUTLIER -62.25 74.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 109.97 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 32' ' ' LEU . 25.0 m120 -130.95 25.26 4.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.468 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -113.01 49.2 0.96 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 109.989 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 38' ' ' ILE . . . -61.1 142.53 93.06 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 110.145 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.52 ' O ' ' O ' ' A' ' 38' ' ' ILE . 2.5 Cg_endo -67.23 30.16 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.413 1.409 . . . . 0.0 111.303 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.52 ' O ' ' O ' ' A' ' 37' ' ' PRO . 8.2 mt 58.77 132.89 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.981 -1.074 . . . . 0.0 110.13 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.507 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.1 Cg_exo -61.46 164.04 16.39 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.719 1.379 . . . . 0.0 110.617 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.457 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 146.78 -8.92 1.34 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -119.46 76.47 18.3 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.001 -1.294 . . . . 0.0 110.474 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.543 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . 2.9 Cg_endo -62.56 128.48 23.61 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.818 1.431 . . . . 0.0 110.473 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.613 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 23.2 m -135.69 142.96 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.615 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.9 OUTLIER 168.23 -52.2 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.398 -0.814 . . . . 0.0 110.305 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 44' ' ' VAL . 3.1 Cg_exo -61.46 -18.01 56.96 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.525 1.276 . . . . 0.0 110.689 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.46 ' O ' ' CG2' ' A' ' 46' ' ' ILE . 84.2 mt -89.09 35.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.117 -0.989 . . . . 0.0 110.022 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' A' ' 48' ' ' CYS . 4.4 mm? 54.13 75.27 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.034 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 47' ' ' LEU . 70.5 m 43.21 95.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.374 -0.829 . . . . 0.0 110.19 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.493 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 9.2 t -56.62 -60.19 3.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.0 110.455 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 21' ' ' LEU . 8.4 m120 -80.26 114.26 45.56 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 0.0 110.273 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -61.7 -5.04 5.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.8 1.421 . . . . 0.0 111.028 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.597 ' HB2' HD13 ' A' ' 21' ' ' LEU . 94.5 m-20 -140.32 33.73 1.88 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.143 -0.973 . . . . 0.0 110.347 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.721 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -75.28 -174.59 0.39 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 109.061 179.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.721 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.5 Cg_exo -57.86 72.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.406 1.214 . . . . 0.0 109.921 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.5 tt0 -41.16 -36.03 0.68 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.711 . . . . 0.0 110.314 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.78 -19.31 2.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 108.829 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.637 ' CD1' ' N ' ' A' ' 57' ' ' LEU . 8.2 mp -94.64 16.29 15.96 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.89 0.853 . . . . 0.0 109.113 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.722 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.76 -52.54 4.95 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.941 -0.474 . . . . 0.0 110.972 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.722 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.14 -44.87 45.33 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.506 1.266 . . . . 0.0 110.07 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.579 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 79.9 mt -59.04 -35.95 74.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.057 -1.027 . . . . 0.0 109.936 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.502 ' O ' HG12 ' A' ' 44' ' ' VAL . 50.6 t -64.65 -25.02 67.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.025 . . . . 0.0 110.384 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -113.45 29.67 7.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.127 -0.983 . . . . 0.0 109.415 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.485 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -118.55 139.91 27.61 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.606 -0.684 . . . . 0.0 110.484 -179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.51 -27.4 76.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.65 1.342 . . . . 0.0 109.964 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.37 -16.7 53.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.153 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -43.56 -39.61 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -54.54 -43.64 72.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.863 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.461 ' HG2' ' NE ' ' A' ' 72' ' ' ARG . 86.5 tt0 -80.05 -38.75 31.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.949 . . . . 0.0 109.88 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.519 HD12 ' CD2' ' A' ' 60' ' ' LEU . 78.6 mt -63.38 -55.19 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.638 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 1.1 tm? -42.34 -64.55 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.436 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.638 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 56.5 mt-30 -47.65 -53.39 15.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.077 -1.014 . . . . 0.0 110.465 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.461 ' NE ' ' HG2' ' A' ' 68' ' ' GLU . 62.2 mtt180 -54.87 -53.58 53.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 110.138 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.471 HD23 ' OD2' ' A' ' 5' ' ' ASP . 86.3 mt -49.86 -53.01 28.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 110.015 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.548 ' HG3' HD23 ' A' ' 70' ' ' LEU . 80.5 mt-10 -53.15 -45.11 68.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 110.237 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.1 tt0 -57.74 -54.02 51.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.353 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 79' ' ' ASP . 29.8 mm -59.43 -36.95 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.153 -0.967 . . . . 0.0 109.738 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.452 ' HB1' HG13 ' A' ' 15' ' ' VAL . . . -58.16 -33.9 69.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 109.575 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.477 ' O ' ' O ' ' A' ' 34' ' ' ASN . 85.8 tt0 -60.31 -40.16 89.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.497 -0.752 . . . . 0.0 110.347 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 76' ' ' ILE . 9.5 m-20 -145.54 153.13 50.97 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.135 -0.978 . . . . 0.0 110.31 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.535 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -59.76 -58.55 0.56 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.884 1.465 . . . . 0.0 110.57 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.14 -137.88 19.12 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.602 ' O ' HG12 ' A' ' 85' ' ' ILE . 53.1 p -82.38 -21.44 35.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -1.171 . . . . 0.0 110.107 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 38.9 t -54.58 -53.39 55.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 110.007 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 82.9 tt0 -60.33 -29.19 68.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 0.0 111.322 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.602 HG12 ' O ' ' A' ' 82' ' ' THR . 6.0 pt -97.22 13.54 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.863 -1.148 . . . . 0.0 110.276 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 62.9 m 55.43 15.15 1.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 0.0 110.574 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.531 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -63.72 -12.59 35.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.117 -0.989 . . . . 0.0 109.891 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.405 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 21.7 m-85 -149.48 173.8 13.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 110.324 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.46 3.85 10.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.393 -0.817 . . . . 0.0 110.453 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.66 -33.8 74.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.586 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -106.58 125.31 50.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.678 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -109.93 152.73 25.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.382 -0.824 . . . . 0.0 110.111 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.98 52.36 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.265 -1.139 . . . . 0.0 110.134 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.491 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 3.8 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.154 0.502 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.4 t -123.51 161.24 25.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.923 . . . . 0.0 110.64 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.512 ' CG2' HD22 ' A' ' 12' ' ' LEU . 71.0 t -91.9 119.72 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.568 -0.708 . . . . 0.0 109.544 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.533 ' HG3' ' OG1' ' A' ' 92' ' ' THR . 36.5 mt-30 -110.49 135.01 51.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.96 . . . . 0.0 110.787 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.429 ' OD2' ' CG2' ' A' ' 69' ' ' ILE . 80.8 m-20 -104.76 11.07 34.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.202 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.28 -131.88 1.97 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -89.6 10.16 24.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.191 -1.182 . . . . 0.0 110.57 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 92.6 m-85 -114.79 154.75 27.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 110.385 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.451 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 60.4 p -105.1 121.55 44.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.603 ' CD1' HD22 ' A' ' 57' ' ' LEU . 19.9 m-85 -118.99 128.06 54.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.942 . . . . 0.0 110.578 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 m -70.8 165.58 22.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.395 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.61 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 5.0 mp -96.37 -8.8 31.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.282 -0.886 . . . . 0.0 110.339 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' SER . 84.4 tt0 -70.97 -70.71 0.29 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.298 -0.876 . . . . 0.0 110.926 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.6 m -43.97 -48.85 8.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.161 -0.962 . . . . 0.0 110.677 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.625 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 14.3 m -59.46 -47.36 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.115 -0.991 . . . . 0.0 110.319 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 20.7 tttm -56.75 -55.27 36.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.831 -1.168 . . . . 0.0 109.075 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.517 ' HG3' ' O ' ' A' ' 20' ' ' ASP . 7.4 tptm -80.43 10.9 4.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.41 -0.806 . . . . 0.0 109.288 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.625 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 47.1 tp -56.31 -45.27 80.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 110.666 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 16.3 tttt -56.87 -46.28 81.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 110.191 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.517 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 22.3 t70 -105.78 122.26 45.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.915 . . . . 0.0 110.198 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.2 137.76 38.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.225 -0.922 . . . . 0.0 110.075 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.479 ' HG2' ' HD2' ' A' ' 24' ' ' PRO . 7.9 tt0 -105.45 120.42 41.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.385 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.65 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -50.56 -53.84 41.72 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 0.0 110.531 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 3.2 Cg_exo -58.52 150.62 67.61 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.607 1.32 . . . . 0.0 110.744 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -83.1 53.05 2.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 110.542 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 53.52 71.98 1.26 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.371 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 24' ' ' PRO . 3.0 Cg_exo -62.56 151.11 85.1 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.852 1.448 . . . . 0.0 110.395 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 27' ' ' PRO . 52.1 mtm180 45.58 -170.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.066 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.83 136.0 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.269 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.29 94.49 1.66 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -60.79 -31.11 70.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -1.123 . . . . 0.0 110.436 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.1 mt -93.73 136.74 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.401 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -139.79 99.21 3.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.841 . . . . 0.0 110.028 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 81.5 m-20 -139.04 176.75 8.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 110.519 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.476 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 60.9 t80 60.9 64.52 1.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 110.303 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.53 ' HB3' ' CA ' ' A' ' 78' ' ' GLU . . . -80.08 171.41 12.46 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.171 -0.955 . . . . 0.0 110.232 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.547 ' HB3' ' HB2' ' A' ' 19' ' ' LYS . 2.9 Cg_endo -63.78 -6.99 11.87 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.923 1.486 . . . . 0.0 110.821 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 1.2 mp 67.39 137.06 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.016 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.479 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.0 Cg_endo -60.75 165.84 11.09 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.797 1.42 . . . . 0.0 110.582 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.51 -1.36 42.78 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.427 ' O ' HD13 ' A' ' 70' ' ' LEU . 1.2 mt-10 -132.46 75.5 73.75 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.211 -1.17 . . . . 0.0 110.147 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.63 143.09 96.44 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.951 1.501 . . . . 0.0 110.329 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.474 HG13 HD22 ' A' ' 18' ' ' LEU . 14.5 m -109.24 48.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 110.282 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.669 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 84.2 t -151.87 48.22 0.46 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.51 -0.744 . . . . 0.0 110.705 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.669 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -60.82 -67.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.616 1.324 . . . . 0.0 110.587 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.0 mt -102.81 -70.6 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 110.087 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -144.93 98.78 3.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 109.85 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 47' ' ' LEU . 99.3 m 49.69 100.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.074 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.575 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 14.0 t -65.85 -73.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 110.89 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 8.6 m-20 -77.84 112.29 23.82 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.389 -0.819 . . . . 0.0 110.574 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.38 -9.17 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 O-C-N 123.673 1.354 . . . . 0.0 109.826 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -119.24 27.13 9.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.449 -0.782 . . . . 0.0 110.274 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.677 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.03 174.73 5.65 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.005 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -56.82 76.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.739 1.389 . . . . 0.0 108.952 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.633 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 2.7 pt-20 -39.38 -26.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.811 -0.556 . . . . 0.0 110.251 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 54' ' ' PRO . 49.2 tp10 -53.05 -19.02 2.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.011 -1.056 . . . . 0.0 108.38 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.603 HD22 ' CD1' ' A' ' 10' ' ' PHE . 58.2 mt -90.8 7.63 38.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.621 . . . . 0.0 109.579 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.713 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.69 -51.67 5.12 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 110.687 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.713 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -55.0 -43.16 62.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.502 1.264 . . . . 0.0 110.159 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.599 HD13 ' CE2' ' A' ' 10' ' ' PHE . 11.5 mt -58.76 -36.69 74.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.089 -1.007 . . . . 0.0 109.947 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.9 t -66.14 -26.57 67.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 110.293 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -92.19 3.73 54.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 111.049 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.535 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 6.1 pt-20 -119.17 145.89 39.34 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.853 -1.155 . . . . 0.0 110.269 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.53 -17.83 60.27 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.923 1.486 . . . . 0.0 111.252 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.479 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 21.8 m120 -79.7 -13.63 59.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.56 -42.37 23.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -59.75 -40.0 86.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 110.418 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -80.13 -36.64 34.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.068 -1.02 . . . . 0.0 109.985 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.535 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 88.7 mt -66.2 -44.53 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 109.986 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.543 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 1.3 tm? -51.02 -56.62 11.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.846 . . . . 0.0 110.214 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.481 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 23.7 mt-30 -47.78 -54.64 11.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 110.247 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -51.49 -54.74 23.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.387 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 52.3 mt -50.66 -49.53 56.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.272 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 79.1 mt-10 -55.29 -49.32 72.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.755 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -57.56 -54.75 43.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.033 -1.042 . . . . 0.0 110.725 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 79' ' ' ASP . 23.0 mm -60.56 -37.11 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.09 -1.006 . . . . 0.0 109.823 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.518 ' CB ' ' HB1' ' A' ' 36' ' ' ALA . . . -57.81 -32.27 67.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 0.0 109.663 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.0 tt0 -63.74 -40.32 96.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.46 -0.775 . . . . 0.0 110.31 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.463 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -151.32 156.41 34.97 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 0.0 110.076 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.505 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -59.08 -65.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.93 1.49 . . . . 0.0 110.643 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.14 -142.12 22.03 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.582 ' O ' HG12 ' A' ' 85' ' ' ILE . 65.0 p -77.42 -19.71 55.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -1.126 . . . . 0.0 109.836 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.69 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 48.8 t -58.79 -51.12 71.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.848 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.3 tt0 -52.96 -30.25 33.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.698 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 82' ' ' THR . 8.2 pt -103.69 11.6 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.093 -1.004 . . . . 0.0 110.123 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 57.9 m 57.92 17.58 4.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.321 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.539 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -70.51 -14.55 62.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.943 . . . . 0.0 110.093 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 37.8 t80 -132.34 165.27 24.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.305 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.22 -0.23 11.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 110.274 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -65.56 -41.73 92.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.158 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.69 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -93.26 111.86 23.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 110.251 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.533 ' OG1' ' HG3' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -110.88 4.21 19.55 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.499 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . -75.12 -52.05 7.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.499 ' C ' ' O ' ' A' ' 93' ' ' GLY . 1.4 m . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.423 -1.045 . . . . 0.0 110.494 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.452 HG22 ' SG ' ' A' ' 91' ' ' CYS . 4.5 m . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.223 0.535 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.4 m -117.83 146.21 44.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 110.387 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 90' ' ' ALA . 1.2 t -84.16 122.35 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.763 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HG2' ' HA ' ' A' ' 9' ' ' SER . 66.9 mt-30 -112.75 124.72 53.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.958 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.505 ' OD2' HD23 ' A' ' 60' ' ' LEU . 44.4 p30 -103.37 12.0 35.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.55 -139.01 3.5 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -89.08 19.59 4.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -1.177 . . . . 0.0 110.194 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.648 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.5 m-85 -126.67 158.37 36.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.305 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 74.2 m -102.64 115.82 31.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.148 -0.97 . . . . 0.0 110.423 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.648 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 17.2 m-30 -116.75 128.01 54.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.365 -0.835 . . . . 0.0 110.596 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.4 t -75.85 170.6 15.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.917 . . . . 0.0 110.116 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.627 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 6.9 mp -93.12 -16.97 24.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.155 -0.965 . . . . 0.0 110.645 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.4 mt-10 -64.47 -71.92 0.16 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.151 -0.968 . . . . 0.0 110.402 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.2 m -42.77 -51.72 5.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 0.0 110.376 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.56 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 49.5 t -56.12 -48.26 79.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.58 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HE3' ' HG3' ' A' ' 17' ' ' LYS . 6.3 ttpp -54.98 -54.67 39.97 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.168 -0.957 . . . . 0.0 108.686 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.455 ' HG3' ' HE3' ' A' ' 16' ' ' LYS . 45.0 mttt -80.62 14.12 2.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.449 -0.782 . . . . 0.0 109.911 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.56 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.8 tt -65.92 -35.05 79.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 110.073 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 41' ' ' GLU . 26.9 mttm -97.61 143.96 27.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 82.7 m-20 53.62 48.66 21.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.984 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.513 ' CD2' ' HB2' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -85.12 129.06 34.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.857 . . . . 0.0 110.251 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.456 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 46.7 tp60 -63.49 167.31 5.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.418 -0.801 . . . . 0.0 110.146 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.643 ' CB ' ' HD3' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -44.27 -55.36 9.93 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.945 . . . . 0.0 110.298 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.643 ' HD3' ' CB ' ' A' ' 23' ' ' GLU . 2.8 Cg_endo -62.76 136.81 59.79 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.591 1.311 . . . . 0.0 110.513 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.464 ' O ' ' CG ' ' A' ' 26' ' ' GLU . 94.9 mt-30 -57.86 -38.7 76.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.98 . . . . 0.0 109.884 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 25' ' ' GLN . 29.2 mp0 -158.97 88.07 2.17 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.482 -0.761 . . . . 0.0 109.862 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.17 -32.81 91.29 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.925 1.487 . . . . 0.0 110.84 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -142.46 134.36 27.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.184 -0.947 . . . . 0.0 110.486 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.9 t -127.25 134.55 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.303 -0.873 . . . . 0.0 110.064 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.05 -173.14 39.91 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -61.81 -20.82 64.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -1.167 . . . . 0.0 110.136 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.2 mt -56.06 113.52 1.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 110.144 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.616 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 22.6 ptt-85 -155.66 -171.2 3.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.837 . . . . 0.0 109.981 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 33' ' ' ARG . 80.2 m-20 60.93 48.32 6.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.0 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.616 ' CD2' ' O ' ' A' ' 33' ' ' ARG . 65.7 m-85 -128.79 4.91 5.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.384 -0.823 . . . . 0.0 110.154 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.447 ' HB1' ' HA ' ' A' ' 16' ' ' LYS . . . -66.09 158.51 76.17 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.603 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.18 -149.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 124.022 1.538 . . . . 0.0 110.765 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.561 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 4.1 mp -108.07 143.86 28.23 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.407 -0.808 . . . . 0.0 110.09 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.576 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo -61.47 169.43 6.69 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.665 1.35 . . . . 0.0 110.541 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.46 5.86 10.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.435 ' HB3' ' NZ ' ' A' ' 19' ' ' LYS . 1.7 mt-10 -133.52 74.0 71.91 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.298 -1.119 . . . . 0.0 110.157 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.547 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -60.67 146.06 97.83 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.836 1.44 . . . . 0.0 110.406 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.626 ' CG1' ' CB ' ' A' ' 49' ' ' SER . 45.4 t -131.38 122.34 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 110.538 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.614 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 21.7 t -160.76 62.0 1.58 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.228 -0.92 . . . . 0.0 110.49 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.543 ' HG2' ' N ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -64.48 -153.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.605 1.318 . . . . 0.0 110.161 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.478 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 76.2 mt -65.59 -38.75 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.078 -1.014 . . . . 0.0 109.711 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.519 ' O ' ' O ' ' A' ' 48' ' ' CYS . 57.6 mt -142.75 64.26 1.37 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.385 -0.822 . . . . 0.0 109.701 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.565 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 74.9 m 57.93 133.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.428 -0.795 . . . . 0.0 110.035 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.626 ' CB ' ' CG1' ' A' ' 43' ' ' VAL . 30.5 t -64.16 -64.86 0.78 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.128 -0.982 . . . . 0.0 110.47 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 10.0 m-20 -80.27 114.15 44.77 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.811 . . . . 0.0 110.081 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -64.85 -2.33 5.31 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.693 1.365 . . . . 0.0 110.772 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.513 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 95.6 m-20 -124.18 22.98 8.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.64 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.79 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 3.6 p90 -80.06 -176.33 0.72 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 108.945 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.79 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 5.0 Cg_exo -56.39 74.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.562 1.296 . . . . 0.0 109.657 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.6 tt0 -41.4 -36.69 0.89 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.509 -0.744 . . . . 0.0 110.132 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -52.03 -17.77 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.92 . . . . 0.0 108.981 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.652 ' CD1' ' N ' ' A' ' 57' ' ' LEU . 8.4 mp -94.51 8.72 41.2 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.017 0.913 . . . . 0.0 109.327 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.752 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -41.79 -51.05 9.87 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.77 -0.581 . . . . 0.0 110.151 179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.752 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -53.8 -41.51 73.92 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.521 1.274 . . . . 0.0 110.1 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.593 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 9.5 mp -56.97 -42.47 80.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.948 -1.095 . . . . 0.0 109.402 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.48 ' O ' HG11 ' A' ' 44' ' ' VAL . 72.9 m -61.16 -24.52 66.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -99.31 1.6 44.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.323 -0.861 . . . . 0.0 110.769 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.492 ' OE2' ' HB2' ' A' ' 65' ' ' ASN . 10.1 pt-20 -117.79 147.28 40.74 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.084 -1.01 . . . . 0.0 110.288 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.01 -17.21 58.93 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.469 1.446 . . . . 0.0 111.258 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.492 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 53.2 m-20 -79.16 -20.83 47.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.09 -1.007 . . . . 0.0 110.87 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.593 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -46.57 -37.62 8.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.928 -1.108 . . . . 0.0 109.675 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.547 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.7 mt-30 -61.12 -41.37 96.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 110.187 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.8 mt-10 -80.14 -34.16 37.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.556 ' CG2' HD22 ' A' ' 60' ' ' LEU . 85.1 mt -73.02 -49.97 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 109.812 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.545 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 1.7 tm? -48.45 -56.59 7.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 109.922 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 93.8 mt-30 -47.3 -51.55 18.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 110.028 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 93.0 mtt-85 -58.18 -60.99 2.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' A' ' 5' ' ' ASP . 8.0 mt -46.17 -54.41 8.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.015 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.502 ' HG2' HD21 ' A' ' 70' ' ' LEU . 76.2 mm-40 -50.92 -42.72 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 109.821 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.576 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 81.1 tt0 -66.8 -51.52 54.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.513 ' O ' ' O ' ' A' ' 79' ' ' ASP . 67.1 mt -65.19 -38.86 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -0.942 . . . . 0.0 109.609 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 34' ' ' ASN . . . -57.6 -35.73 70.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -0.871 . . . . 0.0 109.547 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 83.2 tt0 -63.02 -38.22 90.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.533 -0.729 . . . . 0.0 110.448 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -149.69 157.2 38.67 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.107 -0.996 . . . . 0.0 110.437 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.514 ' HD3' ' ND2' ' A' ' 34' ' ' ASN . 3.1 Cg_exo -59.44 -71.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.981 1.516 . . . . 0.0 110.83 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.4 -140.39 21.96 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.55 ' O ' HG12 ' A' ' 85' ' ' ILE . 52.7 p -78.64 -23.09 46.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -1.178 . . . . 0.0 110.153 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.557 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 25.2 t -54.39 -51.81 63.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.917 . . . . 0.0 109.893 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -55.44 -33.53 63.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 111.115 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 82' ' ' THR . 4.3 pt -100.43 10.85 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.972 -1.08 . . . . 0.0 110.522 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.31 9.15 1.83 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.312 -0.867 . . . . 0.0 110.614 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.502 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -60.54 -14.56 20.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.056 -1.028 . . . . 0.0 109.543 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -135.68 164.52 27.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.464 -0.772 . . . . 0.0 110.123 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.62 3.41 5.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 110.23 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.66 -43.1 94.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.33 -0.856 . . . . 0.0 110.492 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.557 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -96.93 116.0 28.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.945 . . . . 0.0 110.645 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.515 HG22 ' HG3' ' A' ' 4' ' ' GLN . 44.8 p -107.89 171.23 7.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.48 -30.31 10.49 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.436 ' HB3' HG13 ' A' ' 1' ' ' VAL . 26.1 p . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.207 -1.172 . . . . 0.0 110.172 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.487 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 67.4 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.244 0.545 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.5 m -120.73 151.84 39.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.933 . . . . 0.0 110.258 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.559 HG22 ' CG ' ' A' ' 12' ' ' LEU . 61.9 t -81.01 113.41 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.911 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.543 ' HB3' ' CG2' ' A' ' 92' ' ' THR . 42.9 tt0 -111.61 132.23 54.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -93.84 -78.0 0.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.34 -0.85 . . . . 0.0 109.627 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.59 -128.43 5.8 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -80.47 10.26 4.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -1.12 . . . . 0.0 110.622 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.478 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 97.6 m-85 -124.47 137.79 54.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.993 . . . . 0.0 110.576 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.472 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 80.0 p -89.58 133.33 34.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 110.201 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.548 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 92.1 m-85 -115.62 123.07 47.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 110.578 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.5 m -72.77 171.64 12.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.217 -0.927 . . . . 0.0 110.243 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.624 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 4.3 mp -103.57 2.25 33.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.15 -0.969 . . . . 0.0 111.015 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.454 ' OE2' ' OE1' ' A' ' 26' ' ' GLU . 97.3 mt-10 -71.75 -77.27 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.927 -1.108 . . . . 0.0 110.846 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.8 m -41.04 -47.57 3.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.255 -0.903 . . . . 0.0 110.88 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.579 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 14.8 m -63.58 -50.43 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.014 . . . . 0.0 109.886 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.5 ' HE2' ' CB ' ' A' ' 35' ' ' PHE . 39.5 tttm -53.34 -53.28 53.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.075 -1.015 . . . . 0.0 109.075 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.451 ' O ' ' O ' ' A' ' 20' ' ' ASP . 68.6 mttm -80.17 4.89 15.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.371 -0.83 . . . . 0.0 109.871 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 8.8 tp -55.8 -36.31 67.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 110.226 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -53.2 -41.92 65.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.565 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 17' ' ' LYS . 8.6 p-10 -111.67 133.77 53.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.798 . . . . 0.0 109.725 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.617 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -79.98 113.69 18.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.125 -0.984 . . . . 0.0 110.426 -179.559 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.443 ' HG3' ' C ' ' A' ' 21' ' ' LEU . 93.6 mt-30 -151.2 171.5 17.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 0.0 109.926 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -126.77 69.47 71.65 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.193 -0.942 . . . . 0.0 110.318 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD3' ' C ' ' A' ' 22' ' ' GLN . 2.9 Cg_endo -61.94 135.57 56.27 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.902 1.475 . . . . 0.0 110.61 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' GLU . 93.4 mt-30 -64.23 -32.81 74.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 110.059 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.605 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 10.3 mm-40 40.74 55.12 7.43 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.444 -0.785 . . . . 0.0 110.542 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.605 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.8 Cg_endo -61.36 -45.78 17.3 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.79 1.416 . . . . 0.0 110.405 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -137.23 160.88 37.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.466 -0.771 . . . . 0.0 110.044 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.3 m -57.56 132.35 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.147 -0.971 . . . . 0.0 110.187 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.49 174.18 53.15 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.483 ' O ' ' CD2' ' A' ' 32' ' ' LEU . 17.9 mttp -59.53 -46.16 89.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -1.169 . . . . 0.0 110.295 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 31' ' ' LYS . 58.8 mt -144.9 140.29 28.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.157 -0.964 . . . . 0.0 110.329 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.422 ' C ' ' HE3' ' A' ' 16' ' ' LYS . 80.5 mtm-85 -111.24 54.58 0.68 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.911 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.488 ' OD1' ' HD3' ' A' ' 80' ' ' PRO . 73.8 m-20 -118.69 131.09 56.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.379 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.5 ' CB ' ' HE2' ' A' ' 16' ' ' LYS . 57.2 t80 -178.08 -31.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.319 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 78' ' ' GLU . . . -55.49 109.68 1.77 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 110.39 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.571 ' O ' ' O ' ' A' ' 38' ' ' ILE . 2.8 Cg_endo -63.24 81.18 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.766 1.403 . . . . 0.0 110.583 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.576 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 0.1 OUTLIER 48.12 170.38 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.512 -0.743 . . . . 0.0 110.547 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.576 ' HD2' ' HB ' ' A' ' 38' ' ' ILE . 2.9 Cg_endo -63.56 142.86 86.0 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.628 1.331 . . . . 0.0 110.65 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.77 -76.64 1.31 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -165.15 129.56 1.81 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.404 -1.057 . . . . 0.0 110.069 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.482 ' HB2' ' HG3' ' A' ' 67' ' ' GLN . 3.0 Cg_endo -60.86 126.31 19.35 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.702 1.369 . . . . 0.0 110.502 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.519 HG12 ' CB ' ' A' ' 49' ' ' SER . 11.3 p -140.58 138.58 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.322 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 66' ' ' ALA . 73.8 t -155.36 81.07 4.1 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.297 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' HD3' HG23 ' A' ' 43' ' ' VAL . 3.1 Cg_exo -60.59 -142.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.947 1.498 . . . . 0.0 110.259 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.472 ' O ' HD22 ' A' ' 47' ' ' LEU . 88.2 mt -55.45 -37.64 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.917 -1.114 . . . . 0.0 108.628 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.526 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 74.0 mt -135.19 -78.03 0.44 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.533 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 62.7 m -141.03 140.12 34.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.867 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.519 ' CB ' HG12 ' A' ' 43' ' ' VAL . 22.1 t -59.5 -48.27 82.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.178 -0.951 . . . . 0.0 110.487 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.533 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 1.2 m120 -80.13 114.79 49.64 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.352 -0.842 . . . . 0.0 110.324 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -60.33 -10.36 13.05 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.703 1.37 . . . . 0.0 110.649 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.617 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 28.2 m120 -138.92 36.39 2.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.962 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.762 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 2.2 p90 -73.08 -175.84 0.41 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 108.957 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.762 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.7 Cg_exo -58.41 74.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.494 1.26 . . . . 0.0 109.524 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.8 tt0 -42.7 -36.37 1.41 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.414 -0.804 . . . . 0.0 110.441 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -52.55 -19.17 2.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.077 -1.014 . . . . 0.0 108.929 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 54' ' ' PRO . 8.1 mp -93.93 13.82 21.56 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.923 0.868 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.731 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.9 mttp -40.04 -52.01 5.57 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.729 -0.607 . . . . 0.0 110.201 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.731 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.08 -46.05 36.04 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.584 1.307 . . . . 0.0 109.661 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -48.78 -47.19 42.1 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.061 -1.024 . . . . 0.0 109.346 179.296 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 86.6 m -68.24 -27.23 66.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.418 -0.801 . . . . 0.0 110.286 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -86.43 4.96 37.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.998 . . . . 0.0 110.507 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.541 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 5.6 pt-20 -122.12 146.29 46.21 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.148 -0.97 . . . . 0.0 110.161 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.77 -17.98 58.04 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.862 1.454 . . . . 0.0 110.978 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.477 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 22.3 m120 -79.78 -12.09 59.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.578 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -49.94 -39.66 41.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.151 -0.968 . . . . 0.0 109.99 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.482 ' HG3' ' HB2' ' A' ' 42' ' ' PRO . 30.5 tt0 -56.8 -44.61 82.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.367 -0.833 . . . . 0.0 110.487 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.6 mt-10 -80.28 -35.06 36.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.982 . . . . 0.0 110.358 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.541 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 86.7 mt -69.05 -48.65 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.149 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.489 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 1.7 tm? -44.87 -63.53 0.9 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -48.4 -53.13 18.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 110.176 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 82.9 mtp180 -51.59 -58.33 6.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 109.91 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 47.0 mt -46.33 -48.77 18.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.787 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 86.7 mt-10 -54.63 -40.67 69.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.297 -0.877 . . . . 0.0 110.176 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.572 ' CG ' ' HG3' ' A' ' 39' ' ' PRO . 96.5 mt-10 -61.82 -54.78 37.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.031 -1.043 . . . . 0.0 110.269 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.49 HG23 HD22 ' A' ' 12' ' ' LEU . 42.4 mt -63.16 -42.49 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.881 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 16' ' ' LYS . . . -52.0 -37.19 52.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.56 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 84.1 tt0 -65.93 -42.57 89.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.495 -0.753 . . . . 0.0 110.349 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -143.56 153.57 58.73 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.067 -1.02 . . . . 0.0 110.449 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.528 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -61.99 -68.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.069 1.563 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.03 -140.13 18.27 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.533 ' HB ' ' CB ' ' A' ' 87' ' ' ALA . 47.6 p -81.29 -21.98 38.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -1.118 . . . . 0.0 110.033 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 10.7 t -56.47 -50.22 72.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.166 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 78.5 tt0 -63.24 -27.26 69.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.954 . . . . 0.0 111.175 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.526 ' CG1' ' HB2' ' A' ' 87' ' ' ALA . 5.7 pt -102.08 12.76 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.829 -1.169 . . . . 0.0 110.449 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.9 t 57.87 13.59 2.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 110.459 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.533 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -64.66 -21.49 66.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 110.035 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.421 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 2.6 t80 -134.85 169.48 17.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.84 . . . . 0.0 110.04 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.31 1.26 11.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.188 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -58.58 -39.82 81.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.588 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.6 OUTLIER -104.38 122.12 44.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.005 . . . . 0.0 110.786 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.543 ' CG2' ' HB3' ' A' ' 4' ' ' GLN . 25.9 p -101.31 170.15 8.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 110.237 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.18 4.16 78.18 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.257 -1.143 . . . . 0.0 110.143 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.231 0.539 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 88.5 m -126.14 152.98 45.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.31 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.567 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -91.03 117.84 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 109.758 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 9' ' ' SER . 31.2 mt-30 -110.3 139.82 45.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.228 -0.92 . . . . 0.0 110.63 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -108.59 9.62 27.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.697 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.75 -136.21 2.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -79.87 4.85 15.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -1.193 . . . . 0.0 109.566 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.652 ' CE1' ' O ' ' A' ' 9' ' ' SER . 35.7 t80 -119.26 161.32 20.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.473 -0.767 . . . . 0.0 109.78 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.652 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 82.5 p -115.5 133.13 56.33 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.955 -1.09 . . . . 0.0 110.929 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.504 ' O ' HG13 ' A' ' 3' ' ' VAL . 72.0 m-85 -112.47 121.96 46.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 110.779 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.2 p -69.83 168.08 15.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.061 -1.024 . . . . 0.0 109.918 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 43.3 mt -103.13 1.56 33.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.025 -1.047 . . . . 0.0 110.886 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.446 ' OE2' ' N ' ' A' ' 30' ' ' GLY . 97.5 mt-10 -73.96 -75.63 0.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 0.0 110.515 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.1 m -42.53 -50.18 5.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 110.671 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.64 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 5.4 m -57.31 -44.32 83.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.806 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.443 ' H ' HG21 ' A' ' 15' ' ' VAL . 50.5 tttt -56.56 -56.05 26.17 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.847 -1.158 . . . . 0.0 108.68 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' HB3' ' NE2' ' A' ' 22' ' ' GLN . 23.6 mttm -80.5 13.74 2.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.535 -0.728 . . . . 0.0 109.842 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.64 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.5 tt -63.38 -41.38 98.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.87 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -56.6 -42.96 79.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.504 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -93.01 116.23 28.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.546 ' CD2' ' HB3' ' A' ' 50' ' ' ASN . 0.8 OUTLIER -77.08 121.23 23.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.122 -0.986 . . . . 0.0 110.753 -179.26 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.448 ' HG3' ' CD ' ' A' ' 24' ' ' PRO . 21.9 pt20 -154.52 171.35 19.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.415 -0.803 . . . . 0.0 109.863 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.583 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -130.78 54.84 15.86 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.017 -1.052 . . . . 0.0 110.873 -179.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.583 ' HD3' ' N ' ' A' ' 23' ' ' GLU . 2.9 Cg_endo -60.46 144.99 99.55 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.725 1.382 . . . . 0.0 110.377 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.437 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 57.8 mt-30 -62.19 -28.64 69.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 0.0 110.171 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.635 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER 43.1 52.71 8.49 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.356 -0.84 . . . . 0.0 110.655 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.635 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.8 Cg_endo -61.72 -30.08 84.48 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.698 1.367 . . . . 0.0 110.393 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.407 ' O ' ' OE2' ' A' ' 26' ' ' GLU . 56.1 ttt180 -134.77 147.5 50.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.832 . . . . 0.0 110.217 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.9 m -57.46 132.4 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.901 . . . . 0.0 110.21 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' N ' ' OE2' ' A' ' 13' ' ' GLU . . . -61.96 117.49 11.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -60.43 -32.65 71.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -1.146 . . . . 0.0 110.127 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.5 tp -100.2 132.67 45.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 110.207 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' NH2' ' CD ' ' A' ' 84' ' ' GLU . 24.3 ptt85 -137.86 118.22 13.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.955 . . . . 0.0 110.205 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.55 ' O ' ' HB3' ' A' ' 35' ' ' PHE . 37.9 p-10 -174.22 -129.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 0.0 110.431 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.55 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 58.4 t80 63.66 89.83 0.09 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 110.266 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 78' ' ' GLU . . . -50.24 107.27 0.76 Allowed Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.885 . . . . 0.0 110.287 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.498 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 2.8 Cg_endo -64.83 -3.97 7.85 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.808 1.425 . . . . 0.0 110.791 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 2.8 mt 61.64 70.73 0.84 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 110.123 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.49 ' CG ' ' CG ' ' A' ' 75' ' ' GLU . 2.9 Cg_endo -61.29 154.44 58.27 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.968 1.51 . . . . 0.0 110.562 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.424 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 125.02 28.6 1.11 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -125.16 71.74 63.92 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.294 -1.121 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.424 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.07 90.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.864 1.455 . . . . 0.0 110.471 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.466 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 11.5 p -135.75 129.23 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 110.042 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.558 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 14.6 t -158.16 72.58 4.0 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.294 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.22 148.11 93.34 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.755 1.398 . . . . 0.0 110.185 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.56 ' CG2' ' HG ' ' A' ' 47' ' ' LEU . 13.1 tt -49.6 -26.41 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 110.012 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.56 ' HG ' ' CG2' ' A' ' 46' ' ' ILE . 30.0 mt -96.18 9.5 40.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 109.883 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER 70.99 128.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.405 -0.81 . . . . 0.0 110.265 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.554 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 91.5 p -55.48 -79.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.83 . . . . 0.0 110.421 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.546 ' HB3' ' CD2' ' A' ' 21' ' ' LEU . 5.3 m120 -80.08 112.56 31.2 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.374 -0.829 . . . . 0.0 110.3 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.39 -5.38 8.2 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.664 1.349 . . . . 0.0 110.875 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.54 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 47.7 m-80 -132.4 29.64 4.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 110.549 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.797 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.5 p90 -78.61 -175.1 0.51 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 108.83 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.797 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 5.0 Cg_exo -55.64 75.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.383 1.202 . . . . 0.0 109.925 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 53' ' ' PHE . 22.6 pt-20 -44.46 -34.96 2.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.572 -0.705 . . . . 0.0 110.448 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -53.87 -19.34 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.051 -1.031 . . . . 0.0 108.832 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.691 HD11 ' HB2' ' A' ' 54' ' ' PRO . 6.8 mp -96.77 14.22 25.87 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.83 0.824 . . . . 0.0 109.221 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.735 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.76 -51.48 5.31 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.767 -0.583 . . . . 0.0 110.575 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.735 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -53.66 -44.32 50.1 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.37 1.195 . . . . 0.0 110.039 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.612 ' CD1' ' CD1' ' A' ' 69' ' ' ILE . 3.1 mm? -57.59 -38.89 75.63 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 109.608 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.533 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 43.6 t -67.17 -29.4 69.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.15 -0.969 . . . . 0.0 110.181 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.38 6.96 47.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.935 . . . . 0.0 110.08 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.508 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 2.8 mt-10 -99.58 144.34 28.12 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.369 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.03 -26.83 73.79 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.78 1.41 . . . . 0.0 110.178 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.428 ' HB2' HD13 ' A' ' 69' ' ' ILE . 76.1 m-20 -86.94 -3.19 59.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.542 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -42.52 -40.55 2.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.111 -0.993 . . . . 0.0 109.989 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -61.75 -39.72 92.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.476 -0.765 . . . . 0.0 110.454 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -80.3 -31.88 38.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.141 -0.975 . . . . 0.0 109.859 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.612 ' CD1' ' CD1' ' A' ' 60' ' ' LEU . 62.1 mt -74.55 -44.91 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 110.055 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.536 HD11 ' N ' ' A' ' 71' ' ' GLN . 1.7 tm? -50.03 -59.27 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 110.387 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.536 ' N ' HD11 ' A' ' 70' ' ' LEU . 62.6 tt0 -47.91 -52.64 18.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.333 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -55.25 -56.72 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 35.1 mt -49.43 -51.33 36.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 110.205 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 76.7 mm-40 -53.69 -49.82 67.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.967 . . . . 0.0 110.454 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.49 ' CG ' ' CG ' ' A' ' 39' ' ' PRO . 98.8 mt-10 -54.88 -52.14 63.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -0.962 . . . . 0.0 110.523 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.459 HG23 HG23 ' A' ' 3' ' ' VAL . 23.7 mm -62.86 -35.58 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 109.894 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.82 71.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.814 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.1 tt0 -62.05 -38.54 89.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 110.172 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.6 OUTLIER 175.04 94.42 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 110.077 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.558 ' CB ' ' HB3' ' A' ' 83' ' ' CYS . 3.1 Cg_exo -59.74 77.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.931 1.49 . . . . 0.0 110.714 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -42.64 -75.12 0.15 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.598 ' O ' HG12 ' A' ' 85' ' ' ILE . 65.8 p -71.44 -57.29 4.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.396 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.63 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 32.6 t -39.01 -50.79 1.8 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 110.046 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 81.7 tt0 -58.61 -42.97 89.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.041 -1.037 . . . . 0.0 110.731 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 82' ' ' THR . 8.6 pt -89.61 18.04 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.018 . . . . 0.0 110.219 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 7.2 m 57.83 15.0 2.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.317 -0.865 . . . . 0.0 110.547 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 82' ' ' THR . . . -65.53 -19.26 65.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.194 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -135.68 165.43 25.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.72 5.69 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.829 . . . . 0.0 110.563 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -69.58 -31.56 69.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 110.414 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.63 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.7 OUTLIER -108.56 123.81 49.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.818 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.526 ' OG1' ' NE2' ' A' ' 4' ' ' GLN . 44.0 p -110.8 164.05 13.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 110.131 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.6 -3.93 68.81 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.174 -1.192 . . . . 0.0 110.199 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.228 0.537 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 29.8 m -121.42 149.49 42.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 0.0 110.536 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.531 HG22 ' CG ' ' A' ' 12' ' ' LEU . 91.9 t -86.76 118.44 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.707 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.499 ' NE2' HG23 ' A' ' 92' ' ' THR . 21.5 pt20 -111.48 147.91 34.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 111.029 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.515 ' OD2' ' CD2' ' A' ' 73' ' ' LEU . 91.4 m-20 -111.76 12.1 21.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.429 -0.794 . . . . 0.0 109.771 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 174.07 -129.61 1.66 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.02 5.49 22.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -1.166 . . . . 0.0 110.162 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 86.8 m-85 -125.98 147.22 49.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.412 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 94.8 p -101.14 136.61 40.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 0.0 110.144 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.636 ' CD1' HD13 ' A' ' 57' ' ' LEU . 21.5 m-85 -121.35 132.52 54.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.452 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.1 t -71.32 166.69 21.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.295 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.608 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 5.2 mp -97.39 -9.64 27.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.302 -0.874 . . . . 0.0 110.404 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -67.75 -71.51 0.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.842 . . . . 0.0 110.729 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 m -46.34 -46.67 18.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.0 110.467 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.536 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 48.5 t -62.94 -51.62 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.048 -1.032 . . . . 0.0 109.941 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.503 ' NZ ' ' N ' ' A' ' 34' ' ' ASN . 43.0 tttt -54.18 -51.8 63.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.05 -1.031 . . . . 0.0 109.018 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 26' ' ' GLU . 22.3 tttp -80.21 6.86 10.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 0.0 109.793 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.545 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 17.2 tp -61.54 -37.59 84.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HE2' HG12 ' A' ' 38' ' ' ILE . 43.7 mttp -63.44 -37.05 85.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.08 -1.013 . . . . 0.0 110.047 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -113.33 101.78 9.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.08 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 52' ' ' ASN . 33.9 tp -110.26 130.16 55.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.91 . . . . 0.0 110.226 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.432 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 92.9 mt-30 -122.94 161.06 24.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.639 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 0.4 OUTLIER -43.32 -52.57 12.67 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 110.672 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 3.1 Cg_exo -60.48 163.57 14.97 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.642 1.338 . . . . 0.0 110.745 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.442 ' O ' ' O ' ' A' ' 24' ' ' PRO . 93.0 mt-30 -58.31 -154.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.85 . . . . 0.0 110.327 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -116.32 79.52 9.01 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.431 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.436 ' HD3' ' C ' ' A' ' 25' ' ' GLN . 3.0 Cg_endo -61.96 155.45 55.16 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.813 1.428 . . . . 0.0 110.401 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -134.51 152.01 51.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 110.373 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.5 t -124.95 136.1 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.71 141.65 8.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.41 -33.98 75.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -1.155 . . . . 0.0 110.344 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.28 144.21 28.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 110.433 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 70.1 mtt85 -105.3 100.9 10.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.257 -0.902 . . . . 0.0 109.911 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 35.3 p-10 -137.9 155.76 48.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 110.599 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.489 ' O ' ' OE1' ' A' ' 78' ' ' GLU . 66.9 t80 -178.73 159.96 1.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.187 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.545 ' O ' ' CD1' ' A' ' 38' ' ' ILE . . . -54.05 107.67 0.92 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.118 -0.989 . . . . 0.0 110.058 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.474 ' C ' HD11 ' A' ' 38' ' ' ILE . 2.4 Cg_endo -76.99 147.36 26.69 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.607 1.538 . . . . 0.0 109.953 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.545 ' CD1' ' O ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -148.22 64.04 7.78 Favored Pre-proline 0 C--N 1.292 -1.93 0 O-C-N 121.738 -0.601 . . . . 0.0 109.793 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.477 ' HG3' ' HB2' ' A' ' 75' ' ' GLU . 3.0 Cg_endo -60.7 147.33 95.24 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.023 1.538 . . . . 0.0 110.772 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.512 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 126.3 32.44 0.73 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.47 75.5 44.03 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.289 -1.124 . . . . 0.0 110.283 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.469 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 2.9 Cg_endo -62.01 132.25 38.55 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.84 1.442 . . . . 0.0 110.811 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.508 ' CG2' ' OG ' ' A' ' 49' ' ' SER . 6.2 p 179.15 83.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.403 -0.81 . . . . 0.0 110.006 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.525 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 38.8 t -129.37 67.8 79.29 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.479 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.452 ' CD ' ' OG ' ' A' ' 49' ' ' SER . 3.0 Cg_endo -62.95 151.11 86.28 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.814 1.428 . . . . 0.0 110.281 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.534 HG13 ' HG ' ' A' ' 47' ' ' LEU . 15.2 pt -53.73 -25.04 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 109.891 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.534 ' HG ' HG13 ' A' ' 46' ' ' ILE . 58.4 mt -97.77 12.56 33.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 109.95 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.481 ' O ' ' O ' ' A' ' 47' ' ' LEU . 1.3 m 58.84 121.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.394 -0.816 . . . . 0.0 109.976 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.555 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 36.3 m -60.12 -53.19 60.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.67 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 3.2 m120 -80.32 111.5 22.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.433 -0.792 . . . . 0.0 110.506 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -58.95 -12.79 16.26 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.646 1.34 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.459 ' HB3' HD13 ' A' ' 21' ' ' LEU . 31.0 t30 -137.39 42.1 2.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.253 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.733 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.3 p90 -80.18 -177.58 0.95 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.391 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.733 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.5 Cg_exo -57.85 74.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.684 1.36 . . . . 0.0 109.693 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.0 tt0 -42.52 -35.55 1.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.481 -0.762 . . . . 0.0 110.348 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -53.7 -18.16 2.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 108.822 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.636 HD13 ' CD1' ' A' ' 10' ' ' PHE . 8.2 mp -96.39 13.3 28.23 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.754 0.788 . . . . 0.0 109.1 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.714 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -41.15 -52.3 7.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.908 -0.495 . . . . 0.0 111.168 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.714 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -53.8 -43.99 53.08 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.6 1.316 . . . . 0.0 110.17 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 17.9 mt -60.36 -34.36 73.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.139 -0.976 . . . . 0.0 109.902 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.457 ' HA ' HG12 ' A' ' 44' ' ' VAL . 36.8 t -66.27 -25.95 67.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.182 -0.949 . . . . 0.0 110.286 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -107.09 25.35 11.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.943 . . . . 0.0 109.323 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.476 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -110.48 143.19 27.62 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.624 -0.672 . . . . 0.0 110.462 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.53 -30.83 80.07 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.896 1.472 . . . . 0.0 109.816 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' ALA . 81.8 m-20 -86.23 -5.95 59.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 0.0 110.507 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -44.53 -41.56 6.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.106 -0.996 . . . . 0.0 110.068 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -55.13 -42.41 72.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.766 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.11 -37.38 33.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 109.863 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.452 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 87.7 mt -63.34 -49.18 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.098 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 1.3 tm? -48.7 -60.88 2.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 110.558 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.583 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 63.9 tt0 -47.07 -53.99 11.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 0.0 110.533 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -54.76 -53.22 57.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 110.112 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.515 ' CD2' ' OD2' ' A' ' 5' ' ' ASP . 73.5 mt -49.84 -52.0 35.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 86.7 mt-10 -52.53 -46.02 66.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.341 -0.849 . . . . 0.0 110.328 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 82.3 tt0 -62.76 -54.24 42.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.672 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 79' ' ' ASP . 32.8 mm -64.56 -43.4 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 110.185 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -55.75 -37.64 68.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 110.024 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 57.6 mm-40 -65.02 -36.16 83.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.365 -0.834 . . . . 0.0 111.087 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -135.55 149.16 68.52 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.868 -1.145 . . . . 0.0 110.725 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.469 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -60.58 -68.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.831 1.437 . . . . 0.0 110.596 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.53 -139.42 20.18 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.544 ' O ' HG12 ' A' ' 85' ' ' ILE . 64.6 p -80.19 -23.03 41.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.126 -1.22 . . . . 0.0 110.007 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.493 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 14.2 t -53.38 -53.51 50.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.903 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.8 tt0 -58.14 -32.29 68.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.375 -0.828 . . . . 0.0 111.05 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 82' ' ' THR . 5.2 pt -99.08 12.7 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.96 -1.088 . . . . 0.0 110.401 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 54.97 15.49 1.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.875 . . . . 0.0 110.51 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.52 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -62.02 -14.94 40.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.04 -1.037 . . . . 0.0 109.952 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 19.7 m-85 -144.75 174.35 11.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.03 3.18 10.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.847 . . . . 0.0 110.411 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -59.91 -36.78 77.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.609 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -104.22 123.83 48.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 0.0 110.633 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.499 HG23 ' NE2' ' A' ' 4' ' ' GLN . 23.4 p -105.6 160.53 15.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.381 -0.824 . . . . 0.0 110.146 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.65 3.19 56.28 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.349 -1.089 . . . . 0.0 110.218 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.575 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 9.7 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.333 0.587 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 90.8 m -129.44 154.45 46.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.961 . . . . 0.0 110.726 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.513 HG22 HD11 ' A' ' 12' ' ' LEU . 39.0 t -83.91 117.25 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.351 -0.843 . . . . 0.0 109.82 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.545 ' CB ' ' CG2' ' A' ' 92' ' ' THR . 48.7 tt0 -111.73 128.35 56.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 110.504 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.471 ' OD2' ' CD2' ' A' ' 73' ' ' LEU . 76.1 m-20 -114.24 10.38 17.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.471 -0.768 . . . . 0.0 109.692 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.74 -143.55 4.67 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -82.42 7.74 13.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -1.166 . . . . 0.0 110.221 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.416 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 74.4 m-85 -123.98 145.66 49.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 110.372 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -90.74 123.57 34.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.332 -0.855 . . . . 0.0 110.222 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CD1' ' CD2' ' A' ' 57' ' ' LEU . 20.9 m-85 -110.91 123.08 49.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.863 . . . . 0.0 110.329 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.407 ' HA ' HG21 ' A' ' 2' ' ' THR . 63.4 m -62.37 156.15 23.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.534 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.578 ' O ' ' CG2' ' A' ' 15' ' ' VAL . 45.9 tp -98.68 -20.91 16.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.238 -0.914 . . . . 0.0 110.546 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.432 ' OE2' HG11 ' A' ' 29' ' ' VAL . 95.6 mt-10 -62.42 -65.46 0.68 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.139 -0.976 . . . . 0.0 110.51 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.4 m -46.58 -48.54 19.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.968 . . . . 0.0 110.949 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.617 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 31.2 m -60.86 -44.97 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.104 -0.997 . . . . 0.0 110.086 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 1.5 tmmt? -58.54 -56.03 27.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 109.072 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 13.9 ttpt -80.31 8.46 7.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.294 -0.879 . . . . 0.0 109.14 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.617 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 7.7 tp -52.2 -38.67 58.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.582 -0.699 . . . . 0.0 110.027 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.574 ' HD3' ' CE2' ' A' ' 35' ' ' PHE . 65.5 tttt -57.25 -45.4 84.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.094 -1.004 . . . . 0.0 109.574 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -97.47 115.05 27.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.764 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.508 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 29.6 tp -97.42 130.94 44.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.666 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -125.6 147.8 49.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.344 -0.847 . . . . 0.0 109.958 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.624 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 2.5 tt0 -50.58 -53.34 47.06 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 110.445 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 3.0 Cg_endo -60.42 124.75 15.78 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.612 1.322 . . . . 0.0 110.712 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.419 ' O ' ' CB ' ' A' ' 26' ' ' GLU . 63.1 tt0 -64.23 -41.06 97.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.875 . . . . 0.0 110.191 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.429 ' CD ' ' OE1' ' A' ' 13' ' ' GLU . 0.4 OUTLIER 174.18 74.96 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.432 -0.793 . . . . 0.0 110.021 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' A' ' 24' ' ' PRO . 2.9 Cg_endo -62.32 -31.02 81.7 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.877 1.461 . . . . 0.0 110.697 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -137.21 159.59 41.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.857 . . . . 0.0 110.426 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.432 HG11 ' OE2' ' A' ' 13' ' ' GLU . 47.4 t -116.82 132.32 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.847 . . . . 0.0 110.033 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.17 136.71 12.97 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -59.4 -38.85 81.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -1.131 . . . . 0.0 110.115 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.5 mt -118.93 136.52 54.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 110.153 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -124.29 132.09 53.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.216 -0.927 . . . . 0.0 110.317 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 16.7 p30 -164.43 163.95 22.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 110.119 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.574 ' CE2' ' HD3' ' A' ' 19' ' ' LYS . 64.8 t80 -170.38 173.71 5.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.145 -0.972 . . . . 0.0 110.277 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.562 ' N ' ' CD2' ' A' ' 35' ' ' PHE . . . -49.48 177.85 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.823 . . . . 0.0 110.289 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 3.0 Cg_exo -61.83 81.96 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.846 1.445 . . . . 0.0 110.604 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.733 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 2.1 mp -67.91 -40.2 21.87 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 111.247 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.733 ' CD ' ' N ' ' A' ' 38' ' ' ILE . 3.0 Cg_exo -64.73 146.52 88.66 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.323 1.17 . . . . 0.0 110.568 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.31 6.08 29.69 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -137.09 71.01 55.83 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.162 -1.199 . . . . 0.0 110.31 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.74 147.71 94.69 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.865 1.455 . . . . 0.0 110.269 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.513 HG23 ' CB ' ' A' ' 49' ' ' SER . 12.2 p -158.47 72.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.42 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.49 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 30.6 t -127.44 73.8 77.76 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.1 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.467 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 3.1 Cg_exo -60.28 -54.31 2.29 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.97 1.511 . . . . 0.0 110.6 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -177.59 -40.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.319 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.521 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 16.0 tp -109.45 38.81 2.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.137 -0.977 . . . . 0.0 110.248 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.566 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.0 OUTLIER 57.97 123.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.202 -0.936 . . . . 0.0 110.194 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.593 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 85.0 p -61.54 -54.88 37.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -0.92 . . . . 0.0 110.44 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 5.3 m-20 -80.2 110.87 18.08 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.392 -0.818 . . . . 0.0 110.399 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.81 -13.96 33.69 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.623 1.328 . . . . 0.0 110.715 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.508 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 86.3 m-20 -128.21 33.66 4.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 110.55 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.657 ' CE1' ' HA ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -80.25 175.94 4.29 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.129 -0.982 . . . . 0.0 108.792 179.082 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.649 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.1 Cg_exo -56.57 75.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.604 1.318 . . . . 0.0 109.388 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.657 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.5 tt0 -39.35 -27.14 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.712 -0.618 . . . . 0.0 110.387 -178.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.3 mt-10 -53.68 -17.34 2.17 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.964 -1.085 . . . . 0.0 108.657 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.627 ' CD2' ' CD1' ' A' ' 10' ' ' PHE . 34.8 mt -95.09 9.17 40.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.566 -0.709 . . . . 0.0 109.676 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.716 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.6 -51.74 4.95 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.28 -0.887 . . . . 0.0 110.678 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.716 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.84 -41.88 74.07 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.496 1.261 . . . . 0.0 110.017 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 55.9 mt -60.39 -36.6 78.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.113 -0.992 . . . . 0.0 110.163 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.533 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 73.6 m -67.53 -28.32 67.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.957 . . . . 0.0 110.272 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -101.22 24.33 9.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.211 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.487 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -113.45 143.55 29.57 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.588 -0.695 . . . . 0.0 110.588 -179.252 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.26 -31.98 73.6 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.813 1.428 . . . . 0.0 109.818 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -86.98 1.67 52.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.361 -0.837 . . . . 0.0 110.701 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.17 -42.63 20.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.068 -1.02 . . . . 0.0 110.058 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.437 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 92.1 mt-30 -56.15 -41.39 75.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.848 . . . . 0.0 110.098 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -79.92 -35.52 37.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 110.135 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.513 ' CD1' HD21 ' A' ' 60' ' ' LEU . 91.6 mt -67.6 -47.95 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.0 109.79 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.647 HD23 ' HG3' ' A' ' 74' ' ' GLU . 0.4 OUTLIER -53.95 -53.28 54.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 0.0 110.378 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.558 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 97.9 mt-30 -49.7 -51.26 39.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.252 -0.905 . . . . 0.0 110.722 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -55.42 -59.64 4.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.317 -0.864 . . . . 0.0 110.711 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.471 ' CD2' ' OD2' ' A' ' 5' ' ' ASP . 60.9 mt -44.38 -49.09 9.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.301 -0.875 . . . . 0.0 110.42 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.647 ' HG3' HD23 ' A' ' 70' ' ' LEU . 70.7 mt-10 -61.82 -26.72 68.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 0.0 110.752 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.535 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.3 tt0 -71.63 -50.41 30.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.929 -1.107 . . . . 0.0 109.785 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.1 mm -67.82 -36.48 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.346 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.543 ' HA ' ' CG ' ' A' ' 12' ' ' LEU . . . -63.28 -29.16 70.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.617 -0.677 . . . . 0.0 109.667 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 35' ' ' PHE . 84.8 tt0 -62.99 -34.7 78.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.423 -0.798 . . . . 0.0 110.384 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.417 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -161.33 147.01 10.84 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.144 -0.973 . . . . 0.0 110.765 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.48 ' CB ' ' OE1' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.47 84.04 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.052 1.554 . . . . 0.0 110.598 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.68 -130.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.207 -1.957 . . . . 0.0 108.207 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.528 ' HB ' ' CB ' ' A' ' 87' ' ' ALA . 82.8 p -82.76 -16.96 45.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.246 . . . . 0.0 109.321 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.438 ' SG ' ' N ' ' A' ' 91' ' ' CYS . 5.5 t -51.11 -50.38 58.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.733 -0.604 . . . . 0.0 110.37 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' OE1' ' CB ' ' A' ' 80' ' ' PRO . 76.2 tt0 -61.05 -34.87 75.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.268 -0.895 . . . . 0.0 111.364 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.545 ' CG1' ' HB2' ' A' ' 87' ' ' ALA . 4.3 pt -97.24 17.36 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.588 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 m 51.14 17.37 0.46 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.945 . . . . 0.0 110.81 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.545 ' HB2' ' CG1' ' A' ' 85' ' ' ILE . . . -67.55 -13.81 62.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.056 -1.028 . . . . 0.0 109.663 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -141.22 170.27 16.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.79 . . . . 0.0 109.996 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.73 4.43 7.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.12 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -59.27 -40.35 85.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.639 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.531 ' SG ' ' CG2' ' A' ' 1' ' ' VAL . 1.0 OUTLIER -103.04 128.24 49.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.214 -0.929 . . . . 0.0 110.689 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.545 ' CG2' ' CB ' ' A' ' 4' ' ' GLN . 16.9 p -108.0 165.45 11.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.25 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.29 -7.07 61.82 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.319 -1.107 . . . . 0.0 110.21 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.449 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 6.4 m . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.107 0.48 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 14.6 t -129.75 164.09 24.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.565 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 43.2 t -80.06 110.98 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.352 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.54 ' CB ' HG22 ' A' ' 92' ' ' THR . 46.2 tt0 -109.53 121.15 44.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.111 -0.993 . . . . 0.0 110.578 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -99.12 5.65 46.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.821 . . . . 0.0 109.673 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.93 -141.18 3.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -79.92 0.17 32.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -1.193 . . . . 0.0 110.36 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.483 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 92.4 m-85 -112.64 138.07 49.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.179 -0.95 . . . . 0.0 110.462 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.536 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 73.4 m -89.11 128.79 35.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.359 -0.838 . . . . 0.0 110.144 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.58 ' CE1' HD21 ' A' ' 57' ' ' LEU . 91.6 m-85 -111.79 119.14 37.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.897 . . . . 0.0 110.483 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.7 p -70.88 168.38 16.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.93 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.514 ' HA ' ' CG2' ' A' ' 15' ' ' VAL . 65.0 mt -99.51 2.94 45.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.978 . . . . 0.0 110.425 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 14' ' ' SER . 81.7 tt0 -76.28 -71.02 0.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 110.503 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.472 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.6 m -42.42 -49.45 5.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.007 -1.058 . . . . 0.0 110.271 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.607 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 7.8 m -58.9 -48.89 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.181 -0.949 . . . . 0.0 109.851 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' NZ ' ' HB3' ' A' ' 35' ' ' PHE . 21.2 tttt -54.68 -55.91 24.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.894 -1.129 . . . . 0.0 108.972 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -80.33 12.34 3.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.415 -0.803 . . . . 0.0 109.621 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.607 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 39.1 tp -57.96 -37.15 73.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.354 -0.842 . . . . 0.0 110.376 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.543 ' HB2' ' CG ' ' A' ' 37' ' ' PRO . 79.0 tttt -55.29 -43.21 74.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.127 -0.983 . . . . 0.0 110.006 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -99.96 109.94 22.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 110.042 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.542 HD22 ' ND2' ' A' ' 50' ' ' ASN . 93.8 mt -64.4 -36.29 83.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.895 . . . . 0.0 110.277 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.456 ' O ' ' CB ' ' A' ' 23' ' ' GLU . 1.5 tp60 -60.44 137.77 58.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.23 -0.918 . . . . 0.0 110.2 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 22' ' ' GLN . 0.4 OUTLIER 171.85 164.2 0.24 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.157 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.07 156.93 46.95 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.884 1.465 . . . . 0.0 110.629 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -51.77 -34.03 37.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.196 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.536 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 3.1 tp10 47.42 60.63 14.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.902 . . . . 0.0 110.466 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 3.0 Cg_endo -62.07 -28.22 79.94 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.897 1.472 . . . . 0.0 110.271 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -142.61 158.67 43.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.396 -0.815 . . . . 0.0 109.986 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.6 t -112.61 131.18 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.178 -0.951 . . . . 0.0 110.231 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.29 -72.62 0.77 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -90.71 152.92 20.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -1.144 . . . . 0.0 110.154 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 5.6 mp -100.1 137.08 39.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.481 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -112.74 140.27 47.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.812 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 86.9 m-20 -124.68 107.39 10.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 110.76 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.542 ' HB3' ' NZ ' ' A' ' 16' ' ' LYS . 74.7 t80 179.38 66.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.332 -0.855 . . . . 0.0 110.245 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -65.09 145.12 99.15 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.967 . . . . 0.0 110.128 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.669 ' O ' ' CB ' ' A' ' 38' ' ' ILE . 2.8 Cg_endo -62.65 -30.93 79.33 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.823 1.433 . . . . 0.0 110.845 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.669 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 154.68 116.1 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.045 0 O-C-N 121.84 -0.537 . . . . 0.0 109.814 179.736 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.513 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 3.0 Cg_exo -62.44 154.51 63.74 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.678 1.357 . . . . 0.0 110.495 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.476 ' HA3' ' HG2' ' A' ' 71' ' ' GLN . . . 102.02 -0.35 51.43 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.91 139.54 95.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.214 -1.168 . . . . 0.0 110.214 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.68 110.0 0.87 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.756 1.398 . . . . 0.0 110.329 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.488 HG11 HG22 ' A' ' 44' ' ' VAL . 63.3 t -135.97 143.04 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.142 -0.974 . . . . 0.0 110.515 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.585 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 46.4 t 57.59 58.0 7.36 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.775 . . . . 0.0 110.861 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -62.59 -42.22 27.7 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.512 1.27 . . . . 0.0 109.69 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.488 ' O ' ' HB3' ' A' ' 47' ' ' LEU . 39.4 mm -133.3 -28.55 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.501 -0.749 . . . . 0.0 109.927 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.8 OUTLIER 178.97 89.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.388 -0.82 . . . . 0.0 109.891 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.506 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 0.8 OUTLIER 57.21 112.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.15 -0.969 . . . . 0.0 110.038 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.612 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 6.6 p -96.16 -53.46 3.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 110.566 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.542 ' ND2' HD22 ' A' ' 21' ' ' LEU . 9.6 m-20 -80.06 111.35 21.22 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.401 -0.812 . . . . 0.0 110.439 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.612 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.91 -13.62 40.72 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.704 1.37 . . . . 0.0 110.371 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.484 ' HB2' HD21 ' A' ' 21' ' ' LEU . 95.2 m-20 -114.27 20.16 15.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.415 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.639 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.15 173.45 7.7 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 108.961 179.193 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.639 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.1 Cg_exo -57.37 75.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.632 1.333 . . . . 0.0 108.925 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.631 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 23.9 pt-20 -39.11 -26.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.745 -0.597 . . . . 0.0 110.596 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt-10 -51.68 -22.23 3.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.944 -1.097 . . . . 0.0 108.452 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.621 ' CD1' ' HG2' ' A' ' 54' ' ' PRO . 66.7 mt -83.14 8.86 11.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.662 -0.649 . . . . 0.0 109.472 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.725 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.75 -51.49 5.29 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.457 -0.777 . . . . 0.0 110.601 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.725 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.97 -41.43 78.81 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.52 1.274 . . . . 0.0 110.571 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.569 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 5.9 mp -62.48 -35.45 79.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.88 -1.138 . . . . 0.0 110.384 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.517 ' HA ' HG12 ' A' ' 44' ' ' VAL . 84.3 m -67.22 -28.19 67.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.064 -1.023 . . . . 0.0 110.536 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.447 ' NZ ' ' HE2' ' A' ' 58' ' ' LYS . 91.2 mttt -81.64 -3.08 52.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.825 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 11.4 pt-20 -125.38 147.02 56.31 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.94 -1.1 . . . . 0.0 110.376 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.27 -6.94 10.9 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.903 1.475 . . . . 0.0 111.024 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -79.92 -22.69 42.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.087 -1.008 . . . . 0.0 110.161 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.69 -39.37 17.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.419 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.57 -41.51 97.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 110.278 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.39 -38.17 30.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.558 ' CG2' ' CD2' ' A' ' 60' ' ' LEU . 95.7 mt -65.17 -39.39 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 110.489 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.505 ' O ' HD23 ' A' ' 70' ' ' LEU . 2.3 tm? -56.42 -51.34 68.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.937 . . . . 0.0 110.499 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.476 ' HG2' ' HA3' ' A' ' 40' ' ' GLY . 89.6 mt-30 -49.64 -54.78 16.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.103 -0.998 . . . . 0.0 110.117 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 mtm180 -52.36 -54.33 33.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.39 -0.818 . . . . 0.0 110.119 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 41.5 mt -48.43 -50.47 31.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.879 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 69.6 mm-40 -53.9 -51.78 62.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.892 . . . . 0.0 110.279 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -54.78 -56.85 14.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.039 -1.038 . . . . 0.0 110.536 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 79' ' ' ASP . 20.1 mt -58.9 -35.16 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.121 -0.987 . . . . 0.0 109.465 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 34' ' ' ASN . . . -57.89 -34.72 70.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.545 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -60.39 -40.65 91.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -148.01 153.69 42.19 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.163 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -58.56 -59.22 0.52 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.895 1.471 . . . . 0.0 110.574 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.33 -138.69 20.15 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.58 ' O ' HG12 ' A' ' 85' ' ' ILE . 65.5 p -82.31 -21.13 36.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -1.11 . . . . 0.0 110.058 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 42.3 t -55.64 -53.35 57.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.208 -0.933 . . . . 0.0 110.109 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.7 tt0 -60.7 -27.81 68.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 111.22 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 82' ' ' THR . 6.2 pt -99.05 13.51 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 110.273 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 55.37 16.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.504 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.531 ' HB2' ' CG1' ' A' ' 85' ' ' ILE . . . -67.29 -15.35 63.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.967 . . . . 0.0 109.931 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.46 169.49 17.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.13 3.09 11.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 110.185 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.53 -34.8 77.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.458 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -103.51 123.25 46.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.737 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.54 HG22 ' CB ' ' A' ' 4' ' ' GLN . 21.8 p -111.63 154.98 24.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 109.754 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 44.14 4.82 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.342 -1.093 . . . . 0.0 110.282 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.469 HG12 ' HB3' ' A' ' 91' ' ' CYS . 3.4 t . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.164 0.507 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 30.8 m -126.25 142.66 51.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.55 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.56 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 90.4 t -82.24 119.66 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.496 -0.752 . . . . 0.0 109.448 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.483 ' HB2' HG22 ' A' ' 92' ' ' THR . 44.8 tt0 -113.5 133.11 55.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.879 -1.138 . . . . 0.0 110.787 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -92.06 -78.89 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.567 -0.708 . . . . 0.0 109.65 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.0 -122.16 4.67 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -85.19 10.01 13.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.157 . . . . 0.0 110.341 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.466 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 98.1 m-85 -122.45 137.9 54.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.448 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.436 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 60.7 p -89.64 128.35 36.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 110.076 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.705 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 23.2 m-30 -117.07 126.98 53.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 0.0 110.746 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.1 t -61.48 157.92 16.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.079 . . . . 0.0 109.727 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.56 ' HB3' ' CG2' ' A' ' 3' ' ' VAL . 1.5 pt? -100.5 -25.31 14.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -1.0 . . . . 0.0 111.071 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.21 -65.86 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.078 -1.014 . . . . 0.0 110.74 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.6 m -52.59 -38.86 60.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.363 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.567 ' CG1' ' HG ' ' A' ' 73' ' ' LEU . 6.8 t -58.15 -46.4 88.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.135 -0.978 . . . . 0.0 109.621 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HD3' ' CD ' ' A' ' 33' ' ' ARG . 18.9 tttt -57.73 -53.84 53.67 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.056 -1.028 . . . . 0.0 108.74 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 20' ' ' ASP . 51.4 mttm -80.34 12.05 3.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.535 -0.728 . . . . 0.0 109.751 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 8.7 tt -59.55 -39.08 82.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.136 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -50.61 -42.54 56.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 17' ' ' LYS . 39.0 p30 -150.31 146.4 26.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.809 . . . . 0.0 109.605 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.52 ' CD2' ' CG ' ' A' ' 52' ' ' ASN . 14.7 tp -102.95 126.77 50.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.986 . . . . 0.0 110.759 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.478 ' C ' ' CG ' ' A' ' 23' ' ' GLU . 94.3 mt-30 -142.76 157.23 44.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.434 -0.791 . . . . 0.0 109.608 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.6 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 0.7 OUTLIER 55.66 -175.68 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.087 -1.008 . . . . 0.0 109.393 -179.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.6 ' HD2' ' CB ' ' A' ' 23' ' ' GLU . 3.1 Cg_exo -62.59 152.48 77.5 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.556 1.293 . . . . 0.0 110.618 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -55.44 -36.25 66.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.254 -0.904 . . . . 0.0 110.435 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -138.26 80.83 27.24 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.873 . . . . 0.0 110.301 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 24' ' ' PRO . 3.0 Cg_endo -63.09 143.67 90.91 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.948 1.499 . . . . 0.0 110.446 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.512 ' O ' ' C ' ' A' ' 29' ' ' VAL . 83.9 mtt180 -88.1 157.46 18.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.512 ' C ' ' O ' ' A' ' 28' ' ' ARG . 2.8 p 33.72 85.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.457 -0.777 . . . . 0.0 110.524 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.48 -142.08 4.18 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -86.16 163.54 17.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.269 -1.136 . . . . 0.0 110.2 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.556 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 5.7 mp -93.25 146.16 23.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.301 -0.874 . . . . 0.0 110.257 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.488 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 8.8 mmt85 -95.52 102.3 14.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.866 . . . . 0.0 110.454 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.547 ' OD1' ' CE1' ' A' ' 35' ' ' PHE . 18.0 p-10 175.93 54.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 110.305 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.547 ' CE1' ' OD1' ' A' ' 34' ' ' ASN . 15.9 m-85 -122.19 155.73 35.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.23 -0.919 . . . . 0.0 110.079 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.6 106.68 0.57 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.085 -1.009 . . . . 0.0 110.063 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.557 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo -66.86 -161.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.738 1.388 . . . . 0.0 110.861 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.541 HG21 ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -153.32 72.89 6.89 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.664 -0.648 . . . . 0.0 109.754 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.57 148.87 85.49 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.701 1.369 . . . . 0.0 110.71 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.55 12.23 2.54 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.537 ' O ' HD13 ' A' ' 70' ' ' LEU . 3.8 pt-20 -119.48 77.87 19.8 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.094 -1.239 . . . . 0.0 110.138 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.32 143.52 99.7 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.978 1.515 . . . . 0.0 110.672 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.534 ' CG2' HG22 ' A' ' 44' ' ' VAL . 20.2 m -121.77 -166.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 110.273 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.621 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 11.3 t 62.56 53.75 2.08 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.468 -0.77 . . . . 0.0 110.552 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.621 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -61.52 -27.03 81.52 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.698 1.367 . . . . 0.0 110.14 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' A' ' 47' ' ' LEU . 21.0 tt -159.41 -39.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.365 -0.834 . . . . 0.0 109.956 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.566 ' O ' ' O ' ' A' ' 48' ' ' CYS . 1.3 tp -158.78 89.94 0.97 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.124 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.566 ' O ' ' O ' ' A' ' 47' ' ' LEU . 71.8 m 47.58 109.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.33 -0.856 . . . . 0.0 110.752 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.503 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 87.8 p -59.89 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.459 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' LEU . 1.8 m120 -66.09 112.94 10.28 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.868 . . . . 0.0 110.691 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.7 -7.1 15.47 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.713 1.375 . . . . 0.0 109.721 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.52 ' CG ' ' CD2' ' A' ' 21' ' ' LEU . 26.5 p30 -124.95 26.06 7.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.511 -0.743 . . . . 0.0 110.368 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.714 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -79.15 179.89 1.63 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.213 -0.929 . . . . 0.0 108.575 179.102 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.714 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.7 Cg_exo -57.73 75.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 N-CA-C 108.89 -1.235 . . . . 0.0 108.89 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.638 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.2 tt0 -39.2 -27.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.706 -0.621 . . . . 0.0 110.085 -178.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.516 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 96.3 mt-10 -52.6 -17.91 1.5 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.068 -1.02 . . . . 0.0 108.74 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.705 ' CD2' ' CG ' ' A' ' 10' ' ' PHE . 33.5 mt -89.47 8.46 30.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.553 -0.717 . . . . 0.0 109.683 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.749 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.65 -50.42 5.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 110.463 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.749 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.58 -41.04 81.03 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.457 1.24 . . . . 0.0 110.027 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.533 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 34.7 mt -59.81 -41.41 91.21 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.095 -1.003 . . . . 0.0 110.153 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 t -69.13 -31.08 69.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.084 -1.01 . . . . 0.0 110.294 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -80.03 4.62 16.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.565 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.525 ' OE1' ' CD1' ' A' ' 69' ' ' ILE . 8.1 pt-20 -124.0 138.18 30.19 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.074 -1.016 . . . . 0.0 110.128 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.98 -16.51 45.85 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.767 1.403 . . . . 0.0 110.647 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 20.5 m120 -80.05 -8.24 59.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 110.023 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -51.02 -34.45 29.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.818 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -62.79 -38.62 91.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.683 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.29 -43.69 20.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.525 ' CD1' ' OE1' ' A' ' 63' ' ' GLU . 66.8 mt -62.69 -39.94 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.866 . . . . 0.0 109.557 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.623 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 1.5 tm? -46.93 -65.94 0.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.606 -0.684 . . . . 0.0 110.627 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.623 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 92.7 mt-30 -46.56 -53.48 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 110.385 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 18.2 tpp180 -55.49 -54.46 43.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.12 -0.988 . . . . 0.0 109.946 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.567 ' HG ' ' CG1' ' A' ' 15' ' ' VAL . 10.0 tp -50.08 -53.64 25.76 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.295 -0.878 . . . . 0.0 109.96 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 88.0 mt-10 -50.71 -45.24 58.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.557 ' HA ' ' CG ' ' A' ' 37' ' ' PRO . 96.7 mt-10 -54.1 -53.33 54.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.09 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.555 HG23 ' CG2' ' A' ' 3' ' ' VAL . 6.0 mt -61.12 -38.15 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.924 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HA ' ' HB2' ' A' ' 12' ' ' LEU . . . -59.79 -37.17 78.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 110.049 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 47.3 mt-10 -103.66 12.9 34.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.662 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 1.6 t70 -160.26 106.86 1.38 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.487 -0.758 . . . . 0.0 109.696 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.527 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 3.4 Cg_exo -57.17 -65.63 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.803 1.423 . . . . 0.0 110.592 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.56 -136.74 17.09 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.595 ' O ' HG12 ' A' ' 85' ' ' ILE . 80.8 p -78.62 -22.93 46.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.311 -1.111 . . . . 0.0 110.01 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 5.0 t -45.72 -58.04 3.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 0.0 110.522 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.527 ' HG3' ' HB3' ' A' ' 80' ' ' PRO . 56.2 mt-10 -56.96 -37.58 71.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.301 -0.875 . . . . 0.0 111.526 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 82' ' ' THR . 8.0 pt -89.28 12.97 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.853 -1.154 . . . . 0.0 110.503 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 59.9 m 51.45 19.75 0.88 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 110.782 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.561 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -74.3 -2.89 27.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.046 -1.034 . . . . 0.0 109.919 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 3.4 m-85 -151.9 171.47 17.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.306 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.59 4.9 6.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.292 -0.88 . . . . 0.0 110.441 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.32 -31.1 72.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.911 . . . . 0.0 110.67 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.469 ' HB3' HG12 ' A' ' 1' ' ' VAL . 0.7 OUTLIER -114.81 125.84 54.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.05 -1.031 . . . . 0.0 110.637 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 4' ' ' GLN . 33.2 p -114.36 152.2 31.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.389 -0.819 . . . . 0.0 110.396 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.76 -21.61 45.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.295 -1.121 . . . . 0.0 110.273 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.485 ' CG2' ' SG ' ' A' ' 91' ' ' CYS . 3.1 p . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.213 0.53 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.443 HG21 ' HA ' ' A' ' 11' ' ' SER . 57.0 m -118.07 154.5 31.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.302 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.515 HG22 ' HB2' ' A' ' 12' ' ' LEU . 96.3 t -82.25 123.23 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 109.801 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.526 ' CB ' HG22 ' A' ' 92' ' ' THR . 62.6 tt0 -113.09 122.31 47.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.946 . . . . 0.0 110.7 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.431 ' OD2' ' CD2' ' A' ' 73' ' ' LEU . 88.4 m-20 -99.9 13.49 33.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.429 -0.794 . . . . 0.0 109.864 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.521 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . 174.24 -132.96 2.38 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -90.63 15.46 10.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -1.153 . . . . 0.0 109.955 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.604 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . 87.0 m-85 -129.5 128.66 43.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.471 -0.768 . . . . 0.0 110.092 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.3 p -79.95 123.42 27.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 109.998 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' A' ' 8' ' ' PHE . 85.7 m-85 -116.71 125.35 51.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 110.61 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.443 ' HA ' HG21 ' A' ' 2' ' ' THR . 80.8 p -66.16 165.08 14.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 109.787 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' HB2' HG22 ' A' ' 3' ' ' VAL . 15.1 tp -110.93 -8.91 14.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 110.853 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.464 ' HG3' ' HD3' ' A' ' 33' ' ' ARG . 86.2 tt0 -60.17 -69.73 0.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.056 -1.027 . . . . 0.0 110.606 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.9 m -44.67 -39.55 5.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 0.0 110.547 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.6 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 25.2 t -64.99 -49.22 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.035 -1.04 . . . . 0.0 109.535 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.548 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 78.5 mttt -55.22 -50.74 68.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.08 -1.012 . . . . 0.0 108.808 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -80.14 4.54 17.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.529 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.649 HD11 ' HD3' ' A' ' 54' ' ' PRO . 18.7 tp -56.97 -25.79 58.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.0 110.193 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.431 ' HD2' ' HG3' ' A' ' 37' ' ' PRO . 17.5 tttm -61.33 -35.81 78.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.841 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -86.5 109.96 19.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.882 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.651 ' CD2' ' ND2' ' A' ' 50' ' ' ASN . 1.2 mm? -105.74 164.87 11.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.473 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.458 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 56.7 tt0 60.86 56.79 2.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 0.0 110.203 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.481 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -136.06 167.18 23.07 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.334 -0.853 . . . . 0.0 110.276 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.481 ' HD2' ' CG ' ' A' ' 23' ' ' GLU . 3.0 Cg_exo -61.91 145.39 96.94 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.911 1.48 . . . . 0.0 110.552 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.44 ' HG2' ' HD3' ' A' ' 27' ' ' PRO . 51.6 tt0 -55.95 147.56 19.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.893 . . . . 0.0 110.073 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -126.67 71.74 73.66 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.307 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HD3' ' HG2' ' A' ' 25' ' ' GLN . 2.9 Cg_endo -61.81 -35.76 77.08 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.86 1.453 . . . . 0.0 110.275 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 mtp85 -146.11 120.59 9.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.447 -0.783 . . . . 0.0 109.705 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.466 HG13 ' HB3' ' A' ' 31' ' ' LYS . 42.5 t -128.69 133.79 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 110.591 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.98 -3.08 77.01 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.466 ' HB3' HG13 ' A' ' 29' ' ' VAL . 84.1 tttt -70.81 153.0 43.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -1.104 . . . . 0.0 110.146 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.6 mt -68.0 146.23 53.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -0.967 . . . . 0.0 110.202 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.548 ' HB3' ' HD2' ' A' ' 16' ' ' LYS . 74.1 mtt85 -106.85 111.57 24.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.283 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 4.0 p30 168.91 -157.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.233 -0.917 . . . . 0.0 110.159 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.55 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 82.2 m-85 62.09 24.16 14.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.274 -0.891 . . . . 0.0 110.393 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.15 146.07 94.38 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.927 . . . . 0.0 110.058 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HG3' ' HD2' ' A' ' 19' ' ' LYS . 3.0 Cg_exo -62.82 -150.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.797 1.419 . . . . 0.0 110.811 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.581 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 20.3 mm -110.0 144.41 29.96 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.905 . . . . 0.0 110.126 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.581 ' HD2' ' CG2' ' A' ' 38' ' ' ILE . 3.0 Cg_exo -59.98 138.85 84.75 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.673 1.354 . . . . 0.0 110.603 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.45 4.58 2.01 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER 60.72 72.18 0.75 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.084 -1.245 . . . . 0.0 109.988 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.591 ' CD ' HD13 ' A' ' 70' ' ' LEU . 3.0 Cg_endo -61.58 -165.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.952 1.501 . . . . 0.0 110.988 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.561 HG11 ' CB ' ' A' ' 49' ' ' SER . 0.2 OUTLIER -96.05 129.28 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.748 . . . . 0.0 110.175 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.599 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 3.1 p -158.19 52.29 0.53 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.333 -0.854 . . . . 0.0 110.198 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 44' ' ' VAL . 3.0 Cg_endo -57.6 -62.95 0.17 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.649 1.342 . . . . 0.0 110.717 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.427 ' HB ' HD13 ' A' ' 47' ' ' LEU . 59.2 mt -149.21 -33.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.0 110.559 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.567 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 6.0 mp -95.2 3.57 54.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.64 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.532 ' O ' ' O ' ' A' ' 47' ' ' LEU . 1.5 m 57.41 124.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.132 -0.98 . . . . 0.0 109.844 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.731 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 87.3 p -64.02 -41.12 97.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 110.926 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.651 ' ND2' ' CD2' ' A' ' 21' ' ' LEU . 5.8 m-20 -80.68 106.9 6.06 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.897 . . . . 0.0 110.619 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.731 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -61.11 -16.26 44.79 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.682 1.359 . . . . 0.0 110.33 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -128.03 36.54 4.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.232 -0.917 . . . . 0.0 111.145 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.64 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.1 172.23 10.37 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.776 -1.203 . . . . 0.0 108.484 178.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.649 ' HD3' HD11 ' A' ' 18' ' ' LEU . 4.1 Cg_exo -54.45 76.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.505 1.266 . . . . 0.0 109.39 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.6 tt0 -39.65 -27.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.744 -0.598 . . . . 0.0 110.084 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.7 mt-10 -52.7 -17.89 1.54 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.068 -1.02 . . . . 0.0 108.449 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.593 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 89.2 mt -90.24 11.2 21.88 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.609 0.719 . . . . 0.0 109.136 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.722 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -39.95 -51.99 5.43 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.416 -0.803 . . . . 0.0 110.262 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.722 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -54.0 -46.07 36.36 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.461 1.242 . . . . 0.0 109.373 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.588 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 11.7 tp -49.58 -49.46 46.48 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.264 -0.898 . . . . 0.0 109.749 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.498 ' SG ' HG21 ' A' ' 44' ' ' VAL . 1.2 t -61.33 -27.94 68.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 110.609 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 22.7 ttpt -81.01 -2.05 46.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 110.56 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 59' ' ' PRO . 11.2 pt-20 -126.43 144.85 50.85 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.064 -1.023 . . . . 0.0 110.074 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.27 -8.65 12.91 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.785 1.413 . . . . 0.0 110.801 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -79.58 -18.0 52.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 110.668 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' A' ' 60' ' ' LEU . . . -45.08 -40.03 6.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.079 -1.013 . . . . 0.0 109.941 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.44 ' O ' ' CD ' ' A' ' 41' ' ' GLU . 93.7 mt-30 -66.01 -39.12 90.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -0.869 . . . . 0.0 109.979 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -80.5 -44.95 18.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.173 -0.954 . . . . 0.0 109.672 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.583 ' CG2' HD12 ' A' ' 60' ' ' LEU . 57.9 mt -63.73 -42.19 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.814 . . . . 0.0 109.899 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.591 HD13 ' CD ' ' A' ' 42' ' ' PRO . 2.2 tm? -52.34 -52.69 51.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.459 -0.776 . . . . 0.0 109.902 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.5 ' HG3' ' HB2' ' A' ' 39' ' ' PRO . 46.0 tt0 -42.74 -53.53 4.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.095 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -59.11 -53.1 62.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 110.65 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.431 ' CD2' ' OD2' ' A' ' 5' ' ' ASP . 63.6 mt -50.58 -55.7 15.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.085 -1.009 . . . . 0.0 110.145 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.549 ' HG3' HD12 ' A' ' 70' ' ' LEU . 26.9 mt-10 -54.61 -50.74 67.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 110.442 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.26 -54.06 45.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.433 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.487 ' C ' HD22 ' A' ' 12' ' ' LEU . 70.2 mt -61.65 -34.34 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.998 . . . . 0.0 109.735 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.471 ' O ' ' HE2' ' A' ' 16' ' ' LYS . . . -57.07 -34.73 68.57 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.323 -0.861 . . . . 0.0 109.599 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.31 -40.94 92.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 110.115 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -153.71 160.4 30.98 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.901 . . . . 0.0 110.259 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.537 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -60.39 -59.72 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.916 1.482 . . . . 0.0 110.544 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.11 -140.04 25.06 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.55 ' O ' HG12 ' A' ' 85' ' ' ILE . 73.1 p -82.14 -21.94 36.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.272 -1.134 . . . . 0.0 110.163 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 4.6 t -55.8 -49.21 73.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.716 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 82.7 tt0 -59.54 -32.13 70.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.822 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 82' ' ' THR . 5.5 pt -99.3 10.51 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.99 -1.069 . . . . 0.0 110.328 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.7 m 56.96 16.5 2.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.88 . . . . 0.0 110.641 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.543 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -60.53 -18.8 54.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.965 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -140.37 177.82 7.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 110.182 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.81 1.53 12.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.871 . . . . 0.0 110.335 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.45 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . . . -58.56 -40.86 84.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.658 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.553 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER -112.79 122.67 48.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.928 . . . . 0.0 110.81 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.526 HG22 ' CB ' ' A' ' 4' ' ' GLN . 25.6 p -105.18 176.25 5.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 110.262 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.42 -6.81 65.85 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.391 -1.064 . . . . 0.0 110.209 -179.921 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.53 ' CG2' ' SG ' ' A' ' 91' ' ' CYS . 10.6 p . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.211 0.529 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.51 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 30.7 m -90.09 148.03 23.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 110.802 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.599 ' CG2' ' CD2' ' A' ' 12' ' ' LEU . 22.9 t -97.06 118.53 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.581 -0.699 . . . . 0.0 109.435 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.524 ' CB ' ' HA ' ' A' ' 9' ' ' SER . 20.9 pt20 -120.56 177.47 5.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.081 -1.012 . . . . 0.0 110.936 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -151.45 -62.19 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.741 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.82 -115.81 0.74 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -108.21 13.2 26.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.227 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.521 ' CD1' ' OE2' ' A' ' 56' ' ' GLU . 97.9 m-85 -131.77 159.36 38.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.524 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 37.6 m -101.07 136.31 41.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.937 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.689 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 6.6 m-30 -112.69 123.23 49.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.654 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 m -66.33 160.11 25.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.599 ' CD2' ' CG2' ' A' ' 3' ' ' VAL . 99.5 mt -86.97 -27.33 23.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 110.735 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.422 ' OE2' ' O ' ' A' ' 25' ' ' GLN . 81.8 tt0 -61.56 -66.3 0.56 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 0.0 110.671 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.479 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.6 m -44.27 -48.71 9.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.977 -1.077 . . . . 0.0 110.151 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 58.5 t -59.05 -46.72 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.218 -0.926 . . . . 0.0 110.109 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 25.1 tttm -58.9 -52.43 65.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.806 -1.184 . . . . 0.0 108.562 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -80.65 11.98 3.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.35 -0.844 . . . . 0.0 109.368 178.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.548 ' CD1' ' HB2' ' A' ' 53' ' ' PHE . 59.1 tp -57.17 -37.08 71.59 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.416 -0.803 . . . . 0.0 110.097 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -60.75 -38.88 86.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 109.38 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -141.55 124.73 16.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.594 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' CD1' ' CB ' ' A' ' 52' ' ' ASN . 4.5 mm? -49.83 -48.26 51.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.616 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 23' ' ' GLU . 91.7 mt-30 46.4 56.39 6.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.154 -0.966 . . . . 0.0 109.915 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 22' ' ' GLN . 5.6 mp0 42.18 76.3 0.53 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 110.015 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.541 ' HG3' ' CD1' ' A' ' 21' ' ' LEU . 3.1 Cg_exo -61.58 135.92 59.8 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.938 1.494 . . . . 0.0 110.715 -179.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.461 ' HG2' ' HD3' ' A' ' 27' ' ' PRO . 60.9 tt0 -148.68 168.64 22.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.059 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.503 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 5.9 mt-10 -131.39 62.14 63.17 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.205 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -61.7 153.66 65.8 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.851 1.448 . . . . 0.0 110.419 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.467 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 11.9 ptp180 -99.23 137.87 37.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 0.0 110.075 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 28' ' ' ARG . 48.8 t 56.14 109.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.321 -0.862 . . . . 0.0 110.151 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.57 -168.43 32.35 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -64.85 149.9 48.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -1.103 . . . . 0.0 110.19 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.2 mt -68.57 155.95 38.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.95 . . . . 0.0 110.213 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.456 ' NH2' ' CG ' ' A' ' 33' ' ' ARG . 13.4 mmt-85 -99.32 128.73 45.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.11 -0.994 . . . . 0.0 110.403 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.486 ' O ' ' CE ' ' A' ' 16' ' ' LYS . 44.9 p-10 -136.72 151.24 49.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.968 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.562 ' HB3' ' HG2' ' A' ' 78' ' ' GLU . 74.6 t80 -138.94 158.17 44.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.302 -0.874 . . . . 0.0 110.159 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.484 ' O ' HG12 ' A' ' 38' ' ' ILE . . . -59.7 129.65 87.64 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.236 -0.915 . . . . 0.0 110.537 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.539 ' C ' ' CD1' ' A' ' 38' ' ' ILE . 2.8 Cg_endo -64.39 63.64 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.798 1.42 . . . . 0.0 110.569 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.539 ' CD1' ' C ' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -126.65 65.3 60.57 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.133 -0.979 . . . . 0.0 110.309 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.471 ' HD3' ' C ' ' A' ' 37' ' ' PRO . 2.9 Cg_endo -61.64 148.52 92.84 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.798 1.42 . . . . 0.0 110.494 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.529 ' N ' ' HG2' ' A' ' 71' ' ' GLN . . . 117.2 40.16 0.76 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' O ' HD13 ' A' ' 70' ' ' LEU . 6.8 mt-10 -130.14 73.14 81.61 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.308 -1.113 . . . . 0.0 110.374 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.458 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -60.68 141.77 95.96 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.908 1.478 . . . . 0.0 110.146 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.517 ' CG2' HD22 ' A' ' 18' ' ' LEU . 24.0 m -140.51 54.83 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.667 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.67 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 17.1 m -135.2 47.86 2.53 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.583 179.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.67 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -60.19 -149.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.592 1.311 . . . . 0.0 110.372 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.546 ' O ' ' CG2' ' A' ' 46' ' ' ILE . 16.9 tt -59.35 117.21 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.149 -0.97 . . . . 0.0 109.993 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 48' ' ' CYS . 2.5 mm? 62.18 40.67 11.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 1.2 m 62.49 154.4 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 0.0 110.638 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.618 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -87.78 -58.34 2.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.415 -0.803 . . . . 0.0 110.228 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.492 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 6.4 m120 -78.93 110.27 13.9 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.419 -0.801 . . . . 0.0 110.326 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.618 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -61.99 -11.39 21.28 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.721 1.379 . . . . 0.0 110.336 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.562 ' CB ' ' CD1' ' A' ' 21' ' ' LEU . 99.6 m-20 -130.52 34.23 4.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.842 . . . . 0.0 110.734 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.68 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.17 174.23 6.46 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.038 -1.039 . . . . 0.0 108.719 178.953 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.68 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.0 Cg_exo -56.36 76.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.624 1.329 . . . . 0.0 108.889 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.647 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.7 tt0 -39.07 -26.31 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.884 -0.51 . . . . 0.0 110.377 -178.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.521 ' OE2' ' CD1' ' A' ' 8' ' ' PHE . 39.3 tp10 -53.13 -20.76 4.09 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.931 -1.105 . . . . 0.0 108.174 178.145 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.689 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 82.2 mt -84.35 8.45 16.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.623 -0.673 . . . . 0.0 109.657 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.702 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.57 -51.49 4.98 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.73 -179.568 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.702 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -56.71 -44.31 46.47 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.632 1.333 . . . . 0.0 110.744 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.589 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 1.5 mt -60.63 -40.04 90.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.814 -1.179 . . . . 0.0 110.503 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.478 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 46.2 t -65.56 -28.14 68.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.034 -1.041 . . . . 0.0 110.697 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 46.2 tttm -90.75 6.69 43.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.639 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.488 ' OE2' ' HB2' ' A' ' 65' ' ' ASN . 12.7 pt-20 -130.84 144.61 54.21 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.959 -1.088 . . . . 0.0 110.4 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.22 -8.31 12.06 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.91 1.479 . . . . 0.0 110.797 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.488 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 83.9 m-20 -79.23 -23.79 43.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 110.194 -179.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -51.33 -36.3 42.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.083 -1.01 . . . . 0.0 109.685 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.458 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.8 mt-30 -61.65 -43.55 98.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.0 109.758 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -80.27 -41.17 25.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 109.609 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.489 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 86.0 mt -64.24 -46.26 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 109.87 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.504 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 2.2 tm? -49.38 -53.86 20.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.946 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.529 ' HG2' ' N ' ' A' ' 40' ' ' GLY . 87.9 mt-30 -45.41 -53.9 8.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -57.79 -54.62 44.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 48.4 mt -44.98 -56.1 4.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.338 -0.851 . . . . 0.0 109.705 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 64.6 mt-10 -51.12 -53.6 32.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 110.154 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 78' ' ' GLU . 82.8 tt0 -55.23 -54.49 42.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 110.693 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.515 ' CG2' HG23 ' A' ' 3' ' ' VAL . 24.7 mm -58.75 -37.52 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 109.81 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -57.21 -33.06 67.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.591 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.562 ' HG2' ' HB3' ' A' ' 35' ' ' PHE . 99.2 mt-10 -60.12 -41.92 93.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 110.52 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -147.83 159.54 40.37 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.93 . . . . 0.0 110.275 -179.797 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.527 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -59.77 -57.21 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.883 1.465 . . . . 0.0 110.65 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.02 -140.89 26.38 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.617 ' O ' HG12 ' A' ' 85' ' ' ILE . 79.6 p -78.08 -21.51 50.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -1.116 . . . . 0.0 109.932 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.454 ' C ' ' SG ' ' A' ' 91' ' ' CYS . 42.0 t -54.52 -54.15 44.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 109.976 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.0 tt0 -55.77 -32.17 63.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 111.028 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 82' ' ' THR . 7.8 pt -96.92 10.89 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.922 -1.111 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 57.21 18.83 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.521 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -70.89 -7.59 46.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.997 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -147.06 167.64 23.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.37 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.01 4.94 5.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.386 -0.821 . . . . 0.0 110.5 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -65.36 -35.42 80.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.161 -0.962 . . . . 0.0 110.482 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.53 ' SG ' ' CG2' ' A' ' 1' ' ' VAL . 0.1 OUTLIER -96.53 120.48 36.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.705 -179.712 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.462 ' CG2' ' NE2' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -104.77 -5.39 21.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 110.577 -179.438 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . -83.76 -36.05 14.68 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.21 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.402 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 18.5 m . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.243 0.544 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.454 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 37.0 m -88.17 151.16 22.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.387 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.531 HG22 ' CG ' ' A' ' 12' ' ' LEU . 85.2 t -94.23 121.94 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.717 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.526 ' HG2' ' HA ' ' A' ' 9' ' ' SER . 10.4 mt-30 -109.64 139.06 45.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 110.815 -179.391 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -111.59 11.53 21.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 109.784 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.23 -131.38 1.87 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -88.5 8.44 28.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.141 -1.211 . . . . 0.0 110.191 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 92.0 m-85 -121.7 158.83 27.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.193 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.526 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 22.4 t -105.43 123.41 47.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.363 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 17.6 m-30 -119.19 130.46 55.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.843 . . . . 0.0 110.51 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.4 m -78.62 172.73 13.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.021 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.531 ' CG ' HG22 ' A' ' 3' ' ' VAL . 53.0 mt -97.35 -5.29 36.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.0 110.636 -179.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.3 mt-10 -74.29 -73.17 0.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.361 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' ' 13' ' ' GLU . 5.2 m -39.91 -51.43 2.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.677 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.672 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 27.4 m -63.93 -45.67 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.069 -1.019 . . . . 0.0 109.697 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 16.6 tttt -55.12 -56.89 14.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.88 -1.138 . . . . 0.0 109.063 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.434 ' HD3' ' HG2' ' A' ' 27' ' ' PRO . 67.5 mttm -80.22 8.31 7.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.818 . . . . 0.0 109.467 178.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.672 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 15.4 tp -54.57 -34.84 62.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.403 -0.811 . . . . 0.0 110.331 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -60.48 -41.55 94.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.993 . . . . 0.0 109.895 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.39 98.02 10.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.988 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 11.0 tp -70.01 -36.32 75.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.341 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 91.4 mt-30 -54.99 -168.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 110.211 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.531 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 26.2 mm-40 59.43 163.56 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.343 -0.848 . . . . 0.0 109.946 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 23' ' ' GLU . 3.3 Cg_exo -58.54 157.5 26.94 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.715 1.376 . . . . 0.0 110.62 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -68.02 -30.95 70.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.463 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.411 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 1.1 mp0 -131.12 68.17 81.46 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.336 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 24' ' ' PRO . 2.9 Cg_endo -63.18 158.82 42.16 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.913 1.48 . . . . 0.0 110.523 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.481 ' HB3' ' NH1' ' A' ' 28' ' ' ARG . 9.7 mmm180 -51.39 137.87 22.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 110.057 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.89 147.26 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.288 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.1 -175.07 48.08 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -64.3 -29.2 70.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -1.163 . . . . 0.0 110.278 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.3 mt -105.22 140.67 38.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.928 . . . . 0.0 110.461 -179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.501 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 24.3 ptt-85 -130.56 106.05 8.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.355 -0.84 . . . . 0.0 109.594 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 41.9 p-10 -136.56 167.82 20.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.07 -1.019 . . . . 0.0 110.856 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.602 ' CE2' ' HG2' ' A' ' 37' ' ' PRO . 1.9 t80 -112.51 130.46 56.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.515 -0.741 . . . . 0.0 109.891 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.65 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . . . -64.77 -54.84 32.7 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 110.575 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.65 ' HD3' ' CB ' ' A' ' 36' ' ' ALA . 3.1 Cg_exo -62.46 -150.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.599 1.315 . . . . 0.0 110.769 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.583 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 1.3 mp -149.16 151.04 33.35 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.408 -0.807 . . . . 0.0 109.83 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.583 ' HD2' ' CG2' ' A' ' 38' ' ' ILE . 3.3 Cg_exo -57.48 161.65 11.53 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.737 1.388 . . . . 0.0 110.774 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.34 19.32 1.73 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -104.3 117.47 59.22 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 110.06 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.23 101.02 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.658 1.346 . . . . 0.0 110.53 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.589 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 90.7 t -132.12 172.33 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.742 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 0.4 OUTLIER 76.11 38.86 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 0.0 111.441 179.785 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.742 ' CD ' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -59.73 169.5 4.36 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 122.908 0.951 . . . . 0.0 110.191 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' PRO . 76.0 mt -44.06 -41.01 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.099 -1.001 . . . . 0.0 109.59 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 48' ' ' CYS . 49.6 mt -95.93 26.87 3.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 109.607 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.517 ' O ' ' O ' ' A' ' 47' ' ' LEU . 0.5 OUTLIER 53.64 162.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.503 -0.748 . . . . 0.0 110.113 -179.851 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.586 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 13.2 t -107.69 -70.7 0.79 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.944 . . . . 0.0 110.144 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.477 ' HB3' ' CD1' ' A' ' 21' ' ' LEU . 5.6 m-20 -79.2 111.51 20.89 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.591 -0.693 . . . . 0.0 110.092 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -64.45 -9.14 19.14 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.612 1.322 . . . . 0.0 110.114 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.507 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 96.8 m-20 -125.68 31.89 5.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.797 . . . . 0.0 110.218 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.736 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -79.85 178.02 2.59 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 108.803 179.09 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.736 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -57.86 75.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.493 1.26 . . . . 0.0 108.936 179.352 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.627 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.8 tt0 -39.28 -27.54 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.86 -0.525 . . . . 0.0 110.139 -178.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.0 mt-10 -52.21 -18.37 1.49 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.048 -1.032 . . . . 0.0 108.401 178.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.597 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 81.7 mt -88.8 9.95 22.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.637 -0.665 . . . . 0.0 109.571 179.092 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.733 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -39.63 -51.28 5.14 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 110.344 -179.854 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.733 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -54.87 -43.52 58.55 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.5 1.263 . . . . 0.0 109.666 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.584 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -53.42 -42.07 66.68 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.109 -0.994 . . . . 0.0 109.674 179.403 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.5 ' SG ' HG21 ' A' ' 44' ' ' VAL . 22.0 m -64.85 -28.05 69.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.131 -0.981 . . . . 0.0 110.335 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -90.66 2.55 55.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 111.434 -178.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.557 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 25.7 pt-20 -120.83 142.9 35.41 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.625 -1.297 . . . . 0.0 110.317 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -64.0 -18.29 63.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.91 1.479 . . . . 0.0 111.239 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -79.69 -12.3 59.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.985 -1.072 . . . . 0.0 110.344 -179.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.586 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . . . -47.42 -41.16 19.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 110.461 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -56.68 -42.23 78.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 -179.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.4 mt-10 -79.92 -34.35 39.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.173 -0.955 . . . . 0.0 110.322 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.557 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 90.3 mt -68.96 -46.96 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.138 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.554 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 0.9 OUTLIER -47.69 -62.5 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.525 -179.787 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.522 ' N ' HD12 ' A' ' 70' ' ' LEU . 51.4 tt0 -49.62 -54.08 20.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.13 -0.981 . . . . 0.0 110.736 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 75.5 mtt-85 -52.7 -53.59 45.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.229 -0.919 . . . . 0.0 110.518 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.595 ' CD2' HG13 ' A' ' 15' ' ' VAL . 7.2 tp -51.09 -48.83 61.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.072 -1.017 . . . . 0.0 110.015 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 43.1 mt-10 -55.63 -41.13 73.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.376 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.549 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -66.24 -55.94 13.69 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.057 -1.027 . . . . 0.0 110.464 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.471 HG23 HG23 ' A' ' 3' ' ' VAL . 22.2 mm -58.77 -40.77 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.336 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -62.76 -28.48 70.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.534 -0.729 . . . . 0.0 109.08 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 80.6 tt0 -65.36 -36.42 83.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.619 -0.676 . . . . 0.0 110.443 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.2 m-20 -149.14 158.04 39.1 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.824 -1.173 . . . . 0.0 110.524 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.517 ' CB ' ' OE1' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -61.72 -71.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.057 1.556 . . . . 0.0 110.653 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.89 -140.05 23.58 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.56 ' O ' HG12 ' A' ' 85' ' ' ILE . 70.5 p -79.08 -24.32 43.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -1.168 . . . . 0.0 109.732 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 11.3 t -53.18 -53.55 48.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.517 ' OE1' ' CB ' ' A' ' 80' ' ' PRO . 83.2 tt0 -58.47 -32.19 68.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 111.057 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 82' ' ' THR . 5.1 pt -98.46 11.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.957 -1.09 . . . . 0.0 110.291 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 34.4 m 59.39 12.12 2.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.177 -0.952 . . . . 0.0 110.514 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.526 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -64.89 -16.18 62.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 109.997 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -137.17 166.57 23.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 110.188 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.85 2.88 7.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 110.289 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.35 -38.8 90.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 0.0 110.433 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.7 OUTLIER -104.11 118.25 36.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 110.636 -179.663 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.511 HG23 ' NE2' ' A' ' 4' ' ' GLN . 72.8 p -103.13 166.55 10.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.376 -0.827 . . . . 0.0 110.069 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.16 -5.08 78.27 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.303 -1.116 . . . . 0.0 110.213 179.988 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.422 HG11 ' SG ' ' A' ' 91' ' ' CYS . 54.6 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.284 0.564 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.559 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 7.2 t -129.21 168.49 16.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.375 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -93.01 114.83 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.647 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.522 ' OE1' ' CG2' ' A' ' 92' ' ' THR . 61.2 tt0 -110.7 121.02 44.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.952 -179.216 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.49 ' OD2' HD22 ' A' ' 60' ' ' LEU . 58.4 p30 -99.92 3.64 44.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.362 -0.836 . . . . 0.0 109.325 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . -172.53 -142.56 3.82 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -82.1 1.42 36.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.2 -1.176 . . . . 0.0 110.498 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.467 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 98.6 m-85 -109.19 134.43 51.75 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.621 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.559 ' OG ' ' CG2' ' A' ' 2' ' ' THR . 1.0 OUTLIER -85.47 126.55 33.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.355 -0.841 . . . . 0.0 109.981 179.779 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.627 ' CD1' HD13 ' A' ' 57' ' ' LEU . 21.7 m-30 -117.7 127.21 53.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.023 -1.048 . . . . 0.0 110.777 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 15' ' ' VAL . 59.9 p -76.7 172.89 12.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.314 -0.866 . . . . 0.0 110.339 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.611 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 5.0 mp -100.64 -6.34 25.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.309 -0.869 . . . . 0.0 110.61 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.464 ' OE1' ' CG ' ' A' ' 26' ' ' GLU . 92.2 mt-10 -71.72 -73.89 0.17 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 0.0 110.82 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.3 m -43.5 -49.19 7.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.182 -0.949 . . . . 0.0 110.581 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.599 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 6.0 m -59.02 -46.41 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.541 ' CD ' ' HB3' ' A' ' 33' ' ' ARG . 23.0 tttt -58.15 -55.02 40.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.876 -1.14 . . . . 0.0 108.844 179.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.504 ' O ' ' O ' ' A' ' 20' ' ' ASP . 95.6 mttt -80.49 11.48 3.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 178.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.599 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.7 tt -58.73 -29.72 66.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 110.183 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -65.48 -34.91 79.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.182 -0.949 . . . . 0.0 110.144 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' A' ' 17' ' ' LYS . 60.6 t0 -133.82 141.71 47.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 110.147 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.539 HD13 ' CB ' ' A' ' 52' ' ' ASN . 1.9 mm? -85.98 138.73 31.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.041 -1.037 . . . . 0.0 110.569 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.441 ' OE1' ' HD3' ' A' ' 17' ' ' LYS . 88.4 mt-30 -132.67 172.29 12.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.023 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 25' ' ' GLN . 3.3 mt-10 -42.64 136.58 2.52 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.187 -0.946 . . . . 0.0 110.02 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.74 60.24 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.799 1.42 . . . . 0.0 110.602 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 23' ' ' GLU . 91.5 mt-30 -126.94 139.16 53.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.992 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' CG ' ' OE1' ' A' ' 13' ' ' GLU . 1.8 mp0 -130.7 71.71 82.22 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.418 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.82 145.72 96.98 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.904 1.476 . . . . 0.0 110.396 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -111.47 128.14 55.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.137 -0.977 . . . . 0.0 110.259 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.417 HG12 ' HB3' ' A' ' 31' ' ' LYS . 11.8 p -138.0 144.19 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.323 -0.861 . . . . 0.0 110.166 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.37 -29.5 30.69 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 19.7 tttt -69.72 -21.81 63.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -1.171 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 70.3 mt 56.52 -155.17 0.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.323 -0.861 . . . . 0.0 110.291 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.541 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 32.4 mtt-85 -119.74 131.05 55.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 50.3 t30 -142.39 110.32 5.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 110.197 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.492 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 72.3 t80 -125.12 164.13 20.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -0.927 . . . . 0.0 110.251 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.625 ' O ' HG13 ' A' ' 38' ' ' ILE . . . -59.68 122.13 62.66 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.074 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' C ' ' HD3' ' A' ' 39' ' ' PRO . 2.6 Cg_endo -68.32 88.15 0.4 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.769 1.405 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -121.49 69.49 22.87 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.3 -0.875 . . . . 0.0 110.349 179.396 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.49 ' HD3' ' C ' ' A' ' 37' ' ' PRO . 3.0 Cg_exo -60.27 145.72 97.97 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.764 1.402 . . . . 0.0 110.552 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.444 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 162.54 37.45 0.02 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 43' ' ' VAL . 1.2 mm-40 -123.86 72.21 52.7 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.236 -1.155 . . . . 0.0 110.211 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.52 75.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.888 1.467 . . . . 0.0 110.379 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.627 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 88.8 t -120.67 127.39 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.962 . . . . 0.0 110.29 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.633 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.9 OUTLIER 167.06 -52.47 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.409 -0.807 . . . . 0.0 110.158 179.841 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 44' ' ' VAL . 3.2 Cg_exo -60.7 -42.4 39.4 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.512 1.27 . . . . 0.0 110.36 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' A' ' 47' ' ' LEU . 73.8 mt -58.99 -65.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 109.706 179.583 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.538 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.9 OUTLIER 164.34 70.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.418 -0.801 . . . . 0.0 110.004 179.684 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.512 ' O ' ' O ' ' A' ' 47' ' ' LEU . 86.2 m 34.87 95.57 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.477 -0.765 . . . . 0.0 110.505 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.546 ' OG ' ' CG1' ' A' ' 43' ' ' VAL . 44.1 m -51.74 -62.8 1.4 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.263 -0.898 . . . . 0.0 111.083 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 3.9 m-20 -80.32 114.18 45.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.564 -179.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.8 0.84 1.73 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.806 1.424 . . . . 0.0 110.596 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.539 ' CB ' HD13 ' A' ' 21' ' ' LEU . 27.0 m120 -133.67 31.78 3.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.095 -1.003 . . . . 0.0 110.692 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.843 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 10.5 p90 -76.8 -177.23 0.73 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.039 -1.038 . . . . 0.0 108.772 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.843 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 5.0 Cg_exo -54.93 75.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.518 1.273 . . . . 0.0 110.108 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.628 ' N ' ' O ' ' A' ' 53' ' ' PHE . 84.7 tt0 -44.95 -33.87 2.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.571 -0.705 . . . . 0.0 110.032 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.516 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.3 mt-10 -54.39 -18.79 4.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.015 -1.053 . . . . 0.0 108.52 178.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.627 HD13 ' CD1' ' A' ' 10' ' ' PHE . 7.8 mp -97.5 9.2 43.04 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.931 0.872 . . . . 0.0 109.009 178.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.774 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -43.74 -49.35 19.97 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.685 -0.634 . . . . 0.0 109.934 179.556 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.774 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.86 -42.74 64.01 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.436 1.229 . . . . 0.0 109.73 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.58 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 10.7 mp -55.74 -40.74 72.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.051 -1.031 . . . . 0.0 109.129 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.5 ' HA ' HG23 ' A' ' 44' ' ' VAL . 41.4 t -64.3 -26.0 68.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 110.166 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.514 ' CE ' ' HD2' ' A' ' 58' ' ' LYS . 29.6 mttt -88.09 -4.96 58.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.88 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.518 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 9.1 pt-20 -113.1 147.69 37.84 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.012 -1.055 . . . . 0.0 110.337 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.9 -17.81 61.33 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.953 1.501 . . . . 0.0 111.034 -179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.469 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 74.5 m-20 -79.71 -13.73 59.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.085 -1.009 . . . . 0.0 110.59 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -46.93 -40.24 13.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 110.097 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -57.36 -40.79 78.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 110.061 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 98.0 mt-10 -80.3 -34.9 36.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.915 179.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.54 ' CG2' HD22 ' A' ' 60' ' ' LEU . 78.0 mt -72.64 -54.39 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 109.864 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -44.64 -60.15 2.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.87 . . . . 0.0 110.155 179.864 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.555 ' N ' HD12 ' A' ' 70' ' ' LEU . 94.2 mt-30 -51.65 -52.88 44.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.088 -1.007 . . . . 0.0 110.049 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 54.6 mtp180 -55.29 -56.45 19.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.823 . . . . 0.0 109.955 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' A' ' 3' ' ' VAL . 54.0 mt -47.45 -51.04 21.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.143 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 75.6 mm-40 -56.76 -38.39 72.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.859 . . . . 0.0 110.467 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.46 ' HG3' ' HB3' ' A' ' 37' ' ' PRO . 82.7 tt0 -70.67 -54.04 13.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.164 -0.96 . . . . 0.0 110.297 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 79' ' ' ASP . 57.8 mt -65.35 -31.03 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.576 ' CB ' HG22 ' A' ' 15' ' ' VAL . . . -67.12 -34.85 78.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.403 -0.811 . . . . 0.0 109.503 179.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.49 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 97.1 mt-10 -94.18 16.07 15.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.474 -0.766 . . . . 0.0 109.78 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 76' ' ' ILE . 9.8 t0 -169.51 127.74 0.85 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.48 -0.763 . . . . 0.0 110.152 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.409 ' CB ' ' OE1' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -61.66 -74.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.74 1.39 . . . . 0.0 110.749 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.68 -141.65 24.78 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.578 ' O ' HG12 ' A' ' 85' ' ' ILE . 58.5 p -79.32 -22.87 43.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -1.197 . . . . 0.0 109.954 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 9.3 t -53.73 -52.17 60.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' OE1' ' CB ' ' A' ' 80' ' ' PRO . 83.6 tt0 -58.78 -32.32 69.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.88 . . . . 0.0 111.102 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 82' ' ' THR . 7.3 pt -96.59 11.73 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.933 -1.104 . . . . 0.0 110.458 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 58.56 13.6 2.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.58 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.531 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -67.7 -14.62 63.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.181 -0.949 . . . . 0.0 109.912 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.475 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 5.9 m-85 -137.83 165.99 25.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 0.0 110.331 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.14 3.57 5.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.338 -0.851 . . . . 0.0 110.283 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -63.05 -39.87 96.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.925 . . . . 0.0 110.392 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER -103.61 118.73 37.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.548 -179.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.522 ' CG2' ' OE1' ' A' ' 4' ' ' GLN . 6.5 m -112.08 6.25 19.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.375 -0.828 . . . . 0.0 110.3 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.03 -56.56 5.23 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.274 -1.133 . . . . 0.0 110.311 179.955 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.451 HG11 ' SG ' ' A' ' 91' ' ' CYS . 3.2 t . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.165 0.507 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.541 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 12.8 t -126.56 155.79 41.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.547 HG22 ' CD2' ' A' ' 12' ' ' LEU . 53.0 t -95.9 122.77 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.552 -0.717 . . . . 0.0 109.163 179.005 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 8' ' ' PHE . 3.2 pt20 -129.22 -178.71 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.058 . . . . 0.0 111.548 -178.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 4' ' ' GLN . 93.1 m-20 -137.74 -60.3 0.65 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.526 0.679 . . . . 0.0 109.464 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.29 -143.76 15.19 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.581 ' OD1' ' CE2' ' A' ' 8' ' ' PHE . 16.2 p30 -81.08 8.58 8.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.028 -1.278 . . . . 0.0 110.334 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.581 ' CE2' ' OD1' ' A' ' 7' ' ' ASN . 83.6 m-85 -112.91 139.07 48.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -0.973 . . . . 0.0 110.383 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.541 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 50.9 m -101.9 139.06 38.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.334 -0.854 . . . . 0.0 110.627 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.595 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 20.4 m-85 -124.28 134.4 53.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 110.402 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.0 p -75.11 170.89 15.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.239 -0.913 . . . . 0.0 110.177 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.547 ' CD2' HG22 ' A' ' 3' ' ' VAL . 9.3 mt -104.58 -2.28 25.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.217 -0.927 . . . . 0.0 110.524 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.578 ' HG2' ' CD ' ' A' ' 33' ' ' ARG . 36.7 mt-10 -64.23 -71.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 0.0 110.548 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.622 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.5 OUTLIER -57.14 -38.79 74.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.39 -0.819 . . . . 0.0 111.344 -179.12 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.708 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 13.0 t -61.55 -49.92 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.844 -1.16 . . . . 0.0 109.46 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.508 ' CE ' ' O ' ' A' ' 77' ' ' ALA . 17.0 mttt -56.87 -55.05 39.37 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.816 -1.178 . . . . 0.0 108.864 178.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.71 10.96 4.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.018 178.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.708 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 13.1 tp -75.09 -10.37 59.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.088 -1.007 . . . . 0.0 109.893 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.494 ' HE3' ' CG1' ' A' ' 38' ' ' ILE . 71.5 tttt -63.58 -32.48 73.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 0.0 109.391 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -126.49 122.77 36.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.48 -0.762 . . . . 0.0 109.633 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.551 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 1.1 tm? -105.01 114.31 28.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.202 -0.936 . . . . 0.0 110.639 -179.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.7 tt0 175.7 159.95 0.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 110.298 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.54 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 2.2 mt-10 54.87 177.45 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.167 -0.958 . . . . 0.0 110.199 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 23' ' ' GLU . 3.2 Cg_exo -60.65 163.8 14.87 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.885 1.466 . . . . 0.0 110.56 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 26' ' ' GLU . 21.5 pt20 -124.89 163.77 21.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.484 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.639 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER 63.64 52.43 1.43 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 110.638 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.639 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -61.64 155.14 55.36 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.797 1.42 . . . . 0.0 110.283 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -84.07 81.89 8.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 110.063 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.431 HG13 ' HB3' ' A' ' 31' ' ' LYS . 23.5 t -119.51 136.6 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.341 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.69 -4.65 89.42 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HB3' HG13 ' A' ' 29' ' ' VAL . 20.4 tttt -68.35 146.19 53.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -1.142 . . . . 0.0 110.087 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.9 mt -75.64 137.48 40.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.203 -0.936 . . . . 0.0 110.26 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.578 ' CD ' ' HG2' ' A' ' 13' ' ' GLU . 69.6 mtm180 -72.09 135.75 46.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.26 -0.9 . . . . 0.0 110.293 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.431 ' OD1' ' HD3' ' A' ' 80' ' ' PRO . 3.3 m-20 179.79 54.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.887 . . . . 0.0 110.055 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.646 ' O ' ' HD3' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -97.9 130.27 44.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.065 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.495 ' CB ' ' HG3' ' A' ' 78' ' ' GLU . . . -80.08 110.45 16.28 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.355 -0.841 . . . . 0.0 110.177 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 35' ' ' PHE . 2.8 Cg_endo -68.57 -157.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.702 1.369 . . . . 0.0 110.607 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.494 ' CG1' ' HE3' ' A' ' 19' ' ' LYS . 38.1 mm -129.06 77.23 78.18 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 109.966 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.487 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 3.0 Cg_exo -61.85 145.24 97.19 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.941 1.495 . . . . 0.0 110.757 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.1 10.7 55.88 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -94.56 151.18 39.05 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.184 -1.186 . . . . 0.0 110.232 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.79 111.51 1.07 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.876 1.461 . . . . 0.0 110.211 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.483 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 78.4 t -133.79 152.82 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 110.736 -179.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.542 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 74.3 t 57.89 57.44 7.04 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.529 -0.732 . . . . 0.0 111.275 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -61.87 -23.74 76.35 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 N-CA-C 108.819 -1.262 . . . . 0.0 108.819 178.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.461 HG22 ' HG ' ' A' ' 47' ' ' LEU . 16.6 tt -157.57 -29.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.142 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.461 ' HG ' HG22 ' A' ' 46' ' ' ILE . 77.6 mt -144.0 -114.38 0.1 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.486 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 55.6 m -113.34 127.54 56.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.709 -1.245 . . . . 0.0 109.653 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.502 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 38.6 m -60.72 -63.8 1.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.938 . . . . 0.0 110.751 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.535 ' ND2' HD13 ' A' ' 18' ' ' LEU . 4.0 m-20 -72.29 113.42 20.55 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 110.512 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -62.45 -13.02 30.55 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.636 1.335 . . . . 0.0 110.639 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.551 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 87.3 m-20 -128.19 34.02 4.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 110.109 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.702 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.04 -178.63 1.17 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.794 . . . . 0.0 109.249 179.549 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.702 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.8 Cg_exo -61.47 75.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 N-CA-C 108.655 -1.325 . . . . 0.0 108.655 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.639 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.2 tt0 -39.07 -27.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.764 -0.585 . . . . 0.0 110.118 -178.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 54' ' ' PRO . 71.9 mm-40 -53.35 -17.92 2.19 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.977 -1.077 . . . . 0.0 108.614 178.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.62 ' CD1' ' HG2' ' A' ' 54' ' ' PRO . 87.3 mt -92.06 6.53 46.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.692 . . . . 0.0 109.696 179.147 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.731 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.68 -51.4 5.2 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 110.452 -179.722 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.731 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -54.04 -42.42 67.07 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.34 1.179 . . . . 0.0 109.67 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.526 ' HG ' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -54.99 -42.83 72.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.088 -1.007 . . . . 0.0 109.816 179.46 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.463 ' HA ' HG23 ' A' ' 44' ' ' VAL . 73.1 m -68.84 -29.75 68.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.222 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 62' ' ' LYS . 51.6 tptt -79.93 -4.33 51.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.434 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.533 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 6.7 pt-20 -114.04 142.45 27.93 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 110.108 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.58 -17.22 52.9 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.873 1.459 . . . . 0.0 111.099 -179.555 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.497 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 70.1 m-20 -79.9 -7.9 59.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.005 . . . . 0.0 110.33 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -50.42 -37.62 38.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 110.06 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.01 -39.0 93.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.211 -0.931 . . . . 0.0 110.142 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -80.17 -39.01 30.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.533 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 76.7 mt -68.06 -42.81 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.35 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.587 HD23 ' CG ' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -50.73 -59.21 4.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -0.768 . . . . 0.0 110.169 179.861 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.501 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 52.7 tt0 -50.5 -55.77 14.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 110.355 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 73' ' ' LEU . 50.5 mtt180 -55.06 -62.97 1.31 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 0.0 110.431 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.463 ' HG ' HG12 ' A' ' 15' ' ' VAL . 13.1 tp -41.73 -50.29 4.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.957 . . . . 0.0 109.992 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.587 ' CG ' HD23 ' A' ' 70' ' ' LEU . 63.0 mm-40 -55.3 -46.45 76.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 110.318 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -54.89 -53.12 59.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.088 -1.008 . . . . 0.0 110.37 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' ' 79' ' ' ASP . 26.0 mm -59.11 -35.0 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.104 -0.997 . . . . 0.0 109.404 179.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.508 ' O ' ' CE ' ' A' ' 16' ' ' LYS . . . -59.59 -30.49 68.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.559 -0.713 . . . . 0.0 109.527 179.169 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.495 ' HG3' ' CB ' ' A' ' 36' ' ' ALA . 84.6 tt0 -62.0 -40.6 96.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 110.41 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 79' ' ' ASP . 2.5 p30 -148.97 159.52 37.24 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.099 -1.001 . . . . 0.0 110.482 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -62.63 -60.83 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.988 1.52 . . . . 0.0 110.494 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.02 -141.33 24.1 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.532 ' O ' HG12 ' A' ' 85' ' ' ILE . 61.5 p -83.11 -18.3 40.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -1.141 . . . . 0.0 109.775 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 11.0 t -58.53 -53.35 59.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 0.0 110.047 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 48.1 tp10 -59.61 -23.98 63.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 111.081 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 82' ' ' THR . 7.3 pt -105.42 17.26 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.0 -1.062 . . . . 0.0 110.366 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.0 m 49.95 19.36 0.45 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.893 . . . . 0.0 110.65 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.515 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -65.04 -13.47 58.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.035 -1.04 . . . . 0.0 110.005 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -148.24 179.96 7.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.321 -0.862 . . . . 0.0 110.044 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.24 1.68 20.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 110.003 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.97 81.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.332 -0.855 . . . . 0.0 110.415 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 2' ' ' THR . 0.5 OUTLIER -108.05 129.43 55.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.533 -179.653 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.496 ' CG2' ' CD ' ' A' ' 4' ' ' GLN . 19.5 p -109.81 159.81 16.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.378 -0.826 . . . . 0.0 110.146 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.67 -12.77 61.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.278 -1.131 . . . . 0.0 110.228 179.994 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.483 ' CG1' ' SG ' ' A' ' 91' ' ' CYS . 79.0 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.172 0.511 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.472 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 60.8 m -132.45 150.04 52.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.843 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.555 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -92.98 119.39 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 109.419 179.379 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.581 ' CB ' ' HA ' ' A' ' 9' ' ' SER . 1.4 pt20 -116.27 148.29 40.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.079 -1.013 . . . . 0.0 110.933 -179.164 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -96.14 -74.85 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.76 . . . . 0.0 109.478 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.53 -121.12 4.67 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -85.62 14.48 5.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -1.14 . . . . 0.0 110.15 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.692 ' CE1' ' CE1' ' A' ' 10' ' ' PHE . 25.8 t80 -125.89 148.66 49.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.39 -0.819 . . . . 0.0 110.015 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.581 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 12.5 t -107.26 137.74 44.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.17 -0.956 . . . . 0.0 110.724 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.692 ' CE1' ' CE1' ' A' ' 8' ' ' PHE . 84.9 m-85 -119.56 132.1 55.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.19 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -67.14 164.2 18.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.088 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.555 ' CD2' ' HB ' ' A' ' 3' ' ' VAL . 54.1 mt -101.44 -5.19 25.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.982 . . . . 0.0 110.432 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.556 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 83.1 tt0 -69.04 -73.02 0.16 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.426 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.4 m -42.36 -55.3 3.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.032 -1.043 . . . . 0.0 110.545 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.636 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 15.8 m -51.81 -43.95 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.091 -1.006 . . . . 0.0 110.083 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.514 ' O ' ' HG3' ' A' ' 37' ' ' PRO . 37.3 tttm -56.26 -58.75 6.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.832 -1.168 . . . . 0.0 108.644 178.701 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 75.1 mmtt -80.62 17.78 1.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.353 -0.842 . . . . 0.0 109.57 178.528 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.636 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 2.1 tt -65.77 -41.16 92.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.198 -0.939 . . . . 0.0 110.012 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 85.0 tttt -53.16 -41.99 65.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 110.287 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -140.26 80.33 1.75 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.19 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.507 HD22 ' O ' ' A' ' 22' ' ' GLN . 6.6 tt -104.35 130.14 52.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.507 ' O ' HD22 ' A' ' 21' ' ' LEU . 56.7 mt-30 -102.93 -175.29 2.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.151 -0.968 . . . . 0.0 110.612 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.648 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -43.64 -53.53 12.04 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 110.666 179.938 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 3.2 Cg_exo -59.3 139.51 90.27 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.625 1.329 . . . . 0.0 110.524 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -57.3 -37.15 72.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 110.528 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG3' ' OE2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -164.03 101.52 0.91 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 110.552 -179.896 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.06 -24.61 76.77 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.711 1.374 . . . . 0.0 110.448 179.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.435 ' O ' ' OE1' ' A' ' 26' ' ' GLU . 64.6 mtt180 -128.11 141.52 51.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.137 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.408 HG21 ' C ' ' A' ' 28' ' ' ARG . 34.0 t -127.25 141.41 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.111 -0.993 . . . . 0.0 110.21 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.27 155.46 22.48 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -59.0 -46.98 86.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -1.165 . . . . 0.0 110.231 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 tp -124.34 137.44 54.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.229 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.556 ' HD2' ' HA ' ' A' ' 13' ' ' GLU . 82.9 mtm-85 -91.14 113.09 25.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.266 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 63.7 m-20 -140.35 6.34 2.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 110.57 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.497 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 97.6 m-85 -103.29 37.96 1.88 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.299 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.483 ' HB3' ' N ' ' A' ' 78' ' ' GLU . . . -48.73 152.25 1.8 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 110.114 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.553 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 2.7 Cg_endo -65.61 3.84 1.01 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.819 1.431 . . . . 0.0 110.932 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 2.0 mt 72.81 135.26 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.265 -0.897 . . . . 0.0 110.166 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.553 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 2.9 Cg_endo -63.53 172.04 6.05 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.871 1.459 . . . . 0.0 110.53 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.0 17.84 42.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.533 ' CG ' ' OE1' ' A' ' 74' ' ' GLU . 7.9 pt-20 -135.59 79.3 47.77 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.214 -1.168 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HB3' ' HG3' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -61.17 131.59 37.42 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.862 1.454 . . . . 0.0 110.387 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.06 53.18 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 110.435 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.6 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 7.4 p -163.9 53.94 0.38 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 110.696 179.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.6 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -61.39 -35.81 81.52 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.71 1.374 . . . . 0.0 109.747 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' A' ' 47' ' ' LEU . 17.1 pt -133.51 -25.09 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.509 -0.745 . . . . 0.0 110.246 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 48' ' ' CYS . 1.0 OUTLIER 174.02 90.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.975 . . . . 0.0 110.442 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.548 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 73.5 m 39.24 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.458 -0.776 . . . . 0.0 110.603 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.555 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.6 m -54.07 -50.76 66.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 110.144 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 18' ' ' LEU . 2.7 m120 -71.45 112.22 13.05 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.785 . . . . 0.0 110.615 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.555 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -63.08 -10.52 21.02 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.694 1.365 . . . . 0.0 110.118 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.488 ' O ' HD23 ' A' ' 21' ' ' LEU . 14.3 m120 -130.21 33.92 4.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.379 -0.826 . . . . 0.0 110.461 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.68 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -79.09 179.64 1.72 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 108.719 179.082 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.68 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.6 Cg_exo -58.35 74.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.512 1.269 . . . . 0.0 109.184 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 53' ' ' PHE . 82.9 tt0 -39.5 -26.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.668 -0.645 . . . . 0.0 110.349 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.8 mt-10 -56.83 -15.7 5.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.023 -1.048 . . . . 0.0 108.619 178.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.619 HD21 ' CE1' ' A' ' 10' ' ' PHE . 78.4 mt -92.09 14.17 16.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.646 -0.659 . . . . 0.0 109.609 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.729 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.84 -49.49 5.68 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 110.085 179.818 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.3 Cg_exo -56.51 -47.67 22.78 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.444 1.233 . . . . 0.0 109.573 179.147 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.61 ' CD1' ' CG2' ' A' ' 69' ' ' ILE . 12.0 tp -46.55 -52.65 12.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.727 179.428 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.568 ' HA ' ' CG2' ' A' ' 44' ' ' VAL . 85.0 m -67.01 -30.47 70.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 110.55 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 51.2 tttm -79.94 3.44 19.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 110.616 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.518 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 8.2 pt-20 -127.9 144.05 49.97 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.984 -1.072 . . . . 0.0 110.124 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.39 -17.22 56.45 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.805 1.424 . . . . 0.0 110.853 -179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.505 ' O ' HG13 ' A' ' 69' ' ' ILE . 22.6 m120 -79.88 -9.49 59.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 110.417 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.593 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -47.92 -42.37 27.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.013 . . . . 0.0 109.806 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.461 ' HG3' ' HB3' ' A' ' 42' ' ' PRO . 64.0 tt0 -59.62 -43.37 93.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.537 -0.727 . . . . 0.0 110.37 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.26 -39.74 32.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 109.974 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.61 ' CG2' ' CD1' ' A' ' 60' ' ' LEU . 68.7 mt -67.48 -47.84 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.629 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.52 ' O ' ' HG3' ' A' ' 74' ' ' GLU . 1.4 tm? -50.54 -55.6 15.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 110.014 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.553 ' HG3' ' CB ' ' A' ' 39' ' ' PRO . 52.2 tt0 -47.27 -52.18 16.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 110.186 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -54.73 -51.48 65.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 0.0 110.086 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 53.0 mt -53.52 -52.16 60.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 0.0 110.054 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.533 ' OE1' ' CG ' ' A' ' 41' ' ' GLU . 73.2 mt-10 -55.29 -37.9 67.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.873 . . . . 0.0 110.511 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.519 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 82.1 tt0 -65.31 -53.58 41.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.985 . . . . 0.0 110.926 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.475 HG22 ' CG2' ' A' ' 3' ' ' VAL . 20.6 mm -61.35 -39.13 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.594 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.06 -26.92 68.55 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.491 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.9 tt0 -66.3 -35.12 79.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.507 -0.746 . . . . 0.0 111.063 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER -162.11 96.14 1.23 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.809 -1.182 . . . . 0.0 111.041 -179.381 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.613 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 2.7 Cg_endo -67.82 44.71 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.757 1.398 . . . . 0.0 110.483 179.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 79' ' ' ASP . . . -51.52 -74.38 0.3 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.543 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.649 ' O ' HG12 ' A' ' 85' ' ' ILE . 74.3 p -69.37 -58.81 3.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -1.123 . . . . 0.0 110.296 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.633 ' CA ' ' HB2' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -39.16 -46.9 1.52 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 110.495 -179.586 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.613 ' HB2' ' HB2' ' A' ' 80' ' ' PRO . 81.8 tt0 -63.75 -25.1 68.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.043 . . . . 0.0 110.527 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.649 HG12 ' O ' ' A' ' 82' ' ' THR . 26.5 pt -107.23 18.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.268 -179.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.19 15.66 4.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.519 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.531 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -59.75 -23.89 63.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 109.935 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -141.75 169.23 17.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.59 5.16 11.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 110.322 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.11 -43.26 95.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.934 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.633 ' HB2' ' CA ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -94.67 133.61 38.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.193 -0.942 . . . . 0.0 110.389 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.511 HG22 ' CG ' ' A' ' 4' ' ' GLN . 42.3 p -116.16 154.39 30.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.318 -0.864 . . . . 0.0 110.144 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 101.99 -9.02 56.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.44 -1.035 . . . . 0.0 110.386 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.551 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 7.8 p . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.313 0.577 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 53.5 m -127.08 155.59 43.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.95 . . . . 0.0 110.676 -179.544 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.532 ' CG2' HD22 ' A' ' 12' ' ' LEU . 4.0 t -91.13 117.17 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.497 179.389 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.511 ' CB ' ' HA ' ' A' ' 9' ' ' SER . 4.1 pt20 -126.87 175.18 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.073 -1.017 . . . . 0.0 111.201 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.513 ' OD2' ' CG2' ' A' ' 69' ' ' ILE . 96.8 m-20 -136.94 -58.38 0.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.573 0.702 . . . . 0.0 109.5 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.37 -140.18 11.28 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.587 ' OD1' ' CD2' ' A' ' 8' ' ' PHE . 13.9 p30 -79.65 2.04 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.164 -1.198 . . . . 0.0 110.266 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.587 ' CD2' ' OD1' ' A' ' 7' ' ' ASN . 77.9 m-85 -110.71 152.77 26.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.511 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 49.0 m -112.0 136.99 50.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 0.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.651 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 11.2 m-85 -117.16 127.79 54.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.264 -0.897 . . . . 0.0 110.285 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.5 m -72.22 164.67 25.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.352 -179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.532 HD22 ' CG2' ' A' ' 3' ' ' VAL . 83.9 mt -85.24 -24.29 27.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.942 . . . . 0.0 110.431 -179.753 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 14' ' ' SER . 86.0 tt0 -64.18 -69.16 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.308 -0.87 . . . . 0.0 110.372 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.1 m -43.82 -51.41 7.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.125 -0.984 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.608 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 54.4 t -59.16 -49.03 84.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.228 -0.92 . . . . 0.0 109.327 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' A' ' 36' ' ' ALA . 4.0 tptm -53.21 -56.45 16.35 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.523 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 20' ' ' ASP . 57.6 mttt -80.85 13.75 2.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.573 -0.704 . . . . 0.0 110.076 178.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.1 tt -65.65 -47.36 75.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.987 . . . . 0.0 110.297 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.34 -47.17 86.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -0.962 . . . . 0.0 109.834 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 17' ' ' LYS . 83.9 m-20 -103.2 122.5 44.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 109.787 179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.526 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 18.9 tp -100.79 132.09 46.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.744 -179.604 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.506 ' O ' ' HD3' ' A' ' 24' ' ' PRO . 13.9 pt20 -140.69 174.39 10.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.385 -0.822 . . . . 0.0 109.754 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' C ' ' O ' ' A' ' 22' ' ' GLN . 0.2 OUTLIER -36.58 97.92 0.14 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.865 . . . . 0.0 110.145 179.985 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 22' ' ' GLN . 3.0 Cg_exo -62.25 138.44 71.91 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.97 1.511 . . . . 0.0 110.856 -179.594 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.439 ' HG3' ' C ' ' A' ' 24' ' ' PRO . 95.7 mt-30 -150.16 -49.87 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.423 -0.798 . . . . 0.0 109.886 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.606 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 1.7 tt0 46.03 54.76 14.67 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.78 . . . . 0.0 110.846 179.722 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.606 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -61.93 -50.9 4.38 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.723 1.38 . . . . 0.0 110.19 179.572 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.427 ' HG3' ' C ' ' A' ' 27' ' ' PRO . 48.4 mtt-85 -151.9 172.32 16.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.537 -0.727 . . . . 0.0 110.011 179.829 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.1 t -54.35 128.81 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.121 -0.987 . . . . 0.0 110.082 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.81 109.48 2.86 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -62.87 -31.18 72.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -1.147 . . . . 0.0 110.139 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.418 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 46.1 mt -98.71 133.47 43.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 110.317 -179.722 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.473 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 29.5 ptt-85 -176.98 54.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.475 -0.765 . . . . 0.0 109.66 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.581 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 28.3 m-20 -95.95 -70.49 0.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 110.655 -179.58 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -57.4 80.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.429 -0.794 . . . . 0.0 110.754 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.564 ' CB ' ' HA ' ' A' ' 78' ' ' GLU . . . -80.16 164.05 54.38 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.876 . . . . 0.0 109.99 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.525 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 2.7 Cg_endo -63.4 -3.58 5.43 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.913 1.48 . . . . 0.0 110.756 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.525 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 mt 63.26 133.36 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.062 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.1 Cg_exo -61.3 162.12 21.22 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.764 1.402 . . . . 0.0 110.633 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.455 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 145.34 -7.46 1.57 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 43' ' ' VAL . 11.1 mm-40 -119.84 74.81 19.62 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.239 . . . . 0.0 110.396 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_endo -61.74 115.6 2.9 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.78 1.41 . . . . 0.0 110.487 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.625 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 89.6 t -136.42 141.7 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.223 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.686 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 0.9 OUTLIER 164.16 -50.29 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.472 -0.767 . . . . 0.0 110.611 179.936 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 44' ' ' VAL . 3.3 Cg_exo -58.23 -19.15 40.82 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.403 1.212 . . . . 0.0 110.625 -179.569 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.518 ' O ' ' HB2' ' A' ' 47' ' ' LEU . 77.1 mt -89.69 -75.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.783 179.564 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 46' ' ' ILE . 24.3 tp 178.77 67.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 110.348 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.497 ' O ' ' O ' ' A' ' 47' ' ' LEU . 35.3 m 37.7 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.388 -0.82 . . . . 0.0 110.154 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.594 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 58.1 p -52.96 -42.98 66.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.308 -0.87 . . . . 0.0 111.0 -179.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -80.3 110.68 17.53 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.186 -0.946 . . . . 0.0 110.46 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -58.3 -10.62 8.85 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.753 1.397 . . . . 0.0 110.787 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.526 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 97.9 m-20 -139.56 42.95 2.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.121 -0.987 . . . . 0.0 110.712 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.742 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -78.61 177.2 2.98 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.092 -1.005 . . . . 0.0 108.433 178.778 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.742 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.8 Cg_exo -57.51 76.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 N-CA-C 108.628 -1.336 . . . . 0.0 108.628 179.124 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.63 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.9 tt0 -38.88 -28.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.803 -0.561 . . . . 0.0 110.075 -178.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.7 mt-10 -51.66 -18.18 1.11 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.996 -1.065 . . . . 0.0 108.587 178.257 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.651 ' CD2' ' CD2' ' A' ' 10' ' ' PHE . 78.7 mt -86.77 2.95 47.03 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.43 0.633 . . . . 0.0 109.861 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.731 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 20.6 tptt -39.99 -49.61 5.97 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 110.366 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.731 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.85 -41.1 80.78 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.357 1.188 . . . . 0.0 110.434 179.678 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.558 ' CD2' ' CG2' ' A' ' 69' ' ' ILE . 6.2 mp -61.08 -37.6 83.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.876 -1.14 . . . . 0.0 110.179 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.447 ' HA ' HG23 ' A' ' 44' ' ' VAL . 57.3 m -62.73 -25.23 68.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.574 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -98.89 10.94 40.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.115 -0.991 . . . . 0.0 111.399 -179.15 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.528 ' CG ' ' HA ' ' A' ' 60' ' ' LEU . 12.6 pt-20 -133.65 147.1 63.15 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.746 -1.221 . . . . 0.0 110.536 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.25 -11.16 23.98 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.911 1.48 . . . . 0.0 110.939 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.407 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 79.4 m-20 -78.93 -23.72 44.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.1 -1.0 . . . . 0.0 110.428 -179.046 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB3' ' CG2' ' A' ' 44' ' ' VAL . . . -49.14 -39.3 28.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.973 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -57.16 -44.94 83.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.27 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 73.5 mm-40 -79.13 -31.9 44.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.558 ' CG2' ' CD2' ' A' ' 60' ' ' LEU . 95.5 mt -76.34 -53.45 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.096 -1.003 . . . . 0.0 109.928 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.62 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -44.69 -65.42 0.53 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.432 -0.793 . . . . 0.0 110.484 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.62 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 50.9 tt0 -49.06 -54.79 14.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.124 -0.985 . . . . 0.0 110.697 -179.702 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 44.5 mtp85 -54.97 -55.32 32.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 28.7 mt -47.43 -50.77 21.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.158 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 75.4 mt-10 -56.22 -48.19 76.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.446 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 34.8 tt0 -53.79 -52.92 58.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.042 -1.036 . . . . 0.0 109.894 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 79' ' ' ASP . 62.2 mt -59.92 -34.3 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -0.932 . . . . 0.0 109.156 179.224 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 74' ' ' GLU . . . -56.15 -32.83 64.65 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.034 179.031 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 83.2 tt0 -64.2 -43.49 94.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.522 -0.736 . . . . 0.0 109.67 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.48 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 2.0 t70 -143.17 147.58 41.29 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.956 179.784 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.567 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -56.64 -56.11 2.24 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.841 1.442 . . . . 0.0 110.583 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.19 -137.13 21.57 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.554 ' HA ' ' CD1' ' A' ' 85' ' ' ILE . 71.9 p -82.16 -23.09 35.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -1.087 . . . . 0.0 110.625 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 91' ' ' CYS . 7.7 t -56.29 -54.38 46.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.065 -1.022 . . . . 0.0 110.033 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 76.9 tt0 -58.05 -27.34 63.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 111.178 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.554 ' CD1' ' HA ' ' A' ' 82' ' ' THR . 8.9 pt -101.14 14.84 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.89 -1.131 . . . . 0.0 110.27 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 73.3 m 54.76 16.32 1.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.897 . . . . 0.0 110.539 179.594 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.522 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -65.51 -12.31 51.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.82 174.5 11.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.85 3.89 9.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.304 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -61.52 -42.82 99.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.908 . . . . 0.0 110.417 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.535 ' N ' ' SG ' ' A' ' 83' ' ' CYS . 1.2 m -106.2 124.55 49.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.79 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.471 HG22 ' HG2' ' A' ' 4' ' ' GLN . 36.8 p -109.61 163.23 13.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.158 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.02 3.32 51.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.395 -1.061 . . . . 0.0 110.283 179.975 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.517 ' CG1' ' SG ' ' A' ' 91' ' ' CYS . 52.9 t . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.287 0.565 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.526 ' OG1' ' HA ' ' A' ' 11' ' ' SER . 11.7 t -118.48 164.04 15.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 0.0 110.357 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.526 ' CG1' HG22 ' A' ' 76' ' ' ILE . 65.3 t -81.07 124.46 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 109.569 179.492 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.556 ' CB ' ' CG2' ' A' ' 92' ' ' THR . 48.9 tt0 -113.65 121.53 44.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.055 -1.028 . . . . 0.0 110.9 -179.333 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.517 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 52.6 p30 -97.74 13.44 30.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.441 -0.787 . . . . 0.0 109.647 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 173.51 -132.13 2.24 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -93.67 16.57 13.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.164 -1.198 . . . . 0.0 109.773 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.65 ' CB ' ' CZ ' ' A' ' 10' ' ' PHE . 44.8 m-85 -121.06 128.09 52.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.456 -0.777 . . . . 0.0 110.429 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.49 ' HB2' ' CG2' ' A' ' 2' ' ' THR . 14.7 p -82.18 118.29 22.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 8' ' ' PHE . 21.4 m-85 -117.93 123.32 45.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.807 -179.207 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.526 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 45.6 t -67.87 168.78 10.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.28 -0.888 . . . . 0.0 110.083 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.571 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 4.6 mp -95.81 0.84 52.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 110.629 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -73.28 -73.93 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.088 -1.008 . . . . 0.0 110.488 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.52 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.4 m -42.68 -41.09 3.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.114 -0.991 . . . . 0.0 110.556 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.476 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 33.1 t -69.26 -50.89 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 109.805 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.497 ' HD3' ' HB2' ' A' ' 33' ' ' ARG . 9.6 ttpp -48.06 -46.52 33.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.221 -0.924 . . . . 0.0 109.102 179.243 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 18' ' ' LEU . 49.9 mttm -74.03 -54.96 6.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 0.0 109.003 178.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -27.88 -41.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.804 -0.56 . . . . 0.0 110.551 -179.999 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 17' ' ' LYS . 22.4 mttm -51.76 -45.62 63.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 109.947 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 21' ' ' LEU . 52.0 p30 -112.86 -3.15 14.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 110.063 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.541 ' O ' ' O ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER 45.94 104.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.404 -0.81 . . . . 0.0 110.451 -179.984 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 23' ' ' GLU . 96.8 mt-30 -120.96 165.79 14.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.941 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -42.58 165.83 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.17 -179.988 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.88 70.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.827 1.435 . . . . 0.0 110.773 -179.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 23' ' ' GLU . 91.7 mt-30 -84.26 12.63 6.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.918 . . . . 0.0 110.008 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.686 ' N ' ' HD2' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -49.55 -49.9 69.25 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.394 -0.816 . . . . 0.0 110.936 -179.981 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.686 ' HD2' ' N ' ' A' ' 26' ' ' GLU . 3.3 Cg_exo -59.27 -13.93 22.17 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.608 1.32 . . . . 0.0 110.751 -179.559 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.484 ' NH2' ' HG2' ' A' ' 28' ' ' ARG . 47.6 ttp85 -124.85 123.83 40.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 109.917 179.628 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.3 136.29 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.935 . . . . 0.0 110.36 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.85 152.04 34.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -58.72 -35.45 72.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -1.158 . . . . 0.0 110.286 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.7 tp -114.03 131.48 56.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.228 -0.92 . . . . 0.0 110.263 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.497 ' HB2' ' HD3' ' A' ' 16' ' ' LYS . 6.3 ptp180 -117.83 54.25 0.91 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.086 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 41.5 p-10 -125.69 2.2 7.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.202 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -71.21 -7.52 47.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 110.3 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.484 ' CB ' ' HG3' ' A' ' 16' ' ' LYS . . . -63.32 150.19 89.93 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.205 -0.935 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.455 ' HD2' ' HD2' ' A' ' 19' ' ' LYS . 3.1 Cg_exo -61.55 -147.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.798 1.42 . . . . 0.0 110.404 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -121.55 161.27 42.42 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 110.072 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.542 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo -61.52 155.78 50.9 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.791 1.416 . . . . 0.0 110.653 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.94 4.87 1.08 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.821 -1.181 . . . . 0.0 110.169 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.523 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -134.61 60.47 42.57 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.881 -1.364 . . . . 0.0 110.612 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -62.16 139.41 78.03 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.824 1.433 . . . . 0.0 110.515 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.518 ' HB ' ' CB ' ' A' ' 49' ' ' SER . 14.8 m -141.93 119.68 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.334 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.556 ' CG2' ' HB3' ' A' ' 66' ' ' ALA . 69.2 t -145.62 63.36 9.45 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 0.0 110.473 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.506 ' HG2' ' N ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -61.17 -169.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.748 1.394 . . . . 0.0 110.336 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.42 -30.23 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.384 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 48' ' ' CYS . 0.7 OUTLIER -134.81 56.13 1.86 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 -179.99 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.534 ' O ' ' O ' ' A' ' 47' ' ' LEU . 0.5 OUTLIER 56.98 133.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.472 -0.767 . . . . 0.0 110.147 179.95 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.531 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.3 t -69.54 -56.0 8.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 110.442 -179.817 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.535 ' ND2' HD21 ' A' ' 21' ' ' LEU . 7.2 m120 -78.28 113.06 30.54 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.481 -0.762 . . . . 0.0 110.452 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -62.45 -12.69 28.91 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.747 1.393 . . . . 0.0 110.459 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.475 ' HB2' HD12 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -127.8 36.41 4.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 110.045 179.886 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.707 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 3.0 p90 -80.14 178.86 2.11 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.203 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.707 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.2 Cg_exo -56.53 75.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.676 1.356 . . . . 0.0 109.872 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.9 tt0 -43.56 -34.19 1.34 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.833 . . . . 0.0 110.298 -179.503 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -54.31 -18.65 4.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.934 -1.104 . . . . 0.0 108.626 178.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.627 HD11 ' HB2' ' A' ' 54' ' ' PRO . 8.5 mp -95.3 18.69 11.97 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.092 0.949 . . . . 0.0 108.99 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.719 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -43.19 -51.02 14.41 Favored Pre-proline 0 N--CA 1.489 1.483 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.52 179.818 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.719 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.24 -49.12 17.4 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.502 1.264 . . . . 0.0 109.658 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -48.1 -49.1 33.01 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.09 -1.006 . . . . 0.0 109.753 179.446 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.513 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 87.0 m -63.49 -23.95 67.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 19.9 tttt -90.68 5.62 47.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 0.0 110.743 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 59' ' ' PRO . 8.6 pt-20 -125.96 144.76 49.7 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.891 -1.13 . . . . 0.0 110.317 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.54 -13.59 30.44 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.94 1.495 . . . . 0.0 110.803 -179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.489 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 84.7 m-20 -79.78 -22.65 42.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.292 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.591 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -46.23 -40.05 10.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.11 -0.994 . . . . 0.0 109.797 179.775 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -62.48 -36.95 84.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 0.0 109.23 179.3 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.49 -38.9 29.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.524 -0.735 . . . . 0.0 109.407 178.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.561 ' CG2' ' CD1' ' A' ' 60' ' ' LEU . 80.0 mt -70.92 -46.18 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 109.898 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.595 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 2.1 tm? -40.66 -68.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.506 -0.746 . . . . 0.0 110.554 -179.768 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.595 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 25.3 mt-30 -42.77 -52.4 5.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.143 -0.973 . . . . 0.0 110.459 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -53.71 -59.05 5.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.004 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.517 ' CD2' ' HB3' ' A' ' 5' ' ' ASP . 36.7 mt -47.57 -54.14 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 110.051 179.705 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.52 ' HG3' HD23 ' A' ' 70' ' ' LEU . 70.3 mt-10 -52.19 -45.78 65.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 110.06 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.542 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 83.7 tt0 -57.62 -51.36 69.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.809 179.752 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.526 HG22 ' CG1' ' A' ' 3' ' ' VAL . 23.6 mm -60.64 -38.75 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 109.519 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 78' ' ' GLU . . . -54.52 -38.39 66.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.429 -0.794 . . . . 0.0 109.65 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.735 ' O ' ' CB ' ' A' ' 79' ' ' ASP . 83.8 tt0 -44.14 -33.56 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.89 . . . . 0.0 109.611 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.735 ' CB ' ' O ' ' A' ' 78' ' ' GLU . 19.5 t70 95.04 73.13 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 76' ' ' ILE . 3.0 Cg_exo -60.86 -34.97 90.55 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.022 1.538 . . . . 0.0 110.185 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.16 -28.89 9.58 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.195 -2.362 . . . . 0.0 107.195 -178.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.562 ' O ' HG12 ' A' ' 85' ' ' ILE . 75.6 p -74.3 -40.75 62.06 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.11 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.677 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 53.5 t -58.81 -40.96 85.65 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.834 178.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.37 -33.37 75.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.066 -1.021 . . . . 0.0 110.349 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.562 HG12 ' O ' ' A' ' 82' ' ' THR . 17.8 pt -94.44 11.32 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.934 . . . . 0.0 110.237 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER 67.83 12.42 8.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.355 -0.841 . . . . 0.0 110.527 179.721 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.484 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -58.64 -35.76 73.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.22 -0.925 . . . . 0.0 109.897 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -123.15 166.8 14.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.937 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.91 -7.28 47.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.152 -0.967 . . . . 0.0 109.974 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -51.82 -37.1 50.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.83 . . . . 0.0 110.861 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.677 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -104.13 118.8 37.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.906 . . . . 0.0 111.139 -179.149 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.556 ' CG2' ' CB ' ' A' ' 4' ' ' GLN . 18.4 p -98.16 177.86 5.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 110.197 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.75 -5.9 84.16 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.442 ' OXT' ' SG ' ' A' ' 86' ' ' CYS . 23.9 p . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.166 . . . . 0.0 110.118 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.229 0.538 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.435 HG21 ' HA ' ' A' ' 11' ' ' SER . 37.0 m -89.26 150.89 22.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 110.293 -179.851 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.57 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 88.0 t -80.08 104.8 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 110.123 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.513 ' HB3' ' CG2' ' A' ' 92' ' ' THR . 48.1 tt0 -108.64 123.69 49.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 110.36 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -100.75 5.07 43.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.098 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.44 -138.62 2.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -79.74 -0.12 32.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -1.123 . . . . 0.0 110.251 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.433 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 84.4 m-85 -116.8 130.7 56.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.197 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m -86.01 136.18 33.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 110.126 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.581 ' CD1' HD22 ' A' ' 57' ' ' LEU . 57.0 m-85 -115.09 125.73 53.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 110.191 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.435 ' HA ' HG21 ' A' ' 2' ' ' THR . 33.8 t -73.07 169.9 16.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.92 . . . . 0.0 110.179 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.2 mm? -100.63 -3.99 29.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.115 -0.99 . . . . 0.0 110.413 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.435 ' OE1' ' HG3' ' A' ' 26' ' ' GLU . 97.5 mt-10 -70.23 -72.9 0.18 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -0.999 . . . . 0.0 110.432 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.492 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.5 m -41.12 -50.69 3.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 110.662 -179.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 30.8 m -63.1 -47.96 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.096 -1.003 . . . . 0.0 109.743 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.574 ' CD ' ' HA ' ' A' ' 33' ' ' ARG . 6.8 ttpp -56.53 -55.42 34.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.084 -1.01 . . . . 0.0 109.159 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -80.11 7.6 8.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.49 179.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.574 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 13.0 tp -54.1 -35.65 62.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.577 -0.702 . . . . 0.0 110.131 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 32.1 tttt -55.48 -41.84 73.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.116 -0.99 . . . . 0.0 109.507 179.317 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.7 105.92 16.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.778 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.502 ' CD2' ' HD2' ' A' ' 51' ' ' PRO . 11.8 tp -46.82 -42.32 17.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.595 -179.64 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.406 ' C ' ' HG3' ' A' ' 23' ' ' GLU . 94.2 mt-30 -65.29 110.1 2.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.179 -0.951 . . . . 0.0 110.381 -179.705 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' HG3' ' C ' ' A' ' 22' ' ' GLN . 9.1 mt-10 -126.88 128.02 24.3 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.017 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.19 155.06 58.72 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.661 1.348 . . . . 0.0 110.547 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -59.35 139.0 57.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.382 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.435 ' HG3' ' OE1' ' A' ' 13' ' ' GLU . 14.1 mm-40 -123.28 81.8 52.38 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 109.952 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.3 -79.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.934 1.492 . . . . 0.0 110.819 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 29' ' ' VAL . 98.5 mtt180 -139.56 149.2 43.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 110.56 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 28' ' ' ARG . 20.3 t 46.19 101.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 110.697 179.535 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.18 -178.09 48.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.63 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -82.92 -105.0 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -1.165 . . . . 0.0 110.332 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.5 mt -108.74 142.88 38.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 110.128 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.574 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 76.1 mtm180 -123.11 65.12 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.353 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 10.6 p30 -131.63 15.75 4.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.265 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.563 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 68.1 t80 -95.29 7.39 46.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 0.0 110.405 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB3' ' CA ' ' A' ' 78' ' ' GLU . . . -66.02 137.73 95.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 0.0 110.223 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.488 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 3.0 Cg_exo -62.64 -148.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.805 1.424 . . . . 0.0 110.509 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.518 HD11 ' N ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -120.95 162.51 34.74 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.866 . . . . 0.0 110.132 179.869 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 38' ' ' ILE . 2.9 Cg_endo -61.63 166.85 10.95 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.917 1.483 . . . . 0.0 110.479 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.38 8.52 43.61 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.488 ' O ' HD13 ' A' ' 70' ' ' LEU . 3.4 tp10 -123.49 76.04 54.11 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.279 -1.13 . . . . 0.0 110.115 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.47 141.81 96.4 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.001 1.527 . . . . 0.0 110.689 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 49' ' ' SER . 15.5 m -121.21 58.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.378 -0.826 . . . . 0.0 110.186 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.435 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 4.5 t -139.92 64.99 29.44 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.327 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -59.86 -123.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.909 1.478 . . . . 0.0 109.982 179.637 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.491 ' O ' HD22 ' A' ' 47' ' ' LEU . 22.2 mm -67.27 -33.73 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.74 -1.225 . . . . 0.0 107.701 178.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 46' ' ' ILE . 67.3 mt -136.1 -89.28 0.3 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.268 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.8 m -127.44 139.41 52.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.056 -1.028 . . . . 0.0 109.017 178.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.565 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 6.0 t -62.63 -73.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.053 -1.029 . . . . 0.0 111.099 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 28.3 m-20 -79.98 113.68 40.16 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.837 -179.184 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -64.59 -7.2 13.84 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.793 1.417 . . . . 0.0 110.329 179.521 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.48 ' HB2' HD13 ' A' ' 21' ' ' LEU . 15.3 m120 -129.16 32.5 4.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.0 109.864 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.726 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -79.86 -176.55 0.74 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 108.956 179.412 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.726 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.7 Cg_exo -59.28 74.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.442 1.233 . . . . 0.0 109.051 179.201 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.589 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.8 tt0 -39.28 -32.33 0.11 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.687 -0.633 . . . . 0.0 110.551 -178.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 54' ' ' PRO . 77.7 tt0 -52.31 -24.95 8.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.905 -1.122 . . . . 0.0 108.604 178.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.606 ' CD1' ' HG2' ' A' ' 54' ' ' PRO . 91.7 mt -85.28 1.23 49.19 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.437 0.636 . . . . 0.0 109.543 179.151 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.754 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.8 tmmt? -40.93 -49.65 7.7 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.459 -0.775 . . . . 0.0 110.493 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.754 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -53.98 -39.77 83.73 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.398 1.21 . . . . 0.0 110.557 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.561 HD12 ' CG2' ' A' ' 69' ' ' ILE . 9.6 mt -67.64 -30.65 70.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.927 -1.108 . . . . 0.0 110.029 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' A' ' 47' ' ' LEU . 46.0 t -69.34 -26.18 64.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 110.066 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -96.11 20.38 10.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 108.981 179.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.493 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -114.84 142.0 27.69 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.71 -0.619 . . . . 0.0 110.538 -179.11 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.93 -26.49 74.3 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.789 1.415 . . . . 0.0 109.425 178.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -86.06 -5.08 59.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.815 . . . . 0.0 110.538 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -45.26 -37.97 5.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.046 . . . . 0.0 110.101 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 94.0 mt-30 -59.55 -41.05 89.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 110.25 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.33 -39.31 28.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.096 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.561 ' CG2' HD12 ' A' ' 60' ' ' LEU . 84.8 mt -63.29 -47.89 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.135 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.525 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 1.4 tm? -53.05 -53.37 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 110.211 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 67' ' ' GLN . 73.7 mt-30 -48.33 -55.23 11.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.396 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -50.17 -52.16 37.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.363 -0.835 . . . . 0.0 110.188 -179.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 56.5 mt -53.13 -49.2 67.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.26 -0.9 . . . . 0.0 110.094 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 74.4 mt-10 -54.8 -43.38 72.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 110.727 -179.776 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.459 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.8 tt0 -62.9 -55.63 24.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.033 -1.042 . . . . 0.0 110.904 -179.308 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.1 mt -62.12 -38.11 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HB1' HG22 ' A' ' 15' ' ' VAL . . . -60.11 -32.35 70.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.448 -0.783 . . . . 0.0 109.8 179.596 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.525 ' CA ' ' HB3' ' A' ' 36' ' ' ALA . 84.3 tt0 -62.08 -37.06 83.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 110.556 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 78' ' ' GLU . 3.0 m-20 -165.15 151.44 8.97 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.016 . . . . 0.0 110.706 -179.796 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.567 ' HB3' ' CG ' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.38 74.95 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.968 1.509 . . . . 0.0 110.719 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 80' ' ' PRO . . . -61.28 -134.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.269 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.516 ' O ' HG12 ' A' ' 85' ' ' ILE . 59.4 p -75.39 -20.88 58.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.997 -1.296 . . . . 0.0 109.281 179.24 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.613 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 9.9 t -60.29 -46.23 90.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.533 -0.729 . . . . 0.0 109.404 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.567 ' CG ' ' HB3' ' A' ' 80' ' ' PRO . 49.8 tp10 -58.57 -30.23 67.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.271 -0.893 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 82' ' ' THR . 7.4 pt -103.2 12.85 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.96 -1.087 . . . . 0.0 110.39 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 4.4 t 60.52 14.24 4.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.281 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.514 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -64.47 -21.64 66.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.083 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.46 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 1.7 m-85 -131.59 166.51 21.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.58 2.99 3.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 110.368 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -65.9 -38.56 89.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -0.936 . . . . 0.0 110.409 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.613 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -108.56 115.15 29.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 110.715 -179.568 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.513 ' CG2' ' HB3' ' A' ' 4' ' ' GLN . 41.4 p -100.27 176.9 5.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 110.254 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.03 78.47 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.297 -1.119 . . . . 0.0 110.257 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.205 0.526 . . . . 0.0 110.142 . . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.488 ' HB ' ' HB ' ' A' ' 92' ' ' THR . 63.0 m -130.55 149.4 52.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.655 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -92.35 119.92 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.623 -0.673 . . . . 0.0 109.64 179.569 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 51.5 tt0 -111.74 121.31 44.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 110.824 -179.286 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.527 ' OD2' ' CD2' ' A' ' 73' ' ' LEU . 83.0 m-20 -97.31 9.14 43.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 109.818 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.55 -138.13 3.2 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -82.4 4.5 23.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.167 -1.196 . . . . 0.0 110.185 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 78.3 m-85 -121.89 132.63 54.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 110.389 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB3' HG22 ' A' ' 92' ' ' THR . 26.8 p -80.73 127.63 32.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 110.034 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 20.2 m-30 -114.6 126.7 55.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.87 . . . . 0.0 110.445 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.8 m -71.55 166.78 21.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' CD2' ' HB ' ' A' ' 3' ' ' VAL . 51.5 mt -96.91 -8.81 29.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.558 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.531 ' HG2' ' CD ' ' A' ' 33' ' ' ARG . 95.3 mt-10 -63.8 -68.07 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.065 -1.022 . . . . 0.0 110.394 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.465 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.1 m -45.2 -50.69 11.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.271 -0.893 . . . . 0.0 111.191 -179.438 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.529 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 25.1 m -57.58 -48.43 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 0.0 110.269 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.507 ' HG3' ' HA ' ' A' ' 36' ' ' ALA . 28.8 ttpp -50.5 -51.25 49.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.865 -1.147 . . . . 0.0 108.643 179.165 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.631 ' O ' ' C ' ' A' ' 18' ' ' LEU . 63.6 mttp -67.97 -57.36 6.31 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.066 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.631 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.4 OUTLIER 1.66 -71.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 120.832 0.349 . . . . 0.0 111.373 179.32 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.614 ' N ' ' O ' ' A' ' 17' ' ' LYS . 86.0 tttt -49.47 -59.28 3.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.916 -1.115 . . . . 0.0 109.248 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 17' ' ' LYS . 24.7 t70 -109.11 97.24 6.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.426 -0.796 . . . . 0.0 109.461 178.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.523 ' HB3' ' ND2' ' A' ' 50' ' ' ASN . 31.6 tp -95.31 138.6 32.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.893 -179.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -111.89 -170.39 1.64 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.424 -0.797 . . . . 0.0 109.745 179.511 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.54 ' CG ' ' HG3' ' A' ' 27' ' ' PRO . 15.4 pt-20 -45.68 158.9 0.32 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 109.54 179.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 3.3 Cg_exo -59.71 161.32 18.38 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.789 1.415 . . . . 0.0 110.537 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.512 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 39.2 tt0 64.07 84.75 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 -179.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.522 ' CG ' ' HE2' ' A' ' 17' ' ' LYS . 14.1 mp0 -36.38 96.9 0.12 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.347 -0.846 . . . . 0.0 110.425 -179.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.54 ' HG3' ' CG ' ' A' ' 23' ' ' GLU . 2.9 Cg_endo -65.3 -26.05 56.56 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.92 1.484 . . . . 0.0 110.721 -179.811 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -76.9 145.45 38.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.207 -0.933 . . . . 0.0 110.349 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 p -137.35 138.07 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.258 -0.902 . . . . 0.0 110.196 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.97 -172.15 43.63 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 95.6 mttt -116.19 158.31 23.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -1.156 . . . . 0.0 110.295 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 6.7 mp 54.52 102.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.341 -0.85 . . . . 0.0 110.414 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.531 ' CD ' ' HG2' ' A' ' 13' ' ' GLU . 85.2 mtt-85 -103.2 61.64 0.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.003 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 78' ' ' GLU . 88.4 m-20 -89.18 16.15 7.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 0.0 110.31 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -86.8 17.63 3.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.0 110.185 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.507 ' HA ' ' HG3' ' A' ' 16' ' ' LYS . . . -52.28 148.06 12.5 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.216 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.428 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 3.0 Cg_exo -61.84 -149.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.863 1.454 . . . . 0.0 110.407 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.512 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 26.9 mm -125.04 142.43 41.2 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.234 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.512 ' HD2' ' CG2' ' A' ' 38' ' ' ILE . 2.9 Cg_endo -62.02 163.63 18.99 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.747 1.393 . . . . 0.0 110.47 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.52 3.78 49.92 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.96 83.55 37.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.279 -1.13 . . . . 0.0 110.147 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.437 ' HA ' HD21 ' A' ' 70' ' ' LEU . 2.9 Cg_endo -61.6 140.38 86.4 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.9 1.474 . . . . 0.0 110.591 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.555 ' CG2' ' CB ' ' A' ' 49' ' ' SER . 11.3 p -148.12 64.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.507 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 94.5 t -131.65 60.08 49.57 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.293 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -60.35 168.19 6.78 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.793 1.418 . . . . 0.0 110.36 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 94.0 mt -50.36 -41.09 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 110.146 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 48' ' ' CYS . 54.5 mt -104.3 26.79 8.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 110.126 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.518 ' O ' ' O ' ' A' ' 47' ' ' LEU . 85.6 m 58.01 143.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.383 -0.823 . . . . 0.0 109.909 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.555 ' CB ' ' CG2' ' A' ' 43' ' ' VAL . 34.1 t -69.73 -76.2 0.1 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.181 -0.95 . . . . 0.0 110.258 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.528 ' OD1' ' O ' ' A' ' 18' ' ' LEU . 5.8 m120 -80.48 115.86 57.92 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 110.725 -179.837 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -64.63 1.84 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.657 1.346 . . . . 0.0 110.681 179.281 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.512 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 89.0 m-20 -133.84 31.77 3.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 110.064 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.85 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 11.0 p90 -76.21 -176.73 0.63 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 109.132 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.85 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.5 Cg_exo -56.4 73.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.382 1.201 . . . . 0.0 110.037 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.61 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.0 tt0 -42.81 -34.62 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.564 -0.71 . . . . 0.0 110.309 -179.511 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.521 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 96.0 mt-10 -54.87 -17.43 3.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.991 . . . . 0.0 108.809 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.597 HD13 ' CD1' ' A' ' 10' ' ' PHE . 8.7 mp -97.87 11.63 36.73 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.816 0.817 . . . . 0.0 109.184 179.202 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.715 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.87 -52.08 5.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.778 -0.576 . . . . 0.0 110.758 -179.818 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.715 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -53.08 -42.91 61.31 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.428 1.225 . . . . 0.0 110.25 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.569 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 11.0 mp -60.78 -35.58 76.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.064 -1.023 . . . . 0.0 109.769 179.447 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 51.8 t -66.73 -28.99 68.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.16 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -104.4 24.18 12.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 109.191 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.519 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -116.42 140.78 27.0 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.627 -0.671 . . . . 0.0 110.548 -179.232 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.91 -30.39 67.5 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.734 1.386 . . . . 0.0 109.698 179.047 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -80.03 -7.49 58.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.418 -0.801 . . . . 0.0 110.61 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -46.03 -39.65 9.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.043 179.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.35 -41.1 92.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 110.342 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -80.17 -37.62 32.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.918 179.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.503 ' CG2' HD22 ' A' ' 60' ' ' LEU . 90.0 mt -66.08 -41.91 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 110.188 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.466 HD12 ' OE2' ' A' ' 74' ' ' GLU . 1.6 tp -56.44 -57.91 10.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 110.723 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -47.46 -17.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.084 -1.01 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 69' ' ' ILE . 27.5 ttm-85 -86.85 -58.1 2.72 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.617 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.547 ' CD1' HD22 ' A' ' 57' ' ' LEU . 69.6 mt -51.36 -50.79 58.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.392 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.501 ' OE1' ' HA ' ' A' ' 39' ' ' PRO . 88.7 mt-10 -55.41 -54.87 38.38 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.478 -0.764 . . . . 0.0 109.465 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.5 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 83.8 tt0 -61.15 -53.95 50.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 110.16 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.53 ' O ' ' O ' ' A' ' 79' ' ' ASP . 23.3 mm -62.18 -33.83 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 109.749 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 73' ' ' LEU . . . -59.06 -34.38 71.89 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.407 179.454 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 84.8 tt0 -58.7 -39.58 81.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 110.285 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.53 ' O ' ' O ' ' A' ' 76' ' ' ILE . 14.5 p-10 -145.03 153.73 53.74 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.11 -0.993 . . . . 0.0 110.358 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.539 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -58.83 -54.27 2.97 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.888 1.468 . . . . 0.0 110.537 179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.98 -139.67 24.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.597 ' O ' HG12 ' A' ' 85' ' ' ILE . 44.6 p -80.08 -20.76 44.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -1.107 . . . . 0.0 110.164 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.614 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 5.5 t -55.44 -54.24 46.21 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.179 -0.951 . . . . 0.0 109.956 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.5 tt0 -56.08 -30.38 61.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 111.04 -179.493 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 82' ' ' THR . 9.0 pt -98.8 15.41 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.892 -1.13 . . . . 0.0 110.344 -179.507 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.6 m 50.89 23.51 1.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 110.376 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.602 ' O ' ' CD1' ' A' ' 88' ' ' TYR . . . -71.62 -11.23 60.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 34.1 m-85 -150.56 171.56 16.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 110.126 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.82 1.96 18.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.948 . . . . 0.0 110.202 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.1 -11.61 41.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.359 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.614 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.7 OUTLIER -108.41 -172.53 2.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.97 . . . . 0.0 110.382 -179.878 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.488 ' HB ' ' HB ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -150.55 -15.81 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.273 -0.892 . . . . 0.0 110.997 -179.903 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.1 -23.33 72.96 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.488 1.463 0 O-C-N 121.159 -1.201 . . . . 0.0 110.35 -179.9 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.453 HG12 ' SG ' ' A' ' 91' ' ' CYS . 33.8 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.29 0.567 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 61.2 m -119.39 149.43 41.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.238 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 90' ' ' ALA . 1.2 t -83.69 113.16 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.877 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 64.3 tt0 -110.54 119.19 38.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.418 -0.801 . . . . 0.0 110.694 -179.456 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -101.28 7.06 43.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 109.713 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.476 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . -169.67 -143.1 3.77 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -81.02 4.93 18.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.309 -1.112 . . . . 0.0 110.424 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.547 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 66.3 m-85 -125.63 136.86 53.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.311 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.413 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 67.2 m -79.65 131.15 35.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.93 . . . . 0.0 110.037 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.639 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 18.4 m-85 -113.44 121.92 45.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 110.618 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.1 p -75.35 171.29 14.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.241 -0.912 . . . . 0.0 109.871 179.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 12' ' ' LEU . 2.7 mm? -103.2 -12.07 17.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 0.0 110.772 -179.6 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 90.8 mt-10 -63.25 -74.1 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.092 -1.005 . . . . 0.0 110.535 -179.855 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 6.3 m -40.6 -44.37 2.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 110.478 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.64 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.1 t -62.22 -46.51 96.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.158 -0.964 . . . . 0.0 109.457 179.551 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.545 ' NZ ' ' O ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -54.93 -50.28 69.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.021 -1.049 . . . . 0.0 108.551 178.479 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -80.36 6.6 11.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.511 -0.743 . . . . 0.0 109.657 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.64 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 44.3 tp -63.74 -23.36 67.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.38 -0.825 . . . . 0.0 110.426 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HE3' ' CD1' ' A' ' 38' ' ' ILE . 28.0 tttm -67.52 -32.59 73.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.024 -1.048 . . . . 0.0 110.303 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -116.96 122.5 44.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.141 -0.975 . . . . 0.0 110.174 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.531 HD12 ' HB3' ' A' ' 50' ' ' ASN . 8.9 tp -85.32 168.05 15.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.4 -179.861 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 78.5 mt-30 59.82 54.7 4.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 110.225 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.8 mm-40 -137.09 162.9 52.97 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.84 . . . . 0.0 109.885 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.489 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 3.1 Cg_exo -60.01 125.49 17.77 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.897 1.472 . . . . 0.0 110.466 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -58.18 -38.01 75.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.92 . . . . 0.0 110.099 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -143.11 78.27 15.28 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.465 -0.772 . . . . 0.0 109.965 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 24' ' ' PRO . 3.0 Cg_exo -62.51 143.47 93.08 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.985 1.518 . . . . 0.0 110.676 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 29' ' ' VAL . 79.2 mtm180 -52.5 147.19 8.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 30' ' ' GLY . 0.9 OUTLIER 55.68 167.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.322 -0.861 . . . . 0.0 109.981 -179.9 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 29' ' ' VAL . . . 86.33 14.27 66.59 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.527 ' HA ' ' NH2' ' A' ' 33' ' ' ARG . 51.5 mttt -51.5 -28.44 13.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -1.14 . . . . 0.0 110.22 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.49 ' O ' ' C ' ' A' ' 33' ' ' ARG . 59.3 mt -55.98 -41.05 74.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 110.26 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.527 ' NH2' ' HA ' ' A' ' 31' ' ' LYS . 67.4 mtt85 38.08 73.14 0.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.424 -0.798 . . . . 0.0 109.958 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.591 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 14.7 p30 -123.13 44.41 2.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.747 -179.542 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.531 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 92.7 m-85 -107.95 120.01 41.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.11 -0.994 . . . . 0.0 109.903 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.65 116.73 54.6 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.917 . . . . 0.0 110.544 -179.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.53 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 2.9 Cg_endo -64.01 -5.73 9.84 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.802 1.422 . . . . 0.0 110.502 179.538 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 1.1 mp 71.95 78.0 0.21 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 110.203 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.74 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . 3.0 Cg_endo -61.94 156.96 46.07 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.015 1.534 . . . . 0.0 110.592 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.06 42.51 0.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.484 ' HG2' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -122.95 169.72 9.43 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.322 -1.105 . . . . 0.0 110.32 -179.913 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.491 ' O ' ' C ' ' A' ' 43' ' ' VAL . 2.9 Cg_endo -62.26 155.28 57.75 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 124.022 1.538 . . . . 0.0 111.178 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.653 ' O ' HG11 ' A' ' 43' ' ' VAL . 7.1 p 33.73 83.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.598 -0.689 . . . . 0.0 111.047 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.796 ' HB ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER 45.27 -161.4 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.8 -1.187 . . . . 0.0 108.47 179.421 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.796 ' HD2' ' HB ' ' A' ' 44' ' ' VAL . 3.7 Cg_exo -57.05 138.02 84.46 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 122.512 0.743 . . . . 0.0 110.446 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.573 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 2.3 pt -40.38 -39.18 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.459 -0.776 . . . . 0.0 111.197 -179.26 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.65 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 6.5 mp -97.13 14.85 24.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 110.612 -179.332 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.559 ' HB2' ' CD ' ' A' ' 45' ' ' PRO . 35.3 t -70.84 -55.62 8.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.127 -0.983 . . . . 0.0 109.181 179.289 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 43' ' ' VAL . 90.3 p -61.03 -25.96 67.28 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.277 -0.889 . . . . 0.0 108.744 178.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HB3' HD12 ' A' ' 21' ' ' LEU . 1.2 m-20 -50.32 130.79 25.05 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.705 . . . . 0.0 110.143 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.45 1.55 2.5 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.795 1.419 . . . . 0.0 111.106 179.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.516 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 10.8 m120 -113.39 7.12 17.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.067 -1.021 . . . . 0.0 110.842 -179.633 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.74 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -80.1 -177.13 0.84 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.073 -1.017 . . . . 0.0 109.493 179.449 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.74 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.6 Cg_exo -61.0 73.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.7 1.368 . . . . 0.0 109.038 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.594 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.3 tt0 -38.87 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.761 -0.587 . . . . 0.0 110.19 -178.523 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.488 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 50.1 mt-10 -55.11 -22.81 17.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.093 -1.004 . . . . 0.0 109.107 178.797 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.639 ' CD2' ' CG ' ' A' ' 10' ' ' PHE . 31.6 mt -92.38 11.59 25.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.455 -0.778 . . . . 0.0 109.742 179.35 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.721 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.85 -51.39 5.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.43 -0.794 . . . . 0.0 110.677 179.967 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.721 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.33 -44.73 46.04 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.531 1.279 . . . . 0.0 110.511 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.59 ' O ' ' CB ' ' A' ' 66' ' ' ALA . 10.9 mp -57.88 -41.44 82.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.933 -1.104 . . . . 0.0 110.212 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.6 m -66.65 -25.96 66.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.919 -1.113 . . . . 0.0 110.063 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -97.95 1.06 47.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.892 . . . . 0.0 110.427 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.528 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 5.6 pt-20 -108.08 139.9 21.14 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.107 -0.995 . . . . 0.0 110.081 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.89 -21.73 72.87 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.805 1.424 . . . . 0.0 110.988 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.471 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 75.9 m-20 -79.44 -11.31 59.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 110.579 -179.138 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.59 ' CB ' ' O ' ' A' ' 60' ' ' LEU . . . -48.6 -32.02 7.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 109.86 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.79 -38.13 86.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.418 -0.801 . . . . 0.0 109.739 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.3 -41.89 24.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.271 -0.893 . . . . 0.0 109.398 179.101 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.528 ' CD1' ' OE2' ' A' ' 63' ' ' GLU . 65.1 mt -67.33 -49.15 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.372 -0.83 . . . . 0.0 109.67 179.534 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.608 ' CD1' ' N ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -41.8 -67.08 0.28 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.781 . . . . 0.0 110.005 179.898 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.74 ' HA ' ' HB3' ' A' ' 39' ' ' PRO . 90.8 mt-30 -44.99 -51.96 9.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.094 -1.004 . . . . 0.0 110.268 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -63.47 -50.71 68.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.452 -0.78 . . . . 0.0 110.153 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.529 ' CD2' HD12 ' A' ' 57' ' ' LEU . 13.5 tp -46.19 -60.13 2.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.708 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.566 ' HG3' HD23 ' A' ' 70' ' ' LEU . 54.7 mt-10 -50.72 -49.4 57.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.977 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.82 -54.83 24.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 110.246 -179.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.416 HG23 HG23 ' A' ' 3' ' ' VAL . 25.2 mm -57.42 -39.24 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 0.0 109.545 179.759 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -55.82 -34.36 65.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.469 -0.769 . . . . 0.0 109.529 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.591 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.5 tt0 -62.49 -42.98 99.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.51 -0.744 . . . . 0.0 110.017 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.416 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 14.9 p-10 -151.97 158.56 33.82 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.975 -1.078 . . . . 0.0 110.311 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.565 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -59.83 -54.24 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.017 1.535 . . . . 0.0 110.407 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.09 -140.23 29.54 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.609 ' O ' HG12 ' A' ' 85' ' ' ILE . 43.5 p -82.17 -20.43 37.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -1.102 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.593 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 21.8 t -57.99 -46.13 85.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 0.0 109.787 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 80.4 tt0 -62.24 -29.28 70.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.17 -0.956 . . . . 0.0 111.34 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 82' ' ' THR . 3.9 pt -97.38 6.38 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.893 -1.129 . . . . 0.0 110.398 -179.496 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER 67.32 6.2 4.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 179.615 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.452 ' HB1' ' HB ' ' A' ' 82' ' ' THR . . . -66.15 -17.86 64.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 109.93 179.732 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.497 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.3 OUTLIER -128.06 157.63 40.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 110.186 -179.889 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.49 -0.59 10.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.089 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.72 -32.9 74.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.385 -0.822 . . . . 0.0 110.557 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.593 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -108.42 111.9 24.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 110.796 -179.504 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.547 ' CG2' ' HB3' ' A' ' 4' ' ' GLN . 21.0 p -101.85 174.53 5.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.395 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.3 -14.74 64.58 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.423 -1.046 . . . . 0.0 110.227 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.512 HG12 ' SG ' ' A' ' 91' ' ' CYS . 18.1 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.193 0.521 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.959 HG21 ' HB3' ' A' ' 9' ' ' SER . 10.9 t -126.83 163.32 23.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.236 -0.915 . . . . 0.0 110.66 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.079 HG21 HD21 ' A' ' 12' ' ' LEU . 45.6 t -82.78 122.44 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.499 -0.75 . . . . 0.0 109.524 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.491 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 50.3 tt0 -112.32 121.35 44.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.93 . . . . 0.0 110.822 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.965 ' OD2' HD21 ' A' ' 73' ' ' LEU . 93.3 m-20 -98.79 11.51 38.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.426 -0.796 . . . . 0.0 109.657 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.491 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 179.92 -138.36 3.37 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -88.83 14.35 10.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 110.176 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.633 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.4 m-85 -123.79 131.01 53.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.229 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.959 ' HB3' HG21 ' A' ' 2' ' ' THR . 29.6 m -81.63 123.24 28.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.897 . . . . 0.0 110.085 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.778 ' CE2' HD11 ' A' ' 60' ' ' LEU . 22.9 m-85 -119.37 128.66 54.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.369 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.409 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 49.2 m -75.51 172.7 12.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.079 HD21 HG21 ' A' ' 3' ' ' VAL . 88.5 mt -106.47 -3.19 21.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 110.837 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.01 -73.91 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 110.321 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 m -47.83 -43.8 28.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 110.51 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.547 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 18.4 t -61.21 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.03 -1.043 . . . . 0.0 109.809 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.48 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 19.3 tttt -55.23 -53.97 49.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 53.3 mttp -80.2 8.85 6.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.623 HD13 ' HB2' ' A' ' 53' ' ' PHE . 16.6 tp -60.9 -44.98 96.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 110.686 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.491 ' NZ ' ' HA ' ' A' ' 39' ' ' PRO . 57.5 mttt -66.82 -34.01 76.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.351 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -128.99 79.98 1.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.979 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.465 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.0 tt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.11 -0.994 . . . . 0.0 110.392 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 13.5 ptt180 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.294 0.569 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.402 ' OD1' ' C ' ' A' ' 34' ' ' ASN . 30.3 p-10 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.494 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 3.1 Cg_exo . . . . . 0 N--CA 1.482 0.819 0 N-CA-C 110.677 -0.547 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.58 37.12 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.481 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 2.8 tt0 -138.77 64.41 35.63 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.178 -1.189 . . . . 0.0 110.23 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.525 ' CB ' ' HG3' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -61.71 102.27 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.847 1.446 . . . . 0.0 110.721 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.571 ' O ' HG23 ' A' ' 44' ' ' VAL . 14.6 p -134.52 127.87 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 110.083 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.607 ' O ' HG12 ' A' ' 44' ' ' VAL . 32.5 t . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.475 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.567 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.8 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.148 0.499 . . . . 0.0 109.755 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.497 ' HB2' HG22 ' A' ' 43' ' ' VAL . 22.7 t -59.9 -50.78 72.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.568 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 7.1 m120 -79.69 117.89 69.6 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 110.397 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.13 -10.93 13.99 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.762 1.401 . . . . 0.0 110.445 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -138.32 42.3 2.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.85 . . . . 0.0 109.513 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.713 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -80.1 -177.24 0.87 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.552 -0.718 . . . . 0.0 109.568 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 1.094 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -58.03 72.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.674 1.355 . . . . 0.0 109.667 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.619 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 23.1 pt-20 -40.1 -36.9 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.498 -0.751 . . . . 0.0 110.3 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' C ' HD12 ' A' ' 57' ' ' LEU . 96.3 mt-10 -54.12 -17.51 2.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 109.307 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.094 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.9 mp -97.9 8.55 44.55 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.736 0.779 . . . . 0.0 109.7 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.749 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -39.81 -52.04 5.2 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.716 -0.615 . . . . 0.0 110.72 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.749 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.97 -42.63 65.14 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.466 1.245 . . . . 0.0 110.051 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.996 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 16.6 mt -57.75 -41.35 81.76 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.031 -1.043 . . . . 0.0 109.879 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 15.7 m -69.19 -28.1 66.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.091 -1.005 . . . . 0.0 110.221 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 14.2 ttpt -88.28 6.51 36.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 2.4 pt-20 -111.39 144.14 29.91 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.986 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.64 -23.61 72.1 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.834 1.439 . . . . 0.0 111.103 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.514 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 80.1 m-20 -83.31 -4.88 58.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 0.0 110.717 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.996 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -51.48 -39.56 57.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.011 -1.056 . . . . 0.0 110.066 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.525 ' HG3' ' CB ' ' A' ' 42' ' ' PRO . 30.6 tt0 -54.12 -44.05 70.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 109.918 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -79.93 -35.31 37.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.622 HG21 HD13 ' A' ' 60' ' ' LEU . 93.9 mt -67.78 -52.83 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.947 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.3 tm? -43.33 -58.42 2.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.43 -0.794 . . . . 0.0 110.019 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.621 ' N ' HD13 ' A' ' 70' ' ' LEU . 25.9 mt-30 -51.75 -54.94 22.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.033 -1.042 . . . . 0.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.6 ttm-85 -49.61 -56.24 10.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.445 -0.784 . . . . 0.0 109.788 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.965 HD21 ' OD2' ' A' ' 5' ' ' ASP . 57.2 mt -48.32 -46.83 36.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.89 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 74.9 mm-40 -55.53 -45.32 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 110.147 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.0 -54.55 40.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 110.38 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.9 mt -60.21 -31.63 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 109.69 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 33' ' ' ARG . . . -64.1 -32.06 73.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.856 . . . . 0.0 109.292 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 78' ' ' GLU . 79.7 tt0 -92.99 14.71 16.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.581 -0.7 . . . . 0.0 109.68 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 9.7 t70 -178.86 124.61 0.25 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.406 -0.808 . . . . 0.0 109.928 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -61.68 -62.52 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.657 1.346 . . . . 0.0 110.773 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.43 -139.28 18.74 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 1.03 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 60.2 p -79.92 -22.07 43.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.172 . . . . 0.0 110.065 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 7.6 t -54.71 -53.72 51.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 110.001 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 85.2 tt0 -57.96 -31.28 66.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 110.929 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.824 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.2 pt -99.6 13.96 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.981 -1.075 . . . . 0.0 110.334 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 33.8 m 50.44 20.53 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 110.221 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 1.03 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -60.7 -12.2 9.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.913 . . . . 0.0 110.021 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.437 ' CG ' ' O ' ' A' ' 87' ' ' ALA . 50.0 m-85 -154.82 -176.63 6.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.205 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.3 1.93 12.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.883 . . . . 0.0 110.326 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.81 -36.08 71.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.588 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -112.57 129.08 56.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.201 -0.937 . . . . 0.0 110.609 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.481 HG21 ' CD ' ' A' ' 4' ' ' GLN . 25.3 p -107.19 157.21 18.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.168 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.09 0.08 56.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.334 -1.098 . . . . 0.0 110.275 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.449 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 3.0 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.314 0.578 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 57.5 m -121.97 146.53 47.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 110.536 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.051 HG23 HD11 ' A' ' 12' ' ' LEU . 56.0 t -86.11 119.67 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 109.527 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.495 ' CD ' HG21 ' A' ' 92' ' ' THR . 49.7 tt0 -109.88 116.86 32.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 110.848 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -93.08 10.98 29.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.396 -0.815 . . . . 0.0 109.666 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.456 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 179.77 -134.72 2.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -86.66 5.92 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -1.151 . . . . 0.0 110.162 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.672 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 71.0 m-85 -124.1 137.76 54.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.103 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 p -81.17 124.06 28.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.439 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.672 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 18.1 m-30 -113.91 125.62 54.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.344 -0.847 . . . . 0.0 110.399 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.2 p -73.91 168.02 20.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.236 -0.915 . . . . 0.0 110.076 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.051 HD11 HG23 ' A' ' 3' ' ' VAL . 5.0 mp -94.12 -20.85 19.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.235 -0.916 . . . . 0.0 110.539 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.514 ' HG3' ' HE3' ' A' ' 17' ' ' LYS . 88.6 tt0 -57.62 -67.38 0.34 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.306 -0.872 . . . . 0.0 110.781 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.574 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 9.3 m -41.77 -47.44 4.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.09 -1.006 . . . . 0.0 110.317 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 96.9 t -64.4 -50.25 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.081 -1.012 . . . . 0.0 109.704 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -55.17 -49.49 71.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 108.969 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.538 ' HE2' ' NH1' ' A' ' 33' ' ' ARG . 31.0 mttt -80.47 4.4 18.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.8 . . . . 0.0 109.987 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD13 ' HB2' ' A' ' 53' ' ' PHE . 11.0 tp -64.97 -37.11 86.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -0.942 . . . . 0.0 110.446 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -57.92 -37.43 74.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 29.2 p-10 -132.14 126.47 33.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.121 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.517 HD22 ' HB3' ' A' ' 52' ' ' ASN . 11.0 mt . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.16 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.538 ' NH1' ' HE2' ' A' ' 17' ' ' LYS . 34.6 mtt-85 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.254 0.55 . . . . 0.0 110.378 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 55.4 t-20 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.256 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.472 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.1 Cg_exo . . . . . 0 N--CA 1.481 0.767 0 N-CA-C 110.579 -0.585 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.43 21.28 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -134.55 88.66 28.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.087 -1.243 . . . . 0.0 109.972 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -60.32 140.39 91.64 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.953 1.502 . . . . 0.0 110.704 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.927 HG23 HG23 ' A' ' 44' ' ' VAL . 16.6 m -131.33 169.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 110.299 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.927 HG23 HG23 ' A' ' 43' ' ' VAL . 6.3 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.461 -0.775 . . . . 0.0 110.634 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.465 0.65 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.511 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -98.6 -72.54 0.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.163 -0.96 . . . . 0.0 110.092 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.427 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -76.67 113.67 31.7 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.461 -0.775 . . . . 0.0 110.011 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.46 -11.09 18.29 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.668 1.352 . . . . 0.0 110.676 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.517 ' HB3' HD22 ' A' ' 21' ' ' LEU . 42.2 t30 -130.6 34.44 4.14 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.286 -0.884 . . . . 0.0 110.376 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.729 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.2 -175.45 0.6 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.172 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 1.093 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -58.28 74.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.499 1.262 . . . . 0.0 109.843 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 53' ' ' PHE . 87.0 tt0 -42.05 -36.87 1.24 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.451 -0.781 . . . . 0.0 110.222 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.582 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.7 mt-10 -52.79 -18.42 1.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.041 -1.037 . . . . 0.0 108.934 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.093 HD13 ' HB2' ' A' ' 54' ' ' PRO . 9.3 mp -94.12 14.95 18.38 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.901 0.858 . . . . 0.0 109.028 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.743 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -40.19 -52.24 5.7 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.034 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.743 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.9 Cg_exo -52.97 -43.28 58.1 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.509 1.268 . . . . 0.0 110.094 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.043 HD22 HG21 ' A' ' 69' ' ' ILE . 86.4 mt -60.24 -37.88 81.72 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.03 -1.043 . . . . 0.0 109.95 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.629 ' O ' HG11 ' A' ' 44' ' ' VAL . 2.9 t -69.03 -30.62 69.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.02 -1.05 . . . . 0.0 110.216 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 34.4 tttm -89.95 -1.35 57.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.154 -0.967 . . . . 0.0 109.551 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.63 138.28 26.72 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.523 -0.736 . . . . 0.0 110.038 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.71 -20.75 66.94 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.632 1.332 . . . . 0.0 110.039 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.97 -2.39 57.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.377 -0.827 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.951 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.01 -35.55 4.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.098 -1.001 . . . . 0.0 109.8 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.56 -45.54 88.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -80.25 -41.22 25.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.043 HG21 HD22 ' A' ' 60' ' ' LEU . 83.5 mt -57.53 -45.59 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.167 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.948 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -45.77 -58.48 3.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.852 . . . . 0.0 110.248 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.948 ' N ' HD13 ' A' ' 70' ' ' LEU . 84.7 mt-30 -48.7 -56.2 9.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 0.0 110.023 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -48.88 -52.8 22.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.896 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.627 HD11 HD13 ' A' ' 60' ' ' LEU . 33.8 mt -51.42 -49.96 60.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.992 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.566 ' OE2' HD11 ' A' ' 70' ' ' LEU . 86.8 mt-10 -51.89 -54.25 31.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.219 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -55.57 -55.94 26.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.922 . . . . 0.0 110.537 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 79' ' ' ASP . 38.0 mm -58.35 -41.41 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.117 -0.989 . . . . 0.0 109.922 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -52.6 -37.14 57.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.286 -0.884 . . . . 0.0 109.657 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.2 tt0 -63.3 -44.03 96.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.79 . . . . 0.0 110.13 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 76' ' ' ILE . 6.5 t70 -136.73 143.4 42.64 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.054 -1.029 . . . . 0.0 110.231 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.558 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -59.41 -48.15 14.46 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.74 1.39 . . . . 0.0 110.588 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.41 -137.66 19.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.619 ' O ' HG12 ' A' ' 85' ' ' ILE . 44.2 p -76.08 -24.47 55.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -1.177 . . . . 0.0 109.312 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.566 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 22.8 t -47.55 -54.74 10.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.446 -0.784 . . . . 0.0 110.266 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.558 ' HB2' ' CB ' ' A' ' 80' ' ' PRO . 85.0 tt0 -60.39 -36.63 78.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.402 -0.811 . . . . 0.0 111.625 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.619 HG12 ' O ' ' A' ' 82' ' ' THR . 9.5 pt -86.88 10.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.741 -1.225 . . . . 0.0 110.58 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 87.5 m 52.78 19.81 1.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.828 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.559 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -78.33 -4.67 49.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.068 -1.02 . . . . 0.0 109.774 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.65 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 22.5 t80 -146.43 165.81 28.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.45 -0.781 . . . . 0.0 110.143 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.98 3.91 7.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 110.398 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.65 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -62.67 -31.83 72.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.96 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.566 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -108.07 122.3 46.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.173 -0.954 . . . . 0.0 110.662 -179.671 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.495 HG21 ' CD ' ' A' ' 4' ' ' GLN . 14.8 p -105.67 150.09 25.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.363 -0.836 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 94' ' ' CYS . . . 100.16 -6.89 58.31 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 93' ' ' GLY . 22.0 m . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.352 -1.087 . . . . 0.0 110.32 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.246 0.546 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 25.8 m -122.18 145.06 48.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.903 . . . . 0.0 110.399 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.045 HG23 HD11 ' A' ' 12' ' ' LEU . 64.9 t -88.43 119.94 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.042 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.82 ' OE1' HG21 ' A' ' 92' ' ' THR . 12.0 pt20 -115.31 140.41 49.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 110.762 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.463 ' OD2' HD11 ' A' ' 60' ' ' LEU . 51.0 p30 -110.31 13.93 22.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.549 -0.719 . . . . 0.0 109.862 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.07 -135.58 2.61 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -81.99 3.72 25.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -1.126 . . . . 0.0 110.128 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 81.0 m-85 -122.87 151.58 41.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.478 ' OG ' ' HB ' ' A' ' 2' ' ' THR . 3.7 t -104.19 135.06 46.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.697 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 24.6 m-85 -121.62 133.67 54.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.534 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.0 m -73.49 167.2 21.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -0.864 . . . . 0.0 110.36 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.045 HD11 HG23 ' A' ' 3' ' ' VAL . 5.3 mp -95.13 -15.95 22.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 110.508 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.2 mt-10 -65.74 -69.2 0.31 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.078 -1.013 . . . . 0.0 110.282 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' GLU . 5.6 m -40.76 -53.07 2.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 110.606 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.684 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.2 m -57.31 -45.07 85.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.045 -1.034 . . . . 0.0 109.442 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.508 ' N ' HG23 ' A' ' 15' ' ' VAL . 55.2 tttm -54.09 -57.56 10.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.0 109.006 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -80.3 12.6 2.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.376 -0.827 . . . . 0.0 109.979 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.684 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 4.9 tt -65.62 -36.86 84.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 110.52 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -56.39 -48.76 76.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -0.881 . . . . 0.0 110.695 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -134.0 155.65 49.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.118 -0.989 . . . . 0.0 110.388 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.724 HD22 ' HB2' ' A' ' 52' ' ' ASN . 7.8 mt . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 109.978 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.623 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 38.2 t-20 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 120.869 -1.144 . . . . 0.0 111.522 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.816 0 N-CA-C 110.61 -0.573 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.87 13.28 29.92 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -133.55 66.74 74.56 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.307 -1.113 . . . . 0.0 110.163 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.791 ' HA ' HD12 ' A' ' 70' ' ' LEU . 3.0 Cg_exo -61.88 135.09 53.63 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.937 1.493 . . . . 0.0 110.708 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.884 HG22 ' OG ' ' A' ' 49' ' ' SER . 3.1 p 178.46 91.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.1 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.853 ' O ' HG13 ' A' ' 44' ' ' VAL . 6.4 p . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 110.195 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 97.1 m . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.367 0.603 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.884 ' OG ' HG22 ' A' ' 43' ' ' VAL . 48.9 m -61.34 -59.23 5.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 110.916 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -80.12 113.16 36.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.425 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -61.42 -7.59 8.95 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.677 1.356 . . . . 0.0 110.391 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.724 ' HB2' HD22 ' A' ' 21' ' ' LEU . 90.8 m-20 -135.07 40.53 2.89 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.263 -0.898 . . . . 0.0 110.218 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.66 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -80.03 177.19 3.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.93 . . . . 0.0 108.929 179.245 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.733 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.7 Cg_exo -58.06 74.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.544 1.286 . . . . 0.0 109.215 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.611 ' N ' ' O ' ' A' ' 53' ' ' PHE . 84.5 tt0 -39.34 -29.58 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.773 -0.579 . . . . 0.0 110.293 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.579 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.4 mt-10 -51.71 -20.96 2.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.979 -1.076 . . . . 0.0 108.482 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.733 HD12 ' HG2' ' A' ' 54' ' ' PRO . 75.2 mt -87.17 10.02 18.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.597 -0.689 . . . . 0.0 109.58 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.756 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.89 -51.07 5.66 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 110.415 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.756 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.57 -42.98 63.25 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.561 1.295 . . . . 0.0 110.205 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.003 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 6.6 mp -58.18 -42.79 86.84 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.007 -1.058 . . . . 0.0 110.068 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.547 ' HA ' HG22 ' A' ' 44' ' ' VAL . 3.7 t -62.71 -27.49 69.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 110.158 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -90.36 -4.44 57.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 110.874 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 10.4 pt-20 -113.54 142.63 27.95 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 0.0 110.228 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.45 -14.33 41.68 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.87 1.458 . . . . 0.0 110.982 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.498 ' O ' HG13 ' A' ' 69' ' ' ILE . 68.6 m-20 -79.68 -17.4 53.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.181 -0.949 . . . . 0.0 110.603 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.003 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -52.01 -37.01 51.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.999 -1.063 . . . . 0.0 110.079 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -55.65 -44.08 76.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -80.34 -36.61 33.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.706 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.785 HG21 ' CD2' ' A' ' 60' ' ' LEU . 84.1 mt -66.78 -50.68 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 0.0 109.904 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.95 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -42.11 -62.99 0.81 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 0.0 110.343 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.95 ' N ' HD13 ' A' ' 70' ' ' LEU . 54.0 mt-30 -48.09 -52.47 20.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.073 -1.017 . . . . 0.0 110.231 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -55.27 -54.52 42.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 69' ' ' ILE . 3.6 mm? -47.69 -52.51 18.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 109.93 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.73 ' OE2' HD21 ' A' ' 70' ' ' LEU . 68.0 mt-10 -52.78 -50.17 64.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 109.902 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.527 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.0 tt0 -53.76 -54.83 32.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.967 . . . . 0.0 109.971 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 79' ' ' ASP . 39.0 mm -56.07 -35.33 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.127 -0.983 . . . . 0.0 109.233 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -57.81 -32.82 67.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.433 -0.792 . . . . 0.0 109.293 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 94.3 mt-10 -60.19 -42.84 95.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.424 -0.798 . . . . 0.0 109.86 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -147.14 153.62 45.26 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 110.172 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.55 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 3.2 Cg_exo -60.13 -51.96 4.86 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.952 1.501 . . . . 0.0 110.618 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.15 -139.51 20.52 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.586 ' O ' HG12 ' A' ' 85' ' ' ILE . 45.6 p -79.83 -19.76 47.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -1.144 . . . . 0.0 109.778 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.57 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 48.8 t -54.39 -53.81 49.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 110.155 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 80' ' ' PRO . 83.7 tt0 -58.68 -30.34 67.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 111.22 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 82' ' ' THR . 12.0 pt -95.94 12.73 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.913 -1.117 . . . . 0.0 110.56 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 3.4 t 51.47 19.87 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.285 -0.884 . . . . 0.0 110.961 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -77.72 -9.0 58.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 109.751 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.617 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 17.9 t80 -138.45 164.65 28.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.472 -0.767 . . . . 0.0 109.877 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.92 2.09 11.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 110.176 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.617 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -62.84 -37.23 85.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.574 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.57 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -98.2 120.31 38.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.1 -1.0 . . . . 0.0 110.59 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.82 HG21 ' OE1' ' A' ' 4' ' ' GLN . 41.5 p -104.03 154.58 19.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.365 -0.834 . . . . 0.0 110.142 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.76 -11.37 68.19 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 110.274 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 1' ' ' VAL . 23.5 m . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.201 0.524 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.648 HG21 ' OG ' ' A' ' 9' ' ' SER . 43.2 m -126.12 152.02 46.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.445 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.049 HG21 HD11 ' A' ' 12' ' ' LEU . 92.4 t -88.69 113.98 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.393 -0.817 . . . . 0.0 109.836 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.49 ' HB3' HG21 ' A' ' 92' ' ' THR . 47.8 tt0 -108.95 118.07 35.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.133 -0.979 . . . . 0.0 110.525 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.526 ' HB3' HD21 ' A' ' 73' ' ' LEU . 55.0 p30 -99.09 6.45 46.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.704 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -174.15 -143.26 4.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -79.91 3.62 19.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -1.149 . . . . 0.0 110.49 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.456 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 79.4 m-85 -120.23 140.8 50.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.101 -0.999 . . . . 0.0 110.46 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.648 ' OG ' HG21 ' A' ' 2' ' ' THR . 21.8 t -86.59 127.13 34.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.976 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.665 ' CZ ' HD23 ' A' ' 57' ' ' LEU . 22.0 m-30 -116.93 130.07 56.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.139 -0.976 . . . . 0.0 110.656 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.446 ' C ' HD22 ' A' ' 12' ' ' LEU . 75.2 p -80.03 174.6 11.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.324 -0.86 . . . . 0.0 110.286 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.049 HD11 HG21 ' A' ' 3' ' ' VAL . 2.5 mm? -99.89 -7.88 24.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 110.817 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -68.56 -71.3 0.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.178 -0.951 . . . . 0.0 111.056 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.529 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 4.1 m -51.91 -50.6 60.75 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.096 -1.003 . . . . 0.0 111.229 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.616 ' CG2' ' HA ' ' A' ' 12' ' ' LEU . 17.3 m -55.99 -48.65 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.884 -1.135 . . . . 0.0 110.212 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.518 ' N ' HG23 ' A' ' 15' ' ' VAL . 19.3 ttpp -55.69 -52.75 62.79 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.846 -1.159 . . . . 0.0 108.669 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.474 ' HE2' ' NZ ' ' A' ' 16' ' ' LYS . 71.1 mmtt -80.47 12.73 2.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.791 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.649 HD21 HG21 ' A' ' 43' ' ' VAL . 54.9 tp -61.39 -51.0 70.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 110.144 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -62.85 -33.96 76.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.914 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -130.9 100.42 5.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.847 . . . . 0.0 109.623 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 52' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.836 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.407 ' HB3' ' HE2' ' A' ' 16' ' ' LYS . 63.1 mtt180 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.376 0.607 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.613 ' ND2' ' O ' ' A' ' 78' ' ' GLU . 22.5 t-20 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 110.094 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.834 0 N-CA-C 110.542 -0.599 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.05 9.16 34.93 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 82.42 54.48 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.283 -1.128 . . . . 0.0 110.053 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HG3' ' HG3' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -61.58 137.7 70.82 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.934 1.492 . . . . 0.0 110.488 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.649 HG21 HD21 ' A' ' 18' ' ' LEU . 16.2 m -117.44 49.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.179 -0.951 . . . . 0.0 110.278 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 44' ' ' VAL . 2.4 m . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 110.159 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.585 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 98.3 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.538 0.685 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.58 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 15.5 t -51.82 -51.22 58.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.256 -0.903 . . . . 0.0 110.783 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 4.5 m120 -80.06 111.93 25.99 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.407 -0.808 . . . . 0.0 110.679 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.7 -13.41 36.63 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.636 1.335 . . . . 0.0 110.507 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.666 ' HB2' HD22 ' A' ' 21' ' ' LEU . 97.2 m-20 -123.88 29.67 6.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.525 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.736 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -80.3 177.5 2.92 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 109.161 179.251 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.804 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.4 Cg_exo -58.3 74.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.662 1.349 . . . . 0.0 108.929 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.613 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.1 tt0 -39.22 -27.77 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.634 -0.666 . . . . 0.0 110.182 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' PRO . 75.1 mm-40 -53.61 -17.2 1.98 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.03 -1.044 . . . . 0.0 108.592 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.804 HD12 ' HG2' ' A' ' 54' ' ' PRO . 92.7 mt -92.44 9.07 35.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.689 -0.632 . . . . 0.0 109.615 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.736 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -39.88 -50.67 5.69 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 110.278 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.736 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -55.76 -44.93 42.99 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.482 1.254 . . . . 0.0 110.124 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.027 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -54.11 -44.29 71.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 110.093 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.484 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . 82.5 m -64.4 -27.56 69.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.965 . . . . 0.0 110.139 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -91.87 4.88 51.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.893 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -112.9 137.02 21.69 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.355 -0.841 . . . . 0.0 110.179 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.99 -21.64 72.75 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.673 1.354 . . . . 0.0 109.884 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -79.93 -10.91 59.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.43 -0.794 . . . . 0.0 110.867 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.027 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.68 -36.03 10.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.956 -1.09 . . . . 0.0 109.877 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.479 ' HG3' ' HG3' ' A' ' 42' ' ' PRO . 50.2 tt0 -59.97 -42.61 94.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.343 -0.848 . . . . 0.0 110.029 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.16 -39.04 30.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 109.906 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.912 HG21 HD11 ' A' ' 60' ' ' LEU . 89.4 mt -63.51 -44.43 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.829 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.801 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.0 tm? -52.36 -54.31 33.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 0.0 110.209 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.675 ' N ' HD13 ' A' ' 70' ' ' LEU . 94.6 mt-30 -47.94 -52.9 17.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.291 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' LEU . 97.4 mtt180 -58.43 -62.14 2.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.455 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 5' ' ' ASP . 45.5 mt -44.93 -52.92 8.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.19 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.672 ' HG2' HD22 ' A' ' 70' ' ' LEU . 78.4 mm-40 -54.98 -47.59 74.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 110.78 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -56.72 -52.78 63.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.923 . . . . 0.0 110.771 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 79' ' ' ASP . 24.2 mm -63.61 -36.14 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 0.0 109.924 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -58.92 -33.71 70.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.43 -0.794 . . . . 0.0 109.881 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.613 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 83.5 tt0 -61.13 -37.9 84.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.685 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -150.35 160.62 32.71 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.032 -1.043 . . . . 0.0 110.675 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -61.54 -62.11 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.051 1.553 . . . . 0.0 110.569 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.34 -141.83 28.37 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.964 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 70.6 p -79.55 -22.16 44.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -1.154 . . . . 0.0 109.581 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 32.5 t -52.89 -51.63 60.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 109.991 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.5 tt0 -58.62 -33.77 70.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 0.0 111.179 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.772 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.2 pt -97.3 13.49 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.893 -1.129 . . . . 0.0 110.463 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.71 14.14 1.67 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.266 -0.896 . . . . 0.0 110.487 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.964 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.08 -15.11 62.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 109.963 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.592 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 27.0 t80 -139.69 168.41 19.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 0.0 110.267 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.98 3.07 8.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 110.301 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.592 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -63.08 -36.92 85.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.428 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -102.97 121.01 41.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 110.496 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 4' ' ' GLN . 18.9 p -111.54 166.32 11.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 110.227 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.97 -26.19 15.97 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.18 -1.188 . . . . 0.0 110.292 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.771 HG13 ' SG ' ' A' ' 91' ' ' CYS . 47.2 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.317 0.579 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 11' ' ' SER . 28.8 m -119.23 147.31 44.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.182 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.841 HG21 HG21 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -89.62 118.97 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 109.952 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 1.005 ' OE1' HG21 ' A' ' 92' ' ' THR . 65.6 tt0 -111.66 129.3 56.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 110.543 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -93.26 -81.24 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.759 . . . . 0.0 110.016 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.12 -126.32 3.81 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -84.69 8.27 17.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -1.184 . . . . 0.0 110.335 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.3 m-85 -120.2 137.79 54.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.36 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.2 t -88.55 130.26 35.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.729 ' CD1' HD23 ' A' ' 57' ' ' LEU . 18.6 m-85 -119.2 126.84 52.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.816 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.534 ' HA ' HG23 ' A' ' 2' ' ' THR . 38.8 t -75.65 169.14 18.69 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -0.996 . . . . 0.0 110.072 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.72 HD21 ' CB ' ' A' ' 3' ' ' VAL . 64.2 mt -102.36 -2.15 29.48 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.126 -0.984 . . . . 0.0 110.905 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -74.21 -73.6 0.22 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.084 -1.01 . . . . 0.0 110.6 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.6 m -43.0 -42.27 3.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.862 . . . . 0.0 110.826 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.627 ' CG2' ' HA ' ' A' ' 12' ' ' LEU . 6.2 m -65.29 -45.31 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.858 -1.151 . . . . 0.0 109.663 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -53.34 -46.98 69.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.821 -1.174 . . . . 0.0 108.93 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 45.8 tptt -80.23 -1.51 40.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.516 -0.74 . . . . 0.0 109.993 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.587 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 53.9 tp -66.55 -40.84 89.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.137 -0.977 . . . . 0.0 110.194 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -56.62 -45.63 81.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.283 -0.885 . . . . 0.0 110.072 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -116.99 70.2 0.77 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.709 HD11 ' OD1' ' A' ' 52' ' ' ASN . 19.2 tp . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 110.506 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.33 0.586 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.45 ' HB3' ' HA ' ' A' ' 79' ' ' ASP . 76.7 m-20 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.166 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 3.3 Cg_exo . . . . . 0 N--CA 1.483 0.87 0 N-CA-C 110.793 -0.503 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.86 -78.75 1.43 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.99 153.56 35.86 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.287 -1.125 . . . . 0.0 110.257 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.494 ' HB2' ' HG3' ' A' ' 67' ' ' GLN . 3.0 Cg_endo -61.69 139.65 81.96 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.963 1.507 . . . . 0.0 110.614 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.695 ' O ' HG13 ' A' ' 43' ' ' VAL . 13.4 p -177.44 71.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.947 . . . . 0.0 110.261 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.907 HG22 ' HA ' ' A' ' 61' ' ' CYS . 2.8 p . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.864 . . . . 0.0 110.139 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.7 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.368 0.604 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.548 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.1 t -61.0 -44.82 96.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 2.2 m-80 -80.35 112.11 28.12 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.343 -0.848 . . . . 0.0 110.304 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -59.54 -10.26 10.92 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.766 1.403 . . . . 0.0 110.7 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.709 ' OD1' HD11 ' A' ' 21' ' ' LEU . 45.7 p-10 -136.97 41.81 2.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 110.366 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.699 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.24 177.15 3.13 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 109.116 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.73 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.9 Cg_exo -58.3 75.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.591 1.311 . . . . 0.0 109.143 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.626 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.3 tt0 -39.06 -29.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.782 -0.574 . . . . 0.0 110.149 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.3 mt-10 -52.04 -18.88 1.58 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.025 -1.047 . . . . 0.0 108.634 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.73 HD12 ' HG2' ' A' ' 54' ' ' PRO . 88.6 mt -90.8 9.67 29.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.487 -0.758 . . . . 0.0 109.649 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.738 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.3 tmtt? -39.71 -51.51 5.21 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.359 -0.838 . . . . 0.0 110.63 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.738 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.28 -43.58 57.32 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.459 1.242 . . . . 0.0 109.997 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.038 HD11 HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -55.6 -40.7 72.4 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.11 -0.994 . . . . 0.0 110.039 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.907 ' HA ' HG22 ' A' ' 44' ' ' VAL . 82.4 m -58.03 -23.37 54.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.215 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.502 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 35.5 mtmt -113.46 37.05 3.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 109.579 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.502 ' OE1' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -133.12 141.83 42.25 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.849 . . . . 0.0 110.36 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -62.93 -26.28 74.26 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.746 1.393 . . . . 0.0 110.075 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.46 ' O ' HG13 ' A' ' 69' ' ' ILE . 72.1 m-20 -80.19 -18.65 49.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.906 . . . . 0.0 110.439 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.886 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -45.39 -47.33 13.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.328 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 42' ' ' PRO . 61.0 tt0 -54.25 -43.62 71.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.492 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.15 -33.03 38.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.879 . . . . 0.0 110.473 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.038 HD13 HD11 ' A' ' 60' ' ' LEU . 94.5 mt -63.41 -44.88 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 0.0 110.357 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.662 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.6 tm? -43.43 -66.93 0.32 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.439 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.662 ' N ' HD13 ' A' ' 70' ' ' LEU . 97.7 mt-30 -47.31 -54.87 9.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.114 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -50.46 -58.88 4.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 110.094 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.494 ' CD1' HG22 ' A' ' 69' ' ' ILE . 40.2 mt -45.16 -51.68 10.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.183 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 73.3 mm-40 -51.63 -58.01 7.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 110.301 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 85.0 tt0 -52.04 -56.6 13.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.933 . . . . 0.0 110.592 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.841 HG21 HG21 ' A' ' 3' ' ' VAL . 22.4 mm -55.75 -38.42 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.152 -0.968 . . . . 0.0 109.888 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -57.47 -32.54 67.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.595 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 81.8 tt0 -59.72 -43.25 94.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.423 -0.798 . . . . 0.0 110.136 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -147.22 157.31 45.98 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.214 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.558 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -61.55 -48.1 10.06 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.856 1.451 . . . . 0.0 110.6 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.23 -139.98 25.75 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.969 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 32.1 p -84.06 -16.52 43.51 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -1.156 . . . . 0.0 109.954 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.578 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 41.1 t -57.46 -48.72 78.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.986 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.3 tt0 -61.97 -28.03 69.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 111.241 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.674 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.5 pt -97.54 7.26 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.863 -1.148 . . . . 0.0 110.304 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.0 m 61.33 15.86 6.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.0 110.614 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.969 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.2 -16.61 64.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -0.999 . . . . 0.0 109.853 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 87' ' ' ALA . 27.4 m-85 -138.81 166.65 23.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.922 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.7 2.29 10.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.314 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.29 -32.79 73.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.563 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.771 ' SG ' HG13 ' A' ' 1' ' ' VAL . 0.1 OUTLIER -102.84 116.95 33.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.64 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 1.005 HG21 ' OE1' ' A' ' 4' ' ' GLN . 17.7 p -105.39 157.81 17.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 110.133 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.33 -26.0 24.75 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.326 -1.103 . . . . 0.0 110.289 179.938 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 94' ' ' CYS . 10.6 t . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.21 0.528 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 35.5 m -120.33 149.25 42.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 110.335 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.881 HG23 HD11 ' A' ' 12' ' ' LEU . 91.2 t -84.36 117.6 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.336 -0.853 . . . . 0.0 109.774 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.737 ' CD ' HG21 ' A' ' 92' ' ' THR . 19.4 pt20 -111.81 146.09 38.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.178 -0.951 . . . . 0.0 110.869 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.679 ' OD2' HD21 ' A' ' 73' ' ' LEU . 94.0 m-20 -106.13 13.26 29.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 109.792 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.89 -126.96 1.38 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -84.87 5.88 27.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -1.213 . . . . 0.0 110.111 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 87.2 m-85 -124.86 138.58 54.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.24 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.484 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 78.4 p -96.86 137.94 35.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.217 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.74 ' CG ' HD21 ' A' ' 57' ' ' LEU . 24.6 m-85 -125.14 138.04 54.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.277 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.4 t -69.96 165.66 21.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.317 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.881 HD11 HG23 ' A' ' 3' ' ' VAL . 4.5 mp -97.67 -13.29 21.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.874 . . . . 0.0 110.328 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.422 ' OE2' ' HD3' ' A' ' 33' ' ' ARG . 70.9 mm-40 -68.66 -73.36 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.29 -0.881 . . . . 0.0 110.614 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 13' ' ' GLU . 4.0 m -42.49 -48.67 5.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.461 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.704 HG11 ' HB3' ' A' ' 73' ' ' LEU . 36.2 t -58.31 -45.24 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.946 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -56.95 -56.64 19.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.949 . . . . 0.0 109.086 179.043 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -80.61 11.81 3.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -0.811 . . . . 0.0 109.945 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.0 tt -62.06 -41.74 98.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -73.84 -64.52 0.99 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 110.108 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -58.06 -37.8 75.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.034 HD11 ' HB2' ' A' ' 52' ' ' ASN . 16.0 tp . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.302 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.508 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 76.3 mtt85 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.248 0.547 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.551 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 70.5 m-20 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 0.0 110.315 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.512 ' CA ' ' OE1' ' A' ' 74' ' ' GLU . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.86 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.82 -75.16 1.29 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -167.5 144.85 3.78 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.323 -1.104 . . . . 0.0 110.24 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -62.65 138.34 69.18 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.903 1.475 . . . . 0.0 110.517 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' A' ' 49' ' ' SER . 19.7 m -143.0 127.39 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 110.251 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 44' ' ' VAL . 69.4 t . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.994 . . . . 0.0 110.97 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 59.1 m . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.618 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 87.7 p -65.55 -42.23 92.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.021 . . . . 0.0 110.616 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.528 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 8.7 m120 -80.09 110.46 16.34 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.349 -0.845 . . . . 0.0 110.258 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.618 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -60.31 -17.86 49.29 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.734 1.386 . . . . 0.0 110.821 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 1.034 ' HB2' HD11 ' A' ' 21' ' ' LEU . 90.4 m-20 -126.61 36.26 4.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 110.722 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.628 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -80.28 172.97 8.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.078 -1.014 . . . . 0.0 108.954 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.5 Cg_exo -58.03 75.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.507 1.267 . . . . 0.0 108.959 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 53' ' ' PHE . 84.7 tt0 -39.4 -28.43 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.635 -0.666 . . . . 0.0 110.184 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt-10 -52.45 -17.04 1.04 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.053 -1.029 . . . . 0.0 108.65 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.74 HD21 ' CG ' ' A' ' 10' ' ' PHE . 62.2 mt -90.46 9.53 28.84 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.475 0.655 . . . . 0.0 109.583 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.757 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 12.9 mttt -39.87 -50.98 5.66 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 110.427 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.757 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.49 -42.62 66.39 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.596 1.314 . . . . 0.0 109.985 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.057 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 7.6 mp -57.92 -39.48 78.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.973 -1.079 . . . . 0.0 109.902 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.5 m -66.17 -28.86 69.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.128 -0.982 . . . . 0.0 110.474 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -89.6 5.96 43.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 111.145 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 10.0 pt-20 -121.97 148.75 52.25 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.947 -1.095 . . . . 0.0 110.305 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.8 Cg_endo -63.59 -20.34 69.18 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.988 1.52 . . . . 0.0 111.565 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.511 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 79.4 m-20 -80.03 -10.35 59.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.98 -1.075 . . . . 0.0 110.605 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.057 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.43 -45.43 25.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -0.93 . . . . 0.0 110.674 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.0 mt-30 -59.0 -42.55 90.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.903 . . . . 0.0 110.561 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -76.85 -31.91 57.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.093 -1.004 . . . . 0.0 110.152 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.784 HG21 ' CD2' ' A' ' 60' ' ' LEU . 99.8 mt -74.45 -46.03 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.923 . . . . 0.0 110.144 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.66 HD11 ' OE2' ' A' ' 74' ' ' GLU . 1.7 tm? -48.89 -59.3 3.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.882 . . . . 0.0 110.563 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.607 ' N ' HD13 ' A' ' 70' ' ' LEU . 98.3 mt-30 -49.59 -52.93 26.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.059 -1.026 . . . . 0.0 110.096 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -51.41 -54.42 26.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 109.916 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.704 ' HB3' HG11 ' A' ' 15' ' ' VAL . 65.1 mt -51.26 -48.81 62.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.66 ' OE2' HD11 ' A' ' 70' ' ' LEU . 91.2 mt-10 -52.92 -48.4 67.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.062 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.29 -50.23 73.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.972 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.582 ' O ' ' O ' ' A' ' 79' ' ' ASP . 26.5 mm -62.97 -37.41 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.704 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.759 ' HB1' ' HB2' ' A' ' 16' ' ' LYS . . . -56.38 -33.84 66.12 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.475 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.525 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 86.8 tt0 -62.61 -41.34 98.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.456 -0.777 . . . . 0.0 110.524 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -148.23 168.65 10.69 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.214 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HD2' ' OD1' ' A' ' 79' ' ' ASP . 3.2 Cg_exo -58.59 -55.81 1.87 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.658 1.347 . . . . 0.0 110.495 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.831 ' C ' HG23 ' A' ' 82' ' ' THR . . . 72.04 47.65 30.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.929 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 1.2 p 72.45 -40.98 0.49 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.451 -1.029 . . . . 0.0 110.842 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 37.4 t -40.75 -47.46 2.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.941 -1.099 . . . . 0.0 109.907 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 86.4 tt0 -63.16 -42.75 99.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 111.006 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.798 HG13 ' HB2' ' A' ' 87' ' ' ALA . 2.5 pt -84.76 18.7 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.0 -1.063 . . . . 0.0 110.573 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 52.77 16.96 0.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 110.616 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.929 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.79 -22.4 65.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 109.758 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.581 ' CD1' ' CB ' ' A' ' 82' ' ' THR . 19.6 m-85 -131.91 170.26 15.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.762 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.42 0.1 34.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.104 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -59.12 -25.9 64.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 110.496 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -111.18 128.17 55.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.787 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.737 HG21 ' CD ' ' A' ' 4' ' ' GLN . 22.6 p -114.37 163.95 14.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 110.064 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.495 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 88.76 -24.13 13.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.534 ' O ' ' CG2' ' A' ' 1' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.331 -1.099 . . . . 0.0 110.497 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.545 HG13 ' SG ' ' A' ' 91' ' ' CYS . 92.2 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.222 0.534 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.451 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 60.1 m -126.15 149.21 49.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 110.568 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.789 HG23 HD11 ' A' ' 12' ' ' LEU . 92.4 t -82.42 110.83 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.514 -0.741 . . . . 0.0 109.519 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.645 ' CB ' HG21 ' A' ' 92' ' ' THR . 35.3 tt0 -112.78 133.43 54.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 110.685 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -96.03 -71.68 0.66 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 109.421 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.0 -129.76 6.81 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -79.76 4.27 16.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -1.177 . . . . 0.0 110.655 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.51 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 99.2 m-85 -119.05 134.44 55.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.058 -1.026 . . . . 0.0 110.656 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.451 ' OG ' ' CG2' ' A' ' 2' ' ' THR . 27.1 t -87.16 135.61 33.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.861 . . . . 0.0 109.97 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.657 ' CE1' HD23 ' A' ' 57' ' ' LEU . 69.6 m-85 -115.56 125.86 53.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 111.005 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.473 ' C ' HD12 ' A' ' 12' ' ' LEU . 23.0 t -76.43 173.14 11.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.85 . . . . 0.0 109.796 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.03 HD23 ' HA ' ' A' ' 77' ' ' ALA . 4.5 mp -103.27 4.81 36.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.046 -1.034 . . . . 0.0 110.756 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 86.0 tt0 -71.89 -73.03 0.2 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.068 -1.02 . . . . 0.0 110.693 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.504 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 6.1 m -49.06 -45.72 43.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.081 -1.012 . . . . 0.0 110.684 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.637 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 24.2 t -58.38 -50.95 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.967 -1.083 . . . . 0.0 109.746 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.491 ' HE2' ' OD1' ' A' ' 34' ' ' ASN . 51.1 tttm -54.49 -54.45 40.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.779 -1.201 . . . . 0.0 108.656 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -80.47 14.46 2.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -0.756 . . . . 0.0 109.615 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.637 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 35.4 tp -61.44 -40.37 94.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -0.894 . . . . 0.0 110.198 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.506 ' HE3' ' HG3' ' A' ' 41' ' ' GLU . 28.4 mtpt -61.02 -44.68 97.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.004 . . . . 0.0 109.842 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -111.33 115.08 28.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.643 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.557 ' CG ' ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.006 . . . . 0.0 110.715 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 12' ' ' LEU . 82.3 mtt85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.232 0.539 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.596 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 33.2 p-10 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 110.245 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . 3.1 Cg_exo . . . . . 0 N--CA 1.482 0.812 0 N-CA-C 110.489 -0.62 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.402 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . -153.46 18.88 0.7 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HG3' ' HE3' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -125.52 74.96 69.49 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.283 -1.128 . . . . 0.0 110.2 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.65 146.81 96.51 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.885 1.466 . . . . 0.0 110.462 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.103 HG23 HG23 ' A' ' 44' ' ' VAL . 11.0 m -123.12 172.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 110.383 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.103 HG23 HG23 ' A' ' 43' ' ' VAL . 2.9 t . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.452 -0.78 . . . . 0.0 111.015 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.2 m . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.396 0.617 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.588 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.3 t -68.78 -64.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 110.668 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 11.1 m-20 -79.51 111.8 23.76 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.382 -0.824 . . . . 0.0 110.464 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -63.95 -9.02 17.51 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.694 1.365 . . . . 0.0 110.358 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.557 ' HB3' ' CG ' ' A' ' 21' ' ' LEU . 50.3 t-20 -131.1 30.98 4.49 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.289 -0.882 . . . . 0.0 110.178 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.745 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -77.15 -175.6 0.53 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 108.836 179.275 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.948 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.7 Cg_exo -59.02 73.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.536 1.282 . . . . 0.0 109.067 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.3 tt0 -39.43 -32.04 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.688 -0.633 . . . . 0.0 110.562 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.441 ' O ' ' HE1' ' A' ' 10' ' ' PHE . 46.5 tp10 -52.28 -25.3 9.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.957 -1.089 . . . . 0.0 108.625 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.948 HD12 ' HG2' ' A' ' 54' ' ' PRO . 89.2 mt -83.82 12.76 5.57 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.383 0.611 . . . . 0.0 109.814 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.729 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.58 -51.63 4.96 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.93 . . . . 0.0 110.532 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.94 -45.09 41.23 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.551 1.29 . . . . 0.0 110.184 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.021 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 2.8 mm? -53.81 -44.0 69.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.023 -1.048 . . . . 0.0 110.148 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.3 t -68.76 -29.1 67.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 0.0 110.312 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -79.95 3.29 20.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.622 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.533 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 9.7 pt-20 -126.39 141.65 40.59 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 110.155 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.1 Cg_exo -61.16 -11.18 17.71 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.903 1.475 . . . . 0.0 110.667 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -79.88 -15.63 56.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.123 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.021 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -48.54 -36.41 15.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.34 -41.12 98.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 110.093 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -80.45 -40.91 25.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 109.84 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.963 HG21 ' CD1' ' A' ' 60' ' ' LEU . 84.6 mt -64.39 -41.29 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.037 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.779 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.2 tm? -53.02 -55.19 25.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 110.396 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.779 ' N ' HD13 ' A' ' 70' ' ' LEU . 94.7 mt-30 -50.46 -55.37 16.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 0.0 110.186 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -52.57 -57.0 11.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.055 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 35.4 mt -46.82 -49.66 19.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 110.083 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 77.8 mm-40 -54.48 -49.27 70.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.331 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 85.4 tt0 -56.3 -55.91 27.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.721 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 79' ' ' ASP . 28.9 mm -56.75 -36.53 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.062 -1.024 . . . . 0.0 109.462 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 1.03 ' HA ' HD23 ' A' ' 12' ' ' LEU . . . -59.33 -30.03 68.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.502 -0.749 . . . . 0.0 109.275 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 34' ' ' ASN . 85.9 tt0 -62.36 -41.6 98.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 110.321 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.1 p30 -147.0 158.37 45.1 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.196 -0.94 . . . . 0.0 110.482 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.576 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.53 -57.5 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.969 1.51 . . . . 0.0 110.636 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.36 -140.74 24.92 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.944 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 60.4 p -78.14 -22.34 48.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -1.158 . . . . 0.0 109.635 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 52.9 t -52.27 -53.05 48.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 110.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.0 tt0 -57.66 -34.28 69.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 111.261 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.781 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.3 pt -95.11 12.65 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.931 -1.106 . . . . 0.0 110.446 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.8 m 56.47 15.64 2.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 0.0 110.497 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.944 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -66.56 -10.14 42.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 110.026 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -146.19 167.97 22.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 110.387 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.23 4.83 6.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 0.0 110.493 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.68 88.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 110.519 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -99.03 121.95 41.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.526 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.645 HG21 ' CB ' ' A' ' 4' ' ' GLN . 24.8 p -110.58 152.94 25.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.161 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.73 -20.01 51.12 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.272 -1.134 . . . . 0.0 110.231 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.79 HG13 ' O ' ' A' ' 1' ' ' VAL . 14.6 p . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.24 0.543 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 58.4 m -123.33 152.81 41.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.426 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.858 HG23 HD11 ' A' ' 12' ' ' LEU . 52.0 t -82.36 112.19 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.641 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HG21 ' A' ' 92' ' ' THR . 41.4 tt0 -111.49 123.49 50.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.098 -1.001 . . . . 0.0 110.71 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.606 ' OD2' HG23 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -79.73 -77.12 0.19 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 0.0 109.386 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.71 -124.54 5.36 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -81.84 3.64 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -1.152 . . . . 0.0 110.379 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.2 m-85 -114.57 132.9 56.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.145 -0.972 . . . . 0.0 110.436 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.412 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 51.6 p -85.57 130.11 34.66 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.728 ' CG ' HD21 ' A' ' 57' ' ' LEU . 18.4 m-85 -118.71 130.18 55.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 110.703 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.7 p -75.69 170.22 16.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.163 -0.961 . . . . 0.0 110.268 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.858 HD11 HG23 ' A' ' 3' ' ' VAL . 4.5 mp -95.91 -6.45 39.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 110.519 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.7 mt-10 -70.95 -71.62 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.222 -0.924 . . . . 0.0 110.667 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.473 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 4.3 m -43.17 -52.1 5.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.309 -0.869 . . . . 0.0 110.567 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.63 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 15.8 m -56.41 -49.33 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.942 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 14.4 tttp -55.27 -51.66 65.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.981 -1.074 . . . . 0.0 108.8 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -80.41 11.26 3.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.455 -0.778 . . . . 0.0 109.736 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.63 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 27.2 tp -64.58 -33.68 76.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.89 . . . . 0.0 109.948 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -62.19 -42.4 99.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 109.667 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -104.88 124.62 49.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.412 -0.805 . . . . 0.0 109.61 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.83 HD11 ' HB2' ' A' ' 52' ' ' ASN . 15.1 tp . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 110.576 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.542 ' HB3' ' HD2' ' A' ' 16' ' ' LYS . 95.4 mtt-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.196 0.522 . . . . 0.0 110.126 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.558 ' CA ' ' O ' ' A' ' 78' ' ' GLU . 32.6 p-10 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.426 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.552 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.481 0.77 0 N-CA-C 110.64 -0.562 . . . . 0.0 110.64 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.68 7.53 31.62 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 43.6 mt-10 -82.67 145.18 50.18 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.336 -1.097 . . . . 0.0 110.101 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -61.8 122.91 11.67 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.79 1.416 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.019 HG12 HG23 ' A' ' 44' ' ' VAL . 94.7 t -141.87 158.22 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.955 . . . . 0.0 110.506 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.019 HG23 HG12 ' A' ' 43' ' ' VAL . 25.8 t . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.456 -0.777 . . . . 0.0 111.169 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.0 m . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.413 0.625 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.581 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 47.0 t -77.47 -70.82 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.029 -1.044 . . . . 0.0 110.155 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.518 ' CG ' HD13 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -76.7 111.96 19.21 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.494 -0.753 . . . . 0.0 110.263 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.613 ' HD2' HD22 ' A' ' 21' ' ' LEU . 3.0 Cg_exo -63.57 -10.04 20.44 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.627 1.33 . . . . 0.0 110.324 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.83 ' HB2' HD11 ' A' ' 21' ' ' LEU . 94.0 m-20 -127.03 31.62 5.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.727 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.08 -179.35 1.39 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 108.948 179.232 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.758 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.8 Cg_exo -59.36 75.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.562 1.296 . . . . 0.0 109.044 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.601 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.7 tt0 -39.27 -27.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.723 -0.611 . . . . 0.0 110.174 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' PRO . 74.3 mm-40 -53.68 -17.85 2.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.107 -0.996 . . . . 0.0 108.554 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.758 HD12 ' HG2' ' A' ' 54' ' ' PRO . 86.3 mt -91.54 9.63 31.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.658 -0.651 . . . . 0.0 109.608 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.747 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -39.54 -51.49 4.93 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.85 . . . . 0.0 110.756 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.747 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.05 -42.86 63.44 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.495 1.26 . . . . 0.0 109.784 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.902 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 4.1 tt -57.48 -38.85 75.22 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.116 -0.99 . . . . 0.0 109.77 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.892 ' HA ' HG13 ' A' ' 44' ' ' VAL . 49.3 t -63.61 -29.27 70.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 110.474 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.521 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 53.4 mttp -104.05 30.41 5.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.596 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.521 ' OE1' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -129.5 136.74 29.58 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.407 -0.808 . . . . 0.0 110.437 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.8 Cg_endo -64.2 -27.03 64.52 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.662 1.349 . . . . 0.0 109.883 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -81.32 -11.06 59.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 110.846 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.902 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.98 -38.29 16.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.029 -1.045 . . . . 0.0 110.126 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.76 -40.72 80.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -80.27 -39.43 28.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.763 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.712 HG21 HD12 ' A' ' 60' ' ' LEU . 81.1 mt -64.62 -51.39 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.335 -0.853 . . . . 0.0 109.956 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.784 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.4 tm? -46.8 -58.45 3.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.389 -0.82 . . . . 0.0 110.113 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.673 ' N ' HD13 ' A' ' 70' ' ' LEU . 55.7 tt0 -44.85 -51.56 9.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -58.72 -56.5 21.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.431 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.502 HD21 ' OD1' ' A' ' 5' ' ' ASP . 47.6 mt -47.12 -53.1 13.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 0.0 110.216 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.577 ' OE2' HD21 ' A' ' 70' ' ' LEU . 52.4 mt-10 -57.22 -46.06 83.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 110.406 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -57.99 -53.71 55.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.953 -1.092 . . . . 0.0 110.127 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 79' ' ' ASP . 54.2 mt -60.94 -33.94 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.15 -0.969 . . . . 0.0 109.403 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -57.73 -33.69 68.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.379 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.558 ' O ' ' CA ' ' A' ' 34' ' ' ASN . 84.4 tt0 -61.71 -40.81 96.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.479 -0.763 . . . . 0.0 110.22 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -147.11 155.4 47.01 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.078 -1.014 . . . . 0.0 110.26 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.486 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -59.1 -62.27 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.786 1.414 . . . . 0.0 110.669 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.78 -139.07 21.73 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.95 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 45.4 p -81.03 -21.28 40.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -1.148 . . . . 0.0 109.973 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 9.1 t -53.8 -54.09 43.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.965 . . . . 0.0 109.99 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 34.6 tt0 -58.13 -31.05 66.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.331 -0.856 . . . . 0.0 111.113 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.775 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.6 pt -97.26 12.08 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.991 -1.068 . . . . 0.0 110.322 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 34.2 m 54.07 18.73 1.81 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.887 . . . . 0.0 110.578 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.95 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.13 -12.28 59.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 0.0 110.067 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.555 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 26.9 m-85 -146.75 175.55 10.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.82 3.36 10.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 110.302 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.36 -32.46 73.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -114.5 123.37 49.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 0.0 110.564 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.567 HG21 ' OE1' ' A' ' 4' ' ' GLN . 27.0 p -117.13 161.01 20.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.378 -0.826 . . . . 0.0 110.211 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.47 -33.11 5.68 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.299 -1.118 . . . . 0.0 110.303 -179.889 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 1' ' ' VAL . 3.2 m . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.096 0.474 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . 1.039 HG21 ' OG ' ' A' ' 9' ' ' SER . 9.6 t -129.09 163.18 26.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.76 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.835 HG23 HD11 ' A' ' 12' ' ' LEU . 50.8 t -84.41 116.43 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.84 ' OE1' HG21 ' A' ' 92' ' ' THR . 46.4 tt0 -108.61 111.69 23.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.032 -1.042 . . . . 0.0 110.951 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.672 ' OD2' HD21 ' A' ' 73' ' ' LEU . 89.8 m-20 -94.26 4.45 53.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.25 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.509 ' O ' ' CG ' ' A' ' 4' ' ' GLN . . . -169.64 -148.1 5.73 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.32 8.96 6.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -1.167 . . . . 0.0 110.516 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.466 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 95.3 m-85 -119.84 147.82 44.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.031 -1.043 . . . . 0.0 110.51 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 1.039 ' OG ' HG21 ' A' ' 2' ' ' THR . 2.0 t -89.03 120.97 30.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 109.829 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.679 ' CD2' HD23 ' A' ' 57' ' ' LEU . 92.9 m-85 -108.43 117.77 35.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.177 -0.952 . . . . 0.0 110.867 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.481 ' C ' HD12 ' A' ' 12' ' ' LEU . 60.4 p -71.64 169.6 15.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 109.528 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.844 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.1 mp -104.49 -0.93 27.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.978 -1.076 . . . . 0.0 110.763 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -67.13 -69.97 0.28 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.124 -0.985 . . . . 0.0 110.715 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.1 m -42.42 -50.99 5.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.344 -0.848 . . . . 0.0 111.165 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.674 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.6 m -57.79 -48.05 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.102 -0.999 . . . . 0.0 109.669 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.773 ' CG ' ' HB1' ' A' ' 77' ' ' ALA . 15.7 mttt -54.86 -54.58 40.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.1 -1.0 . . . . 0.0 108.811 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 48.1 tttt -80.43 11.02 3.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -0.766 . . . . 0.0 109.552 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.674 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 16.8 tp -59.62 -33.41 71.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -0.97 . . . . 0.0 110.069 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -67.23 -39.23 86.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.589 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 24.7 t70 -118.14 88.15 2.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.633 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 52' ' ' ASN . 6.3 tp . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.39 -0.819 . . . . 0.0 111.045 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 32.6 ptt180 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.272 0.558 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 33' ' ' ARG . 92.0 m-20 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 110.085 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.525 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.804 0 N-CA-C 110.546 -0.598 . . . . 0.0 110.546 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.47 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 104.58 20.77 9.78 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -122.32 74.02 40.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.233 -1.157 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_endo -61.09 143.61 99.02 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.936 1.493 . . . . 0.0 110.583 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.485 ' HB ' ' OG ' ' A' ' 49' ' ' SER . 6.0 m -140.25 54.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.815 ' O ' HG12 ' A' ' 44' ' ' VAL . 54.8 t . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.258 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.564 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 87.2 m . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.311 0.577 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.512 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 60.7 p -60.87 -39.3 88.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.994 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.553 ' HB3' HD22 ' A' ' 21' ' ' LEU . 10.5 m-20 -80.54 113.77 42.26 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.48 -7.63 9.15 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.681 1.359 . . . . 0.0 110.87 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.797 ' HB2' HD21 ' A' ' 21' ' ' LEU . 93.1 m-20 -137.29 31.46 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 110.665 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.769 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.2 p90 -73.34 -175.7 0.41 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.13 -0.981 . . . . 0.0 108.762 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.938 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.9 Cg_exo -60.57 73.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.494 1.26 . . . . 0.0 108.863 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.584 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.1 tt0 -39.22 -31.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.724 -0.61 . . . . 0.0 110.34 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 54' ' ' PRO . 97.4 mt-10 -53.71 -26.72 24.27 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.969 -1.082 . . . . 0.0 108.721 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.938 HD12 ' HG2' ' A' ' 54' ' ' PRO . 90.7 mt -84.38 7.38 19.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.731 -0.605 . . . . 0.0 109.534 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.731 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 7.3 mmtt -39.59 -51.62 4.98 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 110.303 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.731 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.53 -44.91 43.82 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.588 1.31 . . . . 0.0 109.824 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.099 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -52.06 -43.81 63.99 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.054 -1.029 . . . . 0.0 109.844 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.6 m -66.96 -27.52 67.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.371 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -82.63 4.97 22.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.902 . . . . 0.0 110.736 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 8.5 pt-20 -127.98 144.7 52.44 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.025 -1.047 . . . . 0.0 110.229 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.16 -12.66 27.75 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.881 1.464 . . . . 0.0 110.736 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.491 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 83.7 m-20 -80.12 -18.41 49.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.892 . . . . 0.0 110.201 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.099 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.19 -39.36 13.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 110.22 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.06 -44.2 87.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 110.296 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -80.2 -39.12 29.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.208 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.979 HG21 ' CD1' ' A' ' 60' ' ' LEU . 77.8 mt -64.42 -47.45 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.563 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.8 tm? -49.06 -57.27 6.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.537 ' N ' HD13 ' A' ' 70' ' ' LEU . 51.5 tt0 -49.55 -53.02 25.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.114 -0.991 . . . . 0.0 110.013 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -55.01 -50.4 69.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.672 HD21 ' OD2' ' A' ' 5' ' ' ASP . 96.0 mt -51.07 -50.08 59.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.761 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 70.6 mm-40 -53.99 -52.56 60.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 110.292 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.525 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.2 tt0 -52.69 -55.06 25.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 110.499 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 79' ' ' ASP . 28.2 mm -56.85 -34.36 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 0.0 109.41 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.773 ' HB1' ' CG ' ' A' ' 16' ' ' LYS . . . -59.21 -32.79 70.26 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.498 ' OE2' ' HD3' ' A' ' 39' ' ' PRO . 95.4 mt-10 -59.4 -41.2 88.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 110.139 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -149.26 155.3 39.68 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.641 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -60.15 -57.28 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.88 1.463 . . . . 0.0 110.575 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.12 -138.95 19.98 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.775 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 43.6 p -81.09 -21.04 40.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -1.176 . . . . 0.0 109.742 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.576 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 20.7 t -55.2 -53.01 61.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.86 . . . . 0.0 110.184 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 35.5 tt0 -62.49 -27.09 68.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.933 . . . . 0.0 111.407 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.778 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.9 pt -98.01 14.07 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.757 -1.214 . . . . 0.0 110.433 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 50.9 19.74 0.68 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 0.0 110.714 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.778 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -68.82 -11.85 60.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.067 -1.02 . . . . 0.0 110.025 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -148.62 175.4 11.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 110.085 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.41 1.73 15.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.048 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.94 75.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.314 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -105.83 128.15 53.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 110.536 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.84 HG21 ' OE1' ' A' ' 4' ' ' GLN . 33.2 p -110.79 155.79 22.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 110.109 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 93.54 -19.32 53.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.259 -1.142 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.495 ' HA ' ' SG ' ' A' ' 91' ' ' CYS . 25.6 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.266 0.555 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 68.0 m -123.78 148.39 46.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 110.446 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.653 HG21 ' HG ' ' A' ' 12' ' ' LEU . 47.8 t -79.82 110.38 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.307 -0.87 . . . . 0.0 109.742 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.514 ' CD ' HG21 ' A' ' 92' ' ' THR . 43.7 tt0 -110.41 121.09 44.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -0.95 . . . . 0.0 110.716 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.847 ' OD2' HD11 ' A' ' 73' ' ' LEU . 85.0 m-20 -95.94 6.12 49.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 109.576 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 4' ' ' GLN . . . -175.45 -139.85 3.21 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -79.8 3.21 20.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -1.19 . . . . 0.0 110.419 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 83.3 m-85 -121.32 131.15 54.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 110.359 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 2' ' ' THR . 67.8 m -79.96 132.3 36.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.336 -0.852 . . . . 0.0 110.201 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.754 ' CG ' HD21 ' A' ' 57' ' ' LEU . 22.1 m-85 -116.56 128.91 55.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 110.6 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 m -69.25 162.27 27.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.922 . . . . 0.0 110.349 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.747 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.2 mp -87.39 -25.87 23.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.867 . . . . 0.0 110.23 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.507 ' HG3' ' NE ' ' A' ' 33' ' ' ARG . 87.8 tt0 -61.77 -65.6 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.294 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.555 ' O ' ' CB ' ' A' ' 18' ' ' LEU . 4.4 m -43.83 -54.55 5.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.137 -0.977 . . . . 0.0 110.422 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.63 HG23 ' N ' ' A' ' 16' ' ' LYS . 30.3 m -61.46 -48.32 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 110.348 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.635 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 8.7 ttmm -59.33 -55.5 33.97 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.074 -1.016 . . . . 0.0 109.371 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' OD1' ' A' ' 20' ' ' ASP . 28.9 mmtp -80.46 6.78 11.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.367 -0.833 . . . . 0.0 110.124 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.675 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -73.21 -30.89 63.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.95 -1.094 . . . . 0.0 109.869 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -56.41 -39.09 72.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 109.748 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 26.3 p-10 -111.53 98.08 7.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.849 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.766 HD21 ' HB2' ' A' ' 52' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 110.498 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.507 ' NE ' ' HG3' ' A' ' 13' ' ' GLU . 71.3 mtt-85 . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 80.1 m-20 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.055 . . . . 0.0 111.205 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.568 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 3.1 Cg_exo . . . . . 0 N--CA 1.482 0.85 0 N-CA-C 110.684 -0.545 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.509 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 95.31 14.68 47.14 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.527 ' O ' HG23 ' A' ' 43' ' ' VAL . 19.3 mm-40 -114.71 106.64 51.82 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.188 -1.183 . . . . 0.0 110.157 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.464 ' C ' HG23 ' A' ' 43' ' ' VAL . 3.0 Cg_exo -60.9 144.65 99.61 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.822 1.433 . . . . 0.0 110.478 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.777 ' O ' HG23 ' A' ' 44' ' ' VAL . 38.6 t -147.67 54.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 110.234 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.79 ' O ' HG12 ' A' ' 44' ' ' VAL . 24.9 t . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.301 -0.874 . . . . 0.0 110.767 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.571 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 94.2 m . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.256 0.55 . . . . 0.0 109.8 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.583 ' HB3' ' CG1' ' A' ' 43' ' ' VAL . 4.6 t -54.68 -58.1 8.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 111.113 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.457 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -80.09 113.18 36.36 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.33 -0.856 . . . . 0.0 110.853 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -66.03 -13.32 39.32 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.68 1.358 . . . . 0.0 110.298 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.766 ' HB2' HD21 ' A' ' 21' ' ' LEU . 25.8 m120 -116.08 21.27 13.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 0.0 110.471 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.656 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -79.89 175.05 5.17 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 108.983 179.23 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.664 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.5 Cg_exo -57.59 75.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.63 1.331 . . . . 0.0 108.904 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.614 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.7 tt0 -39.44 -28.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.675 -0.641 . . . . 0.0 110.27 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.502 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.7 mt-10 -52.82 -19.37 2.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.023 -1.048 . . . . 0.0 108.55 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.754 HD21 ' CG ' ' A' ' 10' ' ' PHE . 68.0 mt -86.11 4.05 39.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.634 -0.666 . . . . 0.0 109.398 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.758 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -39.92 -51.18 5.68 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.502 -0.748 . . . . 0.0 110.375 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.758 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.32 -40.57 82.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.615 1.324 . . . . 0.0 110.382 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.114 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 6.5 mp -62.24 -36.66 82.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.92 -1.113 . . . . 0.0 109.885 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.4 m -64.79 -28.02 69.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 110.257 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -79.85 -10.23 59.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.609 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.493 ' OE2' ' HB2' ' A' ' 65' ' ' ASN . 8.4 pt-20 -114.67 144.1 31.24 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.014 . . . . 0.0 110.16 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.38 -11.74 27.19 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.875 1.461 . . . . 0.0 110.919 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.493 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 75.6 m-20 -81.39 -14.99 56.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 110.419 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.114 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -48.03 -39.99 21.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.171 -0.956 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -61.05 -39.69 90.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 110.101 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -80.03 -36.57 35.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.972 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.806 HG21 ' CD2' ' A' ' 60' ' ' LEU . 86.6 mt -68.43 -43.06 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.873 . . . . 0.0 109.922 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.764 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.7 OUTLIER -51.83 -54.72 25.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -0.82 . . . . 0.0 110.435 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.764 ' N ' HD13 ' A' ' 70' ' ' LEU . 64.1 tt0 -49.64 -54.9 15.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.102 -0.999 . . . . 0.0 110.664 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -50.36 -54.15 23.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.39 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.847 HD11 ' OD2' ' A' ' 5' ' ' ASP . 54.7 mt -50.26 -47.88 55.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.9 . . . . 0.0 110.406 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.625 ' OE2' HD11 ' A' ' 70' ' ' LEU . 80.3 mt-10 -55.6 -45.88 77.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 110.453 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 96.1 mt-10 -58.64 -54.4 47.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.049 -1.032 . . . . 0.0 110.674 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.9 mt -61.16 -37.63 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.059 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.635 ' HB1' ' HB2' ' A' ' 16' ' ' LYS . . . -61.36 -32.85 72.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.457 -0.777 . . . . 0.0 110.054 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 80.3 tt0 -58.44 -35.88 72.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.653 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.45 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -156.54 151.01 20.13 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.683 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.542 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 3.2 Cg_exo -61.67 82.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.012 1.532 . . . . 0.0 110.702 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.53 -134.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.934 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 72.1 p -79.29 -14.37 59.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.12 -1.223 . . . . 0.0 109.545 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 19.6 t -54.16 -52.11 62.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 110.324 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.542 ' OE1' ' HB2' ' A' ' 80' ' ' PRO . 84.2 tt0 -56.6 -33.01 65.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.208 -0.933 . . . . 0.0 111.272 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.774 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.6 pt -98.05 11.76 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.897 -1.127 . . . . 0.0 110.441 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.8 m 54.3 17.12 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.883 . . . . 0.0 110.553 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.934 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.62 -11.1 41.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 109.9 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.47 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.5 OUTLIER -144.33 172.12 13.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.265 -0.897 . . . . 0.0 110.096 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.54 4.2 6.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 110.38 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.31 -35.26 80.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.0 110.634 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.594 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -106.57 121.16 43.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 0.0 110.632 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.514 HG21 ' CD ' ' A' ' 4' ' ' GLN . 14.6 p -104.92 156.08 18.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 110.126 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.38 -4.39 64.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.204 -1.174 . . . . 0.0 110.273 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.254 0.55 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 55.7 m -89.55 151.36 21.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 0.0 110.34 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 10' ' ' PHE . 0.9 OUTLIER -91.61 120.36 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.463 -0.773 . . . . 0.0 109.873 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 49.0 tt0 -110.27 130.05 55.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.644 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.762 ' OD2' HD21 ' A' ' 73' ' ' LEU . 90.4 m-20 -111.69 9.06 20.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 109.802 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.91 -135.98 2.6 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -81.87 -1.48 47.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -1.195 . . . . 0.0 110.199 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.493 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 55.4 m-85 -119.48 143.77 47.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.214 -0.929 . . . . 0.0 110.325 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.7 p -90.38 128.76 36.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 110.172 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.592 ' CE2' ' HG ' ' A' ' 57' ' ' LEU . 21.7 m-30 -110.01 118.81 37.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.247 -0.908 . . . . 0.0 110.335 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.2 t -70.19 166.95 18.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.0 110.016 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 mp -95.22 1.25 54.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.196 -0.94 . . . . 0.0 110.628 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -74.54 -69.88 0.43 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.213 -0.929 . . . . 0.0 110.461 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 18' ' ' LEU . 3.8 m -52.03 -38.75 58.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.836 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 9.3 t -67.42 -55.41 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.909 -1.119 . . . . 0.0 109.84 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.509 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 39.9 tttp -53.62 -55.78 22.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.941 -1.1 . . . . 0.0 108.904 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 20' ' ' ASP . 52.1 tttt -80.33 8.81 6.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.446 -0.784 . . . . 0.0 109.829 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 5.5 tt -55.7 -43.01 76.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 110.173 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -58.84 -49.14 78.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.934 . . . . 0.0 110.022 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 60.7 t0 -98.81 107.27 19.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 109.867 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 110.438 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.442 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.238 0.542 . . . . 0.0 109.97 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 78' ' ' GLU . 83.3 m-20 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.468 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.523 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.1 Cg_exo . . . . . 0 N--CA 1.481 0.789 0 N-CA-C 110.617 -0.57 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.484 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 146.78 -8.92 1.34 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.55 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -119.46 76.47 18.3 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.001 -1.294 . . . . 0.0 110.474 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.707 ' HA ' HD12 ' A' ' 70' ' ' LEU . 2.9 Cg_endo -62.56 128.48 23.61 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.818 1.431 . . . . 0.0 110.473 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.2 m -135.69 142.96 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.026 HG22 ' HA ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.398 -0.814 . . . . 0.0 110.305 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.368 0.604 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.494 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 9.2 t -56.62 -60.19 3.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.0 110.455 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.556 ' ND2' ' HB2' ' A' ' 21' ' ' LEU . 8.4 m120 -80.26 114.26 45.56 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 0.0 110.273 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -61.7 -5.04 5.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.8 1.421 . . . . 0.0 111.028 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.559 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 94.5 m-20 -140.32 33.73 1.88 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.143 -0.973 . . . . 0.0 110.347 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.746 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -75.28 -174.59 0.39 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 109.061 179.237 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.941 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -57.86 72.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.406 1.214 . . . . 0.0 109.921 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.5 tt0 -41.16 -36.03 0.68 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.711 . . . . 0.0 110.314 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.562 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.9 mt-10 -52.78 -19.31 2.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 108.829 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.941 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.2 mp -94.64 16.29 15.96 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.89 0.853 . . . . 0.0 109.113 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.738 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.76 -52.54 4.95 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.941 -0.474 . . . . 0.0 110.972 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.738 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.14 -44.87 45.33 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.506 1.266 . . . . 0.0 110.07 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.874 HD22 HD13 ' A' ' 69' ' ' ILE . 79.9 mt -59.04 -35.95 74.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.057 -1.027 . . . . 0.0 109.936 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.026 ' HA ' HG22 ' A' ' 44' ' ' VAL . 50.6 t -64.65 -25.02 67.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.025 . . . . 0.0 110.384 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -113.45 29.67 7.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.127 -0.983 . . . . 0.0 109.415 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.55 139.91 27.61 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.606 -0.684 . . . . 0.0 110.484 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.51 -27.4 76.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.65 1.342 . . . . 0.0 109.964 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.37 -16.7 53.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.153 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.0 ' HB1' HG21 ' A' ' 44' ' ' VAL . . . -43.56 -39.61 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -54.54 -43.64 72.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.863 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.48 ' HG2' ' NE ' ' A' ' 72' ' ' ARG . 86.5 tt0 -80.05 -38.75 31.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.949 . . . . 0.0 109.88 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.874 HD13 HD22 ' A' ' 60' ' ' LEU . 78.6 mt -63.38 -55.19 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.987 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.1 tm? -42.34 -64.55 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.436 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.987 ' N ' HD13 ' A' ' 70' ' ' LEU . 56.5 mt-30 -47.65 -53.39 15.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.077 -1.014 . . . . 0.0 110.465 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.48 ' NE ' ' HG2' ' A' ' 68' ' ' GLU . 62.2 mtt180 -54.87 -53.58 53.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 110.138 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.762 HD21 ' OD2' ' A' ' 5' ' ' ASP . 86.3 mt -49.86 -53.01 28.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 110.015 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.651 ' OE2' HD21 ' A' ' 70' ' ' LEU . 80.5 mt-10 -53.15 -45.11 68.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 110.237 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.485 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.1 tt0 -57.74 -54.02 51.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.353 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 79' ' ' ASP . 29.8 mm -59.43 -36.95 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.153 -0.967 . . . . 0.0 109.738 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 16' ' ' LYS . . . -58.16 -33.9 69.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 109.575 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.477 ' O ' ' O ' ' A' ' 34' ' ' ASN . 85.8 tt0 -60.31 -40.16 89.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.497 -0.752 . . . . 0.0 110.347 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 76' ' ' ILE . 9.5 m-20 -145.54 153.13 50.97 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.135 -0.978 . . . . 0.0 110.31 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -59.76 -58.55 0.56 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.884 1.465 . . . . 0.0 110.57 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.14 -137.88 19.12 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 1.002 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 53.1 p -82.38 -21.44 35.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -1.171 . . . . 0.0 110.107 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 38.9 t -54.58 -53.39 55.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 110.007 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 82.9 tt0 -60.33 -29.19 68.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 0.0 111.322 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.774 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.0 pt -97.22 13.54 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.863 -1.148 . . . . 0.0 110.276 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 62.9 m 55.43 15.15 1.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 0.0 110.574 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 1.002 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -63.72 -12.59 35.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.117 -0.989 . . . . 0.0 109.891 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.413 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 21.7 m-85 -149.48 173.8 13.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 110.324 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.46 3.85 10.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.393 -0.817 . . . . 0.0 110.453 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.66 -33.8 74.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.586 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -106.58 125.31 50.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.678 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -109.93 152.73 25.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.382 -0.824 . . . . 0.0 110.111 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.98 52.36 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.265 -1.139 . . . . 0.0 110.134 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.476 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 3.8 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.154 0.502 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.685 HG21 ' HB2' ' A' ' 9' ' ' SER . 8.4 t -123.51 161.24 25.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.923 . . . . 0.0 110.64 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.606 HG23 HD11 ' A' ' 12' ' ' LEU . 71.0 t -91.9 119.72 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.568 -0.708 . . . . 0.0 109.544 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.61 ' OE1' HG21 ' A' ' 92' ' ' THR . 36.5 mt-30 -110.49 135.01 51.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.96 . . . . 0.0 110.787 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.765 ' OD2' HD21 ' A' ' 73' ' ' LEU . 80.8 m-20 -104.76 11.07 34.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.202 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.28 -131.88 1.97 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -89.6 10.16 24.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.191 -1.182 . . . . 0.0 110.57 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 92.6 m-85 -114.79 154.75 27.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 110.385 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.685 ' HB2' HG21 ' A' ' 2' ' ' THR . 60.4 p -105.1 121.55 44.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.577 ' CE2' HD11 ' A' ' 60' ' ' LEU . 19.9 m-85 -118.99 128.06 54.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.942 . . . . 0.0 110.578 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 m -70.8 165.58 22.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.395 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.861 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 mp -96.37 -8.8 31.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.282 -0.886 . . . . 0.0 110.339 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' SER . 84.4 tt0 -70.97 -70.71 0.29 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.298 -0.876 . . . . 0.0 110.926 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.6 m -43.97 -48.85 8.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.161 -0.962 . . . . 0.0 110.677 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.691 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 14.3 m -59.46 -47.36 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.115 -0.991 . . . . 0.0 110.319 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.525 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 20.7 tttm -56.75 -55.27 36.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.831 -1.168 . . . . 0.0 109.075 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 20' ' ' ASP . 7.4 tptm -80.43 10.9 4.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.41 -0.806 . . . . 0.0 109.288 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 47.1 tp -56.31 -45.27 80.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 110.666 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -56.87 -46.28 81.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 110.191 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 22.3 t70 -105.78 122.26 45.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.915 . . . . 0.0 110.198 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.893 HD22 ' HB2' ' A' ' 52' ' ' ASN . 79.4 mt . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.225 -0.922 . . . . 0.0 110.075 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.134 0.492 . . . . 0.0 110.028 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.561 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 81.5 m-20 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 110.519 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.506 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.842 0 N-CA-C 110.582 -0.584 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.51 -1.36 42.78 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -132.46 75.5 73.75 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.211 -1.17 . . . . 0.0 110.147 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.414 ' HA ' ' HG ' ' A' ' 70' ' ' LEU . 3.0 Cg_endo -61.63 143.09 96.44 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.951 1.501 . . . . 0.0 110.329 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.501 ' C ' HG23 ' A' ' 44' ' ' VAL . 14.5 m -109.24 48.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 110.282 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.736 ' O ' HG12 ' A' ' 44' ' ' VAL . 84.2 t . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.51 -0.744 . . . . 0.0 110.705 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 99.3 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.349 0.595 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.574 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 14.0 t -65.85 -73.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 110.89 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 8.6 m-20 -77.84 112.29 23.82 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.389 -0.819 . . . . 0.0 110.574 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.38 -9.17 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 O-C-N 123.673 1.354 . . . . 0.0 109.826 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.893 ' HB2' HD22 ' A' ' 21' ' ' LEU . 93.1 m-20 -119.24 27.13 9.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.449 -0.782 . . . . 0.0 110.274 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.682 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.03 174.73 5.65 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.005 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.682 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -56.82 76.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.739 1.389 . . . . 0.0 108.952 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 53' ' ' PHE . 2.7 pt-20 -39.38 -26.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.811 -0.556 . . . . 0.0 110.251 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 54' ' ' PRO . 49.2 tp10 -53.05 -19.02 2.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.011 -1.056 . . . . 0.0 108.38 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.607 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 58.2 mt -90.8 7.63 38.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.621 . . . . 0.0 109.579 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.734 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.69 -51.67 5.12 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 110.687 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.734 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -55.0 -43.16 62.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.502 1.264 . . . . 0.0 110.159 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.064 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 11.5 mt -58.76 -36.69 74.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.089 -1.007 . . . . 0.0 109.947 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.9 t -66.14 -26.57 67.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 110.293 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -92.19 3.73 54.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 111.049 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.557 ' OE2' HD11 ' A' ' 69' ' ' ILE . 6.1 pt-20 -119.17 145.89 39.34 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.853 -1.155 . . . . 0.0 110.269 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.53 -17.83 60.27 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.923 1.486 . . . . 0.0 111.252 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.495 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 21.8 m120 -79.7 -13.63 59.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.064 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.56 -42.37 23.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -59.75 -40.0 86.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 110.418 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -80.13 -36.64 34.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.068 -1.02 . . . . 0.0 109.985 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.882 HG21 HD13 ' A' ' 60' ' ' LEU . 88.7 mt -66.2 -44.53 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 109.986 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.824 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.3 tm? -51.02 -56.62 11.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.846 . . . . 0.0 110.214 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.824 ' N ' HD13 ' A' ' 70' ' ' LEU . 76.8 mt-30 -47.78 -54.64 11.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 110.247 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -51.49 -54.74 23.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.387 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.765 HD21 ' OD2' ' A' ' 5' ' ' ASP . 52.3 mt -50.66 -49.53 56.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.272 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.571 ' OE2' HD11 ' A' ' 70' ' ' LEU . 79.1 mt-10 -55.29 -49.32 72.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.755 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.46 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -57.56 -54.75 43.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.033 -1.042 . . . . 0.0 110.725 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 79' ' ' ASP . 23.0 mm -60.56 -37.11 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.09 -1.006 . . . . 0.0 109.823 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.81 -32.27 67.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 0.0 109.663 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.0 tt0 -63.74 -40.32 96.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.46 -0.775 . . . . 0.0 110.31 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.457 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -151.32 156.41 34.97 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 0.0 110.076 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.541 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -59.08 -65.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.93 1.49 . . . . 0.0 110.643 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.14 -142.12 22.03 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.854 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 65.0 p -77.42 -19.71 55.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -1.126 . . . . 0.0 109.836 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.745 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 48.8 t -58.79 -51.12 71.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.848 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.3 tt0 -52.96 -30.25 33.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.698 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.742 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.2 pt -103.69 11.6 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.093 -1.004 . . . . 0.0 110.123 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 57.9 m 57.92 17.58 4.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.321 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.854 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -70.51 -14.55 62.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.943 . . . . 0.0 110.093 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.562 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 37.8 t80 -132.34 165.27 24.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.305 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.22 -0.23 11.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 110.274 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.562 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -65.56 -41.73 92.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.158 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.745 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -93.26 111.86 23.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 110.251 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.61 HG21 ' OE1' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -110.88 4.21 19.55 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.499 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . -75.12 -52.05 7.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.499 ' C ' ' O ' ' A' ' 93' ' ' GLY . 1.4 m . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.423 -1.045 . . . . 0.0 110.494 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 94' ' ' CYS . 4.5 m . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.223 0.535 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.4 m -117.83 146.21 44.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 110.387 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.54 ' HB ' HD11 ' A' ' 12' ' ' LEU . 1.2 t -84.16 122.35 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.763 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.89 ' NE2' HG21 ' A' ' 92' ' ' THR . 19.8 mt-30 -112.75 124.72 53.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.958 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.831 ' HB2' HG23 ' A' ' 69' ' ' ILE . 44.4 p30 -103.37 12.0 35.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.55 -139.01 3.5 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -89.08 19.59 4.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -1.177 . . . . 0.0 110.194 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.676 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.5 m-85 -126.67 158.37 36.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.305 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 74.2 m -102.64 115.82 31.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.148 -0.97 . . . . 0.0 110.423 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.68 ' CG ' HD11 ' A' ' 57' ' ' LEU . 17.2 m-30 -116.75 128.01 54.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.365 -0.835 . . . . 0.0 110.596 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.499 ' C ' HD12 ' A' ' 12' ' ' LEU . 34.4 t -75.85 170.6 15.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.917 . . . . 0.0 110.116 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.817 ' N ' HD12 ' A' ' 12' ' ' LEU . 6.9 mp -93.12 -16.97 24.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.155 -0.965 . . . . 0.0 110.645 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.4 mt-10 -64.47 -71.92 0.16 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.151 -0.968 . . . . 0.0 110.402 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.2 m -42.77 -51.72 5.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 0.0 110.376 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.627 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 49.5 t -56.12 -48.26 79.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.58 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HE3' ' HG3' ' A' ' 17' ' ' LYS . 6.3 ttpp -54.98 -54.67 39.97 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.168 -0.957 . . . . 0.0 108.686 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.469 ' HG3' ' HE3' ' A' ' 16' ' ' LYS . 45.0 mttt -80.62 14.12 2.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.449 -0.782 . . . . 0.0 109.911 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.8 tt -65.92 -35.05 79.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 110.073 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' NZ ' ' HB3' ' A' ' 41' ' ' GLU . 26.9 mttm -97.61 143.96 27.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 53.62 48.66 21.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.984 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.535 ' CD2' ' HB2' ' A' ' 52' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.857 . . . . 0.0 110.251 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.539 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 22.6 ptt-85 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.101 0.477 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 33' ' ' ARG . 80.2 m-20 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.0 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.588 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo . . . . . 0 N--CA 1.481 0.788 0 N-CA-C 110.541 -0.6 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.46 5.86 10.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 19' ' ' LYS . 1.7 mt-10 -133.52 74.0 71.91 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.298 -1.119 . . . . 0.0 110.157 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -60.67 146.06 97.83 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.836 1.44 . . . . 0.0 110.406 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 44' ' ' VAL . 45.4 t -131.38 122.34 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 110.538 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.865 ' O ' HG12 ' A' ' 44' ' ' VAL . 21.7 t . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.228 -0.92 . . . . 0.0 110.49 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.565 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 74.9 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.254 0.549 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.746 ' HB3' HG11 ' A' ' 43' ' ' VAL . 30.5 t -64.16 -64.86 0.78 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.128 -0.982 . . . . 0.0 110.47 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 10.0 m-20 -80.27 114.15 44.77 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.811 . . . . 0.0 110.081 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -64.85 -2.33 5.31 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.693 1.365 . . . . 0.0 110.772 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.535 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 95.6 m-20 -124.18 22.98 8.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.64 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.81 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 3.6 p90 -80.06 -176.33 0.72 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 108.945 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 1.004 ' HB2' HD13 ' A' ' 57' ' ' LEU . 5.0 Cg_exo -56.39 74.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.562 1.296 . . . . 0.0 109.657 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.6 tt0 -41.4 -36.69 0.89 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.509 -0.744 . . . . 0.0 110.132 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.576 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.9 mt-10 -52.03 -17.77 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.92 . . . . 0.0 108.981 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.004 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.4 mp -94.51 8.72 41.2 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.017 0.913 . . . . 0.0 109.327 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.77 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -41.79 -51.05 9.87 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.77 -0.581 . . . . 0.0 110.151 179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.77 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -53.8 -41.51 73.92 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.521 1.274 . . . . 0.0 110.1 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.036 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 9.5 mp -56.97 -42.47 80.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.948 -1.095 . . . . 0.0 109.402 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.803 ' O ' HG13 ' A' ' 44' ' ' VAL . 72.9 m -61.16 -24.52 66.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -99.31 1.6 44.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.323 -0.861 . . . . 0.0 110.769 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 60' ' ' LEU . 10.1 pt-20 -117.79 147.28 40.74 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.084 -1.01 . . . . 0.0 110.288 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.8 Cg_endo -64.01 -17.21 58.93 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.469 1.446 . . . . 0.0 111.258 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.509 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 53.2 m-20 -79.16 -20.83 47.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.09 -1.007 . . . . 0.0 110.87 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.036 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.57 -37.62 8.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.928 -1.108 . . . . 0.0 109.675 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.604 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.7 mt-30 -61.12 -41.37 96.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 110.187 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.8 mt-10 -80.14 -34.16 37.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.831 HG23 ' HB2' ' A' ' 5' ' ' ASP . 85.1 mt -73.02 -49.97 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 109.812 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.837 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.7 tm? -48.45 -56.59 7.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 109.922 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.774 ' N ' HD13 ' A' ' 70' ' ' LEU . 93.8 mt-30 -47.3 -51.55 18.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 110.028 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 93.0 mtt-85 -58.18 -60.99 2.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 5' ' ' ASP . 8.0 mt -46.17 -54.41 8.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.015 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.645 ' HG2' HD22 ' A' ' 70' ' ' LEU . 76.2 mm-40 -50.92 -42.72 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 109.821 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.588 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 81.1 tt0 -66.8 -51.52 54.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.513 ' O ' ' O ' ' A' ' 79' ' ' ASP . 67.1 mt -65.19 -38.86 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -0.942 . . . . 0.0 109.609 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 34' ' ' ASN . . . -57.6 -35.73 70.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -0.871 . . . . 0.0 109.547 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 83.2 tt0 -63.02 -38.22 90.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.533 -0.729 . . . . 0.0 110.448 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -149.69 157.2 38.67 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.107 -0.996 . . . . 0.0 110.437 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.511 ' HD3' ' ND2' ' A' ' 34' ' ' ASN . 3.1 Cg_exo -59.44 -71.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.981 1.516 . . . . 0.0 110.83 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.4 -140.39 21.96 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.891 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 52.7 p -78.64 -23.09 46.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -1.178 . . . . 0.0 110.153 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.61 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 25.2 t -54.39 -51.81 63.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.917 . . . . 0.0 109.893 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.5 tt0 -55.44 -33.53 63.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 111.115 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.736 HG13 ' HB2' ' A' ' 87' ' ' ALA . 4.3 pt -100.43 10.85 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.972 -1.08 . . . . 0.0 110.522 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.31 9.15 1.83 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.312 -0.867 . . . . 0.0 110.614 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.891 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -60.54 -14.56 20.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.056 -1.028 . . . . 0.0 109.543 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.595 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 41.4 t80 -135.68 164.52 27.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.464 -0.772 . . . . 0.0 110.123 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.62 3.41 5.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 110.23 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.595 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -64.66 -43.1 94.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.33 -0.856 . . . . 0.0 110.492 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.61 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -96.93 116.0 28.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.945 . . . . 0.0 110.645 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.89 HG21 ' NE2' ' A' ' 4' ' ' GLN . 44.8 p -107.89 171.23 7.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.48 -30.31 10.49 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.42 ' HB3' ' CG1' ' A' ' 1' ' ' VAL . 26.1 p . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.207 -1.172 . . . . 0.0 110.172 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.73 ' O ' HG12 ' A' ' 1' ' ' VAL . 67.4 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.244 0.545 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.722 HG23 ' HA ' ' A' ' 11' ' ' SER . 56.5 m -120.73 151.84 39.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.933 . . . . 0.0 110.258 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.742 HG23 HD11 ' A' ' 12' ' ' LEU . 61.9 t -81.01 113.41 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.911 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.613 ' HB3' HG21 ' A' ' 92' ' ' THR . 42.9 tt0 -111.61 132.23 54.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -93.84 -78.0 0.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.34 -0.85 . . . . 0.0 109.627 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.59 -128.43 5.8 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -80.47 10.26 4.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -1.12 . . . . 0.0 110.622 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.503 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 97.6 m-85 -124.47 137.79 54.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.993 . . . . 0.0 110.576 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.419 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 80.0 p -89.58 133.33 34.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 110.201 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.556 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 92.1 m-85 -115.62 123.07 47.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 110.578 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.722 ' HA ' HG23 ' A' ' 2' ' ' THR . 58.5 m -72.77 171.64 12.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.217 -0.927 . . . . 0.0 110.243 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.886 ' N ' HD12 ' A' ' 12' ' ' LEU . 4.3 mp -103.57 2.25 33.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.15 -0.969 . . . . 0.0 111.015 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 14' ' ' SER . 97.3 mt-10 -71.75 -77.27 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.927 -1.108 . . . . 0.0 110.846 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.628 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.8 m -41.04 -47.57 3.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.255 -0.903 . . . . 0.0 110.88 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.639 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 14.8 m -63.58 -50.43 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.014 . . . . 0.0 109.886 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.568 ' H ' HG23 ' A' ' 15' ' ' VAL . 39.5 tttm -53.34 -53.28 53.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.075 -1.015 . . . . 0.0 109.075 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.451 ' O ' ' O ' ' A' ' 20' ' ' ASP . 68.6 mttm -80.17 4.89 15.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.371 -0.83 . . . . 0.0 109.871 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.639 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 8.8 tp -55.8 -36.31 67.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 110.226 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -53.2 -41.92 65.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.565 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 17' ' ' LYS . 8.6 p-10 -111.67 133.77 53.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.798 . . . . 0.0 109.725 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.89 HD11 ' HB2' ' A' ' 52' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.125 -0.984 . . . . 0.0 110.426 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.437 ' C ' ' HE3' ' A' ' 16' ' ' LYS . 80.5 mtm-85 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.339 0.59 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.488 ' OD1' ' HD3' ' A' ' 80' ' ' PRO . 73.8 m-20 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.379 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.582 ' HG3' ' CG ' ' A' ' 75' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.837 0 N-CA-C 110.65 -0.558 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.77 -76.64 1.31 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -165.15 129.56 1.81 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.404 -1.057 . . . . 0.0 110.069 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HA ' HD12 ' A' ' 70' ' ' LEU . 3.0 Cg_endo -60.86 126.31 19.35 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.702 1.369 . . . . 0.0 110.502 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.538 ' C ' HG23 ' A' ' 44' ' ' VAL . 11.3 p -140.58 138.58 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.322 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.538 HG23 ' C ' ' A' ' 43' ' ' VAL . 73.8 t . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.297 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.533 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 62.7 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.199 0.523 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 22.1 t -59.5 -48.27 82.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.178 -0.951 . . . . 0.0 110.487 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.712 ' ND2' HD23 ' A' ' 21' ' ' LEU . 1.2 m120 -80.13 114.79 49.64 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.352 -0.842 . . . . 0.0 110.324 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -60.33 -10.36 13.05 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.703 1.37 . . . . 0.0 110.649 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.89 ' HB2' HD11 ' A' ' 21' ' ' LEU . 28.2 m120 -138.92 36.39 2.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.962 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.78 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 2.2 p90 -73.08 -175.84 0.41 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 108.957 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 1.025 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.7 Cg_exo -58.41 74.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.494 1.26 . . . . 0.0 109.524 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.8 tt0 -42.7 -36.37 1.41 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.414 -0.804 . . . . 0.0 110.441 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.553 ' C ' HD12 ' A' ' 57' ' ' LEU . 83.8 tt0 -52.55 -19.17 2.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.077 -1.014 . . . . 0.0 108.929 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.025 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.1 mp -93.93 13.82 21.56 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.923 0.868 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.752 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.9 mttp -40.04 -52.01 5.57 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.729 -0.607 . . . . 0.0 110.201 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.752 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.08 -46.05 36.04 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.584 1.307 . . . . 0.0 109.661 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.097 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -48.78 -47.19 42.1 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.061 -1.024 . . . . 0.0 109.346 179.296 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.6 m -68.24 -27.23 66.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.418 -0.801 . . . . 0.0 110.286 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -86.43 4.96 37.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.998 . . . . 0.0 110.507 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.541 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 5.6 pt-20 -122.12 146.29 46.21 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.148 -0.97 . . . . 0.0 110.161 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -61.77 -17.98 58.04 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.862 1.454 . . . . 0.0 110.978 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.484 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 22.3 m120 -79.78 -12.09 59.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.578 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.097 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -49.94 -39.66 41.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.151 -0.968 . . . . 0.0 109.99 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.524 ' HG3' ' HB2' ' A' ' 42' ' ' PRO . 30.5 tt0 -56.8 -44.61 82.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.367 -0.833 . . . . 0.0 110.487 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.6 mt-10 -80.28 -35.06 36.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.982 . . . . 0.0 110.358 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.018 HG21 ' CD1' ' A' ' 60' ' ' LEU . 86.7 mt -69.05 -48.65 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.149 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.697 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.7 tm? -44.87 -63.53 0.9 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.697 ' N ' HD13 ' A' ' 70' ' ' LEU . 50.7 tt0 -48.4 -53.13 18.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 110.176 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 82.9 mtp180 -51.59 -58.33 6.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 109.91 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 47.0 mt -46.33 -48.77 18.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.787 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 86.7 mt-10 -54.63 -40.67 69.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.297 -0.877 . . . . 0.0 110.176 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.582 ' CG ' ' HG3' ' A' ' 39' ' ' PRO . 96.5 mt-10 -61.82 -54.78 37.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.031 -1.043 . . . . 0.0 110.269 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 79' ' ' ASP . 42.4 mt -63.16 -42.49 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.881 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' A' ' 16' ' ' LYS . . . -52.0 -37.19 52.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.56 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 84.1 tt0 -65.93 -42.57 89.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.495 -0.753 . . . . 0.0 110.349 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -143.56 153.57 58.73 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.067 -1.02 . . . . 0.0 110.449 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.577 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -61.99 -68.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.069 1.563 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.03 -140.13 18.27 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.976 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 47.6 p -81.29 -21.98 38.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -1.118 . . . . 0.0 110.033 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 10.7 t -56.47 -50.22 72.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.166 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 78.5 tt0 -63.24 -27.26 69.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.954 . . . . 0.0 111.175 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.764 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.7 pt -102.08 12.76 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.829 -1.169 . . . . 0.0 110.449 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.9 t 57.87 13.59 2.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 110.459 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.976 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -64.66 -21.49 66.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 110.035 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.443 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 2.6 t80 -134.85 169.48 17.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.84 . . . . 0.0 110.04 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.31 1.26 11.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.188 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -58.58 -39.82 81.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.588 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.6 OUTLIER -104.38 122.12 44.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.005 . . . . 0.0 110.786 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.613 HG21 ' HB3' ' A' ' 4' ' ' GLN . 25.9 p -101.31 170.15 8.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 110.237 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.18 4.16 78.18 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.257 -1.143 . . . . 0.0 110.143 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' A' ' 91' ' ' CYS . 21.8 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.231 0.539 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 88.5 m -126.14 152.98 45.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.31 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.663 HG21 HG21 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -91.03 117.84 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 109.758 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.831 ' NE2' HG21 ' A' ' 92' ' ' THR . 6.6 mt-30 -110.3 139.82 45.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.228 -0.92 . . . . 0.0 110.63 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -108.59 9.62 27.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.697 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.75 -136.21 2.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -79.87 4.85 15.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -1.193 . . . . 0.0 109.566 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.652 ' CE1' ' O ' ' A' ' 9' ' ' SER . 35.7 t80 -119.26 161.32 20.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.473 -0.767 . . . . 0.0 109.78 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.652 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 82.5 p -115.5 133.13 56.33 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.955 -1.09 . . . . 0.0 110.929 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.501 ' O ' HG12 ' A' ' 3' ' ' VAL . 72.0 m-85 -112.47 121.96 46.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 110.779 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.2 p -69.83 168.08 15.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.061 -1.024 . . . . 0.0 109.918 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.636 HD13 ' HG3' ' A' ' 80' ' ' PRO . 43.3 mt -103.13 1.56 33.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.025 -1.047 . . . . 0.0 110.886 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -73.96 -75.63 0.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 0.0 110.515 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.1 m -42.53 -50.18 5.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 110.671 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.698 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 5.4 m -57.31 -44.32 83.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.806 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.426 ' HE3' ' C ' ' A' ' 34' ' ' ASN . 50.5 tttt -56.56 -56.05 26.17 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.847 -1.158 . . . . 0.0 108.68 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -80.5 13.74 2.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.535 -0.728 . . . . 0.0 109.842 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.5 tt -63.38 -41.38 98.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.87 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -56.6 -42.96 79.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.504 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -93.01 116.23 28.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.68 HD21 ' H ' ' A' ' 52' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.122 -0.986 . . . . 0.0 110.753 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' NH2' ' CD ' ' A' ' 84' ' ' GLU . 24.3 ptt85 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.225 0.536 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 37.9 p-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 0.0 110.431 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.49 ' CG ' ' CG ' ' A' ' 75' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.835 0 N-CA-C 110.562 -0.591 . . . . 0.0 110.562 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.448 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 125.02 28.6 1.11 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -125.16 71.74 63.92 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.294 -1.121 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.07 90.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.864 1.455 . . . . 0.0 110.471 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.677 ' O ' HG23 ' A' ' 44' ' ' VAL . 11.5 p -135.75 129.23 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 110.042 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.807 ' O ' HG12 ' A' ' 44' ' ' VAL . 14.6 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.294 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.398 0.618 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.553 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 91.5 p -55.48 -79.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.83 . . . . 0.0 110.421 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.678 ' CB ' HD23 ' A' ' 21' ' ' LEU . 41.0 m-20 -80.08 112.56 31.2 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.374 -0.829 . . . . 0.0 110.3 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.39 -5.38 8.2 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.664 1.349 . . . . 0.0 110.875 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.68 ' H ' HD21 ' A' ' 21' ' ' LEU . 15.1 m120 -132.4 29.64 4.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 110.549 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.81 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.5 p90 -78.61 -175.1 0.51 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 108.83 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.994 ' HB2' HD13 ' A' ' 57' ' ' LEU . 5.0 Cg_exo -55.64 75.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.383 1.202 . . . . 0.0 109.925 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 53' ' ' PHE . 22.6 pt-20 -44.46 -34.96 2.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.572 -0.705 . . . . 0.0 110.448 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.643 ' C ' HD12 ' A' ' 57' ' ' LEU . 49.7 mt-10 -53.87 -19.34 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.051 -1.031 . . . . 0.0 108.832 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.994 HD13 ' HB2' ' A' ' 54' ' ' PRO . 6.8 mp -96.77 14.22 25.87 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.83 0.824 . . . . 0.0 109.221 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.755 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.76 -51.48 5.31 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.767 -0.583 . . . . 0.0 110.575 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.755 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -53.66 -44.32 50.1 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.37 1.195 . . . . 0.0 110.039 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.072 ' CD1' HG21 ' A' ' 69' ' ' ILE . 3.1 mm? -57.59 -38.89 75.63 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 109.608 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.578 ' O ' HG13 ' A' ' 44' ' ' VAL . 43.6 t -67.17 -29.4 69.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.15 -0.969 . . . . 0.0 110.181 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.38 6.96 47.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.935 . . . . 0.0 110.08 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 2.8 mt-10 -99.58 144.34 28.12 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.369 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.1 Cg_exo -63.03 -26.83 73.79 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.78 1.41 . . . . 0.0 110.178 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' ALA . 76.1 m-20 -86.94 -3.19 59.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.542 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -42.52 -40.55 2.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.111 -0.993 . . . . 0.0 109.989 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -61.75 -39.72 92.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.476 -0.765 . . . . 0.0 110.454 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -80.3 -31.88 38.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.141 -0.975 . . . . 0.0 109.859 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.072 HG21 ' CD1' ' A' ' 60' ' ' LEU . 62.1 mt -74.55 -44.91 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 110.055 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.794 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.7 tm? -50.03 -59.27 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 110.387 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.794 ' N ' HD13 ' A' ' 70' ' ' LEU . 62.6 tt0 -47.91 -52.64 18.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.333 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.508 HH21 HG23 ' A' ' 69' ' ' ILE . 46.1 mtm180 -55.25 -56.72 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 35.1 mt -49.43 -51.33 36.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 110.205 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 76.7 mm-40 -53.69 -49.82 67.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.967 . . . . 0.0 110.454 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.49 ' CG ' ' CG ' ' A' ' 39' ' ' PRO . 98.8 mt-10 -54.88 -52.14 63.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -0.962 . . . . 0.0 110.523 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.663 HG21 HG21 ' A' ' 3' ' ' VAL . 23.7 mm -62.86 -35.58 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 109.894 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.82 71.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.814 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.1 tt0 -62.05 -38.54 89.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 110.172 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.6 OUTLIER 175.04 94.42 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 110.077 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.636 ' HG3' HD13 ' A' ' 12' ' ' LEU . 3.1 Cg_exo -59.74 77.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.931 1.49 . . . . 0.0 110.714 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -42.64 -75.12 0.15 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.732 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 65.8 p -71.44 -57.29 4.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.396 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.63 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 32.6 t -39.01 -50.79 1.8 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 110.046 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 81.7 tt0 -58.61 -42.97 89.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.041 -1.037 . . . . 0.0 110.731 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.724 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.6 pt -89.61 18.04 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.018 . . . . 0.0 110.219 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 7.2 m 57.83 15.0 2.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.317 -0.865 . . . . 0.0 110.547 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.732 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.53 -19.26 65.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.194 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -135.68 165.43 25.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.72 5.69 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.829 . . . . 0.0 110.563 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -69.58 -31.56 69.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 110.414 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.63 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.7 OUTLIER -108.56 123.81 49.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.818 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.831 HG21 ' NE2' ' A' ' 4' ' ' GLN . 44.0 p -110.8 164.05 13.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 110.131 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.6 -3.93 68.81 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.174 -1.192 . . . . 0.0 110.199 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 1' ' ' VAL . 5.3 m . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.228 0.537 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 29.8 m -121.42 149.49 42.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 0.0 110.536 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.025 HG23 HD11 ' A' ' 12' ' ' LEU . 91.9 t -86.76 118.44 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.707 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.546 ' CD ' HG21 ' A' ' 92' ' ' THR . 21.5 pt20 -111.48 147.91 34.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 111.029 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 1.025 ' OD2' HD21 ' A' ' 73' ' ' LEU . 91.4 m-20 -111.76 12.1 21.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.429 -0.794 . . . . 0.0 109.771 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 174.07 -129.61 1.66 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.02 5.49 22.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -1.166 . . . . 0.0 110.162 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.464 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 86.8 m-85 -125.98 147.22 49.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 94.8 p -101.14 136.61 40.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 0.0 110.144 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.667 ' CE2' HD11 ' A' ' 60' ' ' LEU . 21.5 m-85 -121.35 132.52 54.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.452 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.415 ' C ' HD12 ' A' ' 12' ' ' LEU . 30.1 t -71.32 166.69 21.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.295 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.025 HD11 HG23 ' A' ' 3' ' ' VAL . 5.2 mp -97.39 -9.64 27.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.302 -0.874 . . . . 0.0 110.404 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -67.75 -71.51 0.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.842 . . . . 0.0 110.729 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 m -46.34 -46.67 18.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.0 110.467 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.606 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 48.5 t -62.94 -51.62 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.048 -1.032 . . . . 0.0 109.941 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.503 ' NZ ' ' N ' ' A' ' 34' ' ' ASN . 43.0 tttt -54.18 -51.8 63.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.05 -1.031 . . . . 0.0 109.018 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 22.3 tttp -80.21 6.86 10.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 0.0 109.793 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.606 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 17.2 tp -61.54 -37.59 84.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -63.44 -37.05 85.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.08 -1.013 . . . . 0.0 110.047 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -113.33 101.78 9.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.08 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.754 HD11 ' HB3' ' A' ' 52' ' ' ASN . 33.9 tp . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.91 . . . . 0.0 110.226 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 70.1 mtt85 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.181 0.515 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 35.3 p-10 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 110.599 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.467 ' HG3' ' HB2' ' A' ' 75' ' ' GLU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.838 0 N-CA-C 110.772 -0.511 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.515 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 126.3 32.44 0.73 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.434 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -122.47 75.5 44.03 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.289 -1.124 . . . . 0.0 110.283 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.476 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 2.9 Cg_endo -62.01 132.25 38.55 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.84 1.442 . . . . 0.0 110.811 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.784 HG22 ' OG ' ' A' ' 49' ' ' SER . 6.2 p 179.15 83.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.403 -0.81 . . . . 0.0 110.006 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.797 ' O ' HG12 ' A' ' 44' ' ' VAL . 38.8 t . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.479 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.27 0.557 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.784 ' OG ' HG22 ' A' ' 43' ' ' VAL . 36.3 m -60.12 -53.19 60.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.67 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.629 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 3.2 m120 -80.32 111.5 22.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.433 -0.792 . . . . 0.0 110.506 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -58.95 -12.79 16.26 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.646 1.34 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.754 ' HB3' HD11 ' A' ' 21' ' ' LEU . 31.0 t30 -137.39 42.1 2.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.253 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.75 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.3 p90 -80.18 -177.58 0.95 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.391 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.998 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -57.85 74.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.684 1.36 . . . . 0.0 109.693 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.0 tt0 -42.52 -35.55 1.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.481 -0.762 . . . . 0.0 110.348 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.7 mt-10 -53.7 -18.16 2.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 108.822 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.998 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.2 mp -96.39 13.3 28.23 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.754 0.788 . . . . 0.0 109.1 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.736 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -41.15 -52.3 7.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.908 -0.495 . . . . 0.0 111.168 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.736 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -53.8 -43.99 53.08 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.6 1.316 . . . . 0.0 110.17 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.83 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 17.9 mt -60.36 -34.36 73.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.139 -0.976 . . . . 0.0 109.902 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.754 ' HA ' HG13 ' A' ' 44' ' ' VAL . 36.8 t -66.27 -25.95 67.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.182 -0.949 . . . . 0.0 110.286 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -107.09 25.35 11.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.943 . . . . 0.0 109.323 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -110.48 143.19 27.62 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.624 -0.672 . . . . 0.0 110.462 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.53 -30.83 80.07 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.896 1.472 . . . . 0.0 109.816 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' ALA . 81.8 m-20 -86.23 -5.95 59.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 0.0 110.507 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.83 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -44.53 -41.56 6.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.106 -0.996 . . . . 0.0 110.068 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -55.13 -42.41 72.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.766 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.11 -37.38 33.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 109.863 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.695 HG21 HD13 ' A' ' 60' ' ' LEU . 87.7 mt -63.34 -49.18 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.098 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.919 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.3 tm? -48.7 -60.88 2.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 110.558 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.919 ' N ' HD13 ' A' ' 70' ' ' LEU . 63.9 tt0 -47.07 -53.99 11.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 0.0 110.533 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -54.76 -53.22 57.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 110.112 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 1.025 HD21 ' OD2' ' A' ' 5' ' ' ASP . 73.5 mt -49.84 -52.0 35.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.54 ' OE2' HD11 ' A' ' 70' ' ' LEU . 86.7 mt-10 -52.53 -46.02 66.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.341 -0.849 . . . . 0.0 110.328 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 82.3 tt0 -62.76 -54.24 42.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.672 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 79' ' ' ASP . 32.8 mm -64.56 -43.4 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 110.185 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -55.75 -37.64 68.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 110.024 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 57.6 mm-40 -65.02 -36.16 83.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.365 -0.834 . . . . 0.0 111.087 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -135.55 149.16 68.52 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.868 -1.145 . . . . 0.0 110.725 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.508 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -60.58 -68.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.831 1.437 . . . . 0.0 110.596 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.53 -139.42 20.18 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.956 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 64.6 p -80.19 -23.03 41.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.126 -1.22 . . . . 0.0 110.007 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 14.2 t -53.38 -53.51 50.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.903 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.8 tt0 -58.14 -32.29 68.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.375 -0.828 . . . . 0.0 111.05 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.771 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.2 pt -99.08 12.7 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.96 -1.088 . . . . 0.0 110.401 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 54.97 15.49 1.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.875 . . . . 0.0 110.51 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.956 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -62.02 -14.94 40.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.04 -1.037 . . . . 0.0 109.952 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 19.7 m-85 -144.75 174.35 11.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.03 3.18 10.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.847 . . . . 0.0 110.411 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -59.91 -36.78 77.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.609 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -104.22 123.83 48.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 0.0 110.633 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.546 HG21 ' CD ' ' A' ' 4' ' ' GLN . 23.4 p -105.6 160.53 15.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.381 -0.824 . . . . 0.0 110.146 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.65 3.19 56.28 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.349 -1.089 . . . . 0.0 110.218 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.798 HG22 ' SG ' ' A' ' 91' ' ' CYS . 9.7 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.333 0.587 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 90.8 m -129.44 154.45 46.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.961 . . . . 0.0 110.726 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.759 HG21 HD13 ' A' ' 12' ' ' LEU . 39.0 t -83.91 117.25 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.351 -0.843 . . . . 0.0 109.82 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.783 ' CB ' HG21 ' A' ' 92' ' ' THR . 48.7 tt0 -111.73 128.35 56.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 110.504 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.877 ' OD2' HD21 ' A' ' 73' ' ' LEU . 76.1 m-20 -114.24 10.38 17.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.471 -0.768 . . . . 0.0 109.692 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.74 -143.55 4.67 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -82.42 7.74 13.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -1.166 . . . . 0.0 110.221 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.43 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 74.4 m-85 -123.98 145.66 49.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 110.372 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -90.74 123.57 34.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.332 -0.855 . . . . 0.0 110.222 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.749 ' CD1' HD23 ' A' ' 57' ' ' LEU . 20.9 m-85 -110.91 123.08 49.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.863 . . . . 0.0 110.329 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.466 ' HA ' HG23 ' A' ' 2' ' ' THR . 63.4 m -62.37 156.15 23.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.534 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.885 HD11 ' N ' ' A' ' 77' ' ' ALA . 45.9 tp -98.68 -20.91 16.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.238 -0.914 . . . . 0.0 110.546 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -62.42 -65.46 0.68 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.139 -0.976 . . . . 0.0 110.51 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.4 m -46.58 -48.54 19.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.968 . . . . 0.0 110.949 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.685 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 31.2 m -60.86 -44.97 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.104 -0.997 . . . . 0.0 110.086 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.635 ' CA ' ' HB1' ' A' ' 77' ' ' ALA . 1.5 tmmt? -58.54 -56.03 27.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 109.072 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 13.9 ttpt -80.31 8.46 7.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.294 -0.879 . . . . 0.0 109.14 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.685 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 7.7 tp -52.2 -38.67 58.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.582 -0.699 . . . . 0.0 110.027 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -57.25 -45.4 84.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.094 -1.004 . . . . 0.0 109.574 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -97.47 115.05 27.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.764 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.88 HD11 ' HB2' ' A' ' 52' ' ' ASN . 29.6 tp . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.666 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.318 0.58 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 16.7 p30 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 110.119 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.557 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.866 0 N-CA-C 110.568 -0.589 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.31 6.08 29.69 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.09 71.01 55.83 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.162 -1.199 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.74 147.71 94.69 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.865 1.455 . . . . 0.0 110.269 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.899 HG22 ' HB3' ' A' ' 49' ' ' SER . 12.2 p -158.47 72.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.42 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.749 ' O ' HG12 ' A' ' 44' ' ' VAL . 30.6 t . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.1 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.566 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.316 0.579 . . . . 0.0 110.194 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.899 ' HB3' HG22 ' A' ' 43' ' ' VAL . 85.0 p -61.54 -54.88 37.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -0.92 . . . . 0.0 110.44 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 5.3 m-20 -80.2 110.87 18.08 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.392 -0.818 . . . . 0.0 110.399 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.599 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.81 -13.96 33.69 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.623 1.328 . . . . 0.0 110.715 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.88 ' HB2' HD11 ' A' ' 21' ' ' LEU . 86.3 m-20 -128.21 33.66 4.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 110.55 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.664 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.25 175.94 4.29 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.129 -0.982 . . . . 0.0 108.792 179.082 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.679 ' HG2' HD12 ' A' ' 57' ' ' LEU . 4.1 Cg_exo -56.57 75.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.604 1.318 . . . . 0.0 109.388 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.644 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.5 tt0 -39.35 -27.14 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.712 -0.618 . . . . 0.0 110.387 -178.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.3 mt-10 -53.68 -17.34 2.17 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.964 -1.085 . . . . 0.0 108.657 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.749 HD23 ' CD1' ' A' ' 10' ' ' PHE . 34.8 mt -95.09 9.17 40.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.566 -0.709 . . . . 0.0 109.676 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.741 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.6 -51.74 4.95 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.28 -0.887 . . . . 0.0 110.678 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.741 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.84 -41.88 74.07 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.496 1.261 . . . . 0.0 110.017 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.892 HD22 HD13 ' A' ' 69' ' ' ILE . 55.9 mt -60.39 -36.6 78.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.113 -0.992 . . . . 0.0 110.163 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.533 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 73.6 m -67.53 -28.32 67.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.957 . . . . 0.0 110.272 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -101.22 24.33 9.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.211 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.45 143.55 29.57 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.588 -0.695 . . . . 0.0 110.588 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.26 -31.98 73.6 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.813 1.428 . . . . 0.0 109.818 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -86.98 1.67 52.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.361 -0.837 . . . . 0.0 110.701 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.17 -42.63 20.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.068 -1.02 . . . . 0.0 110.058 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 92.1 mt-30 -56.15 -41.39 75.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.848 . . . . 0.0 110.098 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -79.92 -35.52 37.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 110.135 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.892 HD13 HD22 ' A' ' 60' ' ' LEU . 91.6 mt -67.6 -47.95 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.0 109.79 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -53.95 -53.28 54.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 0.0 110.378 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.954 ' N ' HD13 ' A' ' 70' ' ' LEU . 97.9 mt-30 -49.7 -51.26 39.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.252 -0.905 . . . . 0.0 110.722 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -55.42 -59.64 4.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.317 -0.864 . . . . 0.0 110.711 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.877 HD21 ' OD2' ' A' ' 5' ' ' ASP . 60.9 mt -44.38 -49.09 9.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.301 -0.875 . . . . 0.0 110.42 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.93 ' OE2' HD21 ' A' ' 70' ' ' LEU . 70.7 mt-10 -61.82 -26.72 68.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 0.0 110.752 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.557 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.3 tt0 -71.63 -50.41 30.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.929 -1.107 . . . . 0.0 109.785 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.1 mm -67.82 -36.48 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.346 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.885 ' N ' HD11 ' A' ' 12' ' ' LEU . . . -63.28 -29.16 70.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.617 -0.677 . . . . 0.0 109.667 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 84.8 tt0 -62.99 -34.7 78.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.423 -0.798 . . . . 0.0 110.384 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -161.33 147.01 10.84 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.144 -0.973 . . . . 0.0 110.765 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.5 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.47 84.04 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.052 1.554 . . . . 0.0 110.598 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.68 -130.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.207 -1.957 . . . . 0.0 108.207 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.965 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 82.8 p -82.76 -16.96 45.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.246 . . . . 0.0 109.321 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.438 ' SG ' ' N ' ' A' ' 91' ' ' CYS . 5.5 t -51.11 -50.38 58.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.733 -0.604 . . . . 0.0 110.37 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.5 ' OE1' ' HB2' ' A' ' 80' ' ' PRO . 76.2 tt0 -61.05 -34.87 75.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.268 -0.895 . . . . 0.0 111.364 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.813 HG13 ' HB2' ' A' ' 87' ' ' ALA . 4.3 pt -97.24 17.36 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.588 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 m 51.14 17.37 0.46 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.945 . . . . 0.0 110.81 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.965 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.55 -13.81 62.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.056 -1.028 . . . . 0.0 109.663 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.534 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 52.8 t80 -141.22 170.27 16.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.79 . . . . 0.0 109.996 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.73 4.43 7.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.12 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.534 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -59.27 -40.35 85.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.639 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.798 ' SG ' HG22 ' A' ' 1' ' ' VAL . 1.0 OUTLIER -103.04 128.24 49.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.214 -0.929 . . . . 0.0 110.689 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.783 HG21 ' CB ' ' A' ' 4' ' ' GLN . 16.9 p -108.0 165.45 11.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.25 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.29 -7.07 61.82 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.319 -1.107 . . . . 0.0 110.21 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.456 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 6.4 m . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.107 0.48 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . 1.015 HG21 ' HB3' ' A' ' 9' ' ' SER . 14.6 t -129.75 164.09 24.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.981 ' CG2' HD21 ' A' ' 12' ' ' LEU . 43.2 t -80.06 110.98 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.352 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 46.2 tt0 -109.53 121.15 44.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.111 -0.993 . . . . 0.0 110.578 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -99.12 5.65 46.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.821 . . . . 0.0 109.673 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.93 -141.18 3.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -79.92 0.17 32.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -1.193 . . . . 0.0 110.36 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.501 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 92.4 m-85 -112.64 138.07 49.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.179 -0.95 . . . . 0.0 110.462 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 1.015 ' HB3' HG21 ' A' ' 2' ' ' THR . 73.4 m -89.11 128.79 35.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.359 -0.838 . . . . 0.0 110.144 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.772 ' CE1' HD23 ' A' ' 57' ' ' LEU . 91.6 m-85 -111.79 119.14 37.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.897 . . . . 0.0 110.483 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.7 p -70.88 168.38 16.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.93 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.981 HD21 ' CG2' ' A' ' 3' ' ' VAL . 65.0 mt -99.51 2.94 45.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.978 . . . . 0.0 110.425 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 14' ' ' SER . 81.7 tt0 -76.28 -71.02 0.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 110.503 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.475 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.6 m -42.42 -49.45 5.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.007 -1.058 . . . . 0.0 110.271 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.675 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 7.8 m -58.9 -48.89 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.181 -0.949 . . . . 0.0 109.851 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.51 ' H ' HG23 ' A' ' 15' ' ' VAL . 21.2 tttt -54.68 -55.91 24.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.894 -1.129 . . . . 0.0 108.972 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -80.33 12.34 3.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.415 -0.803 . . . . 0.0 109.621 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 39.1 tp -57.96 -37.15 73.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.354 -0.842 . . . . 0.0 110.376 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -55.29 -43.21 74.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.127 -0.983 . . . . 0.0 110.006 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -99.96 109.94 22.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 110.042 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.043 HD21 ' CG ' ' A' ' 50' ' ' ASN . 93.8 mt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.895 . . . . 0.0 110.277 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.118 0.485 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 86.9 m-20 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 110.76 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.891 0 N-CA-C 110.495 -0.617 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.463 ' HA2' ' HG2' ' A' ' 71' ' ' GLN . . . 102.02 -0.35 51.43 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -66.91 139.54 95.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.214 -1.168 . . . . 0.0 110.214 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.68 110.0 0.87 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.756 1.398 . . . . 0.0 110.329 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.603 HG21 ' HG ' ' A' ' 70' ' ' LEU . 63.3 t -135.97 143.04 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.142 -0.974 . . . . 0.0 110.515 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.829 ' O ' HG12 ' A' ' 44' ' ' VAL . 46.4 t . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.775 . . . . 0.0 110.861 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.506 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.223 0.535 . . . . 0.0 110.038 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.618 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 6.6 p -96.16 -53.46 3.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 110.566 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 1.043 ' CG ' HD21 ' A' ' 21' ' ' LEU . 9.6 m-20 -80.06 111.35 21.22 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.401 -0.812 . . . . 0.0 110.439 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.618 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.91 -13.62 40.72 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.704 1.37 . . . . 0.0 110.371 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.419 ' HB2' HD22 ' A' ' 21' ' ' LEU . 95.2 m-20 -114.27 20.16 15.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.415 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.15 173.45 7.7 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 108.961 179.193 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.641 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.1 Cg_exo -57.37 75.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.632 1.333 . . . . 0.0 108.925 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 53' ' ' PHE . 23.9 pt-20 -39.11 -26.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.745 -0.597 . . . . 0.0 110.596 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt-10 -51.68 -22.23 3.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.944 -1.097 . . . . 0.0 108.452 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.772 HD23 ' CE1' ' A' ' 10' ' ' PHE . 66.7 mt -83.14 8.86 11.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.662 -0.649 . . . . 0.0 109.472 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.744 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.75 -51.49 5.29 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.457 -0.777 . . . . 0.0 110.601 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.744 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.97 -41.43 78.81 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.52 1.274 . . . . 0.0 110.571 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.073 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 5.9 mp -62.48 -35.45 79.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.88 -1.138 . . . . 0.0 110.384 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.449 ' HB3' ' N ' ' A' ' 48' ' ' CYS . 84.3 m -67.22 -28.19 67.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.064 -1.023 . . . . 0.0 110.536 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.467 ' NZ ' ' HE2' ' A' ' 58' ' ' LYS . 91.2 mttt -81.64 -3.08 52.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.825 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 11.4 pt-20 -125.38 147.02 56.31 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.94 -1.1 . . . . 0.0 110.376 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.27 -6.94 10.9 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.903 1.475 . . . . 0.0 111.024 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -79.92 -22.69 42.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.087 -1.008 . . . . 0.0 110.161 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.073 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.69 -39.37 17.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.419 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.57 -41.51 97.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 110.278 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.39 -38.17 30.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.915 HG21 ' CD2' ' A' ' 60' ' ' LEU . 95.7 mt -65.17 -39.39 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 110.489 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.655 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.3 tm? -56.42 -51.34 68.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.937 . . . . 0.0 110.499 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.463 ' HG2' ' HA2' ' A' ' 40' ' ' GLY . 89.6 mt-30 -49.64 -54.78 16.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.103 -0.998 . . . . 0.0 110.117 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.514 HH21 HG23 ' A' ' 69' ' ' ILE . 46.6 mtm180 -52.36 -54.33 33.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.39 -0.818 . . . . 0.0 110.119 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 41.5 mt -48.43 -50.47 31.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.879 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 69.6 mm-40 -53.9 -51.78 62.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.892 . . . . 0.0 110.279 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -54.78 -56.85 14.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.039 -1.038 . . . . 0.0 110.536 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 79' ' ' ASP . 20.1 mt -58.9 -35.16 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.121 -0.987 . . . . 0.0 109.465 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 34' ' ' ASN . . . -57.89 -34.72 70.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.545 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -60.39 -40.65 91.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -148.01 153.69 42.19 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.163 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.584 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -58.56 -59.22 0.52 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.895 1.471 . . . . 0.0 110.574 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.33 -138.69 20.15 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.92 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 65.5 p -82.31 -21.13 36.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -1.11 . . . . 0.0 110.058 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.597 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 42.3 t -55.64 -53.35 57.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.208 -0.933 . . . . 0.0 110.109 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.7 tt0 -60.7 -27.81 68.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 111.22 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.786 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.2 pt -99.05 13.51 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 110.273 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 55.37 16.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.504 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.92 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.29 -15.35 63.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.967 . . . . 0.0 109.931 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.46 169.49 17.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.13 3.09 11.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 110.185 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.53 -34.8 77.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.458 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -103.51 123.25 46.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.737 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.8 p -111.63 154.98 24.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 109.754 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 44.14 4.82 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.342 -1.093 . . . . 0.0 110.282 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.844 HG11 ' HB3' ' A' ' 91' ' ' CYS . 3.4 t . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.164 0.507 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.666 ' H ' HG12 ' A' ' 1' ' ' VAL . 30.8 m -126.25 142.66 51.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.55 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.582 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 90.4 t -82.24 119.66 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.496 -0.752 . . . . 0.0 109.448 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.525 ' CD ' HG21 ' A' ' 92' ' ' THR . 44.8 tt0 -113.5 133.11 55.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.879 -1.138 . . . . 0.0 110.787 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -92.06 -78.89 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.567 -0.708 . . . . 0.0 109.65 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.0 -122.16 4.67 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -85.19 10.01 13.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.157 . . . . 0.0 110.341 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.491 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 98.1 m-85 -122.45 137.9 54.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.448 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.7 p -89.64 128.35 36.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 110.076 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.884 ' HB3' HD21 ' A' ' 57' ' ' LEU . 23.2 m-30 -117.07 126.98 53.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 0.0 110.746 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.1 t -61.48 157.92 16.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.079 . . . . 0.0 109.727 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 12' ' ' LEU . 1.5 pt? -100.5 -25.31 14.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -1.0 . . . . 0.0 111.071 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.21 -65.86 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.078 -1.014 . . . . 0.0 110.74 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.6 m -52.59 -38.86 60.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.363 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.645 ' CG1' ' HB2' ' A' ' 77' ' ' ALA . 6.8 t -58.15 -46.4 88.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.135 -0.978 . . . . 0.0 109.621 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HD3' ' CD ' ' A' ' 33' ' ' ARG . 18.9 tttt -57.73 -53.84 53.67 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.056 -1.028 . . . . 0.0 108.74 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 20' ' ' ASP . 51.4 mttm -80.34 12.05 3.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.535 -0.728 . . . . 0.0 109.751 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 8.7 tt -59.55 -39.08 82.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.136 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -50.61 -42.54 56.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 17' ' ' LYS . 39.0 p30 -150.31 146.4 26.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.809 . . . . 0.0 109.605 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.0 HD22 ' CG ' ' A' ' 52' ' ' ASN . 14.7 tp . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.986 . . . . 0.0 110.759 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.495 ' CD ' ' HD3' ' A' ' 16' ' ' LYS . 8.8 mmt85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.228 0.537 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 18.0 p-10 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 110.305 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.482 0.797 0 N-CA-C 110.71 -0.534 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.413 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 129.55 12.23 2.54 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.49 ' HG3' HD11 ' A' ' 70' ' ' LEU . 3.8 pt-20 -119.48 77.87 19.8 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.094 -1.239 . . . . 0.0 110.138 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.2 Cg_exo -59.32 143.52 99.7 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.978 1.515 . . . . 0.0 110.672 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.014 HG23 HG23 ' A' ' 44' ' ' VAL . 20.2 m -121.77 -166.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 110.273 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.014 HG23 HG23 ' A' ' 43' ' ' VAL . 11.3 t . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.468 -0.77 . . . . 0.0 110.552 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 71.8 m . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.478 0.656 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 87.8 p -59.89 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.459 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' LEU . 1.8 m120 -66.09 112.94 10.28 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.868 . . . . 0.0 110.691 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.7 -7.1 15.47 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.713 1.375 . . . . 0.0 109.721 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 1.0 ' CG ' HD22 ' A' ' 21' ' ' LEU . 26.5 p30 -124.95 26.06 7.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.511 -0.743 . . . . 0.0 110.368 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.733 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -79.15 179.89 1.63 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.213 -0.929 . . . . 0.0 108.575 179.102 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.733 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.7 Cg_exo -57.73 75.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 N-CA-C 108.89 -1.235 . . . . 0.0 108.89 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.624 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.2 tt0 -39.2 -27.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.706 -0.621 . . . . 0.0 110.085 -178.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.516 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 96.3 mt-10 -52.6 -17.91 1.5 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.068 -1.02 . . . . 0.0 108.74 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.884 HD21 ' HB3' ' A' ' 10' ' ' PHE . 33.5 mt -89.47 8.46 30.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.553 -0.717 . . . . 0.0 109.683 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.77 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.65 -50.42 5.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 110.463 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.77 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.58 -41.04 81.03 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.457 1.24 . . . . 0.0 110.027 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.029 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 34.7 mt -59.81 -41.41 91.21 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.095 -1.003 . . . . 0.0 110.153 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 t -69.13 -31.08 69.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.084 -1.01 . . . . 0.0 110.294 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -80.03 4.62 16.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.565 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.69 ' OE2' HD23 ' A' ' 60' ' ' LEU . 8.1 pt-20 -124.0 138.18 30.19 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.074 -1.016 . . . . 0.0 110.128 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.98 -16.51 45.85 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.767 1.403 . . . . 0.0 110.647 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.492 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 20.5 m120 -80.05 -8.24 59.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 110.023 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.029 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -51.02 -34.45 29.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.818 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -62.79 -38.62 91.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.683 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.29 -43.69 20.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.603 HG21 HD22 ' A' ' 60' ' ' LEU . 66.8 mt -62.69 -39.94 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.866 . . . . 0.0 109.557 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.5 tm? -46.93 -65.94 0.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.606 -0.684 . . . . 0.0 110.627 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.965 ' N ' HD13 ' A' ' 70' ' ' LEU . 92.7 mt-30 -46.56 -53.48 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 110.385 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 18.2 tpp180 -55.49 -54.46 43.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.12 -0.988 . . . . 0.0 109.946 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.629 ' HG ' HG11 ' A' ' 15' ' ' VAL . 10.0 tp -50.08 -53.64 25.76 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.295 -0.878 . . . . 0.0 109.96 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.695 ' OE2' HD21 ' A' ' 70' ' ' LEU . 88.0 mt-10 -50.71 -45.24 58.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 96.7 mt-10 -54.1 -53.33 54.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.09 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.513 HG21 HG13 ' A' ' 3' ' ' VAL . 6.0 mt -61.12 -38.15 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.924 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.645 ' HB2' ' CG1' ' A' ' 15' ' ' VAL . . . -59.79 -37.17 78.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 110.049 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.45 ' HG2' ' HG3' ' A' ' 16' ' ' LYS . 47.3 mt-10 -103.66 12.9 34.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.662 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 1.6 t70 -160.26 106.86 1.38 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.487 -0.758 . . . . 0.0 109.696 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.543 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 3.4 Cg_exo -57.17 -65.63 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.803 1.423 . . . . 0.0 110.592 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.56 -136.74 17.09 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.748 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 80.8 p -78.62 -22.93 46.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.311 -1.111 . . . . 0.0 110.01 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 5.0 t -45.72 -58.04 3.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 0.0 110.522 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 80' ' ' PRO . 56.2 mt-10 -56.96 -37.58 71.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.301 -0.875 . . . . 0.0 111.526 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.637 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.0 pt -89.28 12.97 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.853 -1.154 . . . . 0.0 110.503 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 59.9 m 51.45 19.75 0.88 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 110.782 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.748 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -74.3 -2.89 27.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.046 -1.034 . . . . 0.0 109.919 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.489 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 3.4 m-85 -151.9 171.47 17.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.306 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.59 4.9 6.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.292 -0.88 . . . . 0.0 110.441 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.32 -31.1 72.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.911 . . . . 0.0 110.67 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.844 ' HB3' HG11 ' A' ' 1' ' ' VAL . 0.7 OUTLIER -114.81 125.84 54.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.05 -1.031 . . . . 0.0 110.637 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.525 HG21 ' CD ' ' A' ' 4' ' ' GLN . 33.2 p -114.36 152.2 31.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.389 -0.819 . . . . 0.0 110.396 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.76 -21.61 45.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.295 -1.121 . . . . 0.0 110.273 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.488 HG22 ' SG ' ' A' ' 91' ' ' CYS . 3.1 p . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.213 0.53 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.587 HG23 ' HA ' ' A' ' 11' ' ' SER . 57.0 m -118.07 154.5 31.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.302 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' ALA . 96.3 t -82.25 123.23 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 109.801 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.918 ' OE1' HG21 ' A' ' 92' ' ' THR . 62.6 tt0 -113.09 122.31 47.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.946 . . . . 0.0 110.7 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.947 ' OD2' HD21 ' A' ' 73' ' ' LEU . 88.4 m-20 -99.9 13.49 33.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.429 -0.794 . . . . 0.0 109.864 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.521 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . 174.24 -132.96 2.38 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -90.63 15.46 10.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -1.153 . . . . 0.0 109.955 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.628 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . 87.0 m-85 -129.5 128.66 43.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.471 -0.768 . . . . 0.0 110.092 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.3 p -79.95 123.42 27.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 109.998 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.628 ' CE2' ' HB2' ' A' ' 8' ' ' PHE . 85.7 m-85 -116.71 125.35 51.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 110.61 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.587 ' HA ' HG23 ' A' ' 2' ' ' THR . 80.8 p -66.16 165.08 14.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 109.787 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.708 ' CD2' HG22 ' A' ' 76' ' ' ILE . 15.1 tp -110.93 -8.91 14.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 110.853 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.422 ' HG3' ' HD3' ' A' ' 33' ' ' ARG . 86.2 tt0 -60.17 -69.73 0.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.056 -1.027 . . . . 0.0 110.606 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.566 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.9 m -44.67 -39.55 5.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 0.0 110.547 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.658 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 25.2 t -64.99 -49.22 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.035 -1.04 . . . . 0.0 109.535 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.725 ' HG2' ' HB1' ' A' ' 77' ' ' ALA . 78.5 mttt -55.22 -50.74 68.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.08 -1.012 . . . . 0.0 108.808 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -80.14 4.54 17.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.529 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.735 HD13 ' HD3' ' A' ' 54' ' ' PRO . 18.7 tp -56.97 -25.79 58.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.0 110.193 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -61.33 -35.81 78.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.841 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -86.5 109.96 19.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.882 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.83 HD21 ' OD1' ' A' ' 50' ' ' ASN . 1.2 mm? . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.473 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.586 ' HB3' ' HD2' ' A' ' 16' ' ' LYS . 74.1 mtt85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.2 0.524 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 4.0 p30 . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.233 -0.917 . . . . 0.0 110.159 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.548 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 3.0 Cg_exo . . . . . 0 N--CA 1.482 0.834 0 N-CA-C 110.603 -0.576 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.45 4.58 2.01 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER 60.72 72.18 0.75 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.084 -1.245 . . . . 0.0 109.988 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.568 ' HD2' HD12 ' A' ' 70' ' ' LEU . 3.0 Cg_endo -61.58 -165.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.952 1.501 . . . . 0.0 110.988 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -96.05 129.28 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.748 . . . . 0.0 110.175 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.843 ' O ' HG13 ' A' ' 44' ' ' VAL . 3.1 p . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.333 -0.854 . . . . 0.0 110.198 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.456 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 1.5 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.321 0.581 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.89 ' HB3' HG13 ' A' ' 43' ' ' VAL . 87.3 p -64.02 -41.12 97.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 110.926 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.83 ' OD1' HD21 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -80.68 106.9 6.06 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.897 . . . . 0.0 110.619 -179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.745 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -61.11 -16.26 44.79 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.682 1.359 . . . . 0.0 110.33 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -128.03 36.54 4.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.232 -0.917 . . . . 0.0 111.145 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.642 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.1 172.23 10.37 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.776 -1.203 . . . . 0.0 108.484 178.616 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.735 ' HD3' HD13 ' A' ' 18' ' ' LEU . 4.1 Cg_exo -54.45 76.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.505 1.266 . . . . 0.0 109.39 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.6 tt0 -39.65 -27.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.744 -0.598 . . . . 0.0 110.084 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.7 mt-10 -52.7 -17.89 1.54 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.068 -1.02 . . . . 0.0 108.449 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.676 HD12 ' HG2' ' A' ' 54' ' ' PRO . 89.2 mt -90.24 11.2 21.88 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.609 0.719 . . . . 0.0 109.136 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.742 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -39.95 -51.99 5.43 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.416 -0.803 . . . . 0.0 110.262 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.742 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -54.0 -46.07 36.36 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.461 1.242 . . . . 0.0 109.373 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.954 HD11 ' HB ' ' A' ' 69' ' ' ILE . 11.7 tp -49.58 -49.46 46.48 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.264 -0.898 . . . . 0.0 109.749 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.565 ' SG ' HG22 ' A' ' 44' ' ' VAL . 1.2 t -61.33 -27.94 68.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 110.609 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 22.7 ttpt -81.01 -2.05 46.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 110.56 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 11.2 pt-20 -126.43 144.85 50.85 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.064 -1.023 . . . . 0.0 110.074 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.27 -8.65 12.91 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.785 1.413 . . . . 0.0 110.801 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -79.58 -18.0 52.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 110.668 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -45.08 -40.03 6.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.079 -1.013 . . . . 0.0 109.941 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.44 ' O ' ' CD ' ' A' ' 41' ' ' GLU . 93.7 mt-30 -66.01 -39.12 90.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -0.869 . . . . 0.0 109.979 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -80.5 -44.95 18.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.173 -0.954 . . . . 0.0 109.672 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.954 ' HB ' HD11 ' A' ' 60' ' ' LEU . 57.9 mt -63.73 -42.19 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.814 . . . . 0.0 109.899 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.77 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.2 tm? -52.34 -52.69 51.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.459 -0.776 . . . . 0.0 109.902 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.58 ' N ' HD13 ' A' ' 70' ' ' LEU . 46.0 tt0 -42.74 -53.53 4.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.095 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -59.11 -53.1 62.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 110.65 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.947 HD21 ' OD2' ' A' ' 5' ' ' ASP . 63.6 mt -50.58 -55.7 15.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.085 -1.009 . . . . 0.0 110.145 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.703 ' CD ' HD11 ' A' ' 70' ' ' LEU . 26.9 mt-10 -54.61 -50.74 67.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 110.442 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.26 -54.06 45.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.433 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.708 HG22 ' CD2' ' A' ' 12' ' ' LEU . 70.2 mt -61.65 -34.34 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.998 . . . . 0.0 109.735 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.725 ' HB1' ' HG2' ' A' ' 16' ' ' LYS . . . -57.07 -34.73 68.57 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.323 -0.861 . . . . 0.0 109.599 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.31 -40.94 92.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 110.115 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -153.71 160.4 30.98 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.901 . . . . 0.0 110.259 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -60.39 -59.72 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.916 1.482 . . . . 0.0 110.544 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.11 -140.04 25.06 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 1.021 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 73.1 p -82.14 -21.94 36.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.272 -1.134 . . . . 0.0 110.163 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 4.6 t -55.8 -49.21 73.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.716 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 82.7 tt0 -59.54 -32.13 70.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.822 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.705 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.5 pt -99.3 10.51 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.99 -1.069 . . . . 0.0 110.328 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.7 m 56.96 16.5 2.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.88 . . . . 0.0 110.641 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 1.021 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -60.53 -18.8 54.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.965 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -140.37 177.82 7.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 110.182 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.81 1.53 12.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.871 . . . . 0.0 110.335 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -58.56 -40.86 84.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.658 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.553 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER -112.79 122.67 48.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.928 . . . . 0.0 110.81 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.918 HG21 ' OE1' ' A' ' 4' ' ' GLN . 25.6 p -105.18 176.25 5.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 110.262 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.42 -6.81 65.85 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.391 -1.064 . . . . 0.0 110.209 -179.921 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.847 HG23 ' SG ' ' A' ' 91' ' ' CYS . 10.6 p . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.211 0.529 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.527 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 30.7 m -90.09 148.03 23.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 110.802 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.114 ' CG2' HD21 ' A' ' 12' ' ' LEU . 22.9 t -97.06 118.53 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.581 -0.699 . . . . 0.0 109.435 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.639 ' NE2' HG23 ' A' ' 92' ' ' THR . 20.9 pt20 -120.56 177.47 5.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.081 -1.012 . . . . 0.0 110.936 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -151.45 -62.19 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.741 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.82 -115.81 0.74 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -108.21 13.2 26.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.227 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.521 ' CD1' ' OE2' ' A' ' 56' ' ' GLU . 97.9 m-85 -131.77 159.36 38.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.527 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 37.6 m -101.07 136.31 41.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.937 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.841 ' CG ' HD21 ' A' ' 57' ' ' LEU . 6.6 m-30 -112.69 123.23 49.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.654 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 m -66.33 160.11 25.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.114 HD21 ' CG2' ' A' ' 3' ' ' VAL . 99.5 mt -86.97 -27.33 23.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 110.735 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -61.56 -66.3 0.56 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 0.0 110.671 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.5 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.6 m -44.27 -48.71 9.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.977 -1.077 . . . . 0.0 110.151 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.613 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 58.5 t -59.05 -46.72 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.218 -0.926 . . . . 0.0 110.109 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 25.1 tttm -58.9 -52.43 65.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.806 -1.184 . . . . 0.0 108.562 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -80.65 11.98 3.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.35 -0.844 . . . . 0.0 109.368 178.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.785 HD21 HG21 ' A' ' 43' ' ' VAL . 59.1 tp -57.17 -37.08 71.59 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.416 -0.803 . . . . 0.0 110.097 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -60.75 -38.88 86.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 109.38 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -141.55 124.73 16.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.594 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.799 HD11 ' CB ' ' A' ' 52' ' ' ASN . 4.5 mm? . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.616 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.456 ' NH2' ' CG ' ' A' ' 33' ' ' ARG . 13.4 mmt-85 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.3 0.572 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 44.9 p-10 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.968 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.834 0 N-CA-C 110.494 -0.618 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.531 ' N ' ' HG2' ' A' ' 71' ' ' GLN . . . 117.2 40.16 0.76 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -130.14 73.14 81.61 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.308 -1.113 . . . . 0.0 110.374 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -60.68 141.77 95.96 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.908 1.478 . . . . 0.0 110.146 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.785 HG21 HD21 ' A' ' 18' ' ' LEU . 24.0 m -140.51 54.83 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.667 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 17.1 m . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.583 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 1.2 m . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.347 0.594 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.623 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -87.78 -58.34 2.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.415 -0.803 . . . . 0.0 110.228 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 20.8 m-80 -78.93 110.27 13.9 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.419 -0.801 . . . . 0.0 110.326 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.623 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -61.99 -11.39 21.28 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.721 1.379 . . . . 0.0 110.336 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.799 ' CB ' HD11 ' A' ' 21' ' ' LEU . 99.6 m-20 -130.52 34.23 4.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.842 . . . . 0.0 110.734 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.69 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.17 174.23 6.46 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.038 -1.039 . . . . 0.0 108.719 178.953 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.69 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.0 Cg_exo -56.36 76.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.624 1.329 . . . . 0.0 108.889 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.641 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.7 tt0 -39.07 -26.31 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.884 -0.51 . . . . 0.0 110.377 -178.068 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.521 ' OE2' ' CD1' ' A' ' 8' ' ' PHE . 39.3 tp10 -53.13 -20.76 4.09 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.931 -1.105 . . . . 0.0 108.174 178.145 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.841 HD21 ' CG ' ' A' ' 10' ' ' PHE . 82.2 mt -84.35 8.45 16.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.623 -0.673 . . . . 0.0 109.657 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.726 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.57 -51.49 4.98 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.73 -179.568 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.726 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -56.71 -44.31 46.47 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.632 1.333 . . . . 0.0 110.744 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.062 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 1.5 mt -60.63 -40.04 90.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.814 -1.179 . . . . 0.0 110.503 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.506 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 46.2 t -65.56 -28.14 68.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.034 -1.041 . . . . 0.0 110.697 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 46.2 tttm -90.75 6.69 43.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.639 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.508 ' OE2' ' HB2' ' A' ' 65' ' ' ASN . 12.7 pt-20 -130.84 144.61 54.21 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.959 -1.088 . . . . 0.0 110.4 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.22 -8.31 12.06 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.91 1.479 . . . . 0.0 110.797 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.508 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 83.9 m-20 -79.23 -23.79 43.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 110.194 -179.346 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.062 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -51.33 -36.3 42.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.083 -1.01 . . . . 0.0 109.685 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.8 mt-30 -61.65 -43.55 98.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.0 109.758 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -80.27 -41.17 25.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 109.609 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 60' ' ' LEU . 86.0 mt -64.24 -46.26 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 109.87 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.792 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.2 tm? -49.38 -53.86 20.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.946 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.614 ' N ' HD13 ' A' ' 70' ' ' LEU . 87.9 mt-30 -45.41 -53.9 8.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -57.79 -54.62 44.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 48.4 mt -44.98 -56.1 4.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.338 -0.851 . . . . 0.0 109.705 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.746 ' OE2' HD11 ' A' ' 70' ' ' LEU . 64.6 mt-10 -51.12 -53.6 32.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 110.154 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 78' ' ' GLU . 82.8 tt0 -55.23 -54.49 42.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 110.693 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 79' ' ' ASP . 24.7 mm -58.75 -37.52 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 109.81 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -57.21 -33.06 67.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.591 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 34' ' ' ASN . 99.2 mt-10 -60.12 -41.92 93.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 110.52 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -147.83 159.54 40.37 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.93 . . . . 0.0 110.275 -179.797 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.571 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -59.77 -57.21 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.883 1.465 . . . . 0.0 110.65 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.02 -140.89 26.38 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.931 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 79.6 p -78.08 -21.51 50.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -1.116 . . . . 0.0 109.932 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.454 ' C ' ' SG ' ' A' ' 91' ' ' CYS . 42.0 t -54.52 -54.15 44.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 109.976 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.0 tt0 -55.77 -32.17 63.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 111.028 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.726 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.8 pt -96.92 10.89 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.922 -1.111 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 57.21 18.83 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.931 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -70.89 -7.59 46.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.997 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.594 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 53.1 t80 -147.06 167.64 23.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.37 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.01 4.94 5.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.386 -0.821 . . . . 0.0 110.5 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.594 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -65.36 -35.42 80.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.161 -0.962 . . . . 0.0 110.482 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.847 ' SG ' HG23 ' A' ' 1' ' ' VAL . 0.1 OUTLIER -96.53 120.48 36.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.705 -179.712 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.639 HG23 ' NE2' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -104.77 -5.39 21.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 110.577 -179.438 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . -83.76 -36.05 14.68 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.21 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 1' ' ' VAL . 18.5 m . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.243 0.544 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.615 HG21 ' OG ' ' A' ' 9' ' ' SER . 37.0 m -88.17 151.16 22.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.387 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.015 HG21 HD21 ' A' ' 12' ' ' LEU . 85.2 t -94.23 121.94 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.717 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.845 ' NE2' HG21 ' A' ' 92' ' ' THR . 10.4 mt-30 -109.64 139.06 45.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 110.815 -179.391 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -111.59 11.53 21.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 109.784 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.23 -131.38 1.87 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -88.5 8.44 28.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.141 -1.211 . . . . 0.0 110.191 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 92.0 m-85 -121.7 158.83 27.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.193 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.615 ' OG ' HG21 ' A' ' 2' ' ' THR . 22.4 t -105.43 123.41 47.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.363 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 17.6 m-30 -119.19 130.46 55.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.843 . . . . 0.0 110.51 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.4 m -78.62 172.73 13.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.021 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.015 HD21 HG21 ' A' ' 3' ' ' VAL . 53.0 mt -97.35 -5.29 36.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.0 110.636 -179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.3 mt-10 -74.29 -73.17 0.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.361 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' ' 13' ' ' GLU . 5.2 m -39.91 -51.43 2.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.677 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.737 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 27.4 m -63.93 -45.67 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.069 -1.019 . . . . 0.0 109.697 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 16.6 tttt -55.12 -56.89 14.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.88 -1.138 . . . . 0.0 109.063 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -80.22 8.31 7.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.818 . . . . 0.0 109.467 178.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.737 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 15.4 tp -54.57 -34.84 62.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.403 -0.811 . . . . 0.0 110.331 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -60.48 -41.55 94.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.993 . . . . 0.0 109.895 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.39 98.02 10.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.988 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' A' ' 52' ' ' ASN . 11.0 tp . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.341 -179.794 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.75 ' HE ' HD12 ' A' ' 12' ' ' LEU . 24.3 ptt-85 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 41.9 p-10 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.07 -1.019 . . . . 0.0 110.856 -179.574 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.566 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.3 Cg_exo . . . . . 0 N--CA 1.481 0.759 0 N-CA-C 110.774 -0.51 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.34 19.32 1.73 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 43' ' ' VAL . 36.4 mt-10 -104.3 117.47 59.22 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 110.06 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.23 101.02 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.658 1.346 . . . . 0.0 110.53 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.775 ' O ' HG12 ' A' ' 44' ' ' VAL . 90.7 t -132.12 172.33 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.906 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 0.0 111.441 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.322 0.582 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.588 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 13.2 t -107.69 -70.7 0.79 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.944 . . . . 0.0 110.144 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.493 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 5.6 m-20 -79.2 111.51 20.89 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.591 -0.693 . . . . 0.0 110.092 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -64.45 -9.14 19.14 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.612 1.322 . . . . 0.0 110.114 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.592 ' HB2' HD11 ' A' ' 21' ' ' LEU . 96.8 m-20 -125.68 31.89 5.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.797 . . . . 0.0 110.218 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.746 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -79.85 178.02 2.59 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 108.803 179.09 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.746 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -57.86 75.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.493 1.26 . . . . 0.0 108.936 179.352 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.8 tt0 -39.28 -27.54 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.86 -0.525 . . . . 0.0 110.139 -178.577 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.0 mt-10 -52.21 -18.37 1.49 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.048 -1.032 . . . . 0.0 108.401 178.341 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.616 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 81.7 mt -88.8 9.95 22.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.637 -0.665 . . . . 0.0 109.571 179.092 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.751 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -39.63 -51.28 5.14 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 110.344 -179.854 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.751 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -54.87 -43.52 58.55 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.5 1.263 . . . . 0.0 109.666 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.056 HD11 HG21 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -53.42 -42.07 66.68 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.109 -0.994 . . . . 0.0 109.674 179.403 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.0 m -64.85 -28.05 69.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.131 -0.981 . . . . 0.0 110.335 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -90.66 2.55 55.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 111.434 -178.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.557 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 25.7 pt-20 -120.83 142.9 35.41 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.625 -1.297 . . . . 0.0 110.317 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -64.0 -18.29 63.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.91 1.479 . . . . 0.0 111.239 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -79.69 -12.3 59.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.985 -1.072 . . . . 0.0 110.344 -179.56 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.99 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.42 -41.16 19.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 110.461 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -56.68 -42.23 78.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 -179.611 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.4 mt-10 -79.92 -34.35 39.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.173 -0.955 . . . . 0.0 110.322 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.056 HG21 HD11 ' A' ' 60' ' ' LEU . 90.3 mt -68.96 -46.96 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.138 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.666 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.9 OUTLIER -47.69 -62.5 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.525 -179.787 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.666 ' N ' HD13 ' A' ' 70' ' ' LEU . 10.7 tt0 -49.62 -54.08 20.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.13 -0.981 . . . . 0.0 110.736 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 75.5 mtt-85 -52.7 -53.59 45.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.229 -0.919 . . . . 0.0 110.518 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.658 ' CD2' HG11 ' A' ' 15' ' ' VAL . 7.2 tp -51.09 -48.83 61.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.072 -1.017 . . . . 0.0 110.015 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 43.1 mt-10 -55.63 -41.13 73.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.376 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.566 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -66.24 -55.94 13.69 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.057 -1.027 . . . . 0.0 110.464 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 79' ' ' ASP . 22.2 mm -58.77 -40.77 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.336 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.785 ' HA ' HD22 ' A' ' 12' ' ' LEU . . . -62.76 -28.48 70.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.534 -0.729 . . . . 0.0 109.08 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 80.6 tt0 -65.36 -36.42 83.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.619 -0.676 . . . . 0.0 110.443 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.2 m-20 -149.14 158.04 39.1 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.824 -1.173 . . . . 0.0 110.524 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -61.72 -71.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.057 1.556 . . . . 0.0 110.653 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.89 -140.05 23.58 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.926 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 70.5 p -79.08 -24.32 43.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -1.168 . . . . 0.0 109.732 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 11.3 t -53.18 -53.55 48.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.2 tt0 -58.47 -32.19 68.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 111.057 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.761 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.1 pt -98.46 11.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.957 -1.09 . . . . 0.0 110.291 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 34.4 m 59.39 12.12 2.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.177 -0.952 . . . . 0.0 110.514 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.926 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -64.89 -16.18 62.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 109.997 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.54 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 41.8 t80 -137.17 166.57 23.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 110.188 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.85 2.88 7.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 110.289 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.54 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -62.35 -38.8 90.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 0.0 110.433 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.7 OUTLIER -104.11 118.25 36.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 110.636 -179.663 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.845 HG21 ' NE2' ' A' ' 4' ' ' GLN . 72.8 p -103.13 166.55 10.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.376 -0.827 . . . . 0.0 110.069 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.16 -5.08 78.27 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.303 -1.116 . . . . 0.0 110.213 179.988 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.284 0.564 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.969 HG21 ' OG ' ' A' ' 9' ' ' SER . 7.2 t -129.21 168.49 16.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.375 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -93.01 114.83 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.647 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.628 ' OE1' HG21 ' A' ' 92' ' ' THR . 61.2 tt0 -110.7 121.02 44.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.952 -179.216 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.752 ' OD2' HD21 ' A' ' 60' ' ' LEU . 58.4 p30 -99.92 3.64 44.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.362 -0.836 . . . . 0.0 109.325 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . -172.53 -142.56 3.82 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -82.1 1.42 36.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.2 -1.176 . . . . 0.0 110.498 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.482 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 98.6 m-85 -109.19 134.43 51.75 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.621 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.969 ' OG ' HG21 ' A' ' 2' ' ' THR . 1.0 OUTLIER -85.47 126.55 33.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.355 -0.841 . . . . 0.0 109.981 179.779 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.521 ' O ' ' OG1' ' A' ' 2' ' ' THR . 21.7 m-30 -117.7 127.21 53.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.023 -1.048 . . . . 0.0 110.777 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.444 ' C ' HD12 ' A' ' 12' ' ' LEU . 59.9 p -76.7 172.89 12.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.314 -0.866 . . . . 0.0 110.339 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.866 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 mp -100.64 -6.34 25.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.309 -0.869 . . . . 0.0 110.61 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 92.2 mt-10 -71.72 -73.89 0.17 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 0.0 110.82 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.3 m -43.5 -49.19 7.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.182 -0.949 . . . . 0.0 110.581 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.667 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 6.0 m -59.02 -46.41 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.555 ' CD ' ' HB3' ' A' ' 33' ' ' ARG . 23.0 tttt -58.15 -55.02 40.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.876 -1.14 . . . . 0.0 108.844 179.02 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.504 ' O ' ' O ' ' A' ' 20' ' ' ASP . 95.6 mttt -80.49 11.48 3.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 178.651 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.794 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.7 tt -58.73 -29.72 66.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 110.183 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -65.48 -34.91 79.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.182 -0.949 . . . . 0.0 110.144 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' A' ' 17' ' ' LYS . 60.6 t0 -133.82 141.71 47.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 110.147 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.599 HD11 ' CB ' ' A' ' 52' ' ' ASN . 1.9 mm? . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.041 -1.037 . . . . 0.0 110.569 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.555 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 32.4 mtt-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.276 0.56 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 50.3 t30 . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 110.197 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.86 0 N-CA-C 110.552 -0.595 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.47 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 162.54 37.45 0.02 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 43' ' ' VAL . 1.2 mm-40 -123.86 72.21 52.7 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.236 -1.155 . . . . 0.0 110.211 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.52 75.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.888 1.467 . . . . 0.0 110.379 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.859 ' O ' HG23 ' A' ' 44' ' ' VAL . 88.8 t -120.67 127.39 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.962 . . . . 0.0 110.29 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.021 HG21 ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.409 -0.807 . . . . 0.0 110.158 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.307 0.575 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.546 ' OG ' ' CG1' ' A' ' 43' ' ' VAL . 44.1 m -51.74 -62.8 1.4 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.263 -0.898 . . . . 0.0 111.083 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 3.9 m-20 -80.32 114.18 45.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.564 -179.362 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.8 0.84 1.73 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.806 1.424 . . . . 0.0 110.596 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.599 ' CB ' HD11 ' A' ' 21' ' ' LEU . 27.0 m120 -133.67 31.78 3.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.095 -1.003 . . . . 0.0 110.692 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.855 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 10.5 p90 -76.8 -177.23 0.73 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.039 -1.038 . . . . 0.0 108.772 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 1.071 ' HB2' HD13 ' A' ' 57' ' ' LEU . 5.0 Cg_exo -54.93 75.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.518 1.273 . . . . 0.0 110.108 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.628 ' N ' ' O ' ' A' ' 53' ' ' PHE . 84.7 tt0 -44.95 -33.87 2.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.571 -0.705 . . . . 0.0 110.032 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.589 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.3 mt-10 -54.39 -18.79 4.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.015 -1.053 . . . . 0.0 108.52 178.66 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.071 HD13 ' HB2' ' A' ' 54' ' ' PRO . 7.8 mp -97.5 9.2 43.04 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.931 0.872 . . . . 0.0 109.009 178.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.792 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -43.74 -49.35 19.97 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.685 -0.634 . . . . 0.0 109.934 179.556 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.792 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.86 -42.74 64.01 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.436 1.229 . . . . 0.0 109.73 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.1 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 10.7 mp -55.74 -40.74 72.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.051 -1.031 . . . . 0.0 109.129 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.656 ' HA ' HG22 ' A' ' 44' ' ' VAL . 41.4 t -64.3 -26.0 68.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 110.166 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.501 ' CE ' ' HD2' ' A' ' 58' ' ' LYS . 29.6 mttt -88.09 -4.96 58.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.88 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.528 ' CG ' ' HA ' ' A' ' 60' ' ' LEU . 9.1 pt-20 -113.1 147.69 37.84 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.012 -1.055 . . . . 0.0 110.337 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.9 -17.81 61.33 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.953 1.501 . . . . 0.0 111.034 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.484 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 74.5 m-20 -79.71 -13.73 59.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.085 -1.009 . . . . 0.0 110.59 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.1 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.93 -40.24 13.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 110.097 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -57.36 -40.79 78.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 110.061 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.3 -34.9 36.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.915 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.555 HG21 ' CD2' ' A' ' 60' ' ' LEU . 78.0 mt -72.64 -54.39 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 109.864 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -44.64 -60.15 2.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.87 . . . . 0.0 110.155 179.864 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.792 ' N ' HD13 ' A' ' 70' ' ' LEU . 94.2 mt-30 -51.65 -52.88 44.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.088 -1.007 . . . . 0.0 110.049 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -55.29 -56.45 19.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.823 . . . . 0.0 109.955 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.603 ' CD2' HG11 ' A' ' 3' ' ' VAL . 54.0 mt -47.45 -51.04 21.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.143 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 75.6 mm-40 -56.76 -38.39 72.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.859 . . . . 0.0 110.467 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -70.67 -54.04 13.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.164 -0.96 . . . . 0.0 110.297 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.551 HG21 ' CG2' ' A' ' 3' ' ' VAL . 57.8 mt -65.35 -31.03 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.821 ' HA ' HD23 ' A' ' 12' ' ' LEU . . . -67.12 -34.85 78.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.403 -0.811 . . . . 0.0 109.503 179.501 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.49 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 97.1 mt-10 -94.18 16.07 15.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.474 -0.766 . . . . 0.0 109.78 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.413 ' OD1' ' HD2' ' A' ' 80' ' ' PRO . 9.8 t0 -169.51 127.74 0.85 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.48 -0.763 . . . . 0.0 110.152 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD2' ' OD1' ' A' ' 79' ' ' ASP . 3.0 Cg_endo -61.66 -74.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.74 1.39 . . . . 0.0 110.749 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.68 -141.65 24.78 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.864 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 58.5 p -79.32 -22.87 43.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -1.197 . . . . 0.0 109.954 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 9.3 t -53.73 -52.17 60.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' OE1' ' CB ' ' A' ' 80' ' ' PRO . 83.6 tt0 -58.78 -32.32 69.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.88 . . . . 0.0 111.102 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.73 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.3 pt -96.59 11.73 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.933 -1.104 . . . . 0.0 110.458 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 58.56 13.6 2.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.58 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.864 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.7 -14.62 63.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.181 -0.949 . . . . 0.0 109.912 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.48 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 5.9 m-85 -137.83 165.99 25.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 0.0 110.331 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.14 3.57 5.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.338 -0.851 . . . . 0.0 110.283 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -63.05 -39.87 96.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.925 . . . . 0.0 110.392 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER -103.61 118.73 37.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.548 -179.7 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.628 HG21 ' OE1' ' A' ' 4' ' ' GLN . 6.5 m -112.08 6.25 19.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.375 -0.828 . . . . 0.0 110.3 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.03 -56.56 5.23 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.274 -1.133 . . . . 0.0 110.311 179.955 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.606 HG12 ' SG ' ' A' ' 91' ' ' CYS . 3.2 t . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.165 0.507 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.827 HG21 ' HB3' ' A' ' 9' ' ' SER . 12.8 t -126.56 155.79 41.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.851 HG22 ' SG ' ' A' ' 83' ' ' CYS . 53.0 t -95.9 122.77 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.552 -0.717 . . . . 0.0 109.163 179.005 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.92 ' CD ' HG21 ' A' ' 92' ' ' THR . 9.6 pt20 -129.22 -178.71 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.058 . . . . 0.0 111.548 -178.716 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 4' ' ' GLN . 93.1 m-20 -137.74 -60.3 0.65 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.526 0.679 . . . . 0.0 109.464 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.29 -143.76 15.19 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.581 ' OD1' ' CE2' ' A' ' 8' ' ' PHE . 16.2 p30 -81.08 8.58 8.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.028 -1.278 . . . . 0.0 110.334 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.581 ' CE2' ' OD1' ' A' ' 7' ' ' ASN . 83.6 m-85 -112.91 139.07 48.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -0.973 . . . . 0.0 110.383 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.827 ' HB3' HG21 ' A' ' 2' ' ' THR . 50.9 m -101.9 139.06 38.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.334 -0.854 . . . . 0.0 110.627 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.595 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 20.4 m-85 -124.28 134.4 53.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 110.402 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.0 p -75.11 170.89 15.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.239 -0.913 . . . . 0.0 110.177 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.733 HD21 HG21 ' A' ' 3' ' ' VAL . 9.3 mt -104.58 -2.28 25.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.217 -0.927 . . . . 0.0 110.524 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.59 ' HG2' ' CD ' ' A' ' 33' ' ' ARG . 36.7 mt-10 -64.23 -71.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 0.0 110.548 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.633 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.5 OUTLIER -57.14 -38.79 74.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.39 -0.819 . . . . 0.0 111.344 -179.12 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.726 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 13.0 t -61.55 -49.92 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.844 -1.16 . . . . 0.0 109.46 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.518 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 17.0 mttt -56.87 -55.05 39.37 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.816 -1.178 . . . . 0.0 108.864 178.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.71 10.96 4.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.018 178.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.925 HD23 ' OE2' ' A' ' 74' ' ' GLU . 13.1 tp -75.09 -10.37 59.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.088 -1.007 . . . . 0.0 109.893 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -63.58 -32.48 73.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 0.0 109.391 179.093 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -126.49 122.77 36.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.48 -0.762 . . . . 0.0 109.633 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.838 HD11 ' HB2' ' A' ' 52' ' ' ASN . 1.1 tm? . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.202 -0.936 . . . . 0.0 110.639 -179.525 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.59 ' CD ' ' HG2' ' A' ' 13' ' ' GLU . 69.6 mtm180 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.312 0.577 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.443 ' OD1' ' HD3' ' A' ' 80' ' ' PRO . 3.3 m-20 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.887 . . . . 0.0 110.055 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 3.0 Cg_exo . . . . . 0 N--CA 1.482 0.803 0 N-CA-C 110.757 -0.516 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.1 10.7 55.88 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.1 mt-10 -94.56 151.18 39.05 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.184 -1.186 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -60.79 111.51 1.07 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.876 1.461 . . . . 0.0 110.211 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.86 HG12 HG23 ' A' ' 44' ' ' VAL . 78.4 t -133.79 152.82 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 110.736 -179.656 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.86 HG23 HG12 ' A' ' 43' ' ' VAL . 74.3 t . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.529 -0.732 . . . . 0.0 111.275 179.44 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.486 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 55.6 m . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.157 0.503 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 38.6 m -60.72 -63.8 1.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.938 . . . . 0.0 110.751 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.567 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 1.0 OUTLIER -72.29 113.42 20.55 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 110.512 -179.69 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -62.45 -13.02 30.55 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.636 1.335 . . . . 0.0 110.639 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.838 ' HB2' HD11 ' A' ' 21' ' ' LEU . 87.3 m-20 -128.19 34.02 4.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 110.109 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.718 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.04 -178.63 1.17 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.794 . . . . 0.0 109.249 179.549 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.729 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.8 Cg_exo -61.47 75.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 N-CA-C 108.655 -1.325 . . . . 0.0 108.655 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.613 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.2 tt0 -39.07 -27.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.764 -0.585 . . . . 0.0 110.118 -178.379 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 54' ' ' PRO . 71.9 mm-40 -53.35 -17.92 2.19 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.977 -1.077 . . . . 0.0 108.614 178.185 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.729 HD12 ' HG2' ' A' ' 54' ' ' PRO . 87.3 mt -92.06 6.53 46.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.692 . . . . 0.0 109.696 179.147 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.751 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.68 -51.4 5.2 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 110.452 -179.722 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.751 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -54.04 -42.42 67.07 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.34 1.179 . . . . 0.0 109.67 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.011 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -54.99 -42.83 72.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.088 -1.007 . . . . 0.0 109.816 179.46 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.1 m -68.84 -29.75 68.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.222 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 62' ' ' LYS . 51.6 tptt -79.93 -4.33 51.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.434 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.533 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 6.7 pt-20 -114.04 142.45 27.93 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 110.108 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -61.58 -17.22 52.9 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.873 1.459 . . . . 0.0 111.099 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.506 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 70.1 m-20 -79.9 -7.9 59.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.005 . . . . 0.0 110.33 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.011 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -50.42 -37.62 38.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 110.06 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.01 -39.0 93.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.211 -0.931 . . . . 0.0 110.142 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -80.17 -39.01 30.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.986 HG21 ' CD1' ' A' ' 60' ' ' LEU . 76.7 mt -68.06 -42.81 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.35 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.906 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -50.73 -59.21 4.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -0.768 . . . . 0.0 110.169 179.861 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.906 ' N ' HD13 ' A' ' 70' ' ' LEU . 52.7 tt0 -50.5 -55.77 14.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 110.355 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 73' ' ' LEU . 50.5 mtt180 -55.06 -62.97 1.31 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 0.0 110.431 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 72' ' ' ARG . 13.1 tp -41.73 -50.29 4.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.957 . . . . 0.0 109.992 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.925 ' OE2' HD23 ' A' ' 18' ' ' LEU . 63.0 mm-40 -55.3 -46.45 76.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 110.318 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -54.89 -53.12 59.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.088 -1.008 . . . . 0.0 110.37 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' ' 79' ' ' ASP . 26.0 mm -59.11 -35.0 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.104 -0.997 . . . . 0.0 109.404 179.661 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.725 ' HB2' HG12 ' A' ' 15' ' ' VAL . . . -59.59 -30.49 68.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.559 -0.713 . . . . 0.0 109.527 179.169 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.0 -40.6 96.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 110.41 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 2.5 p30 -148.97 159.52 37.24 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.099 -1.001 . . . . 0.0 110.482 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.577 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -62.63 -60.83 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.988 1.52 . . . . 0.0 110.494 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.02 -141.33 24.1 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 61.5 p -83.11 -18.3 40.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -1.141 . . . . 0.0 109.775 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.851 ' SG ' HG22 ' A' ' 3' ' ' VAL . 11.0 t -58.53 -53.35 59.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 0.0 110.047 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 48.1 tp10 -59.61 -23.98 63.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 111.081 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.784 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.3 pt -105.42 17.26 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.0 -1.062 . . . . 0.0 110.366 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.0 m 49.95 19.36 0.45 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.893 . . . . 0.0 110.65 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.983 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.04 -13.47 58.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.035 -1.04 . . . . 0.0 110.005 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -148.24 179.96 7.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.321 -0.862 . . . . 0.0 110.044 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.24 1.68 20.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 110.003 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -58.41 -39.97 81.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.332 -0.855 . . . . 0.0 110.415 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.606 ' SG ' HG12 ' A' ' 1' ' ' VAL . 0.5 OUTLIER -108.05 129.43 55.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.533 -179.653 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.92 HG21 ' CD ' ' A' ' 4' ' ' GLN . 19.5 p -109.81 159.81 16.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.378 -0.826 . . . . 0.0 110.146 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.67 -12.77 61.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.278 -1.131 . . . . 0.0 110.228 179.994 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.483 ' CG1' ' SG ' ' A' ' 91' ' ' CYS . 79.0 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.172 0.511 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.472 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 60.8 m -132.45 150.04 52.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.843 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.812 ' HB ' HD21 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -92.98 119.39 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 109.419 179.379 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.747 ' CD ' HG21 ' A' ' 92' ' ' THR . 17.6 pt20 -116.27 148.29 40.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.079 -1.013 . . . . 0.0 110.933 -179.164 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -96.14 -74.85 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.76 . . . . 0.0 109.478 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.53 -121.12 4.67 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.452 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -85.62 14.48 5.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -1.14 . . . . 0.0 110.15 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.692 ' CE1' ' CE1' ' A' ' 10' ' ' PHE . 25.8 t80 -125.89 148.66 49.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.39 -0.819 . . . . 0.0 110.015 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.56 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 12.5 t -107.26 137.74 44.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.17 -0.956 . . . . 0.0 110.724 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.692 ' CE1' ' CE1' ' A' ' 8' ' ' PHE . 84.9 m-85 -119.56 132.1 55.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.19 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -67.14 164.2 18.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.088 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.812 HD21 ' HB ' ' A' ' 3' ' ' VAL . 54.1 mt -101.44 -5.19 25.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.982 . . . . 0.0 110.432 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.548 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 83.1 tt0 -69.04 -73.02 0.16 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.426 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.4 m -42.36 -55.3 3.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.032 -1.043 . . . . 0.0 110.545 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.698 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 15.8 m -51.81 -43.95 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.091 -1.006 . . . . 0.0 110.083 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.488 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 37.3 tttm -56.26 -58.75 6.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.832 -1.168 . . . . 0.0 108.644 178.701 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 75.1 mmtt -80.62 17.78 1.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.353 -0.842 . . . . 0.0 109.57 178.528 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 2.1 tt -65.77 -41.16 92.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.198 -0.939 . . . . 0.0 110.012 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -53.16 -41.99 65.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 110.287 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -140.26 80.33 1.75 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.19 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 52' ' ' ASN . 6.6 tt . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.548 ' HD2' ' HA ' ' A' ' 13' ' ' GLU . 82.9 mtm-85 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.285 0.564 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 63.7 m-20 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 110.57 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.58 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 2.9 Cg_endo . . . . . 0 N--CA 1.481 0.789 0 N-CA-C 110.53 -0.604 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.0 17.84 42.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.533 ' CG ' ' OE1' ' A' ' 74' ' ' GLU . 7.9 pt-20 -135.59 79.3 47.77 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.214 -1.168 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HB3' ' HG3' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -61.17 131.59 37.42 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.862 1.454 . . . . 0.0 110.387 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 43' ' ' VAL . 27.0 m -120.06 53.18 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 110.435 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.017 HG21 ' HA ' ' A' ' 61' ' ' CYS . 7.4 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 110.696 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.548 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 73.5 m . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.272 0.558 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.549 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.6 m -54.07 -50.76 66.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 110.144 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.487 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 2.7 m120 -71.45 112.22 13.05 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.785 . . . . 0.0 110.615 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -63.08 -10.52 21.02 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.694 1.365 . . . . 0.0 110.118 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.802 ' O ' HD13 ' A' ' 21' ' ' LEU . 84.4 m-20 -130.21 33.92 4.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.379 -0.826 . . . . 0.0 110.461 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.689 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -79.09 179.64 1.72 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 108.719 179.082 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.82 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.6 Cg_exo -58.35 74.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.512 1.269 . . . . 0.0 109.184 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 53' ' ' PHE . 82.9 tt0 -39.5 -26.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.668 -0.645 . . . . 0.0 110.349 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.8 mt-10 -56.83 -15.7 5.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.023 -1.048 . . . . 0.0 108.619 178.484 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.82 HD12 ' HG2' ' A' ' 54' ' ' PRO . 78.4 mt -92.09 14.17 16.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.646 -0.659 . . . . 0.0 109.609 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.751 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.84 -49.49 5.68 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 110.085 179.818 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.751 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.3 Cg_exo -56.51 -47.67 22.78 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.444 1.233 . . . . 0.0 109.573 179.147 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.124 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 12.0 tp -46.55 -52.65 12.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.727 179.428 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 1.017 ' HA ' HG21 ' A' ' 44' ' ' VAL . 85.0 m -67.01 -30.47 70.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 110.55 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 51.2 tttm -79.94 3.44 19.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 110.616 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.518 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 8.2 pt-20 -127.9 144.05 49.97 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.984 -1.072 . . . . 0.0 110.124 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.39 -17.22 56.45 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.805 1.424 . . . . 0.0 110.853 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.495 ' O ' HG13 ' A' ' 69' ' ' ILE . 22.6 m120 -79.88 -9.49 59.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 110.417 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.124 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.92 -42.37 27.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.013 . . . . 0.0 109.806 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.471 ' HG3' ' HB3' ' A' ' 42' ' ' PRO . 64.0 tt0 -59.62 -43.37 93.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.537 -0.727 . . . . 0.0 110.37 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.26 -39.74 32.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 109.974 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.915 ' HB ' HD11 ' A' ' 60' ' ' LEU . 68.7 mt -67.48 -47.84 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.629 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.806 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.4 tm? -50.54 -55.6 15.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 110.014 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.792 ' N ' HD13 ' A' ' 70' ' ' LEU . 52.2 tt0 -47.27 -52.18 16.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 110.186 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -54.73 -51.48 65.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 0.0 110.086 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 53.0 mt -53.52 -52.16 60.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 0.0 110.054 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.757 ' OE2' HD11 ' A' ' 70' ' ' LEU . 73.2 mt-10 -55.29 -37.9 67.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.873 . . . . 0.0 110.511 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.523 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 82.1 tt0 -65.31 -53.58 41.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.985 . . . . 0.0 110.926 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.646 HG21 ' CG2' ' A' ' 3' ' ' VAL . 20.6 mm -61.35 -39.13 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.594 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.06 -26.92 68.55 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.491 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.9 tt0 -66.3 -35.12 79.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.507 -0.746 . . . . 0.0 111.063 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.11 96.14 1.23 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.809 -1.182 . . . . 0.0 111.041 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.637 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 2.7 Cg_endo -67.82 44.71 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.757 1.398 . . . . 0.0 110.483 179.314 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.52 -74.38 0.3 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.991 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 74.3 p -69.37 -58.81 3.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -1.123 . . . . 0.0 110.296 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -39.16 -46.9 1.52 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 110.495 -179.586 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 80' ' ' PRO . 81.8 tt0 -63.75 -25.1 68.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.043 . . . . 0.0 110.527 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 82' ' ' THR . 26.5 pt -107.23 18.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.268 -179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.19 15.66 4.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.519 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.991 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -59.75 -23.89 63.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 109.935 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -141.75 169.23 17.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.59 5.16 11.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 110.322 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.11 -43.26 95.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.934 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -94.67 133.61 38.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.193 -0.942 . . . . 0.0 110.389 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.747 HG21 ' CD ' ' A' ' 4' ' ' GLN . 42.3 p -116.16 154.39 30.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.318 -0.864 . . . . 0.0 110.144 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 101.99 -9.02 56.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.44 -1.035 . . . . 0.0 110.386 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.826 HG22 ' SG ' ' A' ' 91' ' ' CYS . 7.8 p . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.313 0.577 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 53.5 m -127.08 155.59 43.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.95 . . . . 0.0 110.676 -179.544 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.003 ' CG2' HD21 ' A' ' 12' ' ' LEU . 4.0 t -91.13 117.17 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.497 179.389 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 8' ' ' PHE . 4.1 pt20 -126.87 175.18 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.073 -1.017 . . . . 0.0 111.201 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.743 ' OD2' HG23 ' A' ' 69' ' ' ILE . 96.8 m-20 -136.94 -58.38 0.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.573 0.702 . . . . 0.0 109.5 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.37 -140.18 11.28 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.587 ' OD1' ' CD2' ' A' ' 8' ' ' PHE . 13.9 p30 -79.65 2.04 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.164 -1.198 . . . . 0.0 110.266 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.587 ' CD2' ' OD1' ' A' ' 7' ' ' ASN . 77.9 m-85 -110.71 152.77 26.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.505 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 49.0 m -112.0 136.99 50.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 0.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.753 ' CG ' HD21 ' A' ' 57' ' ' LEU . 11.2 m-85 -117.16 127.79 54.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.264 -0.897 . . . . 0.0 110.285 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.504 ' HA ' HG23 ' A' ' 2' ' ' THR . 30.5 m -72.22 164.67 25.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.352 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.003 HD21 ' CG2' ' A' ' 3' ' ' VAL . 83.9 mt -85.24 -24.29 27.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.942 . . . . 0.0 110.431 -179.753 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 14' ' ' SER . 86.0 tt0 -64.18 -69.16 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.308 -0.87 . . . . 0.0 110.372 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.1 m -43.82 -51.41 7.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.125 -0.984 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.669 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 54.4 t -59.16 -49.03 84.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.228 -0.92 . . . . 0.0 109.327 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 tptm -53.21 -56.45 16.35 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.523 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 20' ' ' ASP . 57.6 mttt -80.85 13.75 2.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.573 -0.704 . . . . 0.0 110.076 178.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.669 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.1 tt -65.65 -47.36 75.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.987 . . . . 0.0 110.297 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.34 -47.17 86.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -0.962 . . . . 0.0 109.834 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 17' ' ' LYS . 83.9 m-20 -103.2 122.5 44.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 109.787 179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.883 HD11 ' HB2' ' A' ' 52' ' ' ASN . 18.9 tp . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.744 -179.604 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 29.5 ptt-85 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.31 0.576 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.643 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 28.3 m-20 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 110.655 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.523 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.1 Cg_exo . . . . . 0 N--CA 1.482 0.822 0 N-CA-C 110.633 -0.564 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.484 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 145.34 -7.46 1.57 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -119.84 74.81 19.62 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.239 . . . . 0.0 110.396 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.484 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_endo -61.74 115.6 2.9 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.78 1.41 . . . . 0.0 110.487 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.824 ' O ' HG23 ' A' ' 44' ' ' VAL . 89.6 t -136.42 141.7 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.223 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.023 HG21 ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.472 -0.767 . . . . 0.0 110.611 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.37 0.605 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.673 ' CB ' HG11 ' A' ' 43' ' ' VAL . 58.1 p -52.96 -42.98 66.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.308 -0.87 . . . . 0.0 111.0 -179.295 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -80.3 110.68 17.53 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.186 -0.946 . . . . 0.0 110.46 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -58.3 -10.62 8.85 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.753 1.397 . . . . 0.0 110.787 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.883 ' HB2' HD11 ' A' ' 21' ' ' LEU . 97.9 m-20 -139.56 42.95 2.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.121 -0.987 . . . . 0.0 110.712 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.756 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -78.61 177.2 2.98 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.092 -1.005 . . . . 0.0 108.433 178.778 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.756 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.8 Cg_exo -57.51 76.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 N-CA-C 108.628 -1.336 . . . . 0.0 108.628 179.124 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.623 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.9 tt0 -38.88 -28.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.803 -0.561 . . . . 0.0 110.075 -178.295 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.7 mt-10 -51.66 -18.18 1.11 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.996 -1.065 . . . . 0.0 108.587 178.257 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.753 HD21 ' CG ' ' A' ' 10' ' ' PHE . 78.7 mt -86.77 2.95 47.03 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.43 0.633 . . . . 0.0 109.861 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.753 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 20.6 tptt -39.99 -49.61 5.97 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 110.366 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.753 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.85 -41.1 80.78 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.357 1.188 . . . . 0.0 110.434 179.678 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.012 HD21 HG21 ' A' ' 69' ' ' ILE . 6.2 mp -61.08 -37.6 83.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.876 -1.14 . . . . 0.0 110.179 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.663 ' HA ' HG22 ' A' ' 44' ' ' VAL . 57.3 m -62.73 -25.23 68.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.574 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -98.89 10.94 40.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.115 -0.991 . . . . 0.0 111.399 -179.15 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.575 ' CG ' ' HA ' ' A' ' 60' ' ' LEU . 12.6 pt-20 -133.65 147.1 63.15 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.746 -1.221 . . . . 0.0 110.536 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.25 -11.16 23.98 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.911 1.48 . . . . 0.0 110.939 -179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.42 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 79.4 m-20 -78.93 -23.72 44.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.1 -1.0 . . . . 0.0 110.428 -179.046 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.023 ' HB1' HG21 ' A' ' 44' ' ' VAL . . . -49.14 -39.3 28.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.973 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -57.16 -44.94 83.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.27 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 73.5 mm-40 -79.13 -31.9 44.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.012 HG21 HD21 ' A' ' 60' ' ' LEU . 95.5 mt -76.34 -53.45 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.096 -1.003 . . . . 0.0 109.928 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.01 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -44.69 -65.42 0.53 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.432 -0.793 . . . . 0.0 110.484 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 1.01 ' N ' HD13 ' A' ' 70' ' ' LEU . 50.9 tt0 -49.06 -54.79 14.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.124 -0.985 . . . . 0.0 110.697 -179.702 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 44.5 mtp85 -54.97 -55.32 32.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.549 ' CD1' HG22 ' A' ' 69' ' ' ILE . 28.7 mt -47.43 -50.77 21.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.158 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.819 ' OE2' HD21 ' A' ' 70' ' ' LEU . 75.4 mt-10 -56.22 -48.19 76.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 34.8 tt0 -53.79 -52.92 58.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.042 -1.036 . . . . 0.0 109.894 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 79' ' ' ASP . 62.2 mt -59.92 -34.3 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -0.932 . . . . 0.0 109.156 179.224 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -56.15 -32.83 64.65 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.034 179.031 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.643 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 83.2 tt0 -64.2 -43.49 94.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.522 -0.736 . . . . 0.0 109.67 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.473 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 2.0 t70 -143.17 147.58 41.29 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.956 179.784 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.616 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -56.64 -56.11 2.24 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.841 1.442 . . . . 0.0 110.583 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.19 -137.13 21.57 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.942 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 71.9 p -82.16 -23.09 35.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -1.087 . . . . 0.0 110.625 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 7.7 t -56.29 -54.38 46.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.065 -1.022 . . . . 0.0 110.033 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 76.9 tt0 -58.05 -27.34 63.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 111.178 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.76 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.9 pt -101.14 14.84 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.89 -1.131 . . . . 0.0 110.27 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 73.3 m 54.76 16.32 1.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.897 . . . . 0.0 110.539 179.594 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.942 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.51 -12.31 51.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.82 174.5 11.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.85 3.89 9.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.304 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -61.52 -42.82 99.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.908 . . . . 0.0 110.417 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.826 ' SG ' HG22 ' A' ' 1' ' ' VAL . 1.2 m -106.2 124.55 49.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.79 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.504 HG21 ' CD ' ' A' ' 4' ' ' GLN . 36.8 p -109.61 163.23 13.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.158 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.02 3.32 51.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.489 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.395 -1.061 . . . . 0.0 110.283 179.975 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.517 ' CG1' ' SG ' ' A' ' 91' ' ' CYS . 52.9 t . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.287 0.565 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.724 HG21 ' HB2' ' A' ' 9' ' ' SER . 11.7 t -118.48 164.04 15.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 0.0 110.357 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.697 HG13 HG21 ' A' ' 76' ' ' ILE . 65.3 t -81.07 124.46 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 109.569 179.492 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.791 ' CB ' HG21 ' A' ' 92' ' ' THR . 48.9 tt0 -113.65 121.53 44.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.055 -1.028 . . . . 0.0 110.9 -179.333 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.98 ' HB3' HD21 ' A' ' 73' ' ' LEU . 52.6 p30 -97.74 13.44 30.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.441 -0.787 . . . . 0.0 109.647 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.506 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 173.51 -132.13 2.24 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -93.67 16.57 13.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.164 -1.198 . . . . 0.0 109.773 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.65 ' CB ' ' CZ ' ' A' ' 10' ' ' PHE . 44.8 m-85 -121.06 128.09 52.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.456 -0.777 . . . . 0.0 110.429 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.724 ' HB2' HG21 ' A' ' 2' ' ' THR . 14.7 p -82.18 118.29 22.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 8' ' ' PHE . 21.4 m-85 -117.93 123.32 45.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.807 -179.207 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.492 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 45.6 t -67.87 168.78 10.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.28 -0.888 . . . . 0.0 110.083 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.833 ' N ' HD12 ' A' ' 12' ' ' LEU . 4.6 mp -95.81 0.84 52.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 110.629 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -73.28 -73.93 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.088 -1.008 . . . . 0.0 110.488 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.534 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.4 m -42.68 -41.09 3.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.114 -0.991 . . . . 0.0 110.556 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.531 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 33.1 t -69.26 -50.89 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 109.805 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.503 ' HD3' ' HB2' ' A' ' 33' ' ' ARG . 9.6 ttpp -48.06 -46.52 33.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.221 -0.924 . . . . 0.0 109.102 179.243 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 18' ' ' LEU . 49.9 mttm -74.03 -54.96 6.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 0.0 109.003 178.822 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.77 HD12 ' OD1' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -27.88 -41.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.804 -0.56 . . . . 0.0 110.551 -179.999 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 17' ' ' LYS . 22.4 mttm -51.76 -45.62 63.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 109.947 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 21' ' ' LEU . 52.0 p30 -112.86 -3.15 14.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 110.063 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.984 HD23 ' ND2' ' A' ' 50' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.404 -0.81 . . . . 0.0 110.451 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.503 ' HB2' ' HD3' ' A' ' 16' ' ' LYS . 6.3 ptp180 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.314 0.578 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 41.5 p-10 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.202 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.557 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.801 0 N-CA-C 110.653 -0.557 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.423 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 140.94 4.87 1.08 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.821 -1.181 . . . . 0.0 110.169 179.823 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.54 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -134.61 60.47 42.57 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.881 -1.364 . . . . 0.0 110.612 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -62.16 139.41 78.03 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.824 1.433 . . . . 0.0 110.515 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 49' ' ' SER . 14.8 m -141.93 119.68 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.334 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.724 ' O ' HG12 ' A' ' 44' ' ' VAL . 69.2 t . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 0.0 110.473 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.526 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.383 0.611 . . . . 0.0 110.147 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.53 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.3 t -69.54 -56.0 8.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 110.442 -179.817 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.984 ' ND2' HD23 ' A' ' 21' ' ' LEU . 7.2 m120 -78.28 113.06 30.54 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.481 -0.762 . . . . 0.0 110.452 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -62.45 -12.69 28.91 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.747 1.393 . . . . 0.0 110.459 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.491 ' HB2' HD11 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -127.8 36.41 4.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 110.045 179.886 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.727 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 3.0 p90 -80.14 178.86 2.11 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.203 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 1.021 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.2 Cg_exo -56.53 75.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.676 1.356 . . . . 0.0 109.872 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.9 tt0 -43.56 -34.19 1.34 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.833 . . . . 0.0 110.298 -179.503 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.545 ' C ' HD12 ' A' ' 57' ' ' LEU . 74.4 mm-40 -54.31 -18.65 4.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.934 -1.104 . . . . 0.0 108.626 178.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.021 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.5 mp -95.3 18.69 11.97 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.092 0.949 . . . . 0.0 108.99 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.743 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -43.19 -51.02 14.41 Favored Pre-proline 0 N--CA 1.489 1.483 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.52 179.818 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.743 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.24 -49.12 17.4 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.502 1.264 . . . . 0.0 109.658 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.104 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -48.1 -49.1 33.01 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.09 -1.006 . . . . 0.0 109.753 179.446 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.513 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 87.0 m -63.49 -23.95 67.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 19.9 tttt -90.68 5.62 47.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 0.0 110.743 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 8.6 pt-20 -125.96 144.76 49.7 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.891 -1.13 . . . . 0.0 110.317 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -61.54 -13.59 30.44 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.94 1.495 . . . . 0.0 110.803 -179.799 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.507 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 84.7 m-20 -79.78 -22.65 42.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.292 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.104 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.23 -40.05 10.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.11 -0.994 . . . . 0.0 109.797 179.775 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -62.48 -36.95 84.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 0.0 109.23 179.3 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.49 -38.9 29.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.524 -0.735 . . . . 0.0 109.407 178.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.763 HG23 ' HB2' ' A' ' 5' ' ' ASP . 80.0 mt -70.92 -46.18 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 109.898 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.911 HD13 ' N ' ' A' ' 71' ' ' GLN . 2.1 tm? -40.66 -68.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.506 -0.746 . . . . 0.0 110.554 -179.768 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.911 ' N ' HD13 ' A' ' 70' ' ' LEU . 25.3 mt-30 -42.77 -52.4 5.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.143 -0.973 . . . . 0.0 110.459 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -53.71 -59.05 5.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.004 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.98 HD21 ' HB3' ' A' ' 5' ' ' ASP . 36.7 mt -47.57 -54.14 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 110.051 179.705 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 39' ' ' PRO . 70.3 mt-10 -52.19 -45.78 65.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 110.06 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.557 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 83.7 tt0 -57.62 -51.36 69.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.809 179.752 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.697 HG21 HG13 ' A' ' 3' ' ' VAL . 23.6 mm -60.64 -38.75 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 109.519 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.543 ' HA ' HD23 ' A' ' 12' ' ' LEU . . . -54.52 -38.39 66.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.429 -0.794 . . . . 0.0 109.65 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.735 ' O ' ' CB ' ' A' ' 79' ' ' ASP . 83.8 tt0 -44.14 -33.56 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.89 . . . . 0.0 109.611 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.735 ' CB ' ' O ' ' A' ' 78' ' ' GLU . 19.5 t70 95.04 73.13 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 76' ' ' ILE . 3.0 Cg_exo -60.86 -34.97 90.55 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.022 1.538 . . . . 0.0 110.185 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 85' ' ' ILE . . . 94.16 -28.89 9.58 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.195 -2.362 . . . . 0.0 107.195 -178.249 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.822 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 75.6 p -74.3 -40.75 62.06 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.11 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.677 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 53.5 t -58.81 -40.96 85.65 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.834 178.853 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.37 -33.37 75.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.066 -1.021 . . . . 0.0 110.349 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 82' ' ' THR . 17.8 pt -94.44 11.32 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.934 . . . . 0.0 110.237 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER 67.83 12.42 8.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.355 -0.841 . . . . 0.0 110.527 179.721 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.822 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -58.64 -35.76 73.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.22 -0.925 . . . . 0.0 109.897 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.548 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 29.1 t80 -123.15 166.8 14.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.937 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.91 -7.28 47.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.152 -0.967 . . . . 0.0 109.974 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.548 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -51.82 -37.1 50.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.83 . . . . 0.0 110.861 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.677 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -104.13 118.8 37.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.906 . . . . 0.0 111.139 -179.149 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.791 HG21 ' CB ' ' A' ' 4' ' ' GLN . 18.4 p -98.16 177.86 5.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 110.197 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.75 -5.9 84.16 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.442 ' OXT' ' SG ' ' A' ' 86' ' ' CYS . 23.9 p . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.166 . . . . 0.0 110.118 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 84' ' ' GLU . 3.5 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.229 0.538 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.495 HG23 ' HA ' ' A' ' 11' ' ' SER . 37.0 m -89.26 150.89 22.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 110.293 -179.851 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.01 HG21 HD11 ' A' ' 12' ' ' LEU . 88.0 t -80.08 104.8 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 110.123 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.53 ' HB3' ' CG2' ' A' ' 92' ' ' THR . 48.1 tt0 -108.64 123.69 49.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 110.36 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -100.75 5.07 43.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.098 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . -176.44 -138.62 2.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -79.74 -0.12 32.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -1.123 . . . . 0.0 110.251 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.456 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 84.4 m-85 -116.8 130.7 56.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.197 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m -86.01 136.18 33.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 110.126 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.647 ' CE1' HD23 ' A' ' 57' ' ' LEU . 57.0 m-85 -115.09 125.73 53.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 110.191 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.539 ' C ' HD22 ' A' ' 12' ' ' LEU . 33.8 t -73.07 169.9 16.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.92 . . . . 0.0 110.179 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.01 HD11 HG21 ' A' ' 3' ' ' VAL . 3.2 mm? -100.63 -3.99 29.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.115 -0.99 . . . . 0.0 110.413 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 14' ' ' SER . 97.5 mt-10 -70.23 -72.9 0.18 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -0.999 . . . . 0.0 110.432 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.498 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.5 m -41.12 -50.69 3.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 110.662 -179.722 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.634 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 30.8 m -63.1 -47.96 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.096 -1.003 . . . . 0.0 109.743 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.628 ' CD ' ' HA ' ' A' ' 33' ' ' ARG . 6.8 ttpp -56.53 -55.42 34.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.084 -1.01 . . . . 0.0 109.159 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -80.11 7.6 8.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.49 179.0 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 13.0 tp -54.1 -35.65 62.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.577 -0.702 . . . . 0.0 110.131 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -55.48 -41.84 73.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.116 -0.99 . . . . 0.0 109.507 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.7 105.92 16.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.778 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.781 HD11 ' H ' ' A' ' 52' ' ' ASN . 11.8 tp . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.595 -179.64 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.628 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 76.1 mtm180 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.22 0.533 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 10.6 p30 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.265 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.463 ' HG3' ' HB2' ' A' ' 75' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.481 0.791 0 N-CA-C 110.479 -0.623 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.38 8.52 43.61 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -123.49 76.04 54.11 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.279 -1.13 . . . . 0.0 110.115 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.47 141.81 96.4 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.001 1.527 . . . . 0.0 110.689 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 43' ' ' VAL . 15.5 m -121.21 58.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.378 -0.826 . . . . 0.0 110.186 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.327 -179.856 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.8 m . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.534 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 6.0 t -62.63 -73.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.053 -1.029 . . . . 0.0 111.099 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.698 ' OD1' HD13 ' A' ' 21' ' ' LEU . 28.3 m-20 -79.98 113.68 40.16 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.837 -179.184 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -64.59 -7.2 13.84 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.793 1.417 . . . . 0.0 110.329 179.521 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.781 ' H ' HD11 ' A' ' 21' ' ' LEU . 88.8 m-20 -129.16 32.5 4.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.0 109.864 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.741 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -79.86 -176.55 0.74 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 108.956 179.412 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.966 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.7 Cg_exo -59.28 74.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.442 1.233 . . . . 0.0 109.051 179.201 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.8 tt0 -39.28 -32.33 0.11 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.687 -0.633 . . . . 0.0 110.551 -178.523 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 54' ' ' PRO . 77.7 tt0 -52.31 -24.95 8.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.905 -1.122 . . . . 0.0 108.604 178.817 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.966 HD12 ' HG2' ' A' ' 54' ' ' PRO . 91.7 mt -85.28 1.23 49.19 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.437 0.636 . . . . 0.0 109.543 179.151 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.772 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.8 tmmt? -40.93 -49.65 7.7 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.459 -0.775 . . . . 0.0 110.493 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.772 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -53.98 -39.77 83.73 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.398 1.21 . . . . 0.0 110.557 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.06 HD13 HG21 ' A' ' 69' ' ' ILE . 9.6 mt -67.64 -30.65 70.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.927 -1.108 . . . . 0.0 110.029 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 46.0 t -69.34 -26.18 64.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 110.066 179.783 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -96.11 20.38 10.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 108.981 179.502 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -114.84 142.0 27.69 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.71 -0.619 . . . . 0.0 110.538 -179.11 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.93 -26.49 74.3 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.789 1.415 . . . . 0.0 109.425 178.873 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -86.06 -5.08 59.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.815 . . . . 0.0 110.538 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.889 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -45.26 -37.97 5.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.046 . . . . 0.0 110.101 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 94.0 mt-30 -59.55 -41.05 89.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 110.25 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.33 -39.31 28.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.096 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.06 HG21 HD13 ' A' ' 60' ' ' LEU . 84.8 mt -63.29 -47.89 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.135 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.814 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.4 tm? -53.05 -53.37 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 110.211 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.764 ' N ' HD13 ' A' ' 70' ' ' LEU . 73.7 mt-30 -48.33 -55.23 11.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.396 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -50.17 -52.16 37.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.363 -0.835 . . . . 0.0 110.188 -179.75 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 56.5 mt -53.13 -49.2 67.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.26 -0.9 . . . . 0.0 110.094 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.753 ' OE2' HD11 ' A' ' 70' ' ' LEU . 74.4 mt-10 -54.8 -43.38 72.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 110.727 -179.776 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.463 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.8 tt0 -62.9 -55.63 24.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.033 -1.042 . . . . 0.0 110.904 -179.308 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.1 mt -62.12 -38.11 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.35 70.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.448 -0.783 . . . . 0.0 109.8 179.596 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.3 tt0 -62.08 -37.06 83.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 110.556 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 3.0 m-20 -165.15 151.44 8.97 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.016 . . . . 0.0 110.706 -179.796 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.595 ' HB3' ' CG ' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.38 74.95 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.968 1.509 . . . . 0.0 110.719 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 80' ' ' PRO . . . -61.28 -134.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.269 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.932 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 59.4 p -75.39 -20.88 58.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.997 -1.296 . . . . 0.0 109.281 179.24 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.613 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 9.9 t -60.29 -46.23 90.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.533 -0.729 . . . . 0.0 109.404 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.595 ' CG ' ' HB3' ' A' ' 80' ' ' PRO . 49.8 tp10 -58.57 -30.23 67.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.271 -0.893 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.756 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.4 pt -103.2 12.85 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.96 -1.087 . . . . 0.0 110.39 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 4.4 t 60.52 14.24 4.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.281 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.932 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -64.47 -21.64 66.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.083 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.466 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 1.7 m-85 -131.59 166.51 21.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.58 2.99 3.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 110.368 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -65.9 -38.56 89.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -0.936 . . . . 0.0 110.409 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.613 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -108.56 115.15 29.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 110.715 -179.568 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' A' ' 4' ' ' GLN . 41.4 p -100.27 176.9 5.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 110.254 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.03 78.47 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.297 -1.119 . . . . 0.0 110.257 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.956 HG21 ' HA ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.205 0.526 . . . . 0.0 110.142 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 63.0 m -130.55 149.4 52.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.655 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.852 ' HB ' HD21 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -92.35 119.92 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.623 -0.673 . . . . 0.0 109.64 179.569 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 51.5 tt0 -111.74 121.31 44.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 110.824 -179.286 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 1.009 ' OD2' HD21 ' A' ' 73' ' ' LEU . 83.0 m-20 -97.31 9.14 43.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 109.818 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.449 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . -179.55 -138.13 3.2 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -82.4 4.5 23.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.167 -1.196 . . . . 0.0 110.185 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 78.3 m-85 -121.89 132.63 54.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 110.389 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.483 ' HB3' HG21 ' A' ' 92' ' ' THR . 26.8 p -80.73 127.63 32.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 110.034 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.677 ' HB3' HD11 ' A' ' 57' ' ' LEU . 20.2 m-30 -114.6 126.7 55.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.87 . . . . 0.0 110.445 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.8 m -71.55 166.78 21.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.852 HD21 ' HB ' ' A' ' 3' ' ' VAL . 51.5 mt -96.91 -8.81 29.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.558 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.544 ' HG2' ' CD ' ' A' ' 33' ' ' ARG . 95.3 mt-10 -63.8 -68.07 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.065 -1.022 . . . . 0.0 110.394 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.1 m -45.2 -50.69 11.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.271 -0.893 . . . . 0.0 111.191 -179.438 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.591 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 25.1 m -57.58 -48.43 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 0.0 110.269 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' N ' HG23 ' A' ' 15' ' ' VAL . 28.8 ttpp -50.5 -51.25 49.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.865 -1.147 . . . . 0.0 108.643 179.165 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.631 ' O ' ' C ' ' A' ' 18' ' ' LEU . 63.6 mttp -67.97 -57.36 6.31 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.066 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.678 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 0.4 OUTLIER 1.66 -71.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 120.832 0.349 . . . . 0.0 111.373 179.32 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.614 ' N ' ' O ' ' A' ' 17' ' ' LYS . 86.0 tttt -49.47 -59.28 3.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.916 -1.115 . . . . 0.0 109.248 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 17' ' ' LYS . 24.7 t70 -109.11 97.24 6.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.426 -0.796 . . . . 0.0 109.461 178.924 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.008 HD21 ' HB2' ' A' ' 52' ' ' ASN . 31.6 tp . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.893 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.544 ' CD ' ' HG2' ' A' ' 13' ' ' GLU . 85.2 mtt-85 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.305 0.574 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 78' ' ' GLU . 88.4 m-20 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 0.0 110.31 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.806 0 N-CA-C 110.47 -0.627 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.52 3.78 49.92 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.96 83.55 37.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.279 -1.13 . . . . 0.0 110.147 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.499 ' HA ' HD22 ' A' ' 70' ' ' LEU . 2.9 Cg_endo -61.6 140.38 86.4 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.9 1.474 . . . . 0.0 110.591 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.716 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.3 p -148.12 64.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 44' ' ' VAL . 94.5 t . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.293 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.308 0.575 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.606 ' CB ' HG22 ' A' ' 43' ' ' VAL . 34.1 t -69.73 -76.2 0.1 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.181 -0.95 . . . . 0.0 110.258 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.803 ' HB3' HD22 ' A' ' 21' ' ' LEU . 39.8 m-20 -80.48 115.86 57.92 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 110.725 -179.837 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -64.63 1.84 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.657 1.346 . . . . 0.0 110.681 179.281 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 1.008 ' HB2' HD21 ' A' ' 21' ' ' LEU . 89.0 m-20 -133.84 31.77 3.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 110.064 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.871 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 11.0 p90 -76.21 -176.73 0.63 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 109.132 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 1.019 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -56.4 73.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.382 1.201 . . . . 0.0 110.037 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.61 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.0 tt0 -42.81 -34.62 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.564 -0.71 . . . . 0.0 110.309 -179.511 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.556 ' C ' HD12 ' A' ' 57' ' ' LEU . 96.0 mt-10 -54.87 -17.43 3.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.991 . . . . 0.0 108.809 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.019 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.7 mp -97.87 11.63 36.73 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.816 0.817 . . . . 0.0 109.184 179.202 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.74 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.87 -52.08 5.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.778 -0.576 . . . . 0.0 110.758 -179.818 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.74 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -53.08 -42.91 61.31 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.428 1.225 . . . . 0.0 110.25 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.903 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 11.0 mp -60.78 -35.58 76.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.064 -1.023 . . . . 0.0 109.769 179.447 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 51.8 t -66.73 -28.99 68.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.16 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -104.4 24.18 12.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 109.191 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -116.42 140.78 27.0 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.627 -0.671 . . . . 0.0 110.548 -179.232 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_endo -63.91 -30.39 67.5 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.734 1.386 . . . . 0.0 109.698 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -80.03 -7.49 58.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.418 -0.801 . . . . 0.0 110.61 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.903 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.03 -39.65 9.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.043 179.789 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.35 -41.1 92.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 110.342 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -80.17 -37.62 32.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.918 179.649 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 90.0 mt -66.08 -41.91 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 110.188 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.683 HD11 ' OE2' ' A' ' 74' ' ' GLU . 1.6 tp -56.44 -57.91 10.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 110.723 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -47.46 -17.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.084 -1.01 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.521 ' HB3' ' O ' ' A' ' 69' ' ' ILE . 27.5 ttm-85 -86.85 -58.1 2.72 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.617 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 1.009 HD21 ' OD2' ' A' ' 5' ' ' ASP . 69.6 mt -51.36 -50.79 58.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.392 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.683 ' OE2' HD11 ' A' ' 70' ' ' LEU . 88.7 mt-10 -55.41 -54.87 38.38 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.478 -0.764 . . . . 0.0 109.465 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.503 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 83.8 tt0 -61.15 -53.95 50.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 110.16 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.53 ' O ' ' O ' ' A' ' 79' ' ' ASP . 23.3 mm -62.18 -33.83 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 109.749 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . -59.06 -34.38 71.89 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.407 179.454 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 84.8 tt0 -58.7 -39.58 81.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 110.285 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.53 ' O ' ' O ' ' A' ' 76' ' ' ILE . 14.5 p-10 -145.03 153.73 53.74 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.11 -0.993 . . . . 0.0 110.358 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -58.83 -54.27 2.97 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.888 1.468 . . . . 0.0 110.537 179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.98 -139.67 24.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 44.6 p -80.08 -20.76 44.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -1.107 . . . . 0.0 110.164 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.668 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 5.5 t -55.44 -54.24 46.21 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.179 -0.951 . . . . 0.0 109.956 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.956 ' HA ' HG21 ' A' ' 1' ' ' VAL . 84.5 tt0 -56.08 -30.38 61.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 111.04 -179.493 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.78 HG13 ' HB2' ' A' ' 87' ' ' ALA . 9.0 pt -98.8 15.41 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.892 -1.13 . . . . 0.0 110.344 -179.507 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.6 m 50.89 23.51 1.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 110.376 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.983 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -71.62 -11.23 60.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 34.1 m-85 -150.56 171.56 16.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 110.126 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.82 1.96 18.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.948 . . . . 0.0 110.202 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.1 -11.61 41.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.359 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.945 ' SG ' HG22 ' A' ' 1' ' ' VAL . 0.7 OUTLIER -108.41 -172.53 2.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.97 . . . . 0.0 110.382 -179.878 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.507 ' HB ' ' HB ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -150.55 -15.81 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.273 -0.892 . . . . 0.0 110.997 -179.903 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.1 -23.33 72.96 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.488 1.463 0 O-C-N 121.159 -1.201 . . . . 0.0 110.35 -179.9 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.528 HG13 ' SG ' ' A' ' 91' ' ' CYS . 33.8 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.29 0.567 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.474 HG21 ' HB3' ' A' ' 9' ' ' SER . 61.2 m -119.39 149.43 41.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.238 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.782 HG21 HG21 ' A' ' 76' ' ' ILE . 1.2 t -83.69 113.16 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.877 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.609 ' HB3' HG21 ' A' ' 92' ' ' THR . 64.3 tt0 -110.54 119.19 38.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.418 -0.801 . . . . 0.0 110.694 -179.456 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -101.28 7.06 43.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 109.713 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.476 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . -169.67 -143.1 3.77 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -81.02 4.93 18.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.309 -1.112 . . . . 0.0 110.424 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.566 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 66.3 m-85 -125.63 136.86 53.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.311 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.474 ' HB3' HG21 ' A' ' 2' ' ' THR . 67.2 m -79.65 131.15 35.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.93 . . . . 0.0 110.037 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.905 ' HB3' HD21 ' A' ' 57' ' ' LEU . 18.4 m-85 -113.44 121.92 45.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 110.618 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.519 ' C ' HD22 ' A' ' 12' ' ' LEU . 60.1 p -75.35 171.29 14.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.241 -0.912 . . . . 0.0 109.871 179.645 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.833 HD22 ' N ' ' A' ' 12' ' ' LEU . 2.7 mm? -103.2 -12.07 17.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 0.0 110.772 -179.6 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.549 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 90.8 mt-10 -63.25 -74.1 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.092 -1.005 . . . . 0.0 110.535 -179.855 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 6.3 m -40.6 -44.37 2.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 110.478 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.705 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.1 t -62.22 -46.51 96.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.158 -0.964 . . . . 0.0 109.457 179.551 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.545 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -54.93 -50.28 69.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.021 -1.049 . . . . 0.0 108.551 178.479 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -80.36 6.6 11.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.511 -0.743 . . . . 0.0 109.657 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.705 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 44.3 tp -63.74 -23.36 67.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.38 -0.825 . . . . 0.0 110.426 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -67.52 -32.59 73.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.024 -1.048 . . . . 0.0 110.303 -179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -116.96 122.5 44.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.141 -0.975 . . . . 0.0 110.174 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.84 HD22 ' ND2' ' A' ' 50' ' ' ASN . 8.9 tp . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.4 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.549 ' HD2' ' HG2' ' A' ' 13' ' ' GLU . 67.4 mtt85 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.157 0.503 . . . . 0.0 109.958 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.634 ' ND2' ' O ' ' A' ' 34' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.747 -179.542 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.765 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . 3.0 Cg_endo . . . . . 0 N--CA 1.483 0.883 0 N-CA-C 110.592 -0.58 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.06 42.51 0.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.782 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 0.8 OUTLIER -122.95 169.72 9.43 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.322 -1.105 . . . . 0.0 110.32 -179.913 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.538 ' C ' HG12 ' A' ' 43' ' ' VAL . 2.9 Cg_endo -62.26 155.28 57.75 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 124.022 1.538 . . . . 0.0 111.178 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.734 ' C ' HG23 ' A' ' 44' ' ' VAL . 7.1 p 33.73 83.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.598 -0.689 . . . . 0.0 111.047 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.791 HG13 ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 120.8 -1.187 . . . . 0.0 108.47 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.554 ' CB ' ' HB ' ' A' ' 44' ' ' VAL . 35.3 t . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.3 p -61.03 -25.96 67.28 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.277 -0.889 . . . . 0.0 108.744 178.853 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.84 ' ND2' HD22 ' A' ' 21' ' ' LEU . 1.2 m-20 -50.32 130.79 25.05 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.705 . . . . 0.0 110.143 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -66.45 1.55 2.5 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.795 1.419 . . . . 0.0 111.106 179.816 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.84 ' HB2' HD11 ' A' ' 21' ' ' LEU . 73.2 m-20 -113.39 7.12 17.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.067 -1.021 . . . . 0.0 110.842 -179.633 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.755 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -80.1 -177.13 0.84 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.073 -1.017 . . . . 0.0 109.493 179.449 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.853 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.6 Cg_exo -61.0 73.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.7 1.368 . . . . 0.0 109.038 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.583 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.3 tt0 -38.87 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.761 -0.587 . . . . 0.0 110.19 -178.523 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.488 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 50.1 mt-10 -55.11 -22.81 17.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.093 -1.004 . . . . 0.0 109.107 178.797 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.905 HD21 ' HB3' ' A' ' 10' ' ' PHE . 31.6 mt -92.38 11.59 25.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.455 -0.778 . . . . 0.0 109.742 179.35 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.737 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.85 -51.39 5.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.43 -0.794 . . . . 0.0 110.677 179.967 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.737 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.33 -44.73 46.04 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.531 1.279 . . . . 0.0 110.511 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.024 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 10.9 mp -57.88 -41.44 82.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.933 -1.104 . . . . 0.0 110.212 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.6 m -66.65 -25.96 66.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.919 -1.113 . . . . 0.0 110.063 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -97.95 1.06 47.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.892 . . . . 0.0 110.427 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.586 ' OE2' HD12 ' A' ' 69' ' ' ILE . 5.6 pt-20 -108.08 139.9 21.14 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.107 -0.995 . . . . 0.0 110.081 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.1 Cg_exo -61.89 -21.73 72.87 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.805 1.424 . . . . 0.0 110.988 -179.562 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.484 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 75.9 m-20 -79.44 -11.31 59.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 110.579 -179.138 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.024 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -48.6 -32.02 7.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 109.86 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.79 -38.13 86.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.418 -0.801 . . . . 0.0 109.739 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.3 -41.89 24.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.271 -0.893 . . . . 0.0 109.398 179.101 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.619 HG21 ' CD2' ' A' ' 60' ' ' LEU . 65.1 mt -67.33 -49.15 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.372 -0.83 . . . . 0.0 109.67 179.534 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.999 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -41.8 -67.08 0.28 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.781 . . . . 0.0 110.005 179.898 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.999 ' N ' HD13 ' A' ' 70' ' ' LEU . 90.8 mt-30 -44.99 -51.96 9.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.094 -1.004 . . . . 0.0 110.268 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -63.47 -50.71 68.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.452 -0.78 . . . . 0.0 110.153 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.532 HD21 HD13 ' A' ' 57' ' ' LEU . 13.5 tp -46.19 -60.13 2.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.708 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.824 ' OE2' HD21 ' A' ' 70' ' ' LEU . 54.7 mt-10 -50.72 -49.4 57.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.977 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.82 -54.83 24.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 110.246 -179.771 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.782 HG21 HG21 ' A' ' 3' ' ' VAL . 25.2 mm -57.42 -39.24 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 0.0 109.545 179.759 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -55.82 -34.36 65.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.469 -0.769 . . . . 0.0 109.529 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.5 tt0 -62.49 -42.98 99.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.51 -0.744 . . . . 0.0 110.017 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.42 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 14.9 p-10 -151.97 158.56 33.82 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.975 -1.078 . . . . 0.0 110.311 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.602 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -59.83 -54.24 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.017 1.535 . . . . 0.0 110.407 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.09 -140.23 29.54 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 43.5 p -82.17 -20.43 37.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -1.102 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.593 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 21.8 t -57.99 -46.13 85.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 0.0 109.787 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 80.4 tt0 -62.24 -29.28 70.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.17 -0.956 . . . . 0.0 111.34 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.638 HG13 ' HB2' ' A' ' 87' ' ' ALA . 3.9 pt -97.38 6.38 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.893 -1.129 . . . . 0.0 110.398 -179.496 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER 67.32 6.2 4.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 179.615 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -66.15 -17.86 64.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 109.93 179.732 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.513 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.3 OUTLIER -128.06 157.63 40.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 110.186 -179.889 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.49 -0.59 10.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.089 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.72 -32.9 74.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.385 -0.822 . . . . 0.0 110.557 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.593 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -108.42 111.9 24.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 110.796 -179.504 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.609 HG21 ' HB3' ' A' ' 4' ' ' GLN . 21.0 p -101.85 174.53 5.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.395 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.3 -14.74 64.58 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.423 -1.046 . . . . 0.0 110.227 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.512 HG12 ' SG ' ' A' ' 91' ' ' CYS . 18.1 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.193 0.521 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.959 HG21 ' HB3' ' A' ' 9' ' ' SER . 10.9 t -126.83 163.32 23.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.236 -0.915 . . . . 0.0 110.66 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.079 HG21 HD21 ' A' ' 12' ' ' LEU . 45.6 t -82.78 122.44 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.499 -0.75 . . . . 0.0 109.524 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.491 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 50.3 tt0 -112.32 121.35 44.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.93 . . . . 0.0 110.822 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.965 ' OD2' HD21 ' A' ' 73' ' ' LEU . 93.3 m-20 -98.79 11.51 38.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.426 -0.796 . . . . 0.0 109.657 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.491 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 179.92 -138.36 3.37 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -88.83 14.35 10.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 110.176 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.633 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.4 m-85 -123.79 131.01 53.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.229 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.959 ' HB3' HG21 ' A' ' 2' ' ' THR . 29.6 m -81.63 123.24 28.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.897 . . . . 0.0 110.085 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.778 ' CE2' HD11 ' A' ' 60' ' ' LEU . 22.9 m-85 -119.37 128.66 54.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.369 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.409 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 49.2 m -75.51 172.7 12.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.079 HD21 HG21 ' A' ' 3' ' ' VAL . 88.5 mt -106.47 -3.19 21.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 110.837 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.01 -73.91 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 110.321 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 m -47.83 -43.8 28.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 110.51 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.547 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 18.4 t -61.21 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.03 -1.043 . . . . 0.0 109.809 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.959 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 19.3 tttt -55.23 -53.97 49.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 53.3 mttp -80.2 8.85 6.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.623 HD13 ' HB2' ' A' ' 53' ' ' PHE . 16.6 tp -60.9 -44.98 96.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 110.686 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.491 ' NZ ' ' HA ' ' A' ' 39' ' ' PRO . 57.5 mttt -66.82 -34.01 76.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.351 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -128.99 79.98 1.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.979 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.465 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.0 tt -113.59 125.58 54.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.11 -0.994 . . . . 0.0 110.392 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.421 ' HG3' ' C ' ' A' ' 21' ' ' LEU . 95.3 mt-30 -148.22 54.39 1.03 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.828 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.507 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 12.5 pt-20 -174.46 163.67 2.64 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.326 -0.859 . . . . 0.0 110.095 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 3.0 Cg_exo -61.4 166.25 11.64 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.88 1.463 . . . . 0.0 110.649 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -44.97 136.96 4.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.288 -0.883 . . . . 0.0 110.235 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -119.0 116.14 34.34 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.208 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.46 -158.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.657 1.346 . . . . 0.0 110.582 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -56.2 142.26 37.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 110.181 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 31' ' ' LYS . 41.1 t -118.14 137.35 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.914 . . . . 0.0 110.246 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.1 -27.44 45.83 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.614 ' H ' HG12 ' A' ' 29' ' ' VAL . 96.3 mttt -72.92 156.53 38.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.326 -1.102 . . . . 0.0 110.265 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.439 HD23 ' ND2' ' A' ' 34' ' ' ASN . 23.4 tp -90.43 135.2 33.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 0.0 110.312 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 13.5 ptt180 -70.38 62.74 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.173 -0.954 . . . . 0.0 110.174 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.563 ' OD1' ' CD2' ' A' ' 35' ' ' PHE . 30.3 p-10 -133.37 11.13 4.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.563 ' CD2' ' OD1' ' A' ' 34' ' ' ASN . 94.0 m-85 -101.32 8.08 42.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.959 ' HB2' ' HG3' ' A' ' 16' ' ' LYS . . . -61.01 146.22 88.08 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.253 -0.904 . . . . 0.0 110.303 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 36' ' ' ALA . 2.8 Cg_endo -63.56 -150.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.835 1.439 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.484 ' O ' ' NZ ' ' A' ' 19' ' ' LYS . 1.3 mp -108.1 136.56 19.78 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.946 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.494 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 3.1 Cg_exo -61.1 145.79 98.45 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.677 1.356 . . . . 0.0 110.677 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.58 37.12 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.481 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 2.8 tt0 -138.77 64.41 35.63 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.178 -1.189 . . . . 0.0 110.23 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.525 ' CB ' ' HG3' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -61.71 102.27 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.847 1.446 . . . . 0.0 110.721 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.571 ' O ' HG23 ' A' ' 44' ' ' VAL . 14.6 p -134.52 127.87 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 110.083 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.607 ' O ' HG12 ' A' ' 44' ' ' VAL . 32.5 t -155.0 85.16 3.59 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.475 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 49' ' ' SER . 3.0 Cg_endo -61.66 -149.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.875 1.46 . . . . 0.0 110.117 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.4 mt -52.98 -51.99 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 108.977 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 44.9 mt -111.11 -74.64 0.64 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.495 -0.753 . . . . 0.0 109.105 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.567 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.8 m -147.72 148.74 31.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.755 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.539 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 22.7 t -59.9 -50.78 72.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.568 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 7.1 m120 -79.69 117.89 69.6 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 110.397 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.13 -10.93 13.99 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.762 1.401 . . . . 0.0 110.445 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -138.32 42.3 2.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.85 . . . . 0.0 109.513 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.713 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -80.1 -177.24 0.87 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.552 -0.718 . . . . 0.0 109.568 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.094 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -58.03 72.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.674 1.355 . . . . 0.0 109.667 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.619 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 23.1 pt-20 -40.1 -36.9 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.498 -0.751 . . . . 0.0 110.3 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' C ' HD12 ' A' ' 57' ' ' LEU . 96.3 mt-10 -54.12 -17.51 2.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 109.307 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.094 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.9 mp -97.9 8.55 44.55 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.736 0.779 . . . . 0.0 109.7 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.749 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -39.81 -52.04 5.2 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.716 -0.615 . . . . 0.0 110.72 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.749 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.97 -42.63 65.14 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.466 1.245 . . . . 0.0 110.051 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.996 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 16.6 mt -57.75 -41.35 81.76 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.031 -1.043 . . . . 0.0 109.879 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 15.7 m -69.19 -28.1 66.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.091 -1.005 . . . . 0.0 110.221 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 14.2 ttpt -88.28 6.51 36.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 2.4 pt-20 -111.39 144.14 29.91 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.986 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.64 -23.61 72.1 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.834 1.439 . . . . 0.0 111.103 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.514 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 80.1 m-20 -83.31 -4.88 58.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 0.0 110.717 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.996 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -51.48 -39.56 57.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.011 -1.056 . . . . 0.0 110.066 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.525 ' HG3' ' CB ' ' A' ' 42' ' ' PRO . 30.6 tt0 -54.12 -44.05 70.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 109.918 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -79.93 -35.31 37.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.622 HG21 HD13 ' A' ' 60' ' ' LEU . 93.9 mt -67.78 -52.83 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.947 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.3 tm? -43.33 -58.42 2.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.43 -0.794 . . . . 0.0 110.019 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.621 ' N ' HD13 ' A' ' 70' ' ' LEU . 25.9 mt-30 -51.75 -54.94 22.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.033 -1.042 . . . . 0.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.6 ttm-85 -49.61 -56.24 10.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.445 -0.784 . . . . 0.0 109.788 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.965 HD21 ' OD2' ' A' ' 5' ' ' ASP . 57.2 mt -48.32 -46.83 36.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.89 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 74.9 mm-40 -55.53 -45.32 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 110.147 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.0 -54.55 40.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 110.38 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.9 mt -60.21 -31.63 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 109.69 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 33' ' ' ARG . . . -64.1 -32.06 73.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.856 . . . . 0.0 109.292 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.809 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . 79.7 tt0 -92.99 14.71 16.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.581 -0.7 . . . . 0.0 109.68 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 9.7 t70 -178.86 124.61 0.25 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.406 -0.808 . . . . 0.0 109.928 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -61.68 -62.52 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.657 1.346 . . . . 0.0 110.773 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.43 -139.28 18.74 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 1.03 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 60.2 p -79.92 -22.07 43.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.172 . . . . 0.0 110.065 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 7.6 t -54.71 -53.72 51.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 110.001 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 85.2 tt0 -57.96 -31.28 66.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 110.929 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.824 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.2 pt -99.6 13.96 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.981 -1.075 . . . . 0.0 110.334 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 33.8 m 50.44 20.53 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 110.221 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 1.03 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -60.7 -12.2 9.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.913 . . . . 0.0 110.021 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.437 ' CG ' ' O ' ' A' ' 87' ' ' ALA . 50.0 m-85 -154.82 -176.63 6.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.205 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.3 1.93 12.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.883 . . . . 0.0 110.326 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.81 -36.08 71.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.588 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -112.57 129.08 56.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.201 -0.937 . . . . 0.0 110.609 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.481 HG21 ' CD ' ' A' ' 4' ' ' GLN . 25.3 p -107.19 157.21 18.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.168 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.09 0.08 56.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.334 -1.098 . . . . 0.0 110.275 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.449 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 3.0 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.314 0.578 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 57.5 m -121.97 146.53 47.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 110.536 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.051 HG23 HD11 ' A' ' 12' ' ' LEU . 56.0 t -86.11 119.67 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 109.527 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.495 ' CD ' HG21 ' A' ' 92' ' ' THR . 49.7 tt0 -109.88 116.86 32.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 110.848 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -93.08 10.98 29.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.396 -0.815 . . . . 0.0 109.666 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.456 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 179.77 -134.72 2.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -86.66 5.92 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -1.151 . . . . 0.0 110.162 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.672 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 71.0 m-85 -124.1 137.76 54.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.103 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 p -81.17 124.06 28.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.439 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.672 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 18.1 m-30 -113.91 125.62 54.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.344 -0.847 . . . . 0.0 110.399 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.2 p -73.91 168.02 20.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.236 -0.915 . . . . 0.0 110.076 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.051 HD11 HG23 ' A' ' 3' ' ' VAL . 5.0 mp -94.12 -20.85 19.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.235 -0.916 . . . . 0.0 110.539 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.528 ' OE1' ' CG ' ' A' ' 26' ' ' GLU . 88.6 tt0 -57.62 -67.38 0.34 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.306 -0.872 . . . . 0.0 110.781 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.574 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 9.3 m -41.77 -47.44 4.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.09 -1.006 . . . . 0.0 110.317 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 96.9 t -64.4 -50.25 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.081 -1.012 . . . . 0.0 109.704 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.582 ' CD ' ' HB2' ' A' ' 36' ' ' ALA . 10.1 tptp -55.17 -49.49 71.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 108.969 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.538 ' HE2' ' NH1' ' A' ' 33' ' ' ARG . 31.0 mttt -80.47 4.4 18.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.8 . . . . 0.0 109.987 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD13 ' HB2' ' A' ' 53' ' ' PHE . 11.0 tp -64.97 -37.11 86.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -0.942 . . . . 0.0 110.446 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -57.92 -37.43 74.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 29.2 p-10 -132.14 126.47 33.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.121 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.517 HD22 ' HB3' ' A' ' 52' ' ' ASN . 11.0 mt -87.77 124.69 33.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.16 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.426 ' HG3' ' C ' ' A' ' 21' ' ' LEU . 89.5 mt-30 -145.7 55.32 1.19 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 0.0 110.368 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 0.3 OUTLIER 54.6 62.92 7.75 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.219 -0.926 . . . . 0.0 110.452 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HD2' ' ND2' ' A' ' 52' ' ' ASN . 2.9 Cg_endo -62.78 61.4 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.89 1.469 . . . . 0.0 110.483 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 23' ' ' GLU . 94.4 mt-30 -63.76 -19.54 65.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.188 -0.945 . . . . 0.0 110.277 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.643 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 0.5 OUTLIER 66.98 54.37 0.77 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.353 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -61.48 152.28 74.22 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.778 1.41 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -63.15 101.74 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.177 -0.952 . . . . 0.0 110.058 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.808 HG22 ' H ' ' A' ' 31' ' ' LYS . 13.4 p -123.27 141.44 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 110.296 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.16 2.9 69.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.808 ' H ' HG22 ' A' ' 29' ' ' VAL . 27.2 mttt -80.92 147.53 30.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -1.177 . . . . 0.0 110.169 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.7 tp -99.18 123.32 43.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.133 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.538 ' NH1' ' HE2' ' A' ' 17' ' ' LYS . 34.6 mtt-85 -69.89 136.61 50.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.927 . . . . 0.0 110.378 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 55.4 t-20 -172.09 31.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.256 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.585 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 65.4 t80 -109.82 7.45 24.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.863 . . . . 0.0 110.148 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.646 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . . . -58.35 123.03 64.0 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.174 -0.954 . . . . 0.0 110.303 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.77 -143.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.769 1.405 . . . . 0.0 110.549 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -108.82 165.54 12.47 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.915 . . . . 0.0 110.019 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.516 ' HD2' ' HB ' ' A' ' 38' ' ' ILE . 3.1 Cg_exo -59.8 158.46 28.72 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.808 1.425 . . . . 0.0 110.579 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.43 21.28 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -134.55 88.66 28.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.087 -1.243 . . . . 0.0 109.972 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -60.32 140.39 91.64 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.953 1.502 . . . . 0.0 110.704 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.927 HG23 HG23 ' A' ' 44' ' ' VAL . 16.6 m -131.33 169.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 110.299 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.927 HG23 HG23 ' A' ' 43' ' ' VAL . 6.3 t 66.89 56.06 0.85 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.461 -0.775 . . . . 0.0 110.634 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.8 Cg_endo -61.03 -45.46 19.6 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.796 1.419 . . . . 0.0 109.846 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.809 ' O ' HD23 ' A' ' 47' ' ' LEU . 67.5 mt -147.09 -39.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.459 -0.776 . . . . 0.0 109.44 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.809 HD23 ' O ' ' A' ' 46' ' ' ILE . 69.8 mt -143.75 78.54 1.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.492 -0.755 . . . . 0.0 109.64 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.527 ' O ' ' O ' ' A' ' 47' ' ' LEU . 99.1 m 56.23 144.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.411 -0.806 . . . . 0.0 110.479 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.511 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -98.6 -72.54 0.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.163 -0.96 . . . . 0.0 110.092 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.427 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -76.67 113.67 31.7 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.461 -0.775 . . . . 0.0 110.011 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.46 -11.09 18.29 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.668 1.352 . . . . 0.0 110.676 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.559 ' ND2' ' HD2' ' A' ' 24' ' ' PRO . 42.2 t30 -130.6 34.44 4.14 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.286 -0.884 . . . . 0.0 110.376 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.729 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.2 -175.45 0.6 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.172 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.093 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -58.28 74.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.499 1.262 . . . . 0.0 109.843 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 53' ' ' PHE . 87.0 tt0 -42.05 -36.87 1.24 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.451 -0.781 . . . . 0.0 110.222 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.582 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.7 mt-10 -52.79 -18.42 1.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.041 -1.037 . . . . 0.0 108.934 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.093 HD13 ' HB2' ' A' ' 54' ' ' PRO . 9.3 mp -94.12 14.95 18.38 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.901 0.858 . . . . 0.0 109.028 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.743 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -40.19 -52.24 5.7 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.034 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.743 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.9 Cg_exo -52.97 -43.28 58.1 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.509 1.268 . . . . 0.0 110.094 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.043 HD22 HG21 ' A' ' 69' ' ' ILE . 86.4 mt -60.24 -37.88 81.72 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.03 -1.043 . . . . 0.0 109.95 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.629 ' O ' HG11 ' A' ' 44' ' ' VAL . 2.9 t -69.03 -30.62 69.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.02 -1.05 . . . . 0.0 110.216 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 34.4 tttm -89.95 -1.35 57.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.154 -0.967 . . . . 0.0 109.551 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.63 138.28 26.72 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.523 -0.736 . . . . 0.0 110.038 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.71 -20.75 66.94 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.632 1.332 . . . . 0.0 110.039 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.97 -2.39 57.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.377 -0.827 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.951 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.01 -35.55 4.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.098 -1.001 . . . . 0.0 109.8 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.56 -45.54 88.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -80.25 -41.22 25.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.043 HG21 HD22 ' A' ' 60' ' ' LEU . 83.5 mt -57.53 -45.59 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.167 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.948 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -45.77 -58.48 3.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.852 . . . . 0.0 110.248 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.948 ' N ' HD13 ' A' ' 70' ' ' LEU . 84.7 mt-30 -48.7 -56.2 9.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 0.0 110.023 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -48.88 -52.8 22.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.896 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.627 HD11 HD13 ' A' ' 60' ' ' LEU . 33.8 mt -51.42 -49.96 60.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.992 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.566 ' OE2' HD11 ' A' ' 70' ' ' LEU . 86.8 mt-10 -51.89 -54.25 31.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.219 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -55.57 -55.94 26.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.922 . . . . 0.0 110.537 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 79' ' ' ASP . 38.0 mm -58.35 -41.41 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.117 -0.989 . . . . 0.0 109.922 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -52.6 -37.14 57.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.286 -0.884 . . . . 0.0 109.657 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.646 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . 84.2 tt0 -63.3 -44.03 96.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.79 . . . . 0.0 110.13 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 76' ' ' ILE . 6.5 t70 -136.73 143.4 42.64 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.054 -1.029 . . . . 0.0 110.231 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.558 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -59.41 -48.15 14.46 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.74 1.39 . . . . 0.0 110.588 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.41 -137.66 19.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.619 ' O ' HG12 ' A' ' 85' ' ' ILE . 44.2 p -76.08 -24.47 55.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -1.177 . . . . 0.0 109.312 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.566 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 22.8 t -47.55 -54.74 10.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.446 -0.784 . . . . 0.0 110.266 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.558 ' HB2' ' CB ' ' A' ' 80' ' ' PRO . 85.0 tt0 -60.39 -36.63 78.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.402 -0.811 . . . . 0.0 111.625 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.619 HG12 ' O ' ' A' ' 82' ' ' THR . 9.5 pt -86.88 10.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.741 -1.225 . . . . 0.0 110.58 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 87.5 m 52.78 19.81 1.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.828 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.559 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -78.33 -4.67 49.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.068 -1.02 . . . . 0.0 109.774 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.65 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 22.5 t80 -146.43 165.81 28.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.45 -0.781 . . . . 0.0 110.143 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.98 3.91 7.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 110.398 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.65 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -62.67 -31.83 72.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.96 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.566 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -108.07 122.3 46.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.173 -0.954 . . . . 0.0 110.662 -179.671 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.495 HG21 ' CD ' ' A' ' 4' ' ' GLN . 14.8 p -105.67 150.09 25.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.363 -0.836 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 94' ' ' CYS . . . 100.16 -6.89 58.31 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 93' ' ' GLY . 22.0 m . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.352 -1.087 . . . . 0.0 110.32 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.246 0.546 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 25.8 m -122.18 145.06 48.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.903 . . . . 0.0 110.399 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.045 HG23 HD11 ' A' ' 12' ' ' LEU . 64.9 t -88.43 119.94 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.042 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.82 ' OE1' HG21 ' A' ' 92' ' ' THR . 12.0 pt20 -115.31 140.41 49.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 110.762 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.463 ' OD2' HD11 ' A' ' 60' ' ' LEU . 51.0 p30 -110.31 13.93 22.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.549 -0.719 . . . . 0.0 109.862 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.07 -135.58 2.61 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -81.99 3.72 25.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -1.126 . . . . 0.0 110.128 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 81.0 m-85 -122.87 151.58 41.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.478 ' OG ' ' HB ' ' A' ' 2' ' ' THR . 3.7 t -104.19 135.06 46.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.697 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 24.6 m-85 -121.62 133.67 54.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.534 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.0 m -73.49 167.2 21.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -0.864 . . . . 0.0 110.36 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.045 HD11 HG23 ' A' ' 3' ' ' VAL . 5.3 mp -95.13 -15.95 22.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 110.508 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.2 mt-10 -65.74 -69.2 0.31 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.078 -1.013 . . . . 0.0 110.282 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' GLU . 5.6 m -40.76 -53.07 2.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 110.606 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.684 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.2 m -57.31 -45.07 85.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.045 -1.034 . . . . 0.0 109.442 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 37' ' ' PRO . 55.2 tttm -54.09 -57.56 10.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.0 109.006 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -80.3 12.6 2.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.376 -0.827 . . . . 0.0 109.979 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.684 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 4.9 tt -65.62 -36.86 84.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 110.52 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HD2' ' HB3' ' A' ' 37' ' ' PRO . 21.3 tttt -56.39 -48.76 76.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -0.881 . . . . 0.0 110.695 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -134.0 155.65 49.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.118 -0.989 . . . . 0.0 110.388 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.724 HD22 ' HB2' ' A' ' 52' ' ' ASN . 7.8 mt -114.16 121.91 45.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 109.978 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -136.91 159.35 42.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 110.249 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.609 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 1.5 mt-10 53.27 179.55 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.99 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.609 ' HD2' ' CB ' ' A' ' 23' ' ' GLU . 3.3 Cg_exo -58.27 176.93 0.32 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.721 1.38 . . . . 0.0 110.557 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 24' ' ' PRO . 95.1 mt-30 -41.5 -83.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.512 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -129.16 79.26 74.7 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.095 -1.003 . . . . 0.0 110.357 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.522 ' CG ' ' OE1' ' A' ' 23' ' ' GLU . 3.0 Cg_endo -63.68 133.83 41.25 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.812 1.427 . . . . 0.0 110.553 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 27' ' ' PRO . 28.4 tpt180 41.79 87.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.275 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 29' ' ' VAL . 5.6 p -43.55 124.07 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.271 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.83 106.66 2.78 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -61.01 -29.01 69.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -1.138 . . . . 0.0 110.477 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.2 mt -112.21 135.54 52.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.14 -0.975 . . . . 0.0 110.748 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -122.57 135.76 54.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.428 -0.795 . . . . 0.0 109.353 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.623 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 38.2 t-20 -158.16 -65.99 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.869 -1.144 . . . . 0.0 111.522 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.418 ' C ' ' HE2' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -58.58 70.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.401 -0.812 . . . . 0.0 111.28 -178.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.977 ' HB3' ' HG2' ' A' ' 78' ' ' GLU . . . -80.35 163.0 59.21 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.162 -0.961 . . . . 0.0 109.81 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.581 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 2.9 Cg_endo -65.1 -3.54 7.41 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.736 1.387 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.581 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 3.6 mt 71.44 123.24 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.25 -0.906 . . . . 0.0 110.172 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 2.9 Cg_endo -61.89 -178.24 0.3 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.75 1.395 . . . . 0.0 110.61 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.87 13.28 29.92 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -133.55 66.74 74.56 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.307 -1.113 . . . . 0.0 110.163 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.791 ' HA ' HD12 ' A' ' 70' ' ' LEU . 3.0 Cg_exo -61.88 135.09 53.63 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.937 1.493 . . . . 0.0 110.708 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.884 HG22 ' OG ' ' A' ' 49' ' ' SER . 3.1 p 178.46 91.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.1 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.853 ' O ' HG13 ' A' ' 44' ' ' VAL . 6.4 p -133.63 64.16 66.89 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 110.195 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 3.1 Cg_exo -59.47 159.58 23.08 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.765 1.403 . . . . 0.0 110.477 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.444 ' HB ' HD22 ' A' ' 47' ' ' LEU . 81.2 mt -47.74 -35.18 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 0.0 110.134 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.807 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.9 mm? -86.2 0.55 53.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.083 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 97.1 m 59.38 131.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.36 -0.837 . . . . 0.0 110.207 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.884 ' OG ' HG22 ' A' ' 43' ' ' VAL . 48.9 m -61.34 -59.23 5.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 110.916 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -80.12 113.16 36.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.425 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -61.42 -7.59 8.95 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.677 1.356 . . . . 0.0 110.391 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.724 ' HB2' HD22 ' A' ' 21' ' ' LEU . 90.8 m-20 -135.07 40.53 2.89 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.263 -0.898 . . . . 0.0 110.218 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.66 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -80.03 177.19 3.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.93 . . . . 0.0 108.929 179.245 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.733 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.7 Cg_exo -58.06 74.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.544 1.286 . . . . 0.0 109.215 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.611 ' N ' ' O ' ' A' ' 53' ' ' PHE . 84.5 tt0 -39.34 -29.58 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.773 -0.579 . . . . 0.0 110.293 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.4 mt-10 -51.71 -20.96 2.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.979 -1.076 . . . . 0.0 108.482 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.733 HD12 ' HG2' ' A' ' 54' ' ' PRO . 75.2 mt -87.17 10.02 18.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.597 -0.689 . . . . 0.0 109.58 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.756 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.89 -51.07 5.66 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 110.415 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.756 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.57 -42.98 63.25 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.561 1.295 . . . . 0.0 110.205 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.003 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 6.6 mp -58.18 -42.79 86.84 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.007 -1.058 . . . . 0.0 110.068 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.547 ' HA ' HG22 ' A' ' 44' ' ' VAL . 3.7 t -62.71 -27.49 69.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 110.158 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -90.36 -4.44 57.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 110.874 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 10.4 pt-20 -113.54 142.63 27.95 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 0.0 110.228 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.45 -14.33 41.68 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.87 1.458 . . . . 0.0 110.982 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.498 ' O ' HG13 ' A' ' 69' ' ' ILE . 68.6 m-20 -79.68 -17.4 53.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.181 -0.949 . . . . 0.0 110.603 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.003 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -52.01 -37.01 51.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.999 -1.063 . . . . 0.0 110.079 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -55.65 -44.08 76.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -80.34 -36.61 33.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.706 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.785 HG21 ' CD2' ' A' ' 60' ' ' LEU . 84.1 mt -66.78 -50.68 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 0.0 109.904 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.95 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -42.11 -62.99 0.81 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 0.0 110.343 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.95 ' N ' HD13 ' A' ' 70' ' ' LEU . 54.0 mt-30 -48.09 -52.47 20.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.073 -1.017 . . . . 0.0 110.231 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -55.27 -54.52 42.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 69' ' ' ILE . 3.6 mm? -47.69 -52.51 18.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 109.93 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.73 ' OE2' HD21 ' A' ' 70' ' ' LEU . 68.0 mt-10 -52.78 -50.17 64.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 109.902 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.527 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.0 tt0 -53.76 -54.83 32.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.967 . . . . 0.0 109.971 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 79' ' ' ASP . 39.0 mm -56.07 -35.33 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.127 -0.983 . . . . 0.0 109.233 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -57.81 -32.82 67.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.433 -0.792 . . . . 0.0 109.293 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.977 ' HG2' ' HB3' ' A' ' 36' ' ' ALA . 94.3 mt-10 -60.19 -42.84 95.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.424 -0.798 . . . . 0.0 109.86 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -147.14 153.62 45.26 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 110.172 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.55 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 3.2 Cg_exo -60.13 -51.96 4.86 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.952 1.501 . . . . 0.0 110.618 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.15 -139.51 20.52 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.586 ' O ' HG12 ' A' ' 85' ' ' ILE . 45.6 p -79.83 -19.76 47.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -1.144 . . . . 0.0 109.778 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.57 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 48.8 t -54.39 -53.81 49.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 110.155 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 80' ' ' PRO . 83.7 tt0 -58.68 -30.34 67.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 111.22 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 82' ' ' THR . 12.0 pt -95.94 12.73 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.913 -1.117 . . . . 0.0 110.56 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 3.4 t 51.47 19.87 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.285 -0.884 . . . . 0.0 110.961 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -77.72 -9.0 58.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 109.751 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.617 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 17.9 t80 -138.45 164.65 28.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.472 -0.767 . . . . 0.0 109.877 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.92 2.09 11.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 110.176 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.617 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -62.84 -37.23 85.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.574 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.57 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -98.2 120.31 38.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.1 -1.0 . . . . 0.0 110.59 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.82 HG21 ' OE1' ' A' ' 4' ' ' GLN . 41.5 p -104.03 154.58 19.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.365 -0.834 . . . . 0.0 110.142 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.76 -11.37 68.19 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 110.274 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 1' ' ' VAL . 23.5 m . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.201 0.524 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.648 HG21 ' OG ' ' A' ' 9' ' ' SER . 43.2 m -126.12 152.02 46.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.445 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.049 HG21 HD11 ' A' ' 12' ' ' LEU . 92.4 t -88.69 113.98 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.393 -0.817 . . . . 0.0 109.836 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.49 ' HB3' HG21 ' A' ' 92' ' ' THR . 47.8 tt0 -108.95 118.07 35.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.133 -0.979 . . . . 0.0 110.525 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.526 ' HB3' HD21 ' A' ' 73' ' ' LEU . 55.0 p30 -99.09 6.45 46.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.704 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -174.15 -143.26 4.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -79.91 3.62 19.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -1.149 . . . . 0.0 110.49 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.456 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 79.4 m-85 -120.23 140.8 50.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.101 -0.999 . . . . 0.0 110.46 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.648 ' OG ' HG21 ' A' ' 2' ' ' THR . 21.8 t -86.59 127.13 34.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.976 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.665 ' CZ ' HD23 ' A' ' 57' ' ' LEU . 22.0 m-30 -116.93 130.07 56.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.139 -0.976 . . . . 0.0 110.656 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.446 ' C ' HD22 ' A' ' 12' ' ' LEU . 75.2 p -80.03 174.6 11.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.324 -0.86 . . . . 0.0 110.286 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.049 HD11 HG21 ' A' ' 3' ' ' VAL . 2.5 mm? -99.89 -7.88 24.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 110.817 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -68.56 -71.3 0.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.178 -0.951 . . . . 0.0 111.056 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.529 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 4.1 m -51.91 -50.6 60.75 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.096 -1.003 . . . . 0.0 111.229 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.616 ' CG2' ' HA ' ' A' ' 12' ' ' LEU . 17.3 m -55.99 -48.65 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.884 -1.135 . . . . 0.0 110.212 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.518 ' N ' HG23 ' A' ' 15' ' ' VAL . 19.3 ttpp -55.69 -52.75 62.79 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.846 -1.159 . . . . 0.0 108.669 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.474 ' HE2' ' NZ ' ' A' ' 16' ' ' LYS . 71.1 mmtt -80.47 12.73 2.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.791 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.649 HD21 HG21 ' A' ' 43' ' ' VAL . 54.9 tp -61.39 -51.0 70.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 110.144 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' A' ' 38' ' ' ILE . 62.8 mttp -62.85 -33.96 76.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.914 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -130.9 100.42 5.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.847 . . . . 0.0 109.623 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 52' ' ' ASN . 0.7 OUTLIER -95.33 126.84 40.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.836 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.516 ' O ' ' HG3' ' A' ' 27' ' ' PRO . 92.8 mt-30 -133.22 150.62 51.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.385 -0.822 . . . . 0.0 109.376 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' CB ' ' HB3' ' A' ' 27' ' ' PRO . 2.7 mt-10 42.83 92.3 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.069 -1.02 . . . . 0.0 109.732 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 3.1 Cg_exo -58.69 172.77 1.38 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.885 1.466 . . . . 0.0 110.919 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 26' ' ' GLU . 80.0 mt-30 58.8 52.95 6.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 110.218 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 25' ' ' GLN . 96.4 mt-10 50.55 101.38 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.866 . . . . 0.0 110.404 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.516 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 2.8 Cg_endo -62.44 -20.18 69.69 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.779 1.41 . . . . 0.0 110.418 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 66.6 mtt85 55.27 54.17 9.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 110.067 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.47 143.71 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 0.0 110.113 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.87 117.47 3.48 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' O ' HD23 ' A' ' 32' ' ' LEU . 44.4 tttp -59.96 -42.24 93.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -1.149 . . . . 0.0 110.385 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 31' ' ' LYS . 55.1 mt -119.37 143.3 47.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.391 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.407 ' HB3' ' HE2' ' A' ' 16' ' ' LYS . 63.1 mtt180 -89.94 53.63 2.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.966 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.613 ' ND2' ' O ' ' A' ' 78' ' ' GLU . 22.5 t-20 -108.34 117.79 35.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 110.094 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.535 ' O ' ' HD3' ' A' ' 37' ' ' PRO . 71.4 t80 -162.65 97.11 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.999 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 35' ' ' PHE . . . -39.89 98.42 0.17 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.399 -0.813 . . . . 0.0 110.249 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 35' ' ' PHE . 2.8 Cg_endo -65.91 -11.33 30.43 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.882 1.464 . . . . 0.0 110.567 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 5.0 mt 56.87 88.81 0.12 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.062 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . 3.0 Cg_endo -60.81 164.96 12.7 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.97 1.511 . . . . 0.0 110.542 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.05 9.16 34.93 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 82.42 54.48 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.283 -1.128 . . . . 0.0 110.053 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HG3' ' HG3' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -61.58 137.7 70.82 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.934 1.492 . . . . 0.0 110.488 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.649 HG21 HD21 ' A' ' 18' ' ' LEU . 16.2 m -117.44 49.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.179 -0.951 . . . . 0.0 110.278 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 44' ' ' VAL . 2.4 m -151.66 52.09 0.89 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 110.159 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 3.2 Cg_exo -57.57 -15.87 21.88 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.655 1.345 . . . . 0.0 110.791 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 45' ' ' PRO . 18.7 tt -179.98 -29.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.897 . . . . 0.0 110.074 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.54 ' O ' ' O ' ' A' ' 48' ' ' CYS . 24.3 tp -159.05 70.01 0.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.134 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.585 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 98.3 m 44.58 102.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.361 -0.837 . . . . 0.0 110.397 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.58 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 15.5 t -51.82 -51.22 58.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.256 -0.903 . . . . 0.0 110.783 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 4.5 m120 -80.06 111.93 25.99 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.407 -0.808 . . . . 0.0 110.679 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.7 -13.41 36.63 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.636 1.335 . . . . 0.0 110.507 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.666 ' HB2' HD22 ' A' ' 21' ' ' LEU . 97.2 m-20 -123.88 29.67 6.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.525 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.736 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -80.3 177.5 2.92 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 109.161 179.251 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.804 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.4 Cg_exo -58.3 74.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.662 1.349 . . . . 0.0 108.929 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.613 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.1 tt0 -39.22 -27.77 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.634 -0.666 . . . . 0.0 110.182 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' PRO . 75.1 mm-40 -53.61 -17.2 1.98 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.03 -1.044 . . . . 0.0 108.592 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.804 HD12 ' HG2' ' A' ' 54' ' ' PRO . 92.7 mt -92.44 9.07 35.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.689 -0.632 . . . . 0.0 109.615 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.736 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -39.88 -50.67 5.69 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 110.278 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.736 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -55.76 -44.93 42.99 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.482 1.254 . . . . 0.0 110.124 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.027 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -54.11 -44.29 71.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 110.093 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.484 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . 82.5 m -64.4 -27.56 69.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.965 . . . . 0.0 110.139 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -91.87 4.88 51.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.893 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -112.9 137.02 21.69 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.355 -0.841 . . . . 0.0 110.179 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.99 -21.64 72.75 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.673 1.354 . . . . 0.0 109.884 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -79.93 -10.91 59.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.43 -0.794 . . . . 0.0 110.867 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.027 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.68 -36.03 10.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.956 -1.09 . . . . 0.0 109.877 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.479 ' HG3' ' HG3' ' A' ' 42' ' ' PRO . 50.2 tt0 -59.97 -42.61 94.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.343 -0.848 . . . . 0.0 110.029 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.16 -39.04 30.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 109.906 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.912 HG21 HD11 ' A' ' 60' ' ' LEU . 89.4 mt -63.51 -44.43 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.829 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.801 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.0 tm? -52.36 -54.31 33.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 0.0 110.209 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.675 ' N ' HD13 ' A' ' 70' ' ' LEU . 94.6 mt-30 -47.94 -52.9 17.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.291 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' LEU . 97.4 mtt180 -58.43 -62.14 2.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.455 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 5' ' ' ASP . 45.5 mt -44.93 -52.92 8.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.19 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.672 ' HG2' HD22 ' A' ' 70' ' ' LEU . 78.4 mm-40 -54.98 -47.59 74.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 110.78 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -56.72 -52.78 63.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.923 . . . . 0.0 110.771 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 79' ' ' ASP . 24.2 mm -63.61 -36.14 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 0.0 109.924 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -58.92 -33.71 70.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.43 -0.794 . . . . 0.0 109.881 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.613 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 83.5 tt0 -61.13 -37.9 84.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.685 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -150.35 160.62 32.71 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.032 -1.043 . . . . 0.0 110.675 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -61.54 -62.11 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.051 1.553 . . . . 0.0 110.569 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.34 -141.83 28.37 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.964 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 70.6 p -79.55 -22.16 44.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -1.154 . . . . 0.0 109.581 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 32.5 t -52.89 -51.63 60.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 109.991 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.5 tt0 -58.62 -33.77 70.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 0.0 111.179 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.772 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.2 pt -97.3 13.49 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.893 -1.129 . . . . 0.0 110.463 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.71 14.14 1.67 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.266 -0.896 . . . . 0.0 110.487 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.964 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.08 -15.11 62.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 109.963 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.592 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 27.0 t80 -139.69 168.41 19.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 0.0 110.267 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.98 3.07 8.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 110.301 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.592 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -63.08 -36.92 85.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.428 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -102.97 121.01 41.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 110.496 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 4' ' ' GLN . 18.9 p -111.54 166.32 11.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 110.227 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.97 -26.19 15.97 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.18 -1.188 . . . . 0.0 110.292 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.771 HG13 ' SG ' ' A' ' 91' ' ' CYS . 47.2 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.317 0.579 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 11' ' ' SER . 28.8 m -119.23 147.31 44.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.182 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.841 HG21 HG21 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -89.62 118.97 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 109.952 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 1.005 ' OE1' HG21 ' A' ' 92' ' ' THR . 65.6 tt0 -111.66 129.3 56.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 110.543 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -93.26 -81.24 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.759 . . . . 0.0 110.016 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.12 -126.32 3.81 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -84.69 8.27 17.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -1.184 . . . . 0.0 110.335 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.3 m-85 -120.2 137.79 54.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.36 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.2 t -88.55 130.26 35.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.729 ' CD1' HD23 ' A' ' 57' ' ' LEU . 18.6 m-85 -119.2 126.84 52.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.816 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.534 ' HA ' HG23 ' A' ' 2' ' ' THR . 38.8 t -75.65 169.14 18.69 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -0.996 . . . . 0.0 110.072 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.72 HD21 ' CB ' ' A' ' 3' ' ' VAL . 64.2 mt -102.36 -2.15 29.48 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.126 -0.984 . . . . 0.0 110.905 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -74.21 -73.6 0.22 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.084 -1.01 . . . . 0.0 110.6 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.6 m -43.0 -42.27 3.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.862 . . . . 0.0 110.826 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.627 ' CG2' ' HA ' ' A' ' 12' ' ' LEU . 6.2 m -65.29 -45.31 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.858 -1.151 . . . . 0.0 109.663 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.648 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 46.7 tttm -53.34 -46.98 69.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.821 -1.174 . . . . 0.0 108.93 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 45.8 tptt -80.23 -1.51 40.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.516 -0.74 . . . . 0.0 109.993 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.587 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 53.9 tp -66.55 -40.84 89.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.137 -0.977 . . . . 0.0 110.194 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 38' ' ' ILE . 20.8 tttp -56.62 -45.63 81.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.283 -0.885 . . . . 0.0 110.072 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -116.99 70.2 0.77 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.709 HD11 ' OD1' ' A' ' 52' ' ' ASN . 19.2 tp -54.03 -48.2 70.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 110.506 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 21' ' ' LEU . 3.1 tt0 46.79 -173.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.134 -0.978 . . . . 0.0 109.88 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -50.28 147.04 7.93 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.985 . . . . 0.0 109.946 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.47 133.1 46.96 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.796 1.419 . . . . 0.0 110.491 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.463 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 55.4 tt0 -169.93 50.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.297 -0.877 . . . . 0.0 110.394 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.664 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 0.6 OUTLIER -131.32 49.97 5.39 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 110.688 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.664 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.7 Cg_endo -60.41 -30.79 91.64 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.579 1.305 . . . . 0.0 110.247 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.46 ' O ' ' OE2' ' A' ' 26' ' ' GLU . 88.3 mtm-85 -139.37 174.64 10.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.421 -0.799 . . . . 0.0 110.071 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.0 m -123.91 157.49 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.153 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.34 179.66 48.08 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -64.68 -39.78 94.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -1.147 . . . . 0.0 110.053 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.2 tp -161.5 135.72 6.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.299 -0.876 . . . . 0.0 110.089 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.509 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 48.0 mtt180 -127.67 133.45 49.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 110.199 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 33' ' ' ARG . 33.0 m120 -150.53 46.62 0.88 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.166 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.439 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 13.7 m-85 -108.54 8.31 27.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.217 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.65 ' HB3' ' CA ' ' A' ' 78' ' ' GLU . . . -56.57 125.07 65.86 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 110.06 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HG2' ' HD3' ' A' ' 19' ' ' LYS . 2.9 Cg_endo -62.14 -80.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.714 1.376 . . . . 0.0 110.926 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.635 HG23 ' HD2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -165.1 150.43 8.37 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.927 . . . . 0.0 110.136 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.635 ' HD2' HG23 ' A' ' 38' ' ' ILE . 3.3 Cg_exo -57.62 139.58 90.69 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.907 1.477 . . . . 0.0 110.793 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.86 -78.75 1.43 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.99 153.56 35.86 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.287 -1.125 . . . . 0.0 110.257 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.494 ' HB2' ' HG3' ' A' ' 67' ' ' GLN . 3.0 Cg_endo -61.69 139.65 81.96 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.963 1.507 . . . . 0.0 110.614 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.695 ' O ' HG13 ' A' ' 43' ' ' VAL . 13.4 p -177.44 71.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.947 . . . . 0.0 110.261 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.907 HG22 ' HA ' ' A' ' 61' ' ' CYS . 2.8 p -129.54 66.07 76.15 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.864 . . . . 0.0 110.139 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.462 ' HD3' ' C ' ' A' ' 43' ' ' VAL . 3.1 Cg_exo -61.47 164.81 14.53 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.896 1.472 . . . . 0.0 110.483 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.569 HG23 ' HG2' ' A' ' 62' ' ' LYS . 88.1 mt -48.39 -42.45 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 110.121 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 48' ' ' CYS . 53.1 mt -82.79 -3.29 56.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 110.047 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.7 m 59.52 128.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.248 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.548 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.1 t -61.0 -44.82 96.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 2.2 m-80 -80.35 112.11 28.12 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.343 -0.848 . . . . 0.0 110.304 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -59.54 -10.26 10.92 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.766 1.403 . . . . 0.0 110.7 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.709 ' OD1' HD11 ' A' ' 21' ' ' LEU . 45.7 p-10 -136.97 41.81 2.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 110.366 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.699 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.24 177.15 3.13 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 109.116 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.73 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.9 Cg_exo -58.3 75.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.591 1.311 . . . . 0.0 109.143 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.626 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.3 tt0 -39.06 -29.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.782 -0.574 . . . . 0.0 110.149 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.3 mt-10 -52.04 -18.88 1.58 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.025 -1.047 . . . . 0.0 108.634 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.73 HD12 ' HG2' ' A' ' 54' ' ' PRO . 88.6 mt -90.8 9.67 29.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.487 -0.758 . . . . 0.0 109.649 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.738 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.3 tmtt? -39.71 -51.51 5.21 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.359 -0.838 . . . . 0.0 110.63 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.738 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.28 -43.58 57.32 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.459 1.242 . . . . 0.0 109.997 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.038 HD11 HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -55.6 -40.7 72.4 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.11 -0.994 . . . . 0.0 110.039 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.907 ' HA ' HG22 ' A' ' 44' ' ' VAL . 82.4 m -58.03 -23.37 54.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.215 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.569 ' HG2' HG23 ' A' ' 46' ' ' ILE . 35.5 mtmt -113.46 37.05 3.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 109.579 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.502 ' OE1' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -133.12 141.83 42.25 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.849 . . . . 0.0 110.36 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -62.93 -26.28 74.26 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.746 1.393 . . . . 0.0 110.075 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.46 ' O ' HG13 ' A' ' 69' ' ' ILE . 72.1 m-20 -80.19 -18.65 49.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.906 . . . . 0.0 110.439 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.886 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -45.39 -47.33 13.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.328 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 42' ' ' PRO . 61.0 tt0 -54.25 -43.62 71.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.492 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.15 -33.03 38.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.879 . . . . 0.0 110.473 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.038 HD13 HD11 ' A' ' 60' ' ' LEU . 94.5 mt -63.41 -44.88 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 0.0 110.357 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.662 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.6 tm? -43.43 -66.93 0.32 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.439 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.662 ' N ' HD13 ' A' ' 70' ' ' LEU . 97.7 mt-30 -47.31 -54.87 9.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.114 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -50.46 -58.88 4.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 110.094 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.494 ' CD1' HG22 ' A' ' 69' ' ' ILE . 40.2 mt -45.16 -51.68 10.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.183 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 73.3 mm-40 -51.63 -58.01 7.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 110.301 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 85.0 tt0 -52.04 -56.6 13.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.933 . . . . 0.0 110.592 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.841 HG21 HG21 ' A' ' 3' ' ' VAL . 22.4 mm -55.75 -38.42 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.152 -0.968 . . . . 0.0 109.888 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -57.47 -32.54 67.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.595 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.65 ' CA ' ' HB3' ' A' ' 36' ' ' ALA . 81.8 tt0 -59.72 -43.25 94.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.423 -0.798 . . . . 0.0 110.136 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -147.22 157.31 45.98 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.214 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.558 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -61.55 -48.1 10.06 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.856 1.451 . . . . 0.0 110.6 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.23 -139.98 25.75 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.969 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 32.1 p -84.06 -16.52 43.51 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -1.156 . . . . 0.0 109.954 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.578 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 41.1 t -57.46 -48.72 78.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.986 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.3 tt0 -61.97 -28.03 69.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 111.241 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.674 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.5 pt -97.54 7.26 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.863 -1.148 . . . . 0.0 110.304 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.0 m 61.33 15.86 6.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.0 110.614 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.969 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.2 -16.61 64.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -0.999 . . . . 0.0 109.853 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 87' ' ' ALA . 27.4 m-85 -138.81 166.65 23.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.922 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.7 2.29 10.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.314 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.29 -32.79 73.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.563 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.771 ' SG ' HG13 ' A' ' 1' ' ' VAL . 0.1 OUTLIER -102.84 116.95 33.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.64 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 1.005 HG21 ' OE1' ' A' ' 4' ' ' GLN . 17.7 p -105.39 157.81 17.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 110.133 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.33 -26.0 24.75 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.326 -1.103 . . . . 0.0 110.289 179.938 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 94' ' ' CYS . 10.6 t . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.21 0.528 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 35.5 m -120.33 149.25 42.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 110.335 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.881 HG23 HD11 ' A' ' 12' ' ' LEU . 91.2 t -84.36 117.6 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.336 -0.853 . . . . 0.0 109.774 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.737 ' CD ' HG21 ' A' ' 92' ' ' THR . 19.4 pt20 -111.81 146.09 38.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.178 -0.951 . . . . 0.0 110.869 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.679 ' OD2' HD21 ' A' ' 73' ' ' LEU . 94.0 m-20 -106.13 13.26 29.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 109.792 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.89 -126.96 1.38 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -84.87 5.88 27.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -1.213 . . . . 0.0 110.111 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 87.2 m-85 -124.86 138.58 54.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.24 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.484 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 78.4 p -96.86 137.94 35.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.217 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.74 ' CG ' HD21 ' A' ' 57' ' ' LEU . 24.6 m-85 -125.14 138.04 54.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.277 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.4 t -69.96 165.66 21.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.317 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.881 HD11 HG23 ' A' ' 3' ' ' VAL . 4.5 mp -97.67 -13.29 21.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.874 . . . . 0.0 110.328 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.422 ' OE2' ' HD3' ' A' ' 33' ' ' ARG . 70.9 mm-40 -68.66 -73.36 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.29 -0.881 . . . . 0.0 110.614 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 13' ' ' GLU . 4.0 m -42.49 -48.67 5.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.461 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.704 HG11 ' HB3' ' A' ' 73' ' ' LEU . 36.2 t -58.31 -45.24 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.946 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -56.95 -56.64 19.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.949 . . . . 0.0 109.086 179.043 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -80.61 11.81 3.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -0.811 . . . . 0.0 109.945 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.0 tt -62.06 -41.74 98.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -73.84 -64.52 0.99 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 110.108 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 22' ' ' GLN . 90.0 m-20 -58.06 -37.8 75.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.034 HD11 ' HB2' ' A' ' 52' ' ' ASN . 16.0 tp 52.17 29.24 6.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.302 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 20' ' ' ASP . 95.1 mm-40 -95.24 147.58 23.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.092 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER 49.0 74.14 0.87 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.071 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.22 62.28 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 124.006 1.529 . . . . 0.0 110.731 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' GLU . 32.5 tt0 -144.6 168.61 19.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 110.014 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.488 ' N ' ' HG2' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -124.21 69.02 49.28 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.0 110.393 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 25' ' ' GLN . 2.9 Cg_endo -61.13 145.94 98.19 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.84 1.442 . . . . 0.0 110.348 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.512 ' NH2' ' HB2' ' A' ' 28' ' ' ARG . 43.2 mtm105 -114.19 97.35 6.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.144 -0.972 . . . . 0.0 110.18 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -125.19 118.13 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.112 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.18 9.32 60.29 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.0 mttp 50.27 42.75 26.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.336 -1.096 . . . . 0.0 110.262 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.4 tp -115.19 124.53 51.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 110.253 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.508 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 76.3 mtt85 -114.07 55.1 0.74 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.983 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.551 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 70.5 m-20 -130.1 148.17 51.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 0.0 110.315 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.538 ' N ' ' HE2' ' A' ' 16' ' ' LYS . 62.9 t80 -173.7 -71.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 109.902 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 78' ' ' GLU . . . -56.97 113.43 6.09 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.382 -0.824 . . . . 0.0 109.893 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.563 ' C ' HG13 ' A' ' 38' ' ' ILE . 3.0 Cg_endo -60.84 -27.89 85.53 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.711 1.374 . . . . 0.0 110.832 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.019 HD12 ' N ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -164.64 171.05 5.93 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.251 -0.906 . . . . 0.0 110.17 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.738 ' HD2' HG22 ' A' ' 38' ' ' ILE . 3.0 Cg_exo -62.16 148.89 92.38 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.892 1.469 . . . . 0.0 110.54 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.82 -75.16 1.29 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -167.5 144.85 3.78 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.323 -1.104 . . . . 0.0 110.24 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -62.65 138.34 69.18 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.903 1.475 . . . . 0.0 110.517 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' A' ' 49' ' ' SER . 19.7 m -143.0 127.39 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 110.251 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 44' ' ' VAL . 69.4 t -156.94 70.97 4.68 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.994 . . . . 0.0 110.97 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -61.19 -143.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.778 1.41 . . . . 0.0 109.53 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.009 ' C ' HD12 ' A' ' 47' ' ' LEU . 16.0 mm -49.67 -32.94 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.81 -1.181 . . . . 0.0 108.485 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.009 HD12 ' C ' ' A' ' 46' ' ' ILE . 6.8 mp -142.38 -74.94 0.29 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 59.1 m -139.44 137.7 35.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.534 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.618 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 87.7 p -65.55 -42.23 92.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.021 . . . . 0.0 110.616 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.528 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 8.7 m120 -80.09 110.46 16.34 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.349 -0.845 . . . . 0.0 110.258 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.618 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -60.31 -17.86 49.29 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.734 1.386 . . . . 0.0 110.821 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 1.034 ' HB2' HD11 ' A' ' 21' ' ' LEU . 90.4 m-20 -126.61 36.26 4.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 110.722 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.628 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -80.28 172.97 8.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.078 -1.014 . . . . 0.0 108.954 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.5 Cg_exo -58.03 75.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.507 1.267 . . . . 0.0 108.959 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 53' ' ' PHE . 84.7 tt0 -39.4 -28.43 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.635 -0.666 . . . . 0.0 110.184 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt-10 -52.45 -17.04 1.04 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.053 -1.029 . . . . 0.0 108.65 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.74 HD21 ' CG ' ' A' ' 10' ' ' PHE . 62.2 mt -90.46 9.53 28.84 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.475 0.655 . . . . 0.0 109.583 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.757 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 12.9 mttt -39.87 -50.98 5.66 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 110.427 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.757 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.49 -42.62 66.39 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.596 1.314 . . . . 0.0 109.985 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.057 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 7.6 mp -57.92 -39.48 78.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.973 -1.079 . . . . 0.0 109.902 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 12.5 m -66.17 -28.86 69.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.128 -0.982 . . . . 0.0 110.474 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -89.6 5.96 43.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 111.145 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 10.0 pt-20 -121.97 148.75 52.25 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.947 -1.095 . . . . 0.0 110.305 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.8 Cg_endo -63.59 -20.34 69.18 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.988 1.52 . . . . 0.0 111.565 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.511 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 79.4 m-20 -80.03 -10.35 59.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.98 -1.075 . . . . 0.0 110.605 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.057 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.43 -45.43 25.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -0.93 . . . . 0.0 110.674 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.0 mt-30 -59.0 -42.55 90.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.903 . . . . 0.0 110.561 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -76.85 -31.91 57.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.093 -1.004 . . . . 0.0 110.152 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.784 HG21 ' CD2' ' A' ' 60' ' ' LEU . 99.8 mt -74.45 -46.03 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.923 . . . . 0.0 110.144 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.66 HD11 ' OE2' ' A' ' 74' ' ' GLU . 1.7 tm? -48.89 -59.3 3.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.882 . . . . 0.0 110.563 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.607 ' N ' HD13 ' A' ' 70' ' ' LEU . 98.3 mt-30 -49.59 -52.93 26.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.059 -1.026 . . . . 0.0 110.096 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -51.41 -54.42 26.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 109.916 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.704 ' HB3' HG11 ' A' ' 15' ' ' VAL . 65.1 mt -51.26 -48.81 62.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.66 ' OE2' HD11 ' A' ' 70' ' ' LEU . 91.2 mt-10 -52.92 -48.4 67.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.062 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.29 -50.23 73.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.972 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.582 ' O ' ' O ' ' A' ' 79' ' ' ASP . 26.5 mm -62.97 -37.41 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.704 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.759 ' HB1' ' HB2' ' A' ' 16' ' ' LYS . . . -56.38 -33.84 66.12 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.475 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.525 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 86.8 tt0 -62.61 -41.34 98.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.456 -0.777 . . . . 0.0 110.524 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -148.23 168.65 10.69 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.214 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HD2' ' OD1' ' A' ' 79' ' ' ASP . 3.2 Cg_exo -58.59 -55.81 1.87 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.658 1.347 . . . . 0.0 110.495 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.831 ' C ' HG23 ' A' ' 82' ' ' THR . . . 72.04 47.65 30.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.929 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 1.2 p 72.45 -40.98 0.49 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.451 -1.029 . . . . 0.0 110.842 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 37.4 t -40.75 -47.46 2.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.941 -1.099 . . . . 0.0 109.907 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 86.4 tt0 -63.16 -42.75 99.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 111.006 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.798 HG13 ' HB2' ' A' ' 87' ' ' ALA . 2.5 pt -84.76 18.7 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.0 -1.063 . . . . 0.0 110.573 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 52.77 16.96 0.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 110.616 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.929 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.79 -22.4 65.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 109.758 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.581 ' CD1' ' CB ' ' A' ' 82' ' ' THR . 19.6 m-85 -131.91 170.26 15.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.762 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.42 0.1 34.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.104 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -59.12 -25.9 64.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 110.496 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -111.18 128.17 55.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.787 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.737 HG21 ' CD ' ' A' ' 4' ' ' GLN . 22.6 p -114.37 163.95 14.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 110.064 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.495 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 88.76 -24.13 13.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.534 ' O ' ' CG2' ' A' ' 1' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.331 -1.099 . . . . 0.0 110.497 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.545 HG13 ' SG ' ' A' ' 91' ' ' CYS . 92.2 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.222 0.534 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.451 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 60.1 m -126.15 149.21 49.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 110.568 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.789 HG23 HD11 ' A' ' 12' ' ' LEU . 92.4 t -82.42 110.83 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.514 -0.741 . . . . 0.0 109.519 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.645 ' CB ' HG21 ' A' ' 92' ' ' THR . 35.3 tt0 -112.78 133.43 54.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 110.685 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -96.03 -71.68 0.66 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 109.421 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.0 -129.76 6.81 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -79.76 4.27 16.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -1.177 . . . . 0.0 110.655 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.51 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 99.2 m-85 -119.05 134.44 55.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.058 -1.026 . . . . 0.0 110.656 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.451 ' OG ' ' CG2' ' A' ' 2' ' ' THR . 27.1 t -87.16 135.61 33.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.861 . . . . 0.0 109.97 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.657 ' CE1' HD23 ' A' ' 57' ' ' LEU . 69.6 m-85 -115.56 125.86 53.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 111.005 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.473 ' C ' HD12 ' A' ' 12' ' ' LEU . 23.0 t -76.43 173.14 11.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.85 . . . . 0.0 109.796 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.03 HD23 ' HA ' ' A' ' 77' ' ' ALA . 4.5 mp -103.27 4.81 36.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.046 -1.034 . . . . 0.0 110.756 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 86.0 tt0 -71.89 -73.03 0.2 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.068 -1.02 . . . . 0.0 110.693 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.504 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 6.1 m -49.06 -45.72 43.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.081 -1.012 . . . . 0.0 110.684 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.637 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 24.2 t -58.38 -50.95 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.967 -1.083 . . . . 0.0 109.746 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.491 ' HE2' ' OD1' ' A' ' 34' ' ' ASN . 51.1 tttm -54.49 -54.45 40.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.779 -1.201 . . . . 0.0 108.656 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -80.47 14.46 2.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -0.756 . . . . 0.0 109.615 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.637 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 35.4 tp -61.44 -40.37 94.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -0.894 . . . . 0.0 110.198 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.506 ' HE3' ' HG3' ' A' ' 41' ' ' GLU . 28.4 mtpt -61.02 -44.68 97.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.004 . . . . 0.0 109.842 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -111.33 115.08 28.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.643 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.557 ' CG ' ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -96.08 107.1 19.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.006 . . . . 0.0 110.715 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.514 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 62.5 tt0 179.06 55.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.458 -0.776 . . . . 0.0 109.955 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.525 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 3.4 pm0 -149.69 164.07 22.31 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.068 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 3.1 Cg_exo -61.28 152.32 73.16 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.83 1.437 . . . . 0.0 110.552 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.468 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 56.7 tp60 -58.91 -117.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.91 . . . . 0.0 110.132 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.473 ' CG ' ' OE1' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -129.88 64.6 72.68 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.007 -1.058 . . . . 0.0 110.307 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.468 ' HD3' ' C ' ' A' ' 25' ' ' GLN . 2.9 Cg_endo -61.64 -36.36 75.78 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.754 1.397 . . . . 0.0 110.543 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.495 ' NH2' ' HG3' ' A' ' 28' ' ' ARG . 14.5 mmt85 -140.85 151.52 44.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.343 -0.848 . . . . 0.0 110.212 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.09 142.66 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.127 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.34 22.42 0.79 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HB2' ' NH2' ' A' ' 33' ' ' ARG . 2.2 mtpm? -104.31 153.06 21.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.139 -1.212 . . . . 0.0 110.151 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.8 tp -81.34 137.71 35.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.046 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 12' ' ' LEU . 82.3 mtt85 -126.64 141.49 51.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 110.307 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.596 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 33.2 p-10 -132.94 175.85 9.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 110.245 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.549 ' CD2' ' N ' ' A' ' 36' ' ' ALA . 68.5 t80 -167.19 173.0 9.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.292 -0.88 . . . . 0.0 110.137 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.549 ' N ' ' CD2' ' A' ' 35' ' ' PHE . . . -60.56 149.05 79.71 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 0.0 110.198 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.998 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.9 Cg_endo -61.82 -26.87 79.86 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.94 1.495 . . . . 0.0 110.537 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.998 HD13 ' O ' ' A' ' 37' ' ' PRO . 8.9 mm -128.17 121.52 21.68 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 110.056 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . 3.1 Cg_exo -61.4 138.77 78.6 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.738 1.389 . . . . 0.0 110.489 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . -153.46 18.88 0.7 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HG3' ' HE3' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -125.52 74.96 69.49 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.283 -1.128 . . . . 0.0 110.2 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.65 146.81 96.51 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.885 1.466 . . . . 0.0 110.462 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.103 HG23 HG23 ' A' ' 44' ' ' VAL . 11.0 m -123.12 172.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 110.383 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.103 HG23 HG23 ' A' ' 43' ' ' VAL . 2.9 t 67.38 49.3 0.49 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.452 -0.78 . . . . 0.0 111.015 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.675 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.8 Cg_endo -61.64 -51.34 4.17 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.562 1.296 . . . . 0.0 109.972 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 47' ' ' LEU . 77.9 mt -121.83 -33.36 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.421 -0.799 . . . . 0.0 109.722 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 48' ' ' CYS . 27.1 tp -177.93 98.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.419 -0.801 . . . . 0.0 109.812 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.481 ' O ' ' O ' ' A' ' 47' ' ' LEU . 96.2 m 47.6 99.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 0.0 110.25 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.588 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.3 t -68.78 -64.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 110.668 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.604 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 11.1 m-20 -79.51 111.8 23.76 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.382 -0.824 . . . . 0.0 110.464 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -63.95 -9.02 17.51 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.694 1.365 . . . . 0.0 110.358 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.557 ' HB3' ' CG ' ' A' ' 21' ' ' LEU . 50.3 t-20 -131.1 30.98 4.49 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.289 -0.882 . . . . 0.0 110.178 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.745 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -77.15 -175.6 0.53 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 108.836 179.275 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.948 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.7 Cg_exo -59.02 73.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.536 1.282 . . . . 0.0 109.067 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.3 tt0 -39.43 -32.04 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.688 -0.633 . . . . 0.0 110.562 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.441 ' O ' ' HE1' ' A' ' 10' ' ' PHE . 46.5 tp10 -52.28 -25.3 9.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.957 -1.089 . . . . 0.0 108.625 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.948 HD12 ' HG2' ' A' ' 54' ' ' PRO . 89.2 mt -83.82 12.76 5.57 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.383 0.611 . . . . 0.0 109.814 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.729 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.58 -51.63 4.96 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.93 . . . . 0.0 110.532 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.94 -45.09 41.23 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.551 1.29 . . . . 0.0 110.184 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.021 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 2.8 mm? -53.81 -44.0 69.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.023 -1.048 . . . . 0.0 110.148 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.3 t -68.76 -29.1 67.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 0.0 110.312 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -79.95 3.29 20.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.622 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.533 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 9.7 pt-20 -126.39 141.65 40.59 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 110.155 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.1 Cg_exo -61.16 -11.18 17.71 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.903 1.475 . . . . 0.0 110.667 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -79.88 -15.63 56.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.123 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.021 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -48.54 -36.41 15.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.34 -41.12 98.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 110.093 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -80.45 -40.91 25.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 109.84 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.963 HG21 ' CD1' ' A' ' 60' ' ' LEU . 84.6 mt -64.39 -41.29 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.037 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.779 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.2 tm? -53.02 -55.19 25.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 110.396 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.779 ' N ' HD13 ' A' ' 70' ' ' LEU . 94.7 mt-30 -50.46 -55.37 16.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 0.0 110.186 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -52.57 -57.0 11.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.055 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 35.4 mt -46.82 -49.66 19.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 110.083 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 77.8 mm-40 -54.48 -49.27 70.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.331 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 85.4 tt0 -56.3 -55.91 27.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.721 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 79' ' ' ASP . 28.9 mm -56.75 -36.53 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.062 -1.024 . . . . 0.0 109.462 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 1.03 ' HA ' HD23 ' A' ' 12' ' ' LEU . . . -59.33 -30.03 68.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.502 -0.749 . . . . 0.0 109.275 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 34' ' ' ASN . 85.9 tt0 -62.36 -41.6 98.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 110.321 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.1 p30 -147.0 158.37 45.1 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.196 -0.94 . . . . 0.0 110.482 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.576 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.53 -57.5 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.969 1.51 . . . . 0.0 110.636 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.36 -140.74 24.92 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.944 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 60.4 p -78.14 -22.34 48.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -1.158 . . . . 0.0 109.635 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 52.9 t -52.27 -53.05 48.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 110.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.0 tt0 -57.66 -34.28 69.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 111.261 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.781 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.3 pt -95.11 12.65 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.931 -1.106 . . . . 0.0 110.446 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.8 m 56.47 15.64 2.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 0.0 110.497 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.944 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -66.56 -10.14 42.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 110.026 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -146.19 167.97 22.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 110.387 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.23 4.83 6.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 0.0 110.493 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.68 88.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 110.519 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -99.03 121.95 41.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.526 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.645 HG21 ' CB ' ' A' ' 4' ' ' GLN . 24.8 p -110.58 152.94 25.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.161 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.73 -20.01 51.12 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.272 -1.134 . . . . 0.0 110.231 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.79 HG13 ' O ' ' A' ' 1' ' ' VAL . 14.6 p . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.24 0.543 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 58.4 m -123.33 152.81 41.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.426 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.858 HG23 HD11 ' A' ' 12' ' ' LEU . 52.0 t -82.36 112.19 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.641 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HG21 ' A' ' 92' ' ' THR . 41.4 tt0 -111.49 123.49 50.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.098 -1.001 . . . . 0.0 110.71 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.606 ' OD2' HG23 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -79.73 -77.12 0.19 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 0.0 109.386 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.71 -124.54 5.36 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -81.84 3.64 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -1.152 . . . . 0.0 110.379 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.2 m-85 -114.57 132.9 56.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.145 -0.972 . . . . 0.0 110.436 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.412 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 51.6 p -85.57 130.11 34.66 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.728 ' CG ' HD21 ' A' ' 57' ' ' LEU . 18.4 m-85 -118.71 130.18 55.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 110.703 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.7 p -75.69 170.22 16.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.163 -0.961 . . . . 0.0 110.268 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.858 HD11 HG23 ' A' ' 3' ' ' VAL . 4.5 mp -95.91 -6.45 39.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 110.519 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.7 mt-10 -70.95 -71.62 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.222 -0.924 . . . . 0.0 110.667 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.473 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 4.3 m -43.17 -52.1 5.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.309 -0.869 . . . . 0.0 110.567 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.63 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 15.8 m -56.41 -49.33 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.942 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 14.4 tttp -55.27 -51.66 65.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.981 -1.074 . . . . 0.0 108.8 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -80.41 11.26 3.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.455 -0.778 . . . . 0.0 109.736 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.63 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 27.2 tp -64.58 -33.68 76.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.89 . . . . 0.0 109.948 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -62.19 -42.4 99.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 109.667 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -104.88 124.62 49.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.412 -0.805 . . . . 0.0 109.61 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.83 HD11 ' HB2' ' A' ' 52' ' ' ASN . 15.1 tp -93.57 130.02 39.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 110.576 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 23' ' ' GLU . 80.2 mt-30 -132.7 171.48 13.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.982 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -42.51 156.64 0.24 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.171 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.54 60.64 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 124.0 1.526 . . . . 0.0 110.666 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' GLU . 92.3 mt-30 -121.51 134.91 55.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 110.035 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 22.0 mm-40 -134.77 66.07 67.99 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.119 -0.988 . . . . 0.0 110.483 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -62.18 151.95 79.01 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.836 1.44 . . . . 0.0 110.321 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.4 mtt-85 -109.27 141.01 42.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.225 -0.922 . . . . 0.0 110.257 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 31' ' ' LYS . 45.7 t -123.56 136.36 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.317 -0.865 . . . . 0.0 110.146 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.87 -32.83 55.83 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.542 ' H ' HG12 ' A' ' 29' ' ' VAL . 29.6 tttt -71.05 143.5 50.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -1.132 . . . . 0.0 110.194 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.7 tp -86.35 128.17 34.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.187 -0.946 . . . . 0.0 110.335 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.542 ' HB3' ' HD2' ' A' ' 16' ' ' LYS . 95.4 mtt-85 -73.28 137.67 45.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.126 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.558 ' CA ' ' O ' ' A' ' 78' ' ' GLU . 32.6 p-10 -156.32 19.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.426 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.463 ' HB2' ' NZ ' ' A' ' 16' ' ' LYS . 98.6 m-85 -99.65 18.5 17.9 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.133 -0.979 . . . . 0.0 110.205 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.779 ' HB3' ' CA ' ' A' ' 78' ' ' GLU . . . -55.55 136.23 70.61 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.287 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.75 -149.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.834 1.439 . . . . 0.0 110.717 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.491 HG23 ' HD2' ' A' ' 39' ' ' PRO . 1.9 mp -104.17 139.62 20.28 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 110.204 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.552 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 2.9 Cg_endo -62.63 178.07 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.818 1.431 . . . . 0.0 110.64 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.68 7.53 31.62 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 43.6 mt-10 -82.67 145.18 50.18 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.336 -1.097 . . . . 0.0 110.101 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -61.8 122.91 11.67 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.79 1.416 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.019 HG12 HG23 ' A' ' 44' ' ' VAL . 94.7 t -141.87 158.22 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.955 . . . . 0.0 110.506 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.019 HG23 HG12 ' A' ' 43' ' ' VAL . 25.8 t 62.19 51.46 1.82 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.456 -0.777 . . . . 0.0 111.169 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.694 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.7 Cg_endo -63.52 -145.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.632 1.333 . . . . 0.0 109.851 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.9 mm -65.87 -31.25 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.558 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -150.76 71.89 1.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.577 -0.702 . . . . 0.0 109.526 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.587 ' O ' ' O ' ' A' ' 47' ' ' LEU . 82.0 m 54.35 129.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.444 -0.785 . . . . 0.0 110.504 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.63 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 47.0 t -77.47 -70.82 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.029 -1.044 . . . . 0.0 110.155 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.518 ' CG ' HD13 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -76.7 111.96 19.21 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.494 -0.753 . . . . 0.0 110.263 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.613 ' HD2' HD22 ' A' ' 21' ' ' LEU . 3.0 Cg_exo -63.57 -10.04 20.44 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.627 1.33 . . . . 0.0 110.324 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.83 ' HB2' HD11 ' A' ' 21' ' ' LEU . 94.0 m-20 -127.03 31.62 5.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.727 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.08 -179.35 1.39 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 108.948 179.232 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.758 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.8 Cg_exo -59.36 75.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.562 1.296 . . . . 0.0 109.044 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.601 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.7 tt0 -39.27 -27.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.723 -0.611 . . . . 0.0 110.174 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' PRO . 74.3 mm-40 -53.68 -17.85 2.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.107 -0.996 . . . . 0.0 108.554 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.758 HD12 ' HG2' ' A' ' 54' ' ' PRO . 86.3 mt -91.54 9.63 31.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.658 -0.651 . . . . 0.0 109.608 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.747 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -39.54 -51.49 4.93 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.85 . . . . 0.0 110.756 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.747 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.05 -42.86 63.44 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.495 1.26 . . . . 0.0 109.784 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.902 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 4.1 tt -57.48 -38.85 75.22 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.116 -0.99 . . . . 0.0 109.77 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.892 ' HA ' HG13 ' A' ' 44' ' ' VAL . 49.3 t -63.61 -29.27 70.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 110.474 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.521 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 53.4 mttp -104.05 30.41 5.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.596 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.521 ' OE1' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -129.5 136.74 29.58 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.407 -0.808 . . . . 0.0 110.437 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.8 Cg_endo -64.2 -27.03 64.52 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.662 1.349 . . . . 0.0 109.883 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -81.32 -11.06 59.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 110.846 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.902 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.98 -38.29 16.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.029 -1.045 . . . . 0.0 110.126 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.76 -40.72 80.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -80.27 -39.43 28.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.763 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.712 HG21 HD12 ' A' ' 60' ' ' LEU . 81.1 mt -64.62 -51.39 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.335 -0.853 . . . . 0.0 109.956 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.784 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.4 tm? -46.8 -58.45 3.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.389 -0.82 . . . . 0.0 110.113 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.673 ' N ' HD13 ' A' ' 70' ' ' LEU . 55.7 tt0 -44.85 -51.56 9.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -58.72 -56.5 21.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.431 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.502 HD21 ' OD1' ' A' ' 5' ' ' ASP . 47.6 mt -47.12 -53.1 13.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 0.0 110.216 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.577 ' OE2' HD21 ' A' ' 70' ' ' LEU . 52.4 mt-10 -57.22 -46.06 83.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 110.406 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -57.99 -53.71 55.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.953 -1.092 . . . . 0.0 110.127 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 79' ' ' ASP . 54.2 mt -60.94 -33.94 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.15 -0.969 . . . . 0.0 109.403 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -57.73 -33.69 68.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.379 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.779 ' CA ' ' HB3' ' A' ' 36' ' ' ALA . 84.4 tt0 -61.71 -40.81 96.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.479 -0.763 . . . . 0.0 110.22 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -147.11 155.4 47.01 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.078 -1.014 . . . . 0.0 110.26 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.486 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -59.1 -62.27 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.786 1.414 . . . . 0.0 110.669 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.78 -139.07 21.73 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.95 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 45.4 p -81.03 -21.28 40.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -1.148 . . . . 0.0 109.973 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 9.1 t -53.8 -54.09 43.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.965 . . . . 0.0 109.99 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 34.6 tt0 -58.13 -31.05 66.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.331 -0.856 . . . . 0.0 111.113 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.775 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.6 pt -97.26 12.08 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.991 -1.068 . . . . 0.0 110.322 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 34.2 m 54.07 18.73 1.81 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.887 . . . . 0.0 110.578 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.95 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.13 -12.28 59.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 0.0 110.067 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.555 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 26.9 m-85 -146.75 175.55 10.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.82 3.36 10.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 110.302 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.36 -32.46 73.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -114.5 123.37 49.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 0.0 110.564 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.567 HG21 ' OE1' ' A' ' 4' ' ' GLN . 27.0 p -117.13 161.01 20.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.378 -0.826 . . . . 0.0 110.211 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.47 -33.11 5.68 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.299 -1.118 . . . . 0.0 110.303 -179.889 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 1' ' ' VAL . 3.2 m . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.096 0.474 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 1.039 HG21 ' OG ' ' A' ' 9' ' ' SER . 9.6 t -129.09 163.18 26.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.76 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.835 HG23 HD11 ' A' ' 12' ' ' LEU . 50.8 t -84.41 116.43 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.84 ' OE1' HG21 ' A' ' 92' ' ' THR . 46.4 tt0 -108.61 111.69 23.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.032 -1.042 . . . . 0.0 110.951 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.672 ' OD2' HD21 ' A' ' 73' ' ' LEU . 89.8 m-20 -94.26 4.45 53.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.25 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.509 ' O ' ' CG ' ' A' ' 4' ' ' GLN . . . -169.64 -148.1 5.73 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.32 8.96 6.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -1.167 . . . . 0.0 110.516 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.466 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 95.3 m-85 -119.84 147.82 44.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.031 -1.043 . . . . 0.0 110.51 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 1.039 ' OG ' HG21 ' A' ' 2' ' ' THR . 2.0 t -89.03 120.97 30.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 109.829 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.679 ' CD2' HD23 ' A' ' 57' ' ' LEU . 92.9 m-85 -108.43 117.77 35.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.177 -0.952 . . . . 0.0 110.867 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.481 ' C ' HD12 ' A' ' 12' ' ' LEU . 60.4 p -71.64 169.6 15.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 109.528 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.844 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.1 mp -104.49 -0.93 27.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.978 -1.076 . . . . 0.0 110.763 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -67.13 -69.97 0.28 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.124 -0.985 . . . . 0.0 110.715 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.1 m -42.42 -50.99 5.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.344 -0.848 . . . . 0.0 111.165 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.674 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.6 m -57.79 -48.05 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.102 -0.999 . . . . 0.0 109.669 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.773 ' CG ' ' HB1' ' A' ' 77' ' ' ALA . 15.7 mttt -54.86 -54.58 40.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.1 -1.0 . . . . 0.0 108.811 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 48.1 tttt -80.43 11.02 3.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -0.766 . . . . 0.0 109.552 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.674 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 16.8 tp -59.62 -33.41 71.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -0.97 . . . . 0.0 110.069 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HD2' ' HB3' ' A' ' 37' ' ' PRO . 78.6 tttt -67.23 -39.23 86.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.589 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 24.7 t70 -118.14 88.15 2.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.633 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 52' ' ' ASN . 6.3 tp -61.5 -33.31 73.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.39 -0.819 . . . . 0.0 111.045 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 81.4 mt-30 -79.09 162.73 25.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.108 -0.995 . . . . 0.0 110.427 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 22' ' ' GLN . 3.5 mt-10 56.72 86.11 0.17 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.382 -0.824 . . . . 0.0 110.517 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HA ' ' CE ' ' A' ' 17' ' ' LYS . 2.9 Cg_endo -63.3 102.68 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.979 1.515 . . . . 0.0 110.459 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -64.3 -36.09 82.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.21 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.417 ' OE2' ' HB2' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -129.2 72.71 81.97 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.361 -0.837 . . . . 0.0 110.213 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 24' ' ' PRO . 3.0 Cg_exo -61.78 -21.71 72.78 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.945 1.497 . . . . 0.0 110.7 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -120.21 -177.28 3.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.299 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.25 150.77 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 0.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.88 -9.65 37.28 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -87.12 172.47 9.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -1.156 . . . . 0.0 110.288 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.609 HD13 ' N ' ' A' ' 33' ' ' ARG . 0.2 OUTLIER -63.27 118.81 8.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.172 -0.955 . . . . 0.0 110.191 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.609 ' N ' HD13 ' A' ' 32' ' ' LEU . 32.6 ptt180 -136.67 66.76 1.47 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 110.277 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 33' ' ' ARG . 92.0 m-20 -137.2 72.27 1.42 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 110.085 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 84.1 t80 -178.13 82.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 110.375 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.958 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . . . -77.09 153.06 82.45 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.936 . . . . 0.0 110.032 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 38' ' ' ILE . 2.8 Cg_endo -64.05 52.79 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.804 1.423 . . . . 0.0 111.033 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.523 ' O ' ' O ' ' A' ' 37' ' ' PRO . 10.0 mt 53.81 113.94 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.197 -0.94 . . . . 0.0 110.532 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.525 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo -61.12 162.56 19.23 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.635 1.334 . . . . 0.0 110.546 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.47 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 104.58 20.77 9.78 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -122.32 74.02 40.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.233 -1.157 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_endo -61.09 143.61 99.02 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.936 1.493 . . . . 0.0 110.583 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.485 ' HB ' ' OG ' ' A' ' 49' ' ' SER . 6.0 m -140.25 54.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.815 ' O ' HG12 ' A' ' 44' ' ' VAL . 54.8 t -136.06 54.31 9.59 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.258 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -60.54 -34.93 92.11 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.679 1.357 . . . . 0.0 110.359 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.461 HG13 ' C ' ' A' ' 45' ' ' PRO . 78.6 mt -145.16 -36.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 110.215 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' O ' ' O ' ' A' ' 48' ' ' CYS . 21.3 tp -177.38 101.58 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.109 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.564 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 87.2 m 33.67 95.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.465 -0.772 . . . . 0.0 110.637 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.512 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 60.7 p -60.87 -39.3 88.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.994 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.553 ' HB3' HD22 ' A' ' 21' ' ' LEU . 10.5 m-20 -80.54 113.77 42.26 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.48 -7.63 9.15 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.681 1.359 . . . . 0.0 110.87 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.797 ' HB2' HD21 ' A' ' 21' ' ' LEU . 93.1 m-20 -137.29 31.46 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 110.665 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.769 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.2 p90 -73.34 -175.7 0.41 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.13 -0.981 . . . . 0.0 108.762 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.938 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.9 Cg_exo -60.57 73.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.494 1.26 . . . . 0.0 108.863 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.584 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.1 tt0 -39.22 -31.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.724 -0.61 . . . . 0.0 110.34 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 54' ' ' PRO . 97.4 mt-10 -53.71 -26.72 24.27 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.969 -1.082 . . . . 0.0 108.721 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.938 HD12 ' HG2' ' A' ' 54' ' ' PRO . 90.7 mt -84.38 7.38 19.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.731 -0.605 . . . . 0.0 109.534 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.731 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 7.3 mmtt -39.59 -51.62 4.98 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 110.303 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.731 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.53 -44.91 43.82 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.588 1.31 . . . . 0.0 109.824 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.099 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -52.06 -43.81 63.99 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.054 -1.029 . . . . 0.0 109.844 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.6 m -66.96 -27.52 67.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.371 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -82.63 4.97 22.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.902 . . . . 0.0 110.736 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 8.5 pt-20 -127.98 144.7 52.44 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.025 -1.047 . . . . 0.0 110.229 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.16 -12.66 27.75 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.881 1.464 . . . . 0.0 110.736 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.491 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 83.7 m-20 -80.12 -18.41 49.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.892 . . . . 0.0 110.201 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.099 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.19 -39.36 13.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 110.22 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.06 -44.2 87.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 110.296 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -80.2 -39.12 29.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.208 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.979 HG21 ' CD1' ' A' ' 60' ' ' LEU . 77.8 mt -64.42 -47.45 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.563 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.8 tm? -49.06 -57.27 6.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.537 ' N ' HD13 ' A' ' 70' ' ' LEU . 51.5 tt0 -49.55 -53.02 25.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.114 -0.991 . . . . 0.0 110.013 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -55.01 -50.4 69.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.672 HD21 ' OD2' ' A' ' 5' ' ' ASP . 96.0 mt -51.07 -50.08 59.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.761 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 70.6 mm-40 -53.99 -52.56 60.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 110.292 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.525 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.2 tt0 -52.69 -55.06 25.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 110.499 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 79' ' ' ASP . 28.2 mm -56.85 -34.36 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 0.0 109.41 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.958 ' HB3' ' HB2' ' A' ' 36' ' ' ALA . . . -59.21 -32.79 70.26 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.498 ' OE2' ' HD3' ' A' ' 39' ' ' PRO . 95.4 mt-10 -59.4 -41.2 88.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 110.139 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -149.26 155.3 39.68 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.641 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -60.15 -57.28 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.88 1.463 . . . . 0.0 110.575 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.12 -138.95 19.98 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.775 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 43.6 p -81.09 -21.04 40.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -1.176 . . . . 0.0 109.742 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.576 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 20.7 t -55.2 -53.01 61.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.86 . . . . 0.0 110.184 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 35.5 tt0 -62.49 -27.09 68.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.933 . . . . 0.0 111.407 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.778 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.9 pt -98.01 14.07 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.757 -1.214 . . . . 0.0 110.433 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 50.9 19.74 0.68 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 0.0 110.714 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.778 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -68.82 -11.85 60.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.067 -1.02 . . . . 0.0 110.025 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -148.62 175.4 11.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 110.085 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.41 1.73 15.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.048 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.94 75.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.314 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -105.83 128.15 53.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 110.536 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.84 HG21 ' OE1' ' A' ' 4' ' ' GLN . 33.2 p -110.79 155.79 22.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 110.109 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 93.54 -19.32 53.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.259 -1.142 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.495 ' HA ' ' SG ' ' A' ' 91' ' ' CYS . 25.6 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.266 0.555 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 68.0 m -123.78 148.39 46.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 110.446 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.653 HG21 ' HG ' ' A' ' 12' ' ' LEU . 47.8 t -79.82 110.38 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.307 -0.87 . . . . 0.0 109.742 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.514 ' CD ' HG21 ' A' ' 92' ' ' THR . 43.7 tt0 -110.41 121.09 44.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -0.95 . . . . 0.0 110.716 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.847 ' OD2' HD11 ' A' ' 73' ' ' LEU . 85.0 m-20 -95.94 6.12 49.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 109.576 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 4' ' ' GLN . . . -175.45 -139.85 3.21 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -79.8 3.21 20.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -1.19 . . . . 0.0 110.419 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 83.3 m-85 -121.32 131.15 54.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 110.359 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 2' ' ' THR . 67.8 m -79.96 132.3 36.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.336 -0.852 . . . . 0.0 110.201 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.754 ' CG ' HD21 ' A' ' 57' ' ' LEU . 22.1 m-85 -116.56 128.91 55.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 110.6 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 m -69.25 162.27 27.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.922 . . . . 0.0 110.349 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.747 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.2 mp -87.39 -25.87 23.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.867 . . . . 0.0 110.23 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.507 ' HG3' ' NE ' ' A' ' 33' ' ' ARG . 87.8 tt0 -61.77 -65.6 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.294 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.555 ' O ' ' CB ' ' A' ' 18' ' ' LEU . 4.4 m -43.83 -54.55 5.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.137 -0.977 . . . . 0.0 110.422 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.63 HG23 ' N ' ' A' ' 16' ' ' LYS . 30.3 m -61.46 -48.32 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 110.348 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.635 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 8.7 ttmm -59.33 -55.5 33.97 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.074 -1.016 . . . . 0.0 109.371 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' OD1' ' A' ' 20' ' ' ASP . 28.9 mmtp -80.46 6.78 11.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.367 -0.833 . . . . 0.0 110.124 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.675 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -73.21 -30.89 63.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.95 -1.094 . . . . 0.0 109.869 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HG2' HD13 ' A' ' 38' ' ' ILE . 18.7 tptm -56.41 -39.09 72.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 109.748 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 26.3 p-10 -111.53 98.08 7.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.849 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.766 HD21 ' HB2' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -80.74 113.18 18.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 110.498 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 91.8 mt-30 -142.25 134.3 27.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.852 . . . . 0.0 109.933 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 22' ' ' GLN . 8.7 mt-10 59.41 136.0 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.403 -0.811 . . . . 0.0 110.174 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 3.0 Cg_exo -61.59 155.25 54.42 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.735 1.387 . . . . 0.0 110.542 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 91.8 mt-30 56.6 -159.68 0.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -107.21 110.52 63.33 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 110.2 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HG3' ' HB2' ' A' ' 23' ' ' GLU . 3.0 Cg_exo -61.37 -24.54 78.74 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.709 1.373 . . . . 0.0 110.53 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -125.47 146.26 49.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 110.105 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.4 t -117.19 134.5 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.273 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.407 ' N ' ' NH2' ' A' ' 33' ' ' ARG . . . 174.87 105.47 0.19 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -60.54 -28.86 68.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -1.136 . . . . 0.0 110.126 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 mt -93.36 127.43 38.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 110.421 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.507 ' NE ' ' HG3' ' A' ' 13' ' ' GLU . 71.3 mtt-85 -144.92 153.47 41.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.863 . . . . 0.0 109.701 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 80.1 m-20 -136.61 20.35 3.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.055 . . . . 0.0 111.205 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.56 ' HB3' ' HD3' ' A' ' 16' ' ' LYS . 63.6 t80 -87.27 124.18 33.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.989 -1.07 . . . . 0.0 109.603 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.501 ' CA ' ' HG3' ' A' ' 78' ' ' GLU . . . -79.99 113.88 41.87 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 110.594 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.952 ' C ' HD12 ' A' ' 38' ' ' ILE . 2.9 Cg_endo -65.55 -148.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.797 1.419 . . . . 0.0 110.409 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.952 HD12 ' C ' ' A' ' 37' ' ' PRO . 2.6 mp -132.84 79.7 62.94 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.902 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.568 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 3.1 Cg_exo -60.67 150.21 83.41 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.841 1.443 . . . . 0.0 110.684 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.509 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 95.31 14.68 47.14 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.527 ' O ' HG23 ' A' ' 43' ' ' VAL . 19.3 mm-40 -114.71 106.64 51.82 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.188 -1.183 . . . . 0.0 110.157 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.464 ' C ' HG23 ' A' ' 43' ' ' VAL . 3.0 Cg_exo -60.9 144.65 99.61 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.822 1.433 . . . . 0.0 110.478 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.777 ' O ' HG23 ' A' ' 44' ' ' VAL . 38.6 t -147.67 54.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 110.234 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.79 ' O ' HG12 ' A' ' 44' ' ' VAL . 24.9 t -161.13 74.33 2.59 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.301 -0.874 . . . . 0.0 110.767 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.444 ' C ' HG23 ' A' ' 46' ' ' ILE . 3.0 Cg_endo -61.43 -39.75 53.72 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.755 1.397 . . . . 0.0 109.582 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.526 HG13 ' N ' ' A' ' 47' ' ' LEU . 12.2 pt -148.65 -39.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -130.94 -115.82 0.23 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.595 ' N ' HD12 ' A' ' 47' ' ' LEU . 94.2 m -115.23 116.66 28.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.756 -1.215 . . . . 0.0 109.8 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.583 ' HB3' ' CG1' ' A' ' 43' ' ' VAL . 4.6 t -54.68 -58.1 8.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 111.113 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.457 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -80.09 113.18 36.36 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.33 -0.856 . . . . 0.0 110.853 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -66.03 -13.32 39.32 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.68 1.358 . . . . 0.0 110.298 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.766 ' HB2' HD21 ' A' ' 21' ' ' LEU . 25.8 m120 -116.08 21.27 13.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 0.0 110.471 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.656 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -79.89 175.05 5.17 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 108.983 179.23 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.664 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.5 Cg_exo -57.59 75.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.63 1.331 . . . . 0.0 108.904 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.614 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.7 tt0 -39.44 -28.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.675 -0.641 . . . . 0.0 110.27 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.502 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.7 mt-10 -52.82 -19.37 2.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.023 -1.048 . . . . 0.0 108.55 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.754 HD21 ' CG ' ' A' ' 10' ' ' PHE . 68.0 mt -86.11 4.05 39.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.634 -0.666 . . . . 0.0 109.398 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.758 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -39.92 -51.18 5.68 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.502 -0.748 . . . . 0.0 110.375 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.758 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.32 -40.57 82.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.615 1.324 . . . . 0.0 110.382 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.114 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 6.5 mp -62.24 -36.66 82.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.92 -1.113 . . . . 0.0 109.885 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 81.4 m -64.79 -28.02 69.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 110.257 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -79.85 -10.23 59.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.609 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.493 ' OE2' ' HB2' ' A' ' 65' ' ' ASN . 8.4 pt-20 -114.67 144.1 31.24 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.014 . . . . 0.0 110.16 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.38 -11.74 27.19 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.875 1.461 . . . . 0.0 110.919 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.493 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 75.6 m-20 -81.39 -14.99 56.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 110.419 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.114 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -48.03 -39.99 21.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.171 -0.956 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -61.05 -39.69 90.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 110.101 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -80.03 -36.57 35.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.972 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.806 HG21 ' CD2' ' A' ' 60' ' ' LEU . 86.6 mt -68.43 -43.06 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.873 . . . . 0.0 109.922 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.764 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.7 OUTLIER -51.83 -54.72 25.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -0.82 . . . . 0.0 110.435 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.764 ' N ' HD13 ' A' ' 70' ' ' LEU . 64.1 tt0 -49.64 -54.9 15.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.102 -0.999 . . . . 0.0 110.664 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -50.36 -54.15 23.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.39 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.847 HD11 ' OD2' ' A' ' 5' ' ' ASP . 54.7 mt -50.26 -47.88 55.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.9 . . . . 0.0 110.406 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.625 ' OE2' HD11 ' A' ' 70' ' ' LEU . 80.3 mt-10 -55.6 -45.88 77.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 110.453 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 96.1 mt-10 -58.64 -54.4 47.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.049 -1.032 . . . . 0.0 110.674 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.9 mt -61.16 -37.63 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.059 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.635 ' HB1' ' HB2' ' A' ' 16' ' ' LYS . . . -61.36 -32.85 72.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.457 -0.777 . . . . 0.0 110.054 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 80.3 tt0 -58.44 -35.88 72.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.653 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.45 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -156.54 151.01 20.13 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.683 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.542 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 3.2 Cg_exo -61.67 82.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.012 1.532 . . . . 0.0 110.702 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.53 -134.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.934 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 72.1 p -79.29 -14.37 59.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.12 -1.223 . . . . 0.0 109.545 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 19.6 t -54.16 -52.11 62.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 110.324 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.542 ' OE1' ' HB2' ' A' ' 80' ' ' PRO . 84.2 tt0 -56.6 -33.01 65.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.208 -0.933 . . . . 0.0 111.272 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.774 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.6 pt -98.05 11.76 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.897 -1.127 . . . . 0.0 110.441 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.8 m 54.3 17.12 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.883 . . . . 0.0 110.553 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.934 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.62 -11.1 41.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 109.9 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.47 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.5 OUTLIER -144.33 172.12 13.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.265 -0.897 . . . . 0.0 110.096 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.54 4.2 6.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 110.38 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.31 -35.26 80.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.0 110.634 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.594 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -106.57 121.16 43.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 0.0 110.632 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.514 HG21 ' CD ' ' A' ' 4' ' ' GLN . 14.6 p -104.92 156.08 18.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 110.126 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.38 -4.39 64.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.204 -1.174 . . . . 0.0 110.273 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.254 0.55 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 55.7 m -89.55 151.36 21.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 0.0 110.34 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 10' ' ' PHE . 0.9 OUTLIER -91.61 120.36 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.463 -0.773 . . . . 0.0 109.873 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 49.0 tt0 -110.27 130.05 55.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.644 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.762 ' OD2' HD21 ' A' ' 73' ' ' LEU . 90.4 m-20 -111.69 9.06 20.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 109.802 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.91 -135.98 2.6 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -81.87 -1.48 47.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -1.195 . . . . 0.0 110.199 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.493 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 55.4 m-85 -119.48 143.77 47.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.214 -0.929 . . . . 0.0 110.325 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.7 p -90.38 128.76 36.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 110.172 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.592 ' CE2' ' HG ' ' A' ' 57' ' ' LEU . 21.7 m-30 -110.01 118.81 37.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.247 -0.908 . . . . 0.0 110.335 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.2 t -70.19 166.95 18.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.0 110.016 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 mp -95.22 1.25 54.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.196 -0.94 . . . . 0.0 110.628 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.528 ' OE2' ' N ' ' A' ' 30' ' ' GLY . 93.6 mt-10 -74.54 -69.88 0.43 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.213 -0.929 . . . . 0.0 110.461 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 18' ' ' LEU . 3.8 m -52.03 -38.75 58.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.836 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 9.3 t -67.42 -55.41 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.909 -1.119 . . . . 0.0 109.84 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.509 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 39.9 tttp -53.62 -55.78 22.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.941 -1.1 . . . . 0.0 108.904 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 20' ' ' ASP . 52.1 tttt -80.33 8.81 6.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.446 -0.784 . . . . 0.0 109.829 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 5.5 tt -55.7 -43.01 76.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 110.173 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -58.84 -49.14 78.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.934 . . . . 0.0 110.022 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 60.7 t0 -98.81 107.27 19.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 109.867 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.684 HD13 ' N ' ' A' ' 22' ' ' GLN . 0.2 OUTLIER -112.95 125.48 54.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 110.438 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.684 ' N ' HD13 ' A' ' 21' ' ' LEU . 94.1 mt-30 -121.14 152.89 38.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 110.26 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.661 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 2.5 mm-40 -45.31 -51.92 23.75 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.69 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 3.0 Cg_exo -61.33 147.98 94.13 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.636 1.335 . . . . 0.0 110.761 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.507 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 51.1 tt0 -98.78 167.15 10.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -0.915 . . . . 0.0 110.24 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.495 ' N ' ' HG2' ' A' ' 25' ' ' GLN . 0.4 OUTLIER -113.62 85.5 9.28 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 25' ' ' GLN . 3.0 Cg_exo -60.88 -15.41 38.19 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.01 1.532 . . . . 0.0 110.623 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.469 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 81.2 mtt180 -55.92 152.47 10.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 110.1 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.698 HG11 ' HE2' ' A' ' 31' ' ' LYS . 46.4 t -83.49 148.19 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.278 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' N ' ' OE2' ' A' ' 13' ' ' GLU . . . -70.91 60.21 0.98 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.698 ' HE2' HG11 ' A' ' 29' ' ' VAL . 25.4 mttt -91.11 -65.02 1.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -1.125 . . . . 0.0 110.216 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 34' ' ' ASN . 53.2 mt -89.9 -0.83 57.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 110.169 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.469 ' NH2' ' HB3' ' A' ' 28' ' ' ARG . 0.7 OUTLIER -62.25 74.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 109.97 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 32' ' ' LEU . 83.3 m-20 -130.95 25.26 4.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.468 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -113.01 49.2 0.96 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 109.989 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . . . -61.1 142.53 93.06 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 110.145 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.52 ' O ' ' O ' ' A' ' 38' ' ' ILE . 2.5 Cg_endo -67.23 30.16 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.413 1.409 . . . . 0.0 111.303 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.52 ' O ' ' O ' ' A' ' 37' ' ' PRO . 8.2 mt 58.77 132.89 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.981 -1.074 . . . . 0.0 110.13 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.523 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.1 Cg_exo -61.46 164.04 16.39 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.719 1.379 . . . . 0.0 110.617 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.484 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 146.78 -8.92 1.34 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.55 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -119.46 76.47 18.3 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.001 -1.294 . . . . 0.0 110.474 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.707 ' HA ' HD12 ' A' ' 70' ' ' LEU . 2.9 Cg_endo -62.56 128.48 23.61 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.818 1.431 . . . . 0.0 110.473 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.2 m -135.69 142.96 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.026 HG22 ' HA ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER 168.23 -52.2 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.398 -0.814 . . . . 0.0 110.305 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 44' ' ' VAL . 3.1 Cg_exo -61.46 -18.01 56.96 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.525 1.276 . . . . 0.0 110.689 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 46' ' ' ILE . 84.2 mt -89.09 35.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.117 -0.989 . . . . 0.0 110.022 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' A' ' 48' ' ' CYS . 4.4 mm? 54.13 75.27 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.034 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 47' ' ' LEU . 70.5 m 43.21 95.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.374 -0.829 . . . . 0.0 110.19 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.494 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 9.2 t -56.62 -60.19 3.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.0 110.455 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.556 ' ND2' ' HB2' ' A' ' 21' ' ' LEU . 8.4 m120 -80.26 114.26 45.56 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 0.0 110.273 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -61.7 -5.04 5.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.8 1.421 . . . . 0.0 111.028 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.559 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 94.5 m-20 -140.32 33.73 1.88 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.143 -0.973 . . . . 0.0 110.347 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.746 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -75.28 -174.59 0.39 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 109.061 179.237 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.941 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -57.86 72.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.406 1.214 . . . . 0.0 109.921 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.5 tt0 -41.16 -36.03 0.68 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.711 . . . . 0.0 110.314 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.562 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.9 mt-10 -52.78 -19.31 2.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 108.829 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.941 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.2 mp -94.64 16.29 15.96 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.89 0.853 . . . . 0.0 109.113 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.738 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.76 -52.54 4.95 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.941 -0.474 . . . . 0.0 110.972 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.738 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.14 -44.87 45.33 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.506 1.266 . . . . 0.0 110.07 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.874 HD22 HD13 ' A' ' 69' ' ' ILE . 79.9 mt -59.04 -35.95 74.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.057 -1.027 . . . . 0.0 109.936 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.026 ' HA ' HG22 ' A' ' 44' ' ' VAL . 50.6 t -64.65 -25.02 67.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.025 . . . . 0.0 110.384 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -113.45 29.67 7.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.127 -0.983 . . . . 0.0 109.415 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.55 139.91 27.61 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.606 -0.684 . . . . 0.0 110.484 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.51 -27.4 76.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.65 1.342 . . . . 0.0 109.964 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.37 -16.7 53.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.153 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.0 ' HB1' HG21 ' A' ' 44' ' ' VAL . . . -43.56 -39.61 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -54.54 -43.64 72.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.863 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.48 ' HG2' ' NE ' ' A' ' 72' ' ' ARG . 86.5 tt0 -80.05 -38.75 31.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.949 . . . . 0.0 109.88 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.874 HD13 HD22 ' A' ' 60' ' ' LEU . 78.6 mt -63.38 -55.19 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.987 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.1 tm? -42.34 -64.55 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.436 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.987 ' N ' HD13 ' A' ' 70' ' ' LEU . 56.5 mt-30 -47.65 -53.39 15.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.077 -1.014 . . . . 0.0 110.465 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.48 ' NE ' ' HG2' ' A' ' 68' ' ' GLU . 62.2 mtt180 -54.87 -53.58 53.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 110.138 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.762 HD21 ' OD2' ' A' ' 5' ' ' ASP . 86.3 mt -49.86 -53.01 28.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 110.015 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.651 ' OE2' HD21 ' A' ' 70' ' ' LEU . 80.5 mt-10 -53.15 -45.11 68.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 110.237 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.485 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.1 tt0 -57.74 -54.02 51.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.353 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 79' ' ' ASP . 29.8 mm -59.43 -36.95 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.153 -0.967 . . . . 0.0 109.738 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 16' ' ' LYS . . . -58.16 -33.9 69.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 109.575 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . 85.8 tt0 -60.31 -40.16 89.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.497 -0.752 . . . . 0.0 110.347 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 76' ' ' ILE . 9.5 m-20 -145.54 153.13 50.97 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.135 -0.978 . . . . 0.0 110.31 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -59.76 -58.55 0.56 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.884 1.465 . . . . 0.0 110.57 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.14 -137.88 19.12 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 1.002 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 53.1 p -82.38 -21.44 35.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -1.171 . . . . 0.0 110.107 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 38.9 t -54.58 -53.39 55.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 110.007 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 82.9 tt0 -60.33 -29.19 68.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 0.0 111.322 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.774 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.0 pt -97.22 13.54 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.863 -1.148 . . . . 0.0 110.276 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 62.9 m 55.43 15.15 1.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 0.0 110.574 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 1.002 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -63.72 -12.59 35.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.117 -0.989 . . . . 0.0 109.891 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.413 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 21.7 m-85 -149.48 173.8 13.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 110.324 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.46 3.85 10.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.393 -0.817 . . . . 0.0 110.453 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.66 -33.8 74.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.586 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -106.58 125.31 50.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.678 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -109.93 152.73 25.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.382 -0.824 . . . . 0.0 110.111 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.98 52.36 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.265 -1.139 . . . . 0.0 110.134 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.476 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 3.8 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.154 0.502 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.685 HG21 ' HB2' ' A' ' 9' ' ' SER . 8.4 t -123.51 161.24 25.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.923 . . . . 0.0 110.64 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.606 HG23 HD11 ' A' ' 12' ' ' LEU . 71.0 t -91.9 119.72 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.568 -0.708 . . . . 0.0 109.544 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.61 ' OE1' HG21 ' A' ' 92' ' ' THR . 36.5 mt-30 -110.49 135.01 51.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.96 . . . . 0.0 110.787 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.765 ' OD2' HD21 ' A' ' 73' ' ' LEU . 80.8 m-20 -104.76 11.07 34.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.202 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.28 -131.88 1.97 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -89.6 10.16 24.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.191 -1.182 . . . . 0.0 110.57 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 92.6 m-85 -114.79 154.75 27.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 110.385 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.685 ' HB2' HG21 ' A' ' 2' ' ' THR . 60.4 p -105.1 121.55 44.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.577 ' CE2' HD11 ' A' ' 60' ' ' LEU . 19.9 m-85 -118.99 128.06 54.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.942 . . . . 0.0 110.578 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 m -70.8 165.58 22.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.395 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.861 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 mp -96.37 -8.8 31.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.282 -0.886 . . . . 0.0 110.339 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' SER . 84.4 tt0 -70.97 -70.71 0.29 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.298 -0.876 . . . . 0.0 110.926 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.6 m -43.97 -48.85 8.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.161 -0.962 . . . . 0.0 110.677 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.691 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 14.3 m -59.46 -47.36 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.115 -0.991 . . . . 0.0 110.319 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 20.7 tttm -56.75 -55.27 36.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.831 -1.168 . . . . 0.0 109.075 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 20' ' ' ASP . 7.4 tptm -80.43 10.9 4.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.41 -0.806 . . . . 0.0 109.288 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 47.1 tp -56.31 -45.27 80.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 110.666 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 16.3 tttt -56.87 -46.28 81.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 110.191 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 22.3 t70 -105.78 122.26 45.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.915 . . . . 0.0 110.198 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.893 HD22 ' HB2' ' A' ' 52' ' ' ASN . 79.4 mt -78.2 137.76 38.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.225 -0.922 . . . . 0.0 110.075 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.477 ' HG2' ' HD2' ' A' ' 24' ' ' PRO . 7.9 tt0 -105.45 120.42 41.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.385 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.671 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -50.56 -53.84 41.72 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 0.0 110.531 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 3.2 Cg_exo -58.52 150.62 67.61 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.607 1.32 . . . . 0.0 110.744 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -83.1 53.05 2.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 110.542 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.404 ' HG2' ' OE2' ' A' ' 13' ' ' GLU . 0.3 OUTLIER 53.52 71.98 1.26 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.371 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 24' ' ' PRO . 3.0 Cg_exo -62.56 151.11 85.1 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.852 1.448 . . . . 0.0 110.395 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 27' ' ' PRO . 52.1 mtm180 45.58 -170.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.066 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 29' ' ' VAL . 14.7 p -119.83 136.0 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.269 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.29 94.49 1.66 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -60.79 -31.11 70.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -1.123 . . . . 0.0 110.436 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.1 mt -93.73 136.74 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.401 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -139.79 99.21 3.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.841 . . . . 0.0 110.028 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.561 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 81.5 m-20 -139.04 176.75 8.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 110.519 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.481 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 60.9 t80 60.9 64.52 1.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 110.303 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.762 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -80.08 171.41 12.46 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.171 -0.955 . . . . 0.0 110.232 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.762 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 2.9 Cg_endo -63.78 -6.99 11.87 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.923 1.486 . . . . 0.0 110.821 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 37' ' ' PRO . 1.2 mp 67.39 137.06 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.016 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.506 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.0 Cg_endo -60.75 165.84 11.09 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.797 1.42 . . . . 0.0 110.582 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.51 -1.36 42.78 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -132.46 75.5 73.75 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.211 -1.17 . . . . 0.0 110.147 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.414 ' HA ' ' HG ' ' A' ' 70' ' ' LEU . 3.0 Cg_endo -61.63 143.09 96.44 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.951 1.501 . . . . 0.0 110.329 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.501 ' C ' HG23 ' A' ' 44' ' ' VAL . 14.5 m -109.24 48.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 110.282 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.736 ' O ' HG12 ' A' ' 44' ' ' VAL . 84.2 t -151.87 48.22 0.46 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.51 -0.744 . . . . 0.0 110.705 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.691 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -60.82 -67.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.616 1.324 . . . . 0.0 110.587 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.0 mt -102.81 -70.6 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 110.087 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -144.93 98.78 3.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 109.85 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 47' ' ' LEU . 99.3 m 49.69 100.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.074 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.574 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 14.0 t -65.85 -73.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 110.89 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 8.6 m-20 -77.84 112.29 23.82 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.389 -0.819 . . . . 0.0 110.574 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.38 -9.17 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 O-C-N 123.673 1.354 . . . . 0.0 109.826 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.893 ' HB2' HD22 ' A' ' 21' ' ' LEU . 93.1 m-20 -119.24 27.13 9.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.449 -0.782 . . . . 0.0 110.274 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.682 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.03 174.73 5.65 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.005 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.682 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -56.82 76.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.739 1.389 . . . . 0.0 108.952 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 53' ' ' PHE . 2.7 pt-20 -39.38 -26.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.811 -0.556 . . . . 0.0 110.251 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 54' ' ' PRO . 49.2 tp10 -53.05 -19.02 2.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.011 -1.056 . . . . 0.0 108.38 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.607 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 58.2 mt -90.8 7.63 38.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.621 . . . . 0.0 109.579 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.734 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.69 -51.67 5.12 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 110.687 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.734 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -55.0 -43.16 62.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.502 1.264 . . . . 0.0 110.159 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.064 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 11.5 mt -58.76 -36.69 74.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.089 -1.007 . . . . 0.0 109.947 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.9 t -66.14 -26.57 67.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 110.293 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -92.19 3.73 54.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 111.049 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.557 ' OE2' HD11 ' A' ' 69' ' ' ILE . 6.1 pt-20 -119.17 145.89 39.34 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.853 -1.155 . . . . 0.0 110.269 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.53 -17.83 60.27 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.923 1.486 . . . . 0.0 111.252 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.495 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 21.8 m120 -79.7 -13.63 59.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.064 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.56 -42.37 23.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -59.75 -40.0 86.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 110.418 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -80.13 -36.64 34.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.068 -1.02 . . . . 0.0 109.985 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.882 HG21 HD13 ' A' ' 60' ' ' LEU . 88.7 mt -66.2 -44.53 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 109.986 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.824 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.3 tm? -51.02 -56.62 11.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.846 . . . . 0.0 110.214 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.824 ' N ' HD13 ' A' ' 70' ' ' LEU . 76.8 mt-30 -47.78 -54.64 11.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 110.247 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -51.49 -54.74 23.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.387 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.765 HD21 ' OD2' ' A' ' 5' ' ' ASP . 52.3 mt -50.66 -49.53 56.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.272 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.571 ' OE2' HD11 ' A' ' 70' ' ' LEU . 79.1 mt-10 -55.29 -49.32 72.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.755 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.46 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -57.56 -54.75 43.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.033 -1.042 . . . . 0.0 110.725 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 79' ' ' ASP . 23.0 mm -60.56 -37.11 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.09 -1.006 . . . . 0.0 109.823 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' C ' ' HB2' ' A' ' 36' ' ' ALA . . . -57.81 -32.27 67.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 0.0 109.663 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.623 ' N ' ' HB2' ' A' ' 36' ' ' ALA . 84.0 tt0 -63.74 -40.32 96.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.46 -0.775 . . . . 0.0 110.31 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.457 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -151.32 156.41 34.97 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 0.0 110.076 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.541 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -59.08 -65.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.93 1.49 . . . . 0.0 110.643 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.14 -142.12 22.03 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.854 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 65.0 p -77.42 -19.71 55.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -1.126 . . . . 0.0 109.836 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.745 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 48.8 t -58.79 -51.12 71.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.848 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.3 tt0 -52.96 -30.25 33.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.698 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.742 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.2 pt -103.69 11.6 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.093 -1.004 . . . . 0.0 110.123 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 57.9 m 57.92 17.58 4.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.321 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.854 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -70.51 -14.55 62.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.943 . . . . 0.0 110.093 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.562 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 37.8 t80 -132.34 165.27 24.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.305 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.22 -0.23 11.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 110.274 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.562 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -65.56 -41.73 92.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.158 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.745 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -93.26 111.86 23.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 110.251 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.61 HG21 ' OE1' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -110.88 4.21 19.55 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.499 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . -75.12 -52.05 7.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.499 ' C ' ' O ' ' A' ' 93' ' ' GLY . 1.4 m . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.423 -1.045 . . . . 0.0 110.494 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 94' ' ' CYS . 4.5 m . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.223 0.535 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.4 m -117.83 146.21 44.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 110.387 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.54 ' HB ' HD11 ' A' ' 12' ' ' LEU . 1.2 t -84.16 122.35 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.763 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.89 ' NE2' HG21 ' A' ' 92' ' ' THR . 19.8 mt-30 -112.75 124.72 53.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.958 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.831 ' HB2' HG23 ' A' ' 69' ' ' ILE . 44.4 p30 -103.37 12.0 35.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.55 -139.01 3.5 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -89.08 19.59 4.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -1.177 . . . . 0.0 110.194 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.676 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.5 m-85 -126.67 158.37 36.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.305 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 74.2 m -102.64 115.82 31.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.148 -0.97 . . . . 0.0 110.423 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.68 ' CG ' HD11 ' A' ' 57' ' ' LEU . 17.2 m-30 -116.75 128.01 54.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.365 -0.835 . . . . 0.0 110.596 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.499 ' C ' HD12 ' A' ' 12' ' ' LEU . 34.4 t -75.85 170.6 15.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.917 . . . . 0.0 110.116 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.817 ' N ' HD12 ' A' ' 12' ' ' LEU . 6.9 mp -93.12 -16.97 24.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.155 -0.965 . . . . 0.0 110.645 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.4 mt-10 -64.47 -71.92 0.16 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.151 -0.968 . . . . 0.0 110.402 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.2 m -42.77 -51.72 5.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 0.0 110.376 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.627 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 49.5 t -56.12 -48.26 79.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.58 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.596 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 6.3 ttpp -54.98 -54.67 39.97 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.168 -0.957 . . . . 0.0 108.686 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.469 ' HG3' ' HE3' ' A' ' 16' ' ' LYS . 45.0 mttt -80.62 14.12 2.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.449 -0.782 . . . . 0.0 109.911 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.8 tt -65.92 -35.05 79.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 110.073 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' NZ ' ' HB3' ' A' ' 41' ' ' GLU . 26.9 mttm -97.61 143.96 27.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 53.62 48.66 21.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.984 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.535 ' CD2' ' HB2' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -85.12 129.06 34.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.857 . . . . 0.0 110.251 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.496 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 46.7 tp60 -63.49 167.31 5.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.418 -0.801 . . . . 0.0 110.146 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.663 ' CB ' ' HD3' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -44.27 -55.36 9.93 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.945 . . . . 0.0 110.298 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.663 ' HD3' ' CB ' ' A' ' 23' ' ' GLU . 2.8 Cg_endo -62.76 136.81 59.79 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.591 1.311 . . . . 0.0 110.513 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.474 ' HG2' ' CG ' ' A' ' 52' ' ' ASN . 94.9 mt-30 -57.86 -38.7 76.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.98 . . . . 0.0 109.884 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 25' ' ' GLN . 29.2 mp0 -158.97 88.07 2.17 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.482 -0.761 . . . . 0.0 109.862 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 26' ' ' GLU . 3.0 Cg_exo -61.17 -32.81 91.29 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.925 1.487 . . . . 0.0 110.84 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -142.46 134.36 27.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.184 -0.947 . . . . 0.0 110.486 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.9 t -127.25 134.55 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.303 -0.873 . . . . 0.0 110.064 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.05 -173.14 39.91 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -61.81 -20.82 64.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -1.167 . . . . 0.0 110.136 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.2 mt -56.06 113.52 1.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 110.144 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.616 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 22.6 ptt-85 -155.66 -171.2 3.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.837 . . . . 0.0 109.981 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 33' ' ' ARG . 80.2 m-20 60.93 48.32 6.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.0 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.616 ' CD2' ' O ' ' A' ' 33' ' ' ARG . 65.7 m-85 -128.79 4.91 5.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.384 -0.823 . . . . 0.0 110.154 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -66.09 158.51 76.17 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.603 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.18 -149.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 124.022 1.538 . . . . 0.0 110.765 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.727 HD12 ' N ' ' A' ' 38' ' ' ILE . 4.1 mp -108.07 143.86 28.23 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.407 -0.808 . . . . 0.0 110.09 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.588 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo -61.47 169.43 6.69 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.665 1.35 . . . . 0.0 110.541 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.46 5.86 10.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 19' ' ' LYS . 1.7 mt-10 -133.52 74.0 71.91 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.298 -1.119 . . . . 0.0 110.157 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -60.67 146.06 97.83 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.836 1.44 . . . . 0.0 110.406 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 44' ' ' VAL . 45.4 t -131.38 122.34 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 110.538 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.865 ' O ' HG12 ' A' ' 44' ' ' VAL . 21.7 t -160.76 62.0 1.58 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.228 -0.92 . . . . 0.0 110.49 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.556 ' HG2' ' N ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -64.48 -153.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.605 1.318 . . . . 0.0 110.161 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.785 ' O ' HD23 ' A' ' 47' ' ' LEU . 76.2 mt -65.59 -38.75 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.078 -1.014 . . . . 0.0 109.711 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.785 HD23 ' O ' ' A' ' 46' ' ' ILE . 57.6 mt -142.75 64.26 1.37 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.385 -0.822 . . . . 0.0 109.701 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.565 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 74.9 m 57.93 133.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.428 -0.795 . . . . 0.0 110.035 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.746 ' HB3' HG11 ' A' ' 43' ' ' VAL . 30.5 t -64.16 -64.86 0.78 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.128 -0.982 . . . . 0.0 110.47 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 10.0 m-20 -80.27 114.15 44.77 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.811 . . . . 0.0 110.081 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -64.85 -2.33 5.31 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.693 1.365 . . . . 0.0 110.772 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.535 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 95.6 m-20 -124.18 22.98 8.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.64 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.81 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 3.6 p90 -80.06 -176.33 0.72 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 108.945 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.004 ' HB2' HD13 ' A' ' 57' ' ' LEU . 5.0 Cg_exo -56.39 74.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.562 1.296 . . . . 0.0 109.657 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.6 tt0 -41.4 -36.69 0.89 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.509 -0.744 . . . . 0.0 110.132 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.576 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.9 mt-10 -52.03 -17.77 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.92 . . . . 0.0 108.981 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.004 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.4 mp -94.51 8.72 41.2 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.017 0.913 . . . . 0.0 109.327 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.77 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -41.79 -51.05 9.87 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.77 -0.581 . . . . 0.0 110.151 179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.77 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -53.8 -41.51 73.92 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.521 1.274 . . . . 0.0 110.1 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.036 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 9.5 mp -56.97 -42.47 80.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.948 -1.095 . . . . 0.0 109.402 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.803 ' O ' HG13 ' A' ' 44' ' ' VAL . 72.9 m -61.16 -24.52 66.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -99.31 1.6 44.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.323 -0.861 . . . . 0.0 110.769 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 60' ' ' LEU . 10.1 pt-20 -117.79 147.28 40.74 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.084 -1.01 . . . . 0.0 110.288 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.8 Cg_endo -64.01 -17.21 58.93 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.469 1.446 . . . . 0.0 111.258 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.509 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 53.2 m-20 -79.16 -20.83 47.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.09 -1.007 . . . . 0.0 110.87 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.036 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.57 -37.62 8.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.928 -1.108 . . . . 0.0 109.675 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.604 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.7 mt-30 -61.12 -41.37 96.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 110.187 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.8 mt-10 -80.14 -34.16 37.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.831 HG23 ' HB2' ' A' ' 5' ' ' ASP . 85.1 mt -73.02 -49.97 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 109.812 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.837 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.7 tm? -48.45 -56.59 7.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 109.922 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.774 ' N ' HD13 ' A' ' 70' ' ' LEU . 93.8 mt-30 -47.3 -51.55 18.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 110.028 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 93.0 mtt-85 -58.18 -60.99 2.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 5' ' ' ASP . 8.0 mt -46.17 -54.41 8.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.015 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.645 ' HG2' HD22 ' A' ' 70' ' ' LEU . 76.2 mm-40 -50.92 -42.72 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 109.821 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.588 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 81.1 tt0 -66.8 -51.52 54.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.513 ' O ' ' O ' ' A' ' 79' ' ' ASP . 67.1 mt -65.19 -38.86 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -0.942 . . . . 0.0 109.609 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 34' ' ' ASN . . . -57.6 -35.73 70.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -0.871 . . . . 0.0 109.547 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 83.2 tt0 -63.02 -38.22 90.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.533 -0.729 . . . . 0.0 110.448 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -149.69 157.2 38.67 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.107 -0.996 . . . . 0.0 110.437 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.511 ' HD3' ' ND2' ' A' ' 34' ' ' ASN . 3.1 Cg_exo -59.44 -71.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.981 1.516 . . . . 0.0 110.83 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.4 -140.39 21.96 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.891 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 52.7 p -78.64 -23.09 46.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -1.178 . . . . 0.0 110.153 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.61 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 25.2 t -54.39 -51.81 63.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.917 . . . . 0.0 109.893 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.5 tt0 -55.44 -33.53 63.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 111.115 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.736 HG13 ' HB2' ' A' ' 87' ' ' ALA . 4.3 pt -100.43 10.85 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.972 -1.08 . . . . 0.0 110.522 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.31 9.15 1.83 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.312 -0.867 . . . . 0.0 110.614 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.891 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -60.54 -14.56 20.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.056 -1.028 . . . . 0.0 109.543 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.595 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 41.4 t80 -135.68 164.52 27.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.464 -0.772 . . . . 0.0 110.123 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.62 3.41 5.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 110.23 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.595 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -64.66 -43.1 94.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.33 -0.856 . . . . 0.0 110.492 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.61 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -96.93 116.0 28.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.945 . . . . 0.0 110.645 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.89 HG21 ' NE2' ' A' ' 4' ' ' GLN . 44.8 p -107.89 171.23 7.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.48 -30.31 10.49 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.42 ' HB3' ' CG1' ' A' ' 1' ' ' VAL . 26.1 p . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.207 -1.172 . . . . 0.0 110.172 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.73 ' O ' HG12 ' A' ' 1' ' ' VAL . 67.4 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.244 0.545 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.722 HG23 ' HA ' ' A' ' 11' ' ' SER . 56.5 m -120.73 151.84 39.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.933 . . . . 0.0 110.258 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.742 HG23 HD11 ' A' ' 12' ' ' LEU . 61.9 t -81.01 113.41 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.911 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.613 ' HB3' HG21 ' A' ' 92' ' ' THR . 42.9 tt0 -111.61 132.23 54.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -93.84 -78.0 0.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.34 -0.85 . . . . 0.0 109.627 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.59 -128.43 5.8 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -80.47 10.26 4.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -1.12 . . . . 0.0 110.622 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.503 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 97.6 m-85 -124.47 137.79 54.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.993 . . . . 0.0 110.576 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.419 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 80.0 p -89.58 133.33 34.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 110.201 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.556 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 92.1 m-85 -115.62 123.07 47.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 110.578 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.722 ' HA ' HG23 ' A' ' 2' ' ' THR . 58.5 m -72.77 171.64 12.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.217 -0.927 . . . . 0.0 110.243 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.886 ' N ' HD12 ' A' ' 12' ' ' LEU . 4.3 mp -103.57 2.25 33.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.15 -0.969 . . . . 0.0 111.015 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.454 ' OE2' ' OE1' ' A' ' 26' ' ' GLU . 97.3 mt-10 -71.75 -77.27 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.927 -1.108 . . . . 0.0 110.846 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.628 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.8 m -41.04 -47.57 3.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.255 -0.903 . . . . 0.0 110.88 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.639 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 14.8 m -63.58 -50.43 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.014 . . . . 0.0 109.886 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.568 ' H ' HG23 ' A' ' 15' ' ' VAL . 39.5 tttm -53.34 -53.28 53.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.075 -1.015 . . . . 0.0 109.075 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.451 ' O ' ' O ' ' A' ' 20' ' ' ASP . 68.6 mttm -80.17 4.89 15.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.371 -0.83 . . . . 0.0 109.871 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.639 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 8.8 tp -55.8 -36.31 67.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 110.226 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -53.2 -41.92 65.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.565 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 17' ' ' LYS . 8.6 p-10 -111.67 133.77 53.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.798 . . . . 0.0 109.725 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.89 HD11 ' HB2' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -79.98 113.69 18.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.125 -0.984 . . . . 0.0 110.426 -179.559 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.515 ' N ' HD13 ' A' ' 21' ' ' LEU . 93.6 mt-30 -151.2 171.5 17.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 0.0 109.926 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -126.77 69.47 71.65 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.193 -0.942 . . . . 0.0 110.318 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HD3' ' C ' ' A' ' 22' ' ' GLN . 2.9 Cg_endo -61.94 135.57 56.27 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.902 1.475 . . . . 0.0 110.61 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' GLU . 93.4 mt-30 -64.23 -32.81 74.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 110.059 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.623 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 10.3 mm-40 40.74 55.12 7.43 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.444 -0.785 . . . . 0.0 110.542 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.623 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.8 Cg_endo -61.36 -45.78 17.3 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.79 1.416 . . . . 0.0 110.405 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -137.23 160.88 37.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.466 -0.771 . . . . 0.0 110.044 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 29' ' ' VAL . 12.3 m -57.56 132.35 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.147 -0.971 . . . . 0.0 110.187 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.49 174.18 53.15 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.737 ' O ' HD23 ' A' ' 32' ' ' LEU . 17.9 mttp -59.53 -46.16 89.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -1.169 . . . . 0.0 110.295 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 31' ' ' LYS . 58.8 mt -144.9 140.29 28.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.157 -0.964 . . . . 0.0 110.329 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.437 ' C ' ' HE3' ' A' ' 16' ' ' LYS . 80.5 mtm-85 -111.24 54.58 0.68 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.911 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.488 ' OD1' ' HD3' ' A' ' 80' ' ' PRO . 73.8 m-20 -118.69 131.09 56.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.379 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.504 ' N ' ' HE2' ' A' ' 16' ' ' LYS . 57.2 t80 -178.08 -31.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.319 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 78' ' ' GLU . . . -55.49 109.68 1.77 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 110.39 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.642 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.8 Cg_endo -63.24 81.18 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.766 1.403 . . . . 0.0 110.583 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 48.12 170.38 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.512 -0.743 . . . . 0.0 110.547 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.618 ' HD2' ' HB ' ' A' ' 38' ' ' ILE . 2.9 Cg_endo -63.56 142.86 86.0 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.628 1.331 . . . . 0.0 110.65 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.77 -76.64 1.31 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -165.15 129.56 1.81 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.404 -1.057 . . . . 0.0 110.069 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HA ' HD12 ' A' ' 70' ' ' LEU . 3.0 Cg_endo -60.86 126.31 19.35 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.702 1.369 . . . . 0.0 110.502 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.582 HG22 ' HD3' ' A' ' 45' ' ' PRO . 11.3 p -140.58 138.58 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.322 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.538 HG23 ' C ' ' A' ' 43' ' ' VAL . 73.8 t -155.36 81.07 4.1 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.297 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.582 ' HD3' HG22 ' A' ' 43' ' ' VAL . 3.1 Cg_exo -60.59 -142.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.947 1.498 . . . . 0.0 110.259 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.682 ' O ' HD23 ' A' ' 47' ' ' LEU . 88.2 mt -55.45 -37.64 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.917 -1.114 . . . . 0.0 108.628 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 46' ' ' ILE . 74.0 mt -135.19 -78.03 0.44 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.533 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 62.7 m -141.03 140.12 34.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.867 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 22.1 t -59.5 -48.27 82.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.178 -0.951 . . . . 0.0 110.487 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.712 ' ND2' HD23 ' A' ' 21' ' ' LEU . 1.2 m120 -80.13 114.79 49.64 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.352 -0.842 . . . . 0.0 110.324 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -60.33 -10.36 13.05 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.703 1.37 . . . . 0.0 110.649 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.89 ' HB2' HD11 ' A' ' 21' ' ' LEU . 28.2 m120 -138.92 36.39 2.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.962 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.78 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 2.2 p90 -73.08 -175.84 0.41 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 108.957 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.025 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.7 Cg_exo -58.41 74.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.494 1.26 . . . . 0.0 109.524 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.8 tt0 -42.7 -36.37 1.41 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.414 -0.804 . . . . 0.0 110.441 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.553 ' C ' HD12 ' A' ' 57' ' ' LEU . 83.8 tt0 -52.55 -19.17 2.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.077 -1.014 . . . . 0.0 108.929 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.025 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.1 mp -93.93 13.82 21.56 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.923 0.868 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.752 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.9 mttp -40.04 -52.01 5.57 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.729 -0.607 . . . . 0.0 110.201 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.752 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.08 -46.05 36.04 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.584 1.307 . . . . 0.0 109.661 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.097 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -48.78 -47.19 42.1 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.061 -1.024 . . . . 0.0 109.346 179.296 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 86.6 m -68.24 -27.23 66.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.418 -0.801 . . . . 0.0 110.286 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -86.43 4.96 37.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.998 . . . . 0.0 110.507 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.541 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 5.6 pt-20 -122.12 146.29 46.21 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.148 -0.97 . . . . 0.0 110.161 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -61.77 -17.98 58.04 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.862 1.454 . . . . 0.0 110.978 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.484 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 22.3 m120 -79.78 -12.09 59.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.578 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.097 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -49.94 -39.66 41.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.151 -0.968 . . . . 0.0 109.99 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.524 ' HG3' ' HB2' ' A' ' 42' ' ' PRO . 30.5 tt0 -56.8 -44.61 82.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.367 -0.833 . . . . 0.0 110.487 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.6 mt-10 -80.28 -35.06 36.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.982 . . . . 0.0 110.358 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.018 HG21 ' CD1' ' A' ' 60' ' ' LEU . 86.7 mt -69.05 -48.65 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.149 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.697 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.7 tm? -44.87 -63.53 0.9 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.697 ' N ' HD13 ' A' ' 70' ' ' LEU . 50.7 tt0 -48.4 -53.13 18.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 110.176 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 82.9 mtp180 -51.59 -58.33 6.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 109.91 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 47.0 mt -46.33 -48.77 18.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.787 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 86.7 mt-10 -54.63 -40.67 69.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.297 -0.877 . . . . 0.0 110.176 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.582 ' CG ' ' HG3' ' A' ' 39' ' ' PRO . 96.5 mt-10 -61.82 -54.78 37.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.031 -1.043 . . . . 0.0 110.269 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 79' ' ' ASP . 42.4 mt -63.16 -42.49 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.881 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' A' ' 16' ' ' LYS . . . -52.0 -37.19 52.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.56 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 84.1 tt0 -65.93 -42.57 89.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.495 -0.753 . . . . 0.0 110.349 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -143.56 153.57 58.73 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.067 -1.02 . . . . 0.0 110.449 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.577 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -61.99 -68.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.069 1.563 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.03 -140.13 18.27 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.976 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 47.6 p -81.29 -21.98 38.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -1.118 . . . . 0.0 110.033 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 10.7 t -56.47 -50.22 72.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.166 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 78.5 tt0 -63.24 -27.26 69.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.954 . . . . 0.0 111.175 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.764 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.7 pt -102.08 12.76 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.829 -1.169 . . . . 0.0 110.449 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.9 t 57.87 13.59 2.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 110.459 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.976 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -64.66 -21.49 66.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 110.035 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.443 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 2.6 t80 -134.85 169.48 17.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.84 . . . . 0.0 110.04 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.31 1.26 11.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.188 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -58.58 -39.82 81.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.588 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.6 OUTLIER -104.38 122.12 44.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.005 . . . . 0.0 110.786 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.613 HG21 ' HB3' ' A' ' 4' ' ' GLN . 25.9 p -101.31 170.15 8.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 110.237 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.18 4.16 78.18 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.257 -1.143 . . . . 0.0 110.143 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' A' ' 91' ' ' CYS . 21.8 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.231 0.539 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 88.5 m -126.14 152.98 45.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.31 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.663 HG21 HG21 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -91.03 117.84 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 109.758 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.831 ' NE2' HG21 ' A' ' 92' ' ' THR . 6.6 mt-30 -110.3 139.82 45.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.228 -0.92 . . . . 0.0 110.63 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -108.59 9.62 27.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.697 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.75 -136.21 2.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -79.87 4.85 15.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -1.193 . . . . 0.0 109.566 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.652 ' CE1' ' O ' ' A' ' 9' ' ' SER . 35.7 t80 -119.26 161.32 20.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.473 -0.767 . . . . 0.0 109.78 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.652 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 82.5 p -115.5 133.13 56.33 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.955 -1.09 . . . . 0.0 110.929 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.501 ' O ' HG12 ' A' ' 3' ' ' VAL . 72.0 m-85 -112.47 121.96 46.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 110.779 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.2 p -69.83 168.08 15.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.061 -1.024 . . . . 0.0 109.918 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.636 HD13 ' HG3' ' A' ' 80' ' ' PRO . 43.3 mt -103.13 1.56 33.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.025 -1.047 . . . . 0.0 110.886 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.446 ' OE2' ' N ' ' A' ' 30' ' ' GLY . 97.5 mt-10 -73.96 -75.63 0.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 0.0 110.515 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.1 m -42.53 -50.18 5.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 110.671 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.698 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 5.4 m -57.31 -44.32 83.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.806 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.426 ' HE3' ' C ' ' A' ' 34' ' ' ASN . 50.5 tttt -56.56 -56.05 26.17 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.847 -1.158 . . . . 0.0 108.68 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.412 ' HB3' ' NE2' ' A' ' 22' ' ' GLN . 23.6 mttm -80.5 13.74 2.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.535 -0.728 . . . . 0.0 109.842 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.5 tt -63.38 -41.38 98.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.87 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -56.6 -42.96 79.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.504 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -93.01 116.23 28.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.687 HD13 ' N ' ' A' ' 22' ' ' GLN . 0.8 OUTLIER -77.08 121.23 23.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.122 -0.986 . . . . 0.0 110.753 -179.26 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.687 ' N ' HD13 ' A' ' 21' ' ' LEU . 21.9 pt20 -154.52 171.35 19.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.415 -0.803 . . . . 0.0 109.863 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.601 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -130.78 54.84 15.86 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.017 -1.052 . . . . 0.0 110.873 -179.764 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.601 ' HD3' ' N ' ' A' ' 23' ' ' GLU . 2.9 Cg_endo -60.46 144.99 99.55 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.725 1.382 . . . . 0.0 110.377 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.435 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 57.8 mt-30 -62.19 -28.64 69.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 0.0 110.171 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.656 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER 43.1 52.71 8.49 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.356 -0.84 . . . . 0.0 110.655 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.656 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.8 Cg_endo -61.72 -30.08 84.48 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.698 1.367 . . . . 0.0 110.393 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.407 ' O ' ' OE2' ' A' ' 26' ' ' GLU . 56.1 ttt180 -134.77 147.5 50.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.832 . . . . 0.0 110.217 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 29' ' ' VAL . 9.9 m -57.46 132.4 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.901 . . . . 0.0 110.21 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' N ' ' OE2' ' A' ' 13' ' ' GLU . . . -61.96 117.49 11.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -60.43 -32.65 71.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -1.146 . . . . 0.0 110.127 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.5 tp -100.2 132.67 45.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 110.207 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' NH2' ' CD ' ' A' ' 84' ' ' GLU . 24.3 ptt85 -137.86 118.22 13.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.955 . . . . 0.0 110.205 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.557 ' O ' ' HB3' ' A' ' 35' ' ' PHE . 37.9 p-10 -174.22 -129.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 0.0 110.431 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 58.4 t80 63.66 89.83 0.09 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 110.266 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.657 ' HB2' ' OE2' ' A' ' 78' ' ' GLU . . . -50.24 107.27 0.76 Allowed Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.885 . . . . 0.0 110.287 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 2.8 Cg_endo -64.83 -3.97 7.85 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.808 1.425 . . . . 0.0 110.791 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 2.8 mt 61.64 70.73 0.84 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 110.123 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.49 ' CG ' ' CG ' ' A' ' 75' ' ' GLU . 2.9 Cg_endo -61.29 154.44 58.27 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.968 1.51 . . . . 0.0 110.562 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 125.02 28.6 1.11 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -125.16 71.74 63.92 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.294 -1.121 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.07 90.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.864 1.455 . . . . 0.0 110.471 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.677 ' O ' HG23 ' A' ' 44' ' ' VAL . 11.5 p -135.75 129.23 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 110.042 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.807 ' O ' HG12 ' A' ' 44' ' ' VAL . 14.6 t -158.16 72.58 4.0 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.294 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.545 ' HD3' HG22 ' A' ' 43' ' ' VAL . 3.0 Cg_endo -63.22 148.11 93.34 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.755 1.398 . . . . 0.0 110.185 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.716 HG23 ' HG ' ' A' ' 47' ' ' LEU . 13.1 tt -49.6 -26.41 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 110.012 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.716 ' HG ' HG23 ' A' ' 46' ' ' ILE . 30.0 mt -96.18 9.5 40.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 109.883 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER 70.99 128.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.405 -0.81 . . . . 0.0 110.265 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.553 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 91.5 p -55.48 -79.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.83 . . . . 0.0 110.421 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.678 ' CB ' HD23 ' A' ' 21' ' ' LEU . 41.0 m-20 -80.08 112.56 31.2 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.374 -0.829 . . . . 0.0 110.3 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.39 -5.38 8.2 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.664 1.349 . . . . 0.0 110.875 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.68 ' H ' HD21 ' A' ' 21' ' ' LEU . 15.1 m120 -132.4 29.64 4.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 110.549 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.81 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.5 p90 -78.61 -175.1 0.51 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 108.83 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.994 ' HB2' HD13 ' A' ' 57' ' ' LEU . 5.0 Cg_exo -55.64 75.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.383 1.202 . . . . 0.0 109.925 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 53' ' ' PHE . 22.6 pt-20 -44.46 -34.96 2.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.572 -0.705 . . . . 0.0 110.448 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.643 ' C ' HD12 ' A' ' 57' ' ' LEU . 49.7 mt-10 -53.87 -19.34 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.051 -1.031 . . . . 0.0 108.832 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.994 HD13 ' HB2' ' A' ' 54' ' ' PRO . 6.8 mp -96.77 14.22 25.87 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.83 0.824 . . . . 0.0 109.221 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.755 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.76 -51.48 5.31 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.767 -0.583 . . . . 0.0 110.575 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.755 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -53.66 -44.32 50.1 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.37 1.195 . . . . 0.0 110.039 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.072 ' CD1' HG21 ' A' ' 69' ' ' ILE . 3.1 mm? -57.59 -38.89 75.63 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 109.608 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.578 ' O ' HG13 ' A' ' 44' ' ' VAL . 43.6 t -67.17 -29.4 69.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.15 -0.969 . . . . 0.0 110.181 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.38 6.96 47.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.935 . . . . 0.0 110.08 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 2.8 mt-10 -99.58 144.34 28.12 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.369 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.1 Cg_exo -63.03 -26.83 73.79 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.78 1.41 . . . . 0.0 110.178 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' ALA . 76.1 m-20 -86.94 -3.19 59.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.542 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -42.52 -40.55 2.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.111 -0.993 . . . . 0.0 109.989 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -61.75 -39.72 92.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.476 -0.765 . . . . 0.0 110.454 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -80.3 -31.88 38.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.141 -0.975 . . . . 0.0 109.859 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.072 HG21 ' CD1' ' A' ' 60' ' ' LEU . 62.1 mt -74.55 -44.91 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 110.055 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.794 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.7 tm? -50.03 -59.27 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 110.387 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.794 ' N ' HD13 ' A' ' 70' ' ' LEU . 62.6 tt0 -47.91 -52.64 18.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.333 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.508 HH21 HG23 ' A' ' 69' ' ' ILE . 46.1 mtm180 -55.25 -56.72 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 35.1 mt -49.43 -51.33 36.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 110.205 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 76.7 mm-40 -53.69 -49.82 67.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.967 . . . . 0.0 110.454 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.49 ' CG ' ' CG ' ' A' ' 39' ' ' PRO . 98.8 mt-10 -54.88 -52.14 63.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -0.962 . . . . 0.0 110.523 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.663 HG21 HG21 ' A' ' 3' ' ' VAL . 23.7 mm -62.86 -35.58 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 109.894 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.82 71.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.814 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.657 ' OE2' ' HB2' ' A' ' 36' ' ' ALA . 84.1 tt0 -62.05 -38.54 89.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 110.172 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.6 OUTLIER 175.04 94.42 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 110.077 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.636 ' HG3' HD13 ' A' ' 12' ' ' LEU . 3.1 Cg_exo -59.74 77.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.931 1.49 . . . . 0.0 110.714 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -42.64 -75.12 0.15 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.732 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 65.8 p -71.44 -57.29 4.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.396 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.63 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 32.6 t -39.01 -50.79 1.8 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 110.046 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 81.7 tt0 -58.61 -42.97 89.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.041 -1.037 . . . . 0.0 110.731 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.724 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.6 pt -89.61 18.04 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.018 . . . . 0.0 110.219 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 7.2 m 57.83 15.0 2.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.317 -0.865 . . . . 0.0 110.547 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.732 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.53 -19.26 65.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.194 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -135.68 165.43 25.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.72 5.69 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.829 . . . . 0.0 110.563 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -69.58 -31.56 69.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 110.414 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.63 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.7 OUTLIER -108.56 123.81 49.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.818 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.831 HG21 ' NE2' ' A' ' 4' ' ' GLN . 44.0 p -110.8 164.05 13.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 110.131 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.6 -3.93 68.81 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.174 -1.192 . . . . 0.0 110.199 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 1' ' ' VAL . 5.3 m . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.228 0.537 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 29.8 m -121.42 149.49 42.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 0.0 110.536 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.025 HG23 HD11 ' A' ' 12' ' ' LEU . 91.9 t -86.76 118.44 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.707 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.546 ' CD ' HG21 ' A' ' 92' ' ' THR . 21.5 pt20 -111.48 147.91 34.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 111.029 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 1.025 ' OD2' HD21 ' A' ' 73' ' ' LEU . 91.4 m-20 -111.76 12.1 21.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.429 -0.794 . . . . 0.0 109.771 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 174.07 -129.61 1.66 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.02 5.49 22.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -1.166 . . . . 0.0 110.162 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.464 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 86.8 m-85 -125.98 147.22 49.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 94.8 p -101.14 136.61 40.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 0.0 110.144 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.667 ' CE2' HD11 ' A' ' 60' ' ' LEU . 21.5 m-85 -121.35 132.52 54.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.452 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.415 ' C ' HD12 ' A' ' 12' ' ' LEU . 30.1 t -71.32 166.69 21.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.295 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.025 HD11 HG23 ' A' ' 3' ' ' VAL . 5.2 mp -97.39 -9.64 27.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.302 -0.874 . . . . 0.0 110.404 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -67.75 -71.51 0.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.842 . . . . 0.0 110.729 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 m -46.34 -46.67 18.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.0 110.467 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.606 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 48.5 t -62.94 -51.62 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.048 -1.032 . . . . 0.0 109.941 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.503 ' NZ ' ' N ' ' A' ' 34' ' ' ASN . 43.0 tttt -54.18 -51.8 63.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.05 -1.031 . . . . 0.0 109.018 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 26' ' ' GLU . 22.3 tttp -80.21 6.86 10.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 0.0 109.793 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.606 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 17.2 tp -61.54 -37.59 84.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HE2' HG12 ' A' ' 38' ' ' ILE . 43.7 mttp -63.44 -37.05 85.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.08 -1.013 . . . . 0.0 110.047 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -113.33 101.78 9.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.08 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.754 HD11 ' HB3' ' A' ' 52' ' ' ASN . 33.9 tp -110.26 130.16 55.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.91 . . . . 0.0 110.226 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.438 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 92.9 mt-30 -122.94 161.06 24.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.661 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 0.4 OUTLIER -43.32 -52.57 12.67 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 110.672 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 3.1 Cg_exo -60.48 163.57 14.97 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.642 1.338 . . . . 0.0 110.745 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.459 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 93.0 mt-30 -58.31 -154.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.85 . . . . 0.0 110.327 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.454 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -116.32 79.52 9.01 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.431 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HD3' ' C ' ' A' ' 25' ' ' GLN . 3.0 Cg_endo -61.96 155.45 55.16 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.813 1.428 . . . . 0.0 110.401 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -134.51 152.01 51.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 110.373 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.5 t -124.95 136.1 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.71 141.65 8.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.41 -33.98 75.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -1.155 . . . . 0.0 110.344 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.28 144.21 28.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 110.433 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 70.1 mtt85 -105.3 100.9 10.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.257 -0.902 . . . . 0.0 109.911 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 35.3 p-10 -137.9 155.76 48.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 110.599 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.489 ' O ' ' OE1' ' A' ' 78' ' ' GLU . 66.9 t80 -178.73 159.96 1.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.187 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.574 ' O ' HD13 ' A' ' 38' ' ' ILE . . . -54.05 107.67 0.92 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.118 -0.989 . . . . 0.0 110.058 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.627 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.4 Cg_endo -76.99 147.36 26.69 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.607 1.538 . . . . 0.0 109.953 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.627 HD13 ' C ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -148.22 64.04 7.78 Favored Pre-proline 0 C--N 1.292 -1.93 0 O-C-N 121.738 -0.601 . . . . 0.0 109.793 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 38' ' ' ILE . 3.0 Cg_endo -60.7 147.33 95.24 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.023 1.538 . . . . 0.0 110.772 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.515 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 126.3 32.44 0.73 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -122.47 75.5 44.03 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.289 -1.124 . . . . 0.0 110.283 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.476 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 2.9 Cg_endo -62.01 132.25 38.55 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.84 1.442 . . . . 0.0 110.811 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.784 HG22 ' OG ' ' A' ' 49' ' ' SER . 6.2 p 179.15 83.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.403 -0.81 . . . . 0.0 110.006 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.797 ' O ' HG12 ' A' ' 44' ' ' VAL . 38.8 t -129.37 67.8 79.29 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.479 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 43' ' ' VAL . 3.0 Cg_endo -62.95 151.11 86.28 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.814 1.428 . . . . 0.0 110.281 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.567 HG13 ' HG ' ' A' ' 47' ' ' LEU . 15.2 pt -53.73 -25.04 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 109.891 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.567 ' HG ' HG13 ' A' ' 46' ' ' ILE . 58.4 mt -97.77 12.56 33.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 109.95 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.481 ' O ' ' O ' ' A' ' 47' ' ' LEU . 1.3 m 58.84 121.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.394 -0.816 . . . . 0.0 109.976 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.784 ' OG ' HG22 ' A' ' 43' ' ' VAL . 36.3 m -60.12 -53.19 60.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.67 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.629 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 3.2 m120 -80.32 111.5 22.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.433 -0.792 . . . . 0.0 110.506 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -58.95 -12.79 16.26 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.646 1.34 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.754 ' HB3' HD11 ' A' ' 21' ' ' LEU . 31.0 t30 -137.39 42.1 2.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.253 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.75 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.3 p90 -80.18 -177.58 0.95 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.391 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.998 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -57.85 74.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.684 1.36 . . . . 0.0 109.693 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.0 tt0 -42.52 -35.55 1.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.481 -0.762 . . . . 0.0 110.348 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.7 mt-10 -53.7 -18.16 2.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 108.822 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.998 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.2 mp -96.39 13.3 28.23 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.754 0.788 . . . . 0.0 109.1 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.736 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -41.15 -52.3 7.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.908 -0.495 . . . . 0.0 111.168 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.736 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -53.8 -43.99 53.08 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.6 1.316 . . . . 0.0 110.17 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.83 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 17.9 mt -60.36 -34.36 73.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.139 -0.976 . . . . 0.0 109.902 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.754 ' HA ' HG13 ' A' ' 44' ' ' VAL . 36.8 t -66.27 -25.95 67.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.182 -0.949 . . . . 0.0 110.286 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -107.09 25.35 11.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.943 . . . . 0.0 109.323 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -110.48 143.19 27.62 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.624 -0.672 . . . . 0.0 110.462 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.53 -30.83 80.07 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.896 1.472 . . . . 0.0 109.816 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' ALA . 81.8 m-20 -86.23 -5.95 59.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 0.0 110.507 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.83 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -44.53 -41.56 6.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.106 -0.996 . . . . 0.0 110.068 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -55.13 -42.41 72.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.766 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.11 -37.38 33.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 109.863 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.695 HG21 HD13 ' A' ' 60' ' ' LEU . 87.7 mt -63.34 -49.18 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.098 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.919 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.3 tm? -48.7 -60.88 2.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 110.558 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.919 ' N ' HD13 ' A' ' 70' ' ' LEU . 63.9 tt0 -47.07 -53.99 11.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 0.0 110.533 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -54.76 -53.22 57.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 110.112 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.025 HD21 ' OD2' ' A' ' 5' ' ' ASP . 73.5 mt -49.84 -52.0 35.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.54 ' OE2' HD11 ' A' ' 70' ' ' LEU . 86.7 mt-10 -52.53 -46.02 66.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.341 -0.849 . . . . 0.0 110.328 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 82.3 tt0 -62.76 -54.24 42.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.672 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 79' ' ' ASP . 32.8 mm -64.56 -43.4 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 110.185 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -55.75 -37.64 68.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 110.024 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 57.6 mm-40 -65.02 -36.16 83.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.365 -0.834 . . . . 0.0 111.087 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -135.55 149.16 68.52 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.868 -1.145 . . . . 0.0 110.725 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.508 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -60.58 -68.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.831 1.437 . . . . 0.0 110.596 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.53 -139.42 20.18 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.956 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 64.6 p -80.19 -23.03 41.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.126 -1.22 . . . . 0.0 110.007 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 14.2 t -53.38 -53.51 50.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.903 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.8 tt0 -58.14 -32.29 68.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.375 -0.828 . . . . 0.0 111.05 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.771 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.2 pt -99.08 12.7 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.96 -1.088 . . . . 0.0 110.401 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 54.97 15.49 1.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.875 . . . . 0.0 110.51 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.956 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -62.02 -14.94 40.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.04 -1.037 . . . . 0.0 109.952 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 19.7 m-85 -144.75 174.35 11.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.03 3.18 10.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.847 . . . . 0.0 110.411 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -59.91 -36.78 77.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.609 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -104.22 123.83 48.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 0.0 110.633 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.546 HG21 ' CD ' ' A' ' 4' ' ' GLN . 23.4 p -105.6 160.53 15.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.381 -0.824 . . . . 0.0 110.146 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.65 3.19 56.28 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.349 -1.089 . . . . 0.0 110.218 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.798 HG22 ' SG ' ' A' ' 91' ' ' CYS . 9.7 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.333 0.587 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 90.8 m -129.44 154.45 46.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.961 . . . . 0.0 110.726 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.759 HG21 HD13 ' A' ' 12' ' ' LEU . 39.0 t -83.91 117.25 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.351 -0.843 . . . . 0.0 109.82 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.783 ' CB ' HG21 ' A' ' 92' ' ' THR . 48.7 tt0 -111.73 128.35 56.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 110.504 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.877 ' OD2' HD21 ' A' ' 73' ' ' LEU . 76.1 m-20 -114.24 10.38 17.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.471 -0.768 . . . . 0.0 109.692 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.74 -143.55 4.67 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -82.42 7.74 13.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -1.166 . . . . 0.0 110.221 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.43 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 74.4 m-85 -123.98 145.66 49.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 110.372 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -90.74 123.57 34.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.332 -0.855 . . . . 0.0 110.222 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.749 ' CD1' HD23 ' A' ' 57' ' ' LEU . 20.9 m-85 -110.91 123.08 49.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.863 . . . . 0.0 110.329 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.466 ' HA ' HG23 ' A' ' 2' ' ' THR . 63.4 m -62.37 156.15 23.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.534 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.885 HD11 ' N ' ' A' ' 77' ' ' ALA . 45.9 tp -98.68 -20.91 16.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.238 -0.914 . . . . 0.0 110.546 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.441 ' OE2' HG13 ' A' ' 29' ' ' VAL . 95.6 mt-10 -62.42 -65.46 0.68 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.139 -0.976 . . . . 0.0 110.51 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.4 m -46.58 -48.54 19.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.968 . . . . 0.0 110.949 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.685 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 31.2 m -60.86 -44.97 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.104 -0.997 . . . . 0.0 110.086 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.635 ' CA ' ' HB1' ' A' ' 77' ' ' ALA . 1.5 tmmt? -58.54 -56.03 27.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 109.072 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 13.9 ttpt -80.31 8.46 7.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.294 -0.879 . . . . 0.0 109.14 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.685 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 7.7 tp -52.2 -38.67 58.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.582 -0.699 . . . . 0.0 110.027 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.599 ' HD3' ' CE2' ' A' ' 35' ' ' PHE . 65.5 tttt -57.25 -45.4 84.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.094 -1.004 . . . . 0.0 109.574 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -97.47 115.05 27.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.764 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.88 HD11 ' HB2' ' A' ' 52' ' ' ASN . 29.6 tp -97.42 130.94 44.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.666 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -125.6 147.8 49.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.344 -0.847 . . . . 0.0 109.958 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.638 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 2.5 tt0 -50.58 -53.34 47.06 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 110.445 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 3.0 Cg_endo -60.42 124.75 15.78 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.612 1.322 . . . . 0.0 110.712 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.419 ' O ' ' CB ' ' A' ' 26' ' ' GLU . 63.1 tt0 -64.23 -41.06 97.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.875 . . . . 0.0 110.191 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.429 ' CD ' ' OE1' ' A' ' 13' ' ' GLU . 0.4 OUTLIER 174.18 74.96 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.432 -0.793 . . . . 0.0 110.021 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 24' ' ' PRO . 2.9 Cg_endo -62.32 -31.02 81.7 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.877 1.461 . . . . 0.0 110.697 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -137.21 159.59 41.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.857 . . . . 0.0 110.426 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.441 HG13 ' OE2' ' A' ' 13' ' ' GLU . 47.4 t -116.82 132.32 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.847 . . . . 0.0 110.033 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.17 136.71 12.97 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.449 ' O ' HD23 ' A' ' 32' ' ' LEU . 19.2 mtmt -59.4 -38.85 81.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -1.131 . . . . 0.0 110.115 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 31' ' ' LYS . 45.5 mt -118.93 136.52 54.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 110.153 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -124.29 132.09 53.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.216 -0.927 . . . . 0.0 110.317 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 16.7 p30 -164.43 163.95 22.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 110.119 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.599 ' CE2' ' HD3' ' A' ' 19' ' ' LYS . 64.8 t80 -170.38 173.71 5.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.145 -0.972 . . . . 0.0 110.277 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.947 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -49.48 177.85 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.823 . . . . 0.0 110.289 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.947 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 3.0 Cg_exo -61.83 81.96 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.846 1.445 . . . . 0.0 110.604 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.733 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 2.1 mp -67.91 -40.2 21.87 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 111.247 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.733 ' CD ' ' N ' ' A' ' 38' ' ' ILE . 3.0 Cg_exo -64.73 146.52 88.66 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.323 1.17 . . . . 0.0 110.568 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.31 6.08 29.69 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -137.09 71.01 55.83 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.162 -1.199 . . . . 0.0 110.31 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.74 147.71 94.69 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.865 1.455 . . . . 0.0 110.269 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.899 HG22 ' HB3' ' A' ' 49' ' ' SER . 12.2 p -158.47 72.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.42 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.749 ' O ' HG12 ' A' ' 44' ' ' VAL . 30.6 t -127.44 73.8 77.76 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.1 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.472 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 3.1 Cg_exo -60.28 -54.31 2.29 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.97 1.511 . . . . 0.0 110.6 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.787 ' O ' HD13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -177.59 -40.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.319 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.521 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 16.0 tp -109.45 38.81 2.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.137 -0.977 . . . . 0.0 110.248 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.566 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.0 OUTLIER 57.97 123.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.202 -0.936 . . . . 0.0 110.194 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.899 ' HB3' HG22 ' A' ' 43' ' ' VAL . 85.0 p -61.54 -54.88 37.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -0.92 . . . . 0.0 110.44 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 5.3 m-20 -80.2 110.87 18.08 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.392 -0.818 . . . . 0.0 110.399 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.599 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.81 -13.96 33.69 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.623 1.328 . . . . 0.0 110.715 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.88 ' HB2' HD11 ' A' ' 21' ' ' LEU . 86.3 m-20 -128.21 33.66 4.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 110.55 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.664 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.25 175.94 4.29 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.129 -0.982 . . . . 0.0 108.792 179.082 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.679 ' HG2' HD12 ' A' ' 57' ' ' LEU . 4.1 Cg_exo -56.57 75.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.604 1.318 . . . . 0.0 109.388 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.644 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.5 tt0 -39.35 -27.14 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.712 -0.618 . . . . 0.0 110.387 -178.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.3 mt-10 -53.68 -17.34 2.17 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.964 -1.085 . . . . 0.0 108.657 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.749 HD23 ' CD1' ' A' ' 10' ' ' PHE . 34.8 mt -95.09 9.17 40.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.566 -0.709 . . . . 0.0 109.676 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.741 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.6 -51.74 4.95 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.28 -0.887 . . . . 0.0 110.678 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.741 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.84 -41.88 74.07 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.496 1.261 . . . . 0.0 110.017 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.892 HD22 HD13 ' A' ' 69' ' ' ILE . 55.9 mt -60.39 -36.6 78.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.113 -0.992 . . . . 0.0 110.163 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.533 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 73.6 m -67.53 -28.32 67.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.957 . . . . 0.0 110.272 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -101.22 24.33 9.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.211 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.45 143.55 29.57 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.588 -0.695 . . . . 0.0 110.588 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.26 -31.98 73.6 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.813 1.428 . . . . 0.0 109.818 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -86.98 1.67 52.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.361 -0.837 . . . . 0.0 110.701 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.17 -42.63 20.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.068 -1.02 . . . . 0.0 110.058 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 92.1 mt-30 -56.15 -41.39 75.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.848 . . . . 0.0 110.098 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -79.92 -35.52 37.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 110.135 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.892 HD13 HD22 ' A' ' 60' ' ' LEU . 91.6 mt -67.6 -47.95 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.0 109.79 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -53.95 -53.28 54.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 0.0 110.378 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.954 ' N ' HD13 ' A' ' 70' ' ' LEU . 97.9 mt-30 -49.7 -51.26 39.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.252 -0.905 . . . . 0.0 110.722 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -55.42 -59.64 4.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.317 -0.864 . . . . 0.0 110.711 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.877 HD21 ' OD2' ' A' ' 5' ' ' ASP . 60.9 mt -44.38 -49.09 9.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.301 -0.875 . . . . 0.0 110.42 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.93 ' OE2' HD21 ' A' ' 70' ' ' LEU . 70.7 mt-10 -61.82 -26.72 68.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 0.0 110.752 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.557 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.3 tt0 -71.63 -50.41 30.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.929 -1.107 . . . . 0.0 109.785 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.1 mm -67.82 -36.48 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.346 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.885 ' N ' HD11 ' A' ' 12' ' ' LEU . . . -63.28 -29.16 70.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.617 -0.677 . . . . 0.0 109.667 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 35' ' ' PHE . 84.8 tt0 -62.99 -34.7 78.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.423 -0.798 . . . . 0.0 110.384 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -161.33 147.01 10.84 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.144 -0.973 . . . . 0.0 110.765 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.5 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.47 84.04 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.052 1.554 . . . . 0.0 110.598 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.68 -130.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.207 -1.957 . . . . 0.0 108.207 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.965 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 82.8 p -82.76 -16.96 45.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.246 . . . . 0.0 109.321 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.438 ' SG ' ' N ' ' A' ' 91' ' ' CYS . 5.5 t -51.11 -50.38 58.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.733 -0.604 . . . . 0.0 110.37 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' OE1' ' HB2' ' A' ' 80' ' ' PRO . 76.2 tt0 -61.05 -34.87 75.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.268 -0.895 . . . . 0.0 111.364 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.813 HG13 ' HB2' ' A' ' 87' ' ' ALA . 4.3 pt -97.24 17.36 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.588 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 m 51.14 17.37 0.46 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.945 . . . . 0.0 110.81 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.965 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.55 -13.81 62.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.056 -1.028 . . . . 0.0 109.663 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.534 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 52.8 t80 -141.22 170.27 16.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.79 . . . . 0.0 109.996 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.73 4.43 7.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.12 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.534 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -59.27 -40.35 85.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.639 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.798 ' SG ' HG22 ' A' ' 1' ' ' VAL . 1.0 OUTLIER -103.04 128.24 49.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.214 -0.929 . . . . 0.0 110.689 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.783 HG21 ' CB ' ' A' ' 4' ' ' GLN . 16.9 p -108.0 165.45 11.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.25 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.29 -7.07 61.82 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.319 -1.107 . . . . 0.0 110.21 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.456 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 6.4 m . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.107 0.48 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 1.015 HG21 ' HB3' ' A' ' 9' ' ' SER . 14.6 t -129.75 164.09 24.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.981 ' CG2' HD21 ' A' ' 12' ' ' LEU . 43.2 t -80.06 110.98 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.352 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 46.2 tt0 -109.53 121.15 44.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.111 -0.993 . . . . 0.0 110.578 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -99.12 5.65 46.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.821 . . . . 0.0 109.673 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.93 -141.18 3.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -79.92 0.17 32.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -1.193 . . . . 0.0 110.36 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.501 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 92.4 m-85 -112.64 138.07 49.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.179 -0.95 . . . . 0.0 110.462 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 1.015 ' HB3' HG21 ' A' ' 2' ' ' THR . 73.4 m -89.11 128.79 35.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.359 -0.838 . . . . 0.0 110.144 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.772 ' CE1' HD23 ' A' ' 57' ' ' LEU . 91.6 m-85 -111.79 119.14 37.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.897 . . . . 0.0 110.483 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.7 p -70.88 168.38 16.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.93 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.981 HD21 ' CG2' ' A' ' 3' ' ' VAL . 65.0 mt -99.51 2.94 45.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.978 . . . . 0.0 110.425 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 14' ' ' SER . 81.7 tt0 -76.28 -71.02 0.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 110.503 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.475 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.6 m -42.42 -49.45 5.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.007 -1.058 . . . . 0.0 110.271 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.675 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 7.8 m -58.9 -48.89 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.181 -0.949 . . . . 0.0 109.851 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.569 ' NZ ' ' HB3' ' A' ' 35' ' ' PHE . 21.2 tttt -54.68 -55.91 24.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.894 -1.129 . . . . 0.0 108.972 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HB3' ' CD ' ' A' ' 23' ' ' GLU . 43.1 mttt -80.33 12.34 3.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.415 -0.803 . . . . 0.0 109.621 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 39.1 tp -57.96 -37.15 73.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.354 -0.842 . . . . 0.0 110.376 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HB2' ' CG ' ' A' ' 37' ' ' PRO . 79.0 tttt -55.29 -43.21 74.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.127 -0.983 . . . . 0.0 110.006 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -99.96 109.94 22.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 110.042 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.043 HD21 ' CG ' ' A' ' 50' ' ' ASN . 93.8 mt -64.4 -36.29 83.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.895 . . . . 0.0 110.277 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.456 ' O ' ' CB ' ' A' ' 23' ' ' GLU . 1.5 tp60 -60.44 137.77 58.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.23 -0.918 . . . . 0.0 110.2 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 22' ' ' GLN . 0.4 OUTLIER 171.85 164.2 0.24 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.157 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.07 156.93 46.95 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.884 1.465 . . . . 0.0 110.629 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -51.77 -34.03 37.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.196 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.55 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 3.1 tp10 47.42 60.63 14.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.902 . . . . 0.0 110.466 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 3.0 Cg_endo -62.07 -28.22 79.94 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.897 1.472 . . . . 0.0 110.271 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -142.61 158.67 43.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.396 -0.815 . . . . 0.0 109.986 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.6 t -112.61 131.18 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.178 -0.951 . . . . 0.0 110.231 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.29 -72.62 0.77 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' C ' HD12 ' A' ' 32' ' ' LEU . 74.5 mttt -90.71 152.92 20.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -1.144 . . . . 0.0 110.154 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.792 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -100.1 137.08 39.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.481 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -112.74 140.27 47.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.812 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 86.9 m-20 -124.68 107.39 10.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 110.76 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.569 ' HB3' ' NZ ' ' A' ' 16' ' ' LYS . 74.7 t80 179.38 66.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.332 -0.855 . . . . 0.0 110.245 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.974 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . . . -65.09 145.12 99.15 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.967 . . . . 0.0 110.128 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.829 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.8 Cg_endo -62.65 -30.93 79.33 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.823 1.433 . . . . 0.0 110.845 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 154.68 116.1 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.045 0 O-C-N 121.84 -0.537 . . . . 0.0 109.814 179.736 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 3.0 Cg_exo -62.44 154.51 63.74 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.678 1.357 . . . . 0.0 110.495 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.463 ' HA2' ' HG2' ' A' ' 71' ' ' GLN . . . 102.02 -0.35 51.43 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -66.91 139.54 95.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.214 -1.168 . . . . 0.0 110.214 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.68 110.0 0.87 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.756 1.398 . . . . 0.0 110.329 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.603 HG21 ' HG ' ' A' ' 70' ' ' LEU . 63.3 t -135.97 143.04 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.142 -0.974 . . . . 0.0 110.515 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.829 ' O ' HG12 ' A' ' 44' ' ' VAL . 46.4 t 57.59 58.0 7.36 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.775 . . . . 0.0 110.861 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.822 ' O ' HD13 ' A' ' 46' ' ' ILE . 2.9 Cg_endo -62.59 -42.22 27.7 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.512 1.27 . . . . 0.0 109.69 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 45' ' ' PRO . 39.4 mm -133.3 -28.55 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.501 -0.749 . . . . 0.0 109.927 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.721 HD23 HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER 178.97 89.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.388 -0.82 . . . . 0.0 109.891 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.506 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 0.8 OUTLIER 57.21 112.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.15 -0.969 . . . . 0.0 110.038 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.618 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 6.6 p -96.16 -53.46 3.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 110.566 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 1.043 ' CG ' HD21 ' A' ' 21' ' ' LEU . 9.6 m-20 -80.06 111.35 21.22 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.401 -0.812 . . . . 0.0 110.439 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.618 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.91 -13.62 40.72 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.704 1.37 . . . . 0.0 110.371 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.419 ' HB2' HD22 ' A' ' 21' ' ' LEU . 95.2 m-20 -114.27 20.16 15.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.415 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.15 173.45 7.7 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 108.961 179.193 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.641 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.1 Cg_exo -57.37 75.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.632 1.333 . . . . 0.0 108.925 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 53' ' ' PHE . 23.9 pt-20 -39.11 -26.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.745 -0.597 . . . . 0.0 110.596 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt-10 -51.68 -22.23 3.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.944 -1.097 . . . . 0.0 108.452 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.772 HD23 ' CE1' ' A' ' 10' ' ' PHE . 66.7 mt -83.14 8.86 11.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.662 -0.649 . . . . 0.0 109.472 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.744 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.75 -51.49 5.29 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.457 -0.777 . . . . 0.0 110.601 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.744 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.97 -41.43 78.81 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.52 1.274 . . . . 0.0 110.571 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.073 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 5.9 mp -62.48 -35.45 79.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.88 -1.138 . . . . 0.0 110.384 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.449 ' HB3' ' N ' ' A' ' 48' ' ' CYS . 84.3 m -67.22 -28.19 67.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.064 -1.023 . . . . 0.0 110.536 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' NZ ' ' HE2' ' A' ' 58' ' ' LYS . 91.2 mttt -81.64 -3.08 52.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.825 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 11.4 pt-20 -125.38 147.02 56.31 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.94 -1.1 . . . . 0.0 110.376 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.27 -6.94 10.9 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.903 1.475 . . . . 0.0 111.024 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -79.92 -22.69 42.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.087 -1.008 . . . . 0.0 110.161 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.073 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.69 -39.37 17.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.419 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.57 -41.51 97.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 110.278 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.39 -38.17 30.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.915 HG21 ' CD2' ' A' ' 60' ' ' LEU . 95.7 mt -65.17 -39.39 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 110.489 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.655 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.3 tm? -56.42 -51.34 68.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.937 . . . . 0.0 110.499 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.463 ' HG2' ' HA2' ' A' ' 40' ' ' GLY . 89.6 mt-30 -49.64 -54.78 16.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.103 -0.998 . . . . 0.0 110.117 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.514 HH21 HG23 ' A' ' 69' ' ' ILE . 46.6 mtm180 -52.36 -54.33 33.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.39 -0.818 . . . . 0.0 110.119 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 41.5 mt -48.43 -50.47 31.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.879 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 69.6 mm-40 -53.9 -51.78 62.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.892 . . . . 0.0 110.279 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -54.78 -56.85 14.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.039 -1.038 . . . . 0.0 110.536 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 79' ' ' ASP . 20.1 mt -58.9 -35.16 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.121 -0.987 . . . . 0.0 109.465 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.974 ' HB3' ' HB2' ' A' ' 36' ' ' ALA . . . -57.89 -34.72 70.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.545 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -60.39 -40.65 91.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -148.01 153.69 42.19 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.163 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.584 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -58.56 -59.22 0.52 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.895 1.471 . . . . 0.0 110.574 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.33 -138.69 20.15 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.92 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 65.5 p -82.31 -21.13 36.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -1.11 . . . . 0.0 110.058 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.597 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 42.3 t -55.64 -53.35 57.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.208 -0.933 . . . . 0.0 110.109 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.7 tt0 -60.7 -27.81 68.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 111.22 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.786 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.2 pt -99.05 13.51 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 110.273 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 55.37 16.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.504 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.92 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.29 -15.35 63.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.967 . . . . 0.0 109.931 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.46 169.49 17.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.13 3.09 11.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 110.185 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.53 -34.8 77.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.458 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -103.51 123.25 46.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.737 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.8 p -111.63 154.98 24.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 109.754 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 44.14 4.82 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.342 -1.093 . . . . 0.0 110.282 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.844 HG11 ' HB3' ' A' ' 91' ' ' CYS . 3.4 t . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.164 0.507 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.666 ' H ' HG12 ' A' ' 1' ' ' VAL . 30.8 m -126.25 142.66 51.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.55 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.582 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 90.4 t -82.24 119.66 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.496 -0.752 . . . . 0.0 109.448 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.525 ' CD ' HG21 ' A' ' 92' ' ' THR . 44.8 tt0 -113.5 133.11 55.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.879 -1.138 . . . . 0.0 110.787 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -92.06 -78.89 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.567 -0.708 . . . . 0.0 109.65 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.0 -122.16 4.67 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -85.19 10.01 13.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.157 . . . . 0.0 110.341 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.491 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 98.1 m-85 -122.45 137.9 54.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.448 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.7 p -89.64 128.35 36.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 110.076 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.884 ' HB3' HD21 ' A' ' 57' ' ' LEU . 23.2 m-30 -117.07 126.98 53.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 0.0 110.746 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.1 t -61.48 157.92 16.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.079 . . . . 0.0 109.727 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 12' ' ' LEU . 1.5 pt? -100.5 -25.31 14.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -1.0 . . . . 0.0 111.071 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.21 -65.86 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.078 -1.014 . . . . 0.0 110.74 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.6 m -52.59 -38.86 60.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.363 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.645 ' CG1' ' HB2' ' A' ' 77' ' ' ALA . 6.8 t -58.15 -46.4 88.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.135 -0.978 . . . . 0.0 109.621 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HD3' ' CD ' ' A' ' 33' ' ' ARG . 18.9 tttt -57.73 -53.84 53.67 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.056 -1.028 . . . . 0.0 108.74 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 20' ' ' ASP . 51.4 mttm -80.34 12.05 3.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.535 -0.728 . . . . 0.0 109.751 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 8.7 tt -59.55 -39.08 82.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.136 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -50.61 -42.54 56.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 17' ' ' LYS . 39.0 p30 -150.31 146.4 26.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.809 . . . . 0.0 109.605 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.0 HD22 ' CG ' ' A' ' 52' ' ' ASN . 14.7 tp -102.95 126.77 50.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.986 . . . . 0.0 110.759 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.478 ' C ' ' CG ' ' A' ' 23' ' ' GLU . 94.3 mt-30 -142.76 157.23 44.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.434 -0.791 . . . . 0.0 109.608 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.626 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 0.7 OUTLIER 55.66 -175.68 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.087 -1.008 . . . . 0.0 109.393 -179.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 23' ' ' GLU . 3.1 Cg_exo -62.59 152.48 77.5 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.556 1.293 . . . . 0.0 110.618 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -55.44 -36.25 66.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.254 -0.904 . . . . 0.0 110.435 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -138.26 80.83 27.24 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.873 . . . . 0.0 110.301 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 24' ' ' PRO . 3.0 Cg_endo -63.09 143.67 90.91 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.948 1.499 . . . . 0.0 110.446 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.557 ' C ' HG12 ' A' ' 29' ' ' VAL . 83.9 mtt180 -88.1 157.46 18.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.557 HG12 ' C ' ' A' ' 28' ' ' ARG . 2.8 p 33.72 85.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.457 -0.777 . . . . 0.0 110.524 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.48 -142.08 4.18 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -86.16 163.54 17.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.269 -1.136 . . . . 0.0 110.2 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.796 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.7 mp -93.25 146.16 23.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.301 -0.874 . . . . 0.0 110.257 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.495 ' CD ' ' HD3' ' A' ' 16' ' ' LYS . 8.8 mmt85 -95.52 102.3 14.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.866 . . . . 0.0 110.454 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.547 ' OD1' ' CE1' ' A' ' 35' ' ' PHE . 18.0 p-10 175.93 54.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 110.305 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.547 ' CE1' ' OD1' ' A' ' 34' ' ' ASN . 15.9 m-85 -122.19 155.73 35.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.23 -0.919 . . . . 0.0 110.079 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.6 106.68 0.57 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.085 -1.009 . . . . 0.0 110.063 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.608 ' C ' HD13 ' A' ' 38' ' ' ILE . 3.0 Cg_endo -66.86 -161.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.738 1.388 . . . . 0.0 110.861 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.709 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -153.32 72.89 6.89 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.664 -0.648 . . . . 0.0 109.754 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.57 148.87 85.49 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.701 1.369 . . . . 0.0 110.71 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.413 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 129.55 12.23 2.54 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.49 ' HG3' HD11 ' A' ' 70' ' ' LEU . 3.8 pt-20 -119.48 77.87 19.8 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.094 -1.239 . . . . 0.0 110.138 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.2 Cg_exo -59.32 143.52 99.7 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.978 1.515 . . . . 0.0 110.672 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.014 HG23 HG23 ' A' ' 44' ' ' VAL . 20.2 m -121.77 -166.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 110.273 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.014 HG23 HG23 ' A' ' 43' ' ' VAL . 11.3 t 62.56 53.75 2.08 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.468 -0.77 . . . . 0.0 110.552 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.638 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -61.52 -27.03 81.52 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.698 1.367 . . . . 0.0 110.14 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 47' ' ' LEU . 21.0 tt -159.41 -39.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.365 -0.834 . . . . 0.0 109.956 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.566 ' O ' ' O ' ' A' ' 48' ' ' CYS . 1.3 tp -158.78 89.94 0.97 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.124 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.566 ' O ' ' O ' ' A' ' 47' ' ' LEU . 71.8 m 47.58 109.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.33 -0.856 . . . . 0.0 110.752 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 87.8 p -59.89 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.459 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' LEU . 1.8 m120 -66.09 112.94 10.28 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.868 . . . . 0.0 110.691 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.7 -7.1 15.47 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.713 1.375 . . . . 0.0 109.721 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 1.0 ' CG ' HD22 ' A' ' 21' ' ' LEU . 26.5 p30 -124.95 26.06 7.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.511 -0.743 . . . . 0.0 110.368 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.733 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -79.15 179.89 1.63 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.213 -0.929 . . . . 0.0 108.575 179.102 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.733 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.7 Cg_exo -57.73 75.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 N-CA-C 108.89 -1.235 . . . . 0.0 108.89 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.624 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.2 tt0 -39.2 -27.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.706 -0.621 . . . . 0.0 110.085 -178.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.516 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 96.3 mt-10 -52.6 -17.91 1.5 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.068 -1.02 . . . . 0.0 108.74 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.884 HD21 ' HB3' ' A' ' 10' ' ' PHE . 33.5 mt -89.47 8.46 30.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.553 -0.717 . . . . 0.0 109.683 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.77 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.65 -50.42 5.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 110.463 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.77 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.58 -41.04 81.03 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.457 1.24 . . . . 0.0 110.027 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.029 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 34.7 mt -59.81 -41.41 91.21 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.095 -1.003 . . . . 0.0 110.153 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 t -69.13 -31.08 69.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.084 -1.01 . . . . 0.0 110.294 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -80.03 4.62 16.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.565 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.69 ' OE2' HD23 ' A' ' 60' ' ' LEU . 8.1 pt-20 -124.0 138.18 30.19 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.074 -1.016 . . . . 0.0 110.128 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.98 -16.51 45.85 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.767 1.403 . . . . 0.0 110.647 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.492 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 20.5 m120 -80.05 -8.24 59.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 110.023 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.029 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -51.02 -34.45 29.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.818 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -62.79 -38.62 91.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.683 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.29 -43.69 20.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.603 HG21 HD22 ' A' ' 60' ' ' LEU . 66.8 mt -62.69 -39.94 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.866 . . . . 0.0 109.557 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.5 tm? -46.93 -65.94 0.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.606 -0.684 . . . . 0.0 110.627 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.965 ' N ' HD13 ' A' ' 70' ' ' LEU . 92.7 mt-30 -46.56 -53.48 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 110.385 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 18.2 tpp180 -55.49 -54.46 43.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.12 -0.988 . . . . 0.0 109.946 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.629 ' HG ' HG11 ' A' ' 15' ' ' VAL . 10.0 tp -50.08 -53.64 25.76 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.295 -0.878 . . . . 0.0 109.96 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.695 ' OE2' HD21 ' A' ' 70' ' ' LEU . 88.0 mt-10 -50.71 -45.24 58.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 37' ' ' PRO . 96.7 mt-10 -54.1 -53.33 54.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.09 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.513 HG21 HG13 ' A' ' 3' ' ' VAL . 6.0 mt -61.12 -38.15 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.924 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.645 ' HB2' ' CG1' ' A' ' 15' ' ' VAL . . . -59.79 -37.17 78.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 110.049 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 35' ' ' PHE . 47.3 mt-10 -103.66 12.9 34.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.662 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 1.6 t70 -160.26 106.86 1.38 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.487 -0.758 . . . . 0.0 109.696 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.543 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 3.4 Cg_exo -57.17 -65.63 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.803 1.423 . . . . 0.0 110.592 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.56 -136.74 17.09 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.748 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 80.8 p -78.62 -22.93 46.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.311 -1.111 . . . . 0.0 110.01 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 5.0 t -45.72 -58.04 3.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 0.0 110.522 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 80' ' ' PRO . 56.2 mt-10 -56.96 -37.58 71.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.301 -0.875 . . . . 0.0 111.526 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.637 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.0 pt -89.28 12.97 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.853 -1.154 . . . . 0.0 110.503 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 59.9 m 51.45 19.75 0.88 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 110.782 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.748 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -74.3 -2.89 27.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.046 -1.034 . . . . 0.0 109.919 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.489 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 3.4 m-85 -151.9 171.47 17.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.306 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.59 4.9 6.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.292 -0.88 . . . . 0.0 110.441 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.32 -31.1 72.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.911 . . . . 0.0 110.67 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.844 ' HB3' HG11 ' A' ' 1' ' ' VAL . 0.7 OUTLIER -114.81 125.84 54.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.05 -1.031 . . . . 0.0 110.637 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.525 HG21 ' CD ' ' A' ' 4' ' ' GLN . 33.2 p -114.36 152.2 31.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.389 -0.819 . . . . 0.0 110.396 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.76 -21.61 45.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.295 -1.121 . . . . 0.0 110.273 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.488 HG22 ' SG ' ' A' ' 91' ' ' CYS . 3.1 p . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.213 0.53 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.587 HG23 ' HA ' ' A' ' 11' ' ' SER . 57.0 m -118.07 154.5 31.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.302 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' ALA . 96.3 t -82.25 123.23 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 109.801 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.918 ' OE1' HG21 ' A' ' 92' ' ' THR . 62.6 tt0 -113.09 122.31 47.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.946 . . . . 0.0 110.7 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.947 ' OD2' HD21 ' A' ' 73' ' ' LEU . 88.4 m-20 -99.9 13.49 33.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.429 -0.794 . . . . 0.0 109.864 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.521 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . 174.24 -132.96 2.38 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -90.63 15.46 10.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -1.153 . . . . 0.0 109.955 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.628 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . 87.0 m-85 -129.5 128.66 43.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.471 -0.768 . . . . 0.0 110.092 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.3 p -79.95 123.42 27.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 109.998 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.628 ' CE2' ' HB2' ' A' ' 8' ' ' PHE . 85.7 m-85 -116.71 125.35 51.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 110.61 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.587 ' HA ' HG23 ' A' ' 2' ' ' THR . 80.8 p -66.16 165.08 14.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 109.787 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.708 ' CD2' HG22 ' A' ' 76' ' ' ILE . 15.1 tp -110.93 -8.91 14.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 110.853 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.422 ' HG3' ' HD3' ' A' ' 33' ' ' ARG . 86.2 tt0 -60.17 -69.73 0.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.056 -1.027 . . . . 0.0 110.606 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.566 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.9 m -44.67 -39.55 5.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 0.0 110.547 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.658 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 25.2 t -64.99 -49.22 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.035 -1.04 . . . . 0.0 109.535 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.725 ' HG2' ' HB1' ' A' ' 77' ' ' ALA . 78.5 mttt -55.22 -50.74 68.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.08 -1.012 . . . . 0.0 108.808 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -80.14 4.54 17.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.529 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.735 HD13 ' HD3' ' A' ' 54' ' ' PRO . 18.7 tp -56.97 -25.79 58.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.0 110.193 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' HG3' ' A' ' 37' ' ' PRO . 17.5 tttm -61.33 -35.81 78.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.841 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -86.5 109.96 19.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.882 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.83 HD21 ' OD1' ' A' ' 50' ' ' ASN . 1.2 mm? -105.74 164.87 11.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.473 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 56.7 tt0 60.86 56.79 2.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 0.0 110.203 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -136.06 167.18 23.07 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.334 -0.853 . . . . 0.0 110.276 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HD2' ' CG ' ' A' ' 23' ' ' GLU . 3.0 Cg_exo -61.91 145.39 96.94 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.911 1.48 . . . . 0.0 110.552 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' HG2' ' HD3' ' A' ' 27' ' ' PRO . 51.6 tt0 -55.95 147.56 19.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.893 . . . . 0.0 110.073 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -126.67 71.74 73.66 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.307 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.426 ' HD3' ' HG2' ' A' ' 25' ' ' GLN . 2.9 Cg_endo -61.81 -35.76 77.08 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.86 1.453 . . . . 0.0 110.275 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 mtp85 -146.11 120.59 9.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.447 -0.783 . . . . 0.0 109.705 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 31' ' ' LYS . 42.5 t -128.69 133.79 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 110.591 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.98 -3.08 77.01 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.718 ' H ' HG12 ' A' ' 29' ' ' VAL . 84.1 tttt -70.81 153.0 43.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -1.104 . . . . 0.0 110.146 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.6 mt -68.0 146.23 53.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -0.967 . . . . 0.0 110.202 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.586 ' HB3' ' HD2' ' A' ' 16' ' ' LYS . 74.1 mtt85 -106.85 111.57 24.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.283 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 4.0 p30 168.91 -157.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.233 -0.917 . . . . 0.0 110.159 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 82.2 m-85 62.09 24.16 14.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.274 -0.891 . . . . 0.0 110.393 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . . . -70.15 146.07 94.38 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.927 . . . . 0.0 110.058 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.426 ' HG3' ' HD2' ' A' ' 19' ' ' LYS . 3.0 Cg_exo -62.82 -150.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.797 1.419 . . . . 0.0 110.811 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.587 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 20.3 mm -110.0 144.41 29.96 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.905 . . . . 0.0 110.126 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.587 ' HD2' ' CG2' ' A' ' 38' ' ' ILE . 3.0 Cg_exo -59.98 138.85 84.75 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.673 1.354 . . . . 0.0 110.603 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.45 4.58 2.01 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER 60.72 72.18 0.75 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.084 -1.245 . . . . 0.0 109.988 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.568 ' HD2' HD12 ' A' ' 70' ' ' LEU . 3.0 Cg_endo -61.58 -165.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.952 1.501 . . . . 0.0 110.988 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -96.05 129.28 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.748 . . . . 0.0 110.175 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.843 ' O ' HG13 ' A' ' 44' ' ' VAL . 3.1 p -158.19 52.29 0.53 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.333 -0.854 . . . . 0.0 110.198 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 44' ' ' VAL . 3.0 Cg_endo -57.6 -62.95 0.17 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.649 1.342 . . . . 0.0 110.717 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.484 ' HB ' HD12 ' A' ' 47' ' ' LEU . 59.2 mt -149.21 -33.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.0 110.559 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.808 ' N ' HD12 ' A' ' 47' ' ' LEU . 6.0 mp -95.2 3.57 54.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.64 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.532 ' O ' ' O ' ' A' ' 47' ' ' LEU . 1.5 m 57.41 124.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.132 -0.98 . . . . 0.0 109.844 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.89 ' HB3' HG13 ' A' ' 43' ' ' VAL . 87.3 p -64.02 -41.12 97.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 110.926 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.83 ' OD1' HD21 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -80.68 106.9 6.06 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.897 . . . . 0.0 110.619 -179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.745 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -61.11 -16.26 44.79 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.682 1.359 . . . . 0.0 110.33 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -128.03 36.54 4.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.232 -0.917 . . . . 0.0 111.145 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.642 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.1 172.23 10.37 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.776 -1.203 . . . . 0.0 108.484 178.616 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.735 ' HD3' HD13 ' A' ' 18' ' ' LEU . 4.1 Cg_exo -54.45 76.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.505 1.266 . . . . 0.0 109.39 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.6 tt0 -39.65 -27.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.744 -0.598 . . . . 0.0 110.084 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.7 mt-10 -52.7 -17.89 1.54 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.068 -1.02 . . . . 0.0 108.449 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.676 HD12 ' HG2' ' A' ' 54' ' ' PRO . 89.2 mt -90.24 11.2 21.88 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.609 0.719 . . . . 0.0 109.136 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.742 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -39.95 -51.99 5.43 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.416 -0.803 . . . . 0.0 110.262 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.742 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -54.0 -46.07 36.36 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.461 1.242 . . . . 0.0 109.373 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.954 HD11 ' HB ' ' A' ' 69' ' ' ILE . 11.7 tp -49.58 -49.46 46.48 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.264 -0.898 . . . . 0.0 109.749 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.565 ' SG ' HG22 ' A' ' 44' ' ' VAL . 1.2 t -61.33 -27.94 68.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 110.609 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 22.7 ttpt -81.01 -2.05 46.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 110.56 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 11.2 pt-20 -126.43 144.85 50.85 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.064 -1.023 . . . . 0.0 110.074 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.27 -8.65 12.91 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.785 1.413 . . . . 0.0 110.801 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -79.58 -18.0 52.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 110.668 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -45.08 -40.03 6.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.079 -1.013 . . . . 0.0 109.941 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.44 ' O ' ' CD ' ' A' ' 41' ' ' GLU . 93.7 mt-30 -66.01 -39.12 90.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -0.869 . . . . 0.0 109.979 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -80.5 -44.95 18.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.173 -0.954 . . . . 0.0 109.672 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.954 ' HB ' HD11 ' A' ' 60' ' ' LEU . 57.9 mt -63.73 -42.19 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.814 . . . . 0.0 109.899 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.77 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.2 tm? -52.34 -52.69 51.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.459 -0.776 . . . . 0.0 109.902 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.58 ' N ' HD13 ' A' ' 70' ' ' LEU . 46.0 tt0 -42.74 -53.53 4.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.095 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -59.11 -53.1 62.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 110.65 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.947 HD21 ' OD2' ' A' ' 5' ' ' ASP . 63.6 mt -50.58 -55.7 15.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.085 -1.009 . . . . 0.0 110.145 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.703 ' CD ' HD11 ' A' ' 70' ' ' LEU . 26.9 mt-10 -54.61 -50.74 67.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 110.442 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.26 -54.06 45.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.433 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.708 HG22 ' CD2' ' A' ' 12' ' ' LEU . 70.2 mt -61.65 -34.34 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.998 . . . . 0.0 109.735 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.725 ' HB1' ' HG2' ' A' ' 16' ' ' LYS . . . -57.07 -34.73 68.57 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.323 -0.861 . . . . 0.0 109.599 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HA ' ' H ' ' A' ' 36' ' ' ALA . 84.5 tt0 -60.31 -40.94 92.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 110.115 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -153.71 160.4 30.98 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.901 . . . . 0.0 110.259 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -60.39 -59.72 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.916 1.482 . . . . 0.0 110.544 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.11 -140.04 25.06 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 1.021 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 73.1 p -82.14 -21.94 36.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.272 -1.134 . . . . 0.0 110.163 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 4.6 t -55.8 -49.21 73.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.716 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 82.7 tt0 -59.54 -32.13 70.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.822 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.705 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.5 pt -99.3 10.51 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.99 -1.069 . . . . 0.0 110.328 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.7 m 56.96 16.5 2.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.88 . . . . 0.0 110.641 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 1.021 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -60.53 -18.8 54.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.965 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -140.37 177.82 7.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 110.182 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.81 1.53 12.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.871 . . . . 0.0 110.335 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -58.56 -40.86 84.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.658 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.553 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER -112.79 122.67 48.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.928 . . . . 0.0 110.81 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.918 HG21 ' OE1' ' A' ' 4' ' ' GLN . 25.6 p -105.18 176.25 5.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 110.262 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.42 -6.81 65.85 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.391 -1.064 . . . . 0.0 110.209 -179.921 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.847 HG23 ' SG ' ' A' ' 91' ' ' CYS . 10.6 p . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.211 0.529 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.527 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 30.7 m -90.09 148.03 23.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 110.802 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.114 ' CG2' HD21 ' A' ' 12' ' ' LEU . 22.9 t -97.06 118.53 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.581 -0.699 . . . . 0.0 109.435 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.639 ' NE2' HG23 ' A' ' 92' ' ' THR . 20.9 pt20 -120.56 177.47 5.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.081 -1.012 . . . . 0.0 110.936 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -151.45 -62.19 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.741 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.82 -115.81 0.74 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -108.21 13.2 26.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.227 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.521 ' CD1' ' OE2' ' A' ' 56' ' ' GLU . 97.9 m-85 -131.77 159.36 38.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.527 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 37.6 m -101.07 136.31 41.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.937 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.841 ' CG ' HD21 ' A' ' 57' ' ' LEU . 6.6 m-30 -112.69 123.23 49.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.654 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 m -66.33 160.11 25.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.114 HD21 ' CG2' ' A' ' 3' ' ' VAL . 99.5 mt -86.97 -27.33 23.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 110.735 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.422 ' OE2' ' O ' ' A' ' 25' ' ' GLN . 81.8 tt0 -61.56 -66.3 0.56 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 0.0 110.671 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.5 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.6 m -44.27 -48.71 9.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.977 -1.077 . . . . 0.0 110.151 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.613 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 58.5 t -59.05 -46.72 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.218 -0.926 . . . . 0.0 110.109 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 25.1 tttm -58.9 -52.43 65.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.806 -1.184 . . . . 0.0 108.562 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -80.65 11.98 3.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.35 -0.844 . . . . 0.0 109.368 178.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.785 HD21 HG21 ' A' ' 43' ' ' VAL . 59.1 tp -57.17 -37.08 71.59 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.416 -0.803 . . . . 0.0 110.097 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -60.75 -38.88 86.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 109.38 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -141.55 124.73 16.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.594 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.799 HD11 ' CB ' ' A' ' 52' ' ' ASN . 4.5 mm? -49.83 -48.26 51.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.616 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 23' ' ' GLU . 91.7 mt-30 46.4 56.39 6.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.154 -0.966 . . . . 0.0 109.915 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 22' ' ' GLN . 5.6 mp0 42.18 76.3 0.53 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 110.015 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.656 ' HG3' HD12 ' A' ' 21' ' ' LEU . 3.1 Cg_exo -61.58 135.92 59.8 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.938 1.494 . . . . 0.0 110.715 -179.708 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.469 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 60.9 tt0 -148.68 168.64 22.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.059 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.518 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 5.9 mt-10 -131.39 62.14 63.17 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.205 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -61.7 153.66 65.8 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.851 1.448 . . . . 0.0 110.419 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 11.9 ptp180 -99.23 137.87 37.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 0.0 110.075 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 28' ' ' ARG . 48.8 t 56.14 109.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.321 -0.862 . . . . 0.0 110.151 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.57 -168.43 32.35 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -64.85 149.9 48.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -1.103 . . . . 0.0 110.19 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.2 mt -68.57 155.95 38.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.95 . . . . 0.0 110.213 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.456 ' NH2' ' CG ' ' A' ' 33' ' ' ARG . 13.4 mmt-85 -99.32 128.73 45.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.11 -0.994 . . . . 0.0 110.403 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 44.9 p-10 -136.72 151.24 49.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.968 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.586 ' HB3' ' HG2' ' A' ' 78' ' ' GLU . 74.6 t80 -138.94 158.17 44.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.302 -0.874 . . . . 0.0 110.159 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.487 ' O ' HG12 ' A' ' 38' ' ' ILE . . . -59.7 129.65 87.64 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.236 -0.915 . . . . 0.0 110.537 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.99 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.8 Cg_endo -64.39 63.64 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.798 1.42 . . . . 0.0 110.569 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.99 HD13 ' C ' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -126.65 65.3 60.57 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.133 -0.979 . . . . 0.0 110.309 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.503 ' HD3' ' C ' ' A' ' 37' ' ' PRO . 2.9 Cg_endo -61.64 148.52 92.84 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.798 1.42 . . . . 0.0 110.494 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.531 ' N ' ' HG2' ' A' ' 71' ' ' GLN . . . 117.2 40.16 0.76 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -130.14 73.14 81.61 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.308 -1.113 . . . . 0.0 110.374 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -60.68 141.77 95.96 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.908 1.478 . . . . 0.0 110.146 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.785 HG21 HD21 ' A' ' 18' ' ' LEU . 24.0 m -140.51 54.83 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.667 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.69 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 17.1 m -135.2 47.86 2.53 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.583 179.311 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.69 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -60.19 -149.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.592 1.311 . . . . 0.0 110.372 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 46' ' ' ILE . 16.9 tt -59.35 117.21 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.149 -0.97 . . . . 0.0 109.993 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 48' ' ' CYS . 2.5 mm? 62.18 40.67 11.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 1.2 m 62.49 154.4 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 0.0 110.638 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.623 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -87.78 -58.34 2.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.415 -0.803 . . . . 0.0 110.228 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 20.8 m-80 -78.93 110.27 13.9 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.419 -0.801 . . . . 0.0 110.326 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.623 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -61.99 -11.39 21.28 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.721 1.379 . . . . 0.0 110.336 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.799 ' CB ' HD11 ' A' ' 21' ' ' LEU . 99.6 m-20 -130.52 34.23 4.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.842 . . . . 0.0 110.734 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.69 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.17 174.23 6.46 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.038 -1.039 . . . . 0.0 108.719 178.953 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.69 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.0 Cg_exo -56.36 76.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.624 1.329 . . . . 0.0 108.889 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.641 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.7 tt0 -39.07 -26.31 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.884 -0.51 . . . . 0.0 110.377 -178.068 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.521 ' OE2' ' CD1' ' A' ' 8' ' ' PHE . 39.3 tp10 -53.13 -20.76 4.09 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.931 -1.105 . . . . 0.0 108.174 178.145 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.841 HD21 ' CG ' ' A' ' 10' ' ' PHE . 82.2 mt -84.35 8.45 16.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.623 -0.673 . . . . 0.0 109.657 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.726 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.57 -51.49 4.98 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.73 -179.568 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.726 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -56.71 -44.31 46.47 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.632 1.333 . . . . 0.0 110.744 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.062 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 1.5 mt -60.63 -40.04 90.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.814 -1.179 . . . . 0.0 110.503 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.506 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 46.2 t -65.56 -28.14 68.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.034 -1.041 . . . . 0.0 110.697 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 46.2 tttm -90.75 6.69 43.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.639 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.508 ' OE2' ' HB2' ' A' ' 65' ' ' ASN . 12.7 pt-20 -130.84 144.61 54.21 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.959 -1.088 . . . . 0.0 110.4 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.22 -8.31 12.06 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.91 1.479 . . . . 0.0 110.797 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.508 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 83.9 m-20 -79.23 -23.79 43.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 110.194 -179.346 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.062 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -51.33 -36.3 42.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.083 -1.01 . . . . 0.0 109.685 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.8 mt-30 -61.65 -43.55 98.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.0 109.758 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -80.27 -41.17 25.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 109.609 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 60' ' ' LEU . 86.0 mt -64.24 -46.26 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 109.87 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.792 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.2 tm? -49.38 -53.86 20.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.946 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.614 ' N ' HD13 ' A' ' 70' ' ' LEU . 87.9 mt-30 -45.41 -53.9 8.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -57.79 -54.62 44.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 48.4 mt -44.98 -56.1 4.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.338 -0.851 . . . . 0.0 109.705 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.746 ' OE2' HD11 ' A' ' 70' ' ' LEU . 64.6 mt-10 -51.12 -53.6 32.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 110.154 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 78' ' ' GLU . 82.8 tt0 -55.23 -54.49 42.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 110.693 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 79' ' ' ASP . 24.7 mm -58.75 -37.52 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 109.81 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -57.21 -33.06 67.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.591 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.586 ' HG2' ' HB3' ' A' ' 35' ' ' PHE . 99.2 mt-10 -60.12 -41.92 93.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 110.52 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -147.83 159.54 40.37 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.93 . . . . 0.0 110.275 -179.797 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.571 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -59.77 -57.21 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.883 1.465 . . . . 0.0 110.65 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.02 -140.89 26.38 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.931 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 79.6 p -78.08 -21.51 50.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -1.116 . . . . 0.0 109.932 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.454 ' C ' ' SG ' ' A' ' 91' ' ' CYS . 42.0 t -54.52 -54.15 44.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 109.976 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.0 tt0 -55.77 -32.17 63.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 111.028 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.726 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.8 pt -96.92 10.89 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.922 -1.111 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 57.21 18.83 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.931 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -70.89 -7.59 46.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.997 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.594 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 53.1 t80 -147.06 167.64 23.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.37 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.01 4.94 5.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.386 -0.821 . . . . 0.0 110.5 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.594 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -65.36 -35.42 80.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.161 -0.962 . . . . 0.0 110.482 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.847 ' SG ' HG23 ' A' ' 1' ' ' VAL . 0.1 OUTLIER -96.53 120.48 36.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.705 -179.712 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.639 HG23 ' NE2' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -104.77 -5.39 21.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 110.577 -179.438 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . -83.76 -36.05 14.68 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.21 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 1' ' ' VAL . 18.5 m . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.243 0.544 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.615 HG21 ' OG ' ' A' ' 9' ' ' SER . 37.0 m -88.17 151.16 22.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.387 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.015 HG21 HD21 ' A' ' 12' ' ' LEU . 85.2 t -94.23 121.94 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.717 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.845 ' NE2' HG21 ' A' ' 92' ' ' THR . 10.4 mt-30 -109.64 139.06 45.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 110.815 -179.391 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -111.59 11.53 21.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 109.784 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.23 -131.38 1.87 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -88.5 8.44 28.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.141 -1.211 . . . . 0.0 110.191 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 92.0 m-85 -121.7 158.83 27.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.193 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.615 ' OG ' HG21 ' A' ' 2' ' ' THR . 22.4 t -105.43 123.41 47.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.363 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 17.6 m-30 -119.19 130.46 55.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.843 . . . . 0.0 110.51 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.4 m -78.62 172.73 13.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.021 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.015 HD21 HG21 ' A' ' 3' ' ' VAL . 53.0 mt -97.35 -5.29 36.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.0 110.636 -179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.3 mt-10 -74.29 -73.17 0.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.361 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' ' 13' ' ' GLU . 5.2 m -39.91 -51.43 2.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.677 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.737 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 27.4 m -63.93 -45.67 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.069 -1.019 . . . . 0.0 109.697 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 16.6 tttt -55.12 -56.89 14.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.88 -1.138 . . . . 0.0 109.063 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.466 ' HD3' ' HG2' ' A' ' 27' ' ' PRO . 67.5 mttm -80.22 8.31 7.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.818 . . . . 0.0 109.467 178.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.737 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 15.4 tp -54.57 -34.84 62.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.403 -0.811 . . . . 0.0 110.331 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -60.48 -41.55 94.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.993 . . . . 0.0 109.895 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.39 98.02 10.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.988 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' A' ' 52' ' ' ASN . 11.0 tp -70.01 -36.32 75.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.341 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 91.4 mt-30 -54.99 -168.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 110.211 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.538 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 26.2 mm-40 59.43 163.56 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.343 -0.848 . . . . 0.0 109.946 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 23' ' ' GLU . 3.3 Cg_exo -58.54 157.5 26.94 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.715 1.376 . . . . 0.0 110.62 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 94.8 mt-30 -68.02 -30.95 70.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.463 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.425 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 1.1 mp0 -131.12 68.17 81.46 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.336 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 24' ' ' PRO . 2.9 Cg_endo -63.18 158.82 42.16 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.913 1.48 . . . . 0.0 110.523 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.481 ' HB3' ' NH1' ' A' ' 28' ' ' ARG . 9.7 mmm180 -51.39 137.87 22.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 110.057 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.89 147.26 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.288 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.1 -175.07 48.08 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -64.3 -29.2 70.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -1.163 . . . . 0.0 110.278 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.3 mt -105.22 140.67 38.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.928 . . . . 0.0 110.461 -179.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.75 ' HE ' HD12 ' A' ' 12' ' ' LEU . 24.3 ptt-85 -130.56 106.05 8.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.355 -0.84 . . . . 0.0 109.594 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 41.9 p-10 -136.56 167.82 20.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.07 -1.019 . . . . 0.0 110.856 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.603 ' CE2' ' HG2' ' A' ' 37' ' ' PRO . 1.9 t80 -112.51 130.46 56.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.515 -0.741 . . . . 0.0 109.891 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.017 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . . . -64.77 -54.84 32.7 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 110.575 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.017 ' HD3' ' HB3' ' A' ' 36' ' ' ALA . 3.1 Cg_exo -62.46 -150.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.599 1.315 . . . . 0.0 110.769 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.924 HG23 ' HD2' ' A' ' 39' ' ' PRO . 1.3 mp -149.16 151.04 33.35 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.408 -0.807 . . . . 0.0 109.83 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.924 ' HD2' HG23 ' A' ' 38' ' ' ILE . 3.3 Cg_exo -57.48 161.65 11.53 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.737 1.388 . . . . 0.0 110.774 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.34 19.32 1.73 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 43' ' ' VAL . 36.4 mt-10 -104.3 117.47 59.22 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 110.06 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.23 101.02 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.658 1.346 . . . . 0.0 110.53 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.775 ' O ' HG12 ' A' ' 44' ' ' VAL . 90.7 t -132.12 172.33 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.906 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER 76.11 38.86 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 0.0 111.441 179.785 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.742 ' CD ' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -59.73 169.5 4.36 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 122.908 0.951 . . . . 0.0 110.191 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' PRO . 76.0 mt -44.06 -41.01 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.099 -1.001 . . . . 0.0 109.59 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 48' ' ' CYS . 49.6 mt -95.93 26.87 3.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 109.607 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.517 ' O ' ' O ' ' A' ' 47' ' ' LEU . 0.5 OUTLIER 53.64 162.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.503 -0.748 . . . . 0.0 110.113 -179.851 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.588 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 13.2 t -107.69 -70.7 0.79 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.944 . . . . 0.0 110.144 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.493 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 5.6 m-20 -79.2 111.51 20.89 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.591 -0.693 . . . . 0.0 110.092 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -64.45 -9.14 19.14 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.612 1.322 . . . . 0.0 110.114 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.592 ' HB2' HD11 ' A' ' 21' ' ' LEU . 96.8 m-20 -125.68 31.89 5.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.797 . . . . 0.0 110.218 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.746 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -79.85 178.02 2.59 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 108.803 179.09 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.746 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -57.86 75.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.493 1.26 . . . . 0.0 108.936 179.352 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.8 tt0 -39.28 -27.54 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.86 -0.525 . . . . 0.0 110.139 -178.577 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.0 mt-10 -52.21 -18.37 1.49 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.048 -1.032 . . . . 0.0 108.401 178.341 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.616 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 81.7 mt -88.8 9.95 22.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.637 -0.665 . . . . 0.0 109.571 179.092 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.751 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -39.63 -51.28 5.14 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 110.344 -179.854 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.751 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -54.87 -43.52 58.55 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.5 1.263 . . . . 0.0 109.666 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.056 HD11 HG21 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -53.42 -42.07 66.68 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.109 -0.994 . . . . 0.0 109.674 179.403 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.0 m -64.85 -28.05 69.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.131 -0.981 . . . . 0.0 110.335 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -90.66 2.55 55.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 111.434 -178.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.557 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 25.7 pt-20 -120.83 142.9 35.41 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.625 -1.297 . . . . 0.0 110.317 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -64.0 -18.29 63.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.91 1.479 . . . . 0.0 111.239 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -79.69 -12.3 59.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.985 -1.072 . . . . 0.0 110.344 -179.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.99 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.42 -41.16 19.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 110.461 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -56.68 -42.23 78.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 -179.611 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.4 mt-10 -79.92 -34.35 39.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.173 -0.955 . . . . 0.0 110.322 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.056 HG21 HD11 ' A' ' 60' ' ' LEU . 90.3 mt -68.96 -46.96 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.138 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.666 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.9 OUTLIER -47.69 -62.5 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.525 -179.787 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.666 ' N ' HD13 ' A' ' 70' ' ' LEU . 10.7 tt0 -49.62 -54.08 20.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.13 -0.981 . . . . 0.0 110.736 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 75.5 mtt-85 -52.7 -53.59 45.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.229 -0.919 . . . . 0.0 110.518 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.658 ' CD2' HG11 ' A' ' 15' ' ' VAL . 7.2 tp -51.09 -48.83 61.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.072 -1.017 . . . . 0.0 110.015 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 43.1 mt-10 -55.63 -41.13 73.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.376 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.566 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -66.24 -55.94 13.69 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.057 -1.027 . . . . 0.0 110.464 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 79' ' ' ASP . 22.2 mm -58.77 -40.77 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.336 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.785 ' HA ' HD22 ' A' ' 12' ' ' LEU . . . -62.76 -28.48 70.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.534 -0.729 . . . . 0.0 109.08 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 80.6 tt0 -65.36 -36.42 83.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.619 -0.676 . . . . 0.0 110.443 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.2 m-20 -149.14 158.04 39.1 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.824 -1.173 . . . . 0.0 110.524 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -61.72 -71.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.057 1.556 . . . . 0.0 110.653 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.89 -140.05 23.58 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.926 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 70.5 p -79.08 -24.32 43.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -1.168 . . . . 0.0 109.732 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 11.3 t -53.18 -53.55 48.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.2 tt0 -58.47 -32.19 68.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 111.057 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.761 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.1 pt -98.46 11.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.957 -1.09 . . . . 0.0 110.291 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 34.4 m 59.39 12.12 2.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.177 -0.952 . . . . 0.0 110.514 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.926 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -64.89 -16.18 62.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 109.997 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.54 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 41.8 t80 -137.17 166.57 23.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 110.188 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.85 2.88 7.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 110.289 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.54 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -62.35 -38.8 90.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 0.0 110.433 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.7 OUTLIER -104.11 118.25 36.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 110.636 -179.663 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.845 HG21 ' NE2' ' A' ' 4' ' ' GLN . 72.8 p -103.13 166.55 10.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.376 -0.827 . . . . 0.0 110.069 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.16 -5.08 78.27 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.303 -1.116 . . . . 0.0 110.213 179.988 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.284 0.564 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.969 HG21 ' OG ' ' A' ' 9' ' ' SER . 7.2 t -129.21 168.49 16.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.375 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -93.01 114.83 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.647 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.628 ' OE1' HG21 ' A' ' 92' ' ' THR . 61.2 tt0 -110.7 121.02 44.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.952 -179.216 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.752 ' OD2' HD21 ' A' ' 60' ' ' LEU . 58.4 p30 -99.92 3.64 44.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.362 -0.836 . . . . 0.0 109.325 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . -172.53 -142.56 3.82 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -82.1 1.42 36.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.2 -1.176 . . . . 0.0 110.498 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.482 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 98.6 m-85 -109.19 134.43 51.75 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.621 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.969 ' OG ' HG21 ' A' ' 2' ' ' THR . 1.0 OUTLIER -85.47 126.55 33.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.355 -0.841 . . . . 0.0 109.981 179.779 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.521 ' O ' ' OG1' ' A' ' 2' ' ' THR . 21.7 m-30 -117.7 127.21 53.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.023 -1.048 . . . . 0.0 110.777 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.444 ' C ' HD12 ' A' ' 12' ' ' LEU . 59.9 p -76.7 172.89 12.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.314 -0.866 . . . . 0.0 110.339 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.866 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 mp -100.64 -6.34 25.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.309 -0.869 . . . . 0.0 110.61 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.464 ' OE1' ' CG ' ' A' ' 26' ' ' GLU . 92.2 mt-10 -71.72 -73.89 0.17 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 0.0 110.82 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.3 m -43.5 -49.19 7.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.182 -0.949 . . . . 0.0 110.581 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.667 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 6.0 m -59.02 -46.41 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.555 ' CD ' ' HB3' ' A' ' 33' ' ' ARG . 23.0 tttt -58.15 -55.02 40.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.876 -1.14 . . . . 0.0 108.844 179.02 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.504 ' O ' ' O ' ' A' ' 20' ' ' ASP . 95.6 mttt -80.49 11.48 3.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 178.651 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.794 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.7 tt -58.73 -29.72 66.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 110.183 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -65.48 -34.91 79.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.182 -0.949 . . . . 0.0 110.144 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' A' ' 17' ' ' LYS . 60.6 t0 -133.82 141.71 47.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 110.147 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.599 HD11 ' CB ' ' A' ' 52' ' ' ASN . 1.9 mm? -85.98 138.73 31.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.041 -1.037 . . . . 0.0 110.569 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.44 ' OE1' ' HD3' ' A' ' 17' ' ' LYS . 88.4 mt-30 -132.67 172.29 12.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.023 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 25' ' ' GLN . 3.3 mt-10 -42.64 136.58 2.52 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.187 -0.946 . . . . 0.0 110.02 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.74 60.24 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.799 1.42 . . . . 0.0 110.602 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 23' ' ' GLU . 91.5 mt-30 -126.94 139.16 53.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.992 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' CG ' ' OE1' ' A' ' 13' ' ' GLU . 1.8 mp0 -130.7 71.71 82.22 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.418 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.82 145.72 96.98 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.904 1.476 . . . . 0.0 110.396 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -111.47 128.14 55.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.137 -0.977 . . . . 0.0 110.259 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.61 HG13 ' H ' ' A' ' 32' ' ' LEU . 11.8 p -138.0 144.19 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.323 -0.861 . . . . 0.0 110.166 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.37 -29.5 30.69 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.48 ' H ' HG22 ' A' ' 29' ' ' VAL . 19.7 tttt -69.72 -21.81 63.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -1.171 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.61 ' H ' HG13 ' A' ' 29' ' ' VAL . 70.3 mt 56.52 -155.17 0.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.323 -0.861 . . . . 0.0 110.291 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.555 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 32.4 mtt-85 -119.74 131.05 55.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 50.3 t30 -142.39 110.32 5.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 110.197 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.513 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 72.3 t80 -125.12 164.13 20.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -0.927 . . . . 0.0 110.251 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.635 ' O ' HG13 ' A' ' 38' ' ' ILE . . . -59.68 122.13 62.66 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.074 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.522 ' C ' ' HD3' ' A' ' 39' ' ' PRO . 2.6 Cg_endo -68.32 88.15 0.4 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.769 1.405 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.641 ' H ' HD12 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -121.49 69.49 22.87 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.3 -0.875 . . . . 0.0 110.349 179.396 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.522 ' HD3' ' C ' ' A' ' 37' ' ' PRO . 3.0 Cg_exo -60.27 145.72 97.97 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.764 1.402 . . . . 0.0 110.552 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.47 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 162.54 37.45 0.02 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 43' ' ' VAL . 1.2 mm-40 -123.86 72.21 52.7 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.236 -1.155 . . . . 0.0 110.211 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.52 75.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.888 1.467 . . . . 0.0 110.379 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.859 ' O ' HG23 ' A' ' 44' ' ' VAL . 88.8 t -120.67 127.39 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.962 . . . . 0.0 110.29 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.021 HG21 ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER 167.06 -52.47 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.409 -0.807 . . . . 0.0 110.158 179.841 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 44' ' ' VAL . 3.2 Cg_exo -60.7 -42.4 39.4 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.512 1.27 . . . . 0.0 110.36 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' A' ' 47' ' ' LEU . 73.8 mt -58.99 -65.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 109.706 179.583 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.538 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.9 OUTLIER 164.34 70.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.418 -0.801 . . . . 0.0 110.004 179.684 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.512 ' O ' ' O ' ' A' ' 47' ' ' LEU . 86.2 m 34.87 95.57 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.477 -0.765 . . . . 0.0 110.505 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.546 ' OG ' ' CG1' ' A' ' 43' ' ' VAL . 44.1 m -51.74 -62.8 1.4 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.263 -0.898 . . . . 0.0 111.083 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 3.9 m-20 -80.32 114.18 45.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.564 -179.362 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.8 0.84 1.73 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.806 1.424 . . . . 0.0 110.596 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.599 ' CB ' HD11 ' A' ' 21' ' ' LEU . 27.0 m120 -133.67 31.78 3.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.095 -1.003 . . . . 0.0 110.692 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.855 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 10.5 p90 -76.8 -177.23 0.73 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.039 -1.038 . . . . 0.0 108.772 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.071 ' HB2' HD13 ' A' ' 57' ' ' LEU . 5.0 Cg_exo -54.93 75.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.518 1.273 . . . . 0.0 110.108 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.628 ' N ' ' O ' ' A' ' 53' ' ' PHE . 84.7 tt0 -44.95 -33.87 2.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.571 -0.705 . . . . 0.0 110.032 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.589 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.3 mt-10 -54.39 -18.79 4.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.015 -1.053 . . . . 0.0 108.52 178.66 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.071 HD13 ' HB2' ' A' ' 54' ' ' PRO . 7.8 mp -97.5 9.2 43.04 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.931 0.872 . . . . 0.0 109.009 178.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.792 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -43.74 -49.35 19.97 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.685 -0.634 . . . . 0.0 109.934 179.556 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.792 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.86 -42.74 64.01 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.436 1.229 . . . . 0.0 109.73 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.1 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 10.7 mp -55.74 -40.74 72.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.051 -1.031 . . . . 0.0 109.129 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.656 ' HA ' HG22 ' A' ' 44' ' ' VAL . 41.4 t -64.3 -26.0 68.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 110.166 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.501 ' CE ' ' HD2' ' A' ' 58' ' ' LYS . 29.6 mttt -88.09 -4.96 58.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.88 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.528 ' CG ' ' HA ' ' A' ' 60' ' ' LEU . 9.1 pt-20 -113.1 147.69 37.84 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.012 -1.055 . . . . 0.0 110.337 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.9 -17.81 61.33 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.953 1.501 . . . . 0.0 111.034 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.484 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 74.5 m-20 -79.71 -13.73 59.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.085 -1.009 . . . . 0.0 110.59 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.1 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.93 -40.24 13.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 110.097 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -57.36 -40.79 78.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 110.061 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.3 -34.9 36.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.915 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.555 HG21 ' CD2' ' A' ' 60' ' ' LEU . 78.0 mt -72.64 -54.39 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 109.864 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -44.64 -60.15 2.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.87 . . . . 0.0 110.155 179.864 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.792 ' N ' HD13 ' A' ' 70' ' ' LEU . 94.2 mt-30 -51.65 -52.88 44.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.088 -1.007 . . . . 0.0 110.049 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -55.29 -56.45 19.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.823 . . . . 0.0 109.955 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.603 ' CD2' HG11 ' A' ' 3' ' ' VAL . 54.0 mt -47.45 -51.04 21.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.143 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 75.6 mm-40 -56.76 -38.39 72.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.859 . . . . 0.0 110.467 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.504 ' HG3' ' HB3' ' A' ' 37' ' ' PRO . 82.7 tt0 -70.67 -54.04 13.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.164 -0.96 . . . . 0.0 110.297 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.551 HG21 ' CG2' ' A' ' 3' ' ' VAL . 57.8 mt -65.35 -31.03 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.821 ' HA ' HD23 ' A' ' 12' ' ' LEU . . . -67.12 -34.85 78.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.403 -0.811 . . . . 0.0 109.503 179.501 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 35' ' ' PHE . 97.1 mt-10 -94.18 16.07 15.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.474 -0.766 . . . . 0.0 109.78 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.413 ' OD1' ' HD2' ' A' ' 80' ' ' PRO . 9.8 t0 -169.51 127.74 0.85 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.48 -0.763 . . . . 0.0 110.152 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD2' ' OD1' ' A' ' 79' ' ' ASP . 3.0 Cg_endo -61.66 -74.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.74 1.39 . . . . 0.0 110.749 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.68 -141.65 24.78 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.864 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 58.5 p -79.32 -22.87 43.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -1.197 . . . . 0.0 109.954 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 9.3 t -53.73 -52.17 60.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' OE1' ' CB ' ' A' ' 80' ' ' PRO . 83.6 tt0 -58.78 -32.32 69.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.88 . . . . 0.0 111.102 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.73 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.3 pt -96.59 11.73 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.933 -1.104 . . . . 0.0 110.458 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 58.56 13.6 2.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.58 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.864 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.7 -14.62 63.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.181 -0.949 . . . . 0.0 109.912 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.48 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 5.9 m-85 -137.83 165.99 25.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 0.0 110.331 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.14 3.57 5.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.338 -0.851 . . . . 0.0 110.283 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -63.05 -39.87 96.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.925 . . . . 0.0 110.392 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER -103.61 118.73 37.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.548 -179.7 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.628 HG21 ' OE1' ' A' ' 4' ' ' GLN . 6.5 m -112.08 6.25 19.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.375 -0.828 . . . . 0.0 110.3 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.03 -56.56 5.23 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.274 -1.133 . . . . 0.0 110.311 179.955 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.606 HG12 ' SG ' ' A' ' 91' ' ' CYS . 3.2 t . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.165 0.507 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.827 HG21 ' HB3' ' A' ' 9' ' ' SER . 12.8 t -126.56 155.79 41.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.851 HG22 ' SG ' ' A' ' 83' ' ' CYS . 53.0 t -95.9 122.77 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.552 -0.717 . . . . 0.0 109.163 179.005 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.92 ' CD ' HG21 ' A' ' 92' ' ' THR . 9.6 pt20 -129.22 -178.71 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.058 . . . . 0.0 111.548 -178.716 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 4' ' ' GLN . 93.1 m-20 -137.74 -60.3 0.65 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.526 0.679 . . . . 0.0 109.464 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.29 -143.76 15.19 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.581 ' OD1' ' CE2' ' A' ' 8' ' ' PHE . 16.2 p30 -81.08 8.58 8.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.028 -1.278 . . . . 0.0 110.334 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.581 ' CE2' ' OD1' ' A' ' 7' ' ' ASN . 83.6 m-85 -112.91 139.07 48.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -0.973 . . . . 0.0 110.383 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.827 ' HB3' HG21 ' A' ' 2' ' ' THR . 50.9 m -101.9 139.06 38.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.334 -0.854 . . . . 0.0 110.627 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.595 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 20.4 m-85 -124.28 134.4 53.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 110.402 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.0 p -75.11 170.89 15.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.239 -0.913 . . . . 0.0 110.177 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.733 HD21 HG21 ' A' ' 3' ' ' VAL . 9.3 mt -104.58 -2.28 25.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.217 -0.927 . . . . 0.0 110.524 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.59 ' HG2' ' CD ' ' A' ' 33' ' ' ARG . 36.7 mt-10 -64.23 -71.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 0.0 110.548 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.633 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.5 OUTLIER -57.14 -38.79 74.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.39 -0.819 . . . . 0.0 111.344 -179.12 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.726 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 13.0 t -61.55 -49.92 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.844 -1.16 . . . . 0.0 109.46 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.518 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 17.0 mttt -56.87 -55.05 39.37 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.816 -1.178 . . . . 0.0 108.864 178.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.71 10.96 4.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.018 178.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.925 HD23 ' OE2' ' A' ' 74' ' ' GLU . 13.1 tp -75.09 -10.37 59.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.088 -1.007 . . . . 0.0 109.893 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE3' HG13 ' A' ' 38' ' ' ILE . 71.5 tttt -63.58 -32.48 73.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 0.0 109.391 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -126.49 122.77 36.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.48 -0.762 . . . . 0.0 109.633 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.838 HD11 ' HB2' ' A' ' 52' ' ' ASN . 1.1 tm? -105.01 114.31 28.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.202 -0.936 . . . . 0.0 110.639 -179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.543 ' N ' HD13 ' A' ' 21' ' ' LEU . 1.7 tt0 175.7 159.95 0.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 110.298 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 2.2 mt-10 54.87 177.45 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.167 -0.958 . . . . 0.0 110.199 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 23' ' ' GLU . 3.2 Cg_exo -60.65 163.8 14.87 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.885 1.466 . . . . 0.0 110.56 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 26' ' ' GLU . 21.5 pt20 -124.89 163.77 21.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.484 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.663 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER 63.64 52.43 1.43 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 110.638 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.663 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -61.64 155.14 55.36 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.797 1.42 . . . . 0.0 110.283 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -84.07 81.89 8.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 110.063 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.754 HG12 ' H ' ' A' ' 31' ' ' LYS . 23.5 t -119.51 136.6 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.341 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.69 -4.65 89.42 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.754 ' H ' HG12 ' A' ' 29' ' ' VAL . 20.4 tttt -68.35 146.19 53.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -1.142 . . . . 0.0 110.087 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.9 mt -75.64 137.48 40.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.203 -0.936 . . . . 0.0 110.26 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.59 ' CD ' ' HG2' ' A' ' 13' ' ' GLU . 69.6 mtm180 -72.09 135.75 46.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.26 -0.9 . . . . 0.0 110.293 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.443 ' OD1' ' HD3' ' A' ' 80' ' ' PRO . 3.3 m-20 179.79 54.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.887 . . . . 0.0 110.055 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.645 ' O ' ' HD3' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -97.9 130.27 44.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.065 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.685 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . . . -80.08 110.45 16.28 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.355 -0.841 . . . . 0.0 110.177 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.762 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.8 Cg_endo -68.57 -157.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.702 1.369 . . . . 0.0 110.607 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.762 HD13 ' O ' ' A' ' 37' ' ' PRO . 38.1 mm -129.06 77.23 78.18 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 109.966 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 3.0 Cg_exo -61.85 145.24 97.19 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.941 1.495 . . . . 0.0 110.757 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.1 10.7 55.88 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.1 mt-10 -94.56 151.18 39.05 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.184 -1.186 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -60.79 111.51 1.07 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.876 1.461 . . . . 0.0 110.211 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.86 HG12 HG23 ' A' ' 44' ' ' VAL . 78.4 t -133.79 152.82 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 110.736 -179.656 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.86 HG23 HG12 ' A' ' 43' ' ' VAL . 74.3 t 57.89 57.44 7.04 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.529 -0.732 . . . . 0.0 111.275 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -61.87 -23.74 76.35 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 N-CA-C 108.819 -1.262 . . . . 0.0 108.819 178.676 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.653 HG23 ' HG ' ' A' ' 47' ' ' LEU . 16.6 tt -157.57 -29.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.142 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.653 ' HG ' HG23 ' A' ' 46' ' ' ILE . 77.6 mt -144.0 -114.38 0.1 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.486 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 55.6 m -113.34 127.54 56.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.709 -1.245 . . . . 0.0 109.653 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 38.6 m -60.72 -63.8 1.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.938 . . . . 0.0 110.751 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.567 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 1.0 OUTLIER -72.29 113.42 20.55 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 110.512 -179.69 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -62.45 -13.02 30.55 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.636 1.335 . . . . 0.0 110.639 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.838 ' HB2' HD11 ' A' ' 21' ' ' LEU . 87.3 m-20 -128.19 34.02 4.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 110.109 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.718 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.04 -178.63 1.17 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.794 . . . . 0.0 109.249 179.549 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.729 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.8 Cg_exo -61.47 75.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 N-CA-C 108.655 -1.325 . . . . 0.0 108.655 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.613 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.2 tt0 -39.07 -27.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.764 -0.585 . . . . 0.0 110.118 -178.379 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 54' ' ' PRO . 71.9 mm-40 -53.35 -17.92 2.19 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.977 -1.077 . . . . 0.0 108.614 178.185 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.729 HD12 ' HG2' ' A' ' 54' ' ' PRO . 87.3 mt -92.06 6.53 46.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.692 . . . . 0.0 109.696 179.147 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.751 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.68 -51.4 5.2 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 110.452 -179.722 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.751 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -54.04 -42.42 67.07 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.34 1.179 . . . . 0.0 109.67 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.011 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -54.99 -42.83 72.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.088 -1.007 . . . . 0.0 109.816 179.46 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.1 m -68.84 -29.75 68.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.222 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 62' ' ' LYS . 51.6 tptt -79.93 -4.33 51.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.434 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.533 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 6.7 pt-20 -114.04 142.45 27.93 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 110.108 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -61.58 -17.22 52.9 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.873 1.459 . . . . 0.0 111.099 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.506 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 70.1 m-20 -79.9 -7.9 59.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.005 . . . . 0.0 110.33 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.011 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -50.42 -37.62 38.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 110.06 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.01 -39.0 93.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.211 -0.931 . . . . 0.0 110.142 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -80.17 -39.01 30.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.986 HG21 ' CD1' ' A' ' 60' ' ' LEU . 76.7 mt -68.06 -42.81 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.35 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.906 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -50.73 -59.21 4.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -0.768 . . . . 0.0 110.169 179.861 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.906 ' N ' HD13 ' A' ' 70' ' ' LEU . 52.7 tt0 -50.5 -55.77 14.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 110.355 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 73' ' ' LEU . 50.5 mtt180 -55.06 -62.97 1.31 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 0.0 110.431 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 72' ' ' ARG . 13.1 tp -41.73 -50.29 4.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.957 . . . . 0.0 109.992 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.925 ' OE2' HD23 ' A' ' 18' ' ' LEU . 63.0 mm-40 -55.3 -46.45 76.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 110.318 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -54.89 -53.12 59.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.088 -1.008 . . . . 0.0 110.37 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' ' 79' ' ' ASP . 26.0 mm -59.11 -35.0 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.104 -0.997 . . . . 0.0 109.404 179.661 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.725 ' HB2' HG12 ' A' ' 15' ' ' VAL . . . -59.59 -30.49 68.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.559 -0.713 . . . . 0.0 109.527 179.169 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.685 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 84.6 tt0 -62.0 -40.6 96.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 110.41 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 2.5 p30 -148.97 159.52 37.24 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.099 -1.001 . . . . 0.0 110.482 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.577 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -62.63 -60.83 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.988 1.52 . . . . 0.0 110.494 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.02 -141.33 24.1 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 61.5 p -83.11 -18.3 40.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -1.141 . . . . 0.0 109.775 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.851 ' SG ' HG22 ' A' ' 3' ' ' VAL . 11.0 t -58.53 -53.35 59.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 0.0 110.047 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 48.1 tp10 -59.61 -23.98 63.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 111.081 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.784 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.3 pt -105.42 17.26 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.0 -1.062 . . . . 0.0 110.366 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.0 m 49.95 19.36 0.45 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.893 . . . . 0.0 110.65 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.983 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.04 -13.47 58.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.035 -1.04 . . . . 0.0 110.005 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -148.24 179.96 7.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.321 -0.862 . . . . 0.0 110.044 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.24 1.68 20.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 110.003 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -58.41 -39.97 81.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.332 -0.855 . . . . 0.0 110.415 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.606 ' SG ' HG12 ' A' ' 1' ' ' VAL . 0.5 OUTLIER -108.05 129.43 55.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.533 -179.653 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.92 HG21 ' CD ' ' A' ' 4' ' ' GLN . 19.5 p -109.81 159.81 16.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.378 -0.826 . . . . 0.0 110.146 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.67 -12.77 61.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.278 -1.131 . . . . 0.0 110.228 179.994 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.483 ' CG1' ' SG ' ' A' ' 91' ' ' CYS . 79.0 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.172 0.511 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.472 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 60.8 m -132.45 150.04 52.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.843 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.812 ' HB ' HD21 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -92.98 119.39 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 109.419 179.379 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.747 ' CD ' HG21 ' A' ' 92' ' ' THR . 17.6 pt20 -116.27 148.29 40.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.079 -1.013 . . . . 0.0 110.933 -179.164 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -96.14 -74.85 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.76 . . . . 0.0 109.478 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.53 -121.12 4.67 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.452 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -85.62 14.48 5.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -1.14 . . . . 0.0 110.15 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.692 ' CE1' ' CE1' ' A' ' 10' ' ' PHE . 25.8 t80 -125.89 148.66 49.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.39 -0.819 . . . . 0.0 110.015 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.56 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 12.5 t -107.26 137.74 44.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.17 -0.956 . . . . 0.0 110.724 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.692 ' CE1' ' CE1' ' A' ' 8' ' ' PHE . 84.9 m-85 -119.56 132.1 55.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.19 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -67.14 164.2 18.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.088 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.812 HD21 ' HB ' ' A' ' 3' ' ' VAL . 54.1 mt -101.44 -5.19 25.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.982 . . . . 0.0 110.432 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.548 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 83.1 tt0 -69.04 -73.02 0.16 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.426 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.4 m -42.36 -55.3 3.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.032 -1.043 . . . . 0.0 110.545 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.698 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 15.8 m -51.81 -43.95 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.091 -1.006 . . . . 0.0 110.083 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 37.3 tttm -56.26 -58.75 6.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.832 -1.168 . . . . 0.0 108.644 178.701 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 75.1 mmtt -80.62 17.78 1.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.353 -0.842 . . . . 0.0 109.57 178.528 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 2.1 tt -65.77 -41.16 92.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.198 -0.939 . . . . 0.0 110.012 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 85.0 tttt -53.16 -41.99 65.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 110.287 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -140.26 80.33 1.75 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.19 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 52' ' ' ASN . 6.6 tt -104.35 130.14 52.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.591 ' O ' HD23 ' A' ' 21' ' ' LEU . 56.7 mt-30 -102.93 -175.29 2.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.151 -0.968 . . . . 0.0 110.612 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.666 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -43.64 -53.53 12.04 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 110.666 179.938 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 3.2 Cg_exo -59.3 139.51 90.27 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.625 1.329 . . . . 0.0 110.524 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -57.3 -37.15 72.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 110.528 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HG3' ' OE2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -164.03 101.52 0.91 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 110.552 -179.896 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.06 -24.61 76.77 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.711 1.374 . . . . 0.0 110.448 179.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.435 ' O ' ' OE1' ' A' ' 26' ' ' GLU . 64.6 mtt180 -128.11 141.52 51.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.137 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.0 t -127.25 141.41 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.111 -0.993 . . . . 0.0 110.21 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.27 155.46 22.48 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -59.0 -46.98 86.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -1.165 . . . . 0.0 110.231 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 32' ' ' LEU . 15.0 tp -124.34 137.44 54.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.229 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.548 ' HD2' ' HA ' ' A' ' 13' ' ' GLU . 82.9 mtm-85 -91.14 113.09 25.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.266 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 63.7 m-20 -140.35 6.34 2.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 110.57 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.495 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 97.6 m-85 -103.29 37.96 1.88 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.299 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.477 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . . . -48.73 152.25 1.8 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 110.114 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.565 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 2.7 Cg_endo -65.61 3.84 1.01 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.819 1.431 . . . . 0.0 110.932 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.565 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 2.0 mt 72.81 135.26 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.265 -0.897 . . . . 0.0 110.166 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.58 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 2.9 Cg_endo -63.53 172.04 6.05 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.871 1.459 . . . . 0.0 110.53 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.0 17.84 42.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.533 ' CG ' ' OE1' ' A' ' 74' ' ' GLU . 7.9 pt-20 -135.59 79.3 47.77 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.214 -1.168 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HB3' ' HG3' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -61.17 131.59 37.42 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.862 1.454 . . . . 0.0 110.387 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 43' ' ' VAL . 27.0 m -120.06 53.18 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 110.435 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.017 HG21 ' HA ' ' A' ' 61' ' ' CYS . 7.4 p -163.9 53.94 0.38 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 110.696 179.553 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -61.39 -35.81 81.52 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.71 1.374 . . . . 0.0 109.747 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' A' ' 47' ' ' LEU . 17.1 pt -133.51 -25.09 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.509 -0.745 . . . . 0.0 110.246 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 48' ' ' CYS . 1.0 OUTLIER 174.02 90.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.975 . . . . 0.0 110.442 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.753 ' H ' HG23 ' A' ' 44' ' ' VAL . 73.5 m 39.24 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.458 -0.776 . . . . 0.0 110.603 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.549 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.6 m -54.07 -50.76 66.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 110.144 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.487 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 2.7 m120 -71.45 112.22 13.05 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.785 . . . . 0.0 110.615 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -63.08 -10.52 21.02 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.694 1.365 . . . . 0.0 110.118 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.802 ' O ' HD13 ' A' ' 21' ' ' LEU . 84.4 m-20 -130.21 33.92 4.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.379 -0.826 . . . . 0.0 110.461 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.689 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -79.09 179.64 1.72 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 108.719 179.082 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.82 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.6 Cg_exo -58.35 74.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.512 1.269 . . . . 0.0 109.184 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 53' ' ' PHE . 82.9 tt0 -39.5 -26.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.668 -0.645 . . . . 0.0 110.349 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.8 mt-10 -56.83 -15.7 5.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.023 -1.048 . . . . 0.0 108.619 178.484 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.82 HD12 ' HG2' ' A' ' 54' ' ' PRO . 78.4 mt -92.09 14.17 16.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.646 -0.659 . . . . 0.0 109.609 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.751 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.84 -49.49 5.68 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 110.085 179.818 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.751 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.3 Cg_exo -56.51 -47.67 22.78 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.444 1.233 . . . . 0.0 109.573 179.147 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.124 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 12.0 tp -46.55 -52.65 12.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.727 179.428 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 1.017 ' HA ' HG21 ' A' ' 44' ' ' VAL . 85.0 m -67.01 -30.47 70.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 110.55 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 51.2 tttm -79.94 3.44 19.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 110.616 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.518 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 8.2 pt-20 -127.9 144.05 49.97 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.984 -1.072 . . . . 0.0 110.124 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.39 -17.22 56.45 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.805 1.424 . . . . 0.0 110.853 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.495 ' O ' HG13 ' A' ' 69' ' ' ILE . 22.6 m120 -79.88 -9.49 59.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 110.417 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.124 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.92 -42.37 27.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.013 . . . . 0.0 109.806 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.471 ' HG3' ' HB3' ' A' ' 42' ' ' PRO . 64.0 tt0 -59.62 -43.37 93.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.537 -0.727 . . . . 0.0 110.37 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.26 -39.74 32.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 109.974 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.915 ' HB ' HD11 ' A' ' 60' ' ' LEU . 68.7 mt -67.48 -47.84 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.629 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.806 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.4 tm? -50.54 -55.6 15.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 110.014 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.792 ' N ' HD13 ' A' ' 70' ' ' LEU . 52.2 tt0 -47.27 -52.18 16.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 110.186 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -54.73 -51.48 65.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 0.0 110.086 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 53.0 mt -53.52 -52.16 60.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 0.0 110.054 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.757 ' OE2' HD11 ' A' ' 70' ' ' LEU . 73.2 mt-10 -55.29 -37.9 67.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.873 . . . . 0.0 110.511 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.523 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 82.1 tt0 -65.31 -53.58 41.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.985 . . . . 0.0 110.926 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.646 HG21 ' CG2' ' A' ' 3' ' ' VAL . 20.6 mm -61.35 -39.13 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.594 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.06 -26.92 68.55 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.491 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.9 tt0 -66.3 -35.12 79.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.507 -0.746 . . . . 0.0 111.063 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.11 96.14 1.23 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.809 -1.182 . . . . 0.0 111.041 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.637 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 2.7 Cg_endo -67.82 44.71 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.757 1.398 . . . . 0.0 110.483 179.314 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.52 -74.38 0.3 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.991 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 74.3 p -69.37 -58.81 3.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -1.123 . . . . 0.0 110.296 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -39.16 -46.9 1.52 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 110.495 -179.586 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 80' ' ' PRO . 81.8 tt0 -63.75 -25.1 68.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.043 . . . . 0.0 110.527 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 82' ' ' THR . 26.5 pt -107.23 18.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.268 -179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.19 15.66 4.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.519 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.991 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -59.75 -23.89 63.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 109.935 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -141.75 169.23 17.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.59 5.16 11.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 110.322 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.11 -43.26 95.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.934 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -94.67 133.61 38.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.193 -0.942 . . . . 0.0 110.389 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.747 HG21 ' CD ' ' A' ' 4' ' ' GLN . 42.3 p -116.16 154.39 30.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.318 -0.864 . . . . 0.0 110.144 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 101.99 -9.02 56.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.44 -1.035 . . . . 0.0 110.386 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.826 HG22 ' SG ' ' A' ' 91' ' ' CYS . 7.8 p . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.313 0.577 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 53.5 m -127.08 155.59 43.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.95 . . . . 0.0 110.676 -179.544 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.003 ' CG2' HD21 ' A' ' 12' ' ' LEU . 4.0 t -91.13 117.17 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.497 179.389 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 8' ' ' PHE . 4.1 pt20 -126.87 175.18 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.073 -1.017 . . . . 0.0 111.201 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.743 ' OD2' HG23 ' A' ' 69' ' ' ILE . 96.8 m-20 -136.94 -58.38 0.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.573 0.702 . . . . 0.0 109.5 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.37 -140.18 11.28 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.587 ' OD1' ' CD2' ' A' ' 8' ' ' PHE . 13.9 p30 -79.65 2.04 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.164 -1.198 . . . . 0.0 110.266 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.587 ' CD2' ' OD1' ' A' ' 7' ' ' ASN . 77.9 m-85 -110.71 152.77 26.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.505 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 49.0 m -112.0 136.99 50.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 0.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.753 ' CG ' HD21 ' A' ' 57' ' ' LEU . 11.2 m-85 -117.16 127.79 54.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.264 -0.897 . . . . 0.0 110.285 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.504 ' HA ' HG23 ' A' ' 2' ' ' THR . 30.5 m -72.22 164.67 25.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.352 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.003 HD21 ' CG2' ' A' ' 3' ' ' VAL . 83.9 mt -85.24 -24.29 27.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.942 . . . . 0.0 110.431 -179.753 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 14' ' ' SER . 86.0 tt0 -64.18 -69.16 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.308 -0.87 . . . . 0.0 110.372 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.1 m -43.82 -51.41 7.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.125 -0.984 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.669 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 54.4 t -59.16 -49.03 84.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.228 -0.92 . . . . 0.0 109.327 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' HD2' ' HD3' ' A' ' 37' ' ' PRO . 4.0 tptm -53.21 -56.45 16.35 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.523 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 20' ' ' ASP . 57.6 mttt -80.85 13.75 2.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.573 -0.704 . . . . 0.0 110.076 178.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.669 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.1 tt -65.65 -47.36 75.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.987 . . . . 0.0 110.297 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.34 -47.17 86.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -0.962 . . . . 0.0 109.834 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 17' ' ' LYS . 83.9 m-20 -103.2 122.5 44.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 109.787 179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.883 HD11 ' HB2' ' A' ' 52' ' ' ASN . 18.9 tp -100.79 132.09 46.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.744 -179.604 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.501 ' O ' ' C ' ' A' ' 23' ' ' GLU . 13.9 pt20 -140.69 174.39 10.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.385 -0.822 . . . . 0.0 109.754 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' C ' ' O ' ' A' ' 22' ' ' GLN . 0.2 OUTLIER -36.58 97.92 0.14 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.865 . . . . 0.0 110.145 179.985 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.495 ' N ' ' O ' ' A' ' 22' ' ' GLN . 3.0 Cg_exo -62.25 138.44 71.91 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.97 1.511 . . . . 0.0 110.856 -179.594 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.452 ' HG3' ' C ' ' A' ' 24' ' ' PRO . 95.7 mt-30 -150.16 -49.87 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.423 -0.798 . . . . 0.0 109.886 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.627 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 1.7 tt0 46.03 54.76 14.67 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.78 . . . . 0.0 110.846 179.722 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -61.93 -50.9 4.38 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.723 1.38 . . . . 0.0 110.19 179.572 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HG3' ' C ' ' A' ' 27' ' ' PRO . 48.4 mtt-85 -151.9 172.32 16.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.537 -0.727 . . . . 0.0 110.011 179.829 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.1 t -54.35 128.81 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.121 -0.987 . . . . 0.0 110.082 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.81 109.48 2.86 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -62.87 -31.18 72.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -1.147 . . . . 0.0 110.139 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 46.1 mt -98.71 133.47 43.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 110.317 -179.722 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 29.5 ptt-85 -176.98 54.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.475 -0.765 . . . . 0.0 109.66 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.643 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 28.3 m-20 -95.95 -70.49 0.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 110.655 -179.58 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -57.4 80.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.429 -0.794 . . . . 0.0 110.754 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.737 ' HB2' ' HA ' ' A' ' 78' ' ' GLU . . . -80.16 164.05 54.38 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.876 . . . . 0.0 109.99 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.544 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 2.7 Cg_endo -63.4 -3.58 5.43 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.913 1.48 . . . . 0.0 110.756 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 mt 63.26 133.36 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.062 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.523 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.1 Cg_exo -61.3 162.12 21.22 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.764 1.402 . . . . 0.0 110.633 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.484 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 145.34 -7.46 1.57 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -119.84 74.81 19.62 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.239 . . . . 0.0 110.396 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.484 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_endo -61.74 115.6 2.9 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.78 1.41 . . . . 0.0 110.487 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.824 ' O ' HG23 ' A' ' 44' ' ' VAL . 89.6 t -136.42 141.7 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.223 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.023 HG21 ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER 164.16 -50.29 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.472 -0.767 . . . . 0.0 110.611 179.936 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 44' ' ' VAL . 3.3 Cg_exo -58.23 -19.15 40.82 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.403 1.212 . . . . 0.0 110.625 -179.569 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 47' ' ' LEU . 77.1 mt -89.69 -75.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.783 179.564 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 46' ' ' ILE . 24.3 tp 178.77 67.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 110.348 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.497 ' O ' ' O ' ' A' ' 47' ' ' LEU . 35.3 m 37.7 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.388 -0.82 . . . . 0.0 110.154 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.673 ' CB ' HG11 ' A' ' 43' ' ' VAL . 58.1 p -52.96 -42.98 66.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.308 -0.87 . . . . 0.0 111.0 -179.295 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -80.3 110.68 17.53 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.186 -0.946 . . . . 0.0 110.46 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -58.3 -10.62 8.85 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.753 1.397 . . . . 0.0 110.787 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.883 ' HB2' HD11 ' A' ' 21' ' ' LEU . 97.9 m-20 -139.56 42.95 2.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.121 -0.987 . . . . 0.0 110.712 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.756 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -78.61 177.2 2.98 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.092 -1.005 . . . . 0.0 108.433 178.778 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.756 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.8 Cg_exo -57.51 76.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 N-CA-C 108.628 -1.336 . . . . 0.0 108.628 179.124 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.623 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.9 tt0 -38.88 -28.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.803 -0.561 . . . . 0.0 110.075 -178.295 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.7 mt-10 -51.66 -18.18 1.11 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.996 -1.065 . . . . 0.0 108.587 178.257 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.753 HD21 ' CG ' ' A' ' 10' ' ' PHE . 78.7 mt -86.77 2.95 47.03 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.43 0.633 . . . . 0.0 109.861 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.753 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 20.6 tptt -39.99 -49.61 5.97 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 110.366 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.753 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.85 -41.1 80.78 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.357 1.188 . . . . 0.0 110.434 179.678 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.012 HD21 HG21 ' A' ' 69' ' ' ILE . 6.2 mp -61.08 -37.6 83.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.876 -1.14 . . . . 0.0 110.179 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.663 ' HA ' HG22 ' A' ' 44' ' ' VAL . 57.3 m -62.73 -25.23 68.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.574 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -98.89 10.94 40.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.115 -0.991 . . . . 0.0 111.399 -179.15 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.575 ' CG ' ' HA ' ' A' ' 60' ' ' LEU . 12.6 pt-20 -133.65 147.1 63.15 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.746 -1.221 . . . . 0.0 110.536 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.25 -11.16 23.98 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.911 1.48 . . . . 0.0 110.939 -179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.42 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 79.4 m-20 -78.93 -23.72 44.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.1 -1.0 . . . . 0.0 110.428 -179.046 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.023 ' HB1' HG21 ' A' ' 44' ' ' VAL . . . -49.14 -39.3 28.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.973 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -57.16 -44.94 83.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.27 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 73.5 mm-40 -79.13 -31.9 44.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.012 HG21 HD21 ' A' ' 60' ' ' LEU . 95.5 mt -76.34 -53.45 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.096 -1.003 . . . . 0.0 109.928 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.01 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -44.69 -65.42 0.53 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.432 -0.793 . . . . 0.0 110.484 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 1.01 ' N ' HD13 ' A' ' 70' ' ' LEU . 50.9 tt0 -49.06 -54.79 14.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.124 -0.985 . . . . 0.0 110.697 -179.702 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 44.5 mtp85 -54.97 -55.32 32.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.549 ' CD1' HG22 ' A' ' 69' ' ' ILE . 28.7 mt -47.43 -50.77 21.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.158 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.819 ' OE2' HD21 ' A' ' 70' ' ' LEU . 75.4 mt-10 -56.22 -48.19 76.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 34.8 tt0 -53.79 -52.92 58.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.042 -1.036 . . . . 0.0 109.894 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 79' ' ' ASP . 62.2 mt -59.92 -34.3 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -0.932 . . . . 0.0 109.156 179.224 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -56.15 -32.83 64.65 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.034 179.031 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.737 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 83.2 tt0 -64.2 -43.49 94.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.522 -0.736 . . . . 0.0 109.67 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.473 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 2.0 t70 -143.17 147.58 41.29 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.956 179.784 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.616 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -56.64 -56.11 2.24 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.841 1.442 . . . . 0.0 110.583 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.19 -137.13 21.57 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.942 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 71.9 p -82.16 -23.09 35.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -1.087 . . . . 0.0 110.625 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 7.7 t -56.29 -54.38 46.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.065 -1.022 . . . . 0.0 110.033 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 76.9 tt0 -58.05 -27.34 63.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 111.178 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.76 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.9 pt -101.14 14.84 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.89 -1.131 . . . . 0.0 110.27 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 73.3 m 54.76 16.32 1.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.897 . . . . 0.0 110.539 179.594 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.942 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.51 -12.31 51.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.82 174.5 11.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.85 3.89 9.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.304 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -61.52 -42.82 99.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.908 . . . . 0.0 110.417 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.826 ' SG ' HG22 ' A' ' 1' ' ' VAL . 1.2 m -106.2 124.55 49.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.79 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.504 HG21 ' CD ' ' A' ' 4' ' ' GLN . 36.8 p -109.61 163.23 13.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.158 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.02 3.32 51.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.489 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.395 -1.061 . . . . 0.0 110.283 179.975 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.517 ' CG1' ' SG ' ' A' ' 91' ' ' CYS . 52.9 t . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.287 0.565 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.724 HG21 ' HB2' ' A' ' 9' ' ' SER . 11.7 t -118.48 164.04 15.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 0.0 110.357 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.697 HG13 HG21 ' A' ' 76' ' ' ILE . 65.3 t -81.07 124.46 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 109.569 179.492 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.791 ' CB ' HG21 ' A' ' 92' ' ' THR . 48.9 tt0 -113.65 121.53 44.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.055 -1.028 . . . . 0.0 110.9 -179.333 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.98 ' HB3' HD21 ' A' ' 73' ' ' LEU . 52.6 p30 -97.74 13.44 30.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.441 -0.787 . . . . 0.0 109.647 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.506 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 173.51 -132.13 2.24 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -93.67 16.57 13.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.164 -1.198 . . . . 0.0 109.773 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.65 ' CB ' ' CZ ' ' A' ' 10' ' ' PHE . 44.8 m-85 -121.06 128.09 52.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.456 -0.777 . . . . 0.0 110.429 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.724 ' HB2' HG21 ' A' ' 2' ' ' THR . 14.7 p -82.18 118.29 22.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 8' ' ' PHE . 21.4 m-85 -117.93 123.32 45.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.807 -179.207 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.492 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 45.6 t -67.87 168.78 10.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.28 -0.888 . . . . 0.0 110.083 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.833 ' N ' HD12 ' A' ' 12' ' ' LEU . 4.6 mp -95.81 0.84 52.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 110.629 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -73.28 -73.93 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.088 -1.008 . . . . 0.0 110.488 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.534 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.4 m -42.68 -41.09 3.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.114 -0.991 . . . . 0.0 110.556 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.531 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 33.1 t -69.26 -50.89 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 109.805 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.982 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 9.6 ttpp -48.06 -46.52 33.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.221 -0.924 . . . . 0.0 109.102 179.243 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 18' ' ' LEU . 49.9 mttm -74.03 -54.96 6.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 0.0 109.003 178.822 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.77 HD12 ' OD1' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -27.88 -41.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.804 -0.56 . . . . 0.0 110.551 -179.999 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.667 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 22.4 mttm -51.76 -45.62 63.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 109.947 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 21' ' ' LEU . 52.0 p30 -112.86 -3.15 14.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 110.063 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.984 HD23 ' ND2' ' A' ' 50' ' ' ASN . 0.1 OUTLIER 45.94 104.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.404 -0.81 . . . . 0.0 110.451 -179.984 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 23' ' ' GLU . 96.8 mt-30 -120.96 165.79 14.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.941 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -42.58 165.83 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.17 -179.988 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HD2' ' HG3' ' A' ' 23' ' ' GLU . 3.1 Cg_exo -60.88 70.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.827 1.435 . . . . 0.0 110.773 -179.823 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 23' ' ' GLU . 91.7 mt-30 -84.26 12.63 6.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.918 . . . . 0.0 110.008 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.705 ' N ' ' HD2' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -49.55 -49.9 69.25 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.394 -0.816 . . . . 0.0 110.936 -179.981 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.705 ' HD2' ' N ' ' A' ' 26' ' ' GLU . 3.3 Cg_exo -59.27 -13.93 22.17 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.608 1.32 . . . . 0.0 110.751 -179.559 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.473 ' HG2' ' NH2' ' A' ' 28' ' ' ARG . 47.6 ttp85 -124.85 123.83 40.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 109.917 179.628 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.3 136.29 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.935 . . . . 0.0 110.36 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.85 152.04 34.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -58.72 -35.45 72.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -1.158 . . . . 0.0 110.286 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.626 HD21 ' ND2' ' A' ' 34' ' ' ASN . 29.7 tp -114.03 131.48 56.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.228 -0.92 . . . . 0.0 110.263 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.503 ' HB2' ' HD3' ' A' ' 16' ' ' LYS . 6.3 ptp180 -117.83 54.25 0.91 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.086 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.626 ' ND2' HD21 ' A' ' 32' ' ' LEU . 41.5 p-10 -125.69 2.2 7.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.202 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -71.21 -7.52 47.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 110.3 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.982 ' HB2' ' HG3' ' A' ' 16' ' ' LYS . . . -63.32 150.19 89.93 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.205 -0.935 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD2' ' HD2' ' A' ' 19' ' ' LYS . 3.1 Cg_exo -61.55 -147.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.798 1.42 . . . . 0.0 110.404 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.741 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -121.55 161.27 42.42 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 110.072 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.557 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo -61.52 155.78 50.9 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.791 1.416 . . . . 0.0 110.653 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 140.94 4.87 1.08 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.821 -1.181 . . . . 0.0 110.169 179.823 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.54 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -134.61 60.47 42.57 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.881 -1.364 . . . . 0.0 110.612 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -62.16 139.41 78.03 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.824 1.433 . . . . 0.0 110.515 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 49' ' ' SER . 14.8 m -141.93 119.68 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.334 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.724 ' O ' HG12 ' A' ' 44' ' ' VAL . 69.2 t -145.62 63.36 9.45 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 0.0 110.473 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.514 ' HG2' ' N ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -61.17 -169.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.748 1.394 . . . . 0.0 110.336 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.42 -30.23 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.384 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 48' ' ' CYS . 0.7 OUTLIER -134.81 56.13 1.86 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 -179.99 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.534 ' O ' ' O ' ' A' ' 47' ' ' LEU . 0.5 OUTLIER 56.98 133.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.472 -0.767 . . . . 0.0 110.147 179.95 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.53 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.3 t -69.54 -56.0 8.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 110.442 -179.817 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.984 ' ND2' HD23 ' A' ' 21' ' ' LEU . 7.2 m120 -78.28 113.06 30.54 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.481 -0.762 . . . . 0.0 110.452 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -62.45 -12.69 28.91 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.747 1.393 . . . . 0.0 110.459 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.491 ' HB2' HD11 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -127.8 36.41 4.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 110.045 179.886 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.727 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 3.0 p90 -80.14 178.86 2.11 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.203 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.021 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.2 Cg_exo -56.53 75.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.676 1.356 . . . . 0.0 109.872 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.9 tt0 -43.56 -34.19 1.34 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.833 . . . . 0.0 110.298 -179.503 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.545 ' C ' HD12 ' A' ' 57' ' ' LEU . 74.4 mm-40 -54.31 -18.65 4.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.934 -1.104 . . . . 0.0 108.626 178.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.021 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.5 mp -95.3 18.69 11.97 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.092 0.949 . . . . 0.0 108.99 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.743 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -43.19 -51.02 14.41 Favored Pre-proline 0 N--CA 1.489 1.483 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.52 179.818 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.743 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.24 -49.12 17.4 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.502 1.264 . . . . 0.0 109.658 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.104 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -48.1 -49.1 33.01 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.09 -1.006 . . . . 0.0 109.753 179.446 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.513 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 87.0 m -63.49 -23.95 67.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 19.9 tttt -90.68 5.62 47.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 0.0 110.743 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 8.6 pt-20 -125.96 144.76 49.7 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.891 -1.13 . . . . 0.0 110.317 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -61.54 -13.59 30.44 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.94 1.495 . . . . 0.0 110.803 -179.799 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.507 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 84.7 m-20 -79.78 -22.65 42.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.292 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.104 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.23 -40.05 10.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.11 -0.994 . . . . 0.0 109.797 179.775 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -62.48 -36.95 84.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 0.0 109.23 179.3 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.49 -38.9 29.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.524 -0.735 . . . . 0.0 109.407 178.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.763 HG23 ' HB2' ' A' ' 5' ' ' ASP . 80.0 mt -70.92 -46.18 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 109.898 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.911 HD13 ' N ' ' A' ' 71' ' ' GLN . 2.1 tm? -40.66 -68.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.506 -0.746 . . . . 0.0 110.554 -179.768 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.911 ' N ' HD13 ' A' ' 70' ' ' LEU . 25.3 mt-30 -42.77 -52.4 5.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.143 -0.973 . . . . 0.0 110.459 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -53.71 -59.05 5.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.004 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.98 HD21 ' HB3' ' A' ' 5' ' ' ASP . 36.7 mt -47.57 -54.14 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 110.051 179.705 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 39' ' ' PRO . 70.3 mt-10 -52.19 -45.78 65.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 110.06 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.557 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 83.7 tt0 -57.62 -51.36 69.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.809 179.752 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.697 HG21 HG13 ' A' ' 3' ' ' VAL . 23.6 mm -60.64 -38.75 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 109.519 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.543 ' HA ' HD23 ' A' ' 12' ' ' LEU . . . -54.52 -38.39 66.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.429 -0.794 . . . . 0.0 109.65 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.735 ' O ' ' CB ' ' A' ' 79' ' ' ASP . 83.8 tt0 -44.14 -33.56 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.89 . . . . 0.0 109.611 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.735 ' CB ' ' O ' ' A' ' 78' ' ' GLU . 19.5 t70 95.04 73.13 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 76' ' ' ILE . 3.0 Cg_exo -60.86 -34.97 90.55 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.022 1.538 . . . . 0.0 110.185 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 85' ' ' ILE . . . 94.16 -28.89 9.58 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.195 -2.362 . . . . 0.0 107.195 -178.249 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.822 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 75.6 p -74.3 -40.75 62.06 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.11 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.677 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 53.5 t -58.81 -40.96 85.65 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.834 178.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.37 -33.37 75.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.066 -1.021 . . . . 0.0 110.349 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 82' ' ' THR . 17.8 pt -94.44 11.32 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.934 . . . . 0.0 110.237 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER 67.83 12.42 8.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.355 -0.841 . . . . 0.0 110.527 179.721 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.822 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -58.64 -35.76 73.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.22 -0.925 . . . . 0.0 109.897 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.548 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 29.1 t80 -123.15 166.8 14.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.937 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.91 -7.28 47.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.152 -0.967 . . . . 0.0 109.974 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.548 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -51.82 -37.1 50.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.83 . . . . 0.0 110.861 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.677 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -104.13 118.8 37.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.906 . . . . 0.0 111.139 -179.149 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.791 HG21 ' CB ' ' A' ' 4' ' ' GLN . 18.4 p -98.16 177.86 5.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 110.197 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.75 -5.9 84.16 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.442 ' OXT' ' SG ' ' A' ' 86' ' ' CYS . 23.9 p . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.166 . . . . 0.0 110.118 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 84' ' ' GLU . 3.5 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.229 0.538 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.495 HG23 ' HA ' ' A' ' 11' ' ' SER . 37.0 m -89.26 150.89 22.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 110.293 -179.851 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.01 HG21 HD11 ' A' ' 12' ' ' LEU . 88.0 t -80.08 104.8 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 110.123 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.53 ' HB3' ' CG2' ' A' ' 92' ' ' THR . 48.1 tt0 -108.64 123.69 49.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 110.36 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -100.75 5.07 43.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.098 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . -176.44 -138.62 2.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -79.74 -0.12 32.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -1.123 . . . . 0.0 110.251 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.456 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 84.4 m-85 -116.8 130.7 56.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.197 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m -86.01 136.18 33.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 110.126 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.647 ' CE1' HD23 ' A' ' 57' ' ' LEU . 57.0 m-85 -115.09 125.73 53.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 110.191 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.539 ' C ' HD22 ' A' ' 12' ' ' LEU . 33.8 t -73.07 169.9 16.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.92 . . . . 0.0 110.179 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.01 HD11 HG21 ' A' ' 3' ' ' VAL . 3.2 mm? -100.63 -3.99 29.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.115 -0.99 . . . . 0.0 110.413 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.417 ' OE1' ' HG3' ' A' ' 26' ' ' GLU . 97.5 mt-10 -70.23 -72.9 0.18 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -0.999 . . . . 0.0 110.432 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.498 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.5 m -41.12 -50.69 3.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 110.662 -179.722 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.634 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 30.8 m -63.1 -47.96 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.096 -1.003 . . . . 0.0 109.743 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.628 ' CD ' ' HA ' ' A' ' 33' ' ' ARG . 6.8 ttpp -56.53 -55.42 34.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.084 -1.01 . . . . 0.0 109.159 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -80.11 7.6 8.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.49 179.0 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 13.0 tp -54.1 -35.65 62.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.577 -0.702 . . . . 0.0 110.131 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.523 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 32.1 tttt -55.48 -41.84 73.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.116 -0.99 . . . . 0.0 109.507 179.317 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.7 105.92 16.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.778 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.781 HD11 ' H ' ' A' ' 52' ' ' ASN . 11.8 tp -46.82 -42.32 17.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.595 -179.64 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.407 ' C ' ' HG3' ' A' ' 23' ' ' GLU . 94.2 mt-30 -65.29 110.1 2.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.179 -0.951 . . . . 0.0 110.381 -179.705 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HG3' ' C ' ' A' ' 22' ' ' GLN . 9.1 mt-10 -126.88 128.02 24.3 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.017 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.19 155.06 58.72 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.661 1.348 . . . . 0.0 110.547 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -59.35 139.0 57.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.382 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.417 ' HG3' ' OE1' ' A' ' 13' ' ' GLU . 14.1 mm-40 -123.28 81.8 52.38 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 109.952 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.3 -79.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.934 1.492 . . . . 0.0 110.819 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 29' ' ' VAL . 98.5 mtt180 -139.56 149.2 43.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 110.56 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 28' ' ' ARG . 20.3 t 46.19 101.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 110.697 179.535 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.18 -178.09 48.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.63 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -82.92 -105.0 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -1.165 . . . . 0.0 110.332 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.5 mt -108.74 142.88 38.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 110.128 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.628 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 76.1 mtm180 -123.11 65.12 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.353 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 10.6 p30 -131.63 15.75 4.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.265 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.563 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 68.1 t80 -95.29 7.39 46.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 0.0 110.405 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.878 ' HB3' ' HA ' ' A' ' 78' ' ' GLU . . . -66.02 137.73 95.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 0.0 110.223 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.523 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 3.0 Cg_exo -62.64 -148.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.805 1.424 . . . . 0.0 110.509 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.708 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -120.95 162.51 34.74 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.866 . . . . 0.0 110.132 179.869 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 38' ' ' ILE . 2.9 Cg_endo -61.63 166.85 10.95 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.917 1.483 . . . . 0.0 110.479 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.38 8.52 43.61 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -123.49 76.04 54.11 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.279 -1.13 . . . . 0.0 110.115 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.47 141.81 96.4 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.001 1.527 . . . . 0.0 110.689 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 43' ' ' VAL . 15.5 m -121.21 58.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.378 -0.826 . . . . 0.0 110.186 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.449 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 4.5 t -139.92 64.99 29.44 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.327 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -59.86 -123.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.909 1.478 . . . . 0.0 109.982 179.637 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.742 ' O ' HD23 ' A' ' 47' ' ' LEU . 22.2 mm -67.27 -33.73 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.74 -1.225 . . . . 0.0 107.701 178.774 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.742 HD23 ' O ' ' A' ' 46' ' ' ILE . 67.3 mt -136.1 -89.28 0.3 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.268 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.8 m -127.44 139.41 52.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.056 -1.028 . . . . 0.0 109.017 178.872 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.588 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 6.0 t -62.63 -73.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.053 -1.029 . . . . 0.0 111.099 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.698 ' OD1' HD13 ' A' ' 21' ' ' LEU . 28.3 m-20 -79.98 113.68 40.16 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.837 -179.184 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -64.59 -7.2 13.84 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.793 1.417 . . . . 0.0 110.329 179.521 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.781 ' H ' HD11 ' A' ' 21' ' ' LEU . 88.8 m-20 -129.16 32.5 4.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.0 109.864 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.741 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -79.86 -176.55 0.74 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 108.956 179.412 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.966 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.7 Cg_exo -59.28 74.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.442 1.233 . . . . 0.0 109.051 179.201 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.8 tt0 -39.28 -32.33 0.11 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.687 -0.633 . . . . 0.0 110.551 -178.523 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 54' ' ' PRO . 77.7 tt0 -52.31 -24.95 8.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.905 -1.122 . . . . 0.0 108.604 178.817 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.966 HD12 ' HG2' ' A' ' 54' ' ' PRO . 91.7 mt -85.28 1.23 49.19 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.437 0.636 . . . . 0.0 109.543 179.151 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.772 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.8 tmmt? -40.93 -49.65 7.7 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.459 -0.775 . . . . 0.0 110.493 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.772 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -53.98 -39.77 83.73 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.398 1.21 . . . . 0.0 110.557 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.06 HD13 HG21 ' A' ' 69' ' ' ILE . 9.6 mt -67.64 -30.65 70.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.927 -1.108 . . . . 0.0 110.029 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' A' ' 47' ' ' LEU . 46.0 t -69.34 -26.18 64.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 110.066 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -96.11 20.38 10.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 108.981 179.502 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -114.84 142.0 27.69 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.71 -0.619 . . . . 0.0 110.538 -179.11 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.93 -26.49 74.3 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.789 1.415 . . . . 0.0 109.425 178.873 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -86.06 -5.08 59.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.815 . . . . 0.0 110.538 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.889 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -45.26 -37.97 5.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.046 . . . . 0.0 110.101 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 94.0 mt-30 -59.55 -41.05 89.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 110.25 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.33 -39.31 28.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.096 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.06 HG21 HD13 ' A' ' 60' ' ' LEU . 84.8 mt -63.29 -47.89 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.135 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.814 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.4 tm? -53.05 -53.37 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 110.211 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.764 ' N ' HD13 ' A' ' 70' ' ' LEU . 73.7 mt-30 -48.33 -55.23 11.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.396 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -50.17 -52.16 37.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.363 -0.835 . . . . 0.0 110.188 -179.75 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 56.5 mt -53.13 -49.2 67.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.26 -0.9 . . . . 0.0 110.094 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.753 ' OE2' HD11 ' A' ' 70' ' ' LEU . 74.4 mt-10 -54.8 -43.38 72.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 110.727 -179.776 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.463 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.8 tt0 -62.9 -55.63 24.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.033 -1.042 . . . . 0.0 110.904 -179.308 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.1 mt -62.12 -38.11 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.442 ' C ' ' HB3' ' A' ' 36' ' ' ALA . . . -60.11 -32.35 70.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.448 -0.783 . . . . 0.0 109.8 179.596 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.878 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 84.3 tt0 -62.08 -37.06 83.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 110.556 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 3.0 m-20 -165.15 151.44 8.97 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.016 . . . . 0.0 110.706 -179.796 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.595 ' HB3' ' CG ' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.38 74.95 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.968 1.509 . . . . 0.0 110.719 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 80' ' ' PRO . . . -61.28 -134.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.269 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.932 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 59.4 p -75.39 -20.88 58.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.997 -1.296 . . . . 0.0 109.281 179.24 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.613 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 9.9 t -60.29 -46.23 90.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.533 -0.729 . . . . 0.0 109.404 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.595 ' CG ' ' HB3' ' A' ' 80' ' ' PRO . 49.8 tp10 -58.57 -30.23 67.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.271 -0.893 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.756 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.4 pt -103.2 12.85 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.96 -1.087 . . . . 0.0 110.39 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 4.4 t 60.52 14.24 4.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.281 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.932 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -64.47 -21.64 66.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.083 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.466 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 1.7 m-85 -131.59 166.51 21.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.58 2.99 3.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 110.368 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -65.9 -38.56 89.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -0.936 . . . . 0.0 110.409 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.613 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -108.56 115.15 29.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 110.715 -179.568 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' A' ' 4' ' ' GLN . 41.4 p -100.27 176.9 5.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 110.254 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.03 78.47 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.297 -1.119 . . . . 0.0 110.257 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.956 HG21 ' HA ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.205 0.526 . . . . 0.0 110.142 . . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 63.0 m -130.55 149.4 52.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.655 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.852 ' HB ' HD21 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -92.35 119.92 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.623 -0.673 . . . . 0.0 109.64 179.569 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 51.5 tt0 -111.74 121.31 44.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 110.824 -179.286 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 1.009 ' OD2' HD21 ' A' ' 73' ' ' LEU . 83.0 m-20 -97.31 9.14 43.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 109.818 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.449 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . -179.55 -138.13 3.2 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -82.4 4.5 23.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.167 -1.196 . . . . 0.0 110.185 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 78.3 m-85 -121.89 132.63 54.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 110.389 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.483 ' HB3' HG21 ' A' ' 92' ' ' THR . 26.8 p -80.73 127.63 32.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 110.034 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.677 ' HB3' HD11 ' A' ' 57' ' ' LEU . 20.2 m-30 -114.6 126.7 55.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.87 . . . . 0.0 110.445 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.8 m -71.55 166.78 21.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.852 HD21 ' HB ' ' A' ' 3' ' ' VAL . 51.5 mt -96.91 -8.81 29.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.558 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.544 ' HG2' ' CD ' ' A' ' 33' ' ' ARG . 95.3 mt-10 -63.8 -68.07 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.065 -1.022 . . . . 0.0 110.394 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.1 m -45.2 -50.69 11.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.271 -0.893 . . . . 0.0 111.191 -179.438 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.591 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 25.1 m -57.58 -48.43 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 0.0 110.269 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' N ' HG23 ' A' ' 15' ' ' VAL . 28.8 ttpp -50.5 -51.25 49.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.865 -1.147 . . . . 0.0 108.643 179.165 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.631 ' O ' ' C ' ' A' ' 18' ' ' LEU . 63.6 mttp -67.97 -57.36 6.31 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.066 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.678 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 0.4 OUTLIER 1.66 -71.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 120.832 0.349 . . . . 0.0 111.373 179.32 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.614 ' N ' ' O ' ' A' ' 17' ' ' LYS . 86.0 tttt -49.47 -59.28 3.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.916 -1.115 . . . . 0.0 109.248 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 17' ' ' LYS . 24.7 t70 -109.11 97.24 6.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.426 -0.796 . . . . 0.0 109.461 178.924 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.008 HD21 ' HB2' ' A' ' 52' ' ' ASN . 31.6 tp -95.31 138.6 32.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.893 -179.373 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -111.89 -170.39 1.64 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.424 -0.797 . . . . 0.0 109.745 179.511 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.559 ' CG ' ' HG3' ' A' ' 27' ' ' PRO . 15.4 pt-20 -45.68 158.9 0.32 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 109.54 179.601 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 3.3 Cg_exo -59.71 161.32 18.38 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.789 1.415 . . . . 0.0 110.537 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' PRO . 39.2 tt0 64.07 84.75 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 -179.901 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' CG ' ' HE2' ' A' ' 17' ' ' LYS . 14.1 mp0 -36.38 96.9 0.12 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.347 -0.846 . . . . 0.0 110.425 -179.867 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.559 ' HG3' ' CG ' ' A' ' 23' ' ' GLU . 2.9 Cg_endo -65.3 -26.05 56.56 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.92 1.484 . . . . 0.0 110.721 -179.811 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -76.9 145.45 38.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.207 -0.933 . . . . 0.0 110.349 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 p -137.35 138.07 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.258 -0.902 . . . . 0.0 110.196 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.97 -172.15 43.63 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HB3' HD12 ' A' ' 32' ' ' LEU . 95.6 mttt -116.19 158.31 23.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -1.156 . . . . 0.0 110.295 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.73 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.7 mp 54.52 102.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.341 -0.85 . . . . 0.0 110.414 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.544 ' CD ' ' HG2' ' A' ' 13' ' ' GLU . 85.2 mtt-85 -103.2 61.64 0.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.003 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 78' ' ' GLU . 88.4 m-20 -89.18 16.15 7.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 0.0 110.31 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -86.8 17.63 3.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.0 110.185 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.506 ' HB3' ' CA ' ' A' ' 78' ' ' GLU . . . -52.28 148.06 12.5 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.216 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 3.0 Cg_exo -61.84 -149.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.863 1.454 . . . . 0.0 110.407 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.515 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 26.9 mm -125.04 142.43 41.2 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.234 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 2.9 Cg_endo -62.02 163.63 18.99 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.747 1.393 . . . . 0.0 110.47 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.52 3.78 49.92 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.96 83.55 37.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.279 -1.13 . . . . 0.0 110.147 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.499 ' HA ' HD22 ' A' ' 70' ' ' LEU . 2.9 Cg_endo -61.6 140.38 86.4 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.9 1.474 . . . . 0.0 110.591 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.716 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.3 p -148.12 64.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 44' ' ' VAL . 94.5 t -131.65 60.08 49.57 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.293 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -60.35 168.19 6.78 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.793 1.418 . . . . 0.0 110.36 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 94.0 mt -50.36 -41.09 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 110.146 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 48' ' ' CYS . 54.5 mt -104.3 26.79 8.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 110.126 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.518 ' O ' ' O ' ' A' ' 47' ' ' LEU . 85.6 m 58.01 143.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.383 -0.823 . . . . 0.0 109.909 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.606 ' CB ' HG22 ' A' ' 43' ' ' VAL . 34.1 t -69.73 -76.2 0.1 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.181 -0.95 . . . . 0.0 110.258 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.803 ' HB3' HD22 ' A' ' 21' ' ' LEU . 39.8 m-20 -80.48 115.86 57.92 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 110.725 -179.837 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -64.63 1.84 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.657 1.346 . . . . 0.0 110.681 179.281 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 1.008 ' HB2' HD21 ' A' ' 21' ' ' LEU . 89.0 m-20 -133.84 31.77 3.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 110.064 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.871 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 11.0 p90 -76.21 -176.73 0.63 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 109.132 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.019 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -56.4 73.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.382 1.201 . . . . 0.0 110.037 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.61 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.0 tt0 -42.81 -34.62 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.564 -0.71 . . . . 0.0 110.309 -179.511 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.556 ' C ' HD12 ' A' ' 57' ' ' LEU . 96.0 mt-10 -54.87 -17.43 3.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.991 . . . . 0.0 108.809 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.019 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.7 mp -97.87 11.63 36.73 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.816 0.817 . . . . 0.0 109.184 179.202 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.74 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.87 -52.08 5.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.778 -0.576 . . . . 0.0 110.758 -179.818 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.74 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -53.08 -42.91 61.31 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.428 1.225 . . . . 0.0 110.25 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.903 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 11.0 mp -60.78 -35.58 76.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.064 -1.023 . . . . 0.0 109.769 179.447 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 51.8 t -66.73 -28.99 68.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.16 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -104.4 24.18 12.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 109.191 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -116.42 140.78 27.0 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.627 -0.671 . . . . 0.0 110.548 -179.232 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_endo -63.91 -30.39 67.5 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.734 1.386 . . . . 0.0 109.698 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -80.03 -7.49 58.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.418 -0.801 . . . . 0.0 110.61 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.903 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.03 -39.65 9.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.043 179.789 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.35 -41.1 92.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 110.342 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -80.17 -37.62 32.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.918 179.649 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 90.0 mt -66.08 -41.91 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 110.188 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.683 HD11 ' OE2' ' A' ' 74' ' ' GLU . 1.6 tp -56.44 -57.91 10.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 110.723 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -47.46 -17.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.084 -1.01 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.521 ' HB3' ' O ' ' A' ' 69' ' ' ILE . 27.5 ttm-85 -86.85 -58.1 2.72 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.617 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 1.009 HD21 ' OD2' ' A' ' 5' ' ' ASP . 69.6 mt -51.36 -50.79 58.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.392 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.683 ' OE2' HD11 ' A' ' 70' ' ' LEU . 88.7 mt-10 -55.41 -54.87 38.38 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.478 -0.764 . . . . 0.0 109.465 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.503 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 83.8 tt0 -61.15 -53.95 50.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 110.16 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.53 ' O ' ' O ' ' A' ' 79' ' ' ASP . 23.3 mm -62.18 -33.83 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 109.749 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . -59.06 -34.38 71.89 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.407 179.454 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.506 ' CA ' ' HB3' ' A' ' 36' ' ' ALA . 84.8 tt0 -58.7 -39.58 81.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 110.285 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.53 ' O ' ' O ' ' A' ' 76' ' ' ILE . 14.5 p-10 -145.03 153.73 53.74 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.11 -0.993 . . . . 0.0 110.358 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -58.83 -54.27 2.97 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.888 1.468 . . . . 0.0 110.537 179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.98 -139.67 24.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 44.6 p -80.08 -20.76 44.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -1.107 . . . . 0.0 110.164 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.668 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 5.5 t -55.44 -54.24 46.21 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.179 -0.951 . . . . 0.0 109.956 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.956 ' HA ' HG21 ' A' ' 1' ' ' VAL . 84.5 tt0 -56.08 -30.38 61.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 111.04 -179.493 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.78 HG13 ' HB2' ' A' ' 87' ' ' ALA . 9.0 pt -98.8 15.41 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.892 -1.13 . . . . 0.0 110.344 -179.507 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.6 m 50.89 23.51 1.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 110.376 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.983 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -71.62 -11.23 60.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 34.1 m-85 -150.56 171.56 16.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 110.126 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.82 1.96 18.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.948 . . . . 0.0 110.202 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.1 -11.61 41.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.359 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.945 ' SG ' HG22 ' A' ' 1' ' ' VAL . 0.7 OUTLIER -108.41 -172.53 2.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.97 . . . . 0.0 110.382 -179.878 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.507 ' HB ' ' HB ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -150.55 -15.81 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.273 -0.892 . . . . 0.0 110.997 -179.903 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.1 -23.33 72.96 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.488 1.463 0 O-C-N 121.159 -1.201 . . . . 0.0 110.35 -179.9 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.528 HG13 ' SG ' ' A' ' 91' ' ' CYS . 33.8 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.29 0.567 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.474 HG21 ' HB3' ' A' ' 9' ' ' SER . 61.2 m -119.39 149.43 41.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.238 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.782 HG21 HG21 ' A' ' 76' ' ' ILE . 1.2 t -83.69 113.16 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.877 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.609 ' HB3' HG21 ' A' ' 92' ' ' THR . 64.3 tt0 -110.54 119.19 38.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.418 -0.801 . . . . 0.0 110.694 -179.456 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -101.28 7.06 43.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 109.713 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.476 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . -169.67 -143.1 3.77 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -81.02 4.93 18.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.309 -1.112 . . . . 0.0 110.424 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.566 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 66.3 m-85 -125.63 136.86 53.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.311 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.474 ' HB3' HG21 ' A' ' 2' ' ' THR . 67.2 m -79.65 131.15 35.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.93 . . . . 0.0 110.037 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.905 ' HB3' HD21 ' A' ' 57' ' ' LEU . 18.4 m-85 -113.44 121.92 45.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 110.618 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.519 ' C ' HD22 ' A' ' 12' ' ' LEU . 60.1 p -75.35 171.29 14.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.241 -0.912 . . . . 0.0 109.871 179.645 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.833 ' N ' HD22 ' A' ' 12' ' ' LEU . 2.7 mm? -103.2 -12.07 17.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 0.0 110.772 -179.6 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.549 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 90.8 mt-10 -63.25 -74.1 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.092 -1.005 . . . . 0.0 110.535 -179.855 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 6.3 m -40.6 -44.37 2.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 110.478 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.705 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.1 t -62.22 -46.51 96.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.158 -0.964 . . . . 0.0 109.457 179.551 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.549 ' CE ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -54.93 -50.28 69.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.021 -1.049 . . . . 0.0 108.551 178.479 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -80.36 6.6 11.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.511 -0.743 . . . . 0.0 109.657 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.774 ' O ' HD22 ' A' ' 47' ' ' LEU . 44.3 tp -63.74 -23.36 67.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.38 -0.825 . . . . 0.0 110.426 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.545 ' HE3' ' CD1' ' A' ' 38' ' ' ILE . 28.0 tttm -67.52 -32.59 73.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.024 -1.048 . . . . 0.0 110.303 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -116.96 122.5 44.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.141 -0.975 . . . . 0.0 110.174 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.84 HD11 ' HB2' ' A' ' 52' ' ' ASN . 8.9 tp -85.32 168.05 15.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.4 -179.861 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 78.5 mt-30 59.82 54.7 4.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 110.225 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.8 mm-40 -137.09 162.9 52.97 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.84 . . . . 0.0 109.885 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.492 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 3.1 Cg_exo -60.01 125.49 17.77 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.897 1.472 . . . . 0.0 110.466 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -58.18 -38.01 75.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.92 . . . . 0.0 110.099 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -143.11 78.27 15.28 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.465 -0.772 . . . . 0.0 109.965 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 24' ' ' PRO . 3.0 Cg_exo -62.51 143.47 93.08 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.985 1.518 . . . . 0.0 110.676 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 29' ' ' VAL . 79.2 mtm180 -52.5 147.19 8.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 30' ' ' GLY . 0.9 OUTLIER 55.68 167.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.322 -0.861 . . . . 0.0 109.981 -179.9 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 29' ' ' VAL . . . 86.33 14.27 66.59 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HA ' ' CZ ' ' A' ' 33' ' ' ARG . 51.5 mttt -51.5 -28.44 13.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -1.14 . . . . 0.0 110.22 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.49 ' O ' ' C ' ' A' ' 33' ' ' ARG . 59.3 mt -55.98 -41.05 74.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 110.26 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.549 ' HD2' ' HG2' ' A' ' 13' ' ' GLU . 67.4 mtt85 38.08 73.14 0.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.424 -0.798 . . . . 0.0 109.958 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.634 ' ND2' ' O ' ' A' ' 34' ' ' ASN . 1.0 OUTLIER -123.13 44.41 2.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.747 -179.542 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.549 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 92.7 m-85 -107.95 120.01 41.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.11 -0.994 . . . . 0.0 109.903 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.402 ' O ' HG13 ' A' ' 38' ' ' ILE . . . -73.65 116.73 54.6 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.917 . . . . 0.0 110.544 -179.45 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.806 ' O ' HD12 ' A' ' 38' ' ' ILE . 2.9 Cg_endo -64.01 -5.73 9.84 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.802 1.422 . . . . 0.0 110.502 179.538 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 37' ' ' PRO . 1.1 mp 71.95 78.0 0.21 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 110.203 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.765 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . 3.0 Cg_endo -61.94 156.96 46.07 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.015 1.534 . . . . 0.0 110.592 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.06 42.51 0.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.551 ' CG ' HG23 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -122.95 169.72 9.43 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.322 -1.105 . . . . 0.0 110.32 -179.913 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.538 ' C ' HG12 ' A' ' 43' ' ' VAL . 2.9 Cg_endo -62.26 155.28 57.75 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 124.022 1.538 . . . . 0.0 111.178 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.734 ' C ' HG23 ' A' ' 44' ' ' VAL . 7.1 p 33.73 83.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.598 -0.689 . . . . 0.0 111.047 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.814 ' HB ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER 45.27 -161.4 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.8 -1.187 . . . . 0.0 108.47 179.421 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.971 ' HG3' HD23 ' A' ' 70' ' ' LEU . 3.7 Cg_exo -57.05 138.02 84.46 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 122.512 0.743 . . . . 0.0 110.446 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.677 HG13 HD12 ' A' ' 47' ' ' LEU . 2.3 pt -40.38 -39.18 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.459 -0.776 . . . . 0.0 111.197 -179.26 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 18' ' ' LEU . 6.5 mp -97.13 14.85 24.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 110.612 -179.332 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.57 ' HB2' ' CD ' ' A' ' 45' ' ' PRO . 35.3 t -70.84 -55.62 8.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.127 -0.983 . . . . 0.0 109.181 179.289 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.3 p -61.03 -25.96 67.28 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.277 -0.889 . . . . 0.0 108.744 178.853 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.84 ' ND2' HD22 ' A' ' 21' ' ' LEU . 1.2 m-20 -50.32 130.79 25.05 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.705 . . . . 0.0 110.143 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -66.45 1.55 2.5 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.795 1.419 . . . . 0.0 111.106 179.816 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.84 ' HB2' HD11 ' A' ' 21' ' ' LEU . 73.2 m-20 -113.39 7.12 17.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.067 -1.021 . . . . 0.0 110.842 -179.633 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.755 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -80.1 -177.13 0.84 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.073 -1.017 . . . . 0.0 109.493 179.449 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.853 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.6 Cg_exo -61.0 73.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.7 1.368 . . . . 0.0 109.038 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.583 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.3 tt0 -38.87 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.761 -0.587 . . . . 0.0 110.19 -178.523 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.488 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 50.1 mt-10 -55.11 -22.81 17.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.093 -1.004 . . . . 0.0 109.107 178.797 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.905 HD21 ' HB3' ' A' ' 10' ' ' PHE . 31.6 mt -92.38 11.59 25.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.455 -0.778 . . . . 0.0 109.742 179.35 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.737 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.85 -51.39 5.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.43 -0.794 . . . . 0.0 110.677 179.967 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.737 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.33 -44.73 46.04 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.531 1.279 . . . . 0.0 110.511 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.024 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 10.9 mp -57.88 -41.44 82.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.933 -1.104 . . . . 0.0 110.212 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.6 m -66.65 -25.96 66.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.919 -1.113 . . . . 0.0 110.063 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -97.95 1.06 47.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.892 . . . . 0.0 110.427 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.586 ' OE2' HD12 ' A' ' 69' ' ' ILE . 5.6 pt-20 -108.08 139.9 21.14 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.107 -0.995 . . . . 0.0 110.081 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.1 Cg_exo -61.89 -21.73 72.87 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.805 1.424 . . . . 0.0 110.988 -179.562 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.484 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 75.9 m-20 -79.44 -11.31 59.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 110.579 -179.138 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.024 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -48.6 -32.02 7.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 109.86 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.79 -38.13 86.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.418 -0.801 . . . . 0.0 109.739 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.3 -41.89 24.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.271 -0.893 . . . . 0.0 109.398 179.101 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.619 HG21 ' CD2' ' A' ' 60' ' ' LEU . 65.1 mt -67.33 -49.15 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.372 -0.83 . . . . 0.0 109.67 179.534 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.999 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -41.8 -67.08 0.28 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.781 . . . . 0.0 110.005 179.898 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.999 ' N ' HD13 ' A' ' 70' ' ' LEU . 90.8 mt-30 -44.99 -51.96 9.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.094 -1.004 . . . . 0.0 110.268 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -63.47 -50.71 68.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.452 -0.78 . . . . 0.0 110.153 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.532 HD21 HD13 ' A' ' 57' ' ' LEU . 13.5 tp -46.19 -60.13 2.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.708 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.824 ' OE2' HD21 ' A' ' 70' ' ' LEU . 54.7 mt-10 -50.72 -49.4 57.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.977 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.82 -54.83 24.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 110.246 -179.771 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.782 HG21 HG21 ' A' ' 3' ' ' VAL . 25.2 mm -57.42 -39.24 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 0.0 109.545 179.759 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -55.82 -34.36 65.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.469 -0.769 . . . . 0.0 109.529 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.5 tt0 -62.49 -42.98 99.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.51 -0.744 . . . . 0.0 110.017 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.42 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 14.9 p-10 -151.97 158.56 33.82 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.975 -1.078 . . . . 0.0 110.311 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.602 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -59.83 -54.24 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.017 1.535 . . . . 0.0 110.407 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.09 -140.23 29.54 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 43.5 p -82.17 -20.43 37.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -1.102 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.593 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 21.8 t -57.99 -46.13 85.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 0.0 109.787 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 80.4 tt0 -62.24 -29.28 70.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.17 -0.956 . . . . 0.0 111.34 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.638 HG13 ' HB2' ' A' ' 87' ' ' ALA . 3.9 pt -97.38 6.38 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.893 -1.129 . . . . 0.0 110.398 -179.496 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER 67.32 6.2 4.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 179.615 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -66.15 -17.86 64.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 109.93 179.732 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.513 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.3 OUTLIER -128.06 157.63 40.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 110.186 -179.889 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.49 -0.59 10.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.089 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.72 -32.9 74.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.385 -0.822 . . . . 0.0 110.557 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.593 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -108.42 111.9 24.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 110.796 -179.504 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.609 HG21 ' HB3' ' A' ' 4' ' ' GLN . 21.0 p -101.85 174.53 5.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.395 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.3 -14.74 64.58 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.423 -1.046 . . . . 0.0 110.227 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.512 HG12 ' SG ' ' A' ' 91' ' ' CYS . 18.1 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.193 0.521 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.959 HG21 ' HB3' ' A' ' 9' ' ' SER . 10.9 t -126.83 163.32 23.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.236 -0.915 . . . . 0.0 110.66 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.079 HG21 HD21 ' A' ' 12' ' ' LEU . 45.6 t -82.78 122.44 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.499 -0.75 . . . . 0.0 109.524 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.491 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 50.3 tt0 -112.32 121.35 44.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.93 . . . . 0.0 110.822 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.965 ' OD2' HD21 ' A' ' 73' ' ' LEU . 93.3 m-20 -98.79 11.51 38.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.426 -0.796 . . . . 0.0 109.657 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.491 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 179.92 -138.36 3.37 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -88.83 14.35 10.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 110.176 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.633 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.4 m-85 -123.79 131.01 53.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.229 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.959 ' HB3' HG21 ' A' ' 2' ' ' THR . 29.6 m -81.63 123.24 28.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.897 . . . . 0.0 110.085 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.778 ' CE2' HD11 ' A' ' 60' ' ' LEU . 22.9 m-85 -119.37 128.66 54.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.369 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.409 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 49.2 m -75.51 172.7 12.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.079 HD21 HG21 ' A' ' 3' ' ' VAL . 88.5 mt -106.47 -3.19 21.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 110.837 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.01 -73.91 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 110.321 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 m -47.83 -43.8 28.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 110.51 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.547 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 18.4 t -61.21 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.03 -1.043 . . . . 0.0 109.809 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.48 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 19.3 tttt -55.23 -53.97 49.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 53.3 mttp -80.2 8.85 6.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.623 HD13 ' HB2' ' A' ' 53' ' ' PHE . 16.6 tp -60.9 -44.98 96.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 110.686 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.491 ' NZ ' ' HA ' ' A' ' 39' ' ' PRO . 57.5 mttt -66.82 -34.01 76.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.351 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -128.99 79.98 1.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.979 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.465 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.0 tt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.11 -0.994 . . . . 0.0 110.392 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 13.5 ptt180 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.294 0.569 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.402 ' OD1' ' C ' ' A' ' 34' ' ' ASN . 30.3 p-10 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.494 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 3.1 Cg_exo . . . . . 0 N--CA 1.482 0.819 0 N-CA-C 110.677 -0.547 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.58 37.12 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.481 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 2.8 tt0 -138.77 64.41 35.63 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.178 -1.189 . . . . 0.0 110.23 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.525 ' CB ' ' HG3' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -61.71 102.27 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.847 1.446 . . . . 0.0 110.721 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.571 ' O ' HG23 ' A' ' 44' ' ' VAL . 14.6 p -134.52 127.87 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 110.083 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.607 ' O ' HG12 ' A' ' 44' ' ' VAL . 32.5 t . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.475 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.567 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.8 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.148 0.499 . . . . 0.0 109.755 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.497 ' HB2' HG22 ' A' ' 43' ' ' VAL . 22.7 t -59.9 -50.78 72.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.568 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 7.1 m120 -79.69 117.89 69.6 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 110.397 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.13 -10.93 13.99 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.762 1.401 . . . . 0.0 110.445 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -138.32 42.3 2.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.85 . . . . 0.0 109.513 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.713 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -80.1 -177.24 0.87 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.552 -0.718 . . . . 0.0 109.568 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 1.094 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -58.03 72.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.674 1.355 . . . . 0.0 109.667 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.619 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 23.1 pt-20 -40.1 -36.9 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.498 -0.751 . . . . 0.0 110.3 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' C ' HD12 ' A' ' 57' ' ' LEU . 96.3 mt-10 -54.12 -17.51 2.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 109.307 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.094 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.9 mp -97.9 8.55 44.55 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.736 0.779 . . . . 0.0 109.7 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.749 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -39.81 -52.04 5.2 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.716 -0.615 . . . . 0.0 110.72 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.749 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.97 -42.63 65.14 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.466 1.245 . . . . 0.0 110.051 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.996 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 16.6 mt -57.75 -41.35 81.76 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.031 -1.043 . . . . 0.0 109.879 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 15.7 m -69.19 -28.1 66.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.091 -1.005 . . . . 0.0 110.221 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 14.2 ttpt -88.28 6.51 36.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 2.4 pt-20 -111.39 144.14 29.91 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.986 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.64 -23.61 72.1 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.834 1.439 . . . . 0.0 111.103 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.514 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 80.1 m-20 -83.31 -4.88 58.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 0.0 110.717 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.996 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -51.48 -39.56 57.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.011 -1.056 . . . . 0.0 110.066 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.525 ' HG3' ' CB ' ' A' ' 42' ' ' PRO . 30.6 tt0 -54.12 -44.05 70.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 109.918 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -79.93 -35.31 37.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.622 HG21 HD13 ' A' ' 60' ' ' LEU . 93.9 mt -67.78 -52.83 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.947 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.3 tm? -43.33 -58.42 2.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.43 -0.794 . . . . 0.0 110.019 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.621 ' N ' HD13 ' A' ' 70' ' ' LEU . 25.9 mt-30 -51.75 -54.94 22.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.033 -1.042 . . . . 0.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.6 ttm-85 -49.61 -56.24 10.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.445 -0.784 . . . . 0.0 109.788 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.965 HD21 ' OD2' ' A' ' 5' ' ' ASP . 57.2 mt -48.32 -46.83 36.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.89 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 74.9 mm-40 -55.53 -45.32 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 110.147 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.0 -54.55 40.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 110.38 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.9 mt -60.21 -31.63 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 109.69 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 33' ' ' ARG . . . -64.1 -32.06 73.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.856 . . . . 0.0 109.292 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 78' ' ' GLU . 79.7 tt0 -92.99 14.71 16.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.581 -0.7 . . . . 0.0 109.68 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 9.7 t70 -178.86 124.61 0.25 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.406 -0.808 . . . . 0.0 109.928 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -61.68 -62.52 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.657 1.346 . . . . 0.0 110.773 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.43 -139.28 18.74 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 1.03 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 60.2 p -79.92 -22.07 43.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.172 . . . . 0.0 110.065 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 7.6 t -54.71 -53.72 51.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 110.001 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 85.2 tt0 -57.96 -31.28 66.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 110.929 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.824 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.2 pt -99.6 13.96 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.981 -1.075 . . . . 0.0 110.334 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 33.8 m 50.44 20.53 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 110.221 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 1.03 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -60.7 -12.2 9.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.913 . . . . 0.0 110.021 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.437 ' CG ' ' O ' ' A' ' 87' ' ' ALA . 50.0 m-85 -154.82 -176.63 6.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.205 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.3 1.93 12.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.883 . . . . 0.0 110.326 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.81 -36.08 71.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.588 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -112.57 129.08 56.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.201 -0.937 . . . . 0.0 110.609 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.481 HG21 ' CD ' ' A' ' 4' ' ' GLN . 25.3 p -107.19 157.21 18.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.168 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.09 0.08 56.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.334 -1.098 . . . . 0.0 110.275 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.449 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 3.0 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.314 0.578 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 57.5 m -121.97 146.53 47.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 110.536 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.051 HG23 HD11 ' A' ' 12' ' ' LEU . 56.0 t -86.11 119.67 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 109.527 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.495 ' CD ' HG21 ' A' ' 92' ' ' THR . 49.7 tt0 -109.88 116.86 32.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 110.848 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -93.08 10.98 29.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.396 -0.815 . . . . 0.0 109.666 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.456 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 179.77 -134.72 2.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -86.66 5.92 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -1.151 . . . . 0.0 110.162 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.672 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 71.0 m-85 -124.1 137.76 54.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.103 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 p -81.17 124.06 28.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.439 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.672 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 18.1 m-30 -113.91 125.62 54.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.344 -0.847 . . . . 0.0 110.399 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.2 p -73.91 168.02 20.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.236 -0.915 . . . . 0.0 110.076 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.051 HD11 HG23 ' A' ' 3' ' ' VAL . 5.0 mp -94.12 -20.85 19.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.235 -0.916 . . . . 0.0 110.539 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.514 ' HG3' ' HE3' ' A' ' 17' ' ' LYS . 88.6 tt0 -57.62 -67.38 0.34 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.306 -0.872 . . . . 0.0 110.781 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.574 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 9.3 m -41.77 -47.44 4.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.09 -1.006 . . . . 0.0 110.317 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 96.9 t -64.4 -50.25 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.081 -1.012 . . . . 0.0 109.704 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -55.17 -49.49 71.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 108.969 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.538 ' HE2' ' NH1' ' A' ' 33' ' ' ARG . 31.0 mttt -80.47 4.4 18.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.8 . . . . 0.0 109.987 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.617 HD13 ' HB2' ' A' ' 53' ' ' PHE . 11.0 tp -64.97 -37.11 86.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -0.942 . . . . 0.0 110.446 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -57.92 -37.43 74.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 29.2 p-10 -132.14 126.47 33.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.121 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.517 HD22 ' HB3' ' A' ' 52' ' ' ASN . 11.0 mt . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.16 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.538 ' NH1' ' HE2' ' A' ' 17' ' ' LYS . 34.6 mtt-85 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.254 0.55 . . . . 0.0 110.378 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 55.4 t-20 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.256 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.472 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.1 Cg_exo . . . . . 0 N--CA 1.481 0.767 0 N-CA-C 110.579 -0.585 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.43 21.28 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -134.55 88.66 28.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.087 -1.243 . . . . 0.0 109.972 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -60.32 140.39 91.64 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.953 1.502 . . . . 0.0 110.704 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.927 HG23 HG23 ' A' ' 44' ' ' VAL . 16.6 m -131.33 169.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 110.299 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.927 HG23 HG23 ' A' ' 43' ' ' VAL . 6.3 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.461 -0.775 . . . . 0.0 110.634 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 99.1 m . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.465 0.65 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.511 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -98.6 -72.54 0.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.163 -0.96 . . . . 0.0 110.092 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.427 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -76.67 113.67 31.7 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.461 -0.775 . . . . 0.0 110.011 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.46 -11.09 18.29 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.668 1.352 . . . . 0.0 110.676 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.517 ' HB3' HD22 ' A' ' 21' ' ' LEU . 42.2 t30 -130.6 34.44 4.14 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.286 -0.884 . . . . 0.0 110.376 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.729 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.2 -175.45 0.6 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.172 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 1.093 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -58.28 74.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.499 1.262 . . . . 0.0 109.843 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 53' ' ' PHE . 87.0 tt0 -42.05 -36.87 1.24 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.451 -0.781 . . . . 0.0 110.222 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.582 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.7 mt-10 -52.79 -18.42 1.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.041 -1.037 . . . . 0.0 108.934 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.093 HD13 ' HB2' ' A' ' 54' ' ' PRO . 9.3 mp -94.12 14.95 18.38 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.901 0.858 . . . . 0.0 109.028 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.743 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -40.19 -52.24 5.7 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.034 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.743 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.9 Cg_exo -52.97 -43.28 58.1 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.509 1.268 . . . . 0.0 110.094 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.043 HD22 HG21 ' A' ' 69' ' ' ILE . 86.4 mt -60.24 -37.88 81.72 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.03 -1.043 . . . . 0.0 109.95 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.629 ' O ' HG11 ' A' ' 44' ' ' VAL . 2.9 t -69.03 -30.62 69.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.02 -1.05 . . . . 0.0 110.216 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 34.4 tttm -89.95 -1.35 57.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.154 -0.967 . . . . 0.0 109.551 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.63 138.28 26.72 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.523 -0.736 . . . . 0.0 110.038 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.71 -20.75 66.94 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.632 1.332 . . . . 0.0 110.039 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.97 -2.39 57.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.377 -0.827 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.951 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.01 -35.55 4.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.098 -1.001 . . . . 0.0 109.8 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.56 -45.54 88.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -80.25 -41.22 25.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.043 HG21 HD22 ' A' ' 60' ' ' LEU . 83.5 mt -57.53 -45.59 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.167 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.948 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -45.77 -58.48 3.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.852 . . . . 0.0 110.248 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.948 ' N ' HD13 ' A' ' 70' ' ' LEU . 84.7 mt-30 -48.7 -56.2 9.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 0.0 110.023 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -48.88 -52.8 22.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.896 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.627 HD11 HD13 ' A' ' 60' ' ' LEU . 33.8 mt -51.42 -49.96 60.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.992 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.566 ' OE2' HD11 ' A' ' 70' ' ' LEU . 86.8 mt-10 -51.89 -54.25 31.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.219 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -55.57 -55.94 26.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.922 . . . . 0.0 110.537 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 79' ' ' ASP . 38.0 mm -58.35 -41.41 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.117 -0.989 . . . . 0.0 109.922 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -52.6 -37.14 57.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.286 -0.884 . . . . 0.0 109.657 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.2 tt0 -63.3 -44.03 96.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.79 . . . . 0.0 110.13 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 76' ' ' ILE . 6.5 t70 -136.73 143.4 42.64 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.054 -1.029 . . . . 0.0 110.231 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.558 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -59.41 -48.15 14.46 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.74 1.39 . . . . 0.0 110.588 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.41 -137.66 19.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.619 ' O ' HG12 ' A' ' 85' ' ' ILE . 44.2 p -76.08 -24.47 55.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -1.177 . . . . 0.0 109.312 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.566 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 22.8 t -47.55 -54.74 10.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.446 -0.784 . . . . 0.0 110.266 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.558 ' HB2' ' CB ' ' A' ' 80' ' ' PRO . 85.0 tt0 -60.39 -36.63 78.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.402 -0.811 . . . . 0.0 111.625 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.619 HG12 ' O ' ' A' ' 82' ' ' THR . 9.5 pt -86.88 10.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.741 -1.225 . . . . 0.0 110.58 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 87.5 m 52.78 19.81 1.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.828 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.559 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -78.33 -4.67 49.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.068 -1.02 . . . . 0.0 109.774 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.65 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 22.5 t80 -146.43 165.81 28.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.45 -0.781 . . . . 0.0 110.143 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.98 3.91 7.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 110.398 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.65 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -62.67 -31.83 72.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.96 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.566 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -108.07 122.3 46.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.173 -0.954 . . . . 0.0 110.662 -179.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.495 HG21 ' CD ' ' A' ' 4' ' ' GLN . 14.8 p -105.67 150.09 25.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.363 -0.836 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 94' ' ' CYS . . . 100.16 -6.89 58.31 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 93' ' ' GLY . 22.0 m . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.352 -1.087 . . . . 0.0 110.32 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.246 0.546 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 25.8 m -122.18 145.06 48.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.903 . . . . 0.0 110.399 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.045 HG23 HD11 ' A' ' 12' ' ' LEU . 64.9 t -88.43 119.94 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.042 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.82 ' OE1' HG21 ' A' ' 92' ' ' THR . 12.0 pt20 -115.31 140.41 49.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 110.762 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.463 ' OD2' HD11 ' A' ' 60' ' ' LEU . 51.0 p30 -110.31 13.93 22.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.549 -0.719 . . . . 0.0 109.862 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.07 -135.58 2.61 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -81.99 3.72 25.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -1.126 . . . . 0.0 110.128 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 81.0 m-85 -122.87 151.58 41.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.478 ' OG ' ' HB ' ' A' ' 2' ' ' THR . 3.7 t -104.19 135.06 46.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.697 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 24.6 m-85 -121.62 133.67 54.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.534 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.0 m -73.49 167.2 21.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -0.864 . . . . 0.0 110.36 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.045 HD11 HG23 ' A' ' 3' ' ' VAL . 5.3 mp -95.13 -15.95 22.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 110.508 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.2 mt-10 -65.74 -69.2 0.31 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.078 -1.013 . . . . 0.0 110.282 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' GLU . 5.6 m -40.76 -53.07 2.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 110.606 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.684 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.2 m -57.31 -45.07 85.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.045 -1.034 . . . . 0.0 109.442 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.508 ' N ' HG23 ' A' ' 15' ' ' VAL . 55.2 tttm -54.09 -57.56 10.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.0 109.006 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -80.3 12.6 2.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.376 -0.827 . . . . 0.0 109.979 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.684 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 4.9 tt -65.62 -36.86 84.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 110.52 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -56.39 -48.76 76.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -0.881 . . . . 0.0 110.695 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -134.0 155.65 49.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.118 -0.989 . . . . 0.0 110.388 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.724 HD22 ' HB2' ' A' ' 52' ' ' ASN . 7.8 mt . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 109.978 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.623 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 38.2 t-20 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 120.869 -1.144 . . . . 0.0 111.522 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.816 0 N-CA-C 110.61 -0.573 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.87 13.28 29.92 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -133.55 66.74 74.56 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.307 -1.113 . . . . 0.0 110.163 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.791 ' HA ' HD12 ' A' ' 70' ' ' LEU . 3.0 Cg_exo -61.88 135.09 53.63 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.937 1.493 . . . . 0.0 110.708 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.884 HG22 ' OG ' ' A' ' 49' ' ' SER . 3.1 p 178.46 91.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.1 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.853 ' O ' HG13 ' A' ' 44' ' ' VAL . 6.4 p . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 110.195 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 97.1 m . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.367 0.603 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.884 ' OG ' HG22 ' A' ' 43' ' ' VAL . 48.9 m -61.34 -59.23 5.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 110.916 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -80.12 113.16 36.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.425 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -61.42 -7.59 8.95 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.677 1.356 . . . . 0.0 110.391 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.724 ' HB2' HD22 ' A' ' 21' ' ' LEU . 90.8 m-20 -135.07 40.53 2.89 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.263 -0.898 . . . . 0.0 110.218 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.66 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -80.03 177.19 3.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.93 . . . . 0.0 108.929 179.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.733 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.7 Cg_exo -58.06 74.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.544 1.286 . . . . 0.0 109.215 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.611 ' N ' ' O ' ' A' ' 53' ' ' PHE . 84.5 tt0 -39.34 -29.58 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.773 -0.579 . . . . 0.0 110.293 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.579 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.4 mt-10 -51.71 -20.96 2.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.979 -1.076 . . . . 0.0 108.482 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.733 HD12 ' HG2' ' A' ' 54' ' ' PRO . 75.2 mt -87.17 10.02 18.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.597 -0.689 . . . . 0.0 109.58 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.756 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.89 -51.07 5.66 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 110.415 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.756 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.57 -42.98 63.25 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.561 1.295 . . . . 0.0 110.205 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.003 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 6.6 mp -58.18 -42.79 86.84 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.007 -1.058 . . . . 0.0 110.068 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.547 ' HA ' HG22 ' A' ' 44' ' ' VAL . 3.7 t -62.71 -27.49 69.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 110.158 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -90.36 -4.44 57.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 110.874 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 10.4 pt-20 -113.54 142.63 27.95 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 0.0 110.228 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.45 -14.33 41.68 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.87 1.458 . . . . 0.0 110.982 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.498 ' O ' HG13 ' A' ' 69' ' ' ILE . 68.6 m-20 -79.68 -17.4 53.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.181 -0.949 . . . . 0.0 110.603 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.003 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -52.01 -37.01 51.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.999 -1.063 . . . . 0.0 110.079 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -55.65 -44.08 76.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -80.34 -36.61 33.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.706 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.785 HG21 ' CD2' ' A' ' 60' ' ' LEU . 84.1 mt -66.78 -50.68 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 0.0 109.904 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.95 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -42.11 -62.99 0.81 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 0.0 110.343 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.95 ' N ' HD13 ' A' ' 70' ' ' LEU . 54.0 mt-30 -48.09 -52.47 20.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.073 -1.017 . . . . 0.0 110.231 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -55.27 -54.52 42.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 69' ' ' ILE . 3.6 mm? -47.69 -52.51 18.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 109.93 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.73 ' OE2' HD21 ' A' ' 70' ' ' LEU . 68.0 mt-10 -52.78 -50.17 64.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 109.902 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.527 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.0 tt0 -53.76 -54.83 32.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.967 . . . . 0.0 109.971 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 79' ' ' ASP . 39.0 mm -56.07 -35.33 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.127 -0.983 . . . . 0.0 109.233 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -57.81 -32.82 67.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.433 -0.792 . . . . 0.0 109.293 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 94.3 mt-10 -60.19 -42.84 95.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.424 -0.798 . . . . 0.0 109.86 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -147.14 153.62 45.26 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 110.172 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.55 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 3.2 Cg_exo -60.13 -51.96 4.86 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.952 1.501 . . . . 0.0 110.618 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.15 -139.51 20.52 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.586 ' O ' HG12 ' A' ' 85' ' ' ILE . 45.6 p -79.83 -19.76 47.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -1.144 . . . . 0.0 109.778 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.57 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 48.8 t -54.39 -53.81 49.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 110.155 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 80' ' ' PRO . 83.7 tt0 -58.68 -30.34 67.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 111.22 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 82' ' ' THR . 12.0 pt -95.94 12.73 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.913 -1.117 . . . . 0.0 110.56 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 3.4 t 51.47 19.87 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.285 -0.884 . . . . 0.0 110.961 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -77.72 -9.0 58.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 109.751 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.617 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 17.9 t80 -138.45 164.65 28.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.472 -0.767 . . . . 0.0 109.877 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.92 2.09 11.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 110.176 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.617 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -62.84 -37.23 85.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.574 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.57 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -98.2 120.31 38.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.1 -1.0 . . . . 0.0 110.59 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.82 HG21 ' OE1' ' A' ' 4' ' ' GLN . 41.5 p -104.03 154.58 19.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.365 -0.834 . . . . 0.0 110.142 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.76 -11.37 68.19 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 110.274 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 1' ' ' VAL . 23.5 m . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.201 0.524 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.648 HG21 ' OG ' ' A' ' 9' ' ' SER . 43.2 m -126.12 152.02 46.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.445 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.049 HG21 HD11 ' A' ' 12' ' ' LEU . 92.4 t -88.69 113.98 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.393 -0.817 . . . . 0.0 109.836 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.49 ' HB3' HG21 ' A' ' 92' ' ' THR . 47.8 tt0 -108.95 118.07 35.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.133 -0.979 . . . . 0.0 110.525 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.526 ' HB3' HD21 ' A' ' 73' ' ' LEU . 55.0 p30 -99.09 6.45 46.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.704 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -174.15 -143.26 4.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -79.91 3.62 19.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -1.149 . . . . 0.0 110.49 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.456 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 79.4 m-85 -120.23 140.8 50.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.101 -0.999 . . . . 0.0 110.46 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.648 ' OG ' HG21 ' A' ' 2' ' ' THR . 21.8 t -86.59 127.13 34.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.976 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.665 ' CZ ' HD23 ' A' ' 57' ' ' LEU . 22.0 m-30 -116.93 130.07 56.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.139 -0.976 . . . . 0.0 110.656 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.446 ' C ' HD22 ' A' ' 12' ' ' LEU . 75.2 p -80.03 174.6 11.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.324 -0.86 . . . . 0.0 110.286 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.049 HD11 HG21 ' A' ' 3' ' ' VAL . 2.5 mm? -99.89 -7.88 24.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 110.817 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -68.56 -71.3 0.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.178 -0.951 . . . . 0.0 111.056 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.529 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 4.1 m -51.91 -50.6 60.75 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.096 -1.003 . . . . 0.0 111.229 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.616 ' CG2' ' HA ' ' A' ' 12' ' ' LEU . 17.3 m -55.99 -48.65 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.884 -1.135 . . . . 0.0 110.212 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.518 ' N ' HG23 ' A' ' 15' ' ' VAL . 19.3 ttpp -55.69 -52.75 62.79 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.846 -1.159 . . . . 0.0 108.669 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.474 ' HE2' ' NZ ' ' A' ' 16' ' ' LYS . 71.1 mmtt -80.47 12.73 2.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.791 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.649 HD21 HG21 ' A' ' 43' ' ' VAL . 54.9 tp -61.39 -51.0 70.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 110.144 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -62.85 -33.96 76.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.914 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -130.9 100.42 5.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.847 . . . . 0.0 109.623 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 52' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.836 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.407 ' HB3' ' HE2' ' A' ' 16' ' ' LYS . 63.1 mtt180 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.376 0.607 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 30.3 t30 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 110.094 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.834 0 N-CA-C 110.542 -0.599 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.05 9.16 34.93 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 82.42 54.48 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.283 -1.128 . . . . 0.0 110.053 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HG3' ' HG3' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -61.58 137.7 70.82 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.934 1.492 . . . . 0.0 110.488 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.649 HG21 HD21 ' A' ' 18' ' ' LEU . 16.2 m -117.44 49.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.179 -0.951 . . . . 0.0 110.278 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 44' ' ' VAL . 2.4 m . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 110.159 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.585 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 98.3 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.538 0.685 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.58 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 15.5 t -51.82 -51.22 58.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.256 -0.903 . . . . 0.0 110.783 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 4.5 m120 -80.06 111.93 25.99 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.407 -0.808 . . . . 0.0 110.679 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.7 -13.41 36.63 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.636 1.335 . . . . 0.0 110.507 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.666 ' HB2' HD22 ' A' ' 21' ' ' LEU . 97.2 m-20 -123.88 29.67 6.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.525 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.736 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -80.3 177.5 2.92 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 109.161 179.251 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.804 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.4 Cg_exo -58.3 74.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.662 1.349 . . . . 0.0 108.929 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.613 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.1 tt0 -39.22 -27.77 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.634 -0.666 . . . . 0.0 110.182 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' PRO . 75.1 mm-40 -53.61 -17.2 1.98 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.03 -1.044 . . . . 0.0 108.592 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.804 HD12 ' HG2' ' A' ' 54' ' ' PRO . 92.7 mt -92.44 9.07 35.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.689 -0.632 . . . . 0.0 109.615 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.736 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -39.88 -50.67 5.69 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 110.278 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.736 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -55.76 -44.93 42.99 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.482 1.254 . . . . 0.0 110.124 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.027 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -54.11 -44.29 71.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 110.093 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.484 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . 82.5 m -64.4 -27.56 69.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.965 . . . . 0.0 110.139 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -91.87 4.88 51.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.893 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -112.9 137.02 21.69 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.355 -0.841 . . . . 0.0 110.179 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.99 -21.64 72.75 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.673 1.354 . . . . 0.0 109.884 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -79.93 -10.91 59.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.43 -0.794 . . . . 0.0 110.867 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.027 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.68 -36.03 10.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.956 -1.09 . . . . 0.0 109.877 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.479 ' HG3' ' HG3' ' A' ' 42' ' ' PRO . 50.2 tt0 -59.97 -42.61 94.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.343 -0.848 . . . . 0.0 110.029 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.16 -39.04 30.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 109.906 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.912 HG21 HD11 ' A' ' 60' ' ' LEU . 89.4 mt -63.51 -44.43 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.829 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.801 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.0 tm? -52.36 -54.31 33.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 0.0 110.209 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.675 ' N ' HD13 ' A' ' 70' ' ' LEU . 94.6 mt-30 -47.94 -52.9 17.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.291 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' LEU . 97.4 mtt180 -58.43 -62.14 2.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.455 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 5' ' ' ASP . 45.5 mt -44.93 -52.92 8.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.19 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.672 ' HG2' HD22 ' A' ' 70' ' ' LEU . 78.4 mm-40 -54.98 -47.59 74.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 110.78 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -56.72 -52.78 63.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.923 . . . . 0.0 110.771 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 79' ' ' ASP . 24.2 mm -63.61 -36.14 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 0.0 109.924 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -58.92 -33.71 70.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.43 -0.794 . . . . 0.0 109.881 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.463 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 83.5 tt0 -61.13 -37.9 84.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.685 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -150.35 160.62 32.71 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.032 -1.043 . . . . 0.0 110.675 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -61.54 -62.11 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.051 1.553 . . . . 0.0 110.569 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.34 -141.83 28.37 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.964 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 70.6 p -79.55 -22.16 44.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -1.154 . . . . 0.0 109.581 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 32.5 t -52.89 -51.63 60.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 109.991 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.5 tt0 -58.62 -33.77 70.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 0.0 111.179 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.772 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.2 pt -97.3 13.49 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.893 -1.129 . . . . 0.0 110.463 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.71 14.14 1.67 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.266 -0.896 . . . . 0.0 110.487 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.964 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.08 -15.11 62.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 109.963 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.592 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 27.0 t80 -139.69 168.41 19.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 0.0 110.267 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.98 3.07 8.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 110.301 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.592 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -63.08 -36.92 85.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.428 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -102.97 121.01 41.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 110.496 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 4' ' ' GLN . 18.9 p -111.54 166.32 11.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 110.227 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.97 -26.19 15.97 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.18 -1.188 . . . . 0.0 110.292 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.771 HG13 ' SG ' ' A' ' 91' ' ' CYS . 47.2 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.317 0.579 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 11' ' ' SER . 28.8 m -119.23 147.31 44.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.182 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.841 HG21 HG21 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -89.62 118.97 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 109.952 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 1.005 ' OE1' HG21 ' A' ' 92' ' ' THR . 65.6 tt0 -111.66 129.3 56.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 110.543 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -93.26 -81.24 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.759 . . . . 0.0 110.016 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.12 -126.32 3.81 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -84.69 8.27 17.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -1.184 . . . . 0.0 110.335 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.3 m-85 -120.2 137.79 54.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.36 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.2 t -88.55 130.26 35.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.729 ' CD1' HD23 ' A' ' 57' ' ' LEU . 18.6 m-85 -119.2 126.84 52.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.816 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.534 ' HA ' HG23 ' A' ' 2' ' ' THR . 38.8 t -75.65 169.14 18.69 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -0.996 . . . . 0.0 110.072 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.72 HD21 ' CB ' ' A' ' 3' ' ' VAL . 64.2 mt -102.36 -2.15 29.48 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.126 -0.984 . . . . 0.0 110.905 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -74.21 -73.6 0.22 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.084 -1.01 . . . . 0.0 110.6 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.6 m -43.0 -42.27 3.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.862 . . . . 0.0 110.826 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.627 ' CG2' ' HA ' ' A' ' 12' ' ' LEU . 6.2 m -65.29 -45.31 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.858 -1.151 . . . . 0.0 109.663 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -53.34 -46.98 69.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.821 -1.174 . . . . 0.0 108.93 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 45.8 tptt -80.23 -1.51 40.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.516 -0.74 . . . . 0.0 109.993 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.587 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 53.9 tp -66.55 -40.84 89.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.137 -0.977 . . . . 0.0 110.194 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -56.62 -45.63 81.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.283 -0.885 . . . . 0.0 110.072 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -116.99 70.2 0.77 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.709 HD11 ' OD1' ' A' ' 52' ' ' ASN . 19.2 tp . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 110.506 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.509 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 48.0 mtt180 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.33 0.586 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 33' ' ' ARG . 33.0 m120 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.166 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.565 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 3.3 Cg_exo . . . . . 0 N--CA 1.483 0.87 0 N-CA-C 110.793 -0.503 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.86 -78.75 1.43 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.99 153.56 35.86 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.287 -1.125 . . . . 0.0 110.257 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.494 ' HB2' ' HG3' ' A' ' 67' ' ' GLN . 3.0 Cg_endo -61.69 139.65 81.96 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.963 1.507 . . . . 0.0 110.614 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.695 ' O ' HG13 ' A' ' 43' ' ' VAL . 13.4 p -177.44 71.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.947 . . . . 0.0 110.261 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.907 HG22 ' HA ' ' A' ' 61' ' ' CYS . 2.8 p . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.864 . . . . 0.0 110.139 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.7 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.368 0.604 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.548 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.1 t -61.0 -44.82 96.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 4.2 m120 -80.35 112.11 28.12 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.343 -0.848 . . . . 0.0 110.304 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -59.54 -10.26 10.92 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.766 1.403 . . . . 0.0 110.7 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.709 ' OD1' HD11 ' A' ' 21' ' ' LEU . 45.7 p-10 -136.97 41.81 2.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 110.366 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.699 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.24 177.15 3.13 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 109.116 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.73 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.9 Cg_exo -58.3 75.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.591 1.311 . . . . 0.0 109.143 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.626 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.3 tt0 -39.06 -29.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.782 -0.574 . . . . 0.0 110.149 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.3 mt-10 -52.04 -18.88 1.58 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.025 -1.047 . . . . 0.0 108.634 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.73 HD12 ' HG2' ' A' ' 54' ' ' PRO . 88.6 mt -90.8 9.67 29.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.487 -0.758 . . . . 0.0 109.649 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.738 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.3 tmtt? -39.71 -51.51 5.21 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.359 -0.838 . . . . 0.0 110.63 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.738 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.28 -43.58 57.32 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.459 1.242 . . . . 0.0 109.997 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.038 HD11 HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -55.6 -40.7 72.4 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.11 -0.994 . . . . 0.0 110.039 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.907 ' HA ' HG22 ' A' ' 44' ' ' VAL . 82.4 m -58.03 -23.37 54.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.215 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.502 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 35.5 mtmt -113.46 37.05 3.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 109.579 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.502 ' OE1' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -133.12 141.83 42.25 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.849 . . . . 0.0 110.36 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -62.93 -26.28 74.26 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.746 1.393 . . . . 0.0 110.075 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.46 ' O ' HG13 ' A' ' 69' ' ' ILE . 72.1 m-20 -80.19 -18.65 49.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.906 . . . . 0.0 110.439 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.886 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -45.39 -47.33 13.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.328 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 42' ' ' PRO . 61.0 tt0 -54.25 -43.62 71.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.492 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.15 -33.03 38.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.879 . . . . 0.0 110.473 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.038 HD13 HD11 ' A' ' 60' ' ' LEU . 94.5 mt -63.41 -44.88 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 0.0 110.357 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.662 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.6 tm? -43.43 -66.93 0.32 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.439 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.662 ' N ' HD13 ' A' ' 70' ' ' LEU . 97.7 mt-30 -47.31 -54.87 9.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.114 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -50.46 -58.88 4.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 110.094 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.494 ' CD1' HG22 ' A' ' 69' ' ' ILE . 40.2 mt -45.16 -51.68 10.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.183 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 73.3 mm-40 -51.63 -58.01 7.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 110.301 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 85.0 tt0 -52.04 -56.6 13.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.933 . . . . 0.0 110.592 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.841 HG21 HG21 ' A' ' 3' ' ' VAL . 22.4 mm -55.75 -38.42 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.152 -0.968 . . . . 0.0 109.888 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -57.47 -32.54 67.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.595 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 81.8 tt0 -59.72 -43.25 94.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.423 -0.798 . . . . 0.0 110.136 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -147.22 157.31 45.98 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.214 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.558 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -61.55 -48.1 10.06 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.856 1.451 . . . . 0.0 110.6 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.23 -139.98 25.75 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.969 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 32.1 p -84.06 -16.52 43.51 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -1.156 . . . . 0.0 109.954 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.578 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 41.1 t -57.46 -48.72 78.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.986 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.3 tt0 -61.97 -28.03 69.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 111.241 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.674 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.5 pt -97.54 7.26 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.863 -1.148 . . . . 0.0 110.304 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.0 m 61.33 15.86 6.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.0 110.614 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.969 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.2 -16.61 64.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -0.999 . . . . 0.0 109.853 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 87' ' ' ALA . 27.4 m-85 -138.81 166.65 23.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.922 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.7 2.29 10.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.314 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.29 -32.79 73.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.563 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.771 ' SG ' HG13 ' A' ' 1' ' ' VAL . 0.1 OUTLIER -102.84 116.95 33.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.64 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 1.005 HG21 ' OE1' ' A' ' 4' ' ' GLN . 17.7 p -105.39 157.81 17.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 110.133 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.33 -26.0 24.75 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.326 -1.103 . . . . 0.0 110.289 179.938 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 94' ' ' CYS . 10.6 t . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.21 0.528 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 35.5 m -120.33 149.25 42.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 110.335 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.881 HG23 HD11 ' A' ' 12' ' ' LEU . 91.2 t -84.36 117.6 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.336 -0.853 . . . . 0.0 109.774 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.737 ' CD ' HG21 ' A' ' 92' ' ' THR . 19.4 pt20 -111.81 146.09 38.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.178 -0.951 . . . . 0.0 110.869 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.679 ' OD2' HD21 ' A' ' 73' ' ' LEU . 94.0 m-20 -106.13 13.26 29.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 109.792 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.89 -126.96 1.38 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -84.87 5.88 27.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -1.213 . . . . 0.0 110.111 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 87.2 m-85 -124.86 138.58 54.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.24 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.484 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 78.4 p -96.86 137.94 35.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.217 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.74 ' CG ' HD21 ' A' ' 57' ' ' LEU . 24.6 m-85 -125.14 138.04 54.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.277 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.4 t -69.96 165.66 21.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.317 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.881 HD11 HG23 ' A' ' 3' ' ' VAL . 4.5 mp -97.67 -13.29 21.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.874 . . . . 0.0 110.328 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.422 ' OE2' ' HD3' ' A' ' 33' ' ' ARG . 70.9 mm-40 -68.66 -73.36 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.29 -0.881 . . . . 0.0 110.614 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 13' ' ' GLU . 4.0 m -42.49 -48.67 5.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.461 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.704 HG11 ' HB3' ' A' ' 73' ' ' LEU . 36.2 t -58.31 -45.24 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.946 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -56.95 -56.64 19.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.949 . . . . 0.0 109.086 179.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -80.61 11.81 3.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -0.811 . . . . 0.0 109.945 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.0 tt -62.06 -41.74 98.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -73.84 -64.52 0.99 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 110.108 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -58.06 -37.8 75.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.034 HD11 ' HB2' ' A' ' 52' ' ' ASN . 16.0 tp . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.302 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.508 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 76.3 mtt85 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.248 0.547 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.551 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 70.5 m-20 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 0.0 110.315 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.512 ' CA ' ' OE1' ' A' ' 74' ' ' GLU . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.86 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.82 -75.16 1.29 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -167.5 144.85 3.78 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.323 -1.104 . . . . 0.0 110.24 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -62.65 138.34 69.18 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.903 1.475 . . . . 0.0 110.517 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' A' ' 49' ' ' SER . 19.7 m -143.0 127.39 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 110.251 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 44' ' ' VAL . 69.4 t . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.994 . . . . 0.0 110.97 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 59.1 m . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.618 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 87.7 p -65.55 -42.23 92.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.021 . . . . 0.0 110.616 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.528 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 8.7 m120 -80.09 110.46 16.34 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.349 -0.845 . . . . 0.0 110.258 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.618 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -60.31 -17.86 49.29 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.734 1.386 . . . . 0.0 110.821 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 1.034 ' HB2' HD11 ' A' ' 21' ' ' LEU . 18.2 m120 -126.61 36.26 4.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 110.722 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.628 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -80.28 172.97 8.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.078 -1.014 . . . . 0.0 108.954 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.5 Cg_exo -58.03 75.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.507 1.267 . . . . 0.0 108.959 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 53' ' ' PHE . 84.7 tt0 -39.4 -28.43 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.635 -0.666 . . . . 0.0 110.184 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt-10 -52.45 -17.04 1.04 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.053 -1.029 . . . . 0.0 108.65 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.74 HD21 ' CG ' ' A' ' 10' ' ' PHE . 62.2 mt -90.46 9.53 28.84 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.475 0.655 . . . . 0.0 109.583 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.757 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 12.9 mttt -39.87 -50.98 5.66 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 110.427 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.757 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.49 -42.62 66.39 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.596 1.314 . . . . 0.0 109.985 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.057 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 7.6 mp -57.92 -39.48 78.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.973 -1.079 . . . . 0.0 109.902 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.5 m -66.17 -28.86 69.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.128 -0.982 . . . . 0.0 110.474 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -89.6 5.96 43.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 111.145 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 10.0 pt-20 -121.97 148.75 52.25 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.947 -1.095 . . . . 0.0 110.305 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.8 Cg_endo -63.59 -20.34 69.18 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.988 1.52 . . . . 0.0 111.565 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.511 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 79.4 m-20 -80.03 -10.35 59.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.98 -1.075 . . . . 0.0 110.605 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.057 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.43 -45.43 25.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -0.93 . . . . 0.0 110.674 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.0 mt-30 -59.0 -42.55 90.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.903 . . . . 0.0 110.561 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -76.85 -31.91 57.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.093 -1.004 . . . . 0.0 110.152 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.784 HG21 ' CD2' ' A' ' 60' ' ' LEU . 99.8 mt -74.45 -46.03 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.923 . . . . 0.0 110.144 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.66 HD11 ' OE2' ' A' ' 74' ' ' GLU . 1.7 tm? -48.89 -59.3 3.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.882 . . . . 0.0 110.563 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.607 ' N ' HD13 ' A' ' 70' ' ' LEU . 98.3 mt-30 -49.59 -52.93 26.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.059 -1.026 . . . . 0.0 110.096 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -51.41 -54.42 26.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 109.916 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.704 ' HB3' HG11 ' A' ' 15' ' ' VAL . 65.1 mt -51.26 -48.81 62.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.66 ' OE2' HD11 ' A' ' 70' ' ' LEU . 91.2 mt-10 -52.92 -48.4 67.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.062 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.29 -50.23 73.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.972 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.582 ' O ' ' O ' ' A' ' 79' ' ' ASP . 26.5 mm -62.97 -37.41 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.704 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.759 ' HB1' ' HB2' ' A' ' 16' ' ' LYS . . . -56.38 -33.84 66.12 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.475 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.525 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 86.8 tt0 -62.61 -41.34 98.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.456 -0.777 . . . . 0.0 110.524 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -148.23 168.65 10.69 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.214 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HD2' ' OD1' ' A' ' 79' ' ' ASP . 3.2 Cg_exo -58.59 -55.81 1.87 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.658 1.347 . . . . 0.0 110.495 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.831 ' C ' HG23 ' A' ' 82' ' ' THR . . . 72.04 47.65 30.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.929 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 1.2 p 72.45 -40.98 0.49 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.451 -1.029 . . . . 0.0 110.842 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 37.4 t -40.75 -47.46 2.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.941 -1.099 . . . . 0.0 109.907 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 86.4 tt0 -63.16 -42.75 99.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 111.006 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.798 HG13 ' HB2' ' A' ' 87' ' ' ALA . 2.5 pt -84.76 18.7 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.0 -1.063 . . . . 0.0 110.573 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 52.77 16.96 0.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 110.616 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.929 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.79 -22.4 65.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 109.758 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.581 ' CD1' ' CB ' ' A' ' 82' ' ' THR . 19.6 m-85 -131.91 170.26 15.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.762 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.42 0.1 34.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.104 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -59.12 -25.9 64.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 110.496 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -111.18 128.17 55.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.787 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.737 HG21 ' CD ' ' A' ' 4' ' ' GLN . 22.6 p -114.37 163.95 14.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 110.064 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.495 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 88.76 -24.13 13.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.534 ' O ' ' CG2' ' A' ' 1' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.331 -1.099 . . . . 0.0 110.497 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.545 HG13 ' SG ' ' A' ' 91' ' ' CYS . 92.2 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.222 0.534 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.451 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 60.1 m -126.15 149.21 49.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 110.568 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.789 HG23 HD11 ' A' ' 12' ' ' LEU . 92.4 t -82.42 110.83 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.514 -0.741 . . . . 0.0 109.519 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.645 ' CB ' HG21 ' A' ' 92' ' ' THR . 35.3 tt0 -112.78 133.43 54.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 110.685 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -96.03 -71.68 0.66 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 109.421 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.0 -129.76 6.81 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -79.76 4.27 16.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -1.177 . . . . 0.0 110.655 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.51 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 99.2 m-85 -119.05 134.44 55.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.058 -1.026 . . . . 0.0 110.656 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.451 ' OG ' ' CG2' ' A' ' 2' ' ' THR . 27.1 t -87.16 135.61 33.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.861 . . . . 0.0 109.97 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.657 ' CE1' HD23 ' A' ' 57' ' ' LEU . 69.6 m-85 -115.56 125.86 53.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 111.005 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.473 ' C ' HD12 ' A' ' 12' ' ' LEU . 23.0 t -76.43 173.14 11.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.85 . . . . 0.0 109.796 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.03 HD23 ' HA ' ' A' ' 77' ' ' ALA . 4.5 mp -103.27 4.81 36.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.046 -1.034 . . . . 0.0 110.756 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 86.0 tt0 -71.89 -73.03 0.2 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.068 -1.02 . . . . 0.0 110.693 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.504 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 6.1 m -49.06 -45.72 43.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.081 -1.012 . . . . 0.0 110.684 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.637 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 24.2 t -58.38 -50.95 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.967 -1.083 . . . . 0.0 109.746 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.491 ' HE2' ' OD1' ' A' ' 34' ' ' ASN . 51.1 tttm -54.49 -54.45 40.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.779 -1.201 . . . . 0.0 108.656 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -80.47 14.46 2.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -0.756 . . . . 0.0 109.615 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.637 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 35.4 tp -61.44 -40.37 94.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -0.894 . . . . 0.0 110.198 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.506 ' HE3' ' HG3' ' A' ' 41' ' ' GLU . 28.4 mtpt -61.02 -44.68 97.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.004 . . . . 0.0 109.842 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -111.33 115.08 28.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.643 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.557 ' CG ' ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.006 . . . . 0.0 110.715 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 12' ' ' LEU . 82.3 mtt85 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.232 0.539 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.596 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 33.2 p-10 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 110.245 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . 3.1 Cg_exo . . . . . 0 N--CA 1.482 0.812 0 N-CA-C 110.489 -0.62 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.402 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . -153.46 18.88 0.7 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HG3' ' HE3' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -125.52 74.96 69.49 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.283 -1.128 . . . . 0.0 110.2 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.65 146.81 96.51 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.885 1.466 . . . . 0.0 110.462 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.103 HG23 HG23 ' A' ' 44' ' ' VAL . 11.0 m -123.12 172.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 110.383 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.103 HG23 HG23 ' A' ' 43' ' ' VAL . 2.9 t . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.452 -0.78 . . . . 0.0 111.015 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 96.2 m . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.396 0.617 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.588 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.3 t -68.78 -64.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 110.668 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.511 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 1.3 m120 -79.51 111.8 23.76 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.382 -0.824 . . . . 0.0 110.464 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -63.95 -9.02 17.51 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.694 1.365 . . . . 0.0 110.358 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.557 ' HB3' ' CG ' ' A' ' 21' ' ' LEU . 50.3 t-20 -131.1 30.98 4.49 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.289 -0.882 . . . . 0.0 110.178 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.745 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -77.15 -175.6 0.53 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 108.836 179.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.948 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.7 Cg_exo -59.02 73.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.536 1.282 . . . . 0.0 109.067 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.3 tt0 -39.43 -32.04 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.688 -0.633 . . . . 0.0 110.562 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.441 ' O ' ' HE1' ' A' ' 10' ' ' PHE . 46.5 tp10 -52.28 -25.3 9.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.957 -1.089 . . . . 0.0 108.625 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.948 HD12 ' HG2' ' A' ' 54' ' ' PRO . 89.2 mt -83.82 12.76 5.57 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.383 0.611 . . . . 0.0 109.814 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.729 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.58 -51.63 4.96 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.93 . . . . 0.0 110.532 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.94 -45.09 41.23 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.551 1.29 . . . . 0.0 110.184 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.021 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 2.8 mm? -53.81 -44.0 69.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.023 -1.048 . . . . 0.0 110.148 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.3 t -68.76 -29.1 67.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 0.0 110.312 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -79.95 3.29 20.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.622 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.533 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 9.7 pt-20 -126.39 141.65 40.59 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 110.155 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.1 Cg_exo -61.16 -11.18 17.71 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.903 1.475 . . . . 0.0 110.667 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -79.88 -15.63 56.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.123 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.021 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -48.54 -36.41 15.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.34 -41.12 98.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 110.093 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -80.45 -40.91 25.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 109.84 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.963 HG21 ' CD1' ' A' ' 60' ' ' LEU . 84.6 mt -64.39 -41.29 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.037 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.779 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.2 tm? -53.02 -55.19 25.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 110.396 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.779 ' N ' HD13 ' A' ' 70' ' ' LEU . 94.7 mt-30 -50.46 -55.37 16.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 0.0 110.186 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -52.57 -57.0 11.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.055 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 35.4 mt -46.82 -49.66 19.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 110.083 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 77.8 mm-40 -54.48 -49.27 70.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.331 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 85.4 tt0 -56.3 -55.91 27.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.721 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 79' ' ' ASP . 28.9 mm -56.75 -36.53 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.062 -1.024 . . . . 0.0 109.462 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 1.03 ' HA ' HD23 ' A' ' 12' ' ' LEU . . . -59.33 -30.03 68.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.502 -0.749 . . . . 0.0 109.275 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 34' ' ' ASN . 85.9 tt0 -62.36 -41.6 98.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 110.321 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.1 p30 -147.0 158.37 45.1 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.196 -0.94 . . . . 0.0 110.482 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.576 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.53 -57.5 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.969 1.51 . . . . 0.0 110.636 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.36 -140.74 24.92 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.944 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 60.4 p -78.14 -22.34 48.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -1.158 . . . . 0.0 109.635 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 52.9 t -52.27 -53.05 48.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 110.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.0 tt0 -57.66 -34.28 69.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 111.261 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.781 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.3 pt -95.11 12.65 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.931 -1.106 . . . . 0.0 110.446 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.8 m 56.47 15.64 2.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 0.0 110.497 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.944 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -66.56 -10.14 42.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 110.026 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -146.19 167.97 22.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 110.387 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.23 4.83 6.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 0.0 110.493 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.68 88.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 110.519 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -99.03 121.95 41.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.526 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.645 HG21 ' CB ' ' A' ' 4' ' ' GLN . 24.8 p -110.58 152.94 25.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.161 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.73 -20.01 51.12 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.272 -1.134 . . . . 0.0 110.231 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.79 HG13 ' O ' ' A' ' 1' ' ' VAL . 14.6 p . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.24 0.543 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 58.4 m -123.33 152.81 41.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.426 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.858 HG23 HD11 ' A' ' 12' ' ' LEU . 52.0 t -82.36 112.19 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.641 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HG21 ' A' ' 92' ' ' THR . 41.4 tt0 -111.49 123.49 50.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.098 -1.001 . . . . 0.0 110.71 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.606 ' OD2' HG23 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -79.73 -77.12 0.19 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 0.0 109.386 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.71 -124.54 5.36 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -81.84 3.64 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -1.152 . . . . 0.0 110.379 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.2 m-85 -114.57 132.9 56.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.145 -0.972 . . . . 0.0 110.436 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.412 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 51.6 p -85.57 130.11 34.66 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.728 ' CG ' HD21 ' A' ' 57' ' ' LEU . 18.4 m-85 -118.71 130.18 55.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 110.703 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.7 p -75.69 170.22 16.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.163 -0.961 . . . . 0.0 110.268 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.858 HD11 HG23 ' A' ' 3' ' ' VAL . 4.5 mp -95.91 -6.45 39.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 110.519 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.7 mt-10 -70.95 -71.62 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.222 -0.924 . . . . 0.0 110.667 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.473 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 4.3 m -43.17 -52.1 5.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.309 -0.869 . . . . 0.0 110.567 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.63 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 15.8 m -56.41 -49.33 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.942 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 14.4 tttp -55.27 -51.66 65.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.981 -1.074 . . . . 0.0 108.8 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -80.41 11.26 3.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.455 -0.778 . . . . 0.0 109.736 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.63 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 27.2 tp -64.58 -33.68 76.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.89 . . . . 0.0 109.948 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -62.19 -42.4 99.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 109.667 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -104.88 124.62 49.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.412 -0.805 . . . . 0.0 109.61 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.83 HD11 ' HB2' ' A' ' 52' ' ' ASN . 15.1 tp . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 110.576 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.542 ' HB3' ' HD2' ' A' ' 16' ' ' LYS . 95.4 mtt-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.196 0.522 . . . . 0.0 110.126 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.558 ' CA ' ' O ' ' A' ' 78' ' ' GLU . 32.6 p-10 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.426 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.552 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.481 0.77 0 N-CA-C 110.64 -0.562 . . . . 0.0 110.64 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.68 7.53 31.62 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 43.6 mt-10 -82.67 145.18 50.18 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.336 -1.097 . . . . 0.0 110.101 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -61.8 122.91 11.67 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.79 1.416 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.019 HG12 HG23 ' A' ' 44' ' ' VAL . 94.7 t -141.87 158.22 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.955 . . . . 0.0 110.506 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.019 HG23 HG12 ' A' ' 43' ' ' VAL . 25.8 t . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.456 -0.777 . . . . 0.0 111.169 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 82.0 m . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.413 0.625 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.581 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 47.0 t -77.47 -70.82 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.029 -1.044 . . . . 0.0 110.155 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.518 ' CG ' HD13 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -76.7 111.96 19.21 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.494 -0.753 . . . . 0.0 110.263 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.613 ' HD2' HD22 ' A' ' 21' ' ' LEU . 3.0 Cg_exo -63.57 -10.04 20.44 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.627 1.33 . . . . 0.0 110.324 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.83 ' HB2' HD11 ' A' ' 21' ' ' LEU . 94.0 m-20 -127.03 31.62 5.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.727 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.08 -179.35 1.39 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 108.948 179.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.758 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.8 Cg_exo -59.36 75.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.562 1.296 . . . . 0.0 109.044 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.601 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.7 tt0 -39.27 -27.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.723 -0.611 . . . . 0.0 110.174 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' PRO . 74.3 mm-40 -53.68 -17.85 2.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.107 -0.996 . . . . 0.0 108.554 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.758 HD12 ' HG2' ' A' ' 54' ' ' PRO . 86.3 mt -91.54 9.63 31.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.658 -0.651 . . . . 0.0 109.608 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.747 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -39.54 -51.49 4.93 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.85 . . . . 0.0 110.756 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.747 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.05 -42.86 63.44 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.495 1.26 . . . . 0.0 109.784 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.902 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 4.1 tt -57.48 -38.85 75.22 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.116 -0.99 . . . . 0.0 109.77 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.892 ' HA ' HG13 ' A' ' 44' ' ' VAL . 49.3 t -63.61 -29.27 70.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 110.474 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.521 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 53.4 mttp -104.05 30.41 5.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.596 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.521 ' OE1' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -129.5 136.74 29.58 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.407 -0.808 . . . . 0.0 110.437 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.8 Cg_endo -64.2 -27.03 64.52 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.662 1.349 . . . . 0.0 109.883 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -81.32 -11.06 59.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 110.846 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.902 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.98 -38.29 16.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.029 -1.045 . . . . 0.0 110.126 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.76 -40.72 80.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -80.27 -39.43 28.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.763 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.712 HG21 HD12 ' A' ' 60' ' ' LEU . 81.1 mt -64.62 -51.39 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.335 -0.853 . . . . 0.0 109.956 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.784 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.4 tm? -46.8 -58.45 3.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.389 -0.82 . . . . 0.0 110.113 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.673 ' N ' HD13 ' A' ' 70' ' ' LEU . 55.7 tt0 -44.85 -51.56 9.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -58.72 -56.5 21.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.431 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.502 HD21 ' OD1' ' A' ' 5' ' ' ASP . 47.6 mt -47.12 -53.1 13.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 0.0 110.216 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.577 ' OE2' HD21 ' A' ' 70' ' ' LEU . 52.4 mt-10 -57.22 -46.06 83.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 110.406 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -57.99 -53.71 55.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.953 -1.092 . . . . 0.0 110.127 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 79' ' ' ASP . 54.2 mt -60.94 -33.94 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.15 -0.969 . . . . 0.0 109.403 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -57.73 -33.69 68.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.379 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.558 ' O ' ' CA ' ' A' ' 34' ' ' ASN . 84.4 tt0 -61.71 -40.81 96.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.479 -0.763 . . . . 0.0 110.22 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -147.11 155.4 47.01 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.078 -1.014 . . . . 0.0 110.26 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.486 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -59.1 -62.27 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.786 1.414 . . . . 0.0 110.669 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.78 -139.07 21.73 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.95 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 45.4 p -81.03 -21.28 40.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -1.148 . . . . 0.0 109.973 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 9.1 t -53.8 -54.09 43.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.965 . . . . 0.0 109.99 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 34.6 tt0 -58.13 -31.05 66.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.331 -0.856 . . . . 0.0 111.113 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.775 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.6 pt -97.26 12.08 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.991 -1.068 . . . . 0.0 110.322 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 34.2 m 54.07 18.73 1.81 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.887 . . . . 0.0 110.578 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.95 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.13 -12.28 59.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 0.0 110.067 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.555 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 26.9 m-85 -146.75 175.55 10.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.82 3.36 10.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 110.302 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.36 -32.46 73.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -114.5 123.37 49.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 0.0 110.564 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.567 HG21 ' OE1' ' A' ' 4' ' ' GLN . 27.0 p -117.13 161.01 20.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.378 -0.826 . . . . 0.0 110.211 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.47 -33.11 5.68 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.299 -1.118 . . . . 0.0 110.303 -179.889 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 1' ' ' VAL . 3.2 m . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.096 0.474 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 1.039 HG21 ' OG ' ' A' ' 9' ' ' SER . 9.6 t -129.09 163.18 26.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.76 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.835 HG23 HD11 ' A' ' 12' ' ' LEU . 50.8 t -84.41 116.43 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.84 ' OE1' HG21 ' A' ' 92' ' ' THR . 46.4 tt0 -108.61 111.69 23.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.032 -1.042 . . . . 0.0 110.951 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.672 ' OD2' HD21 ' A' ' 73' ' ' LEU . 89.8 m-20 -94.26 4.45 53.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.25 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.509 ' O ' ' CG ' ' A' ' 4' ' ' GLN . . . -169.64 -148.1 5.73 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.32 8.96 6.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -1.167 . . . . 0.0 110.516 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.466 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 95.3 m-85 -119.84 147.82 44.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.031 -1.043 . . . . 0.0 110.51 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 1.039 ' OG ' HG21 ' A' ' 2' ' ' THR . 2.0 t -89.03 120.97 30.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 109.829 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.679 ' CD2' HD23 ' A' ' 57' ' ' LEU . 92.9 m-85 -108.43 117.77 35.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.177 -0.952 . . . . 0.0 110.867 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.481 ' C ' HD12 ' A' ' 12' ' ' LEU . 60.4 p -71.64 169.6 15.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 109.528 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.844 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.1 mp -104.49 -0.93 27.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.978 -1.076 . . . . 0.0 110.763 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -67.13 -69.97 0.28 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.124 -0.985 . . . . 0.0 110.715 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.1 m -42.42 -50.99 5.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.344 -0.848 . . . . 0.0 111.165 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.674 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.6 m -57.79 -48.05 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.102 -0.999 . . . . 0.0 109.669 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.773 ' CG ' ' HB1' ' A' ' 77' ' ' ALA . 15.7 mttt -54.86 -54.58 40.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.1 -1.0 . . . . 0.0 108.811 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 48.1 tttt -80.43 11.02 3.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -0.766 . . . . 0.0 109.552 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.674 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 16.8 tp -59.62 -33.41 71.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -0.97 . . . . 0.0 110.069 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -67.23 -39.23 86.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.589 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 24.7 t70 -118.14 88.15 2.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.633 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 52' ' ' ASN . 6.3 tp . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.39 -0.819 . . . . 0.0 111.045 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 32.6 ptt180 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.272 0.558 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 33' ' ' ARG . 92.0 m-20 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 110.085 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.525 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.804 0 N-CA-C 110.546 -0.598 . . . . 0.0 110.546 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.47 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 104.58 20.77 9.78 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -122.32 74.02 40.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.233 -1.157 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_endo -61.09 143.61 99.02 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.936 1.493 . . . . 0.0 110.583 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.485 ' HB ' ' OG ' ' A' ' 49' ' ' SER . 6.0 m -140.25 54.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.815 ' O ' HG12 ' A' ' 44' ' ' VAL . 54.8 t . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.258 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.564 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 87.2 m . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.311 0.577 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.512 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 60.7 p -60.87 -39.3 88.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.994 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.553 ' HB3' HD22 ' A' ' 21' ' ' LEU . 10.5 m-20 -80.54 113.77 42.26 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.48 -7.63 9.15 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.681 1.359 . . . . 0.0 110.87 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.797 ' HB2' HD21 ' A' ' 21' ' ' LEU . 93.1 m-20 -137.29 31.46 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 110.665 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.769 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.2 p90 -73.34 -175.7 0.41 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.13 -0.981 . . . . 0.0 108.762 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.938 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.9 Cg_exo -60.57 73.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.494 1.26 . . . . 0.0 108.863 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.584 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.1 tt0 -39.22 -31.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.724 -0.61 . . . . 0.0 110.34 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 54' ' ' PRO . 97.4 mt-10 -53.71 -26.72 24.27 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.969 -1.082 . . . . 0.0 108.721 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.938 HD12 ' HG2' ' A' ' 54' ' ' PRO . 90.7 mt -84.38 7.38 19.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.731 -0.605 . . . . 0.0 109.534 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.731 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 7.3 mmtt -39.59 -51.62 4.98 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 110.303 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.731 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.53 -44.91 43.82 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.588 1.31 . . . . 0.0 109.824 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.099 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -52.06 -43.81 63.99 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.054 -1.029 . . . . 0.0 109.844 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.6 m -66.96 -27.52 67.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.371 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -82.63 4.97 22.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.902 . . . . 0.0 110.736 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 8.5 pt-20 -127.98 144.7 52.44 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.025 -1.047 . . . . 0.0 110.229 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.16 -12.66 27.75 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.881 1.464 . . . . 0.0 110.736 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.491 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 83.7 m-20 -80.12 -18.41 49.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.892 . . . . 0.0 110.201 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.099 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.19 -39.36 13.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 110.22 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.06 -44.2 87.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 110.296 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -80.2 -39.12 29.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.208 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.979 HG21 ' CD1' ' A' ' 60' ' ' LEU . 77.8 mt -64.42 -47.45 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.563 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.8 tm? -49.06 -57.27 6.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.537 ' N ' HD13 ' A' ' 70' ' ' LEU . 51.5 tt0 -49.55 -53.02 25.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.114 -0.991 . . . . 0.0 110.013 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -55.01 -50.4 69.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.672 HD21 ' OD2' ' A' ' 5' ' ' ASP . 96.0 mt -51.07 -50.08 59.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.761 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 70.6 mm-40 -53.99 -52.56 60.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 110.292 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.525 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.2 tt0 -52.69 -55.06 25.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 110.499 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 79' ' ' ASP . 28.2 mm -56.85 -34.36 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 0.0 109.41 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.773 ' HB1' ' CG ' ' A' ' 16' ' ' LYS . . . -59.21 -32.79 70.26 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.498 ' OE2' ' HD3' ' A' ' 39' ' ' PRO . 95.4 mt-10 -59.4 -41.2 88.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 110.139 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -149.26 155.3 39.68 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.641 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -60.15 -57.28 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.88 1.463 . . . . 0.0 110.575 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.12 -138.95 19.98 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.775 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 43.6 p -81.09 -21.04 40.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -1.176 . . . . 0.0 109.742 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.576 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 20.7 t -55.2 -53.01 61.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.86 . . . . 0.0 110.184 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 35.5 tt0 -62.49 -27.09 68.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.933 . . . . 0.0 111.407 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.778 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.9 pt -98.01 14.07 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.757 -1.214 . . . . 0.0 110.433 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 50.9 19.74 0.68 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 0.0 110.714 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.778 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -68.82 -11.85 60.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.067 -1.02 . . . . 0.0 110.025 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -148.62 175.4 11.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 110.085 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.41 1.73 15.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.048 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.94 75.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.314 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -105.83 128.15 53.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 110.536 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.84 HG21 ' OE1' ' A' ' 4' ' ' GLN . 33.2 p -110.79 155.79 22.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 110.109 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 93.54 -19.32 53.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.259 -1.142 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.495 ' HA ' ' SG ' ' A' ' 91' ' ' CYS . 25.6 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.266 0.555 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 68.0 m -123.78 148.39 46.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 110.446 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.653 HG21 ' HG ' ' A' ' 12' ' ' LEU . 47.8 t -79.82 110.38 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.307 -0.87 . . . . 0.0 109.742 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.514 ' CD ' HG21 ' A' ' 92' ' ' THR . 43.7 tt0 -110.41 121.09 44.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -0.95 . . . . 0.0 110.716 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.847 ' OD2' HD11 ' A' ' 73' ' ' LEU . 85.0 m-20 -95.94 6.12 49.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 109.576 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 4' ' ' GLN . . . -175.45 -139.85 3.21 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -79.8 3.21 20.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -1.19 . . . . 0.0 110.419 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 83.3 m-85 -121.32 131.15 54.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 110.359 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 2' ' ' THR . 67.8 m -79.96 132.3 36.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.336 -0.852 . . . . 0.0 110.201 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.754 ' CG ' HD21 ' A' ' 57' ' ' LEU . 22.1 m-85 -116.56 128.91 55.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 110.6 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 m -69.25 162.27 27.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.922 . . . . 0.0 110.349 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.747 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.2 mp -87.39 -25.87 23.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.867 . . . . 0.0 110.23 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.507 ' HG3' ' NE ' ' A' ' 33' ' ' ARG . 87.8 tt0 -61.77 -65.6 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.294 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.555 ' O ' ' CB ' ' A' ' 18' ' ' LEU . 4.4 m -43.83 -54.55 5.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.137 -0.977 . . . . 0.0 110.422 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.63 HG23 ' N ' ' A' ' 16' ' ' LYS . 30.3 m -61.46 -48.32 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 110.348 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.635 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 8.7 ttmm -59.33 -55.5 33.97 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.074 -1.016 . . . . 0.0 109.371 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' OD1' ' A' ' 20' ' ' ASP . 28.9 mmtp -80.46 6.78 11.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.367 -0.833 . . . . 0.0 110.124 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.675 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -73.21 -30.89 63.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.95 -1.094 . . . . 0.0 109.869 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -56.41 -39.09 72.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 109.748 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 26.3 p-10 -111.53 98.08 7.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.849 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.766 HD21 ' HB2' ' A' ' 52' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 110.498 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.507 ' NE ' ' HG3' ' A' ' 13' ' ' GLU . 71.3 mtt-85 . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 80.1 m-20 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.055 . . . . 0.0 111.205 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.568 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 3.1 Cg_exo . . . . . 0 N--CA 1.482 0.85 0 N-CA-C 110.684 -0.545 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.509 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 95.31 14.68 47.14 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.527 ' O ' HG23 ' A' ' 43' ' ' VAL . 19.3 mm-40 -114.71 106.64 51.82 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.188 -1.183 . . . . 0.0 110.157 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.464 ' C ' HG23 ' A' ' 43' ' ' VAL . 3.0 Cg_exo -60.9 144.65 99.61 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.822 1.433 . . . . 0.0 110.478 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.777 ' O ' HG23 ' A' ' 44' ' ' VAL . 38.6 t -147.67 54.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 110.234 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.79 ' O ' HG12 ' A' ' 44' ' ' VAL . 24.9 t . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.301 -0.874 . . . . 0.0 110.767 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.571 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 94.2 m . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.256 0.55 . . . . 0.0 109.8 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.583 ' HB3' ' CG1' ' A' ' 43' ' ' VAL . 4.6 t -54.68 -58.1 8.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 111.113 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 8.8 m-20 -80.09 113.18 36.36 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.33 -0.856 . . . . 0.0 110.853 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -66.03 -13.32 39.32 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.68 1.358 . . . . 0.0 110.298 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.766 ' HB2' HD21 ' A' ' 21' ' ' LEU . 25.8 m120 -116.08 21.27 13.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 0.0 110.471 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.656 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -79.89 175.05 5.17 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 108.983 179.23 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.664 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.5 Cg_exo -57.59 75.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.63 1.331 . . . . 0.0 108.904 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.614 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.7 tt0 -39.44 -28.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.675 -0.641 . . . . 0.0 110.27 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.502 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.7 mt-10 -52.82 -19.37 2.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.023 -1.048 . . . . 0.0 108.55 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.754 HD21 ' CG ' ' A' ' 10' ' ' PHE . 68.0 mt -86.11 4.05 39.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.634 -0.666 . . . . 0.0 109.398 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.758 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -39.92 -51.18 5.68 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.502 -0.748 . . . . 0.0 110.375 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.758 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.32 -40.57 82.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.615 1.324 . . . . 0.0 110.382 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.114 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 6.5 mp -62.24 -36.66 82.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.92 -1.113 . . . . 0.0 109.885 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.4 m -64.79 -28.02 69.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 110.257 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -79.85 -10.23 59.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.609 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.493 ' OE2' ' HB2' ' A' ' 65' ' ' ASN . 8.4 pt-20 -114.67 144.1 31.24 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.014 . . . . 0.0 110.16 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.38 -11.74 27.19 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.875 1.461 . . . . 0.0 110.919 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.493 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 75.6 m-20 -81.39 -14.99 56.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 110.419 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.114 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -48.03 -39.99 21.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.171 -0.956 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -61.05 -39.69 90.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 110.101 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -80.03 -36.57 35.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.972 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.806 HG21 ' CD2' ' A' ' 60' ' ' LEU . 86.6 mt -68.43 -43.06 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.873 . . . . 0.0 109.922 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.764 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.7 OUTLIER -51.83 -54.72 25.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -0.82 . . . . 0.0 110.435 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.764 ' N ' HD13 ' A' ' 70' ' ' LEU . 64.1 tt0 -49.64 -54.9 15.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.102 -0.999 . . . . 0.0 110.664 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -50.36 -54.15 23.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.39 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.847 HD11 ' OD2' ' A' ' 5' ' ' ASP . 54.7 mt -50.26 -47.88 55.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.9 . . . . 0.0 110.406 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.625 ' OE2' HD11 ' A' ' 70' ' ' LEU . 80.3 mt-10 -55.6 -45.88 77.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 110.453 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 96.1 mt-10 -58.64 -54.4 47.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.049 -1.032 . . . . 0.0 110.674 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.9 mt -61.16 -37.63 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.059 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.635 ' HB1' ' HB2' ' A' ' 16' ' ' LYS . . . -61.36 -32.85 72.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.457 -0.777 . . . . 0.0 110.054 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 80.3 tt0 -58.44 -35.88 72.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.653 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.45 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -156.54 151.01 20.13 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.683 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.542 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 3.2 Cg_exo -61.67 82.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.012 1.532 . . . . 0.0 110.702 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.53 -134.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.934 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 72.1 p -79.29 -14.37 59.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.12 -1.223 . . . . 0.0 109.545 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 19.6 t -54.16 -52.11 62.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 110.324 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.542 ' OE1' ' HB2' ' A' ' 80' ' ' PRO . 84.2 tt0 -56.6 -33.01 65.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.208 -0.933 . . . . 0.0 111.272 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.774 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.6 pt -98.05 11.76 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.897 -1.127 . . . . 0.0 110.441 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.8 m 54.3 17.12 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.883 . . . . 0.0 110.553 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.934 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.62 -11.1 41.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 109.9 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.47 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.5 OUTLIER -144.33 172.12 13.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.265 -0.897 . . . . 0.0 110.096 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.54 4.2 6.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 110.38 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.31 -35.26 80.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.0 110.634 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.594 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -106.57 121.16 43.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 0.0 110.632 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.514 HG21 ' CD ' ' A' ' 4' ' ' GLN . 14.6 p -104.92 156.08 18.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 110.126 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.38 -4.39 64.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.204 -1.174 . . . . 0.0 110.273 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.254 0.55 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 55.7 m -89.55 151.36 21.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 0.0 110.34 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 10' ' ' PHE . 0.9 OUTLIER -91.61 120.36 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.463 -0.773 . . . . 0.0 109.873 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 49.0 tt0 -110.27 130.05 55.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.644 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.762 ' OD2' HD21 ' A' ' 73' ' ' LEU . 90.4 m-20 -111.69 9.06 20.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 109.802 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.91 -135.98 2.6 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -81.87 -1.48 47.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -1.195 . . . . 0.0 110.199 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.493 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 55.4 m-85 -119.48 143.77 47.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.214 -0.929 . . . . 0.0 110.325 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.7 p -90.38 128.76 36.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 110.172 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.592 ' CE2' ' HG ' ' A' ' 57' ' ' LEU . 21.7 m-30 -110.01 118.81 37.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.247 -0.908 . . . . 0.0 110.335 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.2 t -70.19 166.95 18.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.0 110.016 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 mp -95.22 1.25 54.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.196 -0.94 . . . . 0.0 110.628 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -74.54 -69.88 0.43 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.213 -0.929 . . . . 0.0 110.461 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 18' ' ' LEU . 3.8 m -52.03 -38.75 58.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.836 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 9.3 t -67.42 -55.41 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.909 -1.119 . . . . 0.0 109.84 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.509 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 39.9 tttp -53.62 -55.78 22.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.941 -1.1 . . . . 0.0 108.904 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 20' ' ' ASP . 52.1 tttt -80.33 8.81 6.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.446 -0.784 . . . . 0.0 109.829 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 5.5 tt -55.7 -43.01 76.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 110.173 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -58.84 -49.14 78.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.934 . . . . 0.0 110.022 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 60.7 t0 -98.81 107.27 19.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 109.867 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.559 ' CD1' ' HB2' ' A' ' 52' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 110.438 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.442 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.238 0.542 . . . . 0.0 109.97 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 78' ' ' GLU . 25.0 m120 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.468 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.523 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.1 Cg_exo . . . . . 0 N--CA 1.481 0.789 0 N-CA-C 110.617 -0.57 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.484 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 146.78 -8.92 1.34 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.55 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -119.46 76.47 18.3 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.001 -1.294 . . . . 0.0 110.474 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.707 ' HA ' HD12 ' A' ' 70' ' ' LEU . 2.9 Cg_endo -62.56 128.48 23.61 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.818 1.431 . . . . 0.0 110.473 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.2 m -135.69 142.96 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.026 HG22 ' HA ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.398 -0.814 . . . . 0.0 110.305 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.368 0.604 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.494 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 9.2 t -56.62 -60.19 3.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.0 110.455 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.556 ' ND2' ' HB2' ' A' ' 21' ' ' LEU . 8.4 m120 -80.26 114.26 45.56 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 0.0 110.273 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -61.7 -5.04 5.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.8 1.421 . . . . 0.0 111.028 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.559 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 94.5 m-20 -140.32 33.73 1.88 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.143 -0.973 . . . . 0.0 110.347 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.746 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -75.28 -174.59 0.39 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 109.061 179.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.941 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -57.86 72.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.406 1.214 . . . . 0.0 109.921 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.5 tt0 -41.16 -36.03 0.68 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.711 . . . . 0.0 110.314 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.562 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.9 mt-10 -52.78 -19.31 2.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 108.829 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.941 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.2 mp -94.64 16.29 15.96 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.89 0.853 . . . . 0.0 109.113 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.738 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.76 -52.54 4.95 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.941 -0.474 . . . . 0.0 110.972 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.738 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.14 -44.87 45.33 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.506 1.266 . . . . 0.0 110.07 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.874 HD22 HD13 ' A' ' 69' ' ' ILE . 79.9 mt -59.04 -35.95 74.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.057 -1.027 . . . . 0.0 109.936 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.026 ' HA ' HG22 ' A' ' 44' ' ' VAL . 50.6 t -64.65 -25.02 67.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.025 . . . . 0.0 110.384 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -113.45 29.67 7.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.127 -0.983 . . . . 0.0 109.415 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.55 139.91 27.61 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.606 -0.684 . . . . 0.0 110.484 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.51 -27.4 76.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.65 1.342 . . . . 0.0 109.964 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.37 -16.7 53.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.153 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.0 ' HB1' HG21 ' A' ' 44' ' ' VAL . . . -43.56 -39.61 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -54.54 -43.64 72.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.863 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.48 ' HG2' ' NE ' ' A' ' 72' ' ' ARG . 86.5 tt0 -80.05 -38.75 31.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.949 . . . . 0.0 109.88 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.874 HD13 HD22 ' A' ' 60' ' ' LEU . 78.6 mt -63.38 -55.19 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.987 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.1 tm? -42.34 -64.55 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.436 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.987 ' N ' HD13 ' A' ' 70' ' ' LEU . 56.5 mt-30 -47.65 -53.39 15.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.077 -1.014 . . . . 0.0 110.465 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.48 ' NE ' ' HG2' ' A' ' 68' ' ' GLU . 62.2 mtt180 -54.87 -53.58 53.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 110.138 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.762 HD21 ' OD2' ' A' ' 5' ' ' ASP . 86.3 mt -49.86 -53.01 28.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 110.015 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.651 ' OE2' HD21 ' A' ' 70' ' ' LEU . 80.5 mt-10 -53.15 -45.11 68.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 110.237 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.485 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.1 tt0 -57.74 -54.02 51.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.353 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 79' ' ' ASP . 29.8 mm -59.43 -36.95 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.153 -0.967 . . . . 0.0 109.738 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 16' ' ' LYS . . . -58.16 -33.9 69.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 109.575 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.477 ' O ' ' O ' ' A' ' 34' ' ' ASN . 85.8 tt0 -60.31 -40.16 89.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.497 -0.752 . . . . 0.0 110.347 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 76' ' ' ILE . 9.5 m-20 -145.54 153.13 50.97 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.135 -0.978 . . . . 0.0 110.31 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -59.76 -58.55 0.56 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.884 1.465 . . . . 0.0 110.57 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.14 -137.88 19.12 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 1.002 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 53.1 p -82.38 -21.44 35.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -1.171 . . . . 0.0 110.107 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 38.9 t -54.58 -53.39 55.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 110.007 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 82.9 tt0 -60.33 -29.19 68.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 0.0 111.322 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.774 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.0 pt -97.22 13.54 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.863 -1.148 . . . . 0.0 110.276 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 62.9 m 55.43 15.15 1.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 0.0 110.574 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 1.002 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -63.72 -12.59 35.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.117 -0.989 . . . . 0.0 109.891 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.413 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 21.7 m-85 -149.48 173.8 13.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 110.324 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.46 3.85 10.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.393 -0.817 . . . . 0.0 110.453 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.66 -33.8 74.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.586 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -106.58 125.31 50.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.678 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -109.93 152.73 25.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.382 -0.824 . . . . 0.0 110.111 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.98 52.36 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.265 -1.139 . . . . 0.0 110.134 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.476 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 3.8 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.154 0.502 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.685 HG21 ' HB2' ' A' ' 9' ' ' SER . 8.4 t -123.51 161.24 25.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.923 . . . . 0.0 110.64 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.606 HG23 HD11 ' A' ' 12' ' ' LEU . 71.0 t -91.9 119.72 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.568 -0.708 . . . . 0.0 109.544 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.61 ' OE1' HG21 ' A' ' 92' ' ' THR . 36.5 mt-30 -110.49 135.01 51.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.96 . . . . 0.0 110.787 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.765 ' OD2' HD21 ' A' ' 73' ' ' LEU . 80.8 m-20 -104.76 11.07 34.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.202 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.28 -131.88 1.97 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -89.6 10.16 24.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.191 -1.182 . . . . 0.0 110.57 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 92.6 m-85 -114.79 154.75 27.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 110.385 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.685 ' HB2' HG21 ' A' ' 2' ' ' THR . 60.4 p -105.1 121.55 44.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.577 ' CE2' HD11 ' A' ' 60' ' ' LEU . 19.9 m-85 -118.99 128.06 54.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.942 . . . . 0.0 110.578 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 m -70.8 165.58 22.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.395 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.861 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 mp -96.37 -8.8 31.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.282 -0.886 . . . . 0.0 110.339 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' SER . 84.4 tt0 -70.97 -70.71 0.29 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.298 -0.876 . . . . 0.0 110.926 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.6 m -43.97 -48.85 8.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.161 -0.962 . . . . 0.0 110.677 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.691 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 14.3 m -59.46 -47.36 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.115 -0.991 . . . . 0.0 110.319 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.525 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 20.7 tttm -56.75 -55.27 36.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.831 -1.168 . . . . 0.0 109.075 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 20' ' ' ASP . 7.4 tptm -80.43 10.9 4.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.41 -0.806 . . . . 0.0 109.288 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 47.1 tp -56.31 -45.27 80.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 110.666 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -56.87 -46.28 81.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 110.191 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 22.3 t70 -105.78 122.26 45.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.915 . . . . 0.0 110.198 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.893 HD22 ' HB2' ' A' ' 52' ' ' ASN . 79.4 mt . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.225 -0.922 . . . . 0.0 110.075 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.134 0.492 . . . . 0.0 110.028 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.561 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 81.5 m-20 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 110.519 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.506 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.842 0 N-CA-C 110.582 -0.584 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.51 -1.36 42.78 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -132.46 75.5 73.75 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.211 -1.17 . . . . 0.0 110.147 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.414 ' HA ' ' HG ' ' A' ' 70' ' ' LEU . 3.0 Cg_endo -61.63 143.09 96.44 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.951 1.501 . . . . 0.0 110.329 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.501 ' C ' HG23 ' A' ' 44' ' ' VAL . 14.5 m -109.24 48.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 110.282 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.736 ' O ' HG12 ' A' ' 44' ' ' VAL . 84.2 t . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.51 -0.744 . . . . 0.0 110.705 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 99.3 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.349 0.595 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.574 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 14.0 t -65.85 -73.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 110.89 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 8.6 m-20 -77.84 112.29 23.82 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.389 -0.819 . . . . 0.0 110.574 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.38 -9.17 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 O-C-N 123.673 1.354 . . . . 0.0 109.826 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.893 ' HB2' HD22 ' A' ' 21' ' ' LEU . 93.1 m-20 -119.24 27.13 9.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.449 -0.782 . . . . 0.0 110.274 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.682 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.03 174.73 5.65 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.005 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.682 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -56.82 76.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.739 1.389 . . . . 0.0 108.952 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 53' ' ' PHE . 2.7 pt-20 -39.38 -26.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.811 -0.556 . . . . 0.0 110.251 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 54' ' ' PRO . 49.2 tp10 -53.05 -19.02 2.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.011 -1.056 . . . . 0.0 108.38 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.607 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 58.2 mt -90.8 7.63 38.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.621 . . . . 0.0 109.579 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.734 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.69 -51.67 5.12 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 110.687 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.734 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -55.0 -43.16 62.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.502 1.264 . . . . 0.0 110.159 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.064 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 11.5 mt -58.76 -36.69 74.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.089 -1.007 . . . . 0.0 109.947 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.9 t -66.14 -26.57 67.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 110.293 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -92.19 3.73 54.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 111.049 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.557 ' OE2' HD11 ' A' ' 69' ' ' ILE . 6.1 pt-20 -119.17 145.89 39.34 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.853 -1.155 . . . . 0.0 110.269 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.53 -17.83 60.27 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.923 1.486 . . . . 0.0 111.252 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.495 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 21.8 m120 -79.7 -13.63 59.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.064 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.56 -42.37 23.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -59.75 -40.0 86.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 110.418 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -80.13 -36.64 34.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.068 -1.02 . . . . 0.0 109.985 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.882 HG21 HD13 ' A' ' 60' ' ' LEU . 88.7 mt -66.2 -44.53 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 109.986 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.824 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.3 tm? -51.02 -56.62 11.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.846 . . . . 0.0 110.214 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.824 ' N ' HD13 ' A' ' 70' ' ' LEU . 23.7 mt-30 -47.78 -54.64 11.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 110.247 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -51.49 -54.74 23.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.387 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.765 HD21 ' OD2' ' A' ' 5' ' ' ASP . 52.3 mt -50.66 -49.53 56.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.272 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.571 ' OE2' HD11 ' A' ' 70' ' ' LEU . 79.1 mt-10 -55.29 -49.32 72.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.755 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.46 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -57.56 -54.75 43.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.033 -1.042 . . . . 0.0 110.725 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 79' ' ' ASP . 23.0 mm -60.56 -37.11 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.09 -1.006 . . . . 0.0 109.823 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.81 -32.27 67.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 0.0 109.663 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.0 tt0 -63.74 -40.32 96.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.46 -0.775 . . . . 0.0 110.31 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.457 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -151.32 156.41 34.97 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 0.0 110.076 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.541 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -59.08 -65.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.93 1.49 . . . . 0.0 110.643 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.14 -142.12 22.03 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.854 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 65.0 p -77.42 -19.71 55.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -1.126 . . . . 0.0 109.836 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.745 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 48.8 t -58.79 -51.12 71.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.848 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.3 tt0 -52.96 -30.25 33.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.698 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.742 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.2 pt -103.69 11.6 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.093 -1.004 . . . . 0.0 110.123 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 57.9 m 57.92 17.58 4.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.321 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.854 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -70.51 -14.55 62.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.943 . . . . 0.0 110.093 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.562 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 37.8 t80 -132.34 165.27 24.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.305 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.22 -0.23 11.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 110.274 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.562 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -65.56 -41.73 92.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.158 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.745 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -93.26 111.86 23.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 110.251 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.61 HG21 ' OE1' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -110.88 4.21 19.55 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.499 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . -75.12 -52.05 7.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.499 ' C ' ' O ' ' A' ' 93' ' ' GLY . 1.4 m . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.423 -1.045 . . . . 0.0 110.494 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 94' ' ' CYS . 4.5 m . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.223 0.535 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.4 m -117.83 146.21 44.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 110.387 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.54 ' HB ' HD11 ' A' ' 12' ' ' LEU . 1.2 t -84.16 122.35 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.763 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.74 ' OE1' HG21 ' A' ' 92' ' ' THR . 66.9 mt-30 -112.75 124.72 53.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.958 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.831 ' HB2' HG23 ' A' ' 69' ' ' ILE . 44.4 p30 -103.37 12.0 35.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.55 -139.01 3.5 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -89.08 19.59 4.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -1.177 . . . . 0.0 110.194 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.676 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.5 m-85 -126.67 158.37 36.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.305 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 74.2 m -102.64 115.82 31.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.148 -0.97 . . . . 0.0 110.423 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.68 ' CG ' HD11 ' A' ' 57' ' ' LEU . 17.2 m-30 -116.75 128.01 54.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.365 -0.835 . . . . 0.0 110.596 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.499 ' C ' HD12 ' A' ' 12' ' ' LEU . 34.4 t -75.85 170.6 15.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.917 . . . . 0.0 110.116 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.817 ' N ' HD12 ' A' ' 12' ' ' LEU . 6.9 mp -93.12 -16.97 24.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.155 -0.965 . . . . 0.0 110.645 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.4 mt-10 -64.47 -71.92 0.16 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.151 -0.968 . . . . 0.0 110.402 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.2 m -42.77 -51.72 5.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 0.0 110.376 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.627 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 49.5 t -56.12 -48.26 79.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.58 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HE3' ' HG3' ' A' ' 17' ' ' LYS . 6.3 ttpp -54.98 -54.67 39.97 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.168 -0.957 . . . . 0.0 108.686 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.469 ' HG3' ' HE3' ' A' ' 16' ' ' LYS . 45.0 mttt -80.62 14.12 2.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.449 -0.782 . . . . 0.0 109.911 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.8 tt -65.92 -35.05 79.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 110.073 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' NZ ' ' HB3' ' A' ' 41' ' ' GLU . 26.9 mttm -97.61 143.96 27.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 53.62 48.66 21.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.984 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.535 ' CD2' ' HB2' ' A' ' 52' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.857 . . . . 0.0 110.251 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.539 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 22.6 ptt-85 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.101 0.477 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 33' ' ' ARG . 80.2 m-20 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.0 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.588 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo . . . . . 0 N--CA 1.481 0.788 0 N-CA-C 110.541 -0.6 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.46 5.86 10.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 19' ' ' LYS . 1.7 mt-10 -133.52 74.0 71.91 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.298 -1.119 . . . . 0.0 110.157 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -60.67 146.06 97.83 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.836 1.44 . . . . 0.0 110.406 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 44' ' ' VAL . 45.4 t -131.38 122.34 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 110.538 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.865 ' O ' HG12 ' A' ' 44' ' ' VAL . 21.7 t . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.228 -0.92 . . . . 0.0 110.49 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.565 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 74.9 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.254 0.549 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.746 ' HB3' HG11 ' A' ' 43' ' ' VAL . 30.5 t -64.16 -64.86 0.78 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.128 -0.982 . . . . 0.0 110.47 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 10.0 m-20 -80.27 114.15 44.77 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.811 . . . . 0.0 110.081 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -64.85 -2.33 5.31 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.693 1.365 . . . . 0.0 110.772 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.535 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 95.6 m-20 -124.18 22.98 8.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.64 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.81 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 3.6 p90 -80.06 -176.33 0.72 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 108.945 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 1.004 ' HB2' HD13 ' A' ' 57' ' ' LEU . 5.0 Cg_exo -56.39 74.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.562 1.296 . . . . 0.0 109.657 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.6 tt0 -41.4 -36.69 0.89 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.509 -0.744 . . . . 0.0 110.132 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.576 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.9 mt-10 -52.03 -17.77 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.92 . . . . 0.0 108.981 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.004 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.4 mp -94.51 8.72 41.2 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.017 0.913 . . . . 0.0 109.327 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.77 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -41.79 -51.05 9.87 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.77 -0.581 . . . . 0.0 110.151 179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.77 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -53.8 -41.51 73.92 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.521 1.274 . . . . 0.0 110.1 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.036 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 9.5 mp -56.97 -42.47 80.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.948 -1.095 . . . . 0.0 109.402 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.803 ' O ' HG13 ' A' ' 44' ' ' VAL . 72.9 m -61.16 -24.52 66.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -99.31 1.6 44.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.323 -0.861 . . . . 0.0 110.769 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 60' ' ' LEU . 10.1 pt-20 -117.79 147.28 40.74 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.084 -1.01 . . . . 0.0 110.288 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.8 Cg_endo -64.01 -17.21 58.93 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.469 1.446 . . . . 0.0 111.258 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.509 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 53.2 m-20 -79.16 -20.83 47.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.09 -1.007 . . . . 0.0 110.87 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.036 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.57 -37.62 8.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.928 -1.108 . . . . 0.0 109.675 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.604 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.7 mt-30 -61.12 -41.37 96.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 110.187 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.8 mt-10 -80.14 -34.16 37.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.831 HG23 ' HB2' ' A' ' 5' ' ' ASP . 85.1 mt -73.02 -49.97 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 109.812 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.837 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.7 tm? -48.45 -56.59 7.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 109.922 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.774 ' N ' HD13 ' A' ' 70' ' ' LEU . 93.8 mt-30 -47.3 -51.55 18.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 110.028 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 93.0 mtt-85 -58.18 -60.99 2.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 5' ' ' ASP . 8.0 mt -46.17 -54.41 8.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.015 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.645 ' HG2' HD22 ' A' ' 70' ' ' LEU . 76.2 mm-40 -50.92 -42.72 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 109.821 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.588 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 81.1 tt0 -66.8 -51.52 54.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.513 ' O ' ' O ' ' A' ' 79' ' ' ASP . 67.1 mt -65.19 -38.86 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -0.942 . . . . 0.0 109.609 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 34' ' ' ASN . . . -57.6 -35.73 70.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -0.871 . . . . 0.0 109.547 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 83.2 tt0 -63.02 -38.22 90.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.533 -0.729 . . . . 0.0 110.448 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -149.69 157.2 38.67 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.107 -0.996 . . . . 0.0 110.437 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.511 ' HD3' ' ND2' ' A' ' 34' ' ' ASN . 3.1 Cg_exo -59.44 -71.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.981 1.516 . . . . 0.0 110.83 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.4 -140.39 21.96 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.891 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 52.7 p -78.64 -23.09 46.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -1.178 . . . . 0.0 110.153 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.61 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 25.2 t -54.39 -51.81 63.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.917 . . . . 0.0 109.893 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.5 tt0 -55.44 -33.53 63.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 111.115 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.736 HG13 ' HB2' ' A' ' 87' ' ' ALA . 4.3 pt -100.43 10.85 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.972 -1.08 . . . . 0.0 110.522 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.31 9.15 1.83 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.312 -0.867 . . . . 0.0 110.614 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.891 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -60.54 -14.56 20.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.056 -1.028 . . . . 0.0 109.543 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.595 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 41.4 t80 -135.68 164.52 27.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.464 -0.772 . . . . 0.0 110.123 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.62 3.41 5.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 110.23 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.595 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -64.66 -43.1 94.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.33 -0.856 . . . . 0.0 110.492 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.61 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -96.93 116.0 28.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.945 . . . . 0.0 110.645 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.74 HG21 ' OE1' ' A' ' 4' ' ' GLN . 44.8 p -107.89 171.23 7.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.48 -30.31 10.49 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.42 ' HB3' ' CG1' ' A' ' 1' ' ' VAL . 26.1 p . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.207 -1.172 . . . . 0.0 110.172 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.73 ' O ' HG12 ' A' ' 1' ' ' VAL . 67.4 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.244 0.545 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.722 HG23 ' HA ' ' A' ' 11' ' ' SER . 56.5 m -120.73 151.84 39.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.933 . . . . 0.0 110.258 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.742 HG23 HD11 ' A' ' 12' ' ' LEU . 61.9 t -81.01 113.41 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.911 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.613 ' HB3' HG21 ' A' ' 92' ' ' THR . 42.9 tt0 -111.61 132.23 54.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -93.84 -78.0 0.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.34 -0.85 . . . . 0.0 109.627 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.59 -128.43 5.8 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -80.47 10.26 4.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -1.12 . . . . 0.0 110.622 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.503 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 97.6 m-85 -124.47 137.79 54.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.993 . . . . 0.0 110.576 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.419 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 80.0 p -89.58 133.33 34.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 110.201 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.556 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 92.1 m-85 -115.62 123.07 47.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 110.578 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.722 ' HA ' HG23 ' A' ' 2' ' ' THR . 58.5 m -72.77 171.64 12.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.217 -0.927 . . . . 0.0 110.243 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.886 ' N ' HD12 ' A' ' 12' ' ' LEU . 4.3 mp -103.57 2.25 33.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.15 -0.969 . . . . 0.0 111.015 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' O ' ' C ' ' A' ' 14' ' ' SER . 97.3 mt-10 -71.75 -77.27 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.927 -1.108 . . . . 0.0 110.846 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.628 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.8 m -41.04 -47.57 3.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.255 -0.903 . . . . 0.0 110.88 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.639 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 14.8 m -63.58 -50.43 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.014 . . . . 0.0 109.886 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.568 ' H ' HG23 ' A' ' 15' ' ' VAL . 39.5 tttm -53.34 -53.28 53.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.075 -1.015 . . . . 0.0 109.075 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.451 ' O ' ' O ' ' A' ' 20' ' ' ASP . 68.6 mttm -80.17 4.89 15.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.371 -0.83 . . . . 0.0 109.871 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.639 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 8.8 tp -55.8 -36.31 67.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 110.226 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -53.2 -41.92 65.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.565 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 17' ' ' LYS . 8.6 p-10 -111.67 133.77 53.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.798 . . . . 0.0 109.725 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.89 HD11 ' HB2' ' A' ' 52' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.125 -0.984 . . . . 0.0 110.426 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.437 ' C ' ' HE3' ' A' ' 16' ' ' LYS . 80.5 mtm-85 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.339 0.59 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.488 ' OD1' ' HD3' ' A' ' 80' ' ' PRO . 73.8 m-20 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.379 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.582 ' HG3' ' CG ' ' A' ' 75' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.837 0 N-CA-C 110.65 -0.558 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.77 -76.64 1.31 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -165.15 129.56 1.81 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.404 -1.057 . . . . 0.0 110.069 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HA ' HD12 ' A' ' 70' ' ' LEU . 3.0 Cg_endo -60.86 126.31 19.35 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.702 1.369 . . . . 0.0 110.502 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.538 ' C ' HG23 ' A' ' 44' ' ' VAL . 11.3 p -140.58 138.58 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.322 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.538 HG23 ' C ' ' A' ' 43' ' ' VAL . 73.8 t . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.297 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.533 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 62.7 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.199 0.523 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 22.1 t -59.5 -48.27 82.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.178 -0.951 . . . . 0.0 110.487 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.712 ' ND2' HD23 ' A' ' 21' ' ' LEU . 1.2 m120 -80.13 114.79 49.64 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.352 -0.842 . . . . 0.0 110.324 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -60.33 -10.36 13.05 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.703 1.37 . . . . 0.0 110.649 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.89 ' HB2' HD11 ' A' ' 21' ' ' LEU . 28.2 m120 -138.92 36.39 2.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.962 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.78 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 2.2 p90 -73.08 -175.84 0.41 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 108.957 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 1.025 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.7 Cg_exo -58.41 74.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.494 1.26 . . . . 0.0 109.524 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.8 tt0 -42.7 -36.37 1.41 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.414 -0.804 . . . . 0.0 110.441 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.553 ' C ' HD12 ' A' ' 57' ' ' LEU . 83.8 tt0 -52.55 -19.17 2.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.077 -1.014 . . . . 0.0 108.929 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.025 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.1 mp -93.93 13.82 21.56 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.923 0.868 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.752 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.9 mttp -40.04 -52.01 5.57 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.729 -0.607 . . . . 0.0 110.201 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.752 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.08 -46.05 36.04 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.584 1.307 . . . . 0.0 109.661 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.097 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -48.78 -47.19 42.1 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.061 -1.024 . . . . 0.0 109.346 179.296 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.6 m -68.24 -27.23 66.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.418 -0.801 . . . . 0.0 110.286 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -86.43 4.96 37.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.998 . . . . 0.0 110.507 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.541 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 5.6 pt-20 -122.12 146.29 46.21 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.148 -0.97 . . . . 0.0 110.161 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -61.77 -17.98 58.04 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.862 1.454 . . . . 0.0 110.978 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.484 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 22.3 m120 -79.78 -12.09 59.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.578 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.097 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -49.94 -39.66 41.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.151 -0.968 . . . . 0.0 109.99 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.524 ' HG3' ' HB2' ' A' ' 42' ' ' PRO . 30.5 tt0 -56.8 -44.61 82.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.367 -0.833 . . . . 0.0 110.487 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.6 mt-10 -80.28 -35.06 36.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.982 . . . . 0.0 110.358 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.018 HG21 ' CD1' ' A' ' 60' ' ' LEU . 86.7 mt -69.05 -48.65 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.149 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.697 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.7 tm? -44.87 -63.53 0.9 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.697 ' N ' HD13 ' A' ' 70' ' ' LEU . 50.7 tt0 -48.4 -53.13 18.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 110.176 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 82.9 mtp180 -51.59 -58.33 6.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 109.91 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 47.0 mt -46.33 -48.77 18.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.787 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 86.7 mt-10 -54.63 -40.67 69.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.297 -0.877 . . . . 0.0 110.176 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.582 ' CG ' ' HG3' ' A' ' 39' ' ' PRO . 96.5 mt-10 -61.82 -54.78 37.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.031 -1.043 . . . . 0.0 110.269 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 79' ' ' ASP . 42.4 mt -63.16 -42.49 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.881 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' A' ' 16' ' ' LYS . . . -52.0 -37.19 52.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.56 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 84.1 tt0 -65.93 -42.57 89.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.495 -0.753 . . . . 0.0 110.349 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -143.56 153.57 58.73 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.067 -1.02 . . . . 0.0 110.449 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.577 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -61.99 -68.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.069 1.563 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.03 -140.13 18.27 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.976 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 47.6 p -81.29 -21.98 38.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -1.118 . . . . 0.0 110.033 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 10.7 t -56.47 -50.22 72.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.166 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 78.5 tt0 -63.24 -27.26 69.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.954 . . . . 0.0 111.175 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.764 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.7 pt -102.08 12.76 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.829 -1.169 . . . . 0.0 110.449 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.9 t 57.87 13.59 2.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 110.459 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.976 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -64.66 -21.49 66.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 110.035 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.443 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 2.6 t80 -134.85 169.48 17.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.84 . . . . 0.0 110.04 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.31 1.26 11.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.188 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -58.58 -39.82 81.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.588 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.6 OUTLIER -104.38 122.12 44.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.005 . . . . 0.0 110.786 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.613 HG21 ' HB3' ' A' ' 4' ' ' GLN . 25.9 p -101.31 170.15 8.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 110.237 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.18 4.16 78.18 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.257 -1.143 . . . . 0.0 110.143 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' A' ' 91' ' ' CYS . 21.8 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.231 0.539 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 88.5 m -126.14 152.98 45.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.31 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.663 HG21 HG21 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -91.03 117.84 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 109.758 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.683 ' OE1' HG21 ' A' ' 92' ' ' THR . 31.2 mt-30 -110.3 139.82 45.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.228 -0.92 . . . . 0.0 110.63 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -108.59 9.62 27.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.697 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.75 -136.21 2.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -79.87 4.85 15.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -1.193 . . . . 0.0 109.566 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.652 ' CE1' ' O ' ' A' ' 9' ' ' SER . 35.7 t80 -119.26 161.32 20.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.473 -0.767 . . . . 0.0 109.78 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.652 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 82.5 p -115.5 133.13 56.33 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.955 -1.09 . . . . 0.0 110.929 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.501 ' O ' HG12 ' A' ' 3' ' ' VAL . 72.0 m-85 -112.47 121.96 46.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 110.779 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.2 p -69.83 168.08 15.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.061 -1.024 . . . . 0.0 109.918 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.636 HD13 ' HG3' ' A' ' 80' ' ' PRO . 43.3 mt -103.13 1.56 33.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.025 -1.047 . . . . 0.0 110.886 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -73.96 -75.63 0.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 0.0 110.515 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.1 m -42.53 -50.18 5.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 110.671 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.698 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 5.4 m -57.31 -44.32 83.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.806 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.426 ' HE3' ' C ' ' A' ' 34' ' ' ASN . 50.5 tttt -56.56 -56.05 26.17 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.847 -1.158 . . . . 0.0 108.68 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -80.5 13.74 2.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.535 -0.728 . . . . 0.0 109.842 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.5 tt -63.38 -41.38 98.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.87 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -56.6 -42.96 79.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.504 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -93.01 116.23 28.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.817 HD23 ' ND2' ' A' ' 50' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.122 -0.986 . . . . 0.0 110.753 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' NH2' ' CD ' ' A' ' 84' ' ' GLU . 24.3 ptt85 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.225 0.536 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 37.9 p-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 0.0 110.431 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.49 ' CG ' ' CG ' ' A' ' 75' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.835 0 N-CA-C 110.562 -0.591 . . . . 0.0 110.562 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.448 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 125.02 28.6 1.11 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -125.16 71.74 63.92 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.294 -1.121 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.07 90.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.864 1.455 . . . . 0.0 110.471 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.677 ' O ' HG23 ' A' ' 44' ' ' VAL . 11.5 p -135.75 129.23 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 110.042 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.807 ' O ' HG12 ' A' ' 44' ' ' VAL . 14.6 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.294 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.398 0.618 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.553 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 91.5 p -55.48 -79.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.83 . . . . 0.0 110.421 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.817 ' ND2' HD23 ' A' ' 21' ' ' LEU . 5.3 m120 -80.08 112.56 31.2 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.374 -0.829 . . . . 0.0 110.3 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.39 -5.38 8.2 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.664 1.349 . . . . 0.0 110.875 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.68 ' H ' HD21 ' A' ' 21' ' ' LEU . 47.7 m-80 -132.4 29.64 4.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 110.549 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.81 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.5 p90 -78.61 -175.1 0.51 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 108.83 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.994 ' HB2' HD13 ' A' ' 57' ' ' LEU . 5.0 Cg_exo -55.64 75.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.383 1.202 . . . . 0.0 109.925 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 53' ' ' PHE . 22.6 pt-20 -44.46 -34.96 2.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.572 -0.705 . . . . 0.0 110.448 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.643 ' C ' HD12 ' A' ' 57' ' ' LEU . 49.7 mt-10 -53.87 -19.34 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.051 -1.031 . . . . 0.0 108.832 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.994 HD13 ' HB2' ' A' ' 54' ' ' PRO . 6.8 mp -96.77 14.22 25.87 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.83 0.824 . . . . 0.0 109.221 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.755 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.76 -51.48 5.31 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.767 -0.583 . . . . 0.0 110.575 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.755 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -53.66 -44.32 50.1 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.37 1.195 . . . . 0.0 110.039 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.072 ' CD1' HG21 ' A' ' 69' ' ' ILE . 3.1 mm? -57.59 -38.89 75.63 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 109.608 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.578 ' O ' HG13 ' A' ' 44' ' ' VAL . 43.6 t -67.17 -29.4 69.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.15 -0.969 . . . . 0.0 110.181 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.38 6.96 47.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.935 . . . . 0.0 110.08 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 2.8 mt-10 -99.58 144.34 28.12 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.369 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.1 Cg_exo -63.03 -26.83 73.79 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.78 1.41 . . . . 0.0 110.178 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' ALA . 76.1 m-20 -86.94 -3.19 59.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.542 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -42.52 -40.55 2.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.111 -0.993 . . . . 0.0 109.989 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -61.75 -39.72 92.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.476 -0.765 . . . . 0.0 110.454 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -80.3 -31.88 38.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.141 -0.975 . . . . 0.0 109.859 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.072 HG21 ' CD1' ' A' ' 60' ' ' LEU . 62.1 mt -74.55 -44.91 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 110.055 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.794 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.7 tm? -50.03 -59.27 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 110.387 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.794 ' N ' HD13 ' A' ' 70' ' ' LEU . 62.6 tt0 -47.91 -52.64 18.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.333 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.508 HH21 HG23 ' A' ' 69' ' ' ILE . 46.1 mtm180 -55.25 -56.72 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 35.1 mt -49.43 -51.33 36.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 110.205 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 76.7 mm-40 -53.69 -49.82 67.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.967 . . . . 0.0 110.454 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.49 ' CG ' ' CG ' ' A' ' 39' ' ' PRO . 98.8 mt-10 -54.88 -52.14 63.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -0.962 . . . . 0.0 110.523 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.663 HG21 HG21 ' A' ' 3' ' ' VAL . 23.7 mm -62.86 -35.58 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 109.894 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.82 71.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.814 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.1 tt0 -62.05 -38.54 89.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 110.172 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.6 OUTLIER 175.04 94.42 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 110.077 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.636 ' HG3' HD13 ' A' ' 12' ' ' LEU . 3.1 Cg_exo -59.74 77.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.931 1.49 . . . . 0.0 110.714 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -42.64 -75.12 0.15 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.732 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 65.8 p -71.44 -57.29 4.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.396 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.63 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 32.6 t -39.01 -50.79 1.8 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 110.046 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 81.7 tt0 -58.61 -42.97 89.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.041 -1.037 . . . . 0.0 110.731 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.724 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.6 pt -89.61 18.04 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.018 . . . . 0.0 110.219 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 7.2 m 57.83 15.0 2.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.317 -0.865 . . . . 0.0 110.547 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.732 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.53 -19.26 65.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.194 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -135.68 165.43 25.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.72 5.69 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.829 . . . . 0.0 110.563 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -69.58 -31.56 69.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 110.414 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.63 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.7 OUTLIER -108.56 123.81 49.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.818 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.683 HG21 ' OE1' ' A' ' 4' ' ' GLN . 44.0 p -110.8 164.05 13.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 110.131 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.6 -3.93 68.81 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.174 -1.192 . . . . 0.0 110.199 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 1' ' ' VAL . 5.3 m . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.228 0.537 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 29.8 m -121.42 149.49 42.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 0.0 110.536 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.025 HG23 HD11 ' A' ' 12' ' ' LEU . 91.9 t -86.76 118.44 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.707 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.546 ' CD ' HG21 ' A' ' 92' ' ' THR . 21.5 pt20 -111.48 147.91 34.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 111.029 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 1.025 ' OD2' HD21 ' A' ' 73' ' ' LEU . 91.4 m-20 -111.76 12.1 21.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.429 -0.794 . . . . 0.0 109.771 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 174.07 -129.61 1.66 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.02 5.49 22.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -1.166 . . . . 0.0 110.162 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.464 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 86.8 m-85 -125.98 147.22 49.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 94.8 p -101.14 136.61 40.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 0.0 110.144 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.667 ' CE2' HD11 ' A' ' 60' ' ' LEU . 21.5 m-85 -121.35 132.52 54.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.452 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.415 ' C ' HD12 ' A' ' 12' ' ' LEU . 30.1 t -71.32 166.69 21.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.295 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.025 HD11 HG23 ' A' ' 3' ' ' VAL . 5.2 mp -97.39 -9.64 27.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.302 -0.874 . . . . 0.0 110.404 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -67.75 -71.51 0.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.842 . . . . 0.0 110.729 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 m -46.34 -46.67 18.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.0 110.467 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.606 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 48.5 t -62.94 -51.62 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.048 -1.032 . . . . 0.0 109.941 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.503 ' NZ ' ' N ' ' A' ' 34' ' ' ASN . 43.0 tttt -54.18 -51.8 63.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.05 -1.031 . . . . 0.0 109.018 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 22.3 tttp -80.21 6.86 10.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 0.0 109.793 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.606 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 17.2 tp -61.54 -37.59 84.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -63.44 -37.05 85.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.08 -1.013 . . . . 0.0 110.047 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -113.33 101.78 9.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.08 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.754 HD11 ' HB3' ' A' ' 52' ' ' ASN . 33.9 tp . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.91 . . . . 0.0 110.226 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 70.1 mtt85 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.181 0.515 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 35.3 p-10 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 110.599 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.467 ' HG3' ' HB2' ' A' ' 75' ' ' GLU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.838 0 N-CA-C 110.772 -0.511 . . . . 0.0 110.772 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.515 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 126.3 32.44 0.73 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.434 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -122.47 75.5 44.03 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.289 -1.124 . . . . 0.0 110.283 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.476 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 2.9 Cg_endo -62.01 132.25 38.55 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.84 1.442 . . . . 0.0 110.811 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.784 HG22 ' OG ' ' A' ' 49' ' ' SER . 6.2 p 179.15 83.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.403 -0.81 . . . . 0.0 110.006 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.797 ' O ' HG12 ' A' ' 44' ' ' VAL . 38.8 t . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.479 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.27 0.557 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.784 ' OG ' HG22 ' A' ' 43' ' ' VAL . 36.3 m -60.12 -53.19 60.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.67 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.629 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 3.2 m120 -80.32 111.5 22.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.433 -0.792 . . . . 0.0 110.506 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -58.95 -12.79 16.26 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.646 1.34 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.754 ' HB3' HD11 ' A' ' 21' ' ' LEU . 31.0 t30 -137.39 42.1 2.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.253 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.75 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.3 p90 -80.18 -177.58 0.95 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.391 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.998 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -57.85 74.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.684 1.36 . . . . 0.0 109.693 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.0 tt0 -42.52 -35.55 1.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.481 -0.762 . . . . 0.0 110.348 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.7 mt-10 -53.7 -18.16 2.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 108.822 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.998 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.2 mp -96.39 13.3 28.23 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.754 0.788 . . . . 0.0 109.1 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.736 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -41.15 -52.3 7.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.908 -0.495 . . . . 0.0 111.168 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.736 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -53.8 -43.99 53.08 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.6 1.316 . . . . 0.0 110.17 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.83 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 17.9 mt -60.36 -34.36 73.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.139 -0.976 . . . . 0.0 109.902 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.754 ' HA ' HG13 ' A' ' 44' ' ' VAL . 36.8 t -66.27 -25.95 67.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.182 -0.949 . . . . 0.0 110.286 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -107.09 25.35 11.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.943 . . . . 0.0 109.323 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -110.48 143.19 27.62 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.624 -0.672 . . . . 0.0 110.462 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.53 -30.83 80.07 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.896 1.472 . . . . 0.0 109.816 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' ALA . 81.8 m-20 -86.23 -5.95 59.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 0.0 110.507 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.83 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -44.53 -41.56 6.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.106 -0.996 . . . . 0.0 110.068 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -55.13 -42.41 72.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.766 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.11 -37.38 33.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 109.863 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.695 HG21 HD13 ' A' ' 60' ' ' LEU . 87.7 mt -63.34 -49.18 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.098 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.919 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.3 tm? -48.7 -60.88 2.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 110.558 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.919 ' N ' HD13 ' A' ' 70' ' ' LEU . 63.9 tt0 -47.07 -53.99 11.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 0.0 110.533 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -54.76 -53.22 57.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 110.112 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 1.025 HD21 ' OD2' ' A' ' 5' ' ' ASP . 73.5 mt -49.84 -52.0 35.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.54 ' OE2' HD11 ' A' ' 70' ' ' LEU . 86.7 mt-10 -52.53 -46.02 66.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.341 -0.849 . . . . 0.0 110.328 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 82.3 tt0 -62.76 -54.24 42.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.672 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 79' ' ' ASP . 32.8 mm -64.56 -43.4 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 110.185 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -55.75 -37.64 68.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 110.024 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 57.6 mm-40 -65.02 -36.16 83.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.365 -0.834 . . . . 0.0 111.087 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -135.55 149.16 68.52 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.868 -1.145 . . . . 0.0 110.725 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.508 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -60.58 -68.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.831 1.437 . . . . 0.0 110.596 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.53 -139.42 20.18 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.956 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 64.6 p -80.19 -23.03 41.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.126 -1.22 . . . . 0.0 110.007 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 14.2 t -53.38 -53.51 50.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.903 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.8 tt0 -58.14 -32.29 68.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.375 -0.828 . . . . 0.0 111.05 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.771 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.2 pt -99.08 12.7 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.96 -1.088 . . . . 0.0 110.401 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 54.97 15.49 1.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.875 . . . . 0.0 110.51 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.956 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -62.02 -14.94 40.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.04 -1.037 . . . . 0.0 109.952 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 19.7 m-85 -144.75 174.35 11.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.03 3.18 10.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.847 . . . . 0.0 110.411 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -59.91 -36.78 77.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.609 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -104.22 123.83 48.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 0.0 110.633 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.546 HG21 ' CD ' ' A' ' 4' ' ' GLN . 23.4 p -105.6 160.53 15.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.381 -0.824 . . . . 0.0 110.146 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.65 3.19 56.28 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.349 -1.089 . . . . 0.0 110.218 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.798 HG22 ' SG ' ' A' ' 91' ' ' CYS . 9.7 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.333 0.587 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 90.8 m -129.44 154.45 46.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.961 . . . . 0.0 110.726 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.759 HG21 HD13 ' A' ' 12' ' ' LEU . 39.0 t -83.91 117.25 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.351 -0.843 . . . . 0.0 109.82 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.783 ' CB ' HG21 ' A' ' 92' ' ' THR . 48.7 tt0 -111.73 128.35 56.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 110.504 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.877 ' OD2' HD21 ' A' ' 73' ' ' LEU . 76.1 m-20 -114.24 10.38 17.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.471 -0.768 . . . . 0.0 109.692 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.74 -143.55 4.67 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -82.42 7.74 13.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -1.166 . . . . 0.0 110.221 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.43 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 74.4 m-85 -123.98 145.66 49.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 110.372 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -90.74 123.57 34.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.332 -0.855 . . . . 0.0 110.222 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.749 ' CD1' HD23 ' A' ' 57' ' ' LEU . 20.9 m-85 -110.91 123.08 49.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.863 . . . . 0.0 110.329 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.466 ' HA ' HG23 ' A' ' 2' ' ' THR . 63.4 m -62.37 156.15 23.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.534 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.885 HD11 ' N ' ' A' ' 77' ' ' ALA . 45.9 tp -98.68 -20.91 16.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.238 -0.914 . . . . 0.0 110.546 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -62.42 -65.46 0.68 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.139 -0.976 . . . . 0.0 110.51 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.4 m -46.58 -48.54 19.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.968 . . . . 0.0 110.949 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.685 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 31.2 m -60.86 -44.97 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.104 -0.997 . . . . 0.0 110.086 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.635 ' CA ' ' HB1' ' A' ' 77' ' ' ALA . 1.5 tmmt? -58.54 -56.03 27.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 109.072 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 13.9 ttpt -80.31 8.46 7.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.294 -0.879 . . . . 0.0 109.14 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.685 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 7.7 tp -52.2 -38.67 58.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.582 -0.699 . . . . 0.0 110.027 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.5 tttt -57.25 -45.4 84.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.094 -1.004 . . . . 0.0 109.574 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -97.47 115.05 27.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.764 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.88 HD11 ' HB2' ' A' ' 52' ' ' ASN . 29.6 tp . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.666 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.318 0.58 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 16.7 p30 . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 110.119 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.557 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.866 0 N-CA-C 110.568 -0.589 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.31 6.08 29.69 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.09 71.01 55.83 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.162 -1.199 . . . . 0.0 110.31 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.74 147.71 94.69 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.865 1.455 . . . . 0.0 110.269 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.899 HG22 ' HB3' ' A' ' 49' ' ' SER . 12.2 p -158.47 72.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.42 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.749 ' O ' HG12 ' A' ' 44' ' ' VAL . 30.6 t . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.1 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.566 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.316 0.579 . . . . 0.0 110.194 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.899 ' HB3' HG22 ' A' ' 43' ' ' VAL . 85.0 p -61.54 -54.88 37.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -0.92 . . . . 0.0 110.44 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 5.3 m-20 -80.2 110.87 18.08 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.392 -0.818 . . . . 0.0 110.399 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.599 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.81 -13.96 33.69 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.623 1.328 . . . . 0.0 110.715 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.88 ' HB2' HD11 ' A' ' 21' ' ' LEU . 86.3 m-20 -128.21 33.66 4.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 110.55 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.664 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.25 175.94 4.29 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.129 -0.982 . . . . 0.0 108.792 179.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.679 ' HG2' HD12 ' A' ' 57' ' ' LEU . 4.1 Cg_exo -56.57 75.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.604 1.318 . . . . 0.0 109.388 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.644 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.5 tt0 -39.35 -27.14 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.712 -0.618 . . . . 0.0 110.387 -178.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.3 mt-10 -53.68 -17.34 2.17 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.964 -1.085 . . . . 0.0 108.657 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.749 HD23 ' CD1' ' A' ' 10' ' ' PHE . 34.8 mt -95.09 9.17 40.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.566 -0.709 . . . . 0.0 109.676 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.741 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.6 -51.74 4.95 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.28 -0.887 . . . . 0.0 110.678 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.741 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.84 -41.88 74.07 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.496 1.261 . . . . 0.0 110.017 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.892 HD22 HD13 ' A' ' 69' ' ' ILE . 55.9 mt -60.39 -36.6 78.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.113 -0.992 . . . . 0.0 110.163 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.533 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 73.6 m -67.53 -28.32 67.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.957 . . . . 0.0 110.272 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -101.22 24.33 9.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.211 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.45 143.55 29.57 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.588 -0.695 . . . . 0.0 110.588 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.26 -31.98 73.6 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.813 1.428 . . . . 0.0 109.818 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -86.98 1.67 52.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.361 -0.837 . . . . 0.0 110.701 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.17 -42.63 20.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.068 -1.02 . . . . 0.0 110.058 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 92.1 mt-30 -56.15 -41.39 75.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.848 . . . . 0.0 110.098 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -79.92 -35.52 37.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 110.135 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.892 HD13 HD22 ' A' ' 60' ' ' LEU . 91.6 mt -67.6 -47.95 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.0 109.79 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -53.95 -53.28 54.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 0.0 110.378 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.954 ' N ' HD13 ' A' ' 70' ' ' LEU . 97.9 mt-30 -49.7 -51.26 39.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.252 -0.905 . . . . 0.0 110.722 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -55.42 -59.64 4.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.317 -0.864 . . . . 0.0 110.711 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.877 HD21 ' OD2' ' A' ' 5' ' ' ASP . 60.9 mt -44.38 -49.09 9.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.301 -0.875 . . . . 0.0 110.42 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.93 ' OE2' HD21 ' A' ' 70' ' ' LEU . 70.7 mt-10 -61.82 -26.72 68.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 0.0 110.752 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.557 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.3 tt0 -71.63 -50.41 30.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.929 -1.107 . . . . 0.0 109.785 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.1 mm -67.82 -36.48 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.346 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.885 ' N ' HD11 ' A' ' 12' ' ' LEU . . . -63.28 -29.16 70.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.617 -0.677 . . . . 0.0 109.667 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 84.8 tt0 -62.99 -34.7 78.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.423 -0.798 . . . . 0.0 110.384 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -161.33 147.01 10.84 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.144 -0.973 . . . . 0.0 110.765 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.5 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.47 84.04 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.052 1.554 . . . . 0.0 110.598 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.68 -130.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.207 -1.957 . . . . 0.0 108.207 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.965 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 82.8 p -82.76 -16.96 45.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.246 . . . . 0.0 109.321 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.438 ' SG ' ' N ' ' A' ' 91' ' ' CYS . 5.5 t -51.11 -50.38 58.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.733 -0.604 . . . . 0.0 110.37 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.5 ' OE1' ' HB2' ' A' ' 80' ' ' PRO . 76.2 tt0 -61.05 -34.87 75.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.268 -0.895 . . . . 0.0 111.364 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.813 HG13 ' HB2' ' A' ' 87' ' ' ALA . 4.3 pt -97.24 17.36 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.588 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 m 51.14 17.37 0.46 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.945 . . . . 0.0 110.81 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.965 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.55 -13.81 62.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.056 -1.028 . . . . 0.0 109.663 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.534 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 52.8 t80 -141.22 170.27 16.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.79 . . . . 0.0 109.996 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.73 4.43 7.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.12 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.534 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -59.27 -40.35 85.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.639 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.798 ' SG ' HG22 ' A' ' 1' ' ' VAL . 1.0 OUTLIER -103.04 128.24 49.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.214 -0.929 . . . . 0.0 110.689 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.783 HG21 ' CB ' ' A' ' 4' ' ' GLN . 16.9 p -108.0 165.45 11.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.25 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.29 -7.07 61.82 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.319 -1.107 . . . . 0.0 110.21 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.456 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 6.4 m . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.107 0.48 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 1.015 HG21 ' HB3' ' A' ' 9' ' ' SER . 14.6 t -129.75 164.09 24.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.981 ' CG2' HD21 ' A' ' 12' ' ' LEU . 43.2 t -80.06 110.98 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.352 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 46.2 tt0 -109.53 121.15 44.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.111 -0.993 . . . . 0.0 110.578 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -99.12 5.65 46.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.821 . . . . 0.0 109.673 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.93 -141.18 3.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -79.92 0.17 32.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -1.193 . . . . 0.0 110.36 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.501 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 92.4 m-85 -112.64 138.07 49.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.179 -0.95 . . . . 0.0 110.462 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 1.015 ' HB3' HG21 ' A' ' 2' ' ' THR . 73.4 m -89.11 128.79 35.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.359 -0.838 . . . . 0.0 110.144 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.772 ' CE1' HD23 ' A' ' 57' ' ' LEU . 91.6 m-85 -111.79 119.14 37.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.897 . . . . 0.0 110.483 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.7 p -70.88 168.38 16.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.93 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.981 HD21 ' CG2' ' A' ' 3' ' ' VAL . 65.0 mt -99.51 2.94 45.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.978 . . . . 0.0 110.425 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 14' ' ' SER . 81.7 tt0 -76.28 -71.02 0.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 110.503 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.475 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.6 m -42.42 -49.45 5.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.007 -1.058 . . . . 0.0 110.271 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.675 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 7.8 m -58.9 -48.89 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.181 -0.949 . . . . 0.0 109.851 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.51 ' H ' HG23 ' A' ' 15' ' ' VAL . 21.2 tttt -54.68 -55.91 24.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.894 -1.129 . . . . 0.0 108.972 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -80.33 12.34 3.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.415 -0.803 . . . . 0.0 109.621 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 39.1 tp -57.96 -37.15 73.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.354 -0.842 . . . . 0.0 110.376 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -55.29 -43.21 74.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.127 -0.983 . . . . 0.0 110.006 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -99.96 109.94 22.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 110.042 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.043 HD21 ' CG ' ' A' ' 50' ' ' ASN . 93.8 mt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.895 . . . . 0.0 110.277 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.118 0.485 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 86.9 m-20 . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 110.76 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.891 0 N-CA-C 110.495 -0.617 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.463 ' HA2' ' HG2' ' A' ' 71' ' ' GLN . . . 102.02 -0.35 51.43 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -66.91 139.54 95.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.214 -1.168 . . . . 0.0 110.214 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.68 110.0 0.87 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.756 1.398 . . . . 0.0 110.329 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.603 HG21 ' HG ' ' A' ' 70' ' ' LEU . 63.3 t -135.97 143.04 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.142 -0.974 . . . . 0.0 110.515 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.829 ' O ' HG12 ' A' ' 44' ' ' VAL . 46.4 t . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.775 . . . . 0.0 110.861 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.506 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.223 0.535 . . . . 0.0 110.038 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.618 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 6.6 p -96.16 -53.46 3.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 110.566 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 1.043 ' CG ' HD21 ' A' ' 21' ' ' LEU . 9.6 m-20 -80.06 111.35 21.22 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.401 -0.812 . . . . 0.0 110.439 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.618 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.91 -13.62 40.72 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.704 1.37 . . . . 0.0 110.371 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.419 ' HB2' HD22 ' A' ' 21' ' ' LEU . 95.2 m-20 -114.27 20.16 15.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.415 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.15 173.45 7.7 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 108.961 179.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.641 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.1 Cg_exo -57.37 75.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.632 1.333 . . . . 0.0 108.925 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 53' ' ' PHE . 23.9 pt-20 -39.11 -26.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.745 -0.597 . . . . 0.0 110.596 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt-10 -51.68 -22.23 3.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.944 -1.097 . . . . 0.0 108.452 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.772 HD23 ' CE1' ' A' ' 10' ' ' PHE . 66.7 mt -83.14 8.86 11.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.662 -0.649 . . . . 0.0 109.472 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.744 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.75 -51.49 5.29 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.457 -0.777 . . . . 0.0 110.601 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.744 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.97 -41.43 78.81 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.52 1.274 . . . . 0.0 110.571 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.073 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 5.9 mp -62.48 -35.45 79.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.88 -1.138 . . . . 0.0 110.384 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.449 ' HB3' ' N ' ' A' ' 48' ' ' CYS . 84.3 m -67.22 -28.19 67.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.064 -1.023 . . . . 0.0 110.536 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.467 ' NZ ' ' HE2' ' A' ' 58' ' ' LYS . 91.2 mttt -81.64 -3.08 52.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.825 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 11.4 pt-20 -125.38 147.02 56.31 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.94 -1.1 . . . . 0.0 110.376 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.27 -6.94 10.9 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.903 1.475 . . . . 0.0 111.024 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -79.92 -22.69 42.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.087 -1.008 . . . . 0.0 110.161 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.073 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.69 -39.37 17.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.419 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.57 -41.51 97.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 110.278 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.39 -38.17 30.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.915 HG21 ' CD2' ' A' ' 60' ' ' LEU . 95.7 mt -65.17 -39.39 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 110.489 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.655 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.3 tm? -56.42 -51.34 68.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.937 . . . . 0.0 110.499 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.463 ' HG2' ' HA2' ' A' ' 40' ' ' GLY . 89.6 mt-30 -49.64 -54.78 16.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.103 -0.998 . . . . 0.0 110.117 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.514 HH21 HG23 ' A' ' 69' ' ' ILE . 46.6 mtm180 -52.36 -54.33 33.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.39 -0.818 . . . . 0.0 110.119 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 41.5 mt -48.43 -50.47 31.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.879 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 69.6 mm-40 -53.9 -51.78 62.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.892 . . . . 0.0 110.279 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -54.78 -56.85 14.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.039 -1.038 . . . . 0.0 110.536 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 79' ' ' ASP . 20.1 mt -58.9 -35.16 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.121 -0.987 . . . . 0.0 109.465 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 34' ' ' ASN . . . -57.89 -34.72 70.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.545 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -60.39 -40.65 91.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -148.01 153.69 42.19 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.163 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.584 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -58.56 -59.22 0.52 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.895 1.471 . . . . 0.0 110.574 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.33 -138.69 20.15 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.92 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 65.5 p -82.31 -21.13 36.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -1.11 . . . . 0.0 110.058 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.597 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 42.3 t -55.64 -53.35 57.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.208 -0.933 . . . . 0.0 110.109 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.7 tt0 -60.7 -27.81 68.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 111.22 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.786 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.2 pt -99.05 13.51 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 110.273 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 55.37 16.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.504 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.92 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.29 -15.35 63.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.967 . . . . 0.0 109.931 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.46 169.49 17.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.13 3.09 11.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 110.185 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.53 -34.8 77.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.458 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -103.51 123.25 46.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.737 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.8 p -111.63 154.98 24.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 109.754 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 44.14 4.82 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.342 -1.093 . . . . 0.0 110.282 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.844 HG11 ' HB3' ' A' ' 91' ' ' CYS . 3.4 t . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.164 0.507 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.666 ' H ' HG12 ' A' ' 1' ' ' VAL . 30.8 m -126.25 142.66 51.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.55 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.582 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 90.4 t -82.24 119.66 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.496 -0.752 . . . . 0.0 109.448 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.525 ' CD ' HG21 ' A' ' 92' ' ' THR . 44.8 tt0 -113.5 133.11 55.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.879 -1.138 . . . . 0.0 110.787 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -92.06 -78.89 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.567 -0.708 . . . . 0.0 109.65 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.0 -122.16 4.67 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -85.19 10.01 13.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.157 . . . . 0.0 110.341 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.491 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 98.1 m-85 -122.45 137.9 54.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.448 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.7 p -89.64 128.35 36.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 110.076 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.884 ' HB3' HD21 ' A' ' 57' ' ' LEU . 23.2 m-30 -117.07 126.98 53.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 0.0 110.746 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.1 t -61.48 157.92 16.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.079 . . . . 0.0 109.727 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 12' ' ' LEU . 1.5 pt? -100.5 -25.31 14.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -1.0 . . . . 0.0 111.071 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.21 -65.86 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.078 -1.014 . . . . 0.0 110.74 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.6 m -52.59 -38.86 60.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.363 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.645 ' CG1' ' HB2' ' A' ' 77' ' ' ALA . 6.8 t -58.15 -46.4 88.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.135 -0.978 . . . . 0.0 109.621 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HD3' ' CD ' ' A' ' 33' ' ' ARG . 18.9 tttt -57.73 -53.84 53.67 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.056 -1.028 . . . . 0.0 108.74 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 20' ' ' ASP . 51.4 mttm -80.34 12.05 3.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.535 -0.728 . . . . 0.0 109.751 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 8.7 tt -59.55 -39.08 82.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.136 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -50.61 -42.54 56.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 17' ' ' LYS . 39.0 p30 -150.31 146.4 26.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.809 . . . . 0.0 109.605 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.0 HD22 ' CG ' ' A' ' 52' ' ' ASN . 14.7 tp . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.986 . . . . 0.0 110.759 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.495 ' CD ' ' HD3' ' A' ' 16' ' ' LYS . 8.8 mmt85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.228 0.537 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 18.0 p-10 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 110.305 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.482 0.797 0 N-CA-C 110.71 -0.534 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.413 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 129.55 12.23 2.54 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.49 ' HG3' HD11 ' A' ' 70' ' ' LEU . 3.8 pt-20 -119.48 77.87 19.8 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.094 -1.239 . . . . 0.0 110.138 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.2 Cg_exo -59.32 143.52 99.7 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.978 1.515 . . . . 0.0 110.672 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.014 HG23 HG23 ' A' ' 44' ' ' VAL . 20.2 m -121.77 -166.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 110.273 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.014 HG23 HG23 ' A' ' 43' ' ' VAL . 11.3 t . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.468 -0.77 . . . . 0.0 110.552 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 71.8 m . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.478 0.656 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 87.8 p -59.89 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.459 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' LEU . 1.8 m120 -66.09 112.94 10.28 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.868 . . . . 0.0 110.691 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.7 -7.1 15.47 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.713 1.375 . . . . 0.0 109.721 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 1.0 ' CG ' HD22 ' A' ' 21' ' ' LEU . 26.5 p30 -124.95 26.06 7.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.511 -0.743 . . . . 0.0 110.368 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.733 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -79.15 179.89 1.63 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.213 -0.929 . . . . 0.0 108.575 179.102 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.733 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.7 Cg_exo -57.73 75.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 N-CA-C 108.89 -1.235 . . . . 0.0 108.89 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.624 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.2 tt0 -39.2 -27.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.706 -0.621 . . . . 0.0 110.085 -178.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.516 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 96.3 mt-10 -52.6 -17.91 1.5 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.068 -1.02 . . . . 0.0 108.74 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.884 HD21 ' HB3' ' A' ' 10' ' ' PHE . 33.5 mt -89.47 8.46 30.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.553 -0.717 . . . . 0.0 109.683 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.77 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.65 -50.42 5.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 110.463 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.77 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.58 -41.04 81.03 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.457 1.24 . . . . 0.0 110.027 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.029 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 34.7 mt -59.81 -41.41 91.21 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.095 -1.003 . . . . 0.0 110.153 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 t -69.13 -31.08 69.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.084 -1.01 . . . . 0.0 110.294 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -80.03 4.62 16.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.565 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.69 ' OE2' HD23 ' A' ' 60' ' ' LEU . 8.1 pt-20 -124.0 138.18 30.19 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.074 -1.016 . . . . 0.0 110.128 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.98 -16.51 45.85 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.767 1.403 . . . . 0.0 110.647 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.492 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 20.5 m120 -80.05 -8.24 59.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 110.023 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.029 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -51.02 -34.45 29.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.818 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -62.79 -38.62 91.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.683 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.29 -43.69 20.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.603 HG21 HD22 ' A' ' 60' ' ' LEU . 66.8 mt -62.69 -39.94 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.866 . . . . 0.0 109.557 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.5 tm? -46.93 -65.94 0.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.606 -0.684 . . . . 0.0 110.627 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.965 ' N ' HD13 ' A' ' 70' ' ' LEU . 92.7 mt-30 -46.56 -53.48 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 110.385 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 18.2 tpp180 -55.49 -54.46 43.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.12 -0.988 . . . . 0.0 109.946 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.629 ' HG ' HG11 ' A' ' 15' ' ' VAL . 10.0 tp -50.08 -53.64 25.76 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.295 -0.878 . . . . 0.0 109.96 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.695 ' OE2' HD21 ' A' ' 70' ' ' LEU . 88.0 mt-10 -50.71 -45.24 58.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 72' ' ' ARG . 96.7 mt-10 -54.1 -53.33 54.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.09 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.513 HG21 HG13 ' A' ' 3' ' ' VAL . 6.0 mt -61.12 -38.15 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.924 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.645 ' HB2' ' CG1' ' A' ' 15' ' ' VAL . . . -59.79 -37.17 78.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 110.049 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.45 ' HG2' ' HG3' ' A' ' 16' ' ' LYS . 47.3 mt-10 -103.66 12.9 34.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.662 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 1.6 t70 -160.26 106.86 1.38 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.487 -0.758 . . . . 0.0 109.696 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.543 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 3.4 Cg_exo -57.17 -65.63 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.803 1.423 . . . . 0.0 110.592 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.56 -136.74 17.09 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.748 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 80.8 p -78.62 -22.93 46.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.311 -1.111 . . . . 0.0 110.01 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 5.0 t -45.72 -58.04 3.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 0.0 110.522 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 80' ' ' PRO . 56.2 mt-10 -56.96 -37.58 71.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.301 -0.875 . . . . 0.0 111.526 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.637 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.0 pt -89.28 12.97 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.853 -1.154 . . . . 0.0 110.503 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 59.9 m 51.45 19.75 0.88 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 110.782 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.748 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -74.3 -2.89 27.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.046 -1.034 . . . . 0.0 109.919 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.489 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 3.4 m-85 -151.9 171.47 17.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.306 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.59 4.9 6.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.292 -0.88 . . . . 0.0 110.441 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.32 -31.1 72.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.911 . . . . 0.0 110.67 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.844 ' HB3' HG11 ' A' ' 1' ' ' VAL . 0.7 OUTLIER -114.81 125.84 54.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.05 -1.031 . . . . 0.0 110.637 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.525 HG21 ' CD ' ' A' ' 4' ' ' GLN . 33.2 p -114.36 152.2 31.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.389 -0.819 . . . . 0.0 110.396 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.76 -21.61 45.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.295 -1.121 . . . . 0.0 110.273 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.488 HG22 ' SG ' ' A' ' 91' ' ' CYS . 3.1 p . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.213 0.53 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.587 HG23 ' HA ' ' A' ' 11' ' ' SER . 57.0 m -118.07 154.5 31.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.302 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' ALA . 96.3 t -82.25 123.23 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 109.801 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.918 ' OE1' HG21 ' A' ' 92' ' ' THR . 62.6 tt0 -113.09 122.31 47.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.946 . . . . 0.0 110.7 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.947 ' OD2' HD21 ' A' ' 73' ' ' LEU . 88.4 m-20 -99.9 13.49 33.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.429 -0.794 . . . . 0.0 109.864 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.521 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . 174.24 -132.96 2.38 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -90.63 15.46 10.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -1.153 . . . . 0.0 109.955 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.628 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . 87.0 m-85 -129.5 128.66 43.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.471 -0.768 . . . . 0.0 110.092 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.3 p -79.95 123.42 27.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 109.998 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.628 ' CE2' ' HB2' ' A' ' 8' ' ' PHE . 85.7 m-85 -116.71 125.35 51.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 110.61 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.587 ' HA ' HG23 ' A' ' 2' ' ' THR . 80.8 p -66.16 165.08 14.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 109.787 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.708 ' CD2' HG22 ' A' ' 76' ' ' ILE . 15.1 tp -110.93 -8.91 14.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 110.853 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.422 ' HG3' ' HD3' ' A' ' 33' ' ' ARG . 86.2 tt0 -60.17 -69.73 0.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.056 -1.027 . . . . 0.0 110.606 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.566 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.9 m -44.67 -39.55 5.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 0.0 110.547 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.658 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 25.2 t -64.99 -49.22 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.035 -1.04 . . . . 0.0 109.535 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.725 ' HG2' ' HB1' ' A' ' 77' ' ' ALA . 78.5 mttt -55.22 -50.74 68.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.08 -1.012 . . . . 0.0 108.808 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -80.14 4.54 17.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.529 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.735 HD13 ' HD3' ' A' ' 54' ' ' PRO . 18.7 tp -56.97 -25.79 58.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.0 110.193 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -61.33 -35.81 78.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.841 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -86.5 109.96 19.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.882 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.957 HD21 ' ND2' ' A' ' 50' ' ' ASN . 1.2 mm? . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.473 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.586 ' HB3' ' HD2' ' A' ' 16' ' ' LYS . 74.1 mtt85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.2 0.524 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 4.0 p30 . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.233 -0.917 . . . . 0.0 110.159 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.548 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 3.0 Cg_exo . . . . . 0 N--CA 1.482 0.834 0 N-CA-C 110.603 -0.576 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.45 4.58 2.01 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER 60.72 72.18 0.75 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.084 -1.245 . . . . 0.0 109.988 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.568 ' HD2' HD12 ' A' ' 70' ' ' LEU . 3.0 Cg_endo -61.58 -165.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.952 1.501 . . . . 0.0 110.988 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -96.05 129.28 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.748 . . . . 0.0 110.175 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.843 ' O ' HG13 ' A' ' 44' ' ' VAL . 3.1 p . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.333 -0.854 . . . . 0.0 110.198 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.456 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 1.5 m . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.321 0.581 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.89 ' HB3' HG13 ' A' ' 43' ' ' VAL . 87.3 p -64.02 -41.12 97.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 110.926 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.957 ' ND2' HD21 ' A' ' 21' ' ' LEU . 5.8 m-20 -80.68 106.9 6.06 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.897 . . . . 0.0 110.619 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.745 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -61.11 -16.26 44.79 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.682 1.359 . . . . 0.0 110.33 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -128.03 36.54 4.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.232 -0.917 . . . . 0.0 111.145 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.642 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.1 172.23 10.37 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.776 -1.203 . . . . 0.0 108.484 178.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.735 ' HD3' HD13 ' A' ' 18' ' ' LEU . 4.1 Cg_exo -54.45 76.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.505 1.266 . . . . 0.0 109.39 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.6 tt0 -39.65 -27.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.744 -0.598 . . . . 0.0 110.084 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.7 mt-10 -52.7 -17.89 1.54 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.068 -1.02 . . . . 0.0 108.449 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.676 HD12 ' HG2' ' A' ' 54' ' ' PRO . 89.2 mt -90.24 11.2 21.88 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.609 0.719 . . . . 0.0 109.136 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.742 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -39.95 -51.99 5.43 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.416 -0.803 . . . . 0.0 110.262 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.742 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -54.0 -46.07 36.36 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.461 1.242 . . . . 0.0 109.373 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.954 HD11 ' HB ' ' A' ' 69' ' ' ILE . 11.7 tp -49.58 -49.46 46.48 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.264 -0.898 . . . . 0.0 109.749 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.565 ' SG ' HG22 ' A' ' 44' ' ' VAL . 1.2 t -61.33 -27.94 68.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 110.609 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 22.7 ttpt -81.01 -2.05 46.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 110.56 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 11.2 pt-20 -126.43 144.85 50.85 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.064 -1.023 . . . . 0.0 110.074 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.27 -8.65 12.91 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.785 1.413 . . . . 0.0 110.801 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -79.58 -18.0 52.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 110.668 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -45.08 -40.03 6.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.079 -1.013 . . . . 0.0 109.941 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.44 ' O ' ' CD ' ' A' ' 41' ' ' GLU . 93.7 mt-30 -66.01 -39.12 90.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -0.869 . . . . 0.0 109.979 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -80.5 -44.95 18.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.173 -0.954 . . . . 0.0 109.672 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.954 ' HB ' HD11 ' A' ' 60' ' ' LEU . 57.9 mt -63.73 -42.19 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.814 . . . . 0.0 109.899 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.77 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.2 tm? -52.34 -52.69 51.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.459 -0.776 . . . . 0.0 109.902 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.58 ' N ' HD13 ' A' ' 70' ' ' LEU . 46.0 tt0 -42.74 -53.53 4.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.095 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -59.11 -53.1 62.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 110.65 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.947 HD21 ' OD2' ' A' ' 5' ' ' ASP . 63.6 mt -50.58 -55.7 15.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.085 -1.009 . . . . 0.0 110.145 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.703 ' CD ' HD11 ' A' ' 70' ' ' LEU . 26.9 mt-10 -54.61 -50.74 67.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 110.442 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.26 -54.06 45.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.433 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.708 HG22 ' CD2' ' A' ' 12' ' ' LEU . 70.2 mt -61.65 -34.34 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.998 . . . . 0.0 109.735 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.725 ' HB1' ' HG2' ' A' ' 16' ' ' LYS . . . -57.07 -34.73 68.57 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.323 -0.861 . . . . 0.0 109.599 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.31 -40.94 92.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 110.115 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -153.71 160.4 30.98 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.901 . . . . 0.0 110.259 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -60.39 -59.72 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.916 1.482 . . . . 0.0 110.544 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.11 -140.04 25.06 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 1.021 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 73.1 p -82.14 -21.94 36.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.272 -1.134 . . . . 0.0 110.163 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 4.6 t -55.8 -49.21 73.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.716 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 82.7 tt0 -59.54 -32.13 70.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.822 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.705 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.5 pt -99.3 10.51 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.99 -1.069 . . . . 0.0 110.328 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.7 m 56.96 16.5 2.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.88 . . . . 0.0 110.641 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 1.021 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -60.53 -18.8 54.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.965 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -140.37 177.82 7.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 110.182 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.81 1.53 12.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.871 . . . . 0.0 110.335 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -58.56 -40.86 84.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.658 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.553 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER -112.79 122.67 48.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.928 . . . . 0.0 110.81 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.918 HG21 ' OE1' ' A' ' 4' ' ' GLN . 25.6 p -105.18 176.25 5.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 110.262 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.42 -6.81 65.85 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.391 -1.064 . . . . 0.0 110.209 -179.921 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.847 HG23 ' SG ' ' A' ' 91' ' ' CYS . 10.6 p . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.211 0.529 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.527 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 30.7 m -90.09 148.03 23.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 110.802 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.114 ' CG2' HD21 ' A' ' 12' ' ' LEU . 22.9 t -97.06 118.53 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.581 -0.699 . . . . 0.0 109.435 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.639 ' NE2' HG23 ' A' ' 92' ' ' THR . 20.9 pt20 -120.56 177.47 5.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.081 -1.012 . . . . 0.0 110.936 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -151.45 -62.19 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.741 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.82 -115.81 0.74 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -108.21 13.2 26.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.227 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.521 ' CD1' ' OE2' ' A' ' 56' ' ' GLU . 97.9 m-85 -131.77 159.36 38.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.527 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 37.6 m -101.07 136.31 41.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.937 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.841 ' CG ' HD21 ' A' ' 57' ' ' LEU . 6.6 m-30 -112.69 123.23 49.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.654 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 m -66.33 160.11 25.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.114 HD21 ' CG2' ' A' ' 3' ' ' VAL . 99.5 mt -86.97 -27.33 23.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 110.735 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -61.56 -66.3 0.56 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 0.0 110.671 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.5 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.6 m -44.27 -48.71 9.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.977 -1.077 . . . . 0.0 110.151 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.613 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 58.5 t -59.05 -46.72 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.218 -0.926 . . . . 0.0 110.109 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 25.1 tttm -58.9 -52.43 65.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.806 -1.184 . . . . 0.0 108.562 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -80.65 11.98 3.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.35 -0.844 . . . . 0.0 109.368 178.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.785 HD21 HG21 ' A' ' 43' ' ' VAL . 59.1 tp -57.17 -37.08 71.59 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.416 -0.803 . . . . 0.0 110.097 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -60.75 -38.88 86.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 109.38 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -141.55 124.73 16.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.594 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.799 HD11 ' CB ' ' A' ' 52' ' ' ASN . 4.5 mm? . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.616 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.456 ' NH2' ' CG ' ' A' ' 33' ' ' ARG . 13.4 mmt-85 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.3 0.572 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 44.9 p-10 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.968 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.834 0 N-CA-C 110.494 -0.618 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.531 ' N ' ' HG2' ' A' ' 71' ' ' GLN . . . 117.2 40.16 0.76 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -130.14 73.14 81.61 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.308 -1.113 . . . . 0.0 110.374 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -60.68 141.77 95.96 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.908 1.478 . . . . 0.0 110.146 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.785 HG21 HD21 ' A' ' 18' ' ' LEU . 24.0 m -140.51 54.83 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.667 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 48' ' ' CYS . 17.1 m . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.583 179.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 1.2 m . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.347 0.594 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.623 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -87.78 -58.34 2.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.415 -0.803 . . . . 0.0 110.228 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 6.4 m120 -78.93 110.27 13.9 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.419 -0.801 . . . . 0.0 110.326 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.623 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -61.99 -11.39 21.28 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.721 1.379 . . . . 0.0 110.336 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.799 ' CB ' HD11 ' A' ' 21' ' ' LEU . 99.6 m-20 -130.52 34.23 4.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.842 . . . . 0.0 110.734 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.69 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.17 174.23 6.46 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.038 -1.039 . . . . 0.0 108.719 178.953 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.69 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.0 Cg_exo -56.36 76.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.624 1.329 . . . . 0.0 108.889 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.641 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.7 tt0 -39.07 -26.31 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.884 -0.51 . . . . 0.0 110.377 -178.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.521 ' OE2' ' CD1' ' A' ' 8' ' ' PHE . 39.3 tp10 -53.13 -20.76 4.09 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.931 -1.105 . . . . 0.0 108.174 178.145 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.841 HD21 ' CG ' ' A' ' 10' ' ' PHE . 82.2 mt -84.35 8.45 16.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.623 -0.673 . . . . 0.0 109.657 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.726 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.57 -51.49 4.98 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.73 -179.568 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.726 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -56.71 -44.31 46.47 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.632 1.333 . . . . 0.0 110.744 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.062 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 1.5 mt -60.63 -40.04 90.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.814 -1.179 . . . . 0.0 110.503 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.506 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 46.2 t -65.56 -28.14 68.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.034 -1.041 . . . . 0.0 110.697 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 46.2 tttm -90.75 6.69 43.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.639 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.508 ' OE2' ' HB2' ' A' ' 65' ' ' ASN . 12.7 pt-20 -130.84 144.61 54.21 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.959 -1.088 . . . . 0.0 110.4 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.22 -8.31 12.06 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.91 1.479 . . . . 0.0 110.797 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.508 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 83.9 m-20 -79.23 -23.79 43.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 110.194 -179.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.062 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -51.33 -36.3 42.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.083 -1.01 . . . . 0.0 109.685 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.8 mt-30 -61.65 -43.55 98.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.0 109.758 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -80.27 -41.17 25.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 109.609 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 60' ' ' LEU . 86.0 mt -64.24 -46.26 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 109.87 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.792 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.2 tm? -49.38 -53.86 20.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.946 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.614 ' N ' HD13 ' A' ' 70' ' ' LEU . 87.9 mt-30 -45.41 -53.9 8.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -57.79 -54.62 44.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 48.4 mt -44.98 -56.1 4.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.338 -0.851 . . . . 0.0 109.705 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.746 ' OE2' HD11 ' A' ' 70' ' ' LEU . 64.6 mt-10 -51.12 -53.6 32.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 110.154 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 78' ' ' GLU . 82.8 tt0 -55.23 -54.49 42.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 110.693 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 79' ' ' ASP . 24.7 mm -58.75 -37.52 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 109.81 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -57.21 -33.06 67.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.591 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 34' ' ' ASN . 99.2 mt-10 -60.12 -41.92 93.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 110.52 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -147.83 159.54 40.37 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.93 . . . . 0.0 110.275 -179.797 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.571 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -59.77 -57.21 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.883 1.465 . . . . 0.0 110.65 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.02 -140.89 26.38 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.931 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 79.6 p -78.08 -21.51 50.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -1.116 . . . . 0.0 109.932 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.454 ' C ' ' SG ' ' A' ' 91' ' ' CYS . 42.0 t -54.52 -54.15 44.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 109.976 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.0 tt0 -55.77 -32.17 63.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 111.028 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.726 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.8 pt -96.92 10.89 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.922 -1.111 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 57.21 18.83 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.931 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -70.89 -7.59 46.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.997 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.594 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 53.1 t80 -147.06 167.64 23.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.37 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.01 4.94 5.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.386 -0.821 . . . . 0.0 110.5 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.594 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -65.36 -35.42 80.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.161 -0.962 . . . . 0.0 110.482 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.847 ' SG ' HG23 ' A' ' 1' ' ' VAL . 0.1 OUTLIER -96.53 120.48 36.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.705 -179.712 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.639 HG23 ' NE2' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -104.77 -5.39 21.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 110.577 -179.438 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . -83.76 -36.05 14.68 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.21 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 1' ' ' VAL . 18.5 m . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.243 0.544 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.615 HG21 ' OG ' ' A' ' 9' ' ' SER . 37.0 m -88.17 151.16 22.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.387 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.015 HG21 HD21 ' A' ' 12' ' ' LEU . 85.2 t -94.23 121.94 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.717 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.845 ' NE2' HG21 ' A' ' 92' ' ' THR . 10.4 mt-30 -109.64 139.06 45.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 110.815 -179.391 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -111.59 11.53 21.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 109.784 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.23 -131.38 1.87 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -88.5 8.44 28.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.141 -1.211 . . . . 0.0 110.191 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 92.0 m-85 -121.7 158.83 27.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.193 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.615 ' OG ' HG21 ' A' ' 2' ' ' THR . 22.4 t -105.43 123.41 47.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.363 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 17.6 m-30 -119.19 130.46 55.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.843 . . . . 0.0 110.51 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.4 m -78.62 172.73 13.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.021 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.015 HD21 HG21 ' A' ' 3' ' ' VAL . 53.0 mt -97.35 -5.29 36.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.0 110.636 -179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.3 mt-10 -74.29 -73.17 0.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.361 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' ' 13' ' ' GLU . 5.2 m -39.91 -51.43 2.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.677 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.737 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 27.4 m -63.93 -45.67 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.069 -1.019 . . . . 0.0 109.697 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 16.6 tttt -55.12 -56.89 14.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.88 -1.138 . . . . 0.0 109.063 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -80.22 8.31 7.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.818 . . . . 0.0 109.467 178.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.737 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 15.4 tp -54.57 -34.84 62.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.403 -0.811 . . . . 0.0 110.331 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -60.48 -41.55 94.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.993 . . . . 0.0 109.895 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.39 98.02 10.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.988 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' A' ' 52' ' ' ASN . 11.0 tp . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.341 -179.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.75 ' HE ' HD12 ' A' ' 12' ' ' LEU . 24.3 ptt-85 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 41.9 p-10 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.07 -1.019 . . . . 0.0 110.856 -179.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.566 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.3 Cg_exo . . . . . 0 N--CA 1.481 0.759 0 N-CA-C 110.774 -0.51 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.34 19.32 1.73 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 43' ' ' VAL . 36.4 mt-10 -104.3 117.47 59.22 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 110.06 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.23 101.02 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.658 1.346 . . . . 0.0 110.53 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.775 ' O ' HG12 ' A' ' 44' ' ' VAL . 90.7 t -132.12 172.33 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.906 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 0.0 111.441 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.322 0.582 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.588 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 13.2 t -107.69 -70.7 0.79 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.944 . . . . 0.0 110.144 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.493 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 5.6 m-20 -79.2 111.51 20.89 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.591 -0.693 . . . . 0.0 110.092 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -64.45 -9.14 19.14 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.612 1.322 . . . . 0.0 110.114 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.592 ' HB2' HD11 ' A' ' 21' ' ' LEU . 96.8 m-20 -125.68 31.89 5.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.797 . . . . 0.0 110.218 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.746 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -79.85 178.02 2.59 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 108.803 179.09 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.746 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -57.86 75.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.493 1.26 . . . . 0.0 108.936 179.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.8 tt0 -39.28 -27.54 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.86 -0.525 . . . . 0.0 110.139 -178.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.0 mt-10 -52.21 -18.37 1.49 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.048 -1.032 . . . . 0.0 108.401 178.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.616 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 81.7 mt -88.8 9.95 22.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.637 -0.665 . . . . 0.0 109.571 179.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.751 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -39.63 -51.28 5.14 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 110.344 -179.854 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.751 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -54.87 -43.52 58.55 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.5 1.263 . . . . 0.0 109.666 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.056 HD11 HG21 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -53.42 -42.07 66.68 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.109 -0.994 . . . . 0.0 109.674 179.403 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.0 m -64.85 -28.05 69.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.131 -0.981 . . . . 0.0 110.335 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -90.66 2.55 55.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 111.434 -178.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.557 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 25.7 pt-20 -120.83 142.9 35.41 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.625 -1.297 . . . . 0.0 110.317 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -64.0 -18.29 63.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.91 1.479 . . . . 0.0 111.239 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -79.69 -12.3 59.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.985 -1.072 . . . . 0.0 110.344 -179.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.99 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.42 -41.16 19.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 110.461 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -56.68 -42.23 78.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 -179.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.4 mt-10 -79.92 -34.35 39.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.173 -0.955 . . . . 0.0 110.322 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.056 HG21 HD11 ' A' ' 60' ' ' LEU . 90.3 mt -68.96 -46.96 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.138 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.666 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.9 OUTLIER -47.69 -62.5 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.525 -179.787 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.666 ' N ' HD13 ' A' ' 70' ' ' LEU . 51.4 tt0 -49.62 -54.08 20.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.13 -0.981 . . . . 0.0 110.736 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 75.5 mtt-85 -52.7 -53.59 45.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.229 -0.919 . . . . 0.0 110.518 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.658 ' CD2' HG11 ' A' ' 15' ' ' VAL . 7.2 tp -51.09 -48.83 61.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.072 -1.017 . . . . 0.0 110.015 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 43.1 mt-10 -55.63 -41.13 73.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.376 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.566 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -66.24 -55.94 13.69 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.057 -1.027 . . . . 0.0 110.464 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 79' ' ' ASP . 22.2 mm -58.77 -40.77 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.336 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.785 ' HA ' HD22 ' A' ' 12' ' ' LEU . . . -62.76 -28.48 70.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.534 -0.729 . . . . 0.0 109.08 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 80.6 tt0 -65.36 -36.42 83.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.619 -0.676 . . . . 0.0 110.443 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.2 m-20 -149.14 158.04 39.1 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.824 -1.173 . . . . 0.0 110.524 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -61.72 -71.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.057 1.556 . . . . 0.0 110.653 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.89 -140.05 23.58 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.926 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 70.5 p -79.08 -24.32 43.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -1.168 . . . . 0.0 109.732 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 11.3 t -53.18 -53.55 48.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.2 tt0 -58.47 -32.19 68.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 111.057 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.761 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.1 pt -98.46 11.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.957 -1.09 . . . . 0.0 110.291 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 34.4 m 59.39 12.12 2.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.177 -0.952 . . . . 0.0 110.514 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.926 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -64.89 -16.18 62.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 109.997 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.54 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 41.8 t80 -137.17 166.57 23.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 110.188 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.85 2.88 7.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 110.289 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.54 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -62.35 -38.8 90.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 0.0 110.433 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.7 OUTLIER -104.11 118.25 36.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 110.636 -179.663 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.845 HG21 ' NE2' ' A' ' 4' ' ' GLN . 72.8 p -103.13 166.55 10.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.376 -0.827 . . . . 0.0 110.069 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.16 -5.08 78.27 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.303 -1.116 . . . . 0.0 110.213 179.988 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.284 0.564 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.969 HG21 ' OG ' ' A' ' 9' ' ' SER . 7.2 t -129.21 168.49 16.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.375 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -93.01 114.83 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.647 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.628 ' OE1' HG21 ' A' ' 92' ' ' THR . 61.2 tt0 -110.7 121.02 44.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.952 -179.216 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.752 ' OD2' HD21 ' A' ' 60' ' ' LEU . 58.4 p30 -99.92 3.64 44.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.362 -0.836 . . . . 0.0 109.325 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . -172.53 -142.56 3.82 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -82.1 1.42 36.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.2 -1.176 . . . . 0.0 110.498 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.482 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 98.6 m-85 -109.19 134.43 51.75 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.621 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.969 ' OG ' HG21 ' A' ' 2' ' ' THR . 1.0 OUTLIER -85.47 126.55 33.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.355 -0.841 . . . . 0.0 109.981 179.779 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.521 ' O ' ' OG1' ' A' ' 2' ' ' THR . 21.7 m-30 -117.7 127.21 53.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.023 -1.048 . . . . 0.0 110.777 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.444 ' C ' HD12 ' A' ' 12' ' ' LEU . 59.9 p -76.7 172.89 12.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.314 -0.866 . . . . 0.0 110.339 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.866 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 mp -100.64 -6.34 25.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.309 -0.869 . . . . 0.0 110.61 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 92.2 mt-10 -71.72 -73.89 0.17 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 0.0 110.82 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.3 m -43.5 -49.19 7.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.182 -0.949 . . . . 0.0 110.581 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.667 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 6.0 m -59.02 -46.41 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.555 ' CD ' ' HB3' ' A' ' 33' ' ' ARG . 23.0 tttt -58.15 -55.02 40.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.876 -1.14 . . . . 0.0 108.844 179.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.504 ' O ' ' O ' ' A' ' 20' ' ' ASP . 95.6 mttt -80.49 11.48 3.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 178.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.794 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.7 tt -58.73 -29.72 66.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 110.183 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -65.48 -34.91 79.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.182 -0.949 . . . . 0.0 110.144 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' A' ' 17' ' ' LYS . 60.6 t0 -133.82 141.71 47.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 110.147 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.599 HD11 ' CB ' ' A' ' 52' ' ' ASN . 1.9 mm? . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.041 -1.037 . . . . 0.0 110.569 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.555 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 32.4 mtt-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.276 0.56 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 50.3 t30 . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 110.197 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.483 0.86 0 N-CA-C 110.552 -0.595 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.47 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 162.54 37.45 0.02 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 43' ' ' VAL . 1.2 mm-40 -123.86 72.21 52.7 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.236 -1.155 . . . . 0.0 110.211 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.52 75.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.888 1.467 . . . . 0.0 110.379 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.859 ' O ' HG23 ' A' ' 44' ' ' VAL . 88.8 t -120.67 127.39 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.962 . . . . 0.0 110.29 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.021 HG21 ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.409 -0.807 . . . . 0.0 110.158 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 86.2 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.307 0.575 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.546 ' OG ' ' CG1' ' A' ' 43' ' ' VAL . 44.1 m -51.74 -62.8 1.4 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.263 -0.898 . . . . 0.0 111.083 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 3.9 m-20 -80.32 114.18 45.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.564 -179.362 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.8 0.84 1.73 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.806 1.424 . . . . 0.0 110.596 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.599 ' CB ' HD11 ' A' ' 21' ' ' LEU . 27.0 m120 -133.67 31.78 3.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.095 -1.003 . . . . 0.0 110.692 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.855 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 10.5 p90 -76.8 -177.23 0.73 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.039 -1.038 . . . . 0.0 108.772 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 1.071 ' HB2' HD13 ' A' ' 57' ' ' LEU . 5.0 Cg_exo -54.93 75.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.518 1.273 . . . . 0.0 110.108 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.628 ' N ' ' O ' ' A' ' 53' ' ' PHE . 84.7 tt0 -44.95 -33.87 2.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.571 -0.705 . . . . 0.0 110.032 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.589 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.3 mt-10 -54.39 -18.79 4.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.015 -1.053 . . . . 0.0 108.52 178.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.071 HD13 ' HB2' ' A' ' 54' ' ' PRO . 7.8 mp -97.5 9.2 43.04 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.931 0.872 . . . . 0.0 109.009 178.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.792 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -43.74 -49.35 19.97 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.685 -0.634 . . . . 0.0 109.934 179.556 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.792 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.86 -42.74 64.01 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.436 1.229 . . . . 0.0 109.73 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.1 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 10.7 mp -55.74 -40.74 72.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.051 -1.031 . . . . 0.0 109.129 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.656 ' HA ' HG22 ' A' ' 44' ' ' VAL . 41.4 t -64.3 -26.0 68.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 110.166 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.501 ' CE ' ' HD2' ' A' ' 58' ' ' LYS . 29.6 mttt -88.09 -4.96 58.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.88 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.528 ' CG ' ' HA ' ' A' ' 60' ' ' LEU . 9.1 pt-20 -113.1 147.69 37.84 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.012 -1.055 . . . . 0.0 110.337 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.9 -17.81 61.33 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.953 1.501 . . . . 0.0 111.034 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.484 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 74.5 m-20 -79.71 -13.73 59.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.085 -1.009 . . . . 0.0 110.59 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.1 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.93 -40.24 13.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 110.097 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -57.36 -40.79 78.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 110.061 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.3 -34.9 36.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.915 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.555 HG21 ' CD2' ' A' ' 60' ' ' LEU . 78.0 mt -72.64 -54.39 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 109.864 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -44.64 -60.15 2.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.87 . . . . 0.0 110.155 179.864 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.792 ' N ' HD13 ' A' ' 70' ' ' LEU . 94.2 mt-30 -51.65 -52.88 44.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.088 -1.007 . . . . 0.0 110.049 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -55.29 -56.45 19.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.823 . . . . 0.0 109.955 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.603 ' CD2' HG11 ' A' ' 3' ' ' VAL . 54.0 mt -47.45 -51.04 21.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.143 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 75.6 mm-40 -56.76 -38.39 72.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.859 . . . . 0.0 110.467 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -70.67 -54.04 13.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.164 -0.96 . . . . 0.0 110.297 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.551 HG21 ' CG2' ' A' ' 3' ' ' VAL . 57.8 mt -65.35 -31.03 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.821 ' HA ' HD23 ' A' ' 12' ' ' LEU . . . -67.12 -34.85 78.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.403 -0.811 . . . . 0.0 109.503 179.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.49 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 97.1 mt-10 -94.18 16.07 15.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.474 -0.766 . . . . 0.0 109.78 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.413 ' OD1' ' HD2' ' A' ' 80' ' ' PRO . 9.8 t0 -169.51 127.74 0.85 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.48 -0.763 . . . . 0.0 110.152 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD2' ' OD1' ' A' ' 79' ' ' ASP . 3.0 Cg_endo -61.66 -74.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.74 1.39 . . . . 0.0 110.749 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.68 -141.65 24.78 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.864 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 58.5 p -79.32 -22.87 43.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -1.197 . . . . 0.0 109.954 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 9.3 t -53.73 -52.17 60.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.409 ' OE1' ' CB ' ' A' ' 80' ' ' PRO . 83.6 tt0 -58.78 -32.32 69.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.88 . . . . 0.0 111.102 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.73 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.3 pt -96.59 11.73 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.933 -1.104 . . . . 0.0 110.458 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 58.56 13.6 2.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.58 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.864 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.7 -14.62 63.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.181 -0.949 . . . . 0.0 109.912 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.48 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 5.9 m-85 -137.83 165.99 25.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 0.0 110.331 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.14 3.57 5.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.338 -0.851 . . . . 0.0 110.283 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -63.05 -39.87 96.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.925 . . . . 0.0 110.392 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER -103.61 118.73 37.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.548 -179.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.628 HG21 ' OE1' ' A' ' 4' ' ' GLN . 6.5 m -112.08 6.25 19.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.375 -0.828 . . . . 0.0 110.3 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.03 -56.56 5.23 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.274 -1.133 . . . . 0.0 110.311 179.955 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.606 HG12 ' SG ' ' A' ' 91' ' ' CYS . 3.2 t . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.165 0.507 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.827 HG21 ' HB3' ' A' ' 9' ' ' SER . 12.8 t -126.56 155.79 41.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.851 HG22 ' SG ' ' A' ' 83' ' ' CYS . 53.0 t -95.9 122.77 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.552 -0.717 . . . . 0.0 109.163 179.005 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.92 ' CD ' HG21 ' A' ' 92' ' ' THR . 3.2 pt20 -129.22 -178.71 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.058 . . . . 0.0 111.548 -178.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 4' ' ' GLN . 93.1 m-20 -137.74 -60.3 0.65 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.526 0.679 . . . . 0.0 109.464 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.29 -143.76 15.19 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.581 ' OD1' ' CE2' ' A' ' 8' ' ' PHE . 16.2 p30 -81.08 8.58 8.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.028 -1.278 . . . . 0.0 110.334 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.581 ' CE2' ' OD1' ' A' ' 7' ' ' ASN . 83.6 m-85 -112.91 139.07 48.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -0.973 . . . . 0.0 110.383 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.827 ' HB3' HG21 ' A' ' 2' ' ' THR . 50.9 m -101.9 139.06 38.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.334 -0.854 . . . . 0.0 110.627 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.595 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 20.4 m-85 -124.28 134.4 53.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 110.402 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.0 p -75.11 170.89 15.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.239 -0.913 . . . . 0.0 110.177 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.733 HD21 HG21 ' A' ' 3' ' ' VAL . 9.3 mt -104.58 -2.28 25.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.217 -0.927 . . . . 0.0 110.524 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.59 ' HG2' ' CD ' ' A' ' 33' ' ' ARG . 36.7 mt-10 -64.23 -71.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 0.0 110.548 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.633 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.5 OUTLIER -57.14 -38.79 74.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.39 -0.819 . . . . 0.0 111.344 -179.12 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.726 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 13.0 t -61.55 -49.92 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.844 -1.16 . . . . 0.0 109.46 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.518 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 17.0 mttt -56.87 -55.05 39.37 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.816 -1.178 . . . . 0.0 108.864 178.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.71 10.96 4.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.018 178.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.925 HD23 ' OE2' ' A' ' 74' ' ' GLU . 13.1 tp -75.09 -10.37 59.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.088 -1.007 . . . . 0.0 109.893 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -63.58 -32.48 73.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 0.0 109.391 179.093 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -126.49 122.77 36.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.48 -0.762 . . . . 0.0 109.633 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.838 HD11 ' HB2' ' A' ' 52' ' ' ASN . 1.1 tm? . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.202 -0.936 . . . . 0.0 110.639 -179.525 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.59 ' CD ' ' HG2' ' A' ' 13' ' ' GLU . 69.6 mtm180 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.312 0.577 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.443 ' OD1' ' HD3' ' A' ' 80' ' ' PRO . 3.3 m-20 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.887 . . . . 0.0 110.055 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 3.0 Cg_exo . . . . . 0 N--CA 1.482 0.803 0 N-CA-C 110.757 -0.516 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.1 10.7 55.88 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.1 mt-10 -94.56 151.18 39.05 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.184 -1.186 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -60.79 111.51 1.07 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.876 1.461 . . . . 0.0 110.211 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.86 HG12 HG23 ' A' ' 44' ' ' VAL . 78.4 t -133.79 152.82 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 110.736 -179.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.86 HG23 HG12 ' A' ' 43' ' ' VAL . 74.3 t . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.529 -0.732 . . . . 0.0 111.275 179.44 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.486 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 55.6 m . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.157 0.503 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 38.6 m -60.72 -63.8 1.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.938 . . . . 0.0 110.751 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.567 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 4.0 m-20 -72.29 113.42 20.55 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 110.512 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -62.45 -13.02 30.55 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.636 1.335 . . . . 0.0 110.639 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.838 ' HB2' HD11 ' A' ' 21' ' ' LEU . 87.3 m-20 -128.19 34.02 4.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 110.109 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.718 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.04 -178.63 1.17 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.794 . . . . 0.0 109.249 179.549 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.729 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.8 Cg_exo -61.47 75.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 N-CA-C 108.655 -1.325 . . . . 0.0 108.655 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.613 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.2 tt0 -39.07 -27.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.764 -0.585 . . . . 0.0 110.118 -178.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 54' ' ' PRO . 71.9 mm-40 -53.35 -17.92 2.19 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.977 -1.077 . . . . 0.0 108.614 178.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.729 HD12 ' HG2' ' A' ' 54' ' ' PRO . 87.3 mt -92.06 6.53 46.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.692 . . . . 0.0 109.696 179.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.751 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.68 -51.4 5.2 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 110.452 -179.722 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.751 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -54.04 -42.42 67.07 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.34 1.179 . . . . 0.0 109.67 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.011 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -54.99 -42.83 72.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.088 -1.007 . . . . 0.0 109.816 179.46 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.1 m -68.84 -29.75 68.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.222 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 62' ' ' LYS . 51.6 tptt -79.93 -4.33 51.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.434 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.533 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 6.7 pt-20 -114.04 142.45 27.93 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 110.108 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -61.58 -17.22 52.9 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.873 1.459 . . . . 0.0 111.099 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.506 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 70.1 m-20 -79.9 -7.9 59.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.005 . . . . 0.0 110.33 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.011 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -50.42 -37.62 38.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 110.06 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.01 -39.0 93.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.211 -0.931 . . . . 0.0 110.142 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -80.17 -39.01 30.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.986 HG21 ' CD1' ' A' ' 60' ' ' LEU . 76.7 mt -68.06 -42.81 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.35 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.906 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -50.73 -59.21 4.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -0.768 . . . . 0.0 110.169 179.861 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.906 ' N ' HD13 ' A' ' 70' ' ' LEU . 52.7 tt0 -50.5 -55.77 14.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 110.355 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 73' ' ' LEU . 50.5 mtt180 -55.06 -62.97 1.31 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 0.0 110.431 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 72' ' ' ARG . 13.1 tp -41.73 -50.29 4.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.957 . . . . 0.0 109.992 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.925 ' OE2' HD23 ' A' ' 18' ' ' LEU . 63.0 mm-40 -55.3 -46.45 76.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 110.318 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -54.89 -53.12 59.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.088 -1.008 . . . . 0.0 110.37 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' ' 79' ' ' ASP . 26.0 mm -59.11 -35.0 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.104 -0.997 . . . . 0.0 109.404 179.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.725 ' HB2' HG12 ' A' ' 15' ' ' VAL . . . -59.59 -30.49 68.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.559 -0.713 . . . . 0.0 109.527 179.169 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.0 -40.6 96.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 110.41 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 2.5 p30 -148.97 159.52 37.24 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.099 -1.001 . . . . 0.0 110.482 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.577 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -62.63 -60.83 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.988 1.52 . . . . 0.0 110.494 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.02 -141.33 24.1 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 61.5 p -83.11 -18.3 40.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -1.141 . . . . 0.0 109.775 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.851 ' SG ' HG22 ' A' ' 3' ' ' VAL . 11.0 t -58.53 -53.35 59.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 0.0 110.047 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 48.1 tp10 -59.61 -23.98 63.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 111.081 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.784 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.3 pt -105.42 17.26 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.0 -1.062 . . . . 0.0 110.366 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.0 m 49.95 19.36 0.45 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.893 . . . . 0.0 110.65 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.983 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.04 -13.47 58.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.035 -1.04 . . . . 0.0 110.005 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -148.24 179.96 7.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.321 -0.862 . . . . 0.0 110.044 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.24 1.68 20.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 110.003 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -58.41 -39.97 81.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.332 -0.855 . . . . 0.0 110.415 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.606 ' SG ' HG12 ' A' ' 1' ' ' VAL . 0.5 OUTLIER -108.05 129.43 55.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.533 -179.653 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.92 HG21 ' CD ' ' A' ' 4' ' ' GLN . 19.5 p -109.81 159.81 16.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.378 -0.826 . . . . 0.0 110.146 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.67 -12.77 61.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.278 -1.131 . . . . 0.0 110.228 179.994 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.483 ' CG1' ' SG ' ' A' ' 91' ' ' CYS . 79.0 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.172 0.511 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.472 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 60.8 m -132.45 150.04 52.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.843 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.812 ' HB ' HD21 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -92.98 119.39 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 109.419 179.379 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.747 ' CD ' HG21 ' A' ' 92' ' ' THR . 1.4 pt20 -116.27 148.29 40.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.079 -1.013 . . . . 0.0 110.933 -179.164 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -96.14 -74.85 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.76 . . . . 0.0 109.478 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.53 -121.12 4.67 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -85.62 14.48 5.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -1.14 . . . . 0.0 110.15 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.692 ' CE1' ' CE1' ' A' ' 10' ' ' PHE . 25.8 t80 -125.89 148.66 49.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.39 -0.819 . . . . 0.0 110.015 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.56 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 12.5 t -107.26 137.74 44.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.17 -0.956 . . . . 0.0 110.724 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.692 ' CE1' ' CE1' ' A' ' 8' ' ' PHE . 84.9 m-85 -119.56 132.1 55.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.19 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -67.14 164.2 18.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.088 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.812 HD21 ' HB ' ' A' ' 3' ' ' VAL . 54.1 mt -101.44 -5.19 25.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.982 . . . . 0.0 110.432 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.548 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 83.1 tt0 -69.04 -73.02 0.16 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.426 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.4 m -42.36 -55.3 3.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.032 -1.043 . . . . 0.0 110.545 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.698 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 15.8 m -51.81 -43.95 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.091 -1.006 . . . . 0.0 110.083 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.488 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 37.3 tttm -56.26 -58.75 6.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.832 -1.168 . . . . 0.0 108.644 178.701 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 75.1 mmtt -80.62 17.78 1.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.353 -0.842 . . . . 0.0 109.57 178.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 2.1 tt -65.77 -41.16 92.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.198 -0.939 . . . . 0.0 110.012 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -53.16 -41.99 65.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 110.287 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -140.26 80.33 1.75 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.19 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 52' ' ' ASN . 6.6 tt . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.548 ' HD2' ' HA ' ' A' ' 13' ' ' GLU . 82.9 mtm-85 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.285 0.564 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 63.7 m-20 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 110.57 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.58 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 2.9 Cg_endo . . . . . 0 N--CA 1.481 0.789 0 N-CA-C 110.53 -0.604 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.0 17.84 42.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.533 ' CG ' ' OE1' ' A' ' 74' ' ' GLU . 7.9 pt-20 -135.59 79.3 47.77 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.214 -1.168 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HB3' ' HG3' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -61.17 131.59 37.42 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.862 1.454 . . . . 0.0 110.387 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 43' ' ' VAL . 27.0 m -120.06 53.18 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 110.435 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.017 HG21 ' HA ' ' A' ' 61' ' ' CYS . 7.4 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 110.696 179.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.548 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 73.5 m . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.272 0.558 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.549 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.6 m -54.07 -50.76 66.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 110.144 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.487 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 2.7 m120 -71.45 112.22 13.05 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.785 . . . . 0.0 110.615 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -63.08 -10.52 21.02 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.694 1.365 . . . . 0.0 110.118 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.802 ' O ' HD13 ' A' ' 21' ' ' LEU . 14.3 m120 -130.21 33.92 4.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.379 -0.826 . . . . 0.0 110.461 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.689 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -79.09 179.64 1.72 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 108.719 179.082 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.82 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.6 Cg_exo -58.35 74.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.512 1.269 . . . . 0.0 109.184 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 53' ' ' PHE . 82.9 tt0 -39.5 -26.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.668 -0.645 . . . . 0.0 110.349 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.8 mt-10 -56.83 -15.7 5.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.023 -1.048 . . . . 0.0 108.619 178.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.82 HD12 ' HG2' ' A' ' 54' ' ' PRO . 78.4 mt -92.09 14.17 16.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.646 -0.659 . . . . 0.0 109.609 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.751 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.84 -49.49 5.68 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 110.085 179.818 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.751 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.3 Cg_exo -56.51 -47.67 22.78 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.444 1.233 . . . . 0.0 109.573 179.147 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.124 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 12.0 tp -46.55 -52.65 12.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.727 179.428 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 1.017 ' HA ' HG21 ' A' ' 44' ' ' VAL . 85.0 m -67.01 -30.47 70.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 110.55 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 51.2 tttm -79.94 3.44 19.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 110.616 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.518 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 8.2 pt-20 -127.9 144.05 49.97 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.984 -1.072 . . . . 0.0 110.124 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.39 -17.22 56.45 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.805 1.424 . . . . 0.0 110.853 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.495 ' O ' HG13 ' A' ' 69' ' ' ILE . 22.6 m120 -79.88 -9.49 59.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 110.417 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.124 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.92 -42.37 27.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.013 . . . . 0.0 109.806 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.471 ' HG3' ' HB3' ' A' ' 42' ' ' PRO . 64.0 tt0 -59.62 -43.37 93.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.537 -0.727 . . . . 0.0 110.37 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.26 -39.74 32.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 109.974 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.915 ' HB ' HD11 ' A' ' 60' ' ' LEU . 68.7 mt -67.48 -47.84 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.629 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.806 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.4 tm? -50.54 -55.6 15.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 110.014 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.792 ' N ' HD13 ' A' ' 70' ' ' LEU . 52.2 tt0 -47.27 -52.18 16.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 110.186 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -54.73 -51.48 65.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 0.0 110.086 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 53.0 mt -53.52 -52.16 60.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 0.0 110.054 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.757 ' OE2' HD11 ' A' ' 70' ' ' LEU . 73.2 mt-10 -55.29 -37.9 67.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.873 . . . . 0.0 110.511 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.523 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 82.1 tt0 -65.31 -53.58 41.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.985 . . . . 0.0 110.926 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.646 HG21 ' CG2' ' A' ' 3' ' ' VAL . 20.6 mm -61.35 -39.13 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.594 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.06 -26.92 68.55 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.491 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.9 tt0 -66.3 -35.12 79.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.507 -0.746 . . . . 0.0 111.063 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.11 96.14 1.23 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.809 -1.182 . . . . 0.0 111.041 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.637 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 2.7 Cg_endo -67.82 44.71 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.757 1.398 . . . . 0.0 110.483 179.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.52 -74.38 0.3 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.991 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 74.3 p -69.37 -58.81 3.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -1.123 . . . . 0.0 110.296 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -39.16 -46.9 1.52 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 110.495 -179.586 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 80' ' ' PRO . 81.8 tt0 -63.75 -25.1 68.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.043 . . . . 0.0 110.527 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 82' ' ' THR . 26.5 pt -107.23 18.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.268 -179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.19 15.66 4.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.519 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.991 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -59.75 -23.89 63.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 109.935 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -141.75 169.23 17.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.59 5.16 11.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 110.322 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.11 -43.26 95.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.934 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -94.67 133.61 38.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.193 -0.942 . . . . 0.0 110.389 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.747 HG21 ' CD ' ' A' ' 4' ' ' GLN . 42.3 p -116.16 154.39 30.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.318 -0.864 . . . . 0.0 110.144 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 101.99 -9.02 56.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.44 -1.035 . . . . 0.0 110.386 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.826 HG22 ' SG ' ' A' ' 91' ' ' CYS . 7.8 p . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.313 0.577 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 53.5 m -127.08 155.59 43.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.95 . . . . 0.0 110.676 -179.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.003 ' CG2' HD21 ' A' ' 12' ' ' LEU . 4.0 t -91.13 117.17 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.497 179.389 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 8' ' ' PHE . 4.1 pt20 -126.87 175.18 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.073 -1.017 . . . . 0.0 111.201 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.743 ' OD2' HG23 ' A' ' 69' ' ' ILE . 96.8 m-20 -136.94 -58.38 0.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.573 0.702 . . . . 0.0 109.5 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.37 -140.18 11.28 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.587 ' OD1' ' CD2' ' A' ' 8' ' ' PHE . 13.9 p30 -79.65 2.04 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.164 -1.198 . . . . 0.0 110.266 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.587 ' CD2' ' OD1' ' A' ' 7' ' ' ASN . 77.9 m-85 -110.71 152.77 26.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.505 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 49.0 m -112.0 136.99 50.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 0.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.753 ' CG ' HD21 ' A' ' 57' ' ' LEU . 11.2 m-85 -117.16 127.79 54.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.264 -0.897 . . . . 0.0 110.285 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.504 ' HA ' HG23 ' A' ' 2' ' ' THR . 30.5 m -72.22 164.67 25.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.352 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.003 HD21 ' CG2' ' A' ' 3' ' ' VAL . 83.9 mt -85.24 -24.29 27.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.942 . . . . 0.0 110.431 -179.753 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 14' ' ' SER . 86.0 tt0 -64.18 -69.16 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.308 -0.87 . . . . 0.0 110.372 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.1 m -43.82 -51.41 7.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.125 -0.984 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.669 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 54.4 t -59.16 -49.03 84.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.228 -0.92 . . . . 0.0 109.327 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 tptm -53.21 -56.45 16.35 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 20' ' ' ASP . 57.6 mttt -80.85 13.75 2.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.573 -0.704 . . . . 0.0 110.076 178.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.669 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.1 tt -65.65 -47.36 75.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.987 . . . . 0.0 110.297 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.34 -47.17 86.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -0.962 . . . . 0.0 109.834 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 17' ' ' LYS . 83.9 m-20 -103.2 122.5 44.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 109.787 179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.883 HD11 ' HB2' ' A' ' 52' ' ' ASN . 18.9 tp . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.744 -179.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 29.5 ptt-85 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.31 0.576 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.643 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 28.3 m-20 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 110.655 -179.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.523 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.1 Cg_exo . . . . . 0 N--CA 1.482 0.822 0 N-CA-C 110.633 -0.564 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.484 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 145.34 -7.46 1.57 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -119.84 74.81 19.62 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.239 . . . . 0.0 110.396 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.484 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_endo -61.74 115.6 2.9 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.78 1.41 . . . . 0.0 110.487 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.824 ' O ' HG23 ' A' ' 44' ' ' VAL . 89.6 t -136.42 141.7 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.223 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.023 HG21 ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.472 -0.767 . . . . 0.0 110.611 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.37 0.605 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.673 ' CB ' HG11 ' A' ' 43' ' ' VAL . 58.1 p -52.96 -42.98 66.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.308 -0.87 . . . . 0.0 111.0 -179.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -80.3 110.68 17.53 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.186 -0.946 . . . . 0.0 110.46 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -58.3 -10.62 8.85 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.753 1.397 . . . . 0.0 110.787 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.883 ' HB2' HD11 ' A' ' 21' ' ' LEU . 97.9 m-20 -139.56 42.95 2.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.121 -0.987 . . . . 0.0 110.712 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.756 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -78.61 177.2 2.98 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.092 -1.005 . . . . 0.0 108.433 178.778 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.756 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.8 Cg_exo -57.51 76.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 N-CA-C 108.628 -1.336 . . . . 0.0 108.628 179.124 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.623 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.9 tt0 -38.88 -28.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.803 -0.561 . . . . 0.0 110.075 -178.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.7 mt-10 -51.66 -18.18 1.11 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.996 -1.065 . . . . 0.0 108.587 178.257 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.753 HD21 ' CG ' ' A' ' 10' ' ' PHE . 78.7 mt -86.77 2.95 47.03 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.43 0.633 . . . . 0.0 109.861 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.753 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 20.6 tptt -39.99 -49.61 5.97 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 110.366 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.753 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.85 -41.1 80.78 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.357 1.188 . . . . 0.0 110.434 179.678 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.012 HD21 HG21 ' A' ' 69' ' ' ILE . 6.2 mp -61.08 -37.6 83.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.876 -1.14 . . . . 0.0 110.179 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.663 ' HA ' HG22 ' A' ' 44' ' ' VAL . 57.3 m -62.73 -25.23 68.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.574 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -98.89 10.94 40.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.115 -0.991 . . . . 0.0 111.399 -179.15 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.575 ' CG ' ' HA ' ' A' ' 60' ' ' LEU . 12.6 pt-20 -133.65 147.1 63.15 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.746 -1.221 . . . . 0.0 110.536 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.25 -11.16 23.98 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.911 1.48 . . . . 0.0 110.939 -179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.42 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 79.4 m-20 -78.93 -23.72 44.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.1 -1.0 . . . . 0.0 110.428 -179.046 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.023 ' HB1' HG21 ' A' ' 44' ' ' VAL . . . -49.14 -39.3 28.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.973 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -57.16 -44.94 83.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.27 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 73.5 mm-40 -79.13 -31.9 44.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.012 HG21 HD21 ' A' ' 60' ' ' LEU . 95.5 mt -76.34 -53.45 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.096 -1.003 . . . . 0.0 109.928 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.01 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -44.69 -65.42 0.53 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.432 -0.793 . . . . 0.0 110.484 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 1.01 ' N ' HD13 ' A' ' 70' ' ' LEU . 50.9 tt0 -49.06 -54.79 14.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.124 -0.985 . . . . 0.0 110.697 -179.702 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 44.5 mtp85 -54.97 -55.32 32.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.549 ' CD1' HG22 ' A' ' 69' ' ' ILE . 28.7 mt -47.43 -50.77 21.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.158 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.819 ' OE2' HD21 ' A' ' 70' ' ' LEU . 75.4 mt-10 -56.22 -48.19 76.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 34.8 tt0 -53.79 -52.92 58.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.042 -1.036 . . . . 0.0 109.894 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 79' ' ' ASP . 62.2 mt -59.92 -34.3 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -0.932 . . . . 0.0 109.156 179.224 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -56.15 -32.83 64.65 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.034 179.031 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.643 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 83.2 tt0 -64.2 -43.49 94.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.522 -0.736 . . . . 0.0 109.67 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.473 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 2.0 t70 -143.17 147.58 41.29 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.956 179.784 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.616 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -56.64 -56.11 2.24 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.841 1.442 . . . . 0.0 110.583 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.19 -137.13 21.57 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.942 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 71.9 p -82.16 -23.09 35.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -1.087 . . . . 0.0 110.625 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 7.7 t -56.29 -54.38 46.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.065 -1.022 . . . . 0.0 110.033 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 76.9 tt0 -58.05 -27.34 63.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 111.178 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.76 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.9 pt -101.14 14.84 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.89 -1.131 . . . . 0.0 110.27 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 73.3 m 54.76 16.32 1.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.897 . . . . 0.0 110.539 179.594 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.942 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.51 -12.31 51.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.82 174.5 11.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.85 3.89 9.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.304 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -61.52 -42.82 99.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.908 . . . . 0.0 110.417 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.826 ' SG ' HG22 ' A' ' 1' ' ' VAL . 1.2 m -106.2 124.55 49.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.79 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.504 HG21 ' CD ' ' A' ' 4' ' ' GLN . 36.8 p -109.61 163.23 13.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.158 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.02 3.32 51.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.395 -1.061 . . . . 0.0 110.283 179.975 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.517 ' CG1' ' SG ' ' A' ' 91' ' ' CYS . 52.9 t . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.287 0.565 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.724 HG21 ' HB2' ' A' ' 9' ' ' SER . 11.7 t -118.48 164.04 15.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 0.0 110.357 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.697 HG13 HG21 ' A' ' 76' ' ' ILE . 65.3 t -81.07 124.46 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 109.569 179.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.791 ' CB ' HG21 ' A' ' 92' ' ' THR . 48.9 tt0 -113.65 121.53 44.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.055 -1.028 . . . . 0.0 110.9 -179.333 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.98 ' HB3' HD21 ' A' ' 73' ' ' LEU . 52.6 p30 -97.74 13.44 30.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.441 -0.787 . . . . 0.0 109.647 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.506 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 173.51 -132.13 2.24 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -93.67 16.57 13.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.164 -1.198 . . . . 0.0 109.773 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.65 ' CB ' ' CZ ' ' A' ' 10' ' ' PHE . 44.8 m-85 -121.06 128.09 52.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.456 -0.777 . . . . 0.0 110.429 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.724 ' HB2' HG21 ' A' ' 2' ' ' THR . 14.7 p -82.18 118.29 22.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 8' ' ' PHE . 21.4 m-85 -117.93 123.32 45.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.807 -179.207 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.492 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 45.6 t -67.87 168.78 10.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.28 -0.888 . . . . 0.0 110.083 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.833 ' N ' HD12 ' A' ' 12' ' ' LEU . 4.6 mp -95.81 0.84 52.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 110.629 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -73.28 -73.93 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.088 -1.008 . . . . 0.0 110.488 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.534 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.4 m -42.68 -41.09 3.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.114 -0.991 . . . . 0.0 110.556 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.531 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 33.1 t -69.26 -50.89 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 109.805 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.503 ' HD3' ' HB2' ' A' ' 33' ' ' ARG . 9.6 ttpp -48.06 -46.52 33.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.221 -0.924 . . . . 0.0 109.102 179.243 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 18' ' ' LEU . 49.9 mttm -74.03 -54.96 6.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 0.0 109.003 178.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.77 HD12 ' OD1' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -27.88 -41.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.804 -0.56 . . . . 0.0 110.551 -179.999 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 17' ' ' LYS . 22.4 mttm -51.76 -45.62 63.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 109.947 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 21' ' ' LEU . 52.0 p30 -112.86 -3.15 14.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 110.063 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.984 HD23 ' ND2' ' A' ' 50' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.404 -0.81 . . . . 0.0 110.451 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.503 ' HB2' ' HD3' ' A' ' 16' ' ' LYS . 6.3 ptp180 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.314 0.578 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 41.5 p-10 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.202 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.557 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.801 0 N-CA-C 110.653 -0.557 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.423 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 140.94 4.87 1.08 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.821 -1.181 . . . . 0.0 110.169 179.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.54 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -134.61 60.47 42.57 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.881 -1.364 . . . . 0.0 110.612 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -62.16 139.41 78.03 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.824 1.433 . . . . 0.0 110.515 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 49' ' ' SER . 14.8 m -141.93 119.68 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.334 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.724 ' O ' HG12 ' A' ' 44' ' ' VAL . 69.2 t . . . . . 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 0.0 110.473 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.526 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.383 0.611 . . . . 0.0 110.147 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.53 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.3 t -69.54 -56.0 8.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 110.442 -179.817 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.984 ' ND2' HD23 ' A' ' 21' ' ' LEU . 7.2 m120 -78.28 113.06 30.54 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.481 -0.762 . . . . 0.0 110.452 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -62.45 -12.69 28.91 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.747 1.393 . . . . 0.0 110.459 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.491 ' HB2' HD11 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -127.8 36.41 4.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 110.045 179.886 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.727 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 3.0 p90 -80.14 178.86 2.11 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.203 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 1.021 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.2 Cg_exo -56.53 75.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.676 1.356 . . . . 0.0 109.872 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.9 tt0 -43.56 -34.19 1.34 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.833 . . . . 0.0 110.298 -179.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.545 ' C ' HD12 ' A' ' 57' ' ' LEU . 74.4 mm-40 -54.31 -18.65 4.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.934 -1.104 . . . . 0.0 108.626 178.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.021 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.5 mp -95.3 18.69 11.97 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.092 0.949 . . . . 0.0 108.99 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.743 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -43.19 -51.02 14.41 Favored Pre-proline 0 N--CA 1.489 1.483 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.52 179.818 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.743 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.24 -49.12 17.4 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.502 1.264 . . . . 0.0 109.658 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.104 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -48.1 -49.1 33.01 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.09 -1.006 . . . . 0.0 109.753 179.446 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.513 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 87.0 m -63.49 -23.95 67.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 19.9 tttt -90.68 5.62 47.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 0.0 110.743 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 8.6 pt-20 -125.96 144.76 49.7 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.891 -1.13 . . . . 0.0 110.317 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -61.54 -13.59 30.44 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.94 1.495 . . . . 0.0 110.803 -179.799 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.507 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 84.7 m-20 -79.78 -22.65 42.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.292 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.104 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.23 -40.05 10.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.11 -0.994 . . . . 0.0 109.797 179.775 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -62.48 -36.95 84.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 0.0 109.23 179.3 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.49 -38.9 29.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.524 -0.735 . . . . 0.0 109.407 178.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.763 HG23 ' HB2' ' A' ' 5' ' ' ASP . 80.0 mt -70.92 -46.18 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 109.898 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.911 HD13 ' N ' ' A' ' 71' ' ' GLN . 2.1 tm? -40.66 -68.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.506 -0.746 . . . . 0.0 110.554 -179.768 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.911 ' N ' HD13 ' A' ' 70' ' ' LEU . 25.3 mt-30 -42.77 -52.4 5.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.143 -0.973 . . . . 0.0 110.459 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -53.71 -59.05 5.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.004 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.98 HD21 ' HB3' ' A' ' 5' ' ' ASP . 36.7 mt -47.57 -54.14 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 110.051 179.705 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 39' ' ' PRO . 70.3 mt-10 -52.19 -45.78 65.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 110.06 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.557 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 83.7 tt0 -57.62 -51.36 69.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.809 179.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.697 HG21 HG13 ' A' ' 3' ' ' VAL . 23.6 mm -60.64 -38.75 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 109.519 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.543 ' HA ' HD23 ' A' ' 12' ' ' LEU . . . -54.52 -38.39 66.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.429 -0.794 . . . . 0.0 109.65 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.735 ' O ' ' CB ' ' A' ' 79' ' ' ASP . 83.8 tt0 -44.14 -33.56 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.89 . . . . 0.0 109.611 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.735 ' CB ' ' O ' ' A' ' 78' ' ' GLU . 19.5 t70 95.04 73.13 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 76' ' ' ILE . 3.0 Cg_exo -60.86 -34.97 90.55 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.022 1.538 . . . . 0.0 110.185 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 85' ' ' ILE . . . 94.16 -28.89 9.58 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.195 -2.362 . . . . 0.0 107.195 -178.249 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.822 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 75.6 p -74.3 -40.75 62.06 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.11 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.677 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 53.5 t -58.81 -40.96 85.65 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.834 178.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.37 -33.37 75.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.066 -1.021 . . . . 0.0 110.349 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 82' ' ' THR . 17.8 pt -94.44 11.32 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.934 . . . . 0.0 110.237 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER 67.83 12.42 8.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.355 -0.841 . . . . 0.0 110.527 179.721 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.822 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -58.64 -35.76 73.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.22 -0.925 . . . . 0.0 109.897 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.548 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 29.1 t80 -123.15 166.8 14.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.937 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.91 -7.28 47.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.152 -0.967 . . . . 0.0 109.974 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.548 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -51.82 -37.1 50.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.83 . . . . 0.0 110.861 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.677 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -104.13 118.8 37.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.906 . . . . 0.0 111.139 -179.149 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.791 HG21 ' CB ' ' A' ' 4' ' ' GLN . 18.4 p -98.16 177.86 5.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 110.197 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.75 -5.9 84.16 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.442 ' OXT' ' SG ' ' A' ' 86' ' ' CYS . 23.9 p . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.166 . . . . 0.0 110.118 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 84' ' ' GLU . 3.5 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.229 0.538 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.495 HG23 ' HA ' ' A' ' 11' ' ' SER . 37.0 m -89.26 150.89 22.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 110.293 -179.851 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.01 HG21 HD11 ' A' ' 12' ' ' LEU . 88.0 t -80.08 104.8 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 110.123 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.53 ' HB3' ' CG2' ' A' ' 92' ' ' THR . 48.1 tt0 -108.64 123.69 49.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 110.36 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -100.75 5.07 43.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.098 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . -176.44 -138.62 2.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -79.74 -0.12 32.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -1.123 . . . . 0.0 110.251 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.456 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 84.4 m-85 -116.8 130.7 56.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.197 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m -86.01 136.18 33.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 110.126 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.647 ' CE1' HD23 ' A' ' 57' ' ' LEU . 57.0 m-85 -115.09 125.73 53.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 110.191 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.539 ' C ' HD22 ' A' ' 12' ' ' LEU . 33.8 t -73.07 169.9 16.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.92 . . . . 0.0 110.179 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.01 HD11 HG21 ' A' ' 3' ' ' VAL . 3.2 mm? -100.63 -3.99 29.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.115 -0.99 . . . . 0.0 110.413 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 14' ' ' SER . 97.5 mt-10 -70.23 -72.9 0.18 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -0.999 . . . . 0.0 110.432 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.498 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.5 m -41.12 -50.69 3.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 110.662 -179.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.634 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 30.8 m -63.1 -47.96 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.096 -1.003 . . . . 0.0 109.743 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.628 ' CD ' ' HA ' ' A' ' 33' ' ' ARG . 6.8 ttpp -56.53 -55.42 34.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.084 -1.01 . . . . 0.0 109.159 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -80.11 7.6 8.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.49 179.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 13.0 tp -54.1 -35.65 62.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.577 -0.702 . . . . 0.0 110.131 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -55.48 -41.84 73.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.116 -0.99 . . . . 0.0 109.507 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.7 105.92 16.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.778 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.781 HD11 ' H ' ' A' ' 52' ' ' ASN . 11.8 tp . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.595 -179.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.628 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 76.1 mtm180 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.22 0.533 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 10.6 p30 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.265 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.463 ' HG3' ' HB2' ' A' ' 75' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.481 0.791 0 N-CA-C 110.479 -0.623 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.38 8.52 43.61 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -123.49 76.04 54.11 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.279 -1.13 . . . . 0.0 110.115 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.47 141.81 96.4 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.001 1.527 . . . . 0.0 110.689 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 43' ' ' VAL . 15.5 m -121.21 58.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.378 -0.826 . . . . 0.0 110.186 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.327 -179.856 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.8 m . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.534 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 6.0 t -62.63 -73.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.053 -1.029 . . . . 0.0 111.099 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.698 ' OD1' HD13 ' A' ' 21' ' ' LEU . 28.3 m-20 -79.98 113.68 40.16 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.837 -179.184 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -64.59 -7.2 13.84 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.793 1.417 . . . . 0.0 110.329 179.521 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.781 ' H ' HD11 ' A' ' 21' ' ' LEU . 15.3 m120 -129.16 32.5 4.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.0 109.864 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.741 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -79.86 -176.55 0.74 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 108.956 179.412 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.966 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.7 Cg_exo -59.28 74.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.442 1.233 . . . . 0.0 109.051 179.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.8 tt0 -39.28 -32.33 0.11 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.687 -0.633 . . . . 0.0 110.551 -178.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 54' ' ' PRO . 77.7 tt0 -52.31 -24.95 8.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.905 -1.122 . . . . 0.0 108.604 178.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.966 HD12 ' HG2' ' A' ' 54' ' ' PRO . 91.7 mt -85.28 1.23 49.19 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.437 0.636 . . . . 0.0 109.543 179.151 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.772 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.8 tmmt? -40.93 -49.65 7.7 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.459 -0.775 . . . . 0.0 110.493 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.772 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -53.98 -39.77 83.73 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.398 1.21 . . . . 0.0 110.557 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.06 HD13 HG21 ' A' ' 69' ' ' ILE . 9.6 mt -67.64 -30.65 70.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.927 -1.108 . . . . 0.0 110.029 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 46.0 t -69.34 -26.18 64.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 110.066 179.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -96.11 20.38 10.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 108.981 179.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -114.84 142.0 27.69 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.71 -0.619 . . . . 0.0 110.538 -179.11 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.93 -26.49 74.3 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.789 1.415 . . . . 0.0 109.425 178.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -86.06 -5.08 59.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.815 . . . . 0.0 110.538 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.889 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -45.26 -37.97 5.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.046 . . . . 0.0 110.101 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 94.0 mt-30 -59.55 -41.05 89.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 110.25 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.33 -39.31 28.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.096 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.06 HG21 HD13 ' A' ' 60' ' ' LEU . 84.8 mt -63.29 -47.89 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.135 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.814 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.4 tm? -53.05 -53.37 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 110.211 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.764 ' N ' HD13 ' A' ' 70' ' ' LEU . 73.7 mt-30 -48.33 -55.23 11.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.396 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -50.17 -52.16 37.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.363 -0.835 . . . . 0.0 110.188 -179.75 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 56.5 mt -53.13 -49.2 67.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.26 -0.9 . . . . 0.0 110.094 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.753 ' OE2' HD11 ' A' ' 70' ' ' LEU . 74.4 mt-10 -54.8 -43.38 72.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 110.727 -179.776 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.463 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.8 tt0 -62.9 -55.63 24.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.033 -1.042 . . . . 0.0 110.904 -179.308 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.1 mt -62.12 -38.11 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.35 70.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.448 -0.783 . . . . 0.0 109.8 179.596 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.3 tt0 -62.08 -37.06 83.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 110.556 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 3.0 m-20 -165.15 151.44 8.97 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.016 . . . . 0.0 110.706 -179.796 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.595 ' HB3' ' CG ' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.38 74.95 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.968 1.509 . . . . 0.0 110.719 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 80' ' ' PRO . . . -61.28 -134.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.269 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.932 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 59.4 p -75.39 -20.88 58.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.997 -1.296 . . . . 0.0 109.281 179.24 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.613 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 9.9 t -60.29 -46.23 90.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.533 -0.729 . . . . 0.0 109.404 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.595 ' CG ' ' HB3' ' A' ' 80' ' ' PRO . 49.8 tp10 -58.57 -30.23 67.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.271 -0.893 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.756 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.4 pt -103.2 12.85 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.96 -1.087 . . . . 0.0 110.39 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 4.4 t 60.52 14.24 4.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.281 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.932 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -64.47 -21.64 66.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.083 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.466 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 1.7 m-85 -131.59 166.51 21.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.58 2.99 3.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 110.368 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -65.9 -38.56 89.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -0.936 . . . . 0.0 110.409 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.613 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -108.56 115.15 29.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 110.715 -179.568 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' A' ' 4' ' ' GLN . 41.4 p -100.27 176.9 5.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 110.254 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.03 78.47 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.297 -1.119 . . . . 0.0 110.257 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.956 HG21 ' HA ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.205 0.526 . . . . 0.0 110.142 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 63.0 m -130.55 149.4 52.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.655 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.852 ' HB ' HD21 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -92.35 119.92 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.623 -0.673 . . . . 0.0 109.64 179.569 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 51.5 tt0 -111.74 121.31 44.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 110.824 -179.286 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 1.009 ' OD2' HD21 ' A' ' 73' ' ' LEU . 83.0 m-20 -97.31 9.14 43.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 109.818 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.449 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . -179.55 -138.13 3.2 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -82.4 4.5 23.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.167 -1.196 . . . . 0.0 110.185 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 78.3 m-85 -121.89 132.63 54.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 110.389 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.483 ' HB3' HG21 ' A' ' 92' ' ' THR . 26.8 p -80.73 127.63 32.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 110.034 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.677 ' HB3' HD11 ' A' ' 57' ' ' LEU . 20.2 m-30 -114.6 126.7 55.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.87 . . . . 0.0 110.445 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.8 m -71.55 166.78 21.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.852 HD21 ' HB ' ' A' ' 3' ' ' VAL . 51.5 mt -96.91 -8.81 29.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.558 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.544 ' HG2' ' CD ' ' A' ' 33' ' ' ARG . 95.3 mt-10 -63.8 -68.07 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.065 -1.022 . . . . 0.0 110.394 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.1 m -45.2 -50.69 11.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.271 -0.893 . . . . 0.0 111.191 -179.438 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.591 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 25.1 m -57.58 -48.43 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 0.0 110.269 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' N ' HG23 ' A' ' 15' ' ' VAL . 28.8 ttpp -50.5 -51.25 49.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.865 -1.147 . . . . 0.0 108.643 179.165 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.631 ' O ' ' C ' ' A' ' 18' ' ' LEU . 63.6 mttp -67.97 -57.36 6.31 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.066 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.631 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.4 OUTLIER 1.66 -71.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 120.832 0.349 . . . . 0.0 111.373 179.32 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.614 ' N ' ' O ' ' A' ' 17' ' ' LYS . 86.0 tttt -49.47 -59.28 3.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.916 -1.115 . . . . 0.0 109.248 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 17' ' ' LYS . 24.7 t70 -109.11 97.24 6.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.426 -0.796 . . . . 0.0 109.461 178.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.008 HD21 ' HB2' ' A' ' 52' ' ' ASN . 31.6 tp . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.893 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.544 ' CD ' ' HG2' ' A' ' 13' ' ' GLU . 85.2 mtt-85 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.305 0.574 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 78' ' ' GLU . 88.4 m-20 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 0.0 110.31 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 2.9 Cg_endo . . . . . 0 N--CA 1.482 0.806 0 N-CA-C 110.47 -0.627 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.52 3.78 49.92 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.96 83.55 37.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.279 -1.13 . . . . 0.0 110.147 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.499 ' HA ' HD22 ' A' ' 70' ' ' LEU . 2.9 Cg_endo -61.6 140.38 86.4 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.9 1.474 . . . . 0.0 110.591 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.716 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.3 p -148.12 64.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 44' ' ' VAL . 94.5 t . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.293 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.308 0.575 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.606 ' CB ' HG22 ' A' ' 43' ' ' VAL . 34.1 t -69.73 -76.2 0.1 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.181 -0.95 . . . . 0.0 110.258 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.803 ' HB3' HD22 ' A' ' 21' ' ' LEU . 5.8 m120 -80.48 115.86 57.92 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 110.725 -179.837 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -64.63 1.84 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.657 1.346 . . . . 0.0 110.681 179.281 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 1.008 ' HB2' HD21 ' A' ' 21' ' ' LEU . 89.0 m-20 -133.84 31.77 3.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 110.064 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.871 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 11.0 p90 -76.21 -176.73 0.63 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 109.132 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 1.019 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -56.4 73.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.382 1.201 . . . . 0.0 110.037 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.61 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.0 tt0 -42.81 -34.62 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.564 -0.71 . . . . 0.0 110.309 -179.511 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.556 ' C ' HD12 ' A' ' 57' ' ' LEU . 96.0 mt-10 -54.87 -17.43 3.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.991 . . . . 0.0 108.809 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.019 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.7 mp -97.87 11.63 36.73 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.816 0.817 . . . . 0.0 109.184 179.202 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.74 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.87 -52.08 5.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.778 -0.576 . . . . 0.0 110.758 -179.818 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.74 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -53.08 -42.91 61.31 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.428 1.225 . . . . 0.0 110.25 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.903 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 11.0 mp -60.78 -35.58 76.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.064 -1.023 . . . . 0.0 109.769 179.447 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 51.8 t -66.73 -28.99 68.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.16 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -104.4 24.18 12.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 109.191 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -116.42 140.78 27.0 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.627 -0.671 . . . . 0.0 110.548 -179.232 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_endo -63.91 -30.39 67.5 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.734 1.386 . . . . 0.0 109.698 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -80.03 -7.49 58.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.418 -0.801 . . . . 0.0 110.61 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.903 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.03 -39.65 9.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.043 179.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.35 -41.1 92.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 110.342 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -80.17 -37.62 32.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.918 179.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 90.0 mt -66.08 -41.91 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 110.188 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.683 HD11 ' OE2' ' A' ' 74' ' ' GLU . 1.6 tp -56.44 -57.91 10.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 110.723 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -47.46 -17.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.084 -1.01 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.521 ' HB3' ' O ' ' A' ' 69' ' ' ILE . 27.5 ttm-85 -86.85 -58.1 2.72 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.617 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 1.009 HD21 ' OD2' ' A' ' 5' ' ' ASP . 69.6 mt -51.36 -50.79 58.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.392 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.683 ' OE2' HD11 ' A' ' 70' ' ' LEU . 88.7 mt-10 -55.41 -54.87 38.38 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.478 -0.764 . . . . 0.0 109.465 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.503 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 83.8 tt0 -61.15 -53.95 50.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 110.16 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.53 ' O ' ' O ' ' A' ' 79' ' ' ASP . 23.3 mm -62.18 -33.83 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 109.749 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . -59.06 -34.38 71.89 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.407 179.454 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 84.8 tt0 -58.7 -39.58 81.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 110.285 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.53 ' O ' ' O ' ' A' ' 76' ' ' ILE . 14.5 p-10 -145.03 153.73 53.74 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.11 -0.993 . . . . 0.0 110.358 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -58.83 -54.27 2.97 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.888 1.468 . . . . 0.0 110.537 179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.98 -139.67 24.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 44.6 p -80.08 -20.76 44.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -1.107 . . . . 0.0 110.164 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.668 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 5.5 t -55.44 -54.24 46.21 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.179 -0.951 . . . . 0.0 109.956 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.956 ' HA ' HG21 ' A' ' 1' ' ' VAL . 84.5 tt0 -56.08 -30.38 61.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 111.04 -179.493 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.78 HG13 ' HB2' ' A' ' 87' ' ' ALA . 9.0 pt -98.8 15.41 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.892 -1.13 . . . . 0.0 110.344 -179.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.6 m 50.89 23.51 1.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 110.376 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.983 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -71.62 -11.23 60.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 34.1 m-85 -150.56 171.56 16.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 110.126 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.82 1.96 18.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.948 . . . . 0.0 110.202 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.1 -11.61 41.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.359 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.945 ' SG ' HG22 ' A' ' 1' ' ' VAL . 0.7 OUTLIER -108.41 -172.53 2.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.97 . . . . 0.0 110.382 -179.878 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.507 ' HB ' ' HB ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -150.55 -15.81 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.273 -0.892 . . . . 0.0 110.997 -179.903 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.1 -23.33 72.96 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.488 1.463 0 O-C-N 121.159 -1.201 . . . . 0.0 110.35 -179.9 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.528 HG13 ' SG ' ' A' ' 91' ' ' CYS . 33.8 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.29 0.567 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.474 HG21 ' HB3' ' A' ' 9' ' ' SER . 61.2 m -119.39 149.43 41.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.238 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.782 HG21 HG21 ' A' ' 76' ' ' ILE . 1.2 t -83.69 113.16 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.877 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.609 ' HB3' HG21 ' A' ' 92' ' ' THR . 64.3 tt0 -110.54 119.19 38.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.418 -0.801 . . . . 0.0 110.694 -179.456 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -101.28 7.06 43.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 109.713 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.476 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . -169.67 -143.1 3.77 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -81.02 4.93 18.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.309 -1.112 . . . . 0.0 110.424 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.566 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 66.3 m-85 -125.63 136.86 53.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.311 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.474 ' HB3' HG21 ' A' ' 2' ' ' THR . 67.2 m -79.65 131.15 35.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.93 . . . . 0.0 110.037 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.905 ' HB3' HD21 ' A' ' 57' ' ' LEU . 18.4 m-85 -113.44 121.92 45.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 110.618 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.519 ' C ' HD22 ' A' ' 12' ' ' LEU . 60.1 p -75.35 171.29 14.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.241 -0.912 . . . . 0.0 109.871 179.645 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.833 HD22 ' N ' ' A' ' 12' ' ' LEU . 2.7 mm? -103.2 -12.07 17.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 0.0 110.772 -179.6 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.549 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 90.8 mt-10 -63.25 -74.1 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.092 -1.005 . . . . 0.0 110.535 -179.855 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 6.3 m -40.6 -44.37 2.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 110.478 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.705 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.1 t -62.22 -46.51 96.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.158 -0.964 . . . . 0.0 109.457 179.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.545 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -54.93 -50.28 69.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.021 -1.049 . . . . 0.0 108.551 178.479 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -80.36 6.6 11.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.511 -0.743 . . . . 0.0 109.657 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.705 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 44.3 tp -63.74 -23.36 67.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.38 -0.825 . . . . 0.0 110.426 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -67.52 -32.59 73.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.024 -1.048 . . . . 0.0 110.303 -179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -116.96 122.5 44.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.141 -0.975 . . . . 0.0 110.174 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.84 HD22 ' ND2' ' A' ' 50' ' ' ASN . 8.9 tp . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.4 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.549 ' HD2' ' HG2' ' A' ' 13' ' ' GLU . 67.4 mtt85 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.157 0.503 . . . . 0.0 109.958 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 14.7 p30 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.747 -179.542 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.765 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . 3.0 Cg_endo . . . . . 0 N--CA 1.483 0.883 0 N-CA-C 110.592 -0.58 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.06 42.51 0.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 0.8 OUTLIER -122.95 169.72 9.43 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.322 -1.105 . . . . 0.0 110.32 -179.913 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.538 ' C ' HG12 ' A' ' 43' ' ' VAL . 2.9 Cg_endo -62.26 155.28 57.75 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 124.022 1.538 . . . . 0.0 111.178 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.734 ' C ' HG23 ' A' ' 44' ' ' VAL . 7.1 p 33.73 83.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.598 -0.689 . . . . 0.0 111.047 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.791 HG13 ' HB1' ' A' ' 66' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 120.8 -1.187 . . . . 0.0 108.47 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.554 ' CB ' ' HB ' ' A' ' 44' ' ' VAL . 35.3 t . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.3 p -61.03 -25.96 67.28 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.277 -0.889 . . . . 0.0 108.744 178.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.84 ' ND2' HD22 ' A' ' 21' ' ' LEU . 1.2 m-20 -50.32 130.79 25.05 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.705 . . . . 0.0 110.143 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -66.45 1.55 2.5 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.795 1.419 . . . . 0.0 111.106 179.816 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.84 ' HB2' HD11 ' A' ' 21' ' ' LEU . 10.8 m120 -113.39 7.12 17.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.067 -1.021 . . . . 0.0 110.842 -179.633 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.755 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -80.1 -177.13 0.84 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.073 -1.017 . . . . 0.0 109.493 179.449 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.853 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.6 Cg_exo -61.0 73.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.7 1.368 . . . . 0.0 109.038 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.583 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.3 tt0 -38.87 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.761 -0.587 . . . . 0.0 110.19 -178.523 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.488 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 50.1 mt-10 -55.11 -22.81 17.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.093 -1.004 . . . . 0.0 109.107 178.797 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.905 HD21 ' HB3' ' A' ' 10' ' ' PHE . 31.6 mt -92.38 11.59 25.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.455 -0.778 . . . . 0.0 109.742 179.35 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.737 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.85 -51.39 5.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.43 -0.794 . . . . 0.0 110.677 179.967 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.737 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.33 -44.73 46.04 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.531 1.279 . . . . 0.0 110.511 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.024 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 10.9 mp -57.88 -41.44 82.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.933 -1.104 . . . . 0.0 110.212 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.6 m -66.65 -25.96 66.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.919 -1.113 . . . . 0.0 110.063 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -97.95 1.06 47.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.892 . . . . 0.0 110.427 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.586 ' OE2' HD12 ' A' ' 69' ' ' ILE . 5.6 pt-20 -108.08 139.9 21.14 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.107 -0.995 . . . . 0.0 110.081 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.1 Cg_exo -61.89 -21.73 72.87 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.805 1.424 . . . . 0.0 110.988 -179.562 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.484 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 75.9 m-20 -79.44 -11.31 59.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 110.579 -179.138 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.024 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -48.6 -32.02 7.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 109.86 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.79 -38.13 86.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.418 -0.801 . . . . 0.0 109.739 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.3 -41.89 24.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.271 -0.893 . . . . 0.0 109.398 179.101 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.619 HG21 ' CD2' ' A' ' 60' ' ' LEU . 65.1 mt -67.33 -49.15 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.372 -0.83 . . . . 0.0 109.67 179.534 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.999 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -41.8 -67.08 0.28 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.781 . . . . 0.0 110.005 179.898 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.999 ' N ' HD13 ' A' ' 70' ' ' LEU . 90.8 mt-30 -44.99 -51.96 9.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.094 -1.004 . . . . 0.0 110.268 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -63.47 -50.71 68.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.452 -0.78 . . . . 0.0 110.153 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.532 HD21 HD13 ' A' ' 57' ' ' LEU . 13.5 tp -46.19 -60.13 2.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.708 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.824 ' OE2' HD21 ' A' ' 70' ' ' LEU . 54.7 mt-10 -50.72 -49.4 57.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.977 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.82 -54.83 24.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 110.246 -179.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.782 HG21 HG21 ' A' ' 3' ' ' VAL . 25.2 mm -57.42 -39.24 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 0.0 109.545 179.759 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -55.82 -34.36 65.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.469 -0.769 . . . . 0.0 109.529 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.5 tt0 -62.49 -42.98 99.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.51 -0.744 . . . . 0.0 110.017 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.42 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 14.9 p-10 -151.97 158.56 33.82 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.975 -1.078 . . . . 0.0 110.311 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.602 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -59.83 -54.24 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.017 1.535 . . . . 0.0 110.407 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.09 -140.23 29.54 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 43.5 p -82.17 -20.43 37.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -1.102 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.593 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 21.8 t -57.99 -46.13 85.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 0.0 109.787 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 80.4 tt0 -62.24 -29.28 70.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.17 -0.956 . . . . 0.0 111.34 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.638 HG13 ' HB2' ' A' ' 87' ' ' ALA . 3.9 pt -97.38 6.38 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.893 -1.129 . . . . 0.0 110.398 -179.496 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER 67.32 6.2 4.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 179.615 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -66.15 -17.86 64.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 109.93 179.732 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.513 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.3 OUTLIER -128.06 157.63 40.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 110.186 -179.889 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.49 -0.59 10.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.089 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.72 -32.9 74.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.385 -0.822 . . . . 0.0 110.557 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.593 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -108.42 111.9 24.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 110.796 -179.504 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.609 HG21 ' HB3' ' A' ' 4' ' ' GLN . 21.0 p -101.85 174.53 5.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.395 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.3 -14.74 64.58 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.423 -1.046 . . . . 0.0 110.227 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.512 HG12 ' SG ' ' A' ' 91' ' ' CYS . 18.1 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.193 0.521 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.959 HG21 ' HB3' ' A' ' 9' ' ' SER . 10.9 t -126.83 163.32 23.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.236 -0.915 . . . . 0.0 110.66 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.079 HG21 HD21 ' A' ' 12' ' ' LEU . 45.6 t -82.78 122.44 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.499 -0.75 . . . . 0.0 109.524 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.491 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 50.3 tt0 -112.32 121.35 44.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.93 . . . . 0.0 110.822 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.965 ' OD2' HD21 ' A' ' 73' ' ' LEU . 93.3 m-20 -98.79 11.51 38.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.426 -0.796 . . . . 0.0 109.657 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.491 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 179.92 -138.36 3.37 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -88.83 14.35 10.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 110.176 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.633 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.4 m-85 -123.79 131.01 53.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.229 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.959 ' HB3' HG21 ' A' ' 2' ' ' THR . 29.6 m -81.63 123.24 28.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -0.897 . . . . 0.0 110.085 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.778 ' CE2' HD11 ' A' ' 60' ' ' LEU . 22.9 m-85 -119.37 128.66 54.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 110.369 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.409 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 49.2 m -75.51 172.7 12.08 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.079 HD21 HG21 ' A' ' 3' ' ' VAL . 88.5 mt -106.47 -3.19 21.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.167 -0.958 . . . . 0.0 110.837 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.01 -73.91 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 110.321 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 m -47.83 -43.8 28.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 110.51 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.547 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 18.4 t -61.21 -50.36 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.03 -1.043 . . . . 0.0 109.809 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.959 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 19.3 tttt -55.23 -53.97 49.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 53.3 mttp -80.2 8.85 6.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.455 -0.778 . . . . 0.0 110.029 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.623 HD13 ' HB2' ' A' ' 53' ' ' PHE . 16.6 tp -60.9 -44.98 96.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 110.686 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.491 ' NZ ' ' HA ' ' A' ' 39' ' ' PRO . 57.5 mttt -66.82 -34.01 76.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.351 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -128.99 79.98 1.95 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.979 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.465 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.0 tt -113.59 125.58 54.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.11 -0.994 . . . . 0.0 110.392 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.421 ' HG3' ' C ' ' A' ' 21' ' ' LEU . 95.3 mt-30 -148.22 54.39 1.03 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.828 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.507 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 12.5 pt-20 -174.46 163.67 2.64 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.326 -0.859 . . . . 0.0 110.095 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 3.0 Cg_exo -61.4 166.25 11.64 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.88 1.463 . . . . 0.0 110.649 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -44.97 136.96 4.4 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.288 -0.883 . . . . 0.0 110.235 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 0.5 OUTLIER -119.0 116.14 34.34 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 110.208 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.46 -158.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.657 1.346 . . . . 0.0 110.582 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -56.2 142.26 37.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.934 . . . . 0.0 110.181 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 31' ' ' LYS . 41.1 t -118.14 137.35 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.237 -0.914 . . . . 0.0 110.246 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.1 -27.44 45.83 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.614 ' H ' HG12 ' A' ' 29' ' ' VAL . 96.3 mttt -72.92 156.53 38.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.326 -1.102 . . . . 0.0 110.265 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.439 HD23 ' ND2' ' A' ' 34' ' ' ASN . 23.4 tp -90.43 135.2 33.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.271 -0.893 . . . . 0.0 110.312 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 13.5 ptt180 -70.38 62.74 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.173 -0.954 . . . . 0.0 110.174 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.563 ' OD1' ' CD2' ' A' ' 35' ' ' PHE . 30.3 p-10 -133.37 11.13 4.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.563 ' CD2' ' OD1' ' A' ' 34' ' ' ASN . 94.0 m-85 -101.32 8.08 42.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.959 ' HB2' ' HG3' ' A' ' 16' ' ' LYS . . . -61.01 146.22 88.08 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.253 -0.904 . . . . 0.0 110.303 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 36' ' ' ALA . 2.8 Cg_endo -63.56 -150.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.835 1.439 . . . . 0.0 110.553 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.484 ' O ' ' NZ ' ' A' ' 19' ' ' LYS . 1.3 mp -108.1 136.56 19.78 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.946 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.494 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 3.1 Cg_exo -61.1 145.79 98.45 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.677 1.356 . . . . 0.0 110.677 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.58 37.12 0.05 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.481 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 2.8 tt0 -138.77 64.41 35.63 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.178 -1.189 . . . . 0.0 110.23 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.525 ' CB ' ' HG3' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -61.71 102.27 0.24 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.847 1.446 . . . . 0.0 110.721 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.571 ' O ' HG23 ' A' ' 44' ' ' VAL . 14.6 p -134.52 127.87 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 110.083 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.607 ' O ' HG12 ' A' ' 44' ' ' VAL . 32.5 t -155.0 85.16 3.59 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.475 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 49' ' ' SER . 3.0 Cg_endo -61.66 -149.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.875 1.46 . . . . 0.0 110.117 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.4 mt -52.98 -51.99 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.153 -0.967 . . . . 0.0 108.977 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.522 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 44.9 mt -111.11 -74.64 0.64 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.495 -0.753 . . . . 0.0 109.105 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.567 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.8 m -147.72 148.74 31.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.863 . . . . 0.0 109.755 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.539 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 22.7 t -59.9 -50.78 72.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 0.0 110.568 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 7.1 m120 -79.69 117.89 69.6 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 110.397 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.13 -10.93 13.99 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.762 1.401 . . . . 0.0 110.445 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -138.32 42.3 2.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.85 . . . . 0.0 109.513 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.713 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -80.1 -177.24 0.87 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.552 -0.718 . . . . 0.0 109.568 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.094 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -58.03 72.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.674 1.355 . . . . 0.0 109.667 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.619 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 23.1 pt-20 -40.1 -36.9 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.498 -0.751 . . . . 0.0 110.3 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' C ' HD12 ' A' ' 57' ' ' LEU . 96.3 mt-10 -54.12 -17.51 2.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 0.0 109.307 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.094 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.9 mp -97.9 8.55 44.55 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.736 0.779 . . . . 0.0 109.7 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.749 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -39.81 -52.04 5.2 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.716 -0.615 . . . . 0.0 110.72 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.749 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.97 -42.63 65.14 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.466 1.245 . . . . 0.0 110.051 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.996 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 16.6 mt -57.75 -41.35 81.76 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.031 -1.043 . . . . 0.0 109.879 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 15.7 m -69.19 -28.1 66.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.091 -1.005 . . . . 0.0 110.221 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 14.2 ttpt -88.28 6.51 36.62 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 0.0 110.196 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 2.4 pt-20 -111.39 144.14 29.91 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.986 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.64 -23.61 72.1 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.834 1.439 . . . . 0.0 111.103 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.514 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 80.1 m-20 -83.31 -4.88 58.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 0.0 110.717 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.996 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -51.48 -39.56 57.76 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.011 -1.056 . . . . 0.0 110.066 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.525 ' HG3' ' CB ' ' A' ' 42' ' ' PRO . 30.6 tt0 -54.12 -44.05 70.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.892 . . . . 0.0 109.918 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -79.93 -35.31 37.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 110.076 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.622 HG21 HD13 ' A' ' 60' ' ' LEU . 93.9 mt -67.78 -52.83 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.947 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.3 tm? -43.33 -58.42 2.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.43 -0.794 . . . . 0.0 110.019 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.621 ' N ' HD13 ' A' ' 70' ' ' LEU . 25.9 mt-30 -51.75 -54.94 22.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.033 -1.042 . . . . 0.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.6 ttm-85 -49.61 -56.24 10.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.445 -0.784 . . . . 0.0 109.788 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.965 HD21 ' OD2' ' A' ' 5' ' ' ASP . 57.2 mt -48.32 -46.83 36.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.89 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 74.9 mm-40 -55.53 -45.32 77.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 110.147 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.0 -54.55 40.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.119 -0.988 . . . . 0.0 110.38 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.9 mt -60.21 -31.63 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 109.69 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 33' ' ' ARG . . . -64.1 -32.06 73.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.856 . . . . 0.0 109.292 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.809 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . 79.7 tt0 -92.99 14.71 16.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.581 -0.7 . . . . 0.0 109.68 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 9.7 t70 -178.86 124.61 0.25 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.406 -0.808 . . . . 0.0 109.928 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.559 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -61.68 -62.52 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.657 1.346 . . . . 0.0 110.773 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.43 -139.28 18.74 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 1.03 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 60.2 p -79.92 -22.07 43.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.172 . . . . 0.0 110.065 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 7.6 t -54.71 -53.72 51.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 110.001 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 85.2 tt0 -57.96 -31.28 66.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 110.929 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.824 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.2 pt -99.6 13.96 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.981 -1.075 . . . . 0.0 110.334 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 33.8 m 50.44 20.53 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 110.221 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 1.03 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -60.7 -12.2 9.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.913 . . . . 0.0 110.021 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.437 ' CG ' ' O ' ' A' ' 87' ' ' ALA . 50.0 m-85 -154.82 -176.63 6.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.288 -0.882 . . . . 0.0 110.205 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.3 1.93 12.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.288 -0.883 . . . . 0.0 110.326 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.81 -36.08 71.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 110.588 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -112.57 129.08 56.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.201 -0.937 . . . . 0.0 110.609 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.481 HG21 ' CD ' ' A' ' 4' ' ' GLN . 25.3 p -107.19 157.21 18.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.168 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.09 0.08 56.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.334 -1.098 . . . . 0.0 110.275 -179.982 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.449 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 3.0 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.314 0.578 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 57.5 m -121.97 146.53 47.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 110.536 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.051 HG23 HD11 ' A' ' 12' ' ' LEU . 56.0 t -86.11 119.67 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.863 . . . . 0.0 109.527 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.495 ' CD ' HG21 ' A' ' 92' ' ' THR . 49.7 tt0 -109.88 116.86 32.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -0.991 . . . . 0.0 110.848 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -93.08 10.98 29.26 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.396 -0.815 . . . . 0.0 109.666 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.456 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 179.77 -134.72 2.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -86.66 5.92 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.243 -1.151 . . . . 0.0 110.162 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.672 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 71.0 m-85 -124.1 137.76 54.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.103 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 p -81.17 124.06 28.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.193 -0.942 . . . . 0.0 110.439 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.672 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 18.1 m-30 -113.91 125.62 54.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.344 -0.847 . . . . 0.0 110.399 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.2 p -73.91 168.02 20.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.236 -0.915 . . . . 0.0 110.076 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.051 HD11 HG23 ' A' ' 3' ' ' VAL . 5.0 mp -94.12 -20.85 19.52 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.235 -0.916 . . . . 0.0 110.539 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.528 ' OE1' ' CG ' ' A' ' 26' ' ' GLU . 88.6 tt0 -57.62 -67.38 0.34 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.306 -0.872 . . . . 0.0 110.781 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.574 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 9.3 m -41.77 -47.44 4.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.09 -1.006 . . . . 0.0 110.317 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 96.9 t -64.4 -50.25 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.081 -1.012 . . . . 0.0 109.704 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.582 ' CD ' ' HB2' ' A' ' 36' ' ' ALA . 10.1 tptp -55.17 -49.49 71.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 108.969 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.538 ' HE2' ' NH1' ' A' ' 33' ' ' ARG . 31.0 mttt -80.47 4.4 18.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.8 . . . . 0.0 109.987 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.617 HD13 ' HB2' ' A' ' 53' ' ' PHE . 11.0 tp -64.97 -37.11 86.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.194 -0.942 . . . . 0.0 110.446 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -57.92 -37.43 74.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.173 -0.954 . . . . 0.0 110.136 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 29.2 p-10 -132.14 126.47 33.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.121 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.517 HD22 ' HB3' ' A' ' 52' ' ' ASN . 11.0 mt -87.77 124.69 33.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.16 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.426 ' HG3' ' C ' ' A' ' 21' ' ' LEU . 89.5 mt-30 -145.7 55.32 1.19 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 0.0 110.368 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 0.3 OUTLIER 54.6 62.92 7.75 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.219 -0.926 . . . . 0.0 110.452 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HD2' ' ND2' ' A' ' 52' ' ' ASN . 2.9 Cg_endo -62.78 61.4 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.89 1.469 . . . . 0.0 110.483 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 23' ' ' GLU . 94.4 mt-30 -63.76 -19.54 65.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.188 -0.945 . . . . 0.0 110.277 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.643 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 0.5 OUTLIER 66.98 54.37 0.77 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.353 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -61.48 152.28 74.22 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.778 1.41 . . . . 0.0 110.375 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 62.8 ttt-85 -63.15 101.74 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.177 -0.952 . . . . 0.0 110.058 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.808 HG22 ' H ' ' A' ' 31' ' ' LYS . 13.4 p -123.27 141.44 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 110.296 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.16 2.9 69.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.808 ' H ' HG22 ' A' ' 29' ' ' VAL . 27.2 mttt -80.92 147.53 30.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -1.177 . . . . 0.0 110.169 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.7 tp -99.18 123.32 43.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.133 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.538 ' NH1' ' HE2' ' A' ' 17' ' ' LYS . 34.6 mtt-85 -69.89 136.61 50.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.927 . . . . 0.0 110.378 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 55.4 t-20 -172.09 31.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.256 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.585 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 65.4 t80 -109.82 7.45 24.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.863 . . . . 0.0 110.148 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.646 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . . . -58.35 123.03 64.0 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.174 -0.954 . . . . 0.0 110.303 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.77 -143.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.769 1.405 . . . . 0.0 110.549 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -108.82 165.54 12.47 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.915 . . . . 0.0 110.019 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.516 ' HD2' ' HB ' ' A' ' 38' ' ' ILE . 3.1 Cg_exo -59.8 158.46 28.72 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.808 1.425 . . . . 0.0 110.579 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.43 21.28 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -134.55 88.66 28.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.087 -1.243 . . . . 0.0 109.972 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -60.32 140.39 91.64 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.953 1.502 . . . . 0.0 110.704 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.927 HG23 HG23 ' A' ' 44' ' ' VAL . 16.6 m -131.33 169.05 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 110.299 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.927 HG23 HG23 ' A' ' 43' ' ' VAL . 6.3 t 66.89 56.06 0.85 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.461 -0.775 . . . . 0.0 110.634 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.596 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.8 Cg_endo -61.03 -45.46 19.6 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.796 1.419 . . . . 0.0 109.846 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.809 ' O ' HD23 ' A' ' 47' ' ' LEU . 67.5 mt -147.09 -39.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.459 -0.776 . . . . 0.0 109.44 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.809 HD23 ' O ' ' A' ' 46' ' ' ILE . 69.8 mt -143.75 78.54 1.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.492 -0.755 . . . . 0.0 109.64 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.527 ' O ' ' O ' ' A' ' 47' ' ' LEU . 99.1 m 56.23 144.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.411 -0.806 . . . . 0.0 110.479 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.511 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -98.6 -72.54 0.65 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.163 -0.96 . . . . 0.0 110.092 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.427 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -76.67 113.67 31.7 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.461 -0.775 . . . . 0.0 110.011 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.46 -11.09 18.29 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.668 1.352 . . . . 0.0 110.676 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.559 ' ND2' ' HD2' ' A' ' 24' ' ' PRO . 42.2 t30 -130.6 34.44 4.14 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.286 -0.884 . . . . 0.0 110.376 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.729 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.2 -175.45 0.6 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.172 179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.093 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -58.28 74.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.499 1.262 . . . . 0.0 109.843 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 53' ' ' PHE . 87.0 tt0 -42.05 -36.87 1.24 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.451 -0.781 . . . . 0.0 110.222 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.582 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.7 mt-10 -52.79 -18.42 1.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.041 -1.037 . . . . 0.0 108.934 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.093 HD13 ' HB2' ' A' ' 54' ' ' PRO . 9.3 mp -94.12 14.95 18.38 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.901 0.858 . . . . 0.0 109.028 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.743 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -40.19 -52.24 5.7 Favored Pre-proline 0 N--CA 1.49 1.57 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.034 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.743 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.9 Cg_exo -52.97 -43.28 58.1 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.509 1.268 . . . . 0.0 110.094 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.043 HD22 HG21 ' A' ' 69' ' ' ILE . 86.4 mt -60.24 -37.88 81.72 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.03 -1.043 . . . . 0.0 109.95 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.629 ' O ' HG11 ' A' ' 44' ' ' VAL . 2.9 t -69.03 -30.62 69.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.02 -1.05 . . . . 0.0 110.216 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 34.4 tttm -89.95 -1.35 57.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.154 -0.967 . . . . 0.0 109.551 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.63 138.28 26.72 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.523 -0.736 . . . . 0.0 110.038 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.71 -20.75 66.94 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.632 1.332 . . . . 0.0 110.039 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.97 -2.39 57.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.377 -0.827 . . . . 0.0 110.595 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.951 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.01 -35.55 4.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.098 -1.001 . . . . 0.0 109.8 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.56 -45.54 88.77 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 109.971 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -80.25 -41.22 25.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.991 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.043 HG21 HD22 ' A' ' 60' ' ' LEU . 83.5 mt -57.53 -45.59 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.167 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.948 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -45.77 -58.48 3.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.852 . . . . 0.0 110.248 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.948 ' N ' HD13 ' A' ' 70' ' ' LEU . 84.7 mt-30 -48.7 -56.2 9.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 0.0 110.023 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -48.88 -52.8 22.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.896 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.627 HD11 HD13 ' A' ' 60' ' ' LEU . 33.8 mt -51.42 -49.96 60.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.992 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.566 ' OE2' HD11 ' A' ' 70' ' ' LEU . 86.8 mt-10 -51.89 -54.25 31.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.219 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -55.57 -55.94 26.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.224 -0.922 . . . . 0.0 110.537 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 79' ' ' ASP . 38.0 mm -58.35 -41.41 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.117 -0.989 . . . . 0.0 109.922 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -52.6 -37.14 57.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.286 -0.884 . . . . 0.0 109.657 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.646 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . 84.2 tt0 -63.3 -44.03 96.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.435 -0.79 . . . . 0.0 110.13 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 76' ' ' ILE . 6.5 t70 -136.73 143.4 42.64 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.054 -1.029 . . . . 0.0 110.231 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.558 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -59.41 -48.15 14.46 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.74 1.39 . . . . 0.0 110.588 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.41 -137.66 19.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.619 ' O ' HG12 ' A' ' 85' ' ' ILE . 44.2 p -76.08 -24.47 55.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -1.177 . . . . 0.0 109.312 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.566 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 22.8 t -47.55 -54.74 10.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.446 -0.784 . . . . 0.0 110.266 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.558 ' HB2' ' CB ' ' A' ' 80' ' ' PRO . 85.0 tt0 -60.39 -36.63 78.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.402 -0.811 . . . . 0.0 111.625 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.619 HG12 ' O ' ' A' ' 82' ' ' THR . 9.5 pt -86.88 10.15 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.741 -1.225 . . . . 0.0 110.58 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 87.5 m 52.78 19.81 1.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 110.828 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.559 ' CB ' HG13 ' A' ' 85' ' ' ILE . . . -78.33 -4.67 49.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.068 -1.02 . . . . 0.0 109.774 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.65 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 22.5 t80 -146.43 165.81 28.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.45 -0.781 . . . . 0.0 110.143 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.98 3.91 7.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 110.398 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.65 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -62.67 -31.83 72.79 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.96 . . . . 0.0 110.555 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.566 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -108.07 122.3 46.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.173 -0.954 . . . . 0.0 110.662 -179.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.495 HG21 ' CD ' ' A' ' 4' ' ' GLN . 14.8 p -105.67 150.09 25.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.363 -0.836 . . . . 0.0 110.054 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 94' ' ' CYS . . . 100.16 -6.89 58.31 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.469 ' O ' ' O ' ' A' ' 93' ' ' GLY . 22.0 m . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.352 -1.087 . . . . 0.0 110.32 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.246 0.546 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 25.8 m -122.18 145.06 48.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.903 . . . . 0.0 110.399 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.045 HG23 HD11 ' A' ' 12' ' ' LEU . 64.9 t -88.43 119.94 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.223 -0.923 . . . . 0.0 110.042 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.82 ' OE1' HG21 ' A' ' 92' ' ' THR . 12.0 pt20 -115.31 140.41 49.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 110.762 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.463 ' OD2' HD11 ' A' ' 60' ' ' LEU . 51.0 p30 -110.31 13.93 22.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.549 -0.719 . . . . 0.0 109.862 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.07 -135.58 2.61 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -81.99 3.72 25.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -1.126 . . . . 0.0 110.128 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 81.0 m-85 -122.87 151.58 41.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.478 ' OG ' ' HB ' ' A' ' 2' ' ' THR . 3.7 t -104.19 135.06 46.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.2 -0.938 . . . . 0.0 110.217 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.697 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 24.6 m-85 -121.62 133.67 54.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 110.534 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.0 m -73.49 167.2 21.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -0.864 . . . . 0.0 110.36 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.045 HD11 HG23 ' A' ' 3' ' ' VAL . 5.3 mp -95.13 -15.95 22.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.199 -0.938 . . . . 0.0 110.508 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.2 mt-10 -65.74 -69.2 0.31 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.078 -1.013 . . . . 0.0 110.282 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' GLU . 5.6 m -40.76 -53.07 2.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 110.606 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.684 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.2 m -57.31 -45.07 85.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.045 -1.034 . . . . 0.0 109.442 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 37' ' ' PRO . 55.2 tttm -54.09 -57.56 10.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.0 109.006 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -80.3 12.6 2.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.376 -0.827 . . . . 0.0 109.979 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.684 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 4.9 tt -65.62 -36.86 84.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -0.901 . . . . 0.0 110.52 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HD2' ' HB3' ' A' ' 37' ' ' PRO . 21.3 tttt -56.39 -48.76 76.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.291 -0.881 . . . . 0.0 110.695 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -134.0 155.65 49.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.118 -0.989 . . . . 0.0 110.388 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.724 HD22 ' HB2' ' A' ' 52' ' ' ASN . 7.8 mt -114.16 121.91 45.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 109.978 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -136.91 159.35 42.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.938 . . . . 0.0 110.249 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.609 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 1.5 mt-10 53.27 179.55 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.99 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.609 ' HD2' ' CB ' ' A' ' 23' ' ' GLU . 3.3 Cg_exo -58.27 176.93 0.32 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.721 1.38 . . . . 0.0 110.557 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 24' ' ' PRO . 95.1 mt-30 -41.5 -83.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 110.512 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -129.16 79.26 74.7 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.095 -1.003 . . . . 0.0 110.357 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.522 ' CG ' ' OE1' ' A' ' 23' ' ' GLU . 3.0 Cg_endo -63.68 133.83 41.25 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.812 1.427 . . . . 0.0 110.553 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 27' ' ' PRO . 28.4 tpt180 41.79 87.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.275 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 29' ' ' VAL . 5.6 p -43.55 124.07 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.271 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.83 106.66 2.78 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -61.01 -29.01 69.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.265 -1.138 . . . . 0.0 110.477 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.2 mt -112.21 135.54 52.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.14 -0.975 . . . . 0.0 110.748 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -122.57 135.76 54.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.428 -0.795 . . . . 0.0 109.353 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.623 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 38.2 t-20 -158.16 -65.99 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.869 -1.144 . . . . 0.0 111.522 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.418 ' C ' ' HE2' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -58.58 70.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.401 -0.812 . . . . 0.0 111.28 -178.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.977 ' HB3' ' HG2' ' A' ' 78' ' ' GLU . . . -80.35 163.0 59.21 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.162 -0.961 . . . . 0.0 109.81 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.581 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 2.9 Cg_endo -65.1 -3.54 7.41 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.736 1.387 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.581 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 3.6 mt 71.44 123.24 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.25 -0.906 . . . . 0.0 110.172 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 2.9 Cg_endo -61.89 -178.24 0.3 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.75 1.395 . . . . 0.0 110.61 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.87 13.28 29.92 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -133.55 66.74 74.56 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.307 -1.113 . . . . 0.0 110.163 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.791 ' HA ' HD12 ' A' ' 70' ' ' LEU . 3.0 Cg_exo -61.88 135.09 53.63 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.937 1.493 . . . . 0.0 110.708 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.884 HG22 ' OG ' ' A' ' 49' ' ' SER . 3.1 p 178.46 91.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 110.1 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.853 ' O ' HG13 ' A' ' 44' ' ' VAL . 6.4 p -133.63 64.16 66.89 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 0.0 110.195 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 3.1 Cg_exo -59.47 159.58 23.08 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.765 1.403 . . . . 0.0 110.477 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.444 ' HB ' HD22 ' A' ' 47' ' ' LEU . 81.2 mt -47.74 -35.18 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 0.0 110.134 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.807 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.9 mm? -86.2 0.55 53.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 110.083 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 97.1 m 59.38 131.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.36 -0.837 . . . . 0.0 110.207 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.884 ' OG ' HG22 ' A' ' 43' ' ' VAL . 48.9 m -61.34 -59.23 5.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 110.916 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -80.12 113.16 36.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 110.425 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -61.42 -7.59 8.95 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.677 1.356 . . . . 0.0 110.391 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.724 ' HB2' HD22 ' A' ' 21' ' ' LEU . 90.8 m-20 -135.07 40.53 2.89 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.263 -0.898 . . . . 0.0 110.218 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.66 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -80.03 177.19 3.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.213 -0.93 . . . . 0.0 108.929 179.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.733 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.7 Cg_exo -58.06 74.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.544 1.286 . . . . 0.0 109.215 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.611 ' N ' ' O ' ' A' ' 53' ' ' PHE . 84.5 tt0 -39.34 -29.58 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.773 -0.579 . . . . 0.0 110.293 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.4 mt-10 -51.71 -20.96 2.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.979 -1.076 . . . . 0.0 108.482 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.733 HD12 ' HG2' ' A' ' 54' ' ' PRO . 75.2 mt -87.17 10.02 18.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.597 -0.689 . . . . 0.0 109.58 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.756 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.89 -51.07 5.66 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.363 -0.836 . . . . 0.0 110.415 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.756 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.57 -42.98 63.25 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.561 1.295 . . . . 0.0 110.205 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.003 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 6.6 mp -58.18 -42.79 86.84 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.007 -1.058 . . . . 0.0 110.068 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.547 ' HA ' HG22 ' A' ' 44' ' ' VAL . 3.7 t -62.71 -27.49 69.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 110.158 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -90.36 -4.44 57.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 110.874 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 10.4 pt-20 -113.54 142.63 27.95 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.977 -1.077 . . . . 0.0 110.228 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.45 -14.33 41.68 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.87 1.458 . . . . 0.0 110.982 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.498 ' O ' HG13 ' A' ' 69' ' ' ILE . 68.6 m-20 -79.68 -17.4 53.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.181 -0.949 . . . . 0.0 110.603 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.003 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -52.01 -37.01 51.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.999 -1.063 . . . . 0.0 110.079 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -55.65 -44.08 76.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -80.34 -36.61 33.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.326 -0.859 . . . . 0.0 109.706 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.785 HG21 ' CD2' ' A' ' 60' ' ' LEU . 84.1 mt -66.78 -50.68 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.897 . . . . 0.0 109.904 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.95 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -42.11 -62.99 0.81 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.423 -0.798 . . . . 0.0 110.343 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.95 ' N ' HD13 ' A' ' 70' ' ' LEU . 54.0 mt-30 -48.09 -52.47 20.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.073 -1.017 . . . . 0.0 110.231 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -55.27 -54.52 42.5 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 69' ' ' ILE . 3.6 mm? -47.69 -52.51 18.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.951 . . . . 0.0 109.93 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.73 ' OE2' HD21 ' A' ' 70' ' ' LEU . 68.0 mt-10 -52.78 -50.17 64.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.182 -0.949 . . . . 0.0 109.902 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.527 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.0 tt0 -53.76 -54.83 32.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.967 . . . . 0.0 109.971 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 79' ' ' ASP . 39.0 mm -56.07 -35.33 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.127 -0.983 . . . . 0.0 109.233 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -57.81 -32.82 67.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.433 -0.792 . . . . 0.0 109.293 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.977 ' HG2' ' HB3' ' A' ' 36' ' ' ALA . 94.3 mt-10 -60.19 -42.84 95.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.424 -0.798 . . . . 0.0 109.86 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -147.14 153.62 45.26 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 110.172 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.55 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 3.2 Cg_exo -60.13 -51.96 4.86 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.952 1.501 . . . . 0.0 110.618 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.15 -139.51 20.52 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.586 ' O ' HG12 ' A' ' 85' ' ' ILE . 45.6 p -79.83 -19.76 47.68 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -1.144 . . . . 0.0 109.778 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.57 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 48.8 t -54.39 -53.81 49.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.242 -0.911 . . . . 0.0 110.155 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.55 ' HB2' ' CB ' ' A' ' 80' ' ' PRO . 83.7 tt0 -58.68 -30.34 67.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 111.22 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 82' ' ' THR . 12.0 pt -95.94 12.73 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.913 -1.117 . . . . 0.0 110.56 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 3.4 t 51.47 19.87 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.285 -0.884 . . . . 0.0 110.961 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -77.72 -9.0 58.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 109.751 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.617 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 17.9 t80 -138.45 164.65 28.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.472 -0.767 . . . . 0.0 109.877 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.92 2.09 11.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 110.176 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.617 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -62.84 -37.23 85.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.574 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.57 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -98.2 120.31 38.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.1 -1.0 . . . . 0.0 110.59 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.82 HG21 ' OE1' ' A' ' 4' ' ' GLN . 41.5 p -104.03 154.58 19.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.365 -0.834 . . . . 0.0 110.142 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.76 -11.37 68.19 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 110.274 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 1' ' ' VAL . 23.5 m . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.201 0.524 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.648 HG21 ' OG ' ' A' ' 9' ' ' SER . 43.2 m -126.12 152.02 46.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 110.445 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.049 HG21 HD11 ' A' ' 12' ' ' LEU . 92.4 t -88.69 113.98 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.393 -0.817 . . . . 0.0 109.836 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.49 ' HB3' HG21 ' A' ' 92' ' ' THR . 47.8 tt0 -108.95 118.07 35.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.133 -0.979 . . . . 0.0 110.525 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.526 ' HB3' HD21 ' A' ' 73' ' ' LEU . 55.0 p30 -99.09 6.45 46.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.704 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -174.15 -143.26 4.3 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -79.91 3.62 19.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -1.149 . . . . 0.0 110.49 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.456 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 79.4 m-85 -120.23 140.8 50.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.101 -0.999 . . . . 0.0 110.46 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.648 ' OG ' HG21 ' A' ' 2' ' ' THR . 21.8 t -86.59 127.13 34.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.976 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.665 ' CZ ' HD23 ' A' ' 57' ' ' LEU . 22.0 m-30 -116.93 130.07 56.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.139 -0.976 . . . . 0.0 110.656 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.446 ' C ' HD22 ' A' ' 12' ' ' LEU . 75.2 p -80.03 174.6 11.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.324 -0.86 . . . . 0.0 110.286 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.049 HD11 HG21 ' A' ' 3' ' ' VAL . 2.5 mm? -99.89 -7.88 24.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 110.817 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -68.56 -71.3 0.22 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.178 -0.951 . . . . 0.0 111.056 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.529 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 4.1 m -51.91 -50.6 60.75 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.096 -1.003 . . . . 0.0 111.229 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.616 ' CG2' ' HA ' ' A' ' 12' ' ' LEU . 17.3 m -55.99 -48.65 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.884 -1.135 . . . . 0.0 110.212 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.518 ' N ' HG23 ' A' ' 15' ' ' VAL . 19.3 ttpp -55.69 -52.75 62.79 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.846 -1.159 . . . . 0.0 108.669 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.474 ' HE2' ' NZ ' ' A' ' 16' ' ' LYS . 71.1 mmtt -80.47 12.73 2.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.48 -0.762 . . . . 0.0 109.791 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.649 HD21 HG21 ' A' ' 43' ' ' VAL . 54.9 tp -61.39 -51.0 70.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.899 . . . . 0.0 110.144 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' A' ' 38' ' ' ILE . 62.8 mttp -62.85 -33.96 76.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.914 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -130.9 100.42 5.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.847 . . . . 0.0 109.623 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 52' ' ' ASN . 0.7 OUTLIER -95.33 126.84 40.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.836 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.516 ' O ' ' HG3' ' A' ' 27' ' ' PRO . 92.8 mt-30 -133.22 150.62 51.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.385 -0.822 . . . . 0.0 109.376 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' CB ' ' HB3' ' A' ' 27' ' ' PRO . 2.7 mt-10 42.83 92.3 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.069 -1.02 . . . . 0.0 109.732 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 3.1 Cg_exo -58.69 172.77 1.38 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.885 1.466 . . . . 0.0 110.919 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 26' ' ' GLU . 80.0 mt-30 58.8 52.95 6.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 110.218 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 25' ' ' GLN . 96.4 mt-10 50.55 101.38 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.866 . . . . 0.0 110.404 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.516 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 2.8 Cg_endo -62.44 -20.18 69.69 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.779 1.41 . . . . 0.0 110.418 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 66.6 mtt85 55.27 54.17 9.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 110.067 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.0 p -135.47 143.71 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 0.0 110.113 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.87 117.47 3.48 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.336 -1.505 . . . . 0.0 109.336 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' O ' HD23 ' A' ' 32' ' ' LEU . 44.4 tttp -59.96 -42.24 93.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -1.149 . . . . 0.0 110.385 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 31' ' ' LYS . 55.1 mt -119.37 143.3 47.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.391 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.407 ' HB3' ' HE2' ' A' ' 16' ' ' LYS . 63.1 mtt180 -89.94 53.63 2.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 109.966 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 30.3 t30 -108.34 117.79 35.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.872 . . . . 0.0 110.094 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.535 ' O ' ' HD3' ' A' ' 37' ' ' PRO . 71.4 t80 -162.65 97.11 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.999 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 35' ' ' PHE . . . -39.89 98.42 0.17 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.399 -0.813 . . . . 0.0 110.249 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 35' ' ' PHE . 2.8 Cg_endo -65.91 -11.33 30.43 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.882 1.464 . . . . 0.0 110.567 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 5.0 mt 56.87 88.81 0.12 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 110.062 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . 3.0 Cg_endo -60.81 164.96 12.7 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.97 1.511 . . . . 0.0 110.542 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.05 9.16 34.93 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 82.42 54.48 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.283 -1.128 . . . . 0.0 110.053 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HG3' ' HG3' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -61.58 137.7 70.82 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.934 1.492 . . . . 0.0 110.488 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.649 HG21 HD21 ' A' ' 18' ' ' LEU . 16.2 m -117.44 49.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.179 -0.951 . . . . 0.0 110.278 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 44' ' ' VAL . 2.4 m -151.66 52.09 0.89 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 110.159 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 3.2 Cg_exo -57.57 -15.87 21.88 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.655 1.345 . . . . 0.0 110.791 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 45' ' ' PRO . 18.7 tt -179.98 -29.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.264 -0.897 . . . . 0.0 110.074 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.54 ' O ' ' O ' ' A' ' 48' ' ' CYS . 24.3 tp -159.05 70.01 0.48 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.134 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.585 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 98.3 m 44.58 102.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.361 -0.837 . . . . 0.0 110.397 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.58 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 15.5 t -51.82 -51.22 58.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.256 -0.903 . . . . 0.0 110.783 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 4.5 m120 -80.06 111.93 25.99 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.407 -0.808 . . . . 0.0 110.679 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.7 -13.41 36.63 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.636 1.335 . . . . 0.0 110.507 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.666 ' HB2' HD22 ' A' ' 21' ' ' LEU . 97.2 m-20 -123.88 29.67 6.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.525 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.736 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -80.3 177.5 2.92 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 109.161 179.251 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.804 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.4 Cg_exo -58.3 74.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.662 1.349 . . . . 0.0 108.929 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.613 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.1 tt0 -39.22 -27.77 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.634 -0.666 . . . . 0.0 110.182 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' PRO . 75.1 mm-40 -53.61 -17.2 1.98 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.03 -1.044 . . . . 0.0 108.592 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.804 HD12 ' HG2' ' A' ' 54' ' ' PRO . 92.7 mt -92.44 9.07 35.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.689 -0.632 . . . . 0.0 109.615 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.736 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.3 OUTLIER -39.88 -50.67 5.69 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 110.278 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.736 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -55.76 -44.93 42.99 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.482 1.254 . . . . 0.0 110.124 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.027 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -54.11 -44.29 71.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 110.093 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.484 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . 82.5 m -64.4 -27.56 69.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.157 -0.965 . . . . 0.0 110.139 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -91.87 4.88 51.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.893 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -112.9 137.02 21.69 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.355 -0.841 . . . . 0.0 110.179 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.99 -21.64 72.75 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.673 1.354 . . . . 0.0 109.884 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -79.93 -10.91 59.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.43 -0.794 . . . . 0.0 110.867 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.027 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.68 -36.03 10.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.956 -1.09 . . . . 0.0 109.877 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.479 ' HG3' ' HG3' ' A' ' 42' ' ' PRO . 50.2 tt0 -59.97 -42.61 94.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.343 -0.848 . . . . 0.0 110.029 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -80.16 -39.04 30.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 109.906 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.912 HG21 HD11 ' A' ' 60' ' ' LEU . 89.4 mt -63.51 -44.43 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.829 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.801 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.0 tm? -52.36 -54.31 33.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 0.0 110.209 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.675 ' N ' HD13 ' A' ' 70' ' ' LEU . 94.6 mt-30 -47.94 -52.9 17.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.291 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 73' ' ' LEU . 97.4 mtt180 -58.43 -62.14 2.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.851 . . . . 0.0 110.455 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 5' ' ' ASP . 45.5 mt -44.93 -52.92 8.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.19 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.672 ' HG2' HD22 ' A' ' 70' ' ' LEU . 78.4 mm-40 -54.98 -47.59 74.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 110.78 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -56.72 -52.78 63.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.222 -0.923 . . . . 0.0 110.771 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.484 ' O ' ' O ' ' A' ' 79' ' ' ASP . 24.2 mm -63.61 -36.14 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 0.0 109.924 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -58.92 -33.71 70.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.43 -0.794 . . . . 0.0 109.881 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.463 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 83.5 tt0 -61.13 -37.9 84.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.685 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.484 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -150.35 160.62 32.71 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.032 -1.043 . . . . 0.0 110.675 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -61.54 -62.11 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.051 1.553 . . . . 0.0 110.569 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.34 -141.83 28.37 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.964 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 70.6 p -79.55 -22.16 44.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.238 -1.154 . . . . 0.0 109.581 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 32.5 t -52.89 -51.63 60.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.397 -0.814 . . . . 0.0 109.991 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.5 tt0 -58.62 -33.77 70.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 0.0 111.179 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.772 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.2 pt -97.3 13.49 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.893 -1.129 . . . . 0.0 110.463 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.71 14.14 1.67 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.266 -0.896 . . . . 0.0 110.487 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.964 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.08 -15.11 62.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 109.963 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.592 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 27.0 t80 -139.69 168.41 19.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 0.0 110.267 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.98 3.07 8.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 110.301 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.592 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -63.08 -36.92 85.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.428 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.568 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -102.97 121.01 41.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 0.0 110.496 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 4' ' ' GLN . 18.9 p -111.54 166.32 11.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 110.227 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.97 -26.19 15.97 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.1 p . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.18 -1.188 . . . . 0.0 110.292 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.771 HG13 ' SG ' ' A' ' 91' ' ' CYS . 47.2 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.317 0.579 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 11' ' ' SER . 28.8 m -119.23 147.31 44.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 110.182 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.841 HG21 HG21 ' A' ' 76' ' ' ILE . 0.9 OUTLIER -89.62 118.97 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 109.952 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 1.005 ' OE1' HG21 ' A' ' 92' ' ' THR . 65.6 tt0 -111.66 129.3 56.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 110.543 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -93.26 -81.24 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.759 . . . . 0.0 110.016 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.12 -126.32 3.81 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -84.69 8.27 17.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -1.184 . . . . 0.0 110.335 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.3 m-85 -120.2 137.79 54.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.36 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.2 t -88.55 130.26 35.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.729 ' CD1' HD23 ' A' ' 57' ' ' LEU . 18.6 m-85 -119.2 126.84 52.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.816 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.534 ' HA ' HG23 ' A' ' 2' ' ' THR . 38.8 t -75.65 169.14 18.69 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -0.996 . . . . 0.0 110.072 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.72 HD21 ' CB ' ' A' ' 3' ' ' VAL . 64.2 mt -102.36 -2.15 29.48 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.126 -0.984 . . . . 0.0 110.905 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -74.21 -73.6 0.22 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.084 -1.01 . . . . 0.0 110.6 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.506 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.6 m -43.0 -42.27 3.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.32 -0.862 . . . . 0.0 110.826 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.627 ' CG2' ' HA ' ' A' ' 12' ' ' LEU . 6.2 m -65.29 -45.31 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.858 -1.151 . . . . 0.0 109.663 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.648 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 46.7 tttm -53.34 -46.98 69.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.821 -1.174 . . . . 0.0 108.93 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 45.8 tptt -80.23 -1.51 40.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.516 -0.74 . . . . 0.0 109.993 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.587 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 53.9 tp -66.55 -40.84 89.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.137 -0.977 . . . . 0.0 110.194 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 38' ' ' ILE . 20.8 tttp -56.62 -45.63 81.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.283 -0.885 . . . . 0.0 110.072 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -116.99 70.2 0.77 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.875 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.709 HD11 ' OD1' ' A' ' 52' ' ' ASN . 19.2 tp -54.03 -48.2 70.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 110.506 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 21' ' ' LEU . 3.1 tt0 46.79 -173.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.134 -0.978 . . . . 0.0 109.88 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -50.28 147.04 7.93 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.123 -0.985 . . . . 0.0 109.946 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.47 133.1 46.96 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.796 1.419 . . . . 0.0 110.491 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.463 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 6.8 tt0 -169.93 50.09 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.297 -0.877 . . . . 0.0 110.394 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.664 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 0.6 OUTLIER -131.32 49.97 5.39 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 110.688 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.664 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.7 Cg_endo -60.41 -30.79 91.64 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.579 1.305 . . . . 0.0 110.247 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.46 ' O ' ' OE2' ' A' ' 26' ' ' GLU . 88.3 mtm-85 -139.37 174.64 10.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.421 -0.799 . . . . 0.0 110.071 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.0 m -123.91 157.49 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 110.153 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.34 179.66 48.08 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -64.68 -39.78 94.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -1.147 . . . . 0.0 110.053 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.2 tp -161.5 135.72 6.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.299 -0.876 . . . . 0.0 110.089 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.509 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 48.0 mtt180 -127.67 133.45 49.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 110.199 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 33' ' ' ARG . 33.0 m120 -150.53 46.62 0.88 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.271 -0.893 . . . . 0.0 110.166 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.439 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 13.7 m-85 -108.54 8.31 27.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.217 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.65 ' HB3' ' CA ' ' A' ' 78' ' ' GLU . . . -56.57 125.07 65.86 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.288 -0.883 . . . . 0.0 110.06 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HG2' ' HD3' ' A' ' 19' ' ' LYS . 2.9 Cg_endo -62.14 -80.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.714 1.376 . . . . 0.0 110.926 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.635 HG23 ' HD2' ' A' ' 39' ' ' PRO . 0.4 OUTLIER -165.1 150.43 8.37 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.927 . . . . 0.0 110.136 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.635 ' HD2' HG23 ' A' ' 38' ' ' ILE . 3.3 Cg_exo -57.62 139.58 90.69 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.907 1.477 . . . . 0.0 110.793 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.86 -78.75 1.43 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.99 153.56 35.86 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.287 -1.125 . . . . 0.0 110.257 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.494 ' HB2' ' HG3' ' A' ' 67' ' ' GLN . 3.0 Cg_endo -61.69 139.65 81.96 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.963 1.507 . . . . 0.0 110.614 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.695 ' O ' HG13 ' A' ' 43' ' ' VAL . 13.4 p -177.44 71.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.947 . . . . 0.0 110.261 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.907 HG22 ' HA ' ' A' ' 61' ' ' CYS . 2.8 p -129.54 66.07 76.15 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.317 -0.864 . . . . 0.0 110.139 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.462 ' HD3' ' C ' ' A' ' 43' ' ' VAL . 3.1 Cg_exo -61.47 164.81 14.53 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.896 1.472 . . . . 0.0 110.483 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.569 HG23 ' HG2' ' A' ' 62' ' ' LYS . 88.1 mt -48.39 -42.45 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 110.121 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 48' ' ' CYS . 53.1 mt -82.79 -3.29 56.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 110.047 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.7 m 59.52 128.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.248 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.548 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.1 t -61.0 -44.82 96.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 4.2 m120 -80.35 112.11 28.12 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.343 -0.848 . . . . 0.0 110.304 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -59.54 -10.26 10.92 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.766 1.403 . . . . 0.0 110.7 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.709 ' OD1' HD11 ' A' ' 21' ' ' LEU . 45.7 p-10 -136.97 41.81 2.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 0.0 110.366 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.699 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.24 177.15 3.13 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.196 -0.94 . . . . 0.0 109.116 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.73 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.9 Cg_exo -58.3 75.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.591 1.311 . . . . 0.0 109.143 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.626 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.3 tt0 -39.06 -29.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.782 -0.574 . . . . 0.0 110.149 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.3 mt-10 -52.04 -18.88 1.58 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.025 -1.047 . . . . 0.0 108.634 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.73 HD12 ' HG2' ' A' ' 54' ' ' PRO . 88.6 mt -90.8 9.67 29.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.487 -0.758 . . . . 0.0 109.649 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.738 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.3 tmtt? -39.71 -51.51 5.21 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.359 -0.838 . . . . 0.0 110.63 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.738 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.28 -43.58 57.32 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.459 1.242 . . . . 0.0 109.997 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.038 HD11 HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -55.6 -40.7 72.4 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.11 -0.994 . . . . 0.0 110.039 179.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.907 ' HA ' HG22 ' A' ' 44' ' ' VAL . 82.4 m -58.03 -23.37 54.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.215 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.569 ' HG2' HG23 ' A' ' 46' ' ' ILE . 35.5 mtmt -113.46 37.05 3.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 109.579 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.502 ' OE1' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -133.12 141.83 42.25 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.849 . . . . 0.0 110.36 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -62.93 -26.28 74.26 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.746 1.393 . . . . 0.0 110.075 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.46 ' O ' HG13 ' A' ' 69' ' ' ILE . 72.1 m-20 -80.19 -18.65 49.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.906 . . . . 0.0 110.439 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.886 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -45.39 -47.33 13.54 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.328 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.494 ' HG3' ' HB2' ' A' ' 42' ' ' PRO . 61.0 tt0 -54.25 -43.62 71.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.492 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.15 -33.03 38.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.879 . . . . 0.0 110.473 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.038 HD13 HD11 ' A' ' 60' ' ' LEU . 94.5 mt -63.41 -44.88 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 0.0 110.357 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.662 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.6 tm? -43.43 -66.93 0.32 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.439 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.662 ' N ' HD13 ' A' ' 70' ' ' LEU . 97.7 mt-30 -47.31 -54.87 9.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 0.0 110.114 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -50.46 -58.88 4.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 110.094 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.494 ' CD1' HG22 ' A' ' 69' ' ' ILE . 40.2 mt -45.16 -51.68 10.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.183 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 73.3 mm-40 -51.63 -58.01 7.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.332 -0.855 . . . . 0.0 110.301 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 85.0 tt0 -52.04 -56.6 13.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.933 . . . . 0.0 110.592 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.841 HG21 HG21 ' A' ' 3' ' ' VAL . 22.4 mm -55.75 -38.42 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.152 -0.968 . . . . 0.0 109.888 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -57.47 -32.54 67.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.595 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.65 ' CA ' ' HB3' ' A' ' 36' ' ' ALA . 81.8 tt0 -59.72 -43.25 94.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.423 -0.798 . . . . 0.0 110.136 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -147.22 157.31 45.98 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.214 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.558 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -61.55 -48.1 10.06 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.856 1.451 . . . . 0.0 110.6 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.23 -139.98 25.75 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.969 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 32.1 p -84.06 -16.52 43.51 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.234 -1.156 . . . . 0.0 109.954 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.578 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 41.1 t -57.46 -48.72 78.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.986 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.3 tt0 -61.97 -28.03 69.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.284 -0.885 . . . . 0.0 111.241 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.674 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.5 pt -97.54 7.26 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.863 -1.148 . . . . 0.0 110.304 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.0 m 61.33 15.86 6.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.0 110.614 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.969 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.2 -16.61 64.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -0.999 . . . . 0.0 109.853 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 87' ' ' ALA . 27.4 m-85 -138.81 166.65 23.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.922 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.7 2.29 10.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.23 -0.919 . . . . 0.0 110.314 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.29 -32.79 73.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.563 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.771 ' SG ' HG13 ' A' ' 1' ' ' VAL . 0.1 OUTLIER -102.84 116.95 33.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.64 -179.593 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 1.005 HG21 ' OE1' ' A' ' 4' ' ' GLN . 17.7 p -105.39 157.81 17.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.353 -0.842 . . . . 0.0 110.133 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.33 -26.0 24.75 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.326 -1.103 . . . . 0.0 110.289 179.938 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 94' ' ' CYS . 10.6 t . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.21 0.528 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 35.5 m -120.33 149.25 42.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.271 -0.893 . . . . 0.0 110.335 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.881 HG23 HD11 ' A' ' 12' ' ' LEU . 91.2 t -84.36 117.6 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.336 -0.853 . . . . 0.0 109.774 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.737 ' CD ' HG21 ' A' ' 92' ' ' THR . 19.4 pt20 -111.81 146.09 38.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.178 -0.951 . . . . 0.0 110.869 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.679 ' OD2' HD21 ' A' ' 73' ' ' LEU . 94.0 m-20 -106.13 13.26 29.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 109.792 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 170.89 -126.96 1.38 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -84.87 5.88 27.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.138 -1.213 . . . . 0.0 110.111 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 87.2 m-85 -124.86 138.58 54.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 110.24 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.484 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 78.4 p -96.86 137.94 35.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.217 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.74 ' CG ' HD21 ' A' ' 57' ' ' LEU . 24.6 m-85 -125.14 138.04 54.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.243 -0.911 . . . . 0.0 110.277 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.4 t -69.96 165.66 21.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 110.317 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.881 HD11 HG23 ' A' ' 3' ' ' VAL . 4.5 mp -97.67 -13.29 21.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.874 . . . . 0.0 110.328 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.422 ' OE2' ' HD3' ' A' ' 33' ' ' ARG . 70.9 mm-40 -68.66 -73.36 0.15 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.29 -0.881 . . . . 0.0 110.614 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 13' ' ' GLU . 4.0 m -42.49 -48.67 5.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.461 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.704 HG11 ' HB3' ' A' ' 73' ' ' LEU . 36.2 t -58.31 -45.24 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.946 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -56.95 -56.64 19.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.949 . . . . 0.0 109.086 179.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -80.61 11.81 3.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -0.811 . . . . 0.0 109.945 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 18' ' ' LEU . 2.0 tt -62.06 -41.74 98.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -73.84 -64.52 0.99 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.22 -0.925 . . . . 0.0 110.108 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 22' ' ' GLN . 90.0 m-20 -58.06 -37.8 75.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.198 -0.939 . . . . 0.0 110.1 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.034 HD11 ' HB2' ' A' ' 52' ' ' ASN . 16.0 tp 52.17 29.24 6.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.302 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 20' ' ' ASP . 95.1 mm-40 -95.24 147.58 23.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.092 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.3 OUTLIER 49.0 74.14 0.87 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.071 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.22 62.28 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 124.006 1.529 . . . . 0.0 110.731 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' GLU . 32.5 tt0 -144.6 168.61 19.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 110.014 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.488 ' N ' ' HG2' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -124.21 69.02 49.28 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.183 -0.948 . . . . 0.0 110.393 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 25' ' ' GLN . 2.9 Cg_endo -61.13 145.94 98.19 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.84 1.442 . . . . 0.0 110.348 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.512 ' NH2' ' HB2' ' A' ' 28' ' ' ARG . 43.2 mtm105 -114.19 97.35 6.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.144 -0.972 . . . . 0.0 110.18 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -125.19 118.13 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.112 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.18 9.32 60.29 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.0 mttp 50.27 42.75 26.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.336 -1.096 . . . . 0.0 110.262 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.4 tp -115.19 124.53 51.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 110.253 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.508 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 76.3 mtt85 -114.07 55.1 0.74 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.947 . . . . 0.0 109.983 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.551 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 70.5 m-20 -130.1 148.17 51.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.839 . . . . 0.0 110.315 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.538 ' N ' ' HE2' ' A' ' 16' ' ' LYS . 62.9 t80 -173.7 -71.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 109.902 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 78' ' ' GLU . . . -56.97 113.43 6.09 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.382 -0.824 . . . . 0.0 109.893 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.563 ' C ' HG13 ' A' ' 38' ' ' ILE . 3.0 Cg_endo -60.84 -27.89 85.53 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.711 1.374 . . . . 0.0 110.832 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.019 HD12 ' N ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -164.64 171.05 5.93 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.251 -0.906 . . . . 0.0 110.17 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.738 ' HD2' HG22 ' A' ' 38' ' ' ILE . 3.0 Cg_exo -62.16 148.89 92.38 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.892 1.469 . . . . 0.0 110.54 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.82 -75.16 1.29 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -167.5 144.85 3.78 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.323 -1.104 . . . . 0.0 110.24 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 2.9 Cg_endo -62.65 138.34 69.18 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.903 1.475 . . . . 0.0 110.517 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' A' ' 49' ' ' SER . 19.7 m -143.0 127.39 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 110.251 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 44' ' ' VAL . 69.4 t -156.94 70.97 4.68 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.11 -0.994 . . . . 0.0 110.97 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -61.19 -143.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.778 1.41 . . . . 0.0 109.53 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.009 ' C ' HD12 ' A' ' 47' ' ' LEU . 16.0 mm -49.67 -32.94 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.81 -1.181 . . . . 0.0 108.485 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.009 HD12 ' C ' ' A' ' 46' ' ' ILE . 6.8 mp -142.38 -74.94 0.29 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.543 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 59.1 m -139.44 137.7 35.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.37 -0.831 . . . . 0.0 109.534 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.618 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 87.7 p -65.55 -42.23 92.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.067 -1.021 . . . . 0.0 110.616 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.528 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 8.7 m120 -80.09 110.46 16.34 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.349 -0.845 . . . . 0.0 110.258 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.618 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -60.31 -17.86 49.29 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.734 1.386 . . . . 0.0 110.821 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 1.034 ' HB2' HD11 ' A' ' 21' ' ' LEU . 18.2 m120 -126.61 36.26 4.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.125 -0.985 . . . . 0.0 110.722 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.628 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -80.28 172.97 8.49 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.078 -1.014 . . . . 0.0 108.954 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.5 Cg_exo -58.03 75.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.507 1.267 . . . . 0.0 108.959 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.603 ' N ' ' O ' ' A' ' 53' ' ' PHE . 84.7 tt0 -39.4 -28.43 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.635 -0.666 . . . . 0.0 110.184 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt-10 -52.45 -17.04 1.04 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.053 -1.029 . . . . 0.0 108.65 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.74 HD21 ' CG ' ' A' ' 10' ' ' PHE . 62.2 mt -90.46 9.53 28.84 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.475 0.655 . . . . 0.0 109.583 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.757 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 12.9 mttt -39.87 -50.98 5.66 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 110.427 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.757 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.49 -42.62 66.39 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.596 1.314 . . . . 0.0 109.985 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.057 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 7.6 mp -57.92 -39.48 78.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.973 -1.079 . . . . 0.0 109.902 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 12.5 m -66.17 -28.86 69.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.128 -0.982 . . . . 0.0 110.474 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -89.6 5.96 43.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 111.145 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 10.0 pt-20 -121.97 148.75 52.25 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 120.947 -1.095 . . . . 0.0 110.305 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.8 Cg_endo -63.59 -20.34 69.18 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.988 1.52 . . . . 0.0 111.565 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.511 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 79.4 m-20 -80.03 -10.35 59.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.98 -1.075 . . . . 0.0 110.605 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.057 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.43 -45.43 25.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -0.93 . . . . 0.0 110.674 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.0 mt-30 -59.0 -42.55 90.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.903 . . . . 0.0 110.561 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -76.85 -31.91 57.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.093 -1.004 . . . . 0.0 110.152 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.784 HG21 ' CD2' ' A' ' 60' ' ' LEU . 99.8 mt -74.45 -46.03 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.923 . . . . 0.0 110.144 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.66 HD11 ' OE2' ' A' ' 74' ' ' GLU . 1.7 tm? -48.89 -59.3 3.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.882 . . . . 0.0 110.563 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.607 ' N ' HD13 ' A' ' 70' ' ' LEU . 98.3 mt-30 -49.59 -52.93 26.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.059 -1.026 . . . . 0.0 110.096 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -51.41 -54.42 26.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.258 -0.901 . . . . 0.0 109.916 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.704 ' HB3' HG11 ' A' ' 15' ' ' VAL . 65.1 mt -51.26 -48.81 62.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.355 -0.841 . . . . 0.0 110.143 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.66 ' OE2' HD11 ' A' ' 70' ' ' LEU . 91.2 mt-10 -52.92 -48.4 67.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 110.062 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.29 -50.23 73.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.972 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.582 ' O ' ' O ' ' A' ' 79' ' ' ASP . 26.5 mm -62.97 -37.41 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.704 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.759 ' HB1' ' HB2' ' A' ' 16' ' ' LYS . . . -56.38 -33.84 66.12 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.475 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.525 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 86.8 tt0 -62.61 -41.34 98.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.456 -0.777 . . . . 0.0 110.524 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.582 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -148.23 168.65 10.69 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.119 -0.988 . . . . 0.0 110.214 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.529 ' HD2' ' OD1' ' A' ' 79' ' ' ASP . 3.2 Cg_exo -58.59 -55.81 1.87 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.658 1.347 . . . . 0.0 110.495 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.831 ' C ' HG23 ' A' ' 82' ' ' THR . . . 72.04 47.65 30.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.929 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 1.2 p 72.45 -40.98 0.49 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.451 -1.029 . . . . 0.0 110.842 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 37.4 t -40.75 -47.46 2.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.941 -1.099 . . . . 0.0 109.907 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 86.4 tt0 -63.16 -42.75 99.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 111.006 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.798 HG13 ' HB2' ' A' ' 87' ' ' ALA . 2.5 pt -84.76 18.7 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.0 -1.063 . . . . 0.0 110.573 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 52.77 16.96 0.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 110.616 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.929 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.79 -22.4 65.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 109.758 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.581 ' CD1' ' CB ' ' A' ' 82' ' ' THR . 19.6 m-85 -131.91 170.26 15.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.396 -0.815 . . . . 0.0 109.762 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.42 0.1 34.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.075 -1.015 . . . . 0.0 110.104 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -59.12 -25.9 64.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 110.496 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -111.18 128.17 55.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 110.787 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.737 HG21 ' CD ' ' A' ' 4' ' ' GLN . 22.6 p -114.37 163.95 14.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 110.064 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.495 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 88.76 -24.13 13.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.534 ' O ' ' CG2' ' A' ' 1' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.331 -1.099 . . . . 0.0 110.497 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.545 HG13 ' SG ' ' A' ' 91' ' ' CYS . 92.2 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.222 0.534 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.451 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 60.1 m -126.15 149.21 49.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 110.568 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.789 HG23 HD11 ' A' ' 12' ' ' LEU . 92.4 t -82.42 110.83 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.514 -0.741 . . . . 0.0 109.519 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.645 ' CB ' HG21 ' A' ' 92' ' ' THR . 35.3 tt0 -112.78 133.43 54.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 110.685 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -96.03 -71.68 0.66 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 109.421 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.0 -129.76 6.81 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -79.76 4.27 16.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -1.177 . . . . 0.0 110.655 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.51 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 99.2 m-85 -119.05 134.44 55.2 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.058 -1.026 . . . . 0.0 110.656 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.451 ' OG ' ' CG2' ' A' ' 2' ' ' THR . 27.1 t -87.16 135.61 33.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.323 -0.861 . . . . 0.0 109.97 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.657 ' CE1' HD23 ' A' ' 57' ' ' LEU . 69.6 m-85 -115.56 125.86 53.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 111.005 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.473 ' C ' HD12 ' A' ' 12' ' ' LEU . 23.0 t -76.43 173.14 11.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.339 -0.85 . . . . 0.0 109.796 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.03 HD23 ' HA ' ' A' ' 77' ' ' ALA . 4.5 mp -103.27 4.81 36.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.046 -1.034 . . . . 0.0 110.756 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 86.0 tt0 -71.89 -73.03 0.2 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.068 -1.02 . . . . 0.0 110.693 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.504 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 6.1 m -49.06 -45.72 43.37 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.081 -1.012 . . . . 0.0 110.684 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.637 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 24.2 t -58.38 -50.95 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.967 -1.083 . . . . 0.0 109.746 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.491 ' HE2' ' OD1' ' A' ' 34' ' ' ASN . 51.1 tttm -54.49 -54.45 40.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.779 -1.201 . . . . 0.0 108.656 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -80.47 14.46 2.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -0.756 . . . . 0.0 109.615 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.637 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 35.4 tp -61.44 -40.37 94.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -0.894 . . . . 0.0 110.198 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.506 ' HE3' ' HG3' ' A' ' 41' ' ' GLU . 28.4 mtpt -61.02 -44.68 97.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.004 . . . . 0.0 109.842 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -111.33 115.08 28.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.26 -0.9 . . . . 0.0 109.643 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.557 ' CG ' ' HB3' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -96.08 107.1 19.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.09 -1.006 . . . . 0.0 110.715 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.514 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 62.5 tt0 179.06 55.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.458 -0.776 . . . . 0.0 109.955 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.525 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 3.4 pm0 -149.69 164.07 22.31 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.068 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 23' ' ' GLU . 3.1 Cg_exo -61.28 152.32 73.16 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.83 1.437 . . . . 0.0 110.552 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.468 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 56.7 tp60 -58.91 -117.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.91 . . . . 0.0 110.132 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.473 ' CG ' ' OE1' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -129.88 64.6 72.68 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.007 -1.058 . . . . 0.0 110.307 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.468 ' HD3' ' C ' ' A' ' 25' ' ' GLN . 2.9 Cg_endo -61.64 -36.36 75.78 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.754 1.397 . . . . 0.0 110.543 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.495 ' NH2' ' HG3' ' A' ' 28' ' ' ARG . 14.5 mmt85 -140.85 151.52 44.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.343 -0.848 . . . . 0.0 110.212 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.09 142.66 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.127 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.34 22.42 0.79 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HB2' ' NH2' ' A' ' 33' ' ' ARG . 2.2 mtpm? -104.31 153.06 21.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.139 -1.212 . . . . 0.0 110.151 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.8 tp -81.34 137.71 35.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.046 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 12' ' ' LEU . 82.3 mtt85 -126.64 141.49 51.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.262 -0.899 . . . . 0.0 110.307 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.596 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 33.2 p-10 -132.94 175.85 9.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 110.245 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.549 ' CD2' ' N ' ' A' ' 36' ' ' ALA . 68.5 t80 -167.19 173.0 9.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.292 -0.88 . . . . 0.0 110.137 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.549 ' N ' ' CD2' ' A' ' 35' ' ' PHE . . . -60.56 149.05 79.71 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.227 -0.921 . . . . 0.0 110.198 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.998 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.9 Cg_endo -61.82 -26.87 79.86 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.94 1.495 . . . . 0.0 110.537 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.998 HD13 ' O ' ' A' ' 37' ' ' PRO . 8.9 mm -128.17 121.52 21.68 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 110.056 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . 3.1 Cg_exo -61.4 138.77 78.6 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.738 1.389 . . . . 0.0 110.489 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . -153.46 18.88 0.7 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.506 ' HG3' ' HE3' ' A' ' 19' ' ' LYS . 0.8 OUTLIER -125.52 74.96 69.49 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.283 -1.128 . . . . 0.0 110.2 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.65 146.81 96.51 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.885 1.466 . . . . 0.0 110.462 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.103 HG23 HG23 ' A' ' 44' ' ' VAL . 11.0 m -123.12 172.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 110.383 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.103 HG23 HG23 ' A' ' 43' ' ' VAL . 2.9 t 67.38 49.3 0.49 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.452 -0.78 . . . . 0.0 111.015 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.675 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.8 Cg_endo -61.64 -51.34 4.17 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.562 1.296 . . . . 0.0 109.972 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 47' ' ' LEU . 77.9 mt -121.83 -33.36 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.421 -0.799 . . . . 0.0 109.722 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 48' ' ' CYS . 27.1 tp -177.93 98.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.419 -0.801 . . . . 0.0 109.812 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.481 ' O ' ' O ' ' A' ' 47' ' ' LEU . 96.2 m 47.6 99.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 0.0 110.25 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.588 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.3 t -68.78 -64.06 0.94 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.266 -0.896 . . . . 0.0 110.668 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.511 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 1.3 m120 -79.51 111.8 23.76 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.382 -0.824 . . . . 0.0 110.464 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -63.95 -9.02 17.51 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.694 1.365 . . . . 0.0 110.358 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.557 ' HB3' ' CG ' ' A' ' 21' ' ' LEU . 50.3 t-20 -131.1 30.98 4.49 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.289 -0.882 . . . . 0.0 110.178 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.745 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -77.15 -175.6 0.53 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 108.836 179.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.948 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.7 Cg_exo -59.02 73.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.536 1.282 . . . . 0.0 109.067 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.3 tt0 -39.43 -32.04 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.688 -0.633 . . . . 0.0 110.562 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.441 ' O ' ' HE1' ' A' ' 10' ' ' PHE . 46.5 tp10 -52.28 -25.3 9.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.957 -1.089 . . . . 0.0 108.625 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.948 HD12 ' HG2' ' A' ' 54' ' ' PRO . 89.2 mt -83.82 12.76 5.57 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.383 0.611 . . . . 0.0 109.814 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.729 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.58 -51.63 4.96 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.93 . . . . 0.0 110.532 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.94 -45.09 41.23 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.551 1.29 . . . . 0.0 110.184 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.021 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 2.8 mm? -53.81 -44.0 69.82 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.023 -1.048 . . . . 0.0 110.148 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.3 t -68.76 -29.1 67.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 0.0 110.312 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -79.95 3.29 20.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.622 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.533 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 9.7 pt-20 -126.39 141.65 40.59 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 110.155 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.1 Cg_exo -61.16 -11.18 17.71 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.903 1.475 . . . . 0.0 110.667 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -79.88 -15.63 56.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.123 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.021 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -48.54 -36.41 15.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.233 -0.917 . . . . 0.0 110.113 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.34 -41.12 98.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 110.093 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -80.45 -40.91 25.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 109.84 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.963 HG21 ' CD1' ' A' ' 60' ' ' LEU . 84.6 mt -64.39 -41.29 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.848 . . . . 0.0 110.037 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.779 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.2 tm? -53.02 -55.19 25.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 110.396 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.779 ' N ' HD13 ' A' ' 70' ' ' LEU . 94.7 mt-30 -50.46 -55.37 16.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 0.0 110.186 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -52.57 -57.0 11.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 110.055 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 35.4 mt -46.82 -49.66 19.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 110.083 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 77.8 mm-40 -54.48 -49.27 70.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.331 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 85.4 tt0 -56.3 -55.91 27.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 0.0 110.721 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 79' ' ' ASP . 28.9 mm -56.75 -36.53 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.062 -1.024 . . . . 0.0 109.462 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 1.03 ' HA ' HD23 ' A' ' 12' ' ' LEU . . . -59.33 -30.03 68.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.502 -0.749 . . . . 0.0 109.275 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 34' ' ' ASN . 85.9 tt0 -62.36 -41.6 98.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.41 -0.806 . . . . 0.0 110.321 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.1 p30 -147.0 158.37 45.1 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.196 -0.94 . . . . 0.0 110.482 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.576 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.53 -57.5 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.969 1.51 . . . . 0.0 110.636 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.36 -140.74 24.92 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.944 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 60.4 p -78.14 -22.34 48.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -1.158 . . . . 0.0 109.635 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 52.9 t -52.27 -53.05 48.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 110.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.0 tt0 -57.66 -34.28 69.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 111.261 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.781 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.3 pt -95.11 12.65 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.931 -1.106 . . . . 0.0 110.446 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 21.8 m 56.47 15.64 2.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 0.0 110.497 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.944 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -66.56 -10.14 42.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 110.026 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -146.19 167.97 22.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 110.387 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.23 4.83 6.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 0.0 110.493 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.16 -37.68 88.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 110.519 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -99.03 121.95 41.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 110.526 -179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.645 HG21 ' CB ' ' A' ' 4' ' ' GLN . 24.8 p -110.58 152.94 25.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.161 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.73 -20.01 51.12 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.272 -1.134 . . . . 0.0 110.231 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.79 HG13 ' O ' ' A' ' 1' ' ' VAL . 14.6 p . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.24 0.543 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 58.4 m -123.33 152.81 41.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 110.426 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.858 HG23 HD11 ' A' ' 12' ' ' LEU . 52.0 t -82.36 112.19 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.641 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' OE1' HG21 ' A' ' 92' ' ' THR . 41.4 tt0 -111.49 123.49 50.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.098 -1.001 . . . . 0.0 110.71 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.606 ' OD2' HG23 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -79.73 -77.12 0.19 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 0.0 109.386 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.71 -124.54 5.36 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -81.84 3.64 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.241 -1.152 . . . . 0.0 110.379 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.2 m-85 -114.57 132.9 56.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.145 -0.972 . . . . 0.0 110.436 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.412 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 51.6 p -85.57 130.11 34.66 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.728 ' CG ' HD21 ' A' ' 57' ' ' LEU . 18.4 m-85 -118.71 130.18 55.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 110.703 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.7 p -75.69 170.22 16.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.163 -0.961 . . . . 0.0 110.268 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.858 HD11 HG23 ' A' ' 3' ' ' VAL . 4.5 mp -95.91 -6.45 39.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 110.519 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.7 mt-10 -70.95 -71.62 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.222 -0.924 . . . . 0.0 110.667 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.473 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 4.3 m -43.17 -52.1 5.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.309 -0.869 . . . . 0.0 110.567 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.63 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 15.8 m -56.41 -49.33 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.942 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 14.4 tttp -55.27 -51.66 65.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.981 -1.074 . . . . 0.0 108.8 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -80.41 11.26 3.77 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.455 -0.778 . . . . 0.0 109.736 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.63 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 27.2 tp -64.58 -33.68 76.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.89 . . . . 0.0 109.948 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -62.19 -42.4 99.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.353 -0.842 . . . . 0.0 109.667 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -104.88 124.62 49.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.412 -0.805 . . . . 0.0 109.61 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.83 HD11 ' HB2' ' A' ' 52' ' ' ASN . 15.1 tp -93.57 130.02 39.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 110.576 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 23' ' ' GLU . 25.4 mt-30 -132.7 171.48 13.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.982 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.8 OUTLIER -42.51 156.64 0.24 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 110.171 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.54 60.64 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 124.0 1.526 . . . . 0.0 110.666 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' GLU . 92.3 mt-30 -121.51 134.91 55.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 110.035 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.444 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 22.0 mm-40 -134.77 66.07 67.99 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.119 -0.988 . . . . 0.0 110.483 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -62.18 151.95 79.01 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.836 1.44 . . . . 0.0 110.321 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.4 mtt-85 -109.27 141.01 42.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.225 -0.922 . . . . 0.0 110.257 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 31' ' ' LYS . 45.7 t -123.56 136.36 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.317 -0.865 . . . . 0.0 110.146 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.87 -32.83 55.83 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.542 ' H ' HG12 ' A' ' 29' ' ' VAL . 29.6 tttt -71.05 143.5 50.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.276 -1.132 . . . . 0.0 110.194 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.7 tp -86.35 128.17 34.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.187 -0.946 . . . . 0.0 110.335 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.542 ' HB3' ' HD2' ' A' ' 16' ' ' LYS . 95.4 mtt-85 -73.28 137.67 45.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.126 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.558 ' CA ' ' O ' ' A' ' 78' ' ' GLU . 32.6 p-10 -156.32 19.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.426 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.463 ' HB2' ' NZ ' ' A' ' 16' ' ' LYS . 98.6 m-85 -99.65 18.5 17.9 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.133 -0.979 . . . . 0.0 110.205 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.779 ' HB3' ' CA ' ' A' ' 78' ' ' GLU . . . -55.55 136.23 70.61 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 110.287 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.75 -149.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.834 1.439 . . . . 0.0 110.717 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.491 HG23 ' HD2' ' A' ' 39' ' ' PRO . 1.9 mp -104.17 139.62 20.28 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.267 -0.896 . . . . 0.0 110.204 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.552 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 2.9 Cg_endo -62.63 178.07 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.818 1.431 . . . . 0.0 110.64 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.68 7.53 31.62 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 43.6 mt-10 -82.67 145.18 50.18 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.336 -1.097 . . . . 0.0 110.101 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -61.8 122.91 11.67 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.79 1.416 . . . . 0.0 110.343 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.019 HG12 HG23 ' A' ' 44' ' ' VAL . 94.7 t -141.87 158.22 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.955 . . . . 0.0 110.506 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.019 HG23 HG12 ' A' ' 43' ' ' VAL . 25.8 t 62.19 51.46 1.82 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.456 -0.777 . . . . 0.0 111.169 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.694 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.7 Cg_endo -63.52 -145.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.632 1.333 . . . . 0.0 109.851 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.9 mm -65.87 -31.25 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.558 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.602 HD12 ' O ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -150.76 71.89 1.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.577 -0.702 . . . . 0.0 109.526 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.587 ' O ' ' O ' ' A' ' 47' ' ' LEU . 82.0 m 54.35 129.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.444 -0.785 . . . . 0.0 110.504 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.63 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 47.0 t -77.47 -70.82 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.029 -1.044 . . . . 0.0 110.155 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.518 ' CG ' HD13 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -76.7 111.96 19.21 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.494 -0.753 . . . . 0.0 110.263 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.613 ' HD2' HD22 ' A' ' 21' ' ' LEU . 3.0 Cg_exo -63.57 -10.04 20.44 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.627 1.33 . . . . 0.0 110.324 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.83 ' HB2' HD11 ' A' ' 21' ' ' LEU . 94.0 m-20 -127.03 31.62 5.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 110.167 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.727 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.08 -179.35 1.39 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 108.948 179.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.758 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.8 Cg_exo -59.36 75.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.562 1.296 . . . . 0.0 109.044 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.601 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.7 tt0 -39.27 -27.95 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.723 -0.611 . . . . 0.0 110.174 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' PRO . 74.3 mm-40 -53.68 -17.85 2.58 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.107 -0.996 . . . . 0.0 108.554 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.758 HD12 ' HG2' ' A' ' 54' ' ' PRO . 86.3 mt -91.54 9.63 31.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.658 -0.651 . . . . 0.0 109.608 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.747 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -39.54 -51.49 4.93 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.339 -0.85 . . . . 0.0 110.756 -179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.747 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.05 -42.86 63.44 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.495 1.26 . . . . 0.0 109.784 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.902 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 4.1 tt -57.48 -38.85 75.22 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.116 -0.99 . . . . 0.0 109.77 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.892 ' HA ' HG13 ' A' ' 44' ' ' VAL . 49.3 t -63.61 -29.27 70.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 110.474 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.521 ' O ' ' OE1' ' A' ' 63' ' ' GLU . 53.4 mttp -104.05 30.41 5.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.596 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.521 ' OE1' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -129.5 136.74 29.58 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.407 -0.808 . . . . 0.0 110.437 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.8 Cg_endo -64.2 -27.03 64.52 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.662 1.349 . . . . 0.0 109.883 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -81.32 -11.06 59.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 0.0 110.846 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.902 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.98 -38.29 16.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.029 -1.045 . . . . 0.0 110.126 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -57.76 -40.72 80.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.763 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -80.27 -39.43 28.92 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.351 -0.843 . . . . 0.0 109.763 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.712 HG21 HD12 ' A' ' 60' ' ' LEU . 81.1 mt -64.62 -51.39 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.335 -0.853 . . . . 0.0 109.956 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.784 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.4 tm? -46.8 -58.45 3.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.389 -0.82 . . . . 0.0 110.113 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.673 ' N ' HD13 ' A' ' 70' ' ' LEU . 55.7 tt0 -44.85 -51.56 9.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.287 -0.883 . . . . 0.0 110.146 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -58.72 -56.5 21.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.431 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.502 HD21 ' OD1' ' A' ' 5' ' ' ASP . 47.6 mt -47.12 -53.1 13.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 0.0 110.216 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.577 ' OE2' HD21 ' A' ' 70' ' ' LEU . 52.4 mt-10 -57.22 -46.06 83.28 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 110.406 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -57.99 -53.71 55.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.953 -1.092 . . . . 0.0 110.127 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.491 ' O ' ' O ' ' A' ' 79' ' ' ASP . 54.2 mt -60.94 -33.94 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.15 -0.969 . . . . 0.0 109.403 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -57.73 -33.69 68.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.379 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.779 ' CA ' ' HB3' ' A' ' 36' ' ' ALA . 84.4 tt0 -61.71 -40.81 96.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.479 -0.763 . . . . 0.0 110.22 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -147.11 155.4 47.01 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.078 -1.014 . . . . 0.0 110.26 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.486 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -59.1 -62.27 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.786 1.414 . . . . 0.0 110.669 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.78 -139.07 21.73 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.95 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 45.4 p -81.03 -21.28 40.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -1.148 . . . . 0.0 109.973 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 9.1 t -53.8 -54.09 43.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.965 . . . . 0.0 109.99 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 34.6 tt0 -58.13 -31.05 66.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.331 -0.856 . . . . 0.0 111.113 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.775 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.6 pt -97.26 12.08 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.991 -1.068 . . . . 0.0 110.322 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 34.2 m 54.07 18.73 1.81 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.887 . . . . 0.0 110.578 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.95 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.13 -12.28 59.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 0.0 110.067 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.555 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 26.9 m-85 -146.75 175.55 10.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.82 3.36 10.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 0.0 110.302 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.36 -32.46 73.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -114.5 123.37 49.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 0.0 110.564 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.567 HG21 ' OE1' ' A' ' 4' ' ' GLN . 27.0 p -117.13 161.01 20.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.378 -0.826 . . . . 0.0 110.211 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.47 -33.11 5.68 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 30.0 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.299 -1.118 . . . . 0.0 110.303 -179.889 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 1' ' ' VAL . 3.2 m . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.096 0.474 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 1.039 HG21 ' OG ' ' A' ' 9' ' ' SER . 9.6 t -129.09 163.18 26.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.76 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.835 HG23 HD11 ' A' ' 12' ' ' LEU . 50.8 t -84.41 116.43 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.84 ' OE1' HG21 ' A' ' 92' ' ' THR . 46.4 tt0 -108.61 111.69 23.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.032 -1.042 . . . . 0.0 110.951 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.672 ' OD2' HD21 ' A' ' 73' ' ' LEU . 89.8 m-20 -94.26 4.45 53.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 109.25 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.509 ' O ' ' CG ' ' A' ' 4' ' ' GLN . . . -169.64 -148.1 5.73 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -80.32 8.96 6.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -1.167 . . . . 0.0 110.516 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.466 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 95.3 m-85 -119.84 147.82 44.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.031 -1.043 . . . . 0.0 110.51 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 1.039 ' OG ' HG21 ' A' ' 2' ' ' THR . 2.0 t -89.03 120.97 30.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 109.829 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.679 ' CD2' HD23 ' A' ' 57' ' ' LEU . 92.9 m-85 -108.43 117.77 35.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.177 -0.952 . . . . 0.0 110.867 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.481 ' C ' HD12 ' A' ' 12' ' ' LEU . 60.4 p -71.64 169.6 15.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 0.0 109.528 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.844 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.1 mp -104.49 -0.93 27.33 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.978 -1.076 . . . . 0.0 110.763 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -67.13 -69.97 0.28 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.124 -0.985 . . . . 0.0 110.715 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.1 m -42.42 -50.99 5.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.344 -0.848 . . . . 0.0 111.165 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.674 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.6 m -57.79 -48.05 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.102 -0.999 . . . . 0.0 109.669 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.773 ' CG ' ' HB1' ' A' ' 77' ' ' ALA . 15.7 mttt -54.86 -54.58 40.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.1 -1.0 . . . . 0.0 108.811 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 48.1 tttt -80.43 11.02 3.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -0.766 . . . . 0.0 109.552 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.674 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 16.8 tp -59.62 -33.41 71.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.148 -0.97 . . . . 0.0 110.069 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HD2' ' HB3' ' A' ' 37' ' ' PRO . 78.6 tttt -67.23 -39.23 86.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.589 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 24.7 t70 -118.14 88.15 2.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.633 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' A' ' 52' ' ' ASN . 6.3 tp -61.5 -33.31 73.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.39 -0.819 . . . . 0.0 111.045 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 25.7 mt-30 -79.09 162.73 25.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.108 -0.995 . . . . 0.0 110.427 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 22' ' ' GLN . 3.5 mt-10 56.72 86.11 0.17 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.382 -0.824 . . . . 0.0 110.517 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HA ' ' CE ' ' A' ' 17' ' ' LYS . 2.9 Cg_endo -63.3 102.68 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.979 1.515 . . . . 0.0 110.459 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -64.3 -36.09 82.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.21 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.417 ' OE2' ' HB2' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -129.2 72.71 81.97 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.361 -0.837 . . . . 0.0 110.213 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 24' ' ' PRO . 3.0 Cg_exo -61.78 -21.71 72.78 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.945 1.497 . . . . 0.0 110.7 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -120.21 -177.28 3.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.299 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.25 150.77 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 0.0 110.246 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.88 -9.65 37.28 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -87.12 172.47 9.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -1.156 . . . . 0.0 110.288 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.609 HD13 ' N ' ' A' ' 33' ' ' ARG . 0.2 OUTLIER -63.27 118.81 8.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.172 -0.955 . . . . 0.0 110.191 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.609 ' N ' HD13 ' A' ' 32' ' ' LEU . 32.6 ptt180 -136.67 66.76 1.47 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 110.277 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 33' ' ' ARG . 92.0 m-20 -137.2 72.27 1.42 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 110.085 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 84.1 t80 -178.13 82.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.166 -0.959 . . . . 0.0 110.375 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.958 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . . . -77.09 153.06 82.45 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.936 . . . . 0.0 110.032 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 38' ' ' ILE . 2.8 Cg_endo -64.05 52.79 0.18 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.804 1.423 . . . . 0.0 111.033 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.523 ' O ' ' O ' ' A' ' 37' ' ' PRO . 10.0 mt 53.81 113.94 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.197 -0.94 . . . . 0.0 110.532 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.525 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo -61.12 162.56 19.23 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.635 1.334 . . . . 0.0 110.546 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.47 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 104.58 20.77 9.78 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -122.32 74.02 40.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.233 -1.157 . . . . 0.0 110.144 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_endo -61.09 143.61 99.02 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 O-C-N 123.936 1.493 . . . . 0.0 110.583 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.485 ' HB ' ' OG ' ' A' ' 49' ' ' SER . 6.0 m -140.25 54.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.815 ' O ' HG12 ' A' ' 44' ' ' VAL . 54.8 t -136.06 54.31 9.59 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.258 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.611 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -60.54 -34.93 92.11 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.679 1.357 . . . . 0.0 110.359 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.461 HG13 ' C ' ' A' ' 45' ' ' PRO . 78.6 mt -145.16 -36.78 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -0.869 . . . . 0.0 110.215 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' O ' ' O ' ' A' ' 48' ' ' CYS . 21.3 tp -177.38 101.58 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.226 -0.921 . . . . 0.0 110.109 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.564 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 87.2 m 33.67 95.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.465 -0.772 . . . . 0.0 110.637 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.512 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 60.7 p -60.87 -39.3 88.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.994 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.553 ' HB3' HD22 ' A' ' 21' ' ' LEU . 10.5 m-20 -80.54 113.77 42.26 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.48 -7.63 9.15 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.681 1.359 . . . . 0.0 110.87 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.797 ' HB2' HD21 ' A' ' 21' ' ' LEU . 93.1 m-20 -137.29 31.46 2.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 110.665 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.769 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.2 p90 -73.34 -175.7 0.41 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.13 -0.981 . . . . 0.0 108.762 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.938 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.9 Cg_exo -60.57 73.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.494 1.26 . . . . 0.0 108.863 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.584 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.1 tt0 -39.22 -31.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.724 -0.61 . . . . 0.0 110.34 -178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 54' ' ' PRO . 97.4 mt-10 -53.71 -26.72 24.27 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.969 -1.082 . . . . 0.0 108.721 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.938 HD12 ' HG2' ' A' ' 54' ' ' PRO . 90.7 mt -84.38 7.38 19.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.731 -0.605 . . . . 0.0 109.534 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.731 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 7.3 mmtt -39.59 -51.62 4.98 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 110.303 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.731 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.53 -44.91 43.82 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.588 1.31 . . . . 0.0 109.824 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.099 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -52.06 -43.81 63.99 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.054 -1.029 . . . . 0.0 109.844 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.6 m -66.96 -27.52 67.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 0.0 110.371 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -82.63 4.97 22.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.902 . . . . 0.0 110.736 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 8.5 pt-20 -127.98 144.7 52.44 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.025 -1.047 . . . . 0.0 110.229 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.16 -12.66 27.75 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.881 1.464 . . . . 0.0 110.736 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.491 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 83.7 m-20 -80.12 -18.41 49.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -0.892 . . . . 0.0 110.201 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.099 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.19 -39.36 13.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.225 -0.922 . . . . 0.0 110.22 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.06 -44.2 87.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 110.296 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -80.2 -39.12 29.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.208 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.979 HG21 ' CD1' ' A' ' 60' ' ' LEU . 77.8 mt -64.42 -47.45 89.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 110.172 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.563 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.8 tm? -49.06 -57.27 6.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.537 ' N ' HD13 ' A' ' 70' ' ' LEU . 51.5 tt0 -49.55 -53.02 25.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.114 -0.991 . . . . 0.0 110.013 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -55.01 -50.4 69.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.672 HD21 ' OD2' ' A' ' 5' ' ' ASP . 96.0 mt -51.07 -50.08 59.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.761 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 70.6 mm-40 -53.99 -52.56 60.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 110.292 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.525 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.2 tt0 -52.69 -55.06 25.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 110.499 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 79' ' ' ASP . 28.2 mm -56.85 -34.36 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 0.0 109.41 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.958 ' HB3' ' HB2' ' A' ' 36' ' ' ALA . . . -59.21 -32.79 70.26 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.498 ' OE2' ' HD3' ' A' ' 39' ' ' PRO . 95.4 mt-10 -59.4 -41.2 88.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 110.139 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -149.26 155.3 39.68 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 110.157 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.641 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -60.15 -57.28 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.88 1.463 . . . . 0.0 110.575 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.12 -138.95 19.98 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.775 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 43.6 p -81.09 -21.04 40.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -1.176 . . . . 0.0 109.742 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.576 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 20.7 t -55.2 -53.01 61.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.323 -0.86 . . . . 0.0 110.184 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 35.5 tt0 -62.49 -27.09 68.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.933 . . . . 0.0 111.407 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.778 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.9 pt -98.01 14.07 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.757 -1.214 . . . . 0.0 110.433 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 50.9 19.74 0.68 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 0.0 110.714 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.778 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -68.82 -11.85 60.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.067 -1.02 . . . . 0.0 110.025 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -148.62 175.4 11.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 110.085 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.41 1.73 15.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 0.0 110.048 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.04 -39.94 75.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 110.314 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -105.83 128.15 53.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.279 -0.888 . . . . 0.0 110.536 -179.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.84 HG21 ' OE1' ' A' ' 4' ' ' GLN . 33.2 p -110.79 155.79 22.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 110.109 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 93.54 -19.32 53.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.455 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.259 -1.142 . . . . 0.0 110.307 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.495 ' HA ' ' SG ' ' A' ' 91' ' ' CYS . 25.6 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.266 0.555 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 68.0 m -123.78 148.39 46.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 110.446 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.653 HG21 ' HG ' ' A' ' 12' ' ' LEU . 47.8 t -79.82 110.38 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.307 -0.87 . . . . 0.0 109.742 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.514 ' CD ' HG21 ' A' ' 92' ' ' THR . 43.7 tt0 -110.41 121.09 44.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -0.95 . . . . 0.0 110.716 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.847 ' OD2' HD11 ' A' ' 73' ' ' LEU . 85.0 m-20 -95.94 6.12 49.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.399 -0.813 . . . . 0.0 109.576 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 4' ' ' GLN . . . -175.45 -139.85 3.21 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -79.8 3.21 20.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.178 -1.19 . . . . 0.0 110.419 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 83.3 m-85 -121.32 131.15 54.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 110.359 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 2' ' ' THR . 67.8 m -79.96 132.3 36.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.336 -0.852 . . . . 0.0 110.201 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.754 ' CG ' HD21 ' A' ' 57' ' ' LEU . 22.1 m-85 -116.56 128.91 55.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.241 -0.912 . . . . 0.0 110.6 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.2 m -69.25 162.27 27.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.224 -0.922 . . . . 0.0 110.349 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.747 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.2 mp -87.39 -25.87 23.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.312 -0.867 . . . . 0.0 110.23 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.507 ' HG3' ' NE ' ' A' ' 33' ' ' ARG . 87.8 tt0 -61.77 -65.6 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.228 -0.92 . . . . 0.0 110.294 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.555 ' O ' ' CB ' ' A' ' 18' ' ' LEU . 4.4 m -43.83 -54.55 5.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.137 -0.977 . . . . 0.0 110.422 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.63 HG23 ' N ' ' A' ' 16' ' ' LYS . 30.3 m -61.46 -48.32 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.945 . . . . 0.0 110.348 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.635 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 8.7 ttmm -59.33 -55.5 33.97 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.074 -1.016 . . . . 0.0 109.371 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' O ' ' OD1' ' A' ' 20' ' ' ASP . 28.9 mmtp -80.46 6.78 11.37 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.367 -0.833 . . . . 0.0 110.124 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.675 ' O ' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -73.21 -30.89 63.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.95 -1.094 . . . . 0.0 109.869 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HG2' HD13 ' A' ' 38' ' ' ILE . 18.7 tptm -56.41 -39.09 72.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.166 -0.959 . . . . 0.0 109.748 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 26.3 p-10 -111.53 98.08 7.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.849 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.766 HD21 ' HB2' ' A' ' 52' ' ' ASN . 0.2 OUTLIER -80.74 113.18 18.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.19 -0.944 . . . . 0.0 110.498 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 91.8 mt-30 -142.25 134.3 27.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.852 . . . . 0.0 109.933 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 22' ' ' GLN . 8.7 mt-10 59.41 136.0 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.403 -0.811 . . . . 0.0 110.174 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 3.0 Cg_exo -61.59 155.25 54.42 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.735 1.387 . . . . 0.0 110.542 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 24' ' ' PRO . 91.8 mt-30 56.6 -159.68 0.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 110.161 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -107.21 110.52 63.33 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.876 . . . . 0.0 110.2 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HG3' ' HB2' ' A' ' 23' ' ' GLU . 3.0 Cg_exo -61.37 -24.54 78.74 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.709 1.373 . . . . 0.0 110.53 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -125.47 146.26 49.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 110.105 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.4 t -117.19 134.5 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.273 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.407 ' N ' ' NH2' ' A' ' 33' ' ' ARG . . . 174.87 105.47 0.19 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -60.54 -28.86 68.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -1.136 . . . . 0.0 110.126 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 mt -93.36 127.43 38.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 110.421 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.507 ' NE ' ' HG3' ' A' ' 13' ' ' GLU . 71.3 mtt-85 -144.92 153.47 41.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.32 -0.863 . . . . 0.0 109.701 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 80.1 m-20 -136.61 20.35 3.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.055 . . . . 0.0 111.205 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.56 ' HB3' ' HD3' ' A' ' 16' ' ' LYS . 63.6 t80 -87.27 124.18 33.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.989 -1.07 . . . . 0.0 109.603 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.501 ' CA ' ' HG3' ' A' ' 78' ' ' GLU . . . -79.99 113.88 41.87 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 110.594 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.952 ' C ' HD12 ' A' ' 38' ' ' ILE . 2.9 Cg_endo -65.55 -148.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.797 1.419 . . . . 0.0 110.409 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.952 HD12 ' C ' ' A' ' 37' ' ' PRO . 2.6 mp -132.84 79.7 62.94 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.902 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.568 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 3.1 Cg_exo -60.67 150.21 83.41 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.841 1.443 . . . . 0.0 110.684 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.509 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 95.31 14.68 47.14 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.527 ' O ' HG23 ' A' ' 43' ' ' VAL . 19.3 mm-40 -114.71 106.64 51.82 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.188 -1.183 . . . . 0.0 110.157 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.464 ' C ' HG23 ' A' ' 43' ' ' VAL . 3.0 Cg_exo -60.9 144.65 99.61 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.822 1.433 . . . . 0.0 110.478 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.777 ' O ' HG23 ' A' ' 44' ' ' VAL . 38.6 t -147.67 54.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 110.234 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.79 ' O ' HG12 ' A' ' 44' ' ' VAL . 24.9 t -161.13 74.33 2.59 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.301 -0.874 . . . . 0.0 110.767 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.444 ' C ' HG23 ' A' ' 46' ' ' ILE . 3.0 Cg_endo -61.43 -39.75 53.72 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.755 1.397 . . . . 0.0 109.582 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.526 HG13 ' N ' ' A' ' 47' ' ' LEU . 12.2 pt -148.65 -39.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -130.94 -115.82 0.23 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.595 ' N ' HD12 ' A' ' 47' ' ' LEU . 94.2 m -115.23 116.66 28.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.756 -1.215 . . . . 0.0 109.8 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.583 ' HB3' ' CG1' ' A' ' 43' ' ' VAL . 4.6 t -54.68 -58.1 8.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 111.113 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 8.8 m-20 -80.09 113.18 36.36 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.33 -0.856 . . . . 0.0 110.853 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.557 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -66.03 -13.32 39.32 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.68 1.358 . . . . 0.0 110.298 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.766 ' HB2' HD21 ' A' ' 21' ' ' LEU . 25.8 m120 -116.08 21.27 13.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 0.0 110.471 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.656 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -79.89 175.05 5.17 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 108.983 179.23 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.664 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.5 Cg_exo -57.59 75.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.63 1.331 . . . . 0.0 108.904 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.614 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.7 tt0 -39.44 -28.83 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.675 -0.641 . . . . 0.0 110.27 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.502 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 95.7 mt-10 -52.82 -19.37 2.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.023 -1.048 . . . . 0.0 108.55 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.754 HD21 ' CG ' ' A' ' 10' ' ' PHE . 68.0 mt -86.11 4.05 39.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.634 -0.666 . . . . 0.0 109.398 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.758 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -39.92 -51.18 5.68 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.502 -0.748 . . . . 0.0 110.375 179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.758 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.32 -40.57 82.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.615 1.324 . . . . 0.0 110.382 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.114 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 6.5 mp -62.24 -36.66 82.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.92 -1.113 . . . . 0.0 109.885 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 81.4 m -64.79 -28.02 69.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 110.257 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -79.85 -10.23 59.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.609 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.493 ' OE2' ' HB2' ' A' ' 65' ' ' ASN . 8.4 pt-20 -114.67 144.1 31.24 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.014 . . . . 0.0 110.16 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.38 -11.74 27.19 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.875 1.461 . . . . 0.0 110.919 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.493 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 75.6 m-20 -81.39 -14.99 56.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 110.419 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.114 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -48.03 -39.99 21.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.171 -0.956 . . . . 0.0 110.247 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -61.05 -39.69 90.8 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 110.101 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -80.03 -36.57 35.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.972 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.806 HG21 ' CD2' ' A' ' 60' ' ' LEU . 86.6 mt -68.43 -43.06 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.873 . . . . 0.0 109.922 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.764 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.7 OUTLIER -51.83 -54.72 25.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -0.82 . . . . 0.0 110.435 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.764 ' N ' HD13 ' A' ' 70' ' ' LEU . 64.1 tt0 -49.64 -54.9 15.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.102 -0.999 . . . . 0.0 110.664 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -50.36 -54.15 23.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.39 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.847 HD11 ' OD2' ' A' ' 5' ' ' ASP . 54.7 mt -50.26 -47.88 55.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.9 . . . . 0.0 110.406 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.625 ' OE2' HD11 ' A' ' 70' ' ' LEU . 80.3 mt-10 -55.6 -45.88 77.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 110.453 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 78' ' ' GLU . 96.1 mt-10 -58.64 -54.4 47.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.049 -1.032 . . . . 0.0 110.674 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.9 mt -61.16 -37.63 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.059 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.635 ' HB1' ' HB2' ' A' ' 16' ' ' LYS . . . -61.36 -32.85 72.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.457 -0.777 . . . . 0.0 110.054 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' HB2' ' HD2' ' A' ' 37' ' ' PRO . 80.3 tt0 -58.44 -35.88 72.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.653 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.45 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -156.54 151.01 20.13 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.135 -0.978 . . . . 0.0 110.683 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.542 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 3.2 Cg_exo -61.67 82.97 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 124.012 1.532 . . . . 0.0 110.702 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.53 -134.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.934 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 72.1 p -79.29 -14.37 59.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.12 -1.223 . . . . 0.0 109.545 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 19.6 t -54.16 -52.11 62.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.468 -0.77 . . . . 0.0 110.324 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.542 ' OE1' ' HB2' ' A' ' 80' ' ' PRO . 84.2 tt0 -56.6 -33.01 65.82 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.208 -0.933 . . . . 0.0 111.272 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.774 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.6 pt -98.05 11.76 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.897 -1.127 . . . . 0.0 110.441 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.8 m 54.3 17.12 1.42 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.883 . . . . 0.0 110.553 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.934 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.62 -11.1 41.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 109.9 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.47 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.5 OUTLIER -144.33 172.12 13.38 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.265 -0.897 . . . . 0.0 110.096 179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.54 4.2 6.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.254 -0.904 . . . . 0.0 110.38 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.31 -35.26 80.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 0.0 110.634 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.594 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -106.57 121.16 43.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 0.0 110.632 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.514 HG21 ' CD ' ' A' ' 4' ' ' GLN . 14.6 p -104.92 156.08 18.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 110.126 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.38 -4.39 64.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.204 -1.174 . . . . 0.0 110.273 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.254 0.55 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 55.7 m -89.55 151.36 21.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 0.0 110.34 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 10' ' ' PHE . 0.9 OUTLIER -91.61 120.36 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.463 -0.773 . . . . 0.0 109.873 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 49.0 tt0 -110.27 130.05 55.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -0.885 . . . . 0.0 110.644 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.762 ' OD2' HD21 ' A' ' 73' ' ' LEU . 90.4 m-20 -111.69 9.06 20.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 109.802 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.91 -135.98 2.6 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -81.87 -1.48 47.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -1.195 . . . . 0.0 110.199 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.493 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 55.4 m-85 -119.48 143.77 47.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.214 -0.929 . . . . 0.0 110.325 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.7 p -90.38 128.76 36.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 110.172 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.592 ' CE2' ' HG ' ' A' ' 57' ' ' LEU . 21.7 m-30 -110.01 118.81 37.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.247 -0.908 . . . . 0.0 110.335 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.2 t -70.19 166.95 18.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.0 110.016 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 mp -95.22 1.25 54.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.196 -0.94 . . . . 0.0 110.628 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.528 ' OE2' ' N ' ' A' ' 30' ' ' GLY . 93.6 mt-10 -74.54 -69.88 0.43 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.213 -0.929 . . . . 0.0 110.461 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 18' ' ' LEU . 3.8 m -52.03 -38.75 58.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.836 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 9.3 t -67.42 -55.41 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.909 -1.119 . . . . 0.0 109.84 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.509 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 39.9 tttp -53.62 -55.78 22.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.941 -1.1 . . . . 0.0 108.904 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 20' ' ' ASP . 52.1 tttt -80.33 8.81 6.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.446 -0.784 . . . . 0.0 109.829 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 5.5 tt -55.7 -43.01 76.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 110.173 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -58.84 -49.14 78.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.206 -0.934 . . . . 0.0 110.022 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 17' ' ' LYS . 60.7 t0 -98.81 107.27 19.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.261 -0.9 . . . . 0.0 109.867 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.684 HD13 ' N ' ' A' ' 22' ' ' GLN . 0.2 OUTLIER -112.95 125.48 54.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 110.438 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.684 ' N ' HD13 ' A' ' 21' ' ' LEU . 94.1 mt-30 -121.14 152.89 38.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 110.26 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.661 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 2.5 mm-40 -45.31 -51.92 23.75 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.69 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 3.0 Cg_exo -61.33 147.98 94.13 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.636 1.335 . . . . 0.0 110.761 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.507 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 51.1 tt0 -98.78 167.15 10.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.235 -0.915 . . . . 0.0 110.24 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.495 ' N ' ' HG2' ' A' ' 25' ' ' GLN . 0.4 OUTLIER -113.62 85.5 9.28 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.181 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 25' ' ' GLN . 3.0 Cg_exo -60.88 -15.41 38.19 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.01 1.532 . . . . 0.0 110.623 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.469 ' HB3' ' NH2' ' A' ' 33' ' ' ARG . 81.2 mtt180 -55.92 152.47 10.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 110.1 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.698 HG11 ' HE2' ' A' ' 31' ' ' LYS . 46.4 t -83.49 148.19 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.278 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' N ' ' OE2' ' A' ' 13' ' ' GLU . . . -70.91 60.21 0.98 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.698 ' HE2' HG11 ' A' ' 29' ' ' VAL . 25.4 mttt -91.11 -65.02 1.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -1.125 . . . . 0.0 110.216 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' A' ' 34' ' ' ASN . 53.2 mt -89.9 -0.83 57.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 110.169 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.469 ' NH2' ' HB3' ' A' ' 28' ' ' ARG . 0.7 OUTLIER -62.25 74.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 109.97 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 32' ' ' LEU . 25.0 m120 -130.95 25.26 4.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.468 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -113.01 49.2 0.96 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 109.989 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . . . -61.1 142.53 93.06 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 110.145 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.52 ' O ' ' O ' ' A' ' 38' ' ' ILE . 2.5 Cg_endo -67.23 30.16 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.413 1.409 . . . . 0.0 111.303 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.52 ' O ' ' O ' ' A' ' 37' ' ' PRO . 8.2 mt 58.77 132.89 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.981 -1.074 . . . . 0.0 110.13 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.523 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.1 Cg_exo -61.46 164.04 16.39 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.719 1.379 . . . . 0.0 110.617 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.484 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 146.78 -8.92 1.34 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.55 ' O ' HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -119.46 76.47 18.3 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.001 -1.294 . . . . 0.0 110.474 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.707 ' HA ' HD12 ' A' ' 70' ' ' LEU . 2.9 Cg_endo -62.56 128.48 23.61 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.818 1.431 . . . . 0.0 110.473 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.2 m -135.69 142.96 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.026 HG22 ' HA ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER 168.23 -52.2 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.398 -0.814 . . . . 0.0 110.305 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 44' ' ' VAL . 3.1 Cg_exo -61.46 -18.01 56.96 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 O-C-N 123.525 1.276 . . . . 0.0 110.689 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 46' ' ' ILE . 84.2 mt -89.09 35.56 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.117 -0.989 . . . . 0.0 110.022 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' A' ' 48' ' ' CYS . 4.4 mm? 54.13 75.27 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.034 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 47' ' ' LEU . 70.5 m 43.21 95.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.374 -0.829 . . . . 0.0 110.19 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.494 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 9.2 t -56.62 -60.19 3.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.0 110.455 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.556 ' ND2' ' HB2' ' A' ' 21' ' ' LEU . 8.4 m120 -80.26 114.26 45.56 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 0.0 110.273 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -61.7 -5.04 5.21 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.8 1.421 . . . . 0.0 111.028 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.559 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 94.5 m-20 -140.32 33.73 1.88 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.143 -0.973 . . . . 0.0 110.347 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.746 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.7 OUTLIER -75.28 -174.59 0.39 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 109.061 179.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.941 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -57.86 72.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.406 1.214 . . . . 0.0 109.921 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.602 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.5 tt0 -41.16 -36.03 0.68 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.562 -0.711 . . . . 0.0 110.314 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.562 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.9 mt-10 -52.78 -19.31 2.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.122 -0.986 . . . . 0.0 108.829 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.941 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.2 mp -94.64 16.29 15.96 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.89 0.853 . . . . 0.0 109.113 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.738 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.76 -52.54 4.95 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.941 -0.474 . . . . 0.0 110.972 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.738 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.14 -44.87 45.33 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.506 1.266 . . . . 0.0 110.07 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.874 HD22 HD13 ' A' ' 69' ' ' ILE . 79.9 mt -59.04 -35.95 74.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.057 -1.027 . . . . 0.0 109.936 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.026 ' HA ' HG22 ' A' ' 44' ' ' VAL . 50.6 t -64.65 -25.02 67.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.025 . . . . 0.0 110.384 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -113.45 29.67 7.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.127 -0.983 . . . . 0.0 109.415 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.55 139.91 27.61 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.606 -0.684 . . . . 0.0 110.484 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.51 -27.4 76.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.65 1.342 . . . . 0.0 109.964 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -80.37 -16.7 53.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.153 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.0 ' HB1' HG21 ' A' ' 44' ' ' VAL . . . -43.56 -39.61 3.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -54.54 -43.64 72.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.863 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.48 ' HG2' ' NE ' ' A' ' 72' ' ' ARG . 86.5 tt0 -80.05 -38.75 31.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.949 . . . . 0.0 109.88 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.874 HD13 HD22 ' A' ' 60' ' ' LEU . 78.6 mt -63.38 -55.19 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.987 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.1 tm? -42.34 -64.55 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.436 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.987 ' N ' HD13 ' A' ' 70' ' ' LEU . 56.5 mt-30 -47.65 -53.39 15.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.077 -1.014 . . . . 0.0 110.465 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.48 ' NE ' ' HG2' ' A' ' 68' ' ' GLU . 62.2 mtt180 -54.87 -53.58 53.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.186 -0.946 . . . . 0.0 110.138 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.762 HD21 ' OD2' ' A' ' 5' ' ' ASP . 86.3 mt -49.86 -53.01 28.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 110.015 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.651 ' OE2' HD21 ' A' ' 70' ' ' LEU . 80.5 mt-10 -53.15 -45.11 68.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.281 -0.887 . . . . 0.0 110.237 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.485 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.1 tt0 -57.74 -54.02 51.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.353 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 79' ' ' ASP . 29.8 mm -59.43 -36.95 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.153 -0.967 . . . . 0.0 109.738 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 16' ' ' LYS . . . -58.16 -33.9 69.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 109.575 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . 85.8 tt0 -60.31 -40.16 89.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.497 -0.752 . . . . 0.0 110.347 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 76' ' ' ILE . 9.5 m-20 -145.54 153.13 50.97 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.135 -0.978 . . . . 0.0 110.31 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -59.76 -58.55 0.56 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.884 1.465 . . . . 0.0 110.57 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.14 -137.88 19.12 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 1.002 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 53.1 p -82.38 -21.44 35.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -1.171 . . . . 0.0 110.107 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 38.9 t -54.58 -53.39 55.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.089 -1.007 . . . . 0.0 110.007 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 82.9 tt0 -60.33 -29.19 68.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -0.822 . . . . 0.0 111.322 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.774 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.0 pt -97.22 13.54 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.863 -1.148 . . . . 0.0 110.276 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 62.9 m 55.43 15.15 1.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 0.0 110.574 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 1.002 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -63.72 -12.59 35.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.117 -0.989 . . . . 0.0 109.891 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.413 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 21.7 m-85 -149.48 173.8 13.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 110.324 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.46 3.85 10.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.393 -0.817 . . . . 0.0 110.453 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.66 -33.8 74.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.941 . . . . 0.0 110.586 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -106.58 125.31 50.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.678 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.1 p -109.93 152.73 25.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.382 -0.824 . . . . 0.0 110.111 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.09 -19.98 52.36 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.265 -1.139 . . . . 0.0 110.134 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.476 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 3.8 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.154 0.502 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.685 HG21 ' HB2' ' A' ' 9' ' ' SER . 8.4 t -123.51 161.24 25.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.224 -0.923 . . . . 0.0 110.64 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.606 HG23 HD11 ' A' ' 12' ' ' LEU . 71.0 t -91.9 119.72 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.568 -0.708 . . . . 0.0 109.544 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.61 ' OE1' HG21 ' A' ' 92' ' ' THR . 36.5 mt-30 -110.49 135.01 51.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.96 . . . . 0.0 110.787 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.765 ' OD2' HD21 ' A' ' 73' ' ' LEU . 80.8 m-20 -104.76 11.07 34.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.202 178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.28 -131.88 1.97 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -89.6 10.16 24.1 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.191 -1.182 . . . . 0.0 110.57 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 92.6 m-85 -114.79 154.75 27.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.007 -1.058 . . . . 0.0 110.385 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.685 ' HB2' HG21 ' A' ' 2' ' ' THR . 60.4 p -105.1 121.55 44.04 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 110.21 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.577 ' CE2' HD11 ' A' ' 60' ' ' LEU . 19.9 m-85 -118.99 128.06 54.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.942 . . . . 0.0 110.578 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 m -70.8 165.58 22.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.172 -0.955 . . . . 0.0 110.395 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.861 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 mp -96.37 -8.8 31.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.282 -0.886 . . . . 0.0 110.339 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' SER . 84.4 tt0 -70.97 -70.71 0.29 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.298 -0.876 . . . . 0.0 110.926 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.6 m -43.97 -48.85 8.69 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.161 -0.962 . . . . 0.0 110.677 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.691 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 14.3 m -59.46 -47.36 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.115 -0.991 . . . . 0.0 110.319 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 20.7 tttm -56.75 -55.27 36.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.831 -1.168 . . . . 0.0 109.075 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 20' ' ' ASP . 7.4 tptm -80.43 10.9 4.07 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.41 -0.806 . . . . 0.0 109.288 178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 47.1 tp -56.31 -45.27 80.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 110.666 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 16.3 tttt -56.87 -46.28 81.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.068 -1.02 . . . . 0.0 110.191 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 22.3 t70 -105.78 122.26 45.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.915 . . . . 0.0 110.198 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.893 HD22 ' HB2' ' A' ' 52' ' ' ASN . 79.4 mt -78.2 137.76 38.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.225 -0.922 . . . . 0.0 110.075 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.477 ' HG2' ' HD2' ' A' ' 24' ' ' PRO . 7.9 tt0 -105.45 120.42 41.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.385 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.671 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -50.56 -53.84 41.72 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 0.0 110.531 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 3.2 Cg_exo -58.52 150.62 67.61 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.607 1.32 . . . . 0.0 110.744 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -83.1 53.05 2.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.297 -0.877 . . . . 0.0 110.542 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.404 ' HG2' ' OE2' ' A' ' 13' ' ' GLU . 0.3 OUTLIER 53.52 71.98 1.26 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 110.371 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 24' ' ' PRO . 3.0 Cg_exo -62.56 151.11 85.1 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.852 1.448 . . . . 0.0 110.395 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 27' ' ' PRO . 52.1 mtm180 45.58 -170.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.066 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 29' ' ' VAL . 14.7 p -119.83 136.0 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.269 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.29 94.49 1.66 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -60.79 -31.11 70.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -1.123 . . . . 0.0 110.436 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.1 mt -93.73 136.74 33.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.401 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -139.79 99.21 3.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.841 . . . . 0.0 110.028 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.561 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 81.5 m-20 -139.04 176.75 8.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 0.0 110.519 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.481 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 60.9 t80 60.9 64.52 1.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.285 -0.884 . . . . 0.0 110.303 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.762 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -80.08 171.41 12.46 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.171 -0.955 . . . . 0.0 110.232 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.762 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 2.9 Cg_endo -63.78 -6.99 11.87 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.923 1.486 . . . . 0.0 110.821 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.702 HD12 ' C ' ' A' ' 37' ' ' PRO . 1.2 mp 67.39 137.06 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.016 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.506 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.0 Cg_endo -60.75 165.84 11.09 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.797 1.42 . . . . 0.0 110.582 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.51 -1.36 42.78 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -132.46 75.5 73.75 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.211 -1.17 . . . . 0.0 110.147 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.414 ' HA ' ' HG ' ' A' ' 70' ' ' LEU . 3.0 Cg_endo -61.63 143.09 96.44 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.951 1.501 . . . . 0.0 110.329 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.501 ' C ' HG23 ' A' ' 44' ' ' VAL . 14.5 m -109.24 48.08 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 110.282 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.736 ' O ' HG12 ' A' ' 44' ' ' VAL . 84.2 t -151.87 48.22 0.46 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.51 -0.744 . . . . 0.0 110.705 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.691 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -60.82 -67.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.616 1.324 . . . . 0.0 110.587 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 87.0 mt -102.81 -70.6 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 110.087 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 48' ' ' CYS . 0.8 OUTLIER -144.93 98.78 3.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 109.85 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 47' ' ' LEU . 99.3 m 49.69 100.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.295 -0.878 . . . . 0.0 110.074 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.574 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 14.0 t -65.85 -73.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 110.89 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 8.6 m-20 -77.84 112.29 23.82 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.389 -0.819 . . . . 0.0 110.574 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.38 -9.17 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 O-C-N 123.673 1.354 . . . . 0.0 109.826 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.893 ' HB2' HD22 ' A' ' 21' ' ' LEU . 93.1 m-20 -119.24 27.13 9.01 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.449 -0.782 . . . . 0.0 110.274 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.682 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.03 174.73 5.65 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.005 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.682 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -56.82 76.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.739 1.389 . . . . 0.0 108.952 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 53' ' ' PHE . 2.7 pt-20 -39.38 -26.5 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.811 -0.556 . . . . 0.0 110.251 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 54' ' ' PRO . 49.2 tp10 -53.05 -19.02 2.4 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.011 -1.056 . . . . 0.0 108.38 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.607 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 58.2 mt -90.8 7.63 38.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.621 . . . . 0.0 109.579 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.734 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.69 -51.67 5.12 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 110.687 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.734 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -55.0 -43.16 62.22 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.502 1.264 . . . . 0.0 110.159 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.064 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 11.5 mt -58.76 -36.69 74.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.089 -1.007 . . . . 0.0 109.947 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.9 t -66.14 -26.57 67.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 110.293 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -92.19 3.73 54.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.183 -0.948 . . . . 0.0 111.049 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.557 ' OE2' HD11 ' A' ' 69' ' ' ILE . 6.1 pt-20 -119.17 145.89 39.34 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.853 -1.155 . . . . 0.0 110.269 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.53 -17.83 60.27 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.923 1.486 . . . . 0.0 111.252 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.495 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 21.8 m120 -79.7 -13.63 59.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 110.503 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.064 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.56 -42.37 23.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.336 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -59.75 -40.0 86.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 110.418 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -80.13 -36.64 34.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.068 -1.02 . . . . 0.0 109.985 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.882 HG21 HD13 ' A' ' 60' ' ' LEU . 88.7 mt -66.2 -44.53 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 109.986 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.824 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.3 tm? -51.02 -56.62 11.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.846 . . . . 0.0 110.214 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.824 ' N ' HD13 ' A' ' 70' ' ' LEU . 23.7 mt-30 -47.78 -54.64 11.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 110.247 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -51.49 -54.74 23.97 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.353 -0.842 . . . . 0.0 110.387 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.765 HD21 ' OD2' ' A' ' 5' ' ' ASP . 52.3 mt -50.66 -49.53 56.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.272 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.571 ' OE2' HD11 ' A' ' 70' ' ' LEU . 79.1 mt-10 -55.29 -49.32 72.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.755 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.46 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -57.56 -54.75 43.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.033 -1.042 . . . . 0.0 110.725 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 79' ' ' ASP . 23.0 mm -60.56 -37.11 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.09 -1.006 . . . . 0.0 109.823 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' C ' ' HB2' ' A' ' 36' ' ' ALA . . . -57.81 -32.27 67.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 0.0 109.663 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.623 ' N ' ' HB2' ' A' ' 36' ' ' ALA . 84.0 tt0 -63.74 -40.32 96.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.46 -0.775 . . . . 0.0 110.31 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.457 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -151.32 156.41 34.97 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 0.0 110.076 -179.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.541 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -59.08 -65.97 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.93 1.49 . . . . 0.0 110.643 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.14 -142.12 22.03 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.854 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 65.0 p -77.42 -19.71 55.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -1.126 . . . . 0.0 109.836 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.745 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 48.8 t -58.79 -51.12 71.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 109.848 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.3 tt0 -52.96 -30.25 33.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 110.698 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.742 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.2 pt -103.69 11.6 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.093 -1.004 . . . . 0.0 110.123 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 57.9 m 57.92 17.58 4.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.321 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.854 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -70.51 -14.55 62.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.943 . . . . 0.0 110.093 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.562 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 37.8 t80 -132.34 165.27 24.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 110.305 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.22 -0.23 11.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 110.274 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.562 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -65.56 -41.73 92.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.158 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.745 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -93.26 111.86 23.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.205 -0.934 . . . . 0.0 110.251 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.61 HG21 ' OE1' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -110.88 4.21 19.55 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.499 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . -75.12 -52.05 7.12 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.499 ' C ' ' O ' ' A' ' 93' ' ' GLY . 1.4 m . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.423 -1.045 . . . . 0.0 110.494 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 94' ' ' CYS . 4.5 m . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.223 0.535 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.4 m -117.83 146.21 44.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.909 . . . . 0.0 110.387 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.54 ' HB ' HD11 ' A' ' 12' ' ' LEU . 1.2 t -84.16 122.35 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.763 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.74 ' OE1' HG21 ' A' ' 92' ' ' THR . 66.9 mt-30 -112.75 124.72 53.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.958 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.831 ' HB2' HG23 ' A' ' 69' ' ' ILE . 44.4 p30 -103.37 12.0 35.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.444 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.55 -139.01 3.5 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -89.08 19.59 4.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -1.177 . . . . 0.0 110.194 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.676 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 97.5 m-85 -126.67 158.37 36.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 110.305 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 74.2 m -102.64 115.82 31.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.148 -0.97 . . . . 0.0 110.423 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.68 ' CG ' HD11 ' A' ' 57' ' ' LEU . 17.2 m-30 -116.75 128.01 54.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.365 -0.835 . . . . 0.0 110.596 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.499 ' C ' HD12 ' A' ' 12' ' ' LEU . 34.4 t -75.85 170.6 15.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.917 . . . . 0.0 110.116 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.817 ' N ' HD12 ' A' ' 12' ' ' LEU . 6.9 mp -93.12 -16.97 24.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.155 -0.965 . . . . 0.0 110.645 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.4 mt-10 -64.47 -71.92 0.16 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.151 -0.968 . . . . 0.0 110.402 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.2 m -42.77 -51.72 5.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 0.0 110.376 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.627 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 49.5 t -56.12 -48.26 79.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.58 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.596 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 6.3 ttpp -54.98 -54.67 39.97 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.168 -0.957 . . . . 0.0 108.686 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.469 ' HG3' ' HE3' ' A' ' 16' ' ' LYS . 45.0 mttt -80.62 14.12 2.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.449 -0.782 . . . . 0.0 109.911 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.71 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.8 tt -65.92 -35.05 79.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.104 -0.997 . . . . 0.0 110.073 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' NZ ' ' HB3' ' A' ' 41' ' ' GLU . 26.9 mttm -97.61 143.96 27.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 53.62 48.66 21.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.984 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.535 ' CD2' ' HB2' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -85.12 129.06 34.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.857 . . . . 0.0 110.251 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.496 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 46.7 tp60 -63.49 167.31 5.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.418 -0.801 . . . . 0.0 110.146 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.663 ' CB ' ' HD3' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -44.27 -55.36 9.93 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.945 . . . . 0.0 110.298 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.663 ' HD3' ' CB ' ' A' ' 23' ' ' GLU . 2.8 Cg_endo -62.76 136.81 59.79 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.591 1.311 . . . . 0.0 110.513 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.474 ' HG2' ' CG ' ' A' ' 52' ' ' ASN . 94.9 mt-30 -57.86 -38.7 76.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.98 . . . . 0.0 109.884 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 25' ' ' GLN . 29.2 mp0 -158.97 88.07 2.17 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.482 -0.761 . . . . 0.0 109.862 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 26' ' ' GLU . 3.0 Cg_exo -61.17 -32.81 91.29 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.925 1.487 . . . . 0.0 110.84 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -142.46 134.36 27.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.184 -0.947 . . . . 0.0 110.486 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.9 t -127.25 134.55 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.303 -0.873 . . . . 0.0 110.064 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.05 -173.14 39.91 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -61.81 -20.82 64.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -1.167 . . . . 0.0 110.136 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.2 mt -56.06 113.52 1.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 110.144 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.616 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 22.6 ptt-85 -155.66 -171.2 3.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.837 . . . . 0.0 109.981 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 33' ' ' ARG . 80.2 m-20 60.93 48.32 6.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -0.886 . . . . 0.0 110.0 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.616 ' CD2' ' O ' ' A' ' 33' ' ' ARG . 65.7 m-85 -128.79 4.91 5.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.384 -0.823 . . . . 0.0 110.154 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -66.09 158.51 76.17 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.863 . . . . 0.0 110.603 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.18 -149.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 124.022 1.538 . . . . 0.0 110.765 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.727 HD12 ' N ' ' A' ' 38' ' ' ILE . 4.1 mp -108.07 143.86 28.23 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.407 -0.808 . . . . 0.0 110.09 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.588 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo -61.47 169.43 6.69 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.665 1.35 . . . . 0.0 110.541 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.46 5.86 10.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 19' ' ' LYS . 1.7 mt-10 -133.52 74.0 71.91 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.298 -1.119 . . . . 0.0 110.157 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -60.67 146.06 97.83 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.836 1.44 . . . . 0.0 110.406 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 44' ' ' VAL . 45.4 t -131.38 122.34 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 110.538 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.865 ' O ' HG12 ' A' ' 44' ' ' VAL . 21.7 t -160.76 62.0 1.58 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.228 -0.92 . . . . 0.0 110.49 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.556 ' HG2' ' N ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -64.48 -153.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.605 1.318 . . . . 0.0 110.161 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.785 ' O ' HD23 ' A' ' 47' ' ' LEU . 76.2 mt -65.59 -38.75 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.078 -1.014 . . . . 0.0 109.711 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.785 HD23 ' O ' ' A' ' 46' ' ' ILE . 57.6 mt -142.75 64.26 1.37 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.385 -0.822 . . . . 0.0 109.701 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.565 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 74.9 m 57.93 133.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.428 -0.795 . . . . 0.0 110.035 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.746 ' HB3' HG11 ' A' ' 43' ' ' VAL . 30.5 t -64.16 -64.86 0.78 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.128 -0.982 . . . . 0.0 110.47 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 10.0 m-20 -80.27 114.15 44.77 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.402 -0.811 . . . . 0.0 110.081 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -64.85 -2.33 5.31 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.693 1.365 . . . . 0.0 110.772 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.535 ' HB2' ' CD2' ' A' ' 21' ' ' LEU . 95.6 m-20 -124.18 22.98 8.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.64 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.81 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 3.6 p90 -80.06 -176.33 0.72 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.191 -0.943 . . . . 0.0 108.945 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.004 ' HB2' HD13 ' A' ' 57' ' ' LEU . 5.0 Cg_exo -56.39 74.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.562 1.296 . . . . 0.0 109.657 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.622 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.6 tt0 -41.4 -36.69 0.89 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.509 -0.744 . . . . 0.0 110.132 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.576 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.9 mt-10 -52.03 -17.77 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.92 . . . . 0.0 108.981 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.004 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.4 mp -94.51 8.72 41.2 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.017 0.913 . . . . 0.0 109.327 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.77 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -41.79 -51.05 9.87 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.77 -0.581 . . . . 0.0 110.151 179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.77 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -53.8 -41.51 73.92 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.521 1.274 . . . . 0.0 110.1 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.036 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 9.5 mp -56.97 -42.47 80.25 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.948 -1.095 . . . . 0.0 109.402 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.803 ' O ' HG13 ' A' ' 44' ' ' VAL . 72.9 m -61.16 -24.52 66.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.177 -0.952 . . . . 0.0 110.061 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -99.31 1.6 44.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.323 -0.861 . . . . 0.0 110.769 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 60' ' ' LEU . 10.1 pt-20 -117.79 147.28 40.74 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.084 -1.01 . . . . 0.0 110.288 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.8 Cg_endo -64.01 -17.21 58.93 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.469 1.446 . . . . 0.0 111.258 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.509 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 53.2 m-20 -79.16 -20.83 47.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.09 -1.007 . . . . 0.0 110.87 -178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.036 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.57 -37.62 8.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.928 -1.108 . . . . 0.0 109.675 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.604 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.7 mt-30 -61.12 -41.37 96.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 110.187 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.8 mt-10 -80.14 -34.16 37.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.94 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.831 HG23 ' HB2' ' A' ' 5' ' ' ASP . 85.1 mt -73.02 -49.97 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 109.812 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.837 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.7 tm? -48.45 -56.59 7.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.332 -0.855 . . . . 0.0 109.922 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.774 ' N ' HD13 ' A' ' 70' ' ' LEU . 93.8 mt-30 -47.3 -51.55 18.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 110.028 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 93.0 mtt-85 -58.18 -60.99 2.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.278 -0.889 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 5' ' ' ASP . 8.0 mt -46.17 -54.41 8.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 110.015 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.645 ' HG2' HD22 ' A' ' 70' ' ' LEU . 76.2 mm-40 -50.92 -42.72 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 109.821 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.588 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 81.1 tt0 -66.8 -51.52 54.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.123 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.513 ' O ' ' O ' ' A' ' 79' ' ' ASP . 67.1 mt -65.19 -38.86 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -0.942 . . . . 0.0 109.609 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 34' ' ' ASN . . . -57.6 -35.73 70.82 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -0.871 . . . . 0.0 109.547 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 83.2 tt0 -63.02 -38.22 90.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.533 -0.729 . . . . 0.0 110.448 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -149.69 157.2 38.67 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.107 -0.996 . . . . 0.0 110.437 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.511 ' HD3' ' ND2' ' A' ' 34' ' ' ASN . 3.1 Cg_exo -59.44 -71.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.981 1.516 . . . . 0.0 110.83 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.4 -140.39 21.96 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.891 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 52.7 p -78.64 -23.09 46.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.197 -1.178 . . . . 0.0 110.153 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.61 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 25.2 t -54.39 -51.81 63.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.917 . . . . 0.0 109.893 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.5 tt0 -55.44 -33.53 63.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 111.115 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.736 HG13 ' HB2' ' A' ' 87' ' ' ALA . 4.3 pt -100.43 10.85 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.972 -1.08 . . . . 0.0 110.522 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.31 9.15 1.83 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.312 -0.867 . . . . 0.0 110.614 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.891 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -60.54 -14.56 20.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.056 -1.028 . . . . 0.0 109.543 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.595 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 41.4 t80 -135.68 164.52 27.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.464 -0.772 . . . . 0.0 110.123 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.62 3.41 5.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 110.23 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.595 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -64.66 -43.1 94.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.33 -0.856 . . . . 0.0 110.492 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.61 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -96.93 116.0 28.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.945 . . . . 0.0 110.645 -179.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.74 HG21 ' OE1' ' A' ' 4' ' ' GLN . 44.8 p -107.89 171.23 7.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.48 -30.31 10.49 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.42 ' HB3' ' CG1' ' A' ' 1' ' ' VAL . 26.1 p . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.207 -1.172 . . . . 0.0 110.172 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.73 ' O ' HG12 ' A' ' 1' ' ' VAL . 67.4 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.244 0.545 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.722 HG23 ' HA ' ' A' ' 11' ' ' SER . 56.5 m -120.73 151.84 39.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.933 . . . . 0.0 110.258 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.742 HG23 HD11 ' A' ' 12' ' ' LEU . 61.9 t -81.01 113.41 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.911 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.613 ' HB3' HG21 ' A' ' 92' ' ' THR . 42.9 tt0 -111.61 132.23 54.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -93.84 -78.0 0.44 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.34 -0.85 . . . . 0.0 109.627 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.59 -128.43 5.8 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -80.47 10.26 4.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -1.12 . . . . 0.0 110.622 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.503 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 97.6 m-85 -124.47 137.79 54.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.993 . . . . 0.0 110.576 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.419 ' HA ' ' HG3' ' A' ' 4' ' ' GLN . 80.0 p -89.58 133.33 34.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 110.201 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.556 ' CD1' ' HG ' ' A' ' 57' ' ' LEU . 92.1 m-85 -115.62 123.07 47.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 110.578 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.722 ' HA ' HG23 ' A' ' 2' ' ' THR . 58.5 m -72.77 171.64 12.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.217 -0.927 . . . . 0.0 110.243 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.886 ' N ' HD12 ' A' ' 12' ' ' LEU . 4.3 mp -103.57 2.25 33.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.15 -0.969 . . . . 0.0 111.015 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.454 ' OE2' ' OE1' ' A' ' 26' ' ' GLU . 97.3 mt-10 -71.75 -77.27 0.1 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.927 -1.108 . . . . 0.0 110.846 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.628 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.8 m -41.04 -47.57 3.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.255 -0.903 . . . . 0.0 110.88 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.639 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 14.8 m -63.58 -50.43 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.014 . . . . 0.0 109.886 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.568 ' H ' HG23 ' A' ' 15' ' ' VAL . 39.5 tttm -53.34 -53.28 53.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.075 -1.015 . . . . 0.0 109.075 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.451 ' O ' ' O ' ' A' ' 20' ' ' ASP . 68.6 mttm -80.17 4.89 15.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.371 -0.83 . . . . 0.0 109.871 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.639 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 8.8 tp -55.8 -36.31 67.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.262 -0.899 . . . . 0.0 110.226 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -53.2 -41.92 65.76 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.565 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' O ' ' O ' ' A' ' 17' ' ' LYS . 8.6 p-10 -111.67 133.77 53.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.422 -0.798 . . . . 0.0 109.725 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.89 HD11 ' HB2' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -79.98 113.69 18.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.125 -0.984 . . . . 0.0 110.426 -179.559 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.515 ' N ' HD13 ' A' ' 21' ' ' LEU . 93.6 mt-30 -151.2 171.5 17.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.87 . . . . 0.0 109.926 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -126.77 69.47 71.65 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.193 -0.942 . . . . 0.0 110.318 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HD3' ' C ' ' A' ' 22' ' ' GLN . 2.9 Cg_endo -61.94 135.57 56.27 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.902 1.475 . . . . 0.0 110.61 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 26' ' ' GLU . 93.4 mt-30 -64.23 -32.81 74.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 110.059 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.623 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 10.3 mm-40 40.74 55.12 7.43 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.444 -0.785 . . . . 0.0 110.542 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.623 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.8 Cg_endo -61.36 -45.78 17.3 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.79 1.416 . . . . 0.0 110.405 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -137.23 160.88 37.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.466 -0.771 . . . . 0.0 110.044 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 29' ' ' VAL . 12.3 m -57.56 132.35 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.147 -0.971 . . . . 0.0 110.187 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.49 174.18 53.15 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.737 ' O ' HD23 ' A' ' 32' ' ' LEU . 17.9 mttp -59.53 -46.16 89.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.212 -1.169 . . . . 0.0 110.295 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 31' ' ' LYS . 58.8 mt -144.9 140.29 28.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.157 -0.964 . . . . 0.0 110.329 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.437 ' C ' ' HE3' ' A' ' 16' ' ' LYS . 80.5 mtm-85 -111.24 54.58 0.68 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.911 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.488 ' OD1' ' HD3' ' A' ' 80' ' ' PRO . 73.8 m-20 -118.69 131.09 56.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.38 -0.825 . . . . 0.0 110.379 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.504 ' N ' ' HE2' ' A' ' 16' ' ' LYS . 57.2 t80 -178.08 -31.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 0.0 110.319 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 78' ' ' GLU . . . -55.49 109.68 1.77 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 110.39 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.642 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.8 Cg_endo -63.24 81.18 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.766 1.403 . . . . 0.0 110.583 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 48.12 170.38 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.512 -0.743 . . . . 0.0 110.547 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.618 ' HD2' ' HB ' ' A' ' 38' ' ' ILE . 2.9 Cg_endo -63.56 142.86 86.0 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.628 1.331 . . . . 0.0 110.65 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.77 -76.64 1.31 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -165.15 129.56 1.81 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.404 -1.057 . . . . 0.0 110.069 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HA ' HD12 ' A' ' 70' ' ' LEU . 3.0 Cg_endo -60.86 126.31 19.35 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.702 1.369 . . . . 0.0 110.502 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.582 HG22 ' HD3' ' A' ' 45' ' ' PRO . 11.3 p -140.58 138.58 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.322 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.538 HG23 ' C ' ' A' ' 43' ' ' VAL . 73.8 t -155.36 81.07 4.1 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.297 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.582 ' HD3' HG22 ' A' ' 43' ' ' VAL . 3.1 Cg_exo -60.59 -142.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.947 1.498 . . . . 0.0 110.259 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.682 ' O ' HD23 ' A' ' 47' ' ' LEU . 88.2 mt -55.45 -37.64 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.917 -1.114 . . . . 0.0 108.628 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 46' ' ' ILE . 74.0 mt -135.19 -78.03 0.44 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.533 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 62.7 m -141.03 140.12 34.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.867 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 22.1 t -59.5 -48.27 82.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.178 -0.951 . . . . 0.0 110.487 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.712 ' ND2' HD23 ' A' ' 21' ' ' LEU . 1.2 m120 -80.13 114.79 49.64 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.352 -0.842 . . . . 0.0 110.324 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -60.33 -10.36 13.05 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.703 1.37 . . . . 0.0 110.649 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.89 ' HB2' HD11 ' A' ' 21' ' ' LEU . 28.2 m120 -138.92 36.39 2.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.962 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.78 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 2.2 p90 -73.08 -175.84 0.41 Allowed Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.406 -0.809 . . . . 0.0 108.957 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.025 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.7 Cg_exo -58.41 74.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.494 1.26 . . . . 0.0 109.524 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.8 tt0 -42.7 -36.37 1.41 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.414 -0.804 . . . . 0.0 110.441 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.553 ' C ' HD12 ' A' ' 57' ' ' LEU . 83.8 tt0 -52.55 -19.17 2.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.077 -1.014 . . . . 0.0 108.929 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.025 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.1 mp -93.93 13.82 21.56 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.923 0.868 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.752 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.9 mttp -40.04 -52.01 5.57 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.729 -0.607 . . . . 0.0 110.201 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.752 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.08 -46.05 36.04 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.584 1.307 . . . . 0.0 109.661 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.097 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -48.78 -47.19 42.1 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.061 -1.024 . . . . 0.0 109.346 179.296 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 86.6 m -68.24 -27.23 66.17 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.418 -0.801 . . . . 0.0 110.286 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -86.43 4.96 37.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.998 . . . . 0.0 110.507 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.541 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 5.6 pt-20 -122.12 146.29 46.21 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.148 -0.97 . . . . 0.0 110.161 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -61.77 -17.98 58.04 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.862 1.454 . . . . 0.0 110.978 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.484 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 22.3 m120 -79.78 -12.09 59.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.15 -0.969 . . . . 0.0 110.578 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.097 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -49.94 -39.66 41.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.151 -0.968 . . . . 0.0 109.99 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.524 ' HG3' ' HB2' ' A' ' 42' ' ' PRO . 30.5 tt0 -56.8 -44.61 82.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.367 -0.833 . . . . 0.0 110.487 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.6 mt-10 -80.28 -35.06 36.39 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.13 -0.982 . . . . 0.0 110.358 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.018 HG21 ' CD1' ' A' ' 60' ' ' LEU . 86.7 mt -69.05 -48.65 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 110.149 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.697 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.7 tm? -44.87 -63.53 0.9 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.697 ' N ' HD13 ' A' ' 70' ' ' LEU . 50.7 tt0 -48.4 -53.13 18.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.0 110.176 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 82.9 mtp180 -51.59 -58.33 6.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 109.91 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 47.0 mt -46.33 -48.77 18.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.787 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 86.7 mt-10 -54.63 -40.67 69.2 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.297 -0.877 . . . . 0.0 110.176 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.582 ' CG ' ' HG3' ' A' ' 39' ' ' PRO . 96.5 mt-10 -61.82 -54.78 37.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.031 -1.043 . . . . 0.0 110.269 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 79' ' ' ASP . 42.4 mt -63.16 -42.49 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.881 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' A' ' 16' ' ' LYS . . . -52.0 -37.19 52.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.56 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 84.1 tt0 -65.93 -42.57 89.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.495 -0.753 . . . . 0.0 110.349 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -143.56 153.57 58.73 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.067 -1.02 . . . . 0.0 110.449 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.577 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -61.99 -68.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.069 1.563 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 85.03 -140.13 18.27 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.976 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 47.6 p -81.29 -21.98 38.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -1.118 . . . . 0.0 110.033 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 10.7 t -56.47 -50.22 72.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 110.166 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 78.5 tt0 -63.24 -27.26 69.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.954 . . . . 0.0 111.175 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.764 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.7 pt -102.08 12.76 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.829 -1.169 . . . . 0.0 110.449 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.9 t 57.87 13.59 2.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.299 -0.876 . . . . 0.0 110.459 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.976 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -64.66 -21.49 66.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 110.035 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.443 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 2.6 t80 -134.85 169.48 17.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.84 . . . . 0.0 110.04 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.31 1.26 11.96 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.188 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -58.58 -39.82 81.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.588 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.56 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.6 OUTLIER -104.38 122.12 44.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.005 . . . . 0.0 110.786 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.613 HG21 ' HB3' ' A' ' 4' ' ' GLN . 25.9 p -101.31 170.15 8.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 110.237 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.18 4.16 78.18 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.257 -1.143 . . . . 0.0 110.143 179.975 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' A' ' 91' ' ' CYS . 21.8 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.231 0.539 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 88.5 m -126.14 152.98 45.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.242 -0.911 . . . . 0.0 110.31 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.663 HG21 HG21 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -91.03 117.84 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 0.0 109.758 179.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.683 ' OE1' HG21 ' A' ' 92' ' ' THR . 31.2 mt-30 -110.3 139.82 45.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.228 -0.92 . . . . 0.0 110.63 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -108.59 9.62 27.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.697 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.75 -136.21 2.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -79.87 4.85 15.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -1.193 . . . . 0.0 109.566 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.652 ' CE1' ' O ' ' A' ' 9' ' ' SER . 35.7 t80 -119.26 161.32 20.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.473 -0.767 . . . . 0.0 109.78 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.652 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 82.5 p -115.5 133.13 56.33 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.955 -1.09 . . . . 0.0 110.929 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.501 ' O ' HG12 ' A' ' 3' ' ' VAL . 72.0 m-85 -112.47 121.96 46.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 110.779 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.2 p -69.83 168.08 15.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.061 -1.024 . . . . 0.0 109.918 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.636 HD13 ' HG3' ' A' ' 80' ' ' PRO . 43.3 mt -103.13 1.56 33.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.025 -1.047 . . . . 0.0 110.886 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.446 ' OE2' ' N ' ' A' ' 30' ' ' GLY . 97.5 mt-10 -73.96 -75.63 0.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 0.0 110.515 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.1 m -42.53 -50.18 5.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 0.0 110.671 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.698 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 5.4 m -57.31 -44.32 83.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.806 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.426 ' HE3' ' C ' ' A' ' 34' ' ' ASN . 50.5 tttt -56.56 -56.05 26.17 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.847 -1.158 . . . . 0.0 108.68 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.412 ' HB3' ' NE2' ' A' ' 22' ' ' GLN . 23.6 mttm -80.5 13.74 2.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.535 -0.728 . . . . 0.0 109.842 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.5 tt -63.38 -41.38 98.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.87 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -56.6 -42.96 79.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.196 -0.94 . . . . 0.0 109.504 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -93.01 116.23 28.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.817 HD23 ' ND2' ' A' ' 50' ' ' ASN . 0.8 OUTLIER -77.08 121.23 23.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.122 -0.986 . . . . 0.0 110.753 -179.26 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.687 ' N ' HD13 ' A' ' 21' ' ' LEU . 21.9 pt20 -154.52 171.35 19.54 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.415 -0.803 . . . . 0.0 109.863 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.601 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -130.78 54.84 15.86 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.017 -1.052 . . . . 0.0 110.873 -179.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.601 ' HD3' ' N ' ' A' ' 23' ' ' GLU . 2.9 Cg_endo -60.46 144.99 99.55 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.725 1.382 . . . . 0.0 110.377 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.435 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 57.8 mt-30 -62.19 -28.64 69.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 0.0 110.171 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.656 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER 43.1 52.71 8.49 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.356 -0.84 . . . . 0.0 110.655 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.656 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.8 Cg_endo -61.72 -30.08 84.48 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.698 1.367 . . . . 0.0 110.393 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.407 ' O ' ' OE2' ' A' ' 26' ' ' GLU . 56.1 ttt180 -134.77 147.5 50.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.368 -0.832 . . . . 0.0 110.217 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 29' ' ' VAL . 9.9 m -57.46 132.4 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.901 . . . . 0.0 110.21 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' N ' ' OE2' ' A' ' 13' ' ' GLU . . . -61.96 117.49 11.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -60.43 -32.65 71.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -1.146 . . . . 0.0 110.127 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.5 tp -100.2 132.67 45.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 110.207 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' NH2' ' CD ' ' A' ' 84' ' ' GLU . 24.3 ptt85 -137.86 118.22 13.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.955 . . . . 0.0 110.205 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.557 ' O ' ' HB3' ' A' ' 35' ' ' PHE . 37.9 p-10 -174.22 -129.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 0.0 110.431 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 34' ' ' ASN . 58.4 t80 63.66 89.83 0.09 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.0 110.266 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.657 ' HB2' ' OE2' ' A' ' 78' ' ' GLU . . . -50.24 107.27 0.76 Allowed Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.885 . . . . 0.0 110.287 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 2.8 Cg_endo -64.83 -3.97 7.85 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.808 1.425 . . . . 0.0 110.791 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 2.8 mt 61.64 70.73 0.84 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 110.123 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.49 ' CG ' ' CG ' ' A' ' 75' ' ' GLU . 2.9 Cg_endo -61.29 154.44 58.27 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.968 1.51 . . . . 0.0 110.562 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.448 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 125.02 28.6 1.11 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -125.16 71.74 63.92 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.294 -1.121 . . . . 0.0 110.149 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.07 90.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.864 1.455 . . . . 0.0 110.471 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.677 ' O ' HG23 ' A' ' 44' ' ' VAL . 11.5 p -135.75 129.23 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -0.862 . . . . 0.0 110.042 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.807 ' O ' HG12 ' A' ' 44' ' ' VAL . 14.6 t -158.16 72.58 4.0 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 110.294 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.545 ' HD3' HG22 ' A' ' 43' ' ' VAL . 3.0 Cg_endo -63.22 148.11 93.34 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.755 1.398 . . . . 0.0 110.185 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.716 HG23 ' HG ' ' A' ' 47' ' ' LEU . 13.1 tt -49.6 -26.41 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.14 -0.975 . . . . 0.0 110.012 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.716 ' HG ' HG23 ' A' ' 46' ' ' ILE . 30.0 mt -96.18 9.5 40.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 109.883 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER 70.99 128.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.405 -0.81 . . . . 0.0 110.265 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.553 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 91.5 p -55.48 -79.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.83 . . . . 0.0 110.421 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.817 ' ND2' HD23 ' A' ' 21' ' ' LEU . 5.3 m120 -80.08 112.56 31.2 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.374 -0.829 . . . . 0.0 110.3 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.39 -5.38 8.2 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.664 1.349 . . . . 0.0 110.875 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.68 ' H ' HD21 ' A' ' 21' ' ' LEU . 47.7 m-80 -132.4 29.64 4.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 110.549 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.81 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.5 p90 -78.61 -175.1 0.51 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 108.83 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.994 ' HB2' HD13 ' A' ' 57' ' ' LEU . 5.0 Cg_exo -55.64 75.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.383 1.202 . . . . 0.0 109.925 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 53' ' ' PHE . 22.6 pt-20 -44.46 -34.96 2.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.572 -0.705 . . . . 0.0 110.448 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.643 ' C ' HD12 ' A' ' 57' ' ' LEU . 49.7 mt-10 -53.87 -19.34 4.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.051 -1.031 . . . . 0.0 108.832 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.994 HD13 ' HB2' ' A' ' 54' ' ' PRO . 6.8 mp -96.77 14.22 25.87 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.83 0.824 . . . . 0.0 109.221 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.755 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.76 -51.48 5.31 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.767 -0.583 . . . . 0.0 110.575 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.755 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -53.66 -44.32 50.1 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.37 1.195 . . . . 0.0 110.039 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.072 ' CD1' HG21 ' A' ' 69' ' ' ILE . 3.1 mm? -57.59 -38.89 75.63 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.152 -0.967 . . . . 0.0 109.608 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.578 ' O ' HG13 ' A' ' 44' ' ' VAL . 43.6 t -67.17 -29.4 69.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.15 -0.969 . . . . 0.0 110.181 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -96.38 6.96 47.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.935 . . . . 0.0 110.08 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 2.8 mt-10 -99.58 144.34 28.12 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.369 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.1 Cg_exo -63.03 -26.83 73.79 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.78 1.41 . . . . 0.0 110.178 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 66' ' ' ALA . 76.1 m-20 -86.94 -3.19 59.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.542 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -42.52 -40.55 2.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.111 -0.993 . . . . 0.0 109.989 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -61.75 -39.72 92.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.476 -0.765 . . . . 0.0 110.454 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -80.3 -31.88 38.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.141 -0.975 . . . . 0.0 109.859 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.072 HG21 ' CD1' ' A' ' 60' ' ' LEU . 62.1 mt -74.55 -44.91 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.224 -0.922 . . . . 0.0 110.055 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.794 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.7 tm? -50.03 -59.27 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 110.387 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.794 ' N ' HD13 ' A' ' 70' ' ' LEU . 62.6 tt0 -47.91 -52.64 18.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.333 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.508 HH21 HG23 ' A' ' 69' ' ' ILE . 46.1 mtm180 -55.25 -56.72 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.19 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 35.1 mt -49.43 -51.33 36.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 110.205 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 76.7 mm-40 -53.69 -49.82 67.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.967 . . . . 0.0 110.454 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.49 ' CG ' ' CG ' ' A' ' 39' ' ' PRO . 98.8 mt-10 -54.88 -52.14 63.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.161 -0.962 . . . . 0.0 110.523 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.663 HG21 HG21 ' A' ' 3' ' ' VAL . 23.7 mm -62.86 -35.58 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.927 . . . . 0.0 109.894 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.82 71.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.814 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.657 ' OE2' ' HB2' ' A' ' 36' ' ' ALA . 84.1 tt0 -62.05 -38.54 89.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 110.172 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.6 OUTLIER 175.04 94.42 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 110.077 -179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.636 ' HG3' HD13 ' A' ' 12' ' ' LEU . 3.1 Cg_exo -59.74 77.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.931 1.49 . . . . 0.0 110.714 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -42.64 -75.12 0.15 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.732 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 65.8 p -71.44 -57.29 4.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -1.151 . . . . 0.0 110.396 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.63 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 32.6 t -39.01 -50.79 1.8 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 110.046 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.533 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 81.7 tt0 -58.61 -42.97 89.4 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.041 -1.037 . . . . 0.0 110.731 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.724 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.6 pt -89.61 18.04 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.018 . . . . 0.0 110.219 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 7.2 m 57.83 15.0 2.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.317 -0.865 . . . . 0.0 110.547 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.732 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.53 -19.26 65.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 110.194 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -135.68 165.43 25.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.72 5.69 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.829 . . . . 0.0 110.563 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -69.58 -31.56 69.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.121 -0.987 . . . . 0.0 110.414 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.63 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.7 OUTLIER -108.56 123.81 49.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.818 -179.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.683 HG21 ' OE1' ' A' ' 4' ' ' GLN . 44.0 p -110.8 164.05 13.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.361 -0.837 . . . . 0.0 110.131 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.6 -3.93 68.81 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.174 -1.192 . . . . 0.0 110.199 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 1' ' ' VAL . 5.3 m . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.228 0.537 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 29.8 m -121.42 149.49 42.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 0.0 110.536 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.025 HG23 HD11 ' A' ' 12' ' ' LEU . 91.9 t -86.76 118.44 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.707 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.546 ' CD ' HG21 ' A' ' 92' ' ' THR . 21.5 pt20 -111.48 147.91 34.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 111.029 -179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 1.025 ' OD2' HD21 ' A' ' 73' ' ' LEU . 91.4 m-20 -111.76 12.1 21.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.429 -0.794 . . . . 0.0 109.771 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 174.07 -129.61 1.66 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.02 5.49 22.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -1.166 . . . . 0.0 110.162 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.464 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 86.8 m-85 -125.98 147.22 49.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.188 -0.945 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 94.8 p -101.14 136.61 40.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 0.0 110.144 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.667 ' CE2' HD11 ' A' ' 60' ' ' LEU . 21.5 m-85 -121.35 132.52 54.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 0.0 110.452 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.415 ' C ' HD12 ' A' ' 12' ' ' LEU . 30.1 t -71.32 166.69 21.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 110.295 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.025 HD11 HG23 ' A' ' 3' ' ' VAL . 5.2 mp -97.39 -9.64 27.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.302 -0.874 . . . . 0.0 110.404 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -67.75 -71.51 0.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.354 -0.842 . . . . 0.0 110.729 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 m -46.34 -46.67 18.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.092 -1.005 . . . . 0.0 110.467 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.606 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 48.5 t -62.94 -51.62 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.048 -1.032 . . . . 0.0 109.941 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.503 ' NZ ' ' N ' ' A' ' 34' ' ' ASN . 43.0 tttt -54.18 -51.8 63.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.05 -1.031 . . . . 0.0 109.018 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 26' ' ' GLU . 22.3 tttp -80.21 6.86 10.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.524 -0.735 . . . . 0.0 109.793 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.606 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 17.2 tp -61.54 -37.59 84.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 110.249 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HE2' HG12 ' A' ' 38' ' ' ILE . 43.7 mttp -63.44 -37.05 85.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.08 -1.013 . . . . 0.0 110.047 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -113.33 101.78 9.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.08 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.754 HD11 ' HB3' ' A' ' 52' ' ' ASN . 33.9 tp -110.26 130.16 55.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.91 . . . . 0.0 110.226 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.438 ' C ' ' HD2' ' A' ' 24' ' ' PRO . 92.9 mt-30 -122.94 161.06 24.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.661 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 0.4 OUTLIER -43.32 -52.57 12.67 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 110.672 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 3.1 Cg_exo -60.48 163.57 14.97 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.642 1.338 . . . . 0.0 110.745 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.459 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 93.0 mt-30 -58.31 -154.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.85 . . . . 0.0 110.327 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.454 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -116.32 79.52 9.01 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.431 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HD3' ' C ' ' A' ' 25' ' ' GLN . 3.0 Cg_endo -61.96 155.45 55.16 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.813 1.428 . . . . 0.0 110.401 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -134.51 152.01 51.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.228 -0.92 . . . . 0.0 110.373 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.5 t -124.95 136.1 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.71 141.65 8.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.41 -33.98 75.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -1.155 . . . . 0.0 110.344 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.28 144.21 28.66 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 110.433 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 70.1 mtt85 -105.3 100.9 10.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.257 -0.902 . . . . 0.0 109.911 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 35.3 p-10 -137.9 155.76 48.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 110.599 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.489 ' O ' ' OE1' ' A' ' 78' ' ' GLU . 66.9 t80 -178.73 159.96 1.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.187 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.574 ' O ' HD13 ' A' ' 38' ' ' ILE . . . -54.05 107.67 0.92 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.118 -0.989 . . . . 0.0 110.058 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.627 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.4 Cg_endo -76.99 147.36 26.69 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 121.607 1.538 . . . . 0.0 109.953 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.627 HD13 ' C ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -148.22 64.04 7.78 Favored Pre-proline 0 C--N 1.292 -1.93 0 O-C-N 121.738 -0.601 . . . . 0.0 109.793 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 38' ' ' ILE . 3.0 Cg_endo -60.7 147.33 95.24 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.023 1.538 . . . . 0.0 110.772 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.515 ' N ' ' HG3' ' A' ' 71' ' ' GLN . . . 126.3 32.44 0.73 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.434 ' O ' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -122.47 75.5 44.03 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.289 -1.124 . . . . 0.0 110.283 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.476 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 2.9 Cg_endo -62.01 132.25 38.55 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.84 1.442 . . . . 0.0 110.811 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.784 HG22 ' OG ' ' A' ' 49' ' ' SER . 6.2 p 179.15 83.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.403 -0.81 . . . . 0.0 110.006 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.797 ' O ' HG12 ' A' ' 44' ' ' VAL . 38.8 t -129.37 67.8 79.29 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.231 -0.918 . . . . 0.0 110.479 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 43' ' ' VAL . 3.0 Cg_endo -62.95 151.11 86.28 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.814 1.428 . . . . 0.0 110.281 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.567 HG13 ' HG ' ' A' ' 47' ' ' LEU . 15.2 pt -53.73 -25.04 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 109.891 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.567 ' HG ' HG13 ' A' ' 46' ' ' ILE . 58.4 mt -97.77 12.56 33.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 109.95 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.481 ' O ' ' O ' ' A' ' 47' ' ' LEU . 1.3 m 58.84 121.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.394 -0.816 . . . . 0.0 109.976 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.784 ' OG ' HG22 ' A' ' 43' ' ' VAL . 36.3 m -60.12 -53.19 60.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 110.67 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.629 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 3.2 m120 -80.32 111.5 22.95 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.433 -0.792 . . . . 0.0 110.506 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -58.95 -12.79 16.26 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.646 1.34 . . . . 0.0 110.818 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.754 ' HB3' HD11 ' A' ' 21' ' ' LEU . 31.0 t30 -137.39 42.1 2.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 110.253 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.75 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 1.3 p90 -80.18 -177.58 0.95 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.391 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.998 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -57.85 74.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.684 1.36 . . . . 0.0 109.693 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 53' ' ' PHE . 86.0 tt0 -42.52 -35.55 1.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.481 -0.762 . . . . 0.0 110.348 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.7 mt-10 -53.7 -18.16 2.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 108.822 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.998 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.2 mp -96.39 13.3 28.23 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.754 0.788 . . . . 0.0 109.1 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.736 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -41.15 -52.3 7.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.908 -0.495 . . . . 0.0 111.168 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.736 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -53.8 -43.99 53.08 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.6 1.316 . . . . 0.0 110.17 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.83 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 17.9 mt -60.36 -34.36 73.76 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.139 -0.976 . . . . 0.0 109.902 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.754 ' HA ' HG13 ' A' ' 44' ' ' VAL . 36.8 t -66.27 -25.95 67.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.182 -0.949 . . . . 0.0 110.286 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -107.09 25.35 11.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.943 . . . . 0.0 109.323 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -110.48 143.19 27.62 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.624 -0.672 . . . . 0.0 110.462 -179.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.53 -30.83 80.07 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.896 1.472 . . . . 0.0 109.816 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' ALA . 81.8 m-20 -86.23 -5.95 59.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.837 . . . . 0.0 110.507 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.83 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -44.53 -41.56 6.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.106 -0.996 . . . . 0.0 110.068 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -55.13 -42.41 72.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.766 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.11 -37.38 33.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 109.863 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.695 HG21 HD13 ' A' ' 60' ' ' LEU . 87.7 mt -63.34 -49.18 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.098 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.919 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.3 tm? -48.7 -60.88 2.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 110.558 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.919 ' N ' HD13 ' A' ' 70' ' ' LEU . 63.9 tt0 -47.07 -53.99 11.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 0.0 110.533 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -54.76 -53.22 57.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 110.112 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.025 HD21 ' OD2' ' A' ' 5' ' ' ASP . 73.5 mt -49.84 -52.0 35.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.54 ' OE2' HD11 ' A' ' 70' ' ' LEU . 86.7 mt-10 -52.53 -46.02 66.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.341 -0.849 . . . . 0.0 110.328 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 82.3 tt0 -62.76 -54.24 42.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.672 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.524 ' O ' ' O ' ' A' ' 79' ' ' ASP . 32.8 mm -64.56 -43.4 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 110.185 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -55.75 -37.64 68.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 110.024 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 57.6 mm-40 -65.02 -36.16 83.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.365 -0.834 . . . . 0.0 111.087 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.524 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.4 OUTLIER -135.55 149.16 68.52 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.868 -1.145 . . . . 0.0 110.725 -179.385 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.508 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -60.58 -68.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.831 1.437 . . . . 0.0 110.596 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.53 -139.42 20.18 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.956 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 64.6 p -80.19 -23.03 41.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.126 -1.22 . . . . 0.0 110.007 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 14.2 t -53.38 -53.51 50.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.903 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.8 tt0 -58.14 -32.29 68.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.375 -0.828 . . . . 0.0 111.05 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.771 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.2 pt -99.08 12.7 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.96 -1.088 . . . . 0.0 110.401 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 54.97 15.49 1.19 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.299 -0.875 . . . . 0.0 110.51 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.956 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -62.02 -14.94 40.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.04 -1.037 . . . . 0.0 109.952 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 19.7 m-85 -144.75 174.35 11.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 110.192 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.03 3.18 10.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.346 -0.847 . . . . 0.0 110.411 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -59.91 -36.78 77.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.609 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.1 OUTLIER -104.22 123.83 48.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.254 -0.904 . . . . 0.0 110.633 -179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.546 HG21 ' CD ' ' A' ' 4' ' ' GLN . 23.4 p -105.6 160.53 15.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.381 -0.824 . . . . 0.0 110.146 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.65 3.19 56.28 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.349 -1.089 . . . . 0.0 110.218 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.798 HG22 ' SG ' ' A' ' 91' ' ' CYS . 9.7 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.333 0.587 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 90.8 m -129.44 154.45 46.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.961 . . . . 0.0 110.726 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.759 HG21 HD13 ' A' ' 12' ' ' LEU . 39.0 t -83.91 117.25 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.351 -0.843 . . . . 0.0 109.82 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.783 ' CB ' HG21 ' A' ' 92' ' ' THR . 48.7 tt0 -111.73 128.35 56.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 110.504 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.877 ' OD2' HD21 ' A' ' 73' ' ' LEU . 76.1 m-20 -114.24 10.38 17.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.471 -0.768 . . . . 0.0 109.692 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.74 -143.55 4.67 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -82.42 7.74 13.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -1.166 . . . . 0.0 110.221 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.43 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 74.4 m-85 -123.98 145.66 49.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 110.372 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -90.74 123.57 34.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.332 -0.855 . . . . 0.0 110.222 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.749 ' CD1' HD23 ' A' ' 57' ' ' LEU . 20.9 m-85 -110.91 123.08 49.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.863 . . . . 0.0 110.329 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.466 ' HA ' HG23 ' A' ' 2' ' ' THR . 63.4 m -62.37 156.15 23.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 0.0 110.534 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.885 HD11 ' N ' ' A' ' 77' ' ' ALA . 45.9 tp -98.68 -20.91 16.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.238 -0.914 . . . . 0.0 110.546 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.441 ' OE2' HG13 ' A' ' 29' ' ' VAL . 95.6 mt-10 -62.42 -65.46 0.68 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.139 -0.976 . . . . 0.0 110.51 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.4 m -46.58 -48.54 19.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.968 . . . . 0.0 110.949 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.685 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 31.2 m -60.86 -44.97 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.104 -0.997 . . . . 0.0 110.086 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.635 ' CA ' ' HB1' ' A' ' 77' ' ' ALA . 1.5 tmmt? -58.54 -56.03 27.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 109.072 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 13.9 ttpt -80.31 8.46 7.42 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.294 -0.879 . . . . 0.0 109.14 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.685 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 7.7 tp -52.2 -38.67 58.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.582 -0.699 . . . . 0.0 110.027 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.599 ' HD3' ' CE2' ' A' ' 35' ' ' PHE . 65.5 tttt -57.25 -45.4 84.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.094 -1.004 . . . . 0.0 109.574 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -97.47 115.05 27.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.764 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.88 HD11 ' HB2' ' A' ' 52' ' ' ASN . 29.6 tp -97.42 130.94 44.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.666 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -125.6 147.8 49.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.344 -0.847 . . . . 0.0 109.958 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.638 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 2.5 tt0 -50.58 -53.34 47.06 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 110.445 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 3.0 Cg_endo -60.42 124.75 15.78 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.612 1.322 . . . . 0.0 110.712 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.419 ' O ' ' CB ' ' A' ' 26' ' ' GLU . 63.1 tt0 -64.23 -41.06 97.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.875 . . . . 0.0 110.191 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.429 ' CD ' ' OE1' ' A' ' 13' ' ' GLU . 0.4 OUTLIER 174.18 74.96 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.432 -0.793 . . . . 0.0 110.021 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 24' ' ' PRO . 2.9 Cg_endo -62.32 -31.02 81.7 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.877 1.461 . . . . 0.0 110.697 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -137.21 159.59 41.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.328 -0.857 . . . . 0.0 110.426 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.441 HG13 ' OE2' ' A' ' 13' ' ' GLU . 47.4 t -116.82 132.32 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.847 . . . . 0.0 110.033 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.17 136.71 12.97 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.449 ' O ' HD23 ' A' ' 32' ' ' LEU . 19.2 mtmt -59.4 -38.85 81.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -1.131 . . . . 0.0 110.115 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 31' ' ' LYS . 45.5 mt -118.93 136.52 54.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.263 -0.898 . . . . 0.0 110.153 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -124.29 132.09 53.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.216 -0.927 . . . . 0.0 110.317 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 16.7 p30 -164.43 163.95 22.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 110.119 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.599 ' CE2' ' HD3' ' A' ' 19' ' ' LYS . 64.8 t80 -170.38 173.71 5.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.145 -0.972 . . . . 0.0 110.277 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.947 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -49.48 177.85 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.823 . . . . 0.0 110.289 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.947 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 3.0 Cg_exo -61.83 81.96 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.846 1.445 . . . . 0.0 110.604 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.733 ' N ' ' CD ' ' A' ' 39' ' ' PRO . 2.1 mp -67.91 -40.2 21.87 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 111.247 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.733 ' CD ' ' N ' ' A' ' 38' ' ' ILE . 3.0 Cg_exo -64.73 146.52 88.66 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.323 1.17 . . . . 0.0 110.568 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.31 6.08 29.69 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -137.09 71.01 55.83 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.162 -1.199 . . . . 0.0 110.31 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.74 147.71 94.69 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.865 1.455 . . . . 0.0 110.269 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.899 HG22 ' HB3' ' A' ' 49' ' ' SER . 12.2 p -158.47 72.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.164 -0.96 . . . . 0.0 110.42 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.749 ' O ' HG12 ' A' ' 44' ' ' VAL . 30.6 t -127.44 73.8 77.76 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.1 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.472 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 3.1 Cg_exo -60.28 -54.31 2.29 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.97 1.511 . . . . 0.0 110.6 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.787 ' O ' HD13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -177.59 -40.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.319 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.521 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 16.0 tp -109.45 38.81 2.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.137 -0.977 . . . . 0.0 110.248 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.566 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 1.0 OUTLIER 57.97 123.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.202 -0.936 . . . . 0.0 110.194 179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.899 ' HB3' HG22 ' A' ' 43' ' ' VAL . 85.0 p -61.54 -54.88 37.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -0.92 . . . . 0.0 110.44 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 5.3 m-20 -80.2 110.87 18.08 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.392 -0.818 . . . . 0.0 110.399 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.599 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -61.81 -13.96 33.69 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.623 1.328 . . . . 0.0 110.715 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.88 ' HB2' HD11 ' A' ' 21' ' ' LEU . 86.3 m-20 -128.21 33.66 4.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 110.55 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.664 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.25 175.94 4.29 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.129 -0.982 . . . . 0.0 108.792 179.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.679 ' HG2' HD12 ' A' ' 57' ' ' LEU . 4.1 Cg_exo -56.57 75.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.604 1.318 . . . . 0.0 109.388 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.644 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.5 tt0 -39.35 -27.14 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.712 -0.618 . . . . 0.0 110.387 -178.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.3 mt-10 -53.68 -17.34 2.17 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.964 -1.085 . . . . 0.0 108.657 178.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.749 HD23 ' CD1' ' A' ' 10' ' ' PHE . 34.8 mt -95.09 9.17 40.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.566 -0.709 . . . . 0.0 109.676 179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.741 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.6 -51.74 4.95 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.28 -0.887 . . . . 0.0 110.678 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.741 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -54.84 -41.88 74.07 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.496 1.261 . . . . 0.0 110.017 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.892 HD22 HD13 ' A' ' 69' ' ' ILE . 55.9 mt -60.39 -36.6 78.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.113 -0.992 . . . . 0.0 110.163 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.533 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 73.6 m -67.53 -28.32 67.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.17 -0.957 . . . . 0.0 110.272 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -101.22 24.33 9.64 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.211 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.45 143.55 29.57 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.588 -0.695 . . . . 0.0 110.588 -179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -63.26 -31.98 73.6 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.813 1.428 . . . . 0.0 109.818 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -86.98 1.67 52.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.361 -0.837 . . . . 0.0 110.701 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.17 -42.63 20.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.068 -1.02 . . . . 0.0 110.058 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 92.1 mt-30 -56.15 -41.39 75.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.848 . . . . 0.0 110.098 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -79.92 -35.52 37.71 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 110.135 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.892 HD13 HD22 ' A' ' 60' ' ' LEU . 91.6 mt -67.6 -47.95 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.0 109.79 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -53.95 -53.28 54.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 0.0 110.378 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.954 ' N ' HD13 ' A' ' 70' ' ' LEU . 97.9 mt-30 -49.7 -51.26 39.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.252 -0.905 . . . . 0.0 110.722 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -55.42 -59.64 4.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.317 -0.864 . . . . 0.0 110.711 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.877 HD21 ' OD2' ' A' ' 5' ' ' ASP . 60.9 mt -44.38 -49.09 9.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.301 -0.875 . . . . 0.0 110.42 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.93 ' OE2' HD21 ' A' ' 70' ' ' LEU . 70.7 mt-10 -61.82 -26.72 68.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 0.0 110.752 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.557 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.3 tt0 -71.63 -50.41 30.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.929 -1.107 . . . . 0.0 109.785 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.1 mm -67.82 -36.48 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.346 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.885 ' N ' HD11 ' A' ' 12' ' ' LEU . . . -63.28 -29.16 70.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.617 -0.677 . . . . 0.0 109.667 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 35' ' ' PHE . 84.8 tt0 -62.99 -34.7 78.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.423 -0.798 . . . . 0.0 110.384 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -161.33 147.01 10.84 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.144 -0.973 . . . . 0.0 110.765 -179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.5 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.47 84.04 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.052 1.554 . . . . 0.0 110.598 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.68 -130.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.207 -1.957 . . . . 0.0 108.207 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.965 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 82.8 p -82.76 -16.96 45.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.246 . . . . 0.0 109.321 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.438 ' SG ' ' N ' ' A' ' 91' ' ' CYS . 5.5 t -51.11 -50.38 58.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.733 -0.604 . . . . 0.0 110.37 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' OE1' ' HB2' ' A' ' 80' ' ' PRO . 76.2 tt0 -61.05 -34.87 75.57 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.268 -0.895 . . . . 0.0 111.364 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.813 HG13 ' HB2' ' A' ' 87' ' ' ALA . 4.3 pt -97.24 17.36 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.588 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 1.2 m 51.14 17.37 0.46 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.945 . . . . 0.0 110.81 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.965 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.55 -13.81 62.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.056 -1.028 . . . . 0.0 109.663 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.534 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 52.8 t80 -141.22 170.27 16.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.79 . . . . 0.0 109.996 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.73 4.43 7.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.12 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.534 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -59.27 -40.35 85.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.639 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.798 ' SG ' HG22 ' A' ' 1' ' ' VAL . 1.0 OUTLIER -103.04 128.24 49.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.214 -0.929 . . . . 0.0 110.689 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.783 HG21 ' CB ' ' A' ' 4' ' ' GLN . 16.9 p -108.0 165.45 11.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.25 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.29 -7.07 61.82 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.319 -1.107 . . . . 0.0 110.21 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.456 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 6.4 m . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.107 0.48 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 1.015 HG21 ' HB3' ' A' ' 9' ' ' SER . 14.6 t -129.75 164.09 24.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.981 ' CG2' HD21 ' A' ' 12' ' ' LEU . 43.2 t -80.06 110.98 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.308 -0.87 . . . . 0.0 109.352 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 46.2 tt0 -109.53 121.15 44.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.111 -0.993 . . . . 0.0 110.578 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -99.12 5.65 46.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.821 . . . . 0.0 109.673 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.93 -141.18 3.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -79.92 0.17 32.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -1.193 . . . . 0.0 110.36 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.501 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 92.4 m-85 -112.64 138.07 49.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.179 -0.95 . . . . 0.0 110.462 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 1.015 ' HB3' HG21 ' A' ' 2' ' ' THR . 73.4 m -89.11 128.79 35.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.359 -0.838 . . . . 0.0 110.144 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.772 ' CE1' HD23 ' A' ' 57' ' ' LEU . 91.6 m-85 -111.79 119.14 37.6 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.897 . . . . 0.0 110.483 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.7 p -70.88 168.38 16.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.93 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.981 HD21 ' CG2' ' A' ' 3' ' ' VAL . 65.0 mt -99.51 2.94 45.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.978 . . . . 0.0 110.425 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 14' ' ' SER . 81.7 tt0 -76.28 -71.02 0.41 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 110.503 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.475 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.6 m -42.42 -49.45 5.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.007 -1.058 . . . . 0.0 110.271 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.675 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 7.8 m -58.9 -48.89 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.181 -0.949 . . . . 0.0 109.851 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.569 ' NZ ' ' HB3' ' A' ' 35' ' ' PHE . 21.2 tttt -54.68 -55.91 24.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.894 -1.129 . . . . 0.0 108.972 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HB3' ' CD ' ' A' ' 23' ' ' GLU . 43.1 mttt -80.33 12.34 3.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.415 -0.803 . . . . 0.0 109.621 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 39.1 tp -57.96 -37.15 73.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.354 -0.842 . . . . 0.0 110.376 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HB2' ' CG ' ' A' ' 37' ' ' PRO . 79.0 tttt -55.29 -43.21 74.59 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.127 -0.983 . . . . 0.0 110.006 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -99.96 109.94 22.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 110.042 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.043 HD21 ' CG ' ' A' ' 50' ' ' ASN . 93.8 mt -64.4 -36.29 83.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.895 . . . . 0.0 110.277 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.456 ' O ' ' CB ' ' A' ' 23' ' ' GLU . 1.5 tp60 -60.44 137.77 58.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.23 -0.918 . . . . 0.0 110.2 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 22' ' ' GLN . 0.4 OUTLIER 171.85 164.2 0.24 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.157 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.07 156.93 46.95 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.884 1.465 . . . . 0.0 110.629 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -51.77 -34.03 37.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.196 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.55 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 3.1 tp10 47.42 60.63 14.94 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.902 . . . . 0.0 110.466 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 3.0 Cg_endo -62.07 -28.22 79.94 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.897 1.472 . . . . 0.0 110.271 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -142.61 158.67 43.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.396 -0.815 . . . . 0.0 109.986 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.6 t -112.61 131.18 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.178 -0.951 . . . . 0.0 110.231 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -108.29 -72.62 0.77 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' C ' HD12 ' A' ' 32' ' ' LEU . 74.5 mttt -90.71 152.92 20.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -1.144 . . . . 0.0 110.154 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.792 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -100.1 137.08 39.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.481 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -112.74 140.27 47.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.812 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 86.9 m-20 -124.68 107.39 10.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 110.76 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.569 ' HB3' ' NZ ' ' A' ' 16' ' ' LYS . 74.7 t80 179.38 66.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.332 -0.855 . . . . 0.0 110.245 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.974 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . . . -65.09 145.12 99.15 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.967 . . . . 0.0 110.128 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.829 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.8 Cg_endo -62.65 -30.93 79.33 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.823 1.433 . . . . 0.0 110.845 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 37' ' ' PRO . 0.1 OUTLIER 154.68 116.1 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.045 0 O-C-N 121.84 -0.537 . . . . 0.0 109.814 179.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 3.0 Cg_exo -62.44 154.51 63.74 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.678 1.357 . . . . 0.0 110.495 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.463 ' HA2' ' HG2' ' A' ' 71' ' ' GLN . . . 102.02 -0.35 51.43 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -66.91 139.54 95.69 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.214 -1.168 . . . . 0.0 110.214 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.68 110.0 0.87 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.756 1.398 . . . . 0.0 110.329 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.603 HG21 ' HG ' ' A' ' 70' ' ' LEU . 63.3 t -135.97 143.04 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.142 -0.974 . . . . 0.0 110.515 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.829 ' O ' HG12 ' A' ' 44' ' ' VAL . 46.4 t 57.59 58.0 7.36 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.775 . . . . 0.0 110.861 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.822 ' O ' HD13 ' A' ' 46' ' ' ILE . 2.9 Cg_endo -62.59 -42.22 27.7 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.512 1.27 . . . . 0.0 109.69 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 45' ' ' PRO . 39.4 mm -133.3 -28.55 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.501 -0.749 . . . . 0.0 109.927 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.721 HD23 HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER 178.97 89.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.388 -0.82 . . . . 0.0 109.891 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.506 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 0.8 OUTLIER 57.21 112.86 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.15 -0.969 . . . . 0.0 110.038 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.618 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 6.6 p -96.16 -53.46 3.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 110.566 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 1.043 ' CG ' HD21 ' A' ' 21' ' ' LEU . 9.6 m-20 -80.06 111.35 21.22 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.401 -0.812 . . . . 0.0 110.439 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.618 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.91 -13.62 40.72 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.704 1.37 . . . . 0.0 110.371 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.419 ' HB2' HD22 ' A' ' 21' ' ' LEU . 95.2 m-20 -114.27 20.16 15.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 110.415 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.15 173.45 7.7 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 108.961 179.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.641 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.1 Cg_exo -57.37 75.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.632 1.333 . . . . 0.0 108.925 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 53' ' ' PHE . 23.9 pt-20 -39.11 -26.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.745 -0.597 . . . . 0.0 110.596 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.9 mt-10 -51.68 -22.23 3.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.944 -1.097 . . . . 0.0 108.452 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.772 HD23 ' CE1' ' A' ' 10' ' ' PHE . 66.7 mt -83.14 8.86 11.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.662 -0.649 . . . . 0.0 109.472 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.744 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.75 -51.49 5.29 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.457 -0.777 . . . . 0.0 110.601 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.744 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.97 -41.43 78.81 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.52 1.274 . . . . 0.0 110.571 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.073 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 5.9 mp -62.48 -35.45 79.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.88 -1.138 . . . . 0.0 110.384 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.449 ' HB3' ' N ' ' A' ' 48' ' ' CYS . 84.3 m -67.22 -28.19 67.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.064 -1.023 . . . . 0.0 110.536 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' NZ ' ' HE2' ' A' ' 58' ' ' LYS . 91.2 mttt -81.64 -3.08 52.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 110.825 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 11.4 pt-20 -125.38 147.02 56.31 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.94 -1.1 . . . . 0.0 110.376 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.27 -6.94 10.9 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.903 1.475 . . . . 0.0 111.024 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -79.92 -22.69 42.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.087 -1.008 . . . . 0.0 110.161 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.073 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.69 -39.37 17.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.366 -0.834 . . . . 0.0 110.419 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.57 -41.51 97.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.935 . . . . 0.0 110.278 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.39 -38.17 30.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.207 -0.933 . . . . 0.0 110.134 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.915 HG21 ' CD2' ' A' ' 60' ' ' LEU . 95.7 mt -65.17 -39.39 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 110.489 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.655 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.3 tm? -56.42 -51.34 68.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.937 . . . . 0.0 110.499 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.463 ' HG2' ' HA2' ' A' ' 40' ' ' GLY . 89.6 mt-30 -49.64 -54.78 16.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.103 -0.998 . . . . 0.0 110.117 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.514 HH21 HG23 ' A' ' 69' ' ' ILE . 46.6 mtm180 -52.36 -54.33 33.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.39 -0.818 . . . . 0.0 110.119 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 41.5 mt -48.43 -50.47 31.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 109.879 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 39' ' ' PRO . 69.6 mm-40 -53.9 -51.78 62.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.272 -0.892 . . . . 0.0 110.279 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -54.78 -56.85 14.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.039 -1.038 . . . . 0.0 110.536 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 79' ' ' ASP . 20.1 mt -58.9 -35.16 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.121 -0.987 . . . . 0.0 109.465 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.974 ' HB3' ' HB2' ' A' ' 36' ' ' ALA . . . -57.89 -34.72 70.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.545 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -60.39 -40.65 91.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.483 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -148.01 153.69 42.19 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.163 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.584 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.1 Cg_exo -58.56 -59.22 0.52 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.895 1.471 . . . . 0.0 110.574 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.33 -138.69 20.15 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.92 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 65.5 p -82.31 -21.13 36.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -1.11 . . . . 0.0 110.058 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.597 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 42.3 t -55.64 -53.35 57.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.208 -0.933 . . . . 0.0 110.109 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.7 tt0 -60.7 -27.81 68.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 111.22 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.786 HG13 ' HB2' ' A' ' 87' ' ' ALA . 6.2 pt -99.05 13.51 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.788 -1.195 . . . . 0.0 110.273 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 55.37 16.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.331 -0.856 . . . . 0.0 110.504 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.92 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.29 -15.35 63.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.967 . . . . 0.0 109.931 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.46 169.49 17.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.13 3.09 11.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 110.185 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.53 -34.8 77.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.0 110.458 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.0 OUTLIER -103.51 123.25 46.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 110.737 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.8 p -111.63 154.98 24.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 109.754 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.1 44.14 4.82 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.342 -1.093 . . . . 0.0 110.282 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.844 HG11 ' HB3' ' A' ' 91' ' ' CYS . 3.4 t . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.164 0.507 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.666 ' H ' HG12 ' A' ' 1' ' ' VAL . 30.8 m -126.25 142.66 51.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 110.55 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.582 ' CG2' ' HB3' ' A' ' 12' ' ' LEU . 90.4 t -82.24 119.66 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.496 -0.752 . . . . 0.0 109.448 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.525 ' CD ' HG21 ' A' ' 92' ' ' THR . 44.8 tt0 -113.5 133.11 55.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.879 -1.138 . . . . 0.0 110.787 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -92.06 -78.89 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.567 -0.708 . . . . 0.0 109.65 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.0 -122.16 4.67 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -85.19 10.01 13.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.157 . . . . 0.0 110.341 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.491 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 98.1 m-85 -122.45 137.9 54.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.448 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.7 p -89.64 128.35 36.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 110.076 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.884 ' HB3' HD21 ' A' ' 57' ' ' LEU . 23.2 m-30 -117.07 126.98 53.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 0.0 110.746 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.1 t -61.48 157.92 16.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.079 . . . . 0.0 109.727 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 12' ' ' LEU . 1.5 pt? -100.5 -25.31 14.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -1.0 . . . . 0.0 111.071 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.21 -65.86 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.078 -1.014 . . . . 0.0 110.74 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.6 m -52.59 -38.86 60.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.241 -0.912 . . . . 0.0 110.363 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.645 ' CG1' ' HB2' ' A' ' 77' ' ' ALA . 6.8 t -58.15 -46.4 88.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.135 -0.978 . . . . 0.0 109.621 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.495 ' HD3' ' CD ' ' A' ' 33' ' ' ARG . 18.9 tttt -57.73 -53.84 53.67 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.056 -1.028 . . . . 0.0 108.74 178.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 20' ' ' ASP . 51.4 mttm -80.34 12.05 3.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.535 -0.728 . . . . 0.0 109.751 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 8.7 tt -59.55 -39.08 82.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 110.136 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -50.61 -42.54 56.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 17' ' ' LYS . 39.0 p30 -150.31 146.4 26.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.405 -0.809 . . . . 0.0 109.605 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.0 HD22 ' CG ' ' A' ' 52' ' ' ASN . 14.7 tp -102.95 126.77 50.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.986 . . . . 0.0 110.759 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.478 ' C ' ' CG ' ' A' ' 23' ' ' GLU . 94.3 mt-30 -142.76 157.23 44.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.434 -0.791 . . . . 0.0 109.608 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.626 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 0.7 OUTLIER 55.66 -175.68 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.087 -1.008 . . . . 0.0 109.393 -179.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 23' ' ' GLU . 3.1 Cg_exo -62.59 152.48 77.5 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.556 1.293 . . . . 0.0 110.618 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -55.44 -36.25 66.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.254 -0.904 . . . . 0.0 110.435 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -138.26 80.83 27.24 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.873 . . . . 0.0 110.301 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 24' ' ' PRO . 3.0 Cg_endo -63.09 143.67 90.91 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.948 1.499 . . . . 0.0 110.446 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.557 ' C ' HG12 ' A' ' 29' ' ' VAL . 83.9 mtt180 -88.1 157.46 18.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.557 HG12 ' C ' ' A' ' 28' ' ' ARG . 2.8 p 33.72 85.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.457 -0.777 . . . . 0.0 110.524 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.48 -142.08 4.18 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -86.16 163.54 17.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.269 -1.136 . . . . 0.0 110.2 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.796 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.7 mp -93.25 146.16 23.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.301 -0.874 . . . . 0.0 110.257 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.495 ' CD ' ' HD3' ' A' ' 16' ' ' LYS . 8.8 mmt85 -95.52 102.3 14.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.866 . . . . 0.0 110.454 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.547 ' OD1' ' CE1' ' A' ' 35' ' ' PHE . 18.0 p-10 175.93 54.36 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.366 -0.834 . . . . 0.0 110.305 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.547 ' CE1' ' OD1' ' A' ' 34' ' ' ASN . 15.9 m-85 -122.19 155.73 35.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.23 -0.919 . . . . 0.0 110.079 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.6 106.68 0.57 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.085 -1.009 . . . . 0.0 110.063 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.608 ' C ' HD13 ' A' ' 38' ' ' ILE . 3.0 Cg_endo -66.86 -161.88 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.738 1.388 . . . . 0.0 110.861 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.709 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -153.32 72.89 6.89 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.664 -0.648 . . . . 0.0 109.754 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.57 148.87 85.49 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.701 1.369 . . . . 0.0 110.71 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.413 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 129.55 12.23 2.54 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.49 ' HG3' HD11 ' A' ' 70' ' ' LEU . 3.8 pt-20 -119.48 77.87 19.8 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.094 -1.239 . . . . 0.0 110.138 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.2 Cg_exo -59.32 143.52 99.7 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.978 1.515 . . . . 0.0 110.672 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.014 HG23 HG23 ' A' ' 44' ' ' VAL . 20.2 m -121.77 -166.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 110.273 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.014 HG23 HG23 ' A' ' 43' ' ' VAL . 11.3 t 62.56 53.75 2.08 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.468 -0.77 . . . . 0.0 110.552 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.638 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -61.52 -27.03 81.52 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.698 1.367 . . . . 0.0 110.14 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 47' ' ' LEU . 21.0 tt -159.41 -39.15 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.365 -0.834 . . . . 0.0 109.956 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.566 ' O ' ' O ' ' A' ' 48' ' ' CYS . 1.3 tp -158.78 89.94 0.97 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 110.124 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.566 ' O ' ' O ' ' A' ' 47' ' ' LEU . 71.8 m 47.58 109.66 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.33 -0.856 . . . . 0.0 110.752 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 87.8 p -59.89 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.261 -0.899 . . . . 0.0 110.459 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 18' ' ' LEU . 1.8 m120 -66.09 112.94 10.28 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.868 . . . . 0.0 110.691 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -65.7 -7.1 15.47 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.713 1.375 . . . . 0.0 109.721 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 1.0 ' CG ' HD22 ' A' ' 21' ' ' LEU . 26.5 p30 -124.95 26.06 7.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.511 -0.743 . . . . 0.0 110.368 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.733 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -79.15 179.89 1.63 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.213 -0.929 . . . . 0.0 108.575 179.102 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.733 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.7 Cg_exo -57.73 75.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 N-CA-C 108.89 -1.235 . . . . 0.0 108.89 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.624 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.2 tt0 -39.2 -27.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.706 -0.621 . . . . 0.0 110.085 -178.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.516 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 96.3 mt-10 -52.6 -17.91 1.5 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.068 -1.02 . . . . 0.0 108.74 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.884 HD21 ' HB3' ' A' ' 10' ' ' PHE . 33.5 mt -89.47 8.46 30.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.553 -0.717 . . . . 0.0 109.683 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.77 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.65 -50.42 5.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.314 -0.866 . . . . 0.0 110.463 -179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.77 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -54.58 -41.04 81.03 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.457 1.24 . . . . 0.0 110.027 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.029 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 34.7 mt -59.81 -41.41 91.21 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.095 -1.003 . . . . 0.0 110.153 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.6 t -69.13 -31.08 69.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.084 -1.01 . . . . 0.0 110.294 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -80.03 4.62 16.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.565 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.69 ' OE2' HD23 ' A' ' 60' ' ' LEU . 8.1 pt-20 -124.0 138.18 30.19 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.074 -1.016 . . . . 0.0 110.128 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.98 -16.51 45.85 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.767 1.403 . . . . 0.0 110.647 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.492 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 20.5 m120 -80.05 -8.24 59.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.143 -0.973 . . . . 0.0 110.023 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.029 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -51.02 -34.45 29.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.818 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -62.79 -38.62 91.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.683 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.29 -43.69 20.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.603 HG21 HD22 ' A' ' 60' ' ' LEU . 66.8 mt -62.69 -39.94 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.866 . . . . 0.0 109.557 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 71' ' ' GLN . 1.5 tm? -46.93 -65.94 0.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.606 -0.684 . . . . 0.0 110.627 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.965 ' N ' HD13 ' A' ' 70' ' ' LEU . 92.7 mt-30 -46.56 -53.48 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 110.385 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 18.2 tpp180 -55.49 -54.46 43.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.12 -0.988 . . . . 0.0 109.946 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.629 ' HG ' HG11 ' A' ' 15' ' ' VAL . 10.0 tp -50.08 -53.64 25.76 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.295 -0.878 . . . . 0.0 109.96 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.695 ' OE2' HD21 ' A' ' 70' ' ' LEU . 88.0 mt-10 -50.71 -45.24 58.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 37' ' ' PRO . 96.7 mt-10 -54.1 -53.33 54.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.09 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.513 HG21 HG13 ' A' ' 3' ' ' VAL . 6.0 mt -61.12 -38.15 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.924 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.645 ' HB2' ' CG1' ' A' ' 15' ' ' VAL . . . -59.79 -37.17 78.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 110.049 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.521 ' HB3' ' O ' ' A' ' 35' ' ' PHE . 47.3 mt-10 -103.66 12.9 34.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.662 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 1.6 t70 -160.26 106.86 1.38 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.487 -0.758 . . . . 0.0 109.696 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.543 ' HB3' ' HG3' ' A' ' 84' ' ' GLU . 3.4 Cg_exo -57.17 -65.63 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.803 1.423 . . . . 0.0 110.592 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.56 -136.74 17.09 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.748 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 80.8 p -78.62 -22.93 46.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.311 -1.111 . . . . 0.0 110.01 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 5.0 t -45.72 -58.04 3.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 0.0 110.522 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.543 ' HG3' ' HB3' ' A' ' 80' ' ' PRO . 56.2 mt-10 -56.96 -37.58 71.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.301 -0.875 . . . . 0.0 111.526 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.637 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.0 pt -89.28 12.97 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.853 -1.154 . . . . 0.0 110.503 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 59.9 m 51.45 19.75 0.88 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.339 -0.851 . . . . 0.0 110.782 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.748 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -74.3 -2.89 27.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.046 -1.034 . . . . 0.0 109.919 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.489 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 3.4 m-85 -151.9 171.47 17.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 110.306 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.59 4.9 6.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.292 -0.88 . . . . 0.0 110.441 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.32 -31.1 72.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.242 -0.911 . . . . 0.0 110.67 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.844 ' HB3' HG11 ' A' ' 1' ' ' VAL . 0.7 OUTLIER -114.81 125.84 54.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.05 -1.031 . . . . 0.0 110.637 -179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.525 HG21 ' CD ' ' A' ' 4' ' ' GLN . 33.2 p -114.36 152.2 31.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.389 -0.819 . . . . 0.0 110.396 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.76 -21.61 45.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.295 -1.121 . . . . 0.0 110.273 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.488 HG22 ' SG ' ' A' ' 91' ' ' CYS . 3.1 p . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.213 0.53 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.587 HG23 ' HA ' ' A' ' 11' ' ' SER . 57.0 m -118.07 154.5 31.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 110.302 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' ALA . 96.3 t -82.25 123.23 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 109.801 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.918 ' OE1' HG21 ' A' ' 92' ' ' THR . 62.6 tt0 -113.09 122.31 47.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.946 . . . . 0.0 110.7 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.947 ' OD2' HD21 ' A' ' 73' ' ' LEU . 88.4 m-20 -99.9 13.49 33.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.429 -0.794 . . . . 0.0 109.864 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.521 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . 174.24 -132.96 2.38 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -90.63 15.46 10.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -1.153 . . . . 0.0 109.955 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.628 ' HB2' ' CE2' ' A' ' 10' ' ' PHE . 87.0 m-85 -129.5 128.66 43.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.471 -0.768 . . . . 0.0 110.092 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.3 p -79.95 123.42 27.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 109.998 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.628 ' CE2' ' HB2' ' A' ' 8' ' ' PHE . 85.7 m-85 -116.71 125.35 51.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 110.61 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.587 ' HA ' HG23 ' A' ' 2' ' ' THR . 80.8 p -66.16 165.08 14.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 109.787 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.708 ' CD2' HG22 ' A' ' 76' ' ' ILE . 15.1 tp -110.93 -8.91 14.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.14 -0.975 . . . . 0.0 110.853 -179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.422 ' HG3' ' HD3' ' A' ' 33' ' ' ARG . 86.2 tt0 -60.17 -69.73 0.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.056 -1.027 . . . . 0.0 110.606 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.566 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 5.9 m -44.67 -39.55 5.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.063 -1.023 . . . . 0.0 110.547 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.658 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 25.2 t -64.99 -49.22 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 O-C-N 121.035 -1.04 . . . . 0.0 109.535 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.725 ' HG2' ' HB1' ' A' ' 77' ' ' ALA . 78.5 mttt -55.22 -50.74 68.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.08 -1.012 . . . . 0.0 108.808 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -80.14 4.54 17.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.529 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.735 HD13 ' HD3' ' A' ' 54' ' ' PRO . 18.7 tp -56.97 -25.79 58.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.814 . . . . 0.0 110.193 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' HG3' ' A' ' 37' ' ' PRO . 17.5 tttm -61.33 -35.81 78.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.841 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -86.5 109.96 19.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.882 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.957 HD21 ' ND2' ' A' ' 50' ' ' ASN . 1.2 mm? -105.74 164.87 11.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.142 -0.974 . . . . 0.0 110.473 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 56.7 tt0 60.86 56.79 2.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 0.0 110.203 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' CG ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -136.06 167.18 23.07 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.334 -0.853 . . . . 0.0 110.276 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HD2' ' CG ' ' A' ' 23' ' ' GLU . 3.0 Cg_exo -61.91 145.39 96.94 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.911 1.48 . . . . 0.0 110.552 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' HG2' ' HD3' ' A' ' 27' ' ' PRO . 51.6 tt0 -55.95 147.56 19.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.893 . . . . 0.0 110.073 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 26' ' ' GLU . 0.1 OUTLIER -126.67 71.74 73.66 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.164 -0.96 . . . . 0.0 110.307 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.426 ' HD3' ' HG2' ' A' ' 25' ' ' GLN . 2.9 Cg_endo -61.81 -35.76 77.08 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.86 1.453 . . . . 0.0 110.275 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.6 mtp85 -146.11 120.59 9.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.447 -0.783 . . . . 0.0 109.705 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 31' ' ' LYS . 42.5 t -128.69 133.79 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 110.591 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.98 -3.08 77.01 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.718 ' H ' HG12 ' A' ' 29' ' ' VAL . 84.1 tttt -70.81 153.0 43.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -1.104 . . . . 0.0 110.146 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.6 mt -68.0 146.23 53.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -0.967 . . . . 0.0 110.202 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.586 ' HB3' ' HD2' ' A' ' 16' ' ' LYS . 74.1 mtt85 -106.85 111.57 24.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.283 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 34' ' ' ASN . 4.0 p30 168.91 -157.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.233 -0.917 . . . . 0.0 110.159 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 82.2 m-85 62.09 24.16 14.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.274 -0.891 . . . . 0.0 110.393 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . . . -70.15 146.07 94.38 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.927 . . . . 0.0 110.058 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.426 ' HG3' ' HD2' ' A' ' 19' ' ' LYS . 3.0 Cg_exo -62.82 -150.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.797 1.419 . . . . 0.0 110.811 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.587 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 20.3 mm -110.0 144.41 29.96 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.905 . . . . 0.0 110.126 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.587 ' HD2' ' CG2' ' A' ' 38' ' ' ILE . 3.0 Cg_exo -59.98 138.85 84.75 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.673 1.354 . . . . 0.0 110.603 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.45 4.58 2.01 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.44 ' CD ' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER 60.72 72.18 0.75 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.084 -1.245 . . . . 0.0 109.988 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.568 ' HD2' HD12 ' A' ' 70' ' ' LEU . 3.0 Cg_endo -61.58 -165.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.952 1.501 . . . . 0.0 110.988 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' A' ' 49' ' ' SER . 0.2 OUTLIER -96.05 129.28 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.504 -0.748 . . . . 0.0 110.175 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.843 ' O ' HG13 ' A' ' 44' ' ' VAL . 3.1 p -158.19 52.29 0.53 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.333 -0.854 . . . . 0.0 110.198 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 44' ' ' VAL . 3.0 Cg_endo -57.6 -62.95 0.17 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.649 1.342 . . . . 0.0 110.717 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.484 ' HB ' HD12 ' A' ' 47' ' ' LEU . 59.2 mt -149.21 -33.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 0.0 110.559 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.808 ' N ' HD12 ' A' ' 47' ' ' LEU . 6.0 mp -95.2 3.57 54.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.64 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.532 ' O ' ' O ' ' A' ' 47' ' ' LEU . 1.5 m 57.41 124.69 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.132 -0.98 . . . . 0.0 109.844 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.89 ' HB3' HG13 ' A' ' 43' ' ' VAL . 87.3 p -64.02 -41.12 97.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 110.926 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.957 ' ND2' HD21 ' A' ' 21' ' ' LEU . 5.8 m-20 -80.68 106.9 6.06 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.266 -0.897 . . . . 0.0 110.619 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.745 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -61.11 -16.26 44.79 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.682 1.359 . . . . 0.0 110.33 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -128.03 36.54 4.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.232 -0.917 . . . . 0.0 111.145 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.642 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -80.1 172.23 10.37 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.776 -1.203 . . . . 0.0 108.484 178.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.735 ' HD3' HD13 ' A' ' 18' ' ' LEU . 4.1 Cg_exo -54.45 76.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.505 1.266 . . . . 0.0 109.39 179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.6 tt0 -39.65 -27.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.744 -0.598 . . . . 0.0 110.084 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.7 mt-10 -52.7 -17.89 1.54 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.068 -1.02 . . . . 0.0 108.449 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.676 HD12 ' HG2' ' A' ' 54' ' ' PRO . 89.2 mt -90.24 11.2 21.88 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.609 0.719 . . . . 0.0 109.136 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.742 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -39.95 -51.99 5.43 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.416 -0.803 . . . . 0.0 110.262 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.742 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -54.0 -46.07 36.36 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.461 1.242 . . . . 0.0 109.373 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.954 HD11 ' HB ' ' A' ' 69' ' ' ILE . 11.7 tp -49.58 -49.46 46.48 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.264 -0.898 . . . . 0.0 109.749 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.565 ' SG ' HG22 ' A' ' 44' ' ' VAL . 1.2 t -61.33 -27.94 68.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 110.609 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.405 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 22.7 ttpt -81.01 -2.05 46.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 110.56 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 11.2 pt-20 -126.43 144.85 50.85 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.064 -1.023 . . . . 0.0 110.074 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.27 -8.65 12.91 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.785 1.413 . . . . 0.0 110.801 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -79.58 -18.0 52.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 110.668 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -45.08 -40.03 6.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.079 -1.013 . . . . 0.0 109.941 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.44 ' O ' ' CD ' ' A' ' 41' ' ' GLU . 93.7 mt-30 -66.01 -39.12 90.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -0.869 . . . . 0.0 109.979 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -80.5 -44.95 18.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.173 -0.954 . . . . 0.0 109.672 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.954 ' HB ' HD11 ' A' ' 60' ' ' LEU . 57.9 mt -63.73 -42.19 95.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.397 -0.814 . . . . 0.0 109.899 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.77 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.2 tm? -52.34 -52.69 51.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.459 -0.776 . . . . 0.0 109.902 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.58 ' N ' HD13 ' A' ' 70' ' ' LEU . 46.0 tt0 -42.74 -53.53 4.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.095 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -59.11 -53.1 62.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.387 -0.821 . . . . 0.0 110.65 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.947 HD21 ' OD2' ' A' ' 5' ' ' ASP . 63.6 mt -50.58 -55.7 15.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.085 -1.009 . . . . 0.0 110.145 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.703 ' CD ' HD11 ' A' ' 70' ' ' LEU . 26.9 mt-10 -54.61 -50.74 67.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.368 -0.832 . . . . 0.0 110.442 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.26 -54.06 45.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 0.0 110.433 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.708 HG22 ' CD2' ' A' ' 12' ' ' LEU . 70.2 mt -61.65 -34.34 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.104 -0.998 . . . . 0.0 109.735 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.725 ' HB1' ' HG2' ' A' ' 16' ' ' LYS . . . -57.07 -34.73 68.57 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.323 -0.861 . . . . 0.0 109.599 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.418 ' HA ' ' H ' ' A' ' 36' ' ' ALA . 84.5 tt0 -60.31 -40.94 92.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 0.0 110.115 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -153.71 160.4 30.98 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.901 . . . . 0.0 110.259 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.579 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -60.39 -59.72 0.34 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.916 1.482 . . . . 0.0 110.544 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.11 -140.04 25.06 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 1.021 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 73.1 p -82.14 -21.94 36.37 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.272 -1.134 . . . . 0.0 110.163 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.553 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 4.6 t -55.8 -49.21 73.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.716 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 82.7 tt0 -59.54 -32.13 70.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.822 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.705 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.5 pt -99.3 10.51 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.99 -1.069 . . . . 0.0 110.328 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.7 m 56.96 16.5 2.84 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.88 . . . . 0.0 110.641 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 1.021 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -60.53 -18.8 54.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.965 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -140.37 177.82 7.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 110.182 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.81 1.53 12.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.871 . . . . 0.0 110.335 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -58.56 -40.86 84.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.658 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.553 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER -112.79 122.67 48.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.928 . . . . 0.0 110.81 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.918 HG21 ' OE1' ' A' ' 4' ' ' GLN . 25.6 p -105.18 176.25 5.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 110.262 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.42 -6.81 65.85 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.391 -1.064 . . . . 0.0 110.209 -179.921 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.847 HG23 ' SG ' ' A' ' 91' ' ' CYS . 10.6 p . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.211 0.529 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.527 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 30.7 m -90.09 148.03 23.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.197 -0.939 . . . . 0.0 110.802 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.114 ' CG2' HD21 ' A' ' 12' ' ' LEU . 22.9 t -97.06 118.53 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.581 -0.699 . . . . 0.0 109.435 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.639 ' NE2' HG23 ' A' ' 92' ' ' THR . 20.9 pt20 -120.56 177.47 5.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.081 -1.012 . . . . 0.0 110.936 -179.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -151.45 -62.19 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.741 . . . . 0.0 110.16 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.82 -115.81 0.74 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -108.21 13.2 26.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.227 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.521 ' CD1' ' OE2' ' A' ' 56' ' ' GLU . 97.9 m-85 -131.77 159.36 38.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.22 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.527 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 37.6 m -101.07 136.31 41.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.937 . . . . 0.0 110.214 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.841 ' CG ' HD21 ' A' ' 57' ' ' LEU . 6.6 m-30 -112.69 123.23 49.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.654 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 m -66.33 160.11 25.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 179.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.114 HD21 ' CG2' ' A' ' 3' ' ' VAL . 99.5 mt -86.97 -27.33 23.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 0.0 110.735 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.422 ' OE2' ' O ' ' A' ' 25' ' ' GLN . 81.8 tt0 -61.56 -66.3 0.56 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 0.0 110.671 -179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.5 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.6 m -44.27 -48.71 9.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.977 -1.077 . . . . 0.0 110.151 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.613 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 58.5 t -59.05 -46.72 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.218 -0.926 . . . . 0.0 110.109 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 25.1 tttm -58.9 -52.43 65.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.806 -1.184 . . . . 0.0 108.562 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -80.65 11.98 3.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.35 -0.844 . . . . 0.0 109.368 178.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.785 HD21 HG21 ' A' ' 43' ' ' VAL . 59.1 tp -57.17 -37.08 71.59 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.416 -0.803 . . . . 0.0 110.097 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -60.75 -38.88 86.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.116 -0.99 . . . . 0.0 109.38 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -141.55 124.73 16.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.786 . . . . 0.0 109.594 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.799 HD11 ' CB ' ' A' ' 52' ' ' ASN . 4.5 mm? -49.83 -48.26 51.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.918 . . . . 0.0 110.616 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 23' ' ' GLU . 91.7 mt-30 46.4 56.39 6.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.154 -0.966 . . . . 0.0 109.915 -179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 22' ' ' GLN . 5.6 mp0 42.18 76.3 0.53 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 110.015 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.656 ' HG3' HD12 ' A' ' 21' ' ' LEU . 3.1 Cg_exo -61.58 135.92 59.8 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.938 1.494 . . . . 0.0 110.715 -179.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.469 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 60.9 tt0 -148.68 168.64 22.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.059 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.518 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 5.9 mt-10 -131.39 62.14 63.17 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.212 -0.93 . . . . 0.0 110.205 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -61.7 153.66 65.8 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.851 1.448 . . . . 0.0 110.419 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 11.9 ptp180 -99.23 137.87 37.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 0.0 110.075 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 28' ' ' ARG . 48.8 t 56.14 109.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.321 -0.862 . . . . 0.0 110.151 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.57 -168.43 32.35 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -64.85 149.9 48.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -1.103 . . . . 0.0 110.19 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 63.2 mt -68.57 155.95 38.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.95 . . . . 0.0 110.213 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.456 ' NH2' ' CG ' ' A' ' 33' ' ' ARG . 13.4 mmt-85 -99.32 128.73 45.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.11 -0.994 . . . . 0.0 110.403 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 78' ' ' GLU . 44.9 p-10 -136.72 151.24 49.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 109.968 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.586 ' HB3' ' HG2' ' A' ' 78' ' ' GLU . 74.6 t80 -138.94 158.17 44.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.302 -0.874 . . . . 0.0 110.159 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.487 ' O ' HG12 ' A' ' 38' ' ' ILE . . . -59.7 129.65 87.64 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.236 -0.915 . . . . 0.0 110.537 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.99 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.8 Cg_endo -64.39 63.64 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.798 1.42 . . . . 0.0 110.569 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.99 HD13 ' C ' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -126.65 65.3 60.57 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.133 -0.979 . . . . 0.0 110.309 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.503 ' HD3' ' C ' ' A' ' 37' ' ' PRO . 2.9 Cg_endo -61.64 148.52 92.84 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.798 1.42 . . . . 0.0 110.494 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.531 ' N ' ' HG2' ' A' ' 71' ' ' GLN . . . 117.2 40.16 0.76 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -130.14 73.14 81.61 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.308 -1.113 . . . . 0.0 110.374 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -60.68 141.77 95.96 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.908 1.478 . . . . 0.0 110.146 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.785 HG21 HD21 ' A' ' 18' ' ' LEU . 24.0 m -140.51 54.83 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 110.667 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.69 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 17.1 m -135.2 47.86 2.53 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 0.0 110.583 179.311 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.69 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -60.19 -149.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.592 1.311 . . . . 0.0 110.372 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 46' ' ' ILE . 16.9 tt -59.35 117.21 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.149 -0.97 . . . . 0.0 109.993 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 48' ' ' CYS . 2.5 mm? 62.18 40.67 11.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 1.2 m 62.49 154.4 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 0.0 110.638 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.623 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -87.78 -58.34 2.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.415 -0.803 . . . . 0.0 110.228 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 6.4 m120 -78.93 110.27 13.9 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.419 -0.801 . . . . 0.0 110.326 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.623 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -61.99 -11.39 21.28 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.721 1.379 . . . . 0.0 110.336 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.799 ' CB ' HD11 ' A' ' 21' ' ' LEU . 99.6 m-20 -130.52 34.23 4.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.842 . . . . 0.0 110.734 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.69 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -80.17 174.23 6.46 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.038 -1.039 . . . . 0.0 108.719 178.953 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.69 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 4.0 Cg_exo -56.36 76.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.624 1.329 . . . . 0.0 108.889 179.359 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.641 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.7 tt0 -39.07 -26.31 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.884 -0.51 . . . . 0.0 110.377 -178.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.521 ' OE2' ' CD1' ' A' ' 8' ' ' PHE . 39.3 tp10 -53.13 -20.76 4.09 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.931 -1.105 . . . . 0.0 108.174 178.145 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.841 HD21 ' CG ' ' A' ' 10' ' ' PHE . 82.2 mt -84.35 8.45 16.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.623 -0.673 . . . . 0.0 109.657 179.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.726 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.57 -51.49 4.98 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.73 -179.568 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.726 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -56.71 -44.31 46.47 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.632 1.333 . . . . 0.0 110.744 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.062 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 1.5 mt -60.63 -40.04 90.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.814 -1.179 . . . . 0.0 110.503 -179.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.506 ' HA ' ' HB ' ' A' ' 44' ' ' VAL . 46.2 t -65.56 -28.14 68.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.034 -1.041 . . . . 0.0 110.697 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 46.2 tttm -90.75 6.69 43.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.089 -1.007 . . . . 0.0 110.639 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.508 ' OE2' ' HB2' ' A' ' 65' ' ' ASN . 12.7 pt-20 -130.84 144.61 54.21 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 120.959 -1.088 . . . . 0.0 110.4 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.22 -8.31 12.06 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.91 1.479 . . . . 0.0 110.797 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.508 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 83.9 m-20 -79.23 -23.79 43.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 110.194 -179.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.062 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -51.33 -36.3 42.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.083 -1.01 . . . . 0.0 109.685 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.442 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 92.8 mt-30 -61.65 -43.55 98.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.0 109.758 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -80.27 -41.17 25.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -0.869 . . . . 0.0 109.609 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 60' ' ' LEU . 86.0 mt -64.24 -46.26 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 109.87 179.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.792 ' C ' HD13 ' A' ' 70' ' ' LEU . 2.2 tm? -49.38 -53.86 20.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.946 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.614 ' N ' HD13 ' A' ' 70' ' ' LEU . 87.9 mt-30 -45.41 -53.9 8.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -57.79 -54.62 44.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.604 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 48.4 mt -44.98 -56.1 4.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.338 -0.851 . . . . 0.0 109.705 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.746 ' OE2' HD11 ' A' ' 70' ' ' LEU . 64.6 mt-10 -51.12 -53.6 32.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 110.154 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 78' ' ' GLU . 82.8 tt0 -55.23 -54.49 42.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 110.693 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.493 ' O ' ' O ' ' A' ' 79' ' ' ASP . 24.7 mm -58.75 -37.52 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 109.81 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . . . -57.21 -33.06 67.14 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.591 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.586 ' HG2' ' HB3' ' A' ' 35' ' ' PHE . 99.2 mt-10 -60.12 -41.92 93.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 110.52 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.493 ' O ' ' O ' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -147.83 159.54 40.37 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.93 . . . . 0.0 110.275 -179.797 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.571 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -59.77 -57.21 0.89 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.883 1.465 . . . . 0.0 110.65 179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.02 -140.89 26.38 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.931 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 79.6 p -78.08 -21.51 50.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -1.116 . . . . 0.0 109.932 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.454 ' C ' ' SG ' ' A' ' 91' ' ' CYS . 42.0 t -54.52 -54.15 44.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 109.976 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 84.0 tt0 -55.77 -32.17 63.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 111.028 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.726 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.8 pt -96.92 10.89 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.922 -1.111 . . . . 0.0 110.312 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 57.21 18.83 4.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.931 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -70.89 -7.59 46.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.997 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.594 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 53.1 t80 -147.06 167.64 23.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 110.37 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.01 4.94 5.77 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.386 -0.821 . . . . 0.0 110.5 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.594 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -65.36 -35.42 80.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.161 -0.962 . . . . 0.0 110.482 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.847 ' SG ' HG23 ' A' ' 1' ' ' VAL . 0.1 OUTLIER -96.53 120.48 36.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.227 -0.921 . . . . 0.0 110.705 -179.712 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.639 HG23 ' NE2' ' A' ' 4' ' ' GLN . 0.2 OUTLIER -104.77 -5.39 21.28 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.519 -0.738 . . . . 0.0 110.577 -179.438 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . -83.76 -36.05 14.68 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.21 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 1' ' ' VAL . 18.5 m . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.243 0.544 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.615 HG21 ' OG ' ' A' ' 9' ' ' SER . 37.0 m -88.17 151.16 22.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.387 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.015 HG21 HD21 ' A' ' 12' ' ' LEU . 85.2 t -94.23 121.94 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.717 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.845 ' NE2' HG21 ' A' ' 92' ' ' THR . 10.4 mt-30 -109.64 139.06 45.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 110.815 -179.391 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -111.59 11.53 21.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 109.784 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 176.23 -131.38 1.87 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -88.5 8.44 28.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.141 -1.211 . . . . 0.0 110.191 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 92.0 m-85 -121.7 158.83 27.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 110.193 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.615 ' OG ' HG21 ' A' ' 2' ' ' THR . 22.4 t -105.43 123.41 47.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.363 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 8' ' ' PHE . 17.6 m-30 -119.19 130.46 55.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.843 . . . . 0.0 110.51 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.4 m -78.62 172.73 13.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.021 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.015 HD21 HG21 ' A' ' 3' ' ' VAL . 53.0 mt -97.35 -5.29 36.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.174 -0.954 . . . . 0.0 110.636 -179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 14' ' ' SER . 96.3 mt-10 -74.29 -73.17 0.24 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.105 -0.997 . . . . 0.0 110.361 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' ' 13' ' ' GLU . 5.2 m -39.91 -51.43 2.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.677 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.737 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 27.4 m -63.93 -45.67 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.069 -1.019 . . . . 0.0 109.697 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 34' ' ' ASN . 16.6 tttt -55.12 -56.89 14.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.88 -1.138 . . . . 0.0 109.063 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.466 ' HD3' ' HG2' ' A' ' 27' ' ' PRO . 67.5 mttm -80.22 8.31 7.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.818 . . . . 0.0 109.467 178.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.737 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 15.4 tp -54.57 -34.84 62.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.403 -0.811 . . . . 0.0 110.331 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -60.48 -41.55 94.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.993 . . . . 0.0 109.895 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.39 98.02 10.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.988 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.592 HD11 ' HB2' ' A' ' 52' ' ' ASN . 11.0 tp -70.01 -36.32 75.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.341 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 91.4 mt-30 -54.99 -168.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.913 . . . . 0.0 110.211 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.538 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 26.2 mm-40 59.43 163.56 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.343 -0.848 . . . . 0.0 109.946 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 23' ' ' GLU . 3.3 Cg_exo -58.54 157.5 26.94 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.715 1.376 . . . . 0.0 110.62 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 94.8 mt-30 -68.02 -30.95 70.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.463 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.425 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 1.1 mp0 -131.12 68.17 81.46 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.336 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 24' ' ' PRO . 2.9 Cg_endo -63.18 158.82 42.16 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.913 1.48 . . . . 0.0 110.523 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.481 ' HB3' ' NH1' ' A' ' 28' ' ' ARG . 9.7 mmm180 -51.39 137.87 22.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 110.057 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.89 147.26 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.252 -0.905 . . . . 0.0 110.288 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.1 -175.07 48.08 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -64.3 -29.2 70.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -1.163 . . . . 0.0 110.278 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.3 mt -105.22 140.67 38.02 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.928 . . . . 0.0 110.461 -179.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.75 ' HE ' HD12 ' A' ' 12' ' ' LEU . 24.3 ptt-85 -130.56 106.05 8.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.355 -0.84 . . . . 0.0 109.594 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 41.9 p-10 -136.56 167.82 20.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.07 -1.019 . . . . 0.0 110.856 -179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.603 ' CE2' ' HG2' ' A' ' 37' ' ' PRO . 1.9 t80 -112.51 130.46 56.0 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.515 -0.741 . . . . 0.0 109.891 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.017 ' HB3' ' HD3' ' A' ' 37' ' ' PRO . . . -64.77 -54.84 32.7 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.155 -0.966 . . . . 0.0 110.575 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.017 ' HD3' ' HB3' ' A' ' 36' ' ' ALA . 3.1 Cg_exo -62.46 -150.96 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.599 1.315 . . . . 0.0 110.769 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.924 HG23 ' HD2' ' A' ' 39' ' ' PRO . 1.3 mp -149.16 151.04 33.35 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.408 -0.807 . . . . 0.0 109.83 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.924 ' HD2' HG23 ' A' ' 38' ' ' ILE . 3.3 Cg_exo -57.48 161.65 11.53 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.737 1.388 . . . . 0.0 110.774 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.34 19.32 1.73 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 43' ' ' VAL . 36.4 mt-10 -104.3 117.47 59.22 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.165 -1.197 . . . . 0.0 110.06 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.23 101.02 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.658 1.346 . . . . 0.0 110.53 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.775 ' O ' HG12 ' A' ' 44' ' ' VAL . 90.7 t -132.12 172.33 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.906 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER 76.11 38.86 0.06 OUTLIER Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.548 -0.72 . . . . 0.0 111.441 179.785 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.742 ' CD ' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -59.73 169.5 4.36 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 122.908 0.951 . . . . 0.0 110.191 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' PRO . 76.0 mt -44.06 -41.01 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.099 -1.001 . . . . 0.0 109.59 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 48' ' ' CYS . 49.6 mt -95.93 26.87 3.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.306 -0.871 . . . . 0.0 109.607 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.517 ' O ' ' O ' ' A' ' 47' ' ' LEU . 0.5 OUTLIER 53.64 162.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.503 -0.748 . . . . 0.0 110.113 -179.851 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.588 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 13.2 t -107.69 -70.7 0.79 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.944 . . . . 0.0 110.144 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.493 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 5.6 m-20 -79.2 111.51 20.89 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.591 -0.693 . . . . 0.0 110.092 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -64.45 -9.14 19.14 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.612 1.322 . . . . 0.0 110.114 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.592 ' HB2' HD11 ' A' ' 21' ' ' LEU . 96.8 m-20 -125.68 31.89 5.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.797 . . . . 0.0 110.218 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.746 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -79.85 178.02 2.59 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 108.803 179.09 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.746 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.9 Cg_exo -57.86 75.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.493 1.26 . . . . 0.0 108.936 179.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.617 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.8 tt0 -39.28 -27.54 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.86 -0.525 . . . . 0.0 110.139 -178.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.0 mt-10 -52.21 -18.37 1.49 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.048 -1.032 . . . . 0.0 108.401 178.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.616 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 81.7 mt -88.8 9.95 22.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.637 -0.665 . . . . 0.0 109.571 179.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.751 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.4 OUTLIER -39.63 -51.28 5.14 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.308 -0.87 . . . . 0.0 110.344 -179.854 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.751 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -54.87 -43.52 58.55 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.5 1.263 . . . . 0.0 109.666 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.056 HD11 HG21 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -53.42 -42.07 66.68 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.109 -0.994 . . . . 0.0 109.674 179.403 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.0 m -64.85 -28.05 69.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.131 -0.981 . . . . 0.0 110.335 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -90.66 2.55 55.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.93 . . . . 0.0 111.434 -178.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.557 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 25.7 pt-20 -120.83 142.9 35.41 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.625 -1.297 . . . . 0.0 110.317 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -64.0 -18.29 63.11 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.91 1.479 . . . . 0.0 111.239 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -79.69 -12.3 59.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.985 -1.072 . . . . 0.0 110.344 -179.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.99 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.42 -41.16 19.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 110.461 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -56.68 -42.23 78.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 110.266 -179.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 97.4 mt-10 -79.92 -34.35 39.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.173 -0.955 . . . . 0.0 110.322 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.056 HG21 HD11 ' A' ' 60' ' ' LEU . 90.3 mt -68.96 -46.96 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.138 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.666 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.9 OUTLIER -47.69 -62.5 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.525 -179.787 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.666 ' N ' HD13 ' A' ' 70' ' ' LEU . 51.4 tt0 -49.62 -54.08 20.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.13 -0.981 . . . . 0.0 110.736 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 75.5 mtt-85 -52.7 -53.59 45.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.229 -0.919 . . . . 0.0 110.518 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.658 ' CD2' HG11 ' A' ' 15' ' ' VAL . 7.2 tp -51.09 -48.83 61.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.072 -1.017 . . . . 0.0 110.015 -179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 70' ' ' LEU . 43.1 mt-10 -55.63 -41.13 73.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 0.0 110.376 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.566 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 84.9 tt0 -66.24 -55.94 13.69 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.057 -1.027 . . . . 0.0 110.464 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 79' ' ' ASP . 22.2 mm -58.77 -40.77 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.336 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.785 ' HA ' HD22 ' A' ' 12' ' ' LEU . . . -62.76 -28.48 70.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.534 -0.729 . . . . 0.0 109.08 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 80.6 tt0 -65.36 -36.42 83.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.619 -0.676 . . . . 0.0 110.443 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 76' ' ' ILE . 1.2 m-20 -149.14 158.04 39.1 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.824 -1.173 . . . . 0.0 110.524 -179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -61.72 -71.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.057 1.556 . . . . 0.0 110.653 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.89 -140.05 23.58 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.926 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 70.5 p -79.08 -24.32 43.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -1.168 . . . . 0.0 109.732 179.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 11.3 t -53.18 -53.55 48.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 83.2 tt0 -58.47 -32.19 68.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.379 -0.826 . . . . 0.0 111.057 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.761 HG13 ' HB2' ' A' ' 87' ' ' ALA . 5.1 pt -98.46 11.14 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.957 -1.09 . . . . 0.0 110.291 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 34.4 m 59.39 12.12 2.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.177 -0.952 . . . . 0.0 110.514 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.926 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -64.89 -16.18 62.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 109.997 179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.54 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 41.8 t80 -137.17 166.57 23.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 110.188 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.85 2.88 7.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.942 . . . . 0.0 110.289 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.54 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -62.35 -38.8 90.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.165 -0.959 . . . . 0.0 110.433 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.7 OUTLIER -104.11 118.25 36.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 110.636 -179.663 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.845 HG21 ' NE2' ' A' ' 4' ' ' GLN . 72.8 p -103.13 166.55 10.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.376 -0.827 . . . . 0.0 110.069 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.16 -5.08 78.27 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.303 -1.116 . . . . 0.0 110.213 179.988 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.284 0.564 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.969 HG21 ' OG ' ' A' ' 9' ' ' SER . 7.2 t -129.21 168.49 16.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.375 -179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.603 HG11 ' CD2' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -93.01 114.83 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.647 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.628 ' OE1' HG21 ' A' ' 92' ' ' THR . 61.2 tt0 -110.7 121.02 44.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -0.859 . . . . 0.0 110.952 -179.216 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.752 ' OD2' HD21 ' A' ' 60' ' ' LEU . 58.4 p30 -99.92 3.64 44.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.362 -0.836 . . . . 0.0 109.325 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.507 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . -172.53 -142.56 3.82 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -82.1 1.42 36.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.2 -1.176 . . . . 0.0 110.498 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.482 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 98.6 m-85 -109.19 134.43 51.75 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.103 -0.998 . . . . 0.0 110.621 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.969 ' OG ' HG21 ' A' ' 2' ' ' THR . 1.0 OUTLIER -85.47 126.55 33.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.355 -0.841 . . . . 0.0 109.981 179.779 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.521 ' O ' ' OG1' ' A' ' 2' ' ' THR . 21.7 m-30 -117.7 127.21 53.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.023 -1.048 . . . . 0.0 110.777 -179.306 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.444 ' C ' HD12 ' A' ' 12' ' ' LEU . 59.9 p -76.7 172.89 12.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.314 -0.866 . . . . 0.0 110.339 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.866 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.0 mp -100.64 -6.34 25.34 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.309 -0.869 . . . . 0.0 110.61 -179.662 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.464 ' OE1' ' CG ' ' A' ' 26' ' ' GLU . 92.2 mt-10 -71.72 -73.89 0.17 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 0.0 110.82 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.3 m -43.5 -49.19 7.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.182 -0.949 . . . . 0.0 110.581 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.667 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 6.0 m -59.02 -46.41 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 110.195 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.555 ' CD ' ' HB3' ' A' ' 33' ' ' ARG . 23.0 tttt -58.15 -55.02 40.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.876 -1.14 . . . . 0.0 108.844 179.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.504 ' O ' ' O ' ' A' ' 20' ' ' ASP . 95.6 mttt -80.49 11.48 3.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 0.0 109.404 178.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.794 ' O ' HD23 ' A' ' 18' ' ' LEU . 5.7 tt -58.73 -29.72 66.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 110.183 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -65.48 -34.91 79.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.182 -0.949 . . . . 0.0 110.144 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' A' ' 17' ' ' LYS . 60.6 t0 -133.82 141.71 47.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 110.147 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.599 HD11 ' CB ' ' A' ' 52' ' ' ASN . 1.9 mm? -85.98 138.73 31.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.041 -1.037 . . . . 0.0 110.569 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.44 ' OE1' ' HD3' ' A' ' 17' ' ' LYS . 88.4 mt-30 -132.67 172.29 12.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.319 -0.863 . . . . 0.0 110.023 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 25' ' ' GLN . 3.3 mt-10 -42.64 136.58 2.52 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.187 -0.946 . . . . 0.0 110.02 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.74 60.24 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.799 1.42 . . . . 0.0 110.602 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 23' ' ' GLU . 91.5 mt-30 -126.94 139.16 53.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.992 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' CG ' ' OE1' ' A' ' 13' ' ' GLU . 1.8 mp0 -130.7 71.71 82.22 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 110.418 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.82 145.72 96.98 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.904 1.476 . . . . 0.0 110.396 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -111.47 128.14 55.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.137 -0.977 . . . . 0.0 110.259 -179.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.61 HG13 ' H ' ' A' ' 32' ' ' LEU . 11.8 p -138.0 144.19 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.323 -0.861 . . . . 0.0 110.166 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -52.37 -29.5 30.69 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.48 ' H ' HG22 ' A' ' 29' ' ' VAL . 19.7 tttt -69.72 -21.81 63.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -1.171 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.61 ' H ' HG13 ' A' ' 29' ' ' VAL . 70.3 mt 56.52 -155.17 0.31 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.323 -0.861 . . . . 0.0 110.291 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.555 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 32.4 mtt-85 -119.74 131.05 55.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 50.3 t30 -142.39 110.32 5.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 110.197 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.513 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 72.3 t80 -125.12 164.13 20.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.216 -0.927 . . . . 0.0 110.251 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.635 ' O ' HG13 ' A' ' 38' ' ' ILE . . . -59.68 122.13 62.66 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.074 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.522 ' C ' ' HD3' ' A' ' 39' ' ' PRO . 2.6 Cg_endo -68.32 88.15 0.4 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.769 1.405 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.641 ' H ' HD12 ' A' ' 38' ' ' ILE . 0.8 OUTLIER -121.49 69.49 22.87 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.3 -0.875 . . . . 0.0 110.349 179.396 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.522 ' HD3' ' C ' ' A' ' 37' ' ' PRO . 3.0 Cg_exo -60.27 145.72 97.97 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.764 1.402 . . . . 0.0 110.552 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.47 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 162.54 37.45 0.02 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 43' ' ' VAL . 1.2 mm-40 -123.86 72.21 52.7 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.236 -1.155 . . . . 0.0 110.211 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_exo -61.52 75.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.888 1.467 . . . . 0.0 110.379 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.859 ' O ' HG23 ' A' ' 44' ' ' VAL . 88.8 t -120.67 127.39 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.962 . . . . 0.0 110.29 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.021 HG21 ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER 167.06 -52.47 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.409 -0.807 . . . . 0.0 110.158 179.841 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 44' ' ' VAL . 3.2 Cg_exo -60.7 -42.4 39.4 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.512 1.27 . . . . 0.0 110.36 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' A' ' 47' ' ' LEU . 73.8 mt -58.99 -65.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.173 -0.954 . . . . 0.0 109.706 179.583 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.538 ' CB ' ' O ' ' A' ' 46' ' ' ILE . 0.9 OUTLIER 164.34 70.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.418 -0.801 . . . . 0.0 110.004 179.684 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.512 ' O ' ' O ' ' A' ' 47' ' ' LEU . 86.2 m 34.87 95.57 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.477 -0.765 . . . . 0.0 110.505 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.546 ' OG ' ' CG1' ' A' ' 43' ' ' VAL . 44.1 m -51.74 -62.8 1.4 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.263 -0.898 . . . . 0.0 111.083 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 18' ' ' LEU . 3.9 m-20 -80.32 114.18 45.07 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 110.564 -179.362 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -63.8 0.84 1.73 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.806 1.424 . . . . 0.0 110.596 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.599 ' CB ' HD11 ' A' ' 21' ' ' LEU . 27.0 m120 -133.67 31.78 3.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.095 -1.003 . . . . 0.0 110.692 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.855 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 10.5 p90 -76.8 -177.23 0.73 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.039 -1.038 . . . . 0.0 108.772 179.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.071 ' HB2' HD13 ' A' ' 57' ' ' LEU . 5.0 Cg_exo -54.93 75.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.518 1.273 . . . . 0.0 110.108 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.628 ' N ' ' O ' ' A' ' 53' ' ' PHE . 84.7 tt0 -44.95 -33.87 2.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.571 -0.705 . . . . 0.0 110.032 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.589 ' C ' HD12 ' A' ' 57' ' ' LEU . 95.3 mt-10 -54.39 -18.79 4.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.015 -1.053 . . . . 0.0 108.52 178.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.071 HD13 ' HB2' ' A' ' 54' ' ' PRO . 7.8 mp -97.5 9.2 43.04 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.931 0.872 . . . . 0.0 109.009 178.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.792 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -43.74 -49.35 19.97 Favored Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.685 -0.634 . . . . 0.0 109.934 179.556 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.792 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -53.86 -42.74 64.01 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.436 1.229 . . . . 0.0 109.73 179.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.1 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 10.7 mp -55.74 -40.74 72.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.051 -1.031 . . . . 0.0 109.129 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.656 ' HA ' HG22 ' A' ' 44' ' ' VAL . 41.4 t -64.3 -26.0 68.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 110.166 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.501 ' CE ' ' HD2' ' A' ' 58' ' ' LYS . 29.6 mttt -88.09 -4.96 58.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.88 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.528 ' CG ' ' HA ' ' A' ' 60' ' ' LEU . 9.1 pt-20 -113.1 147.69 37.84 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.012 -1.055 . . . . 0.0 110.337 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.9 -17.81 61.33 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.953 1.501 . . . . 0.0 111.034 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.484 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 74.5 m-20 -79.71 -13.73 59.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.085 -1.009 . . . . 0.0 110.59 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.1 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.93 -40.24 13.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 110.097 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -57.36 -40.79 78.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.32 -0.863 . . . . 0.0 110.061 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.3 -34.9 36.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.915 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.555 HG21 ' CD2' ' A' ' 60' ' ' LEU . 78.0 mt -72.64 -54.39 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 109.864 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.792 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -44.64 -60.15 2.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.87 . . . . 0.0 110.155 179.864 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.792 ' N ' HD13 ' A' ' 70' ' ' LEU . 94.2 mt-30 -51.65 -52.88 44.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.088 -1.007 . . . . 0.0 110.049 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -55.29 -56.45 19.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.384 -0.823 . . . . 0.0 109.955 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.603 ' CD2' HG11 ' A' ' 3' ' ' VAL . 54.0 mt -47.45 -51.04 21.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 110.143 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 70' ' ' LEU . 75.6 mm-40 -56.76 -38.39 72.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.859 . . . . 0.0 110.467 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.504 ' HG3' ' HB3' ' A' ' 37' ' ' PRO . 82.7 tt0 -70.67 -54.04 13.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.164 -0.96 . . . . 0.0 110.297 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.551 HG21 ' CG2' ' A' ' 3' ' ' VAL . 57.8 mt -65.35 -31.03 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.675 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.821 ' HA ' HD23 ' A' ' 12' ' ' LEU . . . -67.12 -34.85 78.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.403 -0.811 . . . . 0.0 109.503 179.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.493 ' HB3' ' O ' ' A' ' 35' ' ' PHE . 97.1 mt-10 -94.18 16.07 15.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.474 -0.766 . . . . 0.0 109.78 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.413 ' OD1' ' HD2' ' A' ' 80' ' ' PRO . 9.8 t0 -169.51 127.74 0.85 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.48 -0.763 . . . . 0.0 110.152 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD2' ' OD1' ' A' ' 79' ' ' ASP . 3.0 Cg_endo -61.66 -74.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.74 1.39 . . . . 0.0 110.749 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.68 -141.65 24.78 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.864 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 58.5 p -79.32 -22.87 43.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.165 -1.197 . . . . 0.0 109.954 179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 9.3 t -53.73 -52.17 60.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.409 ' OE1' ' CB ' ' A' ' 80' ' ' PRO . 83.6 tt0 -58.78 -32.32 69.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.88 . . . . 0.0 111.102 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.73 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.3 pt -96.59 11.73 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.933 -1.104 . . . . 0.0 110.458 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 58.56 13.6 2.63 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.58 179.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.864 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -67.7 -14.62 63.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.181 -0.949 . . . . 0.0 109.912 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.48 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 5.9 m-85 -137.83 165.99 25.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.387 -0.821 . . . . 0.0 110.331 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.14 3.57 5.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.338 -0.851 . . . . 0.0 110.283 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -63.05 -39.87 96.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.925 . . . . 0.0 110.392 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 1.0 OUTLIER -103.61 118.73 37.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 110.548 -179.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.628 HG21 ' OE1' ' A' ' 4' ' ' GLN . 6.5 m -112.08 6.25 19.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.375 -0.828 . . . . 0.0 110.3 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.03 -56.56 5.23 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.274 -1.133 . . . . 0.0 110.311 179.955 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.606 HG12 ' SG ' ' A' ' 91' ' ' CYS . 3.2 t . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.165 0.507 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.827 HG21 ' HB3' ' A' ' 9' ' ' SER . 12.8 t -126.56 155.79 41.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.192 -0.942 . . . . 0.0 110.68 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.851 HG22 ' SG ' ' A' ' 83' ' ' CYS . 53.0 t -95.9 122.77 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.552 -0.717 . . . . 0.0 109.163 179.005 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.92 ' CD ' HG21 ' A' ' 92' ' ' THR . 3.2 pt20 -129.22 -178.71 4.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.008 -1.058 . . . . 0.0 111.548 -178.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 4' ' ' GLN . 93.1 m-20 -137.74 -60.3 0.65 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.526 0.679 . . . . 0.0 109.464 179.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.29 -143.76 15.19 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.581 ' OD1' ' CE2' ' A' ' 8' ' ' PHE . 16.2 p30 -81.08 8.58 8.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.028 -1.278 . . . . 0.0 110.334 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.581 ' CE2' ' OD1' ' A' ' 7' ' ' ASN . 83.6 m-85 -112.91 139.07 48.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.144 -0.973 . . . . 0.0 110.383 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.827 ' HB3' HG21 ' A' ' 2' ' ' THR . 50.9 m -101.9 139.06 38.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.334 -0.854 . . . . 0.0 110.627 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.595 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 20.4 m-85 -124.28 134.4 53.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.885 . . . . 0.0 110.402 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.0 p -75.11 170.89 15.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.239 -0.913 . . . . 0.0 110.177 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.733 HD21 HG21 ' A' ' 3' ' ' VAL . 9.3 mt -104.58 -2.28 25.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.217 -0.927 . . . . 0.0 110.524 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.59 ' HG2' ' CD ' ' A' ' 33' ' ' ARG . 36.7 mt-10 -64.23 -71.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.276 -0.89 . . . . 0.0 110.548 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.633 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.5 OUTLIER -57.14 -38.79 74.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.39 -0.819 . . . . 0.0 111.344 -179.12 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.726 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 13.0 t -61.55 -49.92 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.844 -1.16 . . . . 0.0 109.46 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.518 ' HD2' ' HB3' ' A' ' 33' ' ' ARG . 17.0 mttt -56.87 -55.05 39.37 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.816 -1.178 . . . . 0.0 108.864 178.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.71 10.96 4.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.018 178.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.925 HD23 ' OE2' ' A' ' 74' ' ' GLU . 13.1 tp -75.09 -10.37 59.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.088 -1.007 . . . . 0.0 109.893 -179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE3' HG13 ' A' ' 38' ' ' ILE . 71.5 tttt -63.58 -32.48 73.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 0.0 109.391 179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -126.49 122.77 36.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.48 -0.762 . . . . 0.0 109.633 179.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.838 HD11 ' HB2' ' A' ' 52' ' ' ASN . 1.1 tm? -105.01 114.31 28.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.202 -0.936 . . . . 0.0 110.639 -179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.543 ' N ' HD13 ' A' ' 21' ' ' LEU . 1.7 tt0 175.7 159.95 0.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.321 -0.862 . . . . 0.0 110.298 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 24' ' ' PRO . 2.2 mt-10 54.87 177.45 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.167 -0.958 . . . . 0.0 110.199 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 23' ' ' GLU . 3.2 Cg_exo -60.65 163.8 14.87 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.885 1.466 . . . . 0.0 110.56 -179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 26' ' ' GLU . 21.5 pt20 -124.89 163.77 21.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.484 -179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.663 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER 63.64 52.43 1.43 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 110.638 179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.663 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -61.64 155.14 55.36 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.797 1.42 . . . . 0.0 110.283 179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -84.07 81.89 8.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 110.063 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.754 HG12 ' H ' ' A' ' 31' ' ' LYS . 23.5 t -119.51 136.6 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 110.341 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.69 -4.65 89.42 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.754 ' H ' HG12 ' A' ' 29' ' ' VAL . 20.4 tttt -68.35 146.19 53.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -1.142 . . . . 0.0 110.087 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.9 mt -75.64 137.48 40.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.203 -0.936 . . . . 0.0 110.26 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.59 ' CD ' ' HG2' ' A' ' 13' ' ' GLU . 69.6 mtm180 -72.09 135.75 46.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.26 -0.9 . . . . 0.0 110.293 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.443 ' OD1' ' HD3' ' A' ' 80' ' ' PRO . 3.3 m-20 179.79 54.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.887 . . . . 0.0 110.055 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.645 ' O ' ' HD3' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -97.9 130.27 44.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.065 -179.993 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.685 ' HB2' ' HG3' ' A' ' 78' ' ' GLU . . . -80.08 110.45 16.28 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.355 -0.841 . . . . 0.0 110.177 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.762 ' O ' HD13 ' A' ' 38' ' ' ILE . 2.8 Cg_endo -68.57 -157.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.702 1.369 . . . . 0.0 110.607 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.762 HD13 ' O ' ' A' ' 37' ' ' PRO . 38.1 mm -129.06 77.23 78.18 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 109.966 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 3.0 Cg_exo -61.85 145.24 97.19 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.941 1.495 . . . . 0.0 110.757 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.1 10.7 55.88 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.1 mt-10 -94.56 151.18 39.05 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.184 -1.186 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -60.79 111.51 1.07 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.876 1.461 . . . . 0.0 110.211 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.86 HG12 HG23 ' A' ' 44' ' ' VAL . 78.4 t -133.79 152.82 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.931 . . . . 0.0 110.736 -179.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.86 HG23 HG12 ' A' ' 43' ' ' VAL . 74.3 t 57.89 57.44 7.04 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.529 -0.732 . . . . 0.0 111.275 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -61.87 -23.74 76.35 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 N-CA-C 108.819 -1.262 . . . . 0.0 108.819 178.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.653 HG23 ' HG ' ' A' ' 47' ' ' LEU . 16.6 tt -157.57 -29.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.142 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.653 ' HG ' HG23 ' A' ' 46' ' ' ILE . 77.6 mt -144.0 -114.38 0.1 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.486 ' SG ' ' CZ ' ' A' ' 53' ' ' PHE . 55.6 m -113.34 127.54 56.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.709 -1.245 . . . . 0.0 109.653 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 38.6 m -60.72 -63.8 1.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.938 . . . . 0.0 110.751 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.567 ' HB2' ' HB3' ' A' ' 53' ' ' PHE . 4.0 m-20 -72.29 113.42 20.55 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 110.512 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.0 Cg_exo -62.45 -13.02 30.55 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.636 1.335 . . . . 0.0 110.639 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.838 ' HB2' HD11 ' A' ' 21' ' ' LEU . 87.3 m-20 -128.19 34.02 4.64 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 110.109 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.718 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -80.04 -178.63 1.17 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.43 -0.794 . . . . 0.0 109.249 179.549 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.729 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.8 Cg_exo -61.47 75.14 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 N-CA-C 108.655 -1.325 . . . . 0.0 108.655 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.613 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 85.2 tt0 -39.07 -27.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.764 -0.585 . . . . 0.0 110.118 -178.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 54' ' ' PRO . 71.9 mm-40 -53.35 -17.92 2.19 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.977 -1.077 . . . . 0.0 108.614 178.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.729 HD12 ' HG2' ' A' ' 54' ' ' PRO . 87.3 mt -92.06 6.53 46.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.692 . . . . 0.0 109.696 179.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.751 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.68 -51.4 5.2 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 110.452 -179.722 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.751 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -54.04 -42.42 67.07 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.34 1.179 . . . . 0.0 109.67 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.011 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 0.3 OUTLIER -54.99 -42.83 72.96 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.088 -1.007 . . . . 0.0 109.816 179.46 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.1 m -68.84 -29.75 68.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.958 . . . . 0.0 110.222 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 62' ' ' LYS . 51.6 tptt -79.93 -4.33 51.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 0.0 110.434 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.533 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 6.7 pt-20 -114.04 142.45 27.93 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 110.108 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -61.58 -17.22 52.9 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.873 1.459 . . . . 0.0 111.099 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.506 ' HB2' ' OE1' ' A' ' 63' ' ' GLU . 70.1 m-20 -79.9 -7.9 59.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.005 . . . . 0.0 110.33 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.011 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -50.42 -37.62 38.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 110.06 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -63.01 -39.0 93.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.211 -0.931 . . . . 0.0 110.142 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -80.17 -39.01 30.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.986 HG21 ' CD1' ' A' ' 60' ' ' LEU . 76.7 mt -68.06 -42.81 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.364 -0.835 . . . . 0.0 109.35 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.906 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -50.73 -59.21 4.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.472 -0.768 . . . . 0.0 110.169 179.861 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.906 ' N ' HD13 ' A' ' 70' ' ' LEU . 52.7 tt0 -50.5 -55.77 14.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.096 -1.003 . . . . 0.0 110.355 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.444 ' O ' ' C ' ' A' ' 73' ' ' LEU . 50.5 mtt180 -55.06 -62.97 1.31 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 0.0 110.431 -179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 72' ' ' ARG . 13.1 tp -41.73 -50.29 4.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.957 . . . . 0.0 109.992 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.925 ' OE2' HD23 ' A' ' 18' ' ' LEU . 63.0 mm-40 -55.3 -46.45 76.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 110.318 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -54.89 -53.12 59.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.088 -1.008 . . . . 0.0 110.37 -179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.442 ' O ' ' O ' ' A' ' 79' ' ' ASP . 26.0 mm -59.11 -35.0 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.104 -0.997 . . . . 0.0 109.404 179.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.725 ' HB2' HG12 ' A' ' 15' ' ' VAL . . . -59.59 -30.49 68.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.559 -0.713 . . . . 0.0 109.527 179.169 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.685 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 84.6 tt0 -62.0 -40.6 96.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 110.41 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 2.5 p30 -148.97 159.52 37.24 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.099 -1.001 . . . . 0.0 110.482 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.577 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -62.63 -60.83 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.988 1.52 . . . . 0.0 110.494 179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.02 -141.33 24.1 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 61.5 p -83.11 -18.3 40.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -1.141 . . . . 0.0 109.775 179.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.851 ' SG ' HG22 ' A' ' 3' ' ' VAL . 11.0 t -58.53 -53.35 59.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 0.0 110.047 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 48.1 tp10 -59.61 -23.98 63.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 111.081 -179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.784 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.3 pt -105.42 17.26 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.0 -1.062 . . . . 0.0 110.366 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 19.0 m 49.95 19.36 0.45 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -0.893 . . . . 0.0 110.65 179.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.983 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.04 -13.47 58.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.035 -1.04 . . . . 0.0 110.005 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -148.24 179.96 7.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.321 -0.862 . . . . 0.0 110.044 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.24 1.68 20.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 110.003 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -58.41 -39.97 81.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.332 -0.855 . . . . 0.0 110.415 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.606 ' SG ' HG12 ' A' ' 1' ' ' VAL . 0.5 OUTLIER -108.05 129.43 55.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.533 -179.653 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.92 HG21 ' CD ' ' A' ' 4' ' ' GLN . 19.5 p -109.81 159.81 16.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.378 -0.826 . . . . 0.0 110.146 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.67 -12.77 61.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.278 -1.131 . . . . 0.0 110.228 179.994 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.483 ' CG1' ' SG ' ' A' ' 91' ' ' CYS . 79.0 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.172 0.511 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.472 ' CG2' ' OG ' ' A' ' 9' ' ' SER . 60.8 m -132.45 150.04 52.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.843 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.812 ' HB ' HD21 ' A' ' 12' ' ' LEU . 0.4 OUTLIER -92.98 119.39 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 109.419 179.379 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.747 ' CD ' HG21 ' A' ' 92' ' ' THR . 1.4 pt20 -116.27 148.29 40.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.079 -1.013 . . . . 0.0 110.933 -179.164 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -96.14 -74.85 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.76 . . . . 0.0 109.478 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.53 -121.12 4.67 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -85.62 14.48 5.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -1.14 . . . . 0.0 110.15 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.692 ' CE1' ' CE1' ' A' ' 10' ' ' PHE . 25.8 t80 -125.89 148.66 49.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.39 -0.819 . . . . 0.0 110.015 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.56 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 12.5 t -107.26 137.74 44.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.17 -0.956 . . . . 0.0 110.724 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.692 ' CE1' ' CE1' ' A' ' 8' ' ' PHE . 84.9 m-85 -119.56 132.1 55.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.19 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -67.14 164.2 18.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.071 -1.018 . . . . 0.0 110.088 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.812 HD21 ' HB ' ' A' ' 3' ' ' VAL . 54.1 mt -101.44 -5.19 25.61 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.982 . . . . 0.0 110.432 -179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.548 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 83.1 tt0 -69.04 -73.02 0.16 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.426 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 18' ' ' LEU . 6.4 m -42.36 -55.3 3.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.032 -1.043 . . . . 0.0 110.545 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.698 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 15.8 m -51.81 -43.95 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.091 -1.006 . . . . 0.0 110.083 -179.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 37.3 tttm -56.26 -58.75 6.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.832 -1.168 . . . . 0.0 108.644 178.701 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 75.1 mmtt -80.62 17.78 1.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.353 -0.842 . . . . 0.0 109.57 178.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 2.1 tt -65.77 -41.16 92.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.198 -0.939 . . . . 0.0 110.012 179.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 37' ' ' PRO . 85.0 tttt -53.16 -41.99 65.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.318 -0.864 . . . . 0.0 110.287 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -140.26 80.33 1.75 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.19 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 52' ' ' ASN . 6.6 tt -104.35 130.14 52.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.06 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.591 ' O ' HD23 ' A' ' 21' ' ' LEU . 56.7 mt-30 -102.93 -175.29 2.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.151 -0.968 . . . . 0.0 110.612 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.666 ' N ' ' HD2' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -43.64 -53.53 12.04 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 110.666 179.938 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.666 ' HD2' ' N ' ' A' ' 23' ' ' GLU . 3.2 Cg_exo -59.3 139.51 90.27 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.625 1.329 . . . . 0.0 110.524 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -57.3 -37.15 72.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 110.528 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HG3' ' OE2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -164.03 101.52 0.91 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 110.552 -179.896 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.06 -24.61 76.77 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 O-C-N 123.711 1.374 . . . . 0.0 110.448 179.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.435 ' O ' ' OE1' ' A' ' 26' ' ' GLU . 64.6 mtt180 -128.11 141.52 51.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 0.0 110.137 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.0 t -127.25 141.41 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.111 -0.993 . . . . 0.0 110.21 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.27 155.46 22.48 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -59.0 -46.98 86.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.219 -1.165 . . . . 0.0 110.231 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 32' ' ' LEU . 15.0 tp -124.34 137.44 54.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.229 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.548 ' HD2' ' HA ' ' A' ' 13' ' ' GLU . 82.9 mtm-85 -91.14 113.09 25.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.266 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 63.7 m-20 -140.35 6.34 2.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 110.57 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.495 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 97.6 m-85 -103.29 37.96 1.88 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.126 -0.984 . . . . 0.0 110.299 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.477 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . . . -48.73 152.25 1.8 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.0 110.114 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.565 ' O ' ' HB ' ' A' ' 38' ' ' ILE . 2.7 Cg_endo -65.61 3.84 1.01 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.819 1.431 . . . . 0.0 110.932 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.565 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 2.0 mt 72.81 135.26 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.265 -0.897 . . . . 0.0 110.166 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.58 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 2.9 Cg_endo -63.53 172.04 6.05 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.871 1.459 . . . . 0.0 110.53 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.0 17.84 42.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.533 ' CG ' ' OE1' ' A' ' 74' ' ' GLU . 7.9 pt-20 -135.59 79.3 47.77 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.214 -1.168 . . . . 0.0 110.21 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HB3' ' HG3' ' A' ' 67' ' ' GLN . 3.0 Cg_exo -61.17 131.59 37.42 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.862 1.454 . . . . 0.0 110.387 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 43' ' ' VAL . 27.0 m -120.06 53.18 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 0.0 110.435 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.017 HG21 ' HA ' ' A' ' 61' ' ' CYS . 7.4 p -163.9 53.94 0.38 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 110.696 179.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.62 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -61.39 -35.81 81.52 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 123.71 1.374 . . . . 0.0 109.747 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' A' ' 47' ' ' LEU . 17.1 pt -133.51 -25.09 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.509 -0.745 . . . . 0.0 110.246 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 48' ' ' CYS . 1.0 OUTLIER 174.02 90.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.975 . . . . 0.0 110.442 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.753 ' H ' HG23 ' A' ' 44' ' ' VAL . 73.5 m 39.24 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.458 -0.776 . . . . 0.0 110.603 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.549 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 26.6 m -54.07 -50.76 66.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 110.144 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.487 ' CB ' ' HB3' ' A' ' 53' ' ' PHE . 2.7 m120 -71.45 112.22 13.05 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.785 . . . . 0.0 110.615 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -63.08 -10.52 21.02 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.694 1.365 . . . . 0.0 110.118 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.802 ' O ' HD13 ' A' ' 21' ' ' LEU . 14.3 m120 -130.21 33.92 4.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.379 -0.826 . . . . 0.0 110.461 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.689 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -79.09 179.64 1.72 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.0 108.719 179.082 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.82 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.6 Cg_exo -58.35 74.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.512 1.269 . . . . 0.0 109.184 179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 53' ' ' PHE . 82.9 tt0 -39.5 -26.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.668 -0.645 . . . . 0.0 110.349 -178.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 54' ' ' PRO . 95.8 mt-10 -56.83 -15.7 5.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.023 -1.048 . . . . 0.0 108.619 178.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.82 HD12 ' HG2' ' A' ' 54' ' ' PRO . 78.4 mt -92.09 14.17 16.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.646 -0.659 . . . . 0.0 109.609 179.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.751 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.84 -49.49 5.68 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 110.085 179.818 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.751 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.3 Cg_exo -56.51 -47.67 22.78 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.444 1.233 . . . . 0.0 109.573 179.147 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.124 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 12.0 tp -46.55 -52.65 12.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.727 179.428 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 1.017 ' HA ' HG21 ' A' ' 44' ' ' VAL . 85.0 m -67.01 -30.47 70.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 110.55 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 51.2 tttm -79.94 3.44 19.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 110.616 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.518 ' OE2' ' CD1' ' A' ' 69' ' ' ILE . 8.2 pt-20 -127.9 144.05 49.97 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.984 -1.072 . . . . 0.0 110.124 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.39 -17.22 56.45 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.805 1.424 . . . . 0.0 110.853 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.495 ' O ' HG13 ' A' ' 69' ' ' ILE . 22.6 m120 -79.88 -9.49 59.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 110.417 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.124 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -47.92 -42.37 27.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.013 . . . . 0.0 109.806 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.471 ' HG3' ' HB3' ' A' ' 42' ' ' PRO . 64.0 tt0 -59.62 -43.37 93.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.537 -0.727 . . . . 0.0 110.37 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -79.26 -39.74 32.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 0.0 109.974 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.915 ' HB ' HD11 ' A' ' 60' ' ' LEU . 68.7 mt -67.48 -47.84 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 109.629 179.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.806 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.4 tm? -50.54 -55.6 15.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.362 -0.836 . . . . 0.0 110.014 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.792 ' N ' HD13 ' A' ' 70' ' ' LEU . 52.2 tt0 -47.27 -52.18 16.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 110.186 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -54.73 -51.48 65.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 0.0 110.086 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 53.0 mt -53.52 -52.16 60.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 0.0 110.054 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.757 ' OE2' HD11 ' A' ' 70' ' ' LEU . 73.2 mt-10 -55.29 -37.9 67.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.873 . . . . 0.0 110.511 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.523 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 82.1 tt0 -65.31 -53.58 41.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.985 . . . . 0.0 110.926 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.646 HG21 ' CG2' ' A' ' 3' ' ' VAL . 20.6 mm -61.35 -39.13 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.594 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.06 -26.92 68.55 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.491 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.9 tt0 -66.3 -35.12 79.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.507 -0.746 . . . . 0.0 111.063 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.11 96.14 1.23 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.809 -1.182 . . . . 0.0 111.041 -179.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.637 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 2.7 Cg_endo -67.82 44.71 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.757 1.398 . . . . 0.0 110.483 179.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.52 -74.38 0.3 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.991 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 74.3 p -69.37 -58.81 3.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -1.123 . . . . 0.0 110.296 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -39.16 -46.9 1.52 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 110.495 -179.586 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 80' ' ' PRO . 81.8 tt0 -63.75 -25.1 68.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.043 . . . . 0.0 110.527 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 82' ' ' THR . 26.5 pt -107.23 18.34 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.079 -1.013 . . . . 0.0 110.268 -179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.19 15.66 4.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 110.519 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.991 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -59.75 -23.89 63.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 109.935 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -141.75 169.23 17.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.315 -0.866 . . . . 0.0 110.374 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.59 5.16 11.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 110.322 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -64.11 -43.26 95.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.934 . . . . 0.0 110.333 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 83' ' ' CYS . 0.5 OUTLIER -94.67 133.61 38.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.193 -0.942 . . . . 0.0 110.389 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.747 HG21 ' CD ' ' A' ' 4' ' ' GLN . 42.3 p -116.16 154.39 30.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.318 -0.864 . . . . 0.0 110.144 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 94' ' ' CYS . . . 101.99 -9.02 56.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.462 ' C ' ' O ' ' A' ' 93' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.44 -1.035 . . . . 0.0 110.386 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.826 HG22 ' SG ' ' A' ' 91' ' ' CYS . 7.8 p . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.313 0.577 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 53.5 m -127.08 155.59 43.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.179 -0.95 . . . . 0.0 110.676 -179.544 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.003 ' CG2' HD21 ' A' ' 12' ' ' LEU . 4.0 t -91.13 117.17 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.497 179.389 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 8' ' ' PHE . 4.1 pt20 -126.87 175.18 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.073 -1.017 . . . . 0.0 111.201 -179.32 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.743 ' OD2' HG23 ' A' ' 69' ' ' ILE . 96.8 m-20 -136.94 -58.38 0.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.573 0.702 . . . . 0.0 109.5 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.37 -140.18 11.28 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.816 -1.713 . . . . 0.0 108.816 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.587 ' OD1' ' CD2' ' A' ' 8' ' ' PHE . 13.9 p30 -79.65 2.04 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.164 -1.198 . . . . 0.0 110.266 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.587 ' CD2' ' OD1' ' A' ' 7' ' ' ASN . 77.9 m-85 -110.71 152.77 26.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.505 ' HA ' ' CB ' ' A' ' 4' ' ' GLN . 49.0 m -112.0 136.99 50.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 0.0 110.358 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.753 ' CG ' HD21 ' A' ' 57' ' ' LEU . 11.2 m-85 -117.16 127.79 54.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.264 -0.897 . . . . 0.0 110.285 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.504 ' HA ' HG23 ' A' ' 2' ' ' THR . 30.5 m -72.22 164.67 25.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 110.352 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.003 HD21 ' CG2' ' A' ' 3' ' ' VAL . 83.9 mt -85.24 -24.29 27.87 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.194 -0.942 . . . . 0.0 110.431 -179.753 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 14' ' ' SER . 86.0 tt0 -64.18 -69.16 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.308 -0.87 . . . . 0.0 110.372 -179.706 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 18' ' ' LEU . 5.1 m -43.82 -51.41 7.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.125 -0.984 . . . . 0.0 110.142 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.669 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 54.4 t -59.16 -49.03 84.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.228 -0.92 . . . . 0.0 109.327 179.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' HD2' ' HD3' ' A' ' 37' ' ' PRO . 4.0 tptm -53.21 -56.45 16.35 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.523 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 20' ' ' ASP . 57.6 mttt -80.85 13.75 2.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.573 -0.704 . . . . 0.0 110.076 178.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.669 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 5.1 tt -65.65 -47.36 75.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.987 . . . . 0.0 110.297 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.34 -47.17 86.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.161 -0.962 . . . . 0.0 109.834 179.746 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 17' ' ' LYS . 83.9 m-20 -103.2 122.5 44.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 0.0 109.787 179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.883 HD11 ' HB2' ' A' ' 52' ' ' ASN . 18.9 tp -100.79 132.09 46.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.744 -179.604 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.501 ' O ' ' C ' ' A' ' 23' ' ' GLU . 13.9 pt20 -140.69 174.39 10.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.385 -0.822 . . . . 0.0 109.754 179.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' C ' ' O ' ' A' ' 22' ' ' GLN . 0.2 OUTLIER -36.58 97.92 0.14 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.865 . . . . 0.0 110.145 179.985 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.495 ' N ' ' O ' ' A' ' 22' ' ' GLN . 3.0 Cg_exo -62.25 138.44 71.91 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.97 1.511 . . . . 0.0 110.856 -179.594 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.452 ' HG3' ' C ' ' A' ' 24' ' ' PRO . 95.7 mt-30 -150.16 -49.87 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.423 -0.798 . . . . 0.0 109.886 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.627 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 1.7 tt0 46.03 54.76 14.67 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.453 -0.78 . . . . 0.0 110.846 179.722 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 26' ' ' GLU . 2.9 Cg_endo -61.93 -50.9 4.38 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.723 1.38 . . . . 0.0 110.19 179.572 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HG3' ' C ' ' A' ' 27' ' ' PRO . 48.4 mtt-85 -151.9 172.32 16.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.537 -0.727 . . . . 0.0 110.011 179.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.1 t -54.35 128.81 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.121 -0.987 . . . . 0.0 110.082 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.81 109.48 2.86 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -62.87 -31.18 72.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -1.147 . . . . 0.0 110.139 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 33' ' ' ARG . 46.1 mt -98.71 133.47 43.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 110.317 -179.722 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 29.5 ptt-85 -176.98 54.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.475 -0.765 . . . . 0.0 109.66 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.643 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 28.3 m-20 -95.95 -70.49 0.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -0.834 . . . . 0.0 110.655 -179.58 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -57.4 80.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.429 -0.794 . . . . 0.0 110.754 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.737 ' HB2' ' HA ' ' A' ' 78' ' ' GLU . . . -80.16 164.05 54.38 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.876 . . . . 0.0 109.99 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.544 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 2.7 Cg_endo -63.4 -3.58 5.43 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.913 1.48 . . . . 0.0 110.756 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 37' ' ' PRO . 2.6 mt 63.26 133.36 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 110.062 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.523 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 3.1 Cg_exo -61.3 162.12 21.22 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.764 1.402 . . . . 0.0 110.633 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.484 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 145.34 -7.46 1.57 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -119.84 74.81 19.62 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.093 -1.239 . . . . 0.0 110.396 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.484 ' HD3' ' C ' ' A' ' 40' ' ' GLY . 3.0 Cg_endo -61.74 115.6 2.9 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.78 1.41 . . . . 0.0 110.487 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.824 ' O ' HG23 ' A' ' 44' ' ' VAL . 89.6 t -136.42 141.7 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 0.0 110.223 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.023 HG21 ' HB1' ' A' ' 66' ' ' ALA . 0.9 OUTLIER 164.16 -50.29 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 121.472 -0.767 . . . . 0.0 110.611 179.936 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.709 ' HD2' ' N ' ' A' ' 44' ' ' VAL . 3.3 Cg_exo -58.23 -19.15 40.82 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.403 1.212 . . . . 0.0 110.625 -179.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 47' ' ' LEU . 77.1 mt -89.69 -75.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.783 179.564 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 46' ' ' ILE . 24.3 tp 178.77 67.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.882 . . . . 0.0 110.348 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.497 ' O ' ' O ' ' A' ' 47' ' ' LEU . 35.3 m 37.7 92.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.388 -0.82 . . . . 0.0 110.154 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.673 ' CB ' HG11 ' A' ' 43' ' ' VAL . 58.1 p -52.96 -42.98 66.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.308 -0.87 . . . . 0.0 111.0 -179.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -80.3 110.68 17.53 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.186 -0.946 . . . . 0.0 110.46 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -58.3 -10.62 8.85 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.753 1.397 . . . . 0.0 110.787 -179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.883 ' HB2' HD11 ' A' ' 21' ' ' LEU . 97.9 m-20 -139.56 42.95 2.01 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.121 -0.987 . . . . 0.0 110.712 -179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.756 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -78.61 177.2 2.98 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.092 -1.005 . . . . 0.0 108.433 178.778 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.756 ' HD2' ' HB2' ' A' ' 53' ' ' PHE . 3.8 Cg_exo -57.51 76.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 N-CA-C 108.628 -1.336 . . . . 0.0 108.628 179.124 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.623 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.9 tt0 -38.88 -28.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.803 -0.561 . . . . 0.0 110.075 -178.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 54' ' ' PRO . 96.7 mt-10 -51.66 -18.18 1.11 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.996 -1.065 . . . . 0.0 108.587 178.257 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.753 HD21 ' CG ' ' A' ' 10' ' ' PHE . 78.7 mt -86.77 2.95 47.03 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.43 0.633 . . . . 0.0 109.861 179.415 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.753 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 20.6 tptt -39.99 -49.61 5.97 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 110.366 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.753 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.85 -41.1 80.78 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.357 1.188 . . . . 0.0 110.434 179.678 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.012 HD21 HG21 ' A' ' 69' ' ' ILE . 6.2 mp -61.08 -37.6 83.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.876 -1.14 . . . . 0.0 110.179 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.663 ' HA ' HG22 ' A' ' 44' ' ' VAL . 57.3 m -62.73 -25.23 68.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.574 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -98.89 10.94 40.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.115 -0.991 . . . . 0.0 111.399 -179.15 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.575 ' CG ' ' HA ' ' A' ' 60' ' ' LEU . 12.6 pt-20 -133.65 147.1 63.15 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.746 -1.221 . . . . 0.0 110.536 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 2.9 Cg_endo -63.25 -11.16 23.98 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.911 1.48 . . . . 0.0 110.939 -179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.42 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 79.4 m-20 -78.93 -23.72 44.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.1 -1.0 . . . . 0.0 110.428 -179.046 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.023 ' HB1' HG21 ' A' ' 44' ' ' VAL . . . -49.14 -39.3 28.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.973 179.503 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -57.16 -44.94 83.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.276 -0.89 . . . . 0.0 110.27 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 73.5 mm-40 -79.13 -31.9 44.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.207 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.012 HG21 HD21 ' A' ' 60' ' ' LEU . 95.5 mt -76.34 -53.45 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.096 -1.003 . . . . 0.0 109.928 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.01 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -44.69 -65.42 0.53 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.432 -0.793 . . . . 0.0 110.484 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 1.01 ' N ' HD13 ' A' ' 70' ' ' LEU . 50.9 tt0 -49.06 -54.79 14.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.124 -0.985 . . . . 0.0 110.697 -179.702 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 44.5 mtp85 -54.97 -55.32 32.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 110.175 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.549 ' CD1' HG22 ' A' ' 69' ' ' ILE . 28.7 mt -47.43 -50.77 21.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.158 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.819 ' OE2' HD21 ' A' ' 70' ' ' LEU . 75.4 mt-10 -56.22 -48.19 76.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 110.235 179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 34.8 tt0 -53.79 -52.92 58.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.042 -1.036 . . . . 0.0 109.894 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 79' ' ' ASP . 62.2 mt -59.92 -34.3 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.209 -0.932 . . . . 0.0 109.156 179.224 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -56.15 -32.83 64.65 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.864 -0.734 . . . . 0.0 109.034 179.031 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.737 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 83.2 tt0 -64.2 -43.49 94.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.522 -0.736 . . . . 0.0 109.67 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.473 ' CG ' ' HD2' ' A' ' 80' ' ' PRO . 2.0 t70 -143.17 147.58 41.29 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.956 179.784 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.616 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -56.64 -56.11 2.24 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.841 1.442 . . . . 0.0 110.583 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.19 -137.13 21.57 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.942 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 71.9 p -82.16 -23.09 35.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -1.087 . . . . 0.0 110.625 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 91' ' ' CYS . 7.7 t -56.29 -54.38 46.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.065 -1.022 . . . . 0.0 110.033 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 76.9 tt0 -58.05 -27.34 63.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 0.0 111.178 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.76 HG13 ' HB2' ' A' ' 87' ' ' ALA . 8.9 pt -101.14 14.84 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.89 -1.131 . . . . 0.0 110.27 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 73.3 m 54.76 16.32 1.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.897 . . . . 0.0 110.539 179.594 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.942 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -65.51 -12.31 51.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 110.015 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.82 174.5 11.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 110.328 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.85 3.89 9.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.327 -0.858 . . . . 0.0 110.304 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -61.52 -42.82 99.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.908 . . . . 0.0 110.417 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.826 ' SG ' HG22 ' A' ' 1' ' ' VAL . 1.2 m -106.2 124.55 49.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.79 -179.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.504 HG21 ' CD ' ' A' ' 4' ' ' GLN . 36.8 p -109.61 163.23 13.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.158 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.02 3.32 51.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 -179.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.395 -1.061 . . . . 0.0 110.283 179.975 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.517 ' CG1' ' SG ' ' A' ' 91' ' ' CYS . 52.9 t . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.287 0.565 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.724 HG21 ' HB2' ' A' ' 9' ' ' SER . 11.7 t -118.48 164.04 15.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 0.0 110.357 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.697 HG13 HG21 ' A' ' 76' ' ' ILE . 65.3 t -81.07 124.46 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 109.569 179.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.791 ' CB ' HG21 ' A' ' 92' ' ' THR . 48.9 tt0 -113.65 121.53 44.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.055 -1.028 . . . . 0.0 110.9 -179.333 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.98 ' HB3' HD21 ' A' ' 73' ' ' LEU . 52.6 p30 -97.74 13.44 30.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.441 -0.787 . . . . 0.0 109.647 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.506 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 173.51 -132.13 2.24 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -93.67 16.57 13.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.164 -1.198 . . . . 0.0 109.773 179.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.65 ' CB ' ' CZ ' ' A' ' 10' ' ' PHE . 44.8 m-85 -121.06 128.09 52.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.456 -0.777 . . . . 0.0 110.429 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.724 ' HB2' HG21 ' A' ' 2' ' ' THR . 14.7 p -82.18 118.29 22.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 179.511 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 8' ' ' PHE . 21.4 m-85 -117.93 123.32 45.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.0 110.807 -179.207 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.492 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 45.6 t -67.87 168.78 10.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.28 -0.888 . . . . 0.0 110.083 179.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.833 ' N ' HD12 ' A' ' 12' ' ' LEU . 4.6 mp -95.81 0.84 52.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 110.629 -179.504 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -73.28 -73.93 0.19 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.088 -1.008 . . . . 0.0 110.488 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.534 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.4 m -42.68 -41.09 3.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.114 -0.991 . . . . 0.0 110.556 -179.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.531 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 33.1 t -69.26 -50.89 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.115 -0.991 . . . . 0.0 109.805 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.982 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 9.6 ttpp -48.06 -46.52 33.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.221 -0.924 . . . . 0.0 109.102 179.243 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 18' ' ' LEU . 49.9 mttm -74.03 -54.96 6.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 0.0 109.003 178.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.77 HD12 ' OD1' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -27.88 -41.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.804 -0.56 . . . . 0.0 110.551 -179.999 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.667 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 22.4 mttm -51.76 -45.62 63.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.189 -0.944 . . . . 0.0 109.947 179.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 21' ' ' LEU . 52.0 p30 -112.86 -3.15 14.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 110.063 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.984 HD23 ' ND2' ' A' ' 50' ' ' ASN . 0.1 OUTLIER 45.94 104.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.404 -0.81 . . . . 0.0 110.451 -179.984 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 23' ' ' GLU . 96.8 mt-30 -120.96 165.79 14.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.886 . . . . 0.0 109.941 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -42.58 165.83 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.17 -179.988 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HD2' ' HG3' ' A' ' 23' ' ' GLU . 3.1 Cg_exo -60.88 70.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.827 1.435 . . . . 0.0 110.773 -179.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 23' ' ' GLU . 91.7 mt-30 -84.26 12.63 6.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -0.918 . . . . 0.0 110.008 179.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.705 ' N ' ' HD2' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -49.55 -49.9 69.25 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.394 -0.816 . . . . 0.0 110.936 -179.981 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.705 ' HD2' ' N ' ' A' ' 26' ' ' GLU . 3.3 Cg_exo -59.27 -13.93 22.17 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.608 1.32 . . . . 0.0 110.751 -179.559 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.473 ' HG2' ' NH2' ' A' ' 28' ' ' ARG . 47.6 ttp85 -124.85 123.83 40.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 109.917 179.628 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.3 136.29 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.935 . . . . 0.0 110.36 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.85 152.04 34.57 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -58.72 -35.45 72.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -1.158 . . . . 0.0 110.286 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.626 HD21 ' ND2' ' A' ' 34' ' ' ASN . 29.7 tp -114.03 131.48 56.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.228 -0.92 . . . . 0.0 110.263 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.503 ' HB2' ' HD3' ' A' ' 16' ' ' LYS . 6.3 ptp180 -117.83 54.25 0.91 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.086 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.626 ' ND2' HD21 ' A' ' 32' ' ' LEU . 41.5 p-10 -125.69 2.2 7.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.202 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -71.21 -7.52 47.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 110.3 -179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.982 ' HB2' ' HG3' ' A' ' 16' ' ' LYS . . . -63.32 150.19 89.93 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.205 -0.935 . . . . 0.0 110.152 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD2' ' HD2' ' A' ' 19' ' ' LYS . 3.1 Cg_exo -61.55 -147.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.798 1.42 . . . . 0.0 110.404 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.741 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -121.55 161.27 42.42 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 110.072 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.557 ' HG3' ' CA ' ' A' ' 75' ' ' GLU . 3.0 Cg_endo -61.52 155.78 50.9 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.791 1.416 . . . . 0.0 110.653 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . 140.94 4.87 1.08 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.821 -1.181 . . . . 0.0 110.169 179.823 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.54 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -134.61 60.47 42.57 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.881 -1.364 . . . . 0.0 110.612 179.968 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' A' ' 41' ' ' GLU . 3.1 Cg_exo -62.16 139.41 78.03 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.824 1.433 . . . . 0.0 110.515 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 49' ' ' SER . 14.8 m -141.93 119.68 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.334 -179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.724 ' O ' HG12 ' A' ' 44' ' ' VAL . 69.2 t -145.62 63.36 9.45 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 0.0 110.473 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.514 ' HG2' ' N ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -61.17 -169.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.748 1.394 . . . . 0.0 110.336 179.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.42 -30.23 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.384 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.534 ' O ' ' O ' ' A' ' 48' ' ' CYS . 0.7 OUTLIER -134.81 56.13 1.86 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 -179.99 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.534 ' O ' ' O ' ' A' ' 47' ' ' LEU . 0.5 OUTLIER 56.98 133.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.472 -0.767 . . . . 0.0 110.147 179.95 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.53 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 23.3 t -69.54 -56.0 8.57 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.096 -1.002 . . . . 0.0 110.442 -179.817 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.984 ' ND2' HD23 ' A' ' 21' ' ' LEU . 7.2 m120 -78.28 113.06 30.54 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.481 -0.762 . . . . 0.0 110.452 -179.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -62.45 -12.69 28.91 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.747 1.393 . . . . 0.0 110.459 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.491 ' HB2' HD11 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -127.8 36.41 4.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 110.045 179.886 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.727 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 3.0 p90 -80.14 178.86 2.11 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.853 . . . . 0.0 109.203 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.021 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.2 Cg_exo -56.53 75.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.676 1.356 . . . . 0.0 109.872 179.264 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.9 tt0 -43.56 -34.19 1.34 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.833 . . . . 0.0 110.298 -179.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.545 ' C ' HD12 ' A' ' 57' ' ' LEU . 74.4 mm-40 -54.31 -18.65 4.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.934 -1.104 . . . . 0.0 108.626 178.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.021 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.5 mp -95.3 18.69 11.97 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.092 0.949 . . . . 0.0 108.99 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.743 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -43.19 -51.02 14.41 Favored Pre-proline 0 N--CA 1.489 1.483 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.52 179.818 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.743 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.6 Cg_exo -55.24 -49.12 17.4 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.502 1.264 . . . . 0.0 109.658 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.104 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 1.0 OUTLIER -48.1 -49.1 33.01 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.09 -1.006 . . . . 0.0 109.753 179.446 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.513 ' SG ' ' CE2' ' A' ' 53' ' ' PHE . 87.0 m -63.49 -23.95 67.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 110.439 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 62' ' ' LYS . 19.9 tttt -90.68 5.62 47.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.187 -0.946 . . . . 0.0 110.743 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 60' ' ' LEU . 8.6 pt-20 -125.96 144.76 49.7 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.891 -1.13 . . . . 0.0 110.317 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -61.54 -13.59 30.44 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.94 1.495 . . . . 0.0 110.803 -179.799 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.507 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 84.7 m-20 -79.78 -22.65 42.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.292 -179.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.104 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.23 -40.05 10.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.11 -0.994 . . . . 0.0 109.797 179.775 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -62.48 -36.95 84.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 0.0 109.23 179.3 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.49 -38.9 29.0 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.524 -0.735 . . . . 0.0 109.407 178.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.763 HG23 ' HB2' ' A' ' 5' ' ' ASP . 80.0 mt -70.92 -46.18 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.441 -0.787 . . . . 0.0 109.898 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.911 HD13 ' N ' ' A' ' 71' ' ' GLN . 2.1 tm? -40.66 -68.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.506 -0.746 . . . . 0.0 110.554 -179.768 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.911 ' N ' HD13 ' A' ' 70' ' ' LEU . 25.3 mt-30 -42.77 -52.4 5.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.143 -0.973 . . . . 0.0 110.459 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -53.71 -59.05 5.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.004 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.98 HD21 ' HB3' ' A' ' 5' ' ' ASP . 36.7 mt -47.57 -54.14 12.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 110.051 179.705 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 39' ' ' PRO . 70.3 mt-10 -52.19 -45.78 65.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 110.06 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.557 ' CA ' ' HG3' ' A' ' 39' ' ' PRO . 83.7 tt0 -57.62 -51.36 69.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 0.0 109.809 179.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.697 HG21 HG13 ' A' ' 3' ' ' VAL . 23.6 mm -60.64 -38.75 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 109.519 179.496 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.543 ' HA ' HD23 ' A' ' 12' ' ' LEU . . . -54.52 -38.39 66.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.429 -0.794 . . . . 0.0 109.65 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.735 ' O ' ' CB ' ' A' ' 79' ' ' ASP . 83.8 tt0 -44.14 -33.56 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.89 . . . . 0.0 109.611 179.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.735 ' CB ' ' O ' ' A' ' 78' ' ' GLU . 19.5 t70 95.04 73.13 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 76' ' ' ILE . 3.0 Cg_exo -60.86 -34.97 90.55 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 124.022 1.538 . . . . 0.0 110.185 179.573 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 85' ' ' ILE . . . 94.16 -28.89 9.58 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.195 -2.362 . . . . 0.0 107.195 -178.249 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.822 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 75.6 p -74.3 -40.75 62.06 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.11 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.677 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 53.5 t -58.81 -40.96 85.65 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.834 178.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.37 -33.37 75.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.066 -1.021 . . . . 0.0 110.349 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 82' ' ' THR . 17.8 pt -94.44 11.32 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.934 . . . . 0.0 110.237 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER 67.83 12.42 8.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.355 -0.841 . . . . 0.0 110.527 179.721 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.822 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -58.64 -35.76 73.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.22 -0.925 . . . . 0.0 109.897 179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.548 ' HD2' ' HB2' ' A' ' 90' ' ' ALA . 29.1 t80 -123.15 166.8 14.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.937 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.91 -7.28 47.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.152 -0.967 . . . . 0.0 109.974 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.548 ' HB2' ' HD2' ' A' ' 88' ' ' TYR . . . -51.82 -37.1 50.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.83 . . . . 0.0 110.861 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.677 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -104.13 118.8 37.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.906 . . . . 0.0 111.139 -179.149 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.791 HG21 ' CB ' ' A' ' 4' ' ' GLN . 18.4 p -98.16 177.86 5.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -0.934 . . . . 0.0 110.197 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.75 -5.9 84.16 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.442 ' OXT' ' SG ' ' A' ' 86' ' ' CYS . 23.9 p . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.166 . . . . 0.0 110.118 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 84' ' ' GLU . 3.5 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.229 0.538 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.495 HG23 ' HA ' ' A' ' 11' ' ' SER . 37.0 m -89.26 150.89 22.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 110.293 -179.851 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.01 HG21 HD11 ' A' ' 12' ' ' LEU . 88.0 t -80.08 104.8 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 110.123 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.53 ' HB3' ' CG2' ' A' ' 92' ' ' THR . 48.1 tt0 -108.64 123.69 49.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.173 -0.954 . . . . 0.0 110.36 -179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -100.75 5.07 43.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 0.0 110.098 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . -176.44 -138.62 2.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -79.74 -0.12 32.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -1.123 . . . . 0.0 110.251 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.456 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 84.4 m-85 -116.8 130.7 56.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.197 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m -86.01 136.18 33.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 110.126 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.647 ' CE1' HD23 ' A' ' 57' ' ' LEU . 57.0 m-85 -115.09 125.73 53.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 0.0 110.191 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.539 ' C ' HD22 ' A' ' 12' ' ' LEU . 33.8 t -73.07 169.9 16.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.92 . . . . 0.0 110.179 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.01 HD11 HG21 ' A' ' 3' ' ' VAL . 3.2 mm? -100.63 -3.99 29.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.115 -0.99 . . . . 0.0 110.413 -179.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.417 ' OE1' ' HG3' ' A' ' 26' ' ' GLU . 97.5 mt-10 -70.23 -72.9 0.18 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.101 -0.999 . . . . 0.0 110.432 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.498 ' HB2' ' HG3' ' A' ' 54' ' ' PRO . 5.5 m -41.12 -50.69 3.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.326 -0.859 . . . . 0.0 110.662 -179.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.634 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 30.8 m -63.1 -47.96 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.096 -1.003 . . . . 0.0 109.743 179.822 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.628 ' CD ' ' HA ' ' A' ' 33' ' ' ARG . 6.8 ttpp -56.53 -55.42 34.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.084 -1.01 . . . . 0.0 109.159 179.102 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -80.11 7.6 8.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.49 179.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.634 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . 13.0 tp -54.1 -35.65 62.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.577 -0.702 . . . . 0.0 110.131 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.523 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 32.1 tttt -55.48 -41.84 73.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.116 -0.99 . . . . 0.0 109.507 179.317 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.7 105.92 16.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.778 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.781 HD11 ' H ' ' A' ' 52' ' ' ASN . 11.8 tp -46.82 -42.32 17.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.222 -0.924 . . . . 0.0 110.595 -179.64 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.407 ' C ' ' HG3' ' A' ' 23' ' ' GLU . 94.2 mt-30 -65.29 110.1 2.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.179 -0.951 . . . . 0.0 110.381 -179.705 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HG3' ' C ' ' A' ' 22' ' ' GLN . 9.1 mt-10 -126.88 128.02 24.3 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.279 -0.888 . . . . 0.0 110.017 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.19 155.06 58.72 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.661 1.348 . . . . 0.0 110.547 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -59.35 139.0 57.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.382 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.417 ' HG3' ' OE1' ' A' ' 13' ' ' GLU . 14.1 mm-40 -123.28 81.8 52.38 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 0.0 109.952 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.3 -79.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.934 1.492 . . . . 0.0 110.819 -179.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 29' ' ' VAL . 98.5 mtt180 -139.56 149.2 43.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 110.56 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.483 ' O ' ' O ' ' A' ' 28' ' ' ARG . 20.3 t 46.19 101.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 110.697 179.535 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.18 -178.09 48.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.63 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -82.92 -105.0 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -1.165 . . . . 0.0 110.332 -179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.5 mt -108.74 142.88 38.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 110.128 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.628 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 76.1 mtm180 -123.11 65.12 0.98 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 110.353 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 10.6 p30 -131.63 15.75 4.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 110.265 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.563 ' O ' ' CD2' ' A' ' 35' ' ' PHE . 68.1 t80 -95.29 7.39 46.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 0.0 110.405 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.878 ' HB3' ' HA ' ' A' ' 78' ' ' GLU . . . -66.02 137.73 95.98 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.156 -0.965 . . . . 0.0 110.223 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.523 ' HG3' ' HB2' ' A' ' 19' ' ' LYS . 3.0 Cg_exo -62.64 -148.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.805 1.424 . . . . 0.0 110.509 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.708 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -120.95 162.51 34.74 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.866 . . . . 0.0 110.132 179.869 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 38' ' ' ILE . 2.9 Cg_endo -61.63 166.85 10.95 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.917 1.483 . . . . 0.0 110.479 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.38 8.52 43.61 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -123.49 76.04 54.11 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.279 -1.13 . . . . 0.0 110.115 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.47 141.81 96.4 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 124.001 1.527 . . . . 0.0 110.689 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 43' ' ' VAL . 15.5 m -121.21 58.23 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.378 -0.826 . . . . 0.0 110.186 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.449 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 4.5 t -139.92 64.99 29.44 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 110.327 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 49' ' ' SER . 3.1 Cg_exo -59.86 -123.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.909 1.478 . . . . 0.0 109.982 179.637 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.742 ' O ' HD23 ' A' ' 47' ' ' LEU . 22.2 mm -67.27 -33.73 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.74 -1.225 . . . . 0.0 107.701 178.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.742 HD23 ' O ' ' A' ' 46' ' ' ILE . 67.3 mt -136.1 -89.28 0.3 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.268 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 80.8 m -127.44 139.41 52.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.056 -1.028 . . . . 0.0 109.017 178.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.588 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 6.0 t -62.63 -73.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.053 -1.029 . . . . 0.0 111.099 -179.056 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.698 ' OD1' HD13 ' A' ' 21' ' ' LEU . 28.3 m-20 -79.98 113.68 40.16 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 110.837 -179.184 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.8 Cg_endo -64.59 -7.2 13.84 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.793 1.417 . . . . 0.0 110.329 179.521 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.781 ' H ' HD11 ' A' ' 21' ' ' LEU . 15.3 m120 -129.16 32.5 4.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.0 109.864 179.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.741 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -79.86 -176.55 0.74 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 108.956 179.412 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.966 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.7 Cg_exo -59.28 74.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.442 1.233 . . . . 0.0 109.051 179.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.8 tt0 -39.28 -32.33 0.11 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.687 -0.633 . . . . 0.0 110.551 -178.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 54' ' ' PRO . 77.7 tt0 -52.31 -24.95 8.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.905 -1.122 . . . . 0.0 108.604 178.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.966 HD12 ' HG2' ' A' ' 54' ' ' PRO . 91.7 mt -85.28 1.23 49.19 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.437 0.636 . . . . 0.0 109.543 179.151 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.772 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 1.8 tmmt? -40.93 -49.65 7.7 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.459 -0.775 . . . . 0.0 110.493 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.772 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.4 Cg_exo -53.98 -39.77 83.73 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.398 1.21 . . . . 0.0 110.557 179.818 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.06 HD13 HG21 ' A' ' 69' ' ' ILE . 9.6 mt -67.64 -30.65 70.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.927 -1.108 . . . . 0.0 110.029 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.429 ' SG ' ' O ' ' A' ' 47' ' ' LEU . 46.0 t -69.34 -26.18 64.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 110.066 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -96.11 20.38 10.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 108.981 179.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -114.84 142.0 27.69 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.71 -0.619 . . . . 0.0 110.538 -179.11 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_exo -62.93 -26.49 74.3 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.789 1.415 . . . . 0.0 109.425 178.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -86.06 -5.08 59.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.397 -0.815 . . . . 0.0 110.538 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.889 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -45.26 -37.97 5.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.027 -1.046 . . . . 0.0 110.101 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 94.0 mt-30 -59.55 -41.05 89.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 110.25 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.33 -39.31 28.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.109 -0.994 . . . . 0.0 110.096 179.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.06 HG21 HD13 ' A' ' 60' ' ' LEU . 84.8 mt -63.29 -47.89 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.135 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.814 ' C ' HD13 ' A' ' 70' ' ' LEU . 1.4 tm? -53.05 -53.37 51.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 110.211 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.764 ' N ' HD13 ' A' ' 70' ' ' LEU . 73.7 mt-30 -48.33 -55.23 11.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.11 -0.994 . . . . 0.0 110.396 179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -50.17 -52.16 37.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.363 -0.835 . . . . 0.0 110.188 -179.75 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 69' ' ' ILE . 56.5 mt -53.13 -49.2 67.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.26 -0.9 . . . . 0.0 110.094 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.753 ' OE2' HD11 ' A' ' 70' ' ' LEU . 74.4 mt-10 -54.8 -43.38 72.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 110.727 -179.776 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.463 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 84.8 tt0 -62.9 -55.63 24.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.033 -1.042 . . . . 0.0 110.904 -179.308 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.1 mt -62.12 -38.11 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 109.958 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.442 ' C ' ' HB3' ' A' ' 36' ' ' ALA . . . -60.11 -32.35 70.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.448 -0.783 . . . . 0.0 109.8 179.596 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.878 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 84.3 tt0 -62.08 -37.06 83.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.354 -0.841 . . . . 0.0 110.556 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 80' ' ' PRO . 3.0 m-20 -165.15 151.44 8.97 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.016 . . . . 0.0 110.706 -179.796 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.595 ' HB3' ' CG ' ' A' ' 84' ' ' GLU . 2.9 Cg_endo -62.38 74.95 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 O-C-N 123.968 1.509 . . . . 0.0 110.719 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 80' ' ' PRO . . . -61.28 -134.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 179.269 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.932 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 59.4 p -75.39 -20.88 58.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.997 -1.296 . . . . 0.0 109.281 179.24 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.613 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 9.9 t -60.29 -46.23 90.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.533 -0.729 . . . . 0.0 109.404 179.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.595 ' CG ' ' HB3' ' A' ' 80' ' ' PRO . 49.8 tp10 -58.57 -30.23 67.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.271 -0.893 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.756 HG13 ' HB2' ' A' ' 87' ' ' ALA . 7.4 pt -103.2 12.85 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.96 -1.087 . . . . 0.0 110.39 -179.491 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 4.4 t 60.52 14.24 4.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 110.281 179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.932 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -64.47 -21.64 66.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 110.083 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.466 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 1.7 m-85 -131.59 166.51 21.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.58 2.99 3.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.303 -0.873 . . . . 0.0 110.368 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -65.9 -38.56 89.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -0.936 . . . . 0.0 110.409 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.613 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -108.56 115.15 29.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 110.715 -179.568 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' A' ' 4' ' ' GLN . 41.4 p -100.27 176.9 5.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 110.254 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.7 12.03 78.47 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.297 -1.119 . . . . 0.0 110.257 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.956 HG21 ' HA ' ' A' ' 84' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.205 0.526 . . . . 0.0 110.142 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 63.0 m -130.55 149.4 52.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.0 110.655 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.852 ' HB ' HD21 ' A' ' 12' ' ' LEU . 0.5 OUTLIER -92.35 119.92 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.623 -0.673 . . . . 0.0 109.64 179.569 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 51.5 tt0 -111.74 121.31 44.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 110.824 -179.286 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 1.009 ' OD2' HD21 ' A' ' 73' ' ' LEU . 83.0 m-20 -97.31 9.14 43.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 109.818 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.449 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . -179.55 -138.13 3.2 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -82.4 4.5 23.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.167 -1.196 . . . . 0.0 110.185 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.627 ' HB2' ' CZ ' ' A' ' 10' ' ' PHE . 78.3 m-85 -121.89 132.63 54.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.304 -0.873 . . . . 0.0 110.389 -179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.483 ' HB3' HG21 ' A' ' 92' ' ' THR . 26.8 p -80.73 127.63 32.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 0.0 110.034 179.818 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.677 ' HB3' HD11 ' A' ' 57' ' ' LEU . 20.2 m-30 -114.6 126.7 55.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.87 . . . . 0.0 110.445 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.8 m -71.55 166.78 21.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 0.0 110.167 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.852 HD21 ' HB ' ' A' ' 3' ' ' VAL . 51.5 mt -96.91 -8.81 29.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.558 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.544 ' HG2' ' CD ' ' A' ' 33' ' ' ARG . 95.3 mt-10 -63.8 -68.07 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.065 -1.022 . . . . 0.0 110.394 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 4.1 m -45.2 -50.69 11.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.271 -0.893 . . . . 0.0 111.191 -179.438 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.591 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 25.1 m -57.58 -48.43 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.944 -1.098 . . . . 0.0 110.269 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' N ' HG23 ' A' ' 15' ' ' VAL . 28.8 ttpp -50.5 -51.25 49.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.865 -1.147 . . . . 0.0 108.643 179.165 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.631 ' O ' ' C ' ' A' ' 18' ' ' LEU . 63.6 mttp -67.97 -57.36 6.31 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.066 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.631 ' C ' ' O ' ' A' ' 17' ' ' LYS . 0.4 OUTLIER 1.66 -71.54 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 120.832 0.349 . . . . 0.0 111.373 179.32 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.614 ' N ' ' O ' ' A' ' 17' ' ' LYS . 86.0 tttt -49.47 -59.28 3.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.916 -1.115 . . . . 0.0 109.248 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 17' ' ' LYS . 24.7 t70 -109.11 97.24 6.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.426 -0.796 . . . . 0.0 109.461 178.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.008 HD21 ' HB2' ' A' ' 52' ' ' ASN . 31.6 tp -95.31 138.6 32.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.893 -179.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -111.89 -170.39 1.64 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.424 -0.797 . . . . 0.0 109.745 179.511 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.559 ' CG ' ' HG3' ' A' ' 27' ' ' PRO . 15.4 pt-20 -45.68 158.9 0.32 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 109.54 179.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 3.3 Cg_exo -59.71 161.32 18.38 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.789 1.415 . . . . 0.0 110.537 -179.696 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' PRO . 39.2 tt0 64.07 84.75 0.14 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 -179.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' CG ' ' HE2' ' A' ' 17' ' ' LYS . 14.1 mp0 -36.38 96.9 0.12 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.347 -0.846 . . . . 0.0 110.425 -179.867 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.559 ' HG3' ' CG ' ' A' ' 23' ' ' GLU . 2.9 Cg_endo -65.3 -26.05 56.56 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.92 1.484 . . . . 0.0 110.721 -179.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -76.9 145.45 38.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.207 -0.933 . . . . 0.0 110.349 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.5 p -137.35 138.07 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.258 -0.902 . . . . 0.0 110.196 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.97 -172.15 43.63 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HB3' HD12 ' A' ' 32' ' ' LEU . 95.6 mttt -116.19 158.31 23.49 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -1.156 . . . . 0.0 110.295 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.73 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.7 mp 54.52 102.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.341 -0.85 . . . . 0.0 110.414 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.544 ' CD ' ' HG2' ' A' ' 13' ' ' GLU . 85.2 mtt-85 -103.2 61.64 0.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.003 179.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 78' ' ' GLU . 88.4 m-20 -89.18 16.15 7.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 0.0 110.31 -179.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -86.8 17.63 3.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.0 110.185 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.506 ' HB3' ' CA ' ' A' ' 78' ' ' GLU . . . -52.28 148.06 12.5 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.274 -0.891 . . . . 0.0 110.216 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 3.0 Cg_exo -61.84 -149.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.863 1.454 . . . . 0.0 110.407 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.515 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 26.9 mm -125.04 142.43 41.2 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.234 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.515 ' HA ' ' OE1' ' A' ' 74' ' ' GLU . 2.9 Cg_endo -62.02 163.63 18.99 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.747 1.393 . . . . 0.0 110.47 -179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.52 3.78 49.92 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.96 83.55 37.66 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.279 -1.13 . . . . 0.0 110.147 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.499 ' HA ' HD22 ' A' ' 70' ' ' LEU . 2.9 Cg_endo -61.6 140.38 86.4 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.9 1.474 . . . . 0.0 110.591 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.716 ' O ' HG13 ' A' ' 43' ' ' VAL . 11.3 p -148.12 64.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.145 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.672 ' O ' HG12 ' A' ' 44' ' ' VAL . 94.5 t -131.65 60.08 49.57 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.293 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 44' ' ' VAL . 2.9 Cg_endo -60.35 168.19 6.78 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.793 1.418 . . . . 0.0 110.36 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 94.0 mt -50.36 -41.09 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 0.0 110.146 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 48' ' ' CYS . 54.5 mt -104.3 26.79 8.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 110.126 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.518 ' O ' ' O ' ' A' ' 47' ' ' LEU . 85.6 m 58.01 143.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.383 -0.823 . . . . 0.0 109.909 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.606 ' CB ' HG22 ' A' ' 43' ' ' VAL . 34.1 t -69.73 -76.2 0.1 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.181 -0.95 . . . . 0.0 110.258 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.803 ' HB3' HD22 ' A' ' 21' ' ' LEU . 5.8 m120 -80.48 115.86 57.92 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.231 -0.918 . . . . 0.0 110.725 -179.837 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 49' ' ' SER . 2.9 Cg_endo -64.63 1.84 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.657 1.346 . . . . 0.0 110.681 179.281 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 1.008 ' HB2' HD21 ' A' ' 21' ' ' LEU . 89.0 m-20 -133.84 31.77 3.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.145 -0.972 . . . . 0.0 110.064 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.871 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 11.0 p90 -76.21 -176.73 0.63 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.85 . . . . 0.0 109.132 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.019 ' HB2' HD13 ' A' ' 57' ' ' LEU . 4.5 Cg_exo -56.4 73.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.382 1.201 . . . . 0.0 110.037 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.61 ' N ' ' O ' ' A' ' 53' ' ' PHE . 85.0 tt0 -42.81 -34.62 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.564 -0.71 . . . . 0.0 110.309 -179.511 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.556 ' C ' HD12 ' A' ' 57' ' ' LEU . 96.0 mt-10 -54.87 -17.43 3.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.991 . . . . 0.0 108.809 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.019 HD13 ' HB2' ' A' ' 54' ' ' PRO . 8.7 mp -97.87 11.63 36.73 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.816 0.817 . . . . 0.0 109.184 179.202 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.74 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.87 -52.08 5.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.778 -0.576 . . . . 0.0 110.758 -179.818 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.74 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.7 Cg_exo -53.08 -42.91 61.31 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.428 1.225 . . . . 0.0 110.25 179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.903 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 11.0 mp -60.78 -35.58 76.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.064 -1.023 . . . . 0.0 109.769 179.447 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 51.8 t -66.73 -28.99 68.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.924 . . . . 0.0 110.16 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -104.4 24.18 12.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 109.191 179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -116.42 140.78 27.0 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.627 -0.671 . . . . 0.0 110.548 -179.232 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.0 Cg_endo -63.91 -30.39 67.5 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.734 1.386 . . . . 0.0 109.698 179.047 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -80.03 -7.49 58.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.418 -0.801 . . . . 0.0 110.61 -179.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.903 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -46.03 -39.65 9.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 110.043 179.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.35 -41.1 92.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 110.342 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -80.17 -37.62 32.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.918 179.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 90.0 mt -66.08 -41.91 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 110.188 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.683 HD11 ' OE2' ' A' ' 74' ' ' GLU . 1.6 tp -56.44 -57.91 10.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -0.971 . . . . 0.0 110.723 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -47.46 -17.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.084 -1.01 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.521 ' HB3' ' O ' ' A' ' 69' ' ' ILE . 27.5 ttm-85 -86.85 -58.1 2.72 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.617 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 1.009 HD21 ' OD2' ' A' ' 5' ' ' ASP . 69.6 mt -51.36 -50.79 58.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.392 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.683 ' OE2' HD11 ' A' ' 70' ' ' LEU . 88.7 mt-10 -55.41 -54.87 38.38 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.478 -0.764 . . . . 0.0 109.465 179.182 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.503 ' HB2' ' HG3' ' A' ' 39' ' ' PRO . 83.8 tt0 -61.15 -53.95 50.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 110.16 179.602 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.53 ' O ' ' O ' ' A' ' 79' ' ' ASP . 23.3 mm -62.18 -33.83 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.149 -0.969 . . . . 0.0 109.749 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 73' ' ' LEU . . . -59.06 -34.38 71.89 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.407 179.454 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.506 ' CA ' ' HB3' ' A' ' 36' ' ' ALA . 84.8 tt0 -58.7 -39.58 81.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 110.285 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.53 ' O ' ' O ' ' A' ' 76' ' ' ILE . 14.5 p-10 -145.03 153.73 53.74 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.11 -0.993 . . . . 0.0 110.358 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_exo -58.83 -54.27 2.97 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.888 1.468 . . . . 0.0 110.537 179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.98 -139.67 24.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 44.6 p -80.08 -20.76 44.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -1.107 . . . . 0.0 110.164 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.668 ' HA ' ' HB2' ' A' ' 91' ' ' CYS . 5.5 t -55.44 -54.24 46.21 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.179 -0.951 . . . . 0.0 109.956 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.956 ' HA ' HG21 ' A' ' 1' ' ' VAL . 84.5 tt0 -56.08 -30.38 61.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.849 . . . . 0.0 111.04 -179.493 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.78 HG13 ' HB2' ' A' ' 87' ' ' ALA . 9.0 pt -98.8 15.41 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.892 -1.13 . . . . 0.0 110.344 -179.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 8.6 m 50.89 23.51 1.47 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 110.376 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.983 ' HB3' ' HB ' ' A' ' 82' ' ' THR . . . -71.62 -11.23 60.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.151 -0.968 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 87' ' ' ALA . 34.1 m-85 -150.56 171.56 16.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.214 -0.929 . . . . 0.0 110.126 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.82 1.96 18.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.184 -0.948 . . . . 0.0 110.202 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.1 -11.61 41.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.22 -0.925 . . . . 0.0 110.359 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.945 ' SG ' HG22 ' A' ' 1' ' ' VAL . 0.7 OUTLIER -108.41 -172.53 2.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.97 . . . . 0.0 110.382 -179.878 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.507 ' HB ' ' HB ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -150.55 -15.81 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.273 -0.892 . . . . 0.0 110.997 -179.903 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -67.1 -23.33 72.96 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.488 1.463 0 O-C-N 121.159 -1.201 . . . . 0.0 110.35 -179.9 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.528 HG13 ' SG ' ' A' ' 91' ' ' CYS . 33.8 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.29 0.567 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.474 HG21 ' HB3' ' A' ' 9' ' ' SER . 61.2 m -119.39 149.43 41.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.238 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.782 HG21 HG21 ' A' ' 76' ' ' ILE . 1.2 t -83.69 113.16 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.877 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.609 ' HB3' HG21 ' A' ' 92' ' ' THR . 64.3 tt0 -110.54 119.19 38.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.418 -0.801 . . . . 0.0 110.694 -179.456 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -101.28 7.06 43.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 109.713 179.401 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.476 ' O ' ' NE2' ' A' ' 4' ' ' GLN . . . -169.67 -143.1 3.77 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -81.02 4.93 18.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.309 -1.112 . . . . 0.0 110.424 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.566 ' O ' ' HG3' ' A' ' 4' ' ' GLN . 66.3 m-85 -125.63 136.86 53.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.311 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.474 ' HB3' HG21 ' A' ' 2' ' ' THR . 67.2 m -79.65 131.15 35.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.93 . . . . 0.0 110.037 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.905 ' HB3' HD21 ' A' ' 57' ' ' LEU . 18.4 m-85 -113.44 121.92 45.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 110.618 -179.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.519 ' C ' HD22 ' A' ' 12' ' ' LEU . 60.1 p -75.35 171.29 14.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.241 -0.912 . . . . 0.0 109.871 179.645 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.833 ' N ' HD22 ' A' ' 12' ' ' LEU . 2.7 mm? -103.2 -12.07 17.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 0.0 110.772 -179.6 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.549 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 90.8 mt-10 -63.25 -74.1 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.092 -1.005 . . . . 0.0 110.535 -179.855 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.502 ' HB2' ' HB3' ' A' ' 54' ' ' PRO . 6.3 m -40.6 -44.37 2.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.294 -0.879 . . . . 0.0 110.478 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.705 ' HA ' ' HB2' ' A' ' 18' ' ' LEU . 29.1 t -62.22 -46.51 96.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.158 -0.964 . . . . 0.0 109.457 179.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.549 ' CE ' ' HB2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -54.93 -50.28 69.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.021 -1.049 . . . . 0.0 108.551 178.479 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt -80.36 6.6 11.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.511 -0.743 . . . . 0.0 109.657 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.774 ' O ' HD22 ' A' ' 47' ' ' LEU . 44.3 tp -63.74 -23.36 67.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.38 -0.825 . . . . 0.0 110.426 179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.545 ' HE3' ' CD1' ' A' ' 38' ' ' ILE . 28.0 tttm -67.52 -32.59 73.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.024 -1.048 . . . . 0.0 110.303 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -116.96 122.5 44.43 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.141 -0.975 . . . . 0.0 110.174 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.84 HD11 ' HB2' ' A' ' 52' ' ' ASN . 8.9 tp -85.32 168.05 15.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 110.4 -179.861 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 78.5 mt-30 59.82 54.7 4.22 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.3 -0.875 . . . . 0.0 110.225 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.8 mm-40 -137.09 162.9 52.97 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.357 -0.84 . . . . 0.0 109.885 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.492 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 3.1 Cg_exo -60.01 125.49 17.77 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.897 1.472 . . . . 0.0 110.466 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -58.18 -38.01 75.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.92 . . . . 0.0 110.099 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -143.11 78.27 15.28 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.465 -0.772 . . . . 0.0 109.965 179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 24' ' ' PRO . 3.0 Cg_exo -62.51 143.47 93.08 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.985 1.518 . . . . 0.0 110.676 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 29' ' ' VAL . 79.2 mtm180 -52.5 147.19 8.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.21 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 30' ' ' GLY . 0.9 OUTLIER 55.68 167.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.322 -0.861 . . . . 0.0 109.981 -179.9 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 29' ' ' VAL . . . 86.33 14.27 66.59 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HA ' ' CZ ' ' A' ' 33' ' ' ARG . 51.5 mttt -51.5 -28.44 13.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -1.14 . . . . 0.0 110.22 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.49 ' O ' ' C ' ' A' ' 33' ' ' ARG . 59.3 mt -55.98 -41.05 74.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 110.26 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.549 ' HD2' ' HG2' ' A' ' 13' ' ' GLU . 67.4 mtt85 38.08 73.14 0.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.424 -0.798 . . . . 0.0 109.958 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 78' ' ' GLU . 14.7 p30 -123.13 44.41 2.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.17 -0.956 . . . . 0.0 110.747 -179.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.549 ' HB2' ' CE ' ' A' ' 16' ' ' LYS . 92.7 m-85 -107.95 120.01 41.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.11 -0.994 . . . . 0.0 109.903 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.402 ' O ' HG13 ' A' ' 38' ' ' ILE . . . -73.65 116.73 54.6 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.917 . . . . 0.0 110.544 -179.45 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.806 ' O ' HD12 ' A' ' 38' ' ' ILE . 2.9 Cg_endo -64.01 -5.73 9.84 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.802 1.422 . . . . 0.0 110.502 179.538 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 37' ' ' PRO . 1.1 mp 71.95 78.0 0.21 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 0.0 110.203 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.765 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . 3.0 Cg_endo -61.94 156.96 46.07 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.015 1.534 . . . . 0.0 110.592 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.06 42.51 0.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.551 ' CG ' HG23 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -122.95 169.72 9.43 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.322 -1.105 . . . . 0.0 110.32 -179.913 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.538 ' C ' HG12 ' A' ' 43' ' ' VAL . 2.9 Cg_endo -62.26 155.28 57.75 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 124.022 1.538 . . . . 0.0 111.178 -179.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.734 ' C ' HG23 ' A' ' 44' ' ' VAL . 7.1 p 33.73 83.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.598 -0.689 . . . . 0.0 111.047 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.814 ' HB ' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER 45.27 -161.4 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.8 -1.187 . . . . 0.0 108.47 179.421 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.971 ' HG3' HD23 ' A' ' 70' ' ' LEU . 3.7 Cg_exo -57.05 138.02 84.46 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 122.512 0.743 . . . . 0.0 110.446 -179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.677 HG13 HD12 ' A' ' 47' ' ' LEU . 2.3 pt -40.38 -39.18 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.459 -0.776 . . . . 0.0 111.197 -179.26 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.774 HD22 ' O ' ' A' ' 18' ' ' LEU . 6.5 mp -97.13 14.85 24.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 110.612 -179.332 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.57 ' HB2' ' CD ' ' A' ' 45' ' ' PRO . 35.3 t -70.84 -55.62 8.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.127 -0.983 . . . . 0.0 109.181 179.289 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.3 p -61.03 -25.96 67.28 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.277 -0.889 . . . . 0.0 108.744 178.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.84 ' ND2' HD22 ' A' ' 21' ' ' LEU . 1.2 m-20 -50.32 130.79 25.05 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.572 -0.705 . . . . 0.0 110.143 179.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 50' ' ' ASN . 2.8 Cg_endo -66.45 1.55 2.5 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.795 1.419 . . . . 0.0 111.106 179.816 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.84 ' HB2' HD11 ' A' ' 21' ' ' LEU . 10.8 m120 -113.39 7.12 17.51 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.067 -1.021 . . . . 0.0 110.842 -179.633 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.755 ' HB2' ' HD2' ' A' ' 54' ' ' PRO . 0.8 OUTLIER -80.1 -177.13 0.84 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.073 -1.017 . . . . 0.0 109.493 179.449 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.853 ' HG2' HD12 ' A' ' 57' ' ' LEU . 3.6 Cg_exo -61.0 73.34 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.7 1.368 . . . . 0.0 109.038 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.583 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 84.3 tt0 -38.87 -28.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.761 -0.587 . . . . 0.0 110.19 -178.523 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.488 ' O ' ' CE1' ' A' ' 10' ' ' PHE . 50.1 mt-10 -55.11 -22.81 17.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.093 -1.004 . . . . 0.0 109.107 178.797 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.905 HD21 ' HB3' ' A' ' 10' ' ' PHE . 31.6 mt -92.38 11.59 25.54 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.455 -0.778 . . . . 0.0 109.742 179.35 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.737 ' N ' ' HD2' ' A' ' 59' ' ' PRO . 0.0 OUTLIER -39.85 -51.39 5.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.43 -0.794 . . . . 0.0 110.677 179.967 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.737 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 3.5 Cg_exo -55.33 -44.73 46.04 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.531 1.279 . . . . 0.0 110.511 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.024 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 10.9 mp -57.88 -41.44 82.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.933 -1.104 . . . . 0.0 110.212 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.6 m -66.65 -25.96 66.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.919 -1.113 . . . . 0.0 110.063 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -97.95 1.06 47.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.892 . . . . 0.0 110.427 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.586 ' OE2' HD12 ' A' ' 69' ' ' ILE . 5.6 pt-20 -108.08 139.9 21.14 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.107 -0.995 . . . . 0.0 110.081 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 63' ' ' GLU . 3.1 Cg_exo -61.89 -21.73 72.87 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.805 1.424 . . . . 0.0 110.988 -179.562 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.484 ' HB2' ' OE2' ' A' ' 63' ' ' GLU . 75.9 m-20 -79.44 -11.31 59.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.073 -1.017 . . . . 0.0 110.579 -179.138 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.024 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -48.6 -32.02 7.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.043 -1.036 . . . . 0.0 109.86 179.69 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.79 -38.13 86.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.418 -0.801 . . . . 0.0 109.739 179.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.3 -41.89 24.05 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.271 -0.893 . . . . 0.0 109.398 179.101 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.619 HG21 ' CD2' ' A' ' 60' ' ' LEU . 65.1 mt -67.33 -49.15 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.372 -0.83 . . . . 0.0 109.67 179.534 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.999 HD13 ' N ' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -41.8 -67.08 0.28 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.781 . . . . 0.0 110.005 179.898 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.999 ' N ' HD13 ' A' ' 70' ' ' LEU . 90.8 mt-30 -44.99 -51.96 9.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.094 -1.004 . . . . 0.0 110.268 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -63.47 -50.71 68.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.452 -0.78 . . . . 0.0 110.153 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.532 HD21 HD13 ' A' ' 57' ' ' LEU . 13.5 tp -46.19 -60.13 2.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.708 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.824 ' OE2' HD21 ' A' ' 70' ' ' LEU . 54.7 mt-10 -50.72 -49.4 57.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.977 179.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.82 -54.83 24.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.925 . . . . 0.0 110.246 -179.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.782 HG21 HG21 ' A' ' 3' ' ' VAL . 25.2 mm -57.42 -39.24 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 0.0 109.545 179.759 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 74' ' ' GLU . . . -55.82 -34.36 65.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.469 -0.769 . . . . 0.0 109.529 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 84.5 tt0 -62.49 -42.98 99.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.51 -0.744 . . . . 0.0 110.017 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.42 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 14.9 p-10 -151.97 158.56 33.82 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.975 -1.078 . . . . 0.0 110.311 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.602 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 3.0 Cg_endo -59.83 -54.24 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.017 1.535 . . . . 0.0 110.407 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.09 -140.23 29.54 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 43.5 p -82.17 -20.43 37.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -1.102 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.593 ' O ' ' CB ' ' A' ' 91' ' ' CYS . 21.8 t -57.99 -46.13 85.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 0.0 109.787 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 80' ' ' PRO . 80.4 tt0 -62.24 -29.28 70.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.17 -0.956 . . . . 0.0 111.34 -179.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.638 HG13 ' HB2' ' A' ' 87' ' ' ALA . 3.9 pt -97.38 6.38 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.893 -1.129 . . . . 0.0 110.398 -179.496 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER 67.32 6.2 4.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 0.0 110.601 179.615 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB2' HG13 ' A' ' 85' ' ' ILE . . . -66.15 -17.86 64.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 109.93 179.732 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.513 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.3 OUTLIER -128.06 157.63 40.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.393 -0.817 . . . . 0.0 110.186 -179.889 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.49 -0.59 10.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.089 179.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 3' ' ' VAL . . . -62.72 -32.9 74.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.385 -0.822 . . . . 0.0 110.557 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.593 ' CB ' ' O ' ' A' ' 83' ' ' CYS . 0.8 OUTLIER -108.42 111.9 24.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 110.796 -179.504 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.609 HG21 ' HB3' ' A' ' 4' ' ' GLN . 21.0 p -101.85 174.53 5.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.898 . . . . 0.0 110.395 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.3 -14.74 64.58 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.423 -1.046 . . . . 0.0 110.227 -179.983 . . . . . . . . 1 1 . 1 stop_ save_